Case ID;Condition;Age;Sex;Clinical Note;Treatment
brain_glioma_0001;Brain Glioma;74;F;Patient is experiencing memory lapses and speech difficulties for the last few weeks. The symptoms are described as intense in nature.;surgery
brain_glioma_0002;Brain Glioma;66;F;Patient is experiencing visual disturbances and confusion over the past 2 months. The symptoms are described as moderate in nature.;chemotherapy
brain_glioma_0003;Brain Glioma;62;F;Patient is experiencing memory lapses and dizziness for more than 6 months. The symptoms are described as intense in nature.;surgery
brain_glioma_0004;Brain Glioma;24;M;Patient is experiencing memory lapses and persistent headaches for more than 6 months. The symptoms are described as high-grade in nature.;surgery
brain_glioma_0005;Brain Glioma;69;M;Patient is experiencing dizziness and frequent seizures over the past 2 months. The symptoms are described as high-grade in nature.;surgery
brain_glioma_0006;Brain Glioma;37;M;Patient is experiencing frequent seizures and speech difficulties for more than 6 months. The symptoms are described as debilitating in nature.;radiation therapy
brain_glioma_0007;Brain Glioma;65;M;Patient is experiencing confusion and persistent headaches for more than 6 months. The symptoms are described as high-grade in nature.;surgery
brain_glioma_0008;Brain Glioma;41;M;Patient is experiencing persistent headaches and frequent seizures for more than 6 months. The symptoms are described as moderate in nature.;chemotherapy
brain_glioma_0009;Brain Glioma;28;F;Patient is experiencing frequent seizures and memory lapses for the last few weeks. The symptoms are described as intense in nature.;radiation therapy
brain_glioma_0010;Brain Glioma;66;M;Patient is experiencing memory lapses and frequent seizures for the last few weeks. The symptoms are described as significant in nature.;radiation therapy
brain_glioma_0011;Brain Glioma;44;F;Patient is experiencing persistent headaches and memory lapses for the last few weeks. The symptoms are described as debilitating in nature.;radiation therapy
brain_glioma_0012;Brain Glioma;49;F;Patient is experiencing memory lapses and speech difficulties over the past 2 months. The symptoms are described as noticeable in nature.;chemotherapy
brain_glioma_0013;Brain Glioma;20;F;Patient is experiencing dizziness and visual disturbances for more than 6 months. The symptoms are described as moderate in nature.;radiation therapy
brain_glioma_0014;Brain Glioma;18;F;Patient is experiencing persistent headaches and memory lapses for more than 6 months. The symptoms are described as severe in nature.;surgery
brain_glioma_0015;Brain Glioma;32;M;Patient is experiencing visual disturbances and persistent headaches for more than 6 months. The symptoms are described as noticeable in nature.;chemotherapy
brain_glioma_0016;Brain Glioma;75;M;Patient is experiencing persistent headaches and confusion over the past 2 months. The symptoms are described as moderate in nature.;surgery
brain_glioma_0017;Brain Glioma;81;F;Patient is experiencing visual disturbances and confusion for the last few weeks. The symptoms are described as intense in nature.;surgery
brain_glioma_0018;Brain Glioma;60;F;Patient is experiencing memory lapses and frequent seizures over the past 2 months. The symptoms are described as severe in nature.;radiation therapy
brain_glioma_0019;Brain Glioma;47;F;Patient is experiencing visual disturbances and frequent seizures for the last few weeks. The symptoms are described as noticeable in nature.;radiation therapy
brain_glioma_0020;Brain Glioma;70;M;Patient is experiencing frequent seizures and persistent headaches for more than 6 months. The symptoms are described as high-grade in nature.;chemotherapy
brain_glioma_0021;Brain Glioma;82;F;Patient is experiencing confusion and frequent seizures for the last few weeks. The symptoms are described as moderate in nature.;radiation therapy
brain_glioma_0022;Brain Glioma;71;F;Patient is experiencing visual disturbances and dizziness for the last few weeks. The symptoms are described as significant in nature.;radiation therapy
brain_glioma_0023;Brain Glioma;77;M;Patient is experiencing visual disturbances and frequent seizures for the last few weeks. The symptoms are described as moderate in nature.;surgery
brain_glioma_0024;Brain Glioma;37;F;Patient is experiencing frequent seizures and persistent headaches for the last few weeks. The symptoms are described as significant in nature.;surgery
brain_glioma_0025;Brain Glioma;19;M;Patient is experiencing speech difficulties and visual disturbances for the last few weeks. The symptoms are described as severe in nature.;surgery
brain_glioma_0026;Brain Glioma;69;F;Patient is experiencing confusion and dizziness for the last few weeks. The symptoms are described as noticeable in nature.;radiation therapy
brain_glioma_0027;Brain Glioma;83;F;Patient is experiencing speech difficulties and frequent seizures for the last few weeks. The symptoms are described as intense in nature.;surgery
brain_glioma_0028;Brain Glioma;41;M;Patient is experiencing speech difficulties and persistent headaches over the past 2 months. The symptoms are described as debilitating in nature.;radiation therapy
brain_glioma_0029;Brain Glioma;54;M;Patient is experiencing visual disturbances and persistent headaches for the last few weeks. The symptoms are described as intense in nature.;chemotherapy
brain_glioma_0030;Brain Glioma;42;F;Patient is experiencing visual disturbances and dizziness for more than 6 months. The symptoms are described as severe in nature.;surgery
brain_glioma_0031;Brain Glioma;63;M;Patient is experiencing speech difficulties and persistent headaches for the last few weeks. The symptoms are described as intense in nature.;chemotherapy
brain_glioma_0032;Brain Glioma;73;M;Patient is experiencing visual disturbances and persistent headaches for the last few weeks. The symptoms are described as significant in nature.;radiation therapy
brain_glioma_0033;Brain Glioma;46;F;Patient is experiencing frequent seizures and persistent headaches over the past 2 months. The symptoms are described as intense in nature.;radiation therapy
brain_glioma_0034;Brain Glioma;24;M;Patient is experiencing persistent headaches and frequent seizures over the past 2 months. The symptoms are described as significant in nature.;radiation therapy
brain_glioma_0035;Brain Glioma;53;M;Patient is experiencing persistent headaches and visual disturbances over the past 2 months. The symptoms are described as significant in nature.;radiation therapy
brain_glioma_0036;Brain Glioma;64;F;Patient is experiencing frequent seizures and memory lapses over the past 2 months. The symptoms are described as moderate in nature.;surgery
brain_glioma_0037;Brain Glioma;50;M;Patient is experiencing dizziness and speech difficulties for more than 6 months. The symptoms are described as moderate in nature.;surgery
brain_glioma_0038;Brain Glioma;43;M;Patient is experiencing memory lapses and frequent seizures for the last few weeks. The symptoms are described as significant in nature.;surgery
brain_glioma_0039;Brain Glioma;26;F;Patient is experiencing visual disturbances and persistent headaches for the last few weeks. The symptoms are described as significant in nature.;radiation therapy
brain_glioma_0040;Brain Glioma;42;M;Patient is experiencing frequent seizures and speech difficulties for the last few weeks. The symptoms are described as severe in nature.;chemotherapy
brain_glioma_0041;Brain Glioma;51;M;Patient is experiencing confusion and persistent headaches for the last few weeks. The symptoms are described as noticeable in nature.;chemotherapy
brain_glioma_0042;Brain Glioma;59;M;Patient is experiencing frequent seizures and dizziness over the past 2 months. The symptoms are described as significant in nature.;radiation therapy
brain_glioma_0043;Brain Glioma;18;M;Patient is experiencing frequent seizures and dizziness for more than 6 months. The symptoms are described as intense in nature.;radiation therapy
brain_glioma_0044;Brain Glioma;51;M;Patient is experiencing memory lapses and confusion over the past 2 months. The symptoms are described as noticeable in nature.;surgery
brain_glioma_0045;Brain Glioma;41;F;Patient is experiencing speech difficulties and visual disturbances over the past 2 months. The symptoms are described as noticeable in nature.;surgery
brain_glioma_0046;Brain Glioma;31;F;Patient is experiencing memory lapses and speech difficulties over the past 2 months. The symptoms are described as debilitating in nature.;surgery
brain_glioma_0047;Brain Glioma;34;M;Patient is experiencing confusion and memory lapses for more than 6 months. The symptoms are described as high-grade in nature.;chemotherapy
brain_glioma_0048;Brain Glioma;40;M;Patient is experiencing dizziness and frequent seizures over the past 2 months. The symptoms are described as severe in nature.;radiation therapy
brain_glioma_0049;Brain Glioma;68;M;Patient is experiencing visual disturbances and memory lapses for the last few weeks. The symptoms are described as intense in nature.;radiation therapy
brain_glioma_0050;Brain Glioma;45;F;Patient is experiencing speech difficulties and dizziness for the last few weeks. The symptoms are described as severe in nature.;surgery
brain_glioma_0051;Brain Glioma;41;F;Patient is experiencing speech difficulties and visual disturbances for the last few weeks. The symptoms are described as significant in nature.;chemotherapy
brain_glioma_0052;Brain Glioma;66;M;Patient is experiencing dizziness and confusion for the last few weeks. The symptoms are described as significant in nature.;surgery
brain_glioma_0053;Brain Glioma;74;M;Patient is experiencing visual disturbances and dizziness over the past 2 months. The symptoms are described as intense in nature.;radiation therapy
brain_glioma_0054;Brain Glioma;84;F;Patient is experiencing memory lapses and dizziness over the past 2 months. The symptoms are described as intense in nature.;surgery
brain_glioma_0055;Brain Glioma;26;F;Patient is experiencing visual disturbances and dizziness for the last few weeks. The symptoms are described as high-grade in nature.;chemotherapy
brain_glioma_0056;Brain Glioma;73;F;Patient is experiencing dizziness and persistent headaches for the last few weeks. The symptoms are described as severe in nature.;chemotherapy
brain_glioma_0057;Brain Glioma;69;F;Patient is experiencing confusion and persistent headaches over the past 2 months. The symptoms are described as significant in nature.;surgery
brain_glioma_0058;Brain Glioma;50;M;Patient is experiencing memory lapses and persistent headaches over the past 2 months. The symptoms are described as high-grade in nature.;surgery
brain_glioma_0059;Brain Glioma;70;F;Patient is experiencing frequent seizures and visual disturbances over the past 2 months. The symptoms are described as debilitating in nature.;radiation therapy
brain_glioma_0060;Brain Glioma;76;M;Patient is experiencing dizziness and confusion for the last few weeks. The symptoms are described as noticeable in nature.;radiation therapy
brain_glioma_0061;Brain Glioma;66;F;Patient is experiencing frequent seizures and memory lapses for the last few weeks. The symptoms are described as severe in nature.;surgery
brain_glioma_0062;Brain Glioma;40;M;Patient is experiencing confusion and memory lapses for the last few weeks. The symptoms are described as debilitating in nature.;surgery
brain_glioma_0063;Brain Glioma;53;M;Patient is experiencing dizziness and confusion for more than 6 months. The symptoms are described as severe in nature.;radiation therapy
brain_glioma_0064;Brain Glioma;56;F;Patient is experiencing frequent seizures and confusion for the last few weeks. The symptoms are described as debilitating in nature.;radiation therapy
brain_glioma_0065;Brain Glioma;36;M;Patient is experiencing speech difficulties and dizziness for more than 6 months. The symptoms are described as intense in nature.;radiation therapy
brain_glioma_0066;Brain Glioma;37;M;Patient is experiencing persistent headaches and visual disturbances for the last few weeks. The symptoms are described as high-grade in nature.;radiation therapy
brain_glioma_0067;Brain Glioma;22;F;Patient is experiencing memory lapses and confusion over the past 2 months. The symptoms are described as debilitating in nature.;surgery
brain_glioma_0068;Brain Glioma;46;F;Patient is experiencing confusion and frequent seizures for the last few weeks. The symptoms are described as noticeable in nature.;radiation therapy
brain_glioma_0069;Brain Glioma;55;M;Patient is experiencing speech difficulties and memory lapses over the past 2 months. The symptoms are described as significant in nature.;radiation therapy
brain_glioma_0070;Brain Glioma;44;M;Patient is experiencing confusion and dizziness for more than 6 months. The symptoms are described as moderate in nature.;surgery
brain_glioma_0071;Brain Glioma;60;M;Patient is experiencing dizziness and visual disturbances over the past 2 months. The symptoms are described as moderate in nature.;surgery
brain_glioma_0072;Brain Glioma;45;M;Patient is experiencing visual disturbances and memory lapses for the last few weeks. The symptoms are described as severe in nature.;surgery
brain_glioma_0073;Brain Glioma;53;F;Patient is experiencing persistent headaches and dizziness for more than 6 months. The symptoms are described as high-grade in nature.;radiation therapy
brain_glioma_0074;Brain Glioma;33;F;Patient is experiencing memory lapses and speech difficulties over the past 2 months. The symptoms are described as noticeable in nature.;surgery
brain_glioma_0075;Brain Glioma;65;F;Patient is experiencing confusion and dizziness over the past 2 months. The symptoms are described as moderate in nature.;radiation therapy
brain_glioma_0076;Brain Glioma;77;M;Patient is experiencing speech difficulties and frequent seizures for more than 6 months. The symptoms are described as intense in nature.;chemotherapy
brain_glioma_0077;Brain Glioma;31;F;Patient is experiencing visual disturbances and confusion over the past 2 months. The symptoms are described as significant in nature.;radiation therapy
brain_glioma_0078;Brain Glioma;18;F;Patient is experiencing speech difficulties and dizziness for the last few weeks. The symptoms are described as debilitating in nature.;chemotherapy
brain_glioma_0079;Brain Glioma;28;M;Patient is experiencing confusion and visual disturbances over the past 2 months. The symptoms are described as debilitating in nature.;surgery
brain_glioma_0080;Brain Glioma;51;M;Patient is experiencing dizziness and confusion over the past 2 months. The symptoms are described as severe in nature.;chemotherapy
brain_glioma_0081;Brain Glioma;22;M;Patient is experiencing memory lapses and dizziness over the past 2 months. The symptoms are described as debilitating in nature.;surgery
brain_glioma_0082;Brain Glioma;71;M;Patient is experiencing persistent headaches and memory lapses over the past 2 months. The symptoms are described as noticeable in nature.;radiation therapy
brain_glioma_0083;Brain Glioma;58;F;Patient is experiencing visual disturbances and dizziness for more than 6 months. The symptoms are described as intense in nature.;surgery
brain_glioma_0084;Brain Glioma;57;M;Patient is experiencing speech difficulties and visual disturbances over the past 2 months. The symptoms are described as severe in nature.;chemotherapy
brain_glioma_0085;Brain Glioma;79;M;Patient is experiencing dizziness and memory lapses over the past 2 months. The symptoms are described as moderate in nature.;chemotherapy
brain_glioma_0086;Brain Glioma;73;F;Patient is experiencing persistent headaches and frequent seizures for more than 6 months. The symptoms are described as moderate in nature.;chemotherapy
brain_glioma_0087;Brain Glioma;20;M;Patient is experiencing speech difficulties and memory lapses over the past 2 months. The symptoms are described as significant in nature.;chemotherapy
brain_glioma_0088;Brain Glioma;26;F;Patient is experiencing visual disturbances and dizziness for more than 6 months. The symptoms are described as debilitating in nature.;radiation therapy
brain_glioma_0089;Brain Glioma;46;F;Patient is experiencing frequent seizures and persistent headaches for the last few weeks. The symptoms are described as moderate in nature.;surgery
brain_glioma_0090;Brain Glioma;66;F;Patient is experiencing dizziness and frequent seizures for more than 6 months. The symptoms are described as debilitating in nature.;surgery
brain_glioma_0091;Brain Glioma;72;F;Patient is experiencing frequent seizures and speech difficulties for the last few weeks. The symptoms are described as noticeable in nature.;surgery
brain_glioma_0092;Brain Glioma;23;F;Patient is experiencing memory lapses and dizziness for more than 6 months. The symptoms are described as intense in nature.;chemotherapy
brain_glioma_0093;Brain Glioma;51;F;Patient is experiencing confusion and persistent headaches for the last few weeks. The symptoms are described as significant in nature.;surgery
brain_glioma_0094;Brain Glioma;83;F;Patient is experiencing frequent seizures and confusion for more than 6 months. The symptoms are described as severe in nature.;surgery
brain_glioma_0095;Brain Glioma;61;F;Patient is experiencing dizziness and speech difficulties for more than 6 months. The symptoms are described as moderate in nature.;surgery
brain_glioma_0096;Brain Glioma;71;M;Patient is experiencing speech difficulties and memory lapses over the past 2 months. The symptoms are described as high-grade in nature.;chemotherapy
brain_glioma_0097;Brain Glioma;22;F;Patient is experiencing frequent seizures and confusion over the past 2 months. The symptoms are described as moderate in nature.;chemotherapy
brain_glioma_0098;Brain Glioma;49;M;Patient is experiencing confusion and visual disturbances over the past 2 months. The symptoms are described as moderate in nature.;radiation therapy
brain_glioma_0099;Brain Glioma;65;F;Patient is experiencing dizziness and frequent seizures for the last few weeks. The symptoms are described as high-grade in nature.;radiation therapy
brain_glioma_0100;Brain Glioma;41;F;Patient is experiencing memory lapses and confusion for more than 6 months. The symptoms are described as noticeable in nature.;radiation therapy
brain_glioma_0101;Brain Glioma;41;F;Patient is experiencing memory lapses and persistent headaches over the past 2 months. The symptoms are described as significant in nature.;chemotherapy
brain_glioma_0102;Brain Glioma;72;F;Patient is experiencing speech difficulties and confusion over the past 2 months. The symptoms are described as high-grade in nature.;radiation therapy
brain_glioma_0103;Brain Glioma;58;F;Patient is experiencing dizziness and persistent headaches for the last few weeks. The symptoms are described as high-grade in nature.;surgery
brain_glioma_0104;Brain Glioma;80;M;Patient is experiencing speech difficulties and persistent headaches over the past 2 months. The symptoms are described as significant in nature.;chemotherapy
brain_glioma_0105;Brain Glioma;56;F;Patient is experiencing memory lapses and confusion for more than 6 months. The symptoms are described as moderate in nature.;chemotherapy
brain_glioma_0106;Brain Glioma;37;M;Patient is experiencing visual disturbances and frequent seizures for the last few weeks. The symptoms are described as high-grade in nature.;surgery
brain_glioma_0107;Brain Glioma;57;M;Patient is experiencing speech difficulties and persistent headaches over the past 2 months. The symptoms are described as noticeable in nature.;chemotherapy
brain_glioma_0108;Brain Glioma;79;F;Patient is experiencing dizziness and visual disturbances for more than 6 months. The symptoms are described as noticeable in nature.;surgery
brain_glioma_0109;Brain Glioma;81;F;Patient is experiencing visual disturbances and persistent headaches for more than 6 months. The symptoms are described as high-grade in nature.;surgery
brain_glioma_0110;Brain Glioma;29;M;Patient is experiencing memory lapses and frequent seizures for the last few weeks. The symptoms are described as moderate in nature.;chemotherapy
brain_glioma_0111;Brain Glioma;76;M;Patient is experiencing memory lapses and frequent seizures for the last few weeks. The symptoms are described as intense in nature.;chemotherapy
brain_glioma_0112;Brain Glioma;80;F;Patient is experiencing memory lapses and dizziness for more than 6 months. The symptoms are described as debilitating in nature.;radiation therapy
brain_glioma_0113;Brain Glioma;72;F;Patient is experiencing speech difficulties and dizziness for the last few weeks. The symptoms are described as moderate in nature.;surgery
brain_glioma_0114;Brain Glioma;45;F;Patient is experiencing dizziness and persistent headaches for more than 6 months. The symptoms are described as debilitating in nature.;radiation therapy
brain_glioma_0115;Brain Glioma;36;M;Patient is experiencing persistent headaches and confusion for more than 6 months. The symptoms are described as intense in nature.;surgery
brain_glioma_0116;Brain Glioma;69;F;Patient is experiencing memory lapses and speech difficulties over the past 2 months. The symptoms are described as noticeable in nature.;chemotherapy
brain_glioma_0117;Brain Glioma;49;M;Patient is experiencing visual disturbances and dizziness over the past 2 months. The symptoms are described as noticeable in nature.;radiation therapy
brain_glioma_0118;Brain Glioma;25;F;Patient is experiencing memory lapses and visual disturbances for more than 6 months. The symptoms are described as intense in nature.;surgery
brain_glioma_0119;Brain Glioma;35;F;Patient is experiencing confusion and frequent seizures over the past 2 months. The symptoms are described as high-grade in nature.;chemotherapy
brain_glioma_0120;Brain Glioma;36;M;Patient is experiencing persistent headaches and dizziness for more than 6 months. The symptoms are described as moderate in nature.;radiation therapy
brain_glioma_0121;Brain Glioma;25;M;Patient is experiencing memory lapses and speech difficulties for the last few weeks. The symptoms are described as moderate in nature.;surgery
brain_glioma_0122;Brain Glioma;57;F;Patient is experiencing speech difficulties and confusion for the last few weeks. The symptoms are described as high-grade in nature.;radiation therapy
brain_glioma_0123;Brain Glioma;31;M;Patient is experiencing memory lapses and persistent headaches for the last few weeks. The symptoms are described as severe in nature.;chemotherapy
brain_glioma_0124;Brain Glioma;38;M;Patient is experiencing dizziness and speech difficulties over the past 2 months. The symptoms are described as noticeable in nature.;radiation therapy
brain_glioma_0125;Brain Glioma;19;M;Patient is experiencing visual disturbances and dizziness over the past 2 months. The symptoms are described as debilitating in nature.;surgery
brain_glioma_0126;Brain Glioma;55;M;Patient is experiencing persistent headaches and frequent seizures for more than 6 months. The symptoms are described as intense in nature.;radiation therapy
brain_glioma_0127;Brain Glioma;44;F;Patient is experiencing confusion and speech difficulties for the last few weeks. The symptoms are described as noticeable in nature.;radiation therapy
brain_glioma_0128;Brain Glioma;40;F;Patient is experiencing confusion and speech difficulties over the past 2 months. The symptoms are described as intense in nature.;surgery
brain_glioma_0129;Brain Glioma;56;F;Patient is experiencing dizziness and visual disturbances over the past 2 months. The symptoms are described as high-grade in nature.;chemotherapy
brain_glioma_0130;Brain Glioma;72;F;Patient is experiencing confusion and frequent seizures for more than 6 months. The symptoms are described as intense in nature.;radiation therapy
brain_glioma_0131;Brain Glioma;73;M;Patient is experiencing speech difficulties and persistent headaches for more than 6 months. The symptoms are described as significant in nature.;surgery
brain_glioma_0132;Brain Glioma;79;F;Patient is experiencing visual disturbances and speech difficulties over the past 2 months. The symptoms are described as significant in nature.;chemotherapy
brain_glioma_0133;Brain Glioma;32;F;Patient is experiencing speech difficulties and confusion for the last few weeks. The symptoms are described as severe in nature.;chemotherapy
brain_glioma_0134;Brain Glioma;61;M;Patient is experiencing persistent headaches and dizziness for the last few weeks. The symptoms are described as high-grade in nature.;chemotherapy
brain_glioma_0135;Brain Glioma;19;F;Patient is experiencing memory lapses and confusion for the last few weeks. The symptoms are described as noticeable in nature.;surgery
brain_glioma_0136;Brain Glioma;28;F;Patient is experiencing memory lapses and dizziness for the last few weeks. The symptoms are described as intense in nature.;surgery
brain_glioma_0137;Brain Glioma;33;F;Patient is experiencing dizziness and speech difficulties over the past 2 months. The symptoms are described as severe in nature.;radiation therapy
brain_glioma_0138;Brain Glioma;33;F;Patient is experiencing frequent seizures and memory lapses over the past 2 months. The symptoms are described as moderate in nature.;radiation therapy
brain_glioma_0139;Brain Glioma;27;F;Patient is experiencing dizziness and confusion for more than 6 months. The symptoms are described as significant in nature.;surgery
brain_glioma_0140;Brain Glioma;67;F;Patient is experiencing frequent seizures and dizziness over the past 2 months. The symptoms are described as noticeable in nature.;chemotherapy
brain_glioma_0141;Brain Glioma;21;M;Patient is experiencing speech difficulties and confusion for the last few weeks. The symptoms are described as noticeable in nature.;radiation therapy
brain_glioma_0142;Brain Glioma;44;M;Patient is experiencing frequent seizures and visual disturbances for the last few weeks. The symptoms are described as severe in nature.;radiation therapy
brain_glioma_0143;Brain Glioma;45;M;Patient is experiencing speech difficulties and memory lapses for more than 6 months. The symptoms are described as high-grade in nature.;radiation therapy
brain_glioma_0144;Brain Glioma;62;M;Patient is experiencing confusion and speech difficulties for the last few weeks. The symptoms are described as significant in nature.;radiation therapy
brain_glioma_0145;Brain Glioma;61;F;Patient is experiencing memory lapses and confusion over the past 2 months. The symptoms are described as significant in nature.;chemotherapy
brain_glioma_0146;Brain Glioma;31;M;Patient is experiencing dizziness and confusion for the last few weeks. The symptoms are described as noticeable in nature.;chemotherapy
brain_glioma_0147;Brain Glioma;78;F;Patient is experiencing dizziness and speech difficulties for more than 6 months. The symptoms are described as moderate in nature.;chemotherapy
brain_glioma_0148;Brain Glioma;31;F;Patient is experiencing memory lapses and confusion for the last few weeks. The symptoms are described as noticeable in nature.;surgery
brain_glioma_0149;Brain Glioma;44;F;Patient is experiencing frequent seizures and visual disturbances for the last few weeks. The symptoms are described as high-grade in nature.;radiation therapy
brain_glioma_0150;Brain Glioma;63;F;Patient is experiencing frequent seizures and confusion for the last few weeks. The symptoms are described as significant in nature.;surgery
brain_glioma_0151;Brain Glioma;76;F;Patient is experiencing dizziness and confusion over the past 2 months. The symptoms are described as moderate in nature.;surgery
brain_glioma_0152;Brain Glioma;65;F;Patient is experiencing persistent headaches and memory lapses over the past 2 months. The symptoms are described as severe in nature.;surgery
brain_glioma_0153;Brain Glioma;81;M;Patient is experiencing persistent headaches and dizziness for the last few weeks. The symptoms are described as moderate in nature.;surgery
brain_glioma_0154;Brain Glioma;53;F;Patient is experiencing persistent headaches and visual disturbances over the past 2 months. The symptoms are described as intense in nature.;surgery
brain_glioma_0155;Brain Glioma;20;F;Patient is experiencing persistent headaches and confusion for more than 6 months. The symptoms are described as severe in nature.;surgery
brain_glioma_0156;Brain Glioma;65;M;Patient is experiencing visual disturbances and persistent headaches for more than 6 months. The symptoms are described as high-grade in nature.;surgery
brain_glioma_0157;Brain Glioma;37;M;Patient is experiencing speech difficulties and frequent seizures for the last few weeks. The symptoms are described as moderate in nature.;surgery
brain_glioma_0158;Brain Glioma;78;F;Patient is experiencing speech difficulties and visual disturbances for the last few weeks. The symptoms are described as debilitating in nature.;surgery
brain_glioma_0159;Brain Glioma;55;F;Patient is experiencing confusion and persistent headaches over the past 2 months. The symptoms are described as intense in nature.;chemotherapy
brain_glioma_0160;Brain Glioma;73;M;Patient is experiencing visual disturbances and confusion for the last few weeks. The symptoms are described as significant in nature.;chemotherapy
brain_glioma_0161;Brain Glioma;80;F;Patient is experiencing memory lapses and visual disturbances for more than 6 months. The symptoms are described as high-grade in nature.;chemotherapy
brain_glioma_0162;Brain Glioma;50;M;Patient is experiencing speech difficulties and persistent headaches for the last few weeks. The symptoms are described as significant in nature.;chemotherapy
brain_glioma_0163;Brain Glioma;60;M;Patient is experiencing memory lapses and dizziness over the past 2 months. The symptoms are described as significant in nature.;radiation therapy
brain_glioma_0164;Brain Glioma;41;F;Patient is experiencing memory lapses and visual disturbances over the past 2 months. The symptoms are described as intense in nature.;chemotherapy
brain_glioma_0165;Brain Glioma;52;M;Patient is experiencing visual disturbances and speech difficulties for more than 6 months. The symptoms are described as severe in nature.;chemotherapy
brain_glioma_0166;Brain Glioma;22;M;Patient is experiencing persistent headaches and visual disturbances for the last few weeks. The symptoms are described as significant in nature.;chemotherapy
brain_glioma_0167;Brain Glioma;45;M;Patient is experiencing speech difficulties and confusion for more than 6 months. The symptoms are described as high-grade in nature.;surgery
brain_glioma_0168;Brain Glioma;76;M;Patient is experiencing memory lapses and dizziness over the past 2 months. The symptoms are described as significant in nature.;chemotherapy
brain_glioma_0169;Brain Glioma;30;F;Patient is experiencing dizziness and persistent headaches for the last few weeks. The symptoms are described as intense in nature.;surgery
brain_glioma_0170;Brain Glioma;63;M;Patient is experiencing visual disturbances and dizziness over the past 2 months. The symptoms are described as severe in nature.;chemotherapy
brain_glioma_0171;Brain Glioma;28;F;Patient is experiencing persistent headaches and memory lapses over the past 2 months. The symptoms are described as significant in nature.;chemotherapy
brain_glioma_0172;Brain Glioma;47;F;Patient is experiencing persistent headaches and confusion over the past 2 months. The symptoms are described as high-grade in nature.;surgery
brain_glioma_0173;Brain Glioma;82;M;Patient is experiencing visual disturbances and confusion for more than 6 months. The symptoms are described as significant in nature.;chemotherapy
brain_glioma_0174;Brain Glioma;54;M;Patient is experiencing confusion and dizziness over the past 2 months. The symptoms are described as moderate in nature.;radiation therapy
brain_glioma_0175;Brain Glioma;33;M;Patient is experiencing frequent seizures and memory lapses for more than 6 months. The symptoms are described as significant in nature.;chemotherapy
brain_glioma_0176;Brain Glioma;45;M;Patient is experiencing confusion and persistent headaches for more than 6 months. The symptoms are described as moderate in nature.;radiation therapy
brain_glioma_0177;Brain Glioma;49;M;Patient is experiencing speech difficulties and confusion over the past 2 months. The symptoms are described as moderate in nature.;chemotherapy
brain_glioma_0178;Brain Glioma;51;F;Patient is experiencing speech difficulties and visual disturbances for more than 6 months. The symptoms are described as high-grade in nature.;surgery
brain_glioma_0179;Brain Glioma;29;F;Patient is experiencing dizziness and visual disturbances for more than 6 months. The symptoms are described as high-grade in nature.;radiation therapy
brain_glioma_0180;Brain Glioma;26;M;Patient is experiencing memory lapses and persistent headaches for more than 6 months. The symptoms are described as moderate in nature.;surgery
brain_glioma_0181;Brain Glioma;62;M;Patient is experiencing persistent headaches and memory lapses over the past 2 months. The symptoms are described as high-grade in nature.;radiation therapy
brain_glioma_0182;Brain Glioma;38;M;Patient is experiencing memory lapses and visual disturbances for more than 6 months. The symptoms are described as high-grade in nature.;radiation therapy
brain_glioma_0183;Brain Glioma;54;F;Patient is experiencing memory lapses and speech difficulties for more than 6 months. The symptoms are described as significant in nature.;surgery
brain_glioma_0184;Brain Glioma;68;M;Patient is experiencing persistent headaches and confusion for more than 6 months. The symptoms are described as debilitating in nature.;radiation therapy
brain_glioma_0185;Brain Glioma;49;M;Patient is experiencing confusion and dizziness for the last few weeks. The symptoms are described as noticeable in nature.;radiation therapy
brain_glioma_0186;Brain Glioma;21;M;Patient is experiencing visual disturbances and speech difficulties over the past 2 months. The symptoms are described as noticeable in nature.;surgery
brain_glioma_0187;Brain Glioma;75;F;Patient is experiencing frequent seizures and confusion over the past 2 months. The symptoms are described as moderate in nature.;radiation therapy
brain_glioma_0188;Brain Glioma;68;F;Patient is experiencing visual disturbances and persistent headaches over the past 2 months. The symptoms are described as intense in nature.;chemotherapy
brain_glioma_0189;Brain Glioma;25;F;Patient is experiencing persistent headaches and confusion for more than 6 months. The symptoms are described as high-grade in nature.;surgery
brain_glioma_0190;Brain Glioma;72;M;Patient is experiencing confusion and dizziness for the last few weeks. The symptoms are described as severe in nature.;chemotherapy
brain_glioma_0191;Brain Glioma;21;F;Patient is experiencing memory lapses and visual disturbances for more than 6 months. The symptoms are described as intense in nature.;chemotherapy
brain_glioma_0192;Brain Glioma;57;M;Patient is experiencing persistent headaches and visual disturbances over the past 2 months. The symptoms are described as intense in nature.;chemotherapy
brain_glioma_0193;Brain Glioma;66;F;Patient is experiencing confusion and visual disturbances for more than 6 months. The symptoms are described as noticeable in nature.;chemotherapy
brain_glioma_0194;Brain Glioma;25;M;Patient is experiencing memory lapses and visual disturbances for more than 6 months. The symptoms are described as moderate in nature.;radiation therapy
brain_glioma_0195;Brain Glioma;25;F;Patient is experiencing memory lapses and speech difficulties for the last few weeks. The symptoms are described as high-grade in nature.;surgery
brain_glioma_0196;Brain Glioma;46;M;Patient is experiencing frequent seizures and visual disturbances for the last few weeks. The symptoms are described as significant in nature.;chemotherapy
brain_glioma_0197;Brain Glioma;64;M;Patient is experiencing memory lapses and persistent headaches for the last few weeks. The symptoms are described as high-grade in nature.;radiation therapy
brain_glioma_0198;Brain Glioma;28;F;Patient is experiencing persistent headaches and dizziness over the past 2 months. The symptoms are described as noticeable in nature.;surgery
brain_glioma_0199;Brain Glioma;31;M;Patient is experiencing speech difficulties and persistent headaches over the past 2 months. The symptoms are described as significant in nature.;surgery
brain_glioma_0200;Brain Glioma;47;M;Patient is experiencing frequent seizures and persistent headaches for more than 6 months. The symptoms are described as high-grade in nature.;chemotherapy
brain_glioma_0201;Brain Glioma;18;F;Patient is experiencing confusion and speech difficulties for the last few weeks. The symptoms are described as significant in nature.;radiation therapy
brain_glioma_0202;Brain Glioma;18;F;Patient is experiencing confusion and memory lapses over the past 2 months. The symptoms are described as noticeable in nature.;surgery
brain_glioma_0203;Brain Glioma;72;F;Patient is experiencing memory lapses and confusion for more than 6 months. The symptoms are described as debilitating in nature.;radiation therapy
brain_glioma_0204;Brain Glioma;84;F;Patient is experiencing frequent seizures and memory lapses over the past 2 months. The symptoms are described as high-grade in nature.;radiation therapy
brain_glioma_0205;Brain Glioma;30;M;Patient is experiencing visual disturbances and speech difficulties for the last few weeks. The symptoms are described as significant in nature.;surgery
brain_glioma_0206;Brain Glioma;83;M;Patient is experiencing dizziness and visual disturbances for more than 6 months. The symptoms are described as debilitating in nature.;radiation therapy
brain_glioma_0207;Brain Glioma;31;F;Patient is experiencing frequent seizures and persistent headaches over the past 2 months. The symptoms are described as debilitating in nature.;radiation therapy
brain_glioma_0208;Brain Glioma;37;F;Patient is experiencing visual disturbances and speech difficulties for the last few weeks. The symptoms are described as significant in nature.;radiation therapy
brain_glioma_0209;Brain Glioma;66;F;Patient is experiencing confusion and visual disturbances for more than 6 months. The symptoms are described as debilitating in nature.;radiation therapy
brain_glioma_0210;Brain Glioma;76;F;Patient is experiencing persistent headaches and confusion over the past 2 months. The symptoms are described as significant in nature.;radiation therapy
brain_glioma_0211;Brain Glioma;42;M;Patient is experiencing dizziness and frequent seizures for more than 6 months. The symptoms are described as significant in nature.;surgery
brain_glioma_0212;Brain Glioma;44;M;Patient is experiencing confusion and frequent seizures over the past 2 months. The symptoms are described as noticeable in nature.;surgery
brain_glioma_0213;Brain Glioma;37;M;Patient is experiencing visual disturbances and confusion over the past 2 months. The symptoms are described as severe in nature.;surgery
brain_glioma_0214;Brain Glioma;42;F;Patient is experiencing speech difficulties and persistent headaches over the past 2 months. The symptoms are described as significant in nature.;radiation therapy
brain_glioma_0215;Brain Glioma;38;F;Patient is experiencing memory lapses and confusion for more than 6 months. The symptoms are described as significant in nature.;chemotherapy
brain_glioma_0216;Brain Glioma;72;M;Patient is experiencing memory lapses and frequent seizures for more than 6 months. The symptoms are described as moderate in nature.;surgery
brain_glioma_0217;Brain Glioma;37;M;Patient is experiencing dizziness and speech difficulties for the last few weeks. The symptoms are described as significant in nature.;chemotherapy
brain_glioma_0218;Brain Glioma;46;F;Patient is experiencing memory lapses and persistent headaches for the last few weeks. The symptoms are described as debilitating in nature.;radiation therapy
brain_glioma_0219;Brain Glioma;23;M;Patient is experiencing dizziness and frequent seizures for the last few weeks. The symptoms are described as moderate in nature.;surgery
brain_glioma_0220;Brain Glioma;18;M;Patient is experiencing persistent headaches and frequent seizures for the last few weeks. The symptoms are described as significant in nature.;surgery
brain_glioma_0221;Brain Glioma;52;M;Patient is experiencing speech difficulties and persistent headaches for more than 6 months. The symptoms are described as noticeable in nature.;chemotherapy
brain_glioma_0222;Brain Glioma;25;F;Patient is experiencing visual disturbances and memory lapses for the last few weeks. The symptoms are described as noticeable in nature.;radiation therapy
brain_glioma_0223;Brain Glioma;68;F;Patient is experiencing visual disturbances and speech difficulties for more than 6 months. The symptoms are described as significant in nature.;radiation therapy
brain_glioma_0224;Brain Glioma;24;F;Patient is experiencing persistent headaches and frequent seizures for the last few weeks. The symptoms are described as intense in nature.;surgery
brain_glioma_0225;Brain Glioma;26;M;Patient is experiencing speech difficulties and persistent headaches over the past 2 months. The symptoms are described as significant in nature.;surgery
brain_glioma_0226;Brain Glioma;77;F;Patient is experiencing memory lapses and persistent headaches over the past 2 months. The symptoms are described as moderate in nature.;radiation therapy
brain_glioma_0227;Brain Glioma;75;F;Patient is experiencing dizziness and memory lapses for the last few weeks. The symptoms are described as significant in nature.;surgery
brain_glioma_0228;Brain Glioma;25;M;Patient is experiencing confusion and visual disturbances over the past 2 months. The symptoms are described as significant in nature.;radiation therapy
brain_glioma_0229;Brain Glioma;37;F;Patient is experiencing memory lapses and persistent headaches for more than 6 months. The symptoms are described as moderate in nature.;surgery
brain_glioma_0230;Brain Glioma;42;M;Patient is experiencing speech difficulties and dizziness for the last few weeks. The symptoms are described as moderate in nature.;radiation therapy
brain_glioma_0231;Brain Glioma;78;M;Patient is experiencing dizziness and confusion for the last few weeks. The symptoms are described as noticeable in nature.;surgery
brain_glioma_0232;Brain Glioma;80;F;Patient is experiencing dizziness and memory lapses for the last few weeks. The symptoms are described as significant in nature.;surgery
brain_glioma_0233;Brain Glioma;23;F;Patient is experiencing speech difficulties and frequent seizures for the last few weeks. The symptoms are described as noticeable in nature.;surgery
brain_glioma_0234;Brain Glioma;23;M;Patient is experiencing dizziness and confusion over the past 2 months. The symptoms are described as intense in nature.;surgery
brain_glioma_0235;Brain Glioma;73;M;Patient is experiencing persistent headaches and frequent seizures for more than 6 months. The symptoms are described as high-grade in nature.;chemotherapy
brain_glioma_0236;Brain Glioma;60;F;Patient is experiencing visual disturbances and frequent seizures over the past 2 months. The symptoms are described as debilitating in nature.;radiation therapy
brain_glioma_0237;Brain Glioma;25;M;Patient is experiencing speech difficulties and dizziness for more than 6 months. The symptoms are described as debilitating in nature.;chemotherapy
brain_glioma_0238;Brain Glioma;72;M;Patient is experiencing persistent headaches and frequent seizures for more than 6 months. The symptoms are described as debilitating in nature.;chemotherapy
brain_glioma_0239;Brain Glioma;52;F;Patient is experiencing persistent headaches and speech difficulties over the past 2 months. The symptoms are described as noticeable in nature.;chemotherapy
brain_glioma_0240;Brain Glioma;71;F;Patient is experiencing dizziness and confusion over the past 2 months. The symptoms are described as intense in nature.;surgery
brain_glioma_0241;Brain Glioma;72;M;Patient is experiencing dizziness and speech difficulties for more than 6 months. The symptoms are described as intense in nature.;radiation therapy
brain_glioma_0242;Brain Glioma;69;F;Patient is experiencing visual disturbances and frequent seizures over the past 2 months. The symptoms are described as high-grade in nature.;surgery
brain_glioma_0243;Brain Glioma;39;M;Patient is experiencing visual disturbances and dizziness for the last few weeks. The symptoms are described as high-grade in nature.;surgery
brain_glioma_0244;Brain Glioma;58;F;Patient is experiencing visual disturbances and dizziness for more than 6 months. The symptoms are described as high-grade in nature.;chemotherapy
brain_glioma_0245;Brain Glioma;24;M;Patient is experiencing frequent seizures and visual disturbances over the past 2 months. The symptoms are described as significant in nature.;chemotherapy
brain_glioma_0246;Brain Glioma;34;F;Patient is experiencing memory lapses and dizziness over the past 2 months. The symptoms are described as moderate in nature.;surgery
brain_glioma_0247;Brain Glioma;62;F;Patient is experiencing confusion and frequent seizures over the past 2 months. The symptoms are described as significant in nature.;chemotherapy
brain_glioma_0248;Brain Glioma;64;F;Patient is experiencing confusion and persistent headaches for more than 6 months. The symptoms are described as noticeable in nature.;chemotherapy
brain_glioma_0249;Brain Glioma;30;M;Patient is experiencing memory lapses and dizziness for more than 6 months. The symptoms are described as noticeable in nature.;radiation therapy
brain_glioma_0250;Brain Glioma;61;M;Patient is experiencing dizziness and frequent seizures over the past 2 months. The symptoms are described as significant in nature.;surgery
brain_glioma_0251;Brain Glioma;22;M;Patient is experiencing persistent headaches and speech difficulties over the past 2 months. The symptoms are described as significant in nature.;chemotherapy
brain_glioma_0252;Brain Glioma;49;M;Patient is experiencing confusion and speech difficulties for the last few weeks. The symptoms are described as significant in nature.;chemotherapy
brain_glioma_0253;Brain Glioma;51;F;Patient is experiencing dizziness and confusion for more than 6 months. The symptoms are described as severe in nature.;chemotherapy
brain_glioma_0254;Brain Glioma;47;M;Patient is experiencing memory lapses and frequent seizures for more than 6 months. The symptoms are described as significant in nature.;surgery
brain_glioma_0255;Brain Glioma;32;F;Patient is experiencing speech difficulties and dizziness for the last few weeks. The symptoms are described as significant in nature.;chemotherapy
brain_glioma_0256;Brain Glioma;55;F;Patient is experiencing visual disturbances and dizziness for more than 6 months. The symptoms are described as intense in nature.;radiation therapy
brain_glioma_0257;Brain Glioma;66;M;Patient is experiencing memory lapses and persistent headaches for the last few weeks. The symptoms are described as moderate in nature.;chemotherapy
brain_glioma_0258;Brain Glioma;67;M;Patient is experiencing memory lapses and confusion for more than 6 months. The symptoms are described as severe in nature.;chemotherapy
brain_glioma_0259;Brain Glioma;24;F;Patient is experiencing persistent headaches and memory lapses over the past 2 months. The symptoms are described as moderate in nature.;chemotherapy
brain_glioma_0260;Brain Glioma;77;F;Patient is experiencing confusion and visual disturbances over the past 2 months. The symptoms are described as high-grade in nature.;radiation therapy
brain_glioma_0261;Brain Glioma;47;M;Patient is experiencing memory lapses and speech difficulties for the last few weeks. The symptoms are described as high-grade in nature.;radiation therapy
brain_glioma_0262;Brain Glioma;60;F;Patient is experiencing persistent headaches and dizziness over the past 2 months. The symptoms are described as noticeable in nature.;surgery
brain_glioma_0263;Brain Glioma;49;M;Patient is experiencing visual disturbances and confusion for more than 6 months. The symptoms are described as significant in nature.;chemotherapy
brain_glioma_0264;Brain Glioma;25;F;Patient is experiencing memory lapses and dizziness for the last few weeks. The symptoms are described as high-grade in nature.;chemotherapy
brain_glioma_0265;Brain Glioma;32;F;Patient is experiencing dizziness and visual disturbances over the past 2 months. The symptoms are described as high-grade in nature.;chemotherapy
brain_glioma_0266;Brain Glioma;52;M;Patient is experiencing visual disturbances and confusion over the past 2 months. The symptoms are described as debilitating in nature.;surgery
brain_glioma_0267;Brain Glioma;85;F;Patient is experiencing confusion and memory lapses for more than 6 months. The symptoms are described as severe in nature.;chemotherapy
brain_glioma_0268;Brain Glioma;62;M;Patient is experiencing persistent headaches and confusion over the past 2 months. The symptoms are described as noticeable in nature.;chemotherapy
brain_glioma_0269;Brain Glioma;30;F;Patient is experiencing dizziness and confusion for the last few weeks. The symptoms are described as debilitating in nature.;chemotherapy
brain_glioma_0270;Brain Glioma;41;M;Patient is experiencing confusion and persistent headaches over the past 2 months. The symptoms are described as significant in nature.;surgery
brain_glioma_0271;Brain Glioma;28;M;Patient is experiencing frequent seizures and confusion over the past 2 months. The symptoms are described as moderate in nature.;radiation therapy
brain_glioma_0272;Brain Glioma;28;F;Patient is experiencing memory lapses and dizziness over the past 2 months. The symptoms are described as high-grade in nature.;radiation therapy
brain_glioma_0273;Brain Glioma;65;F;Patient is experiencing frequent seizures and dizziness for the last few weeks. The symptoms are described as noticeable in nature.;chemotherapy
brain_glioma_0274;Brain Glioma;52;F;Patient is experiencing visual disturbances and confusion over the past 2 months. The symptoms are described as debilitating in nature.;radiation therapy
brain_glioma_0275;Brain Glioma;43;F;Patient is experiencing dizziness and frequent seizures for the last few weeks. The symptoms are described as significant in nature.;chemotherapy
brain_glioma_0276;Brain Glioma;67;M;Patient is experiencing dizziness and frequent seizures for the last few weeks. The symptoms are described as significant in nature.;chemotherapy
brain_glioma_0277;Brain Glioma;46;M;Patient is experiencing visual disturbances and dizziness for more than 6 months. The symptoms are described as noticeable in nature.;surgery
brain_glioma_0278;Brain Glioma;24;F;Patient is experiencing persistent headaches and visual disturbances over the past 2 months. The symptoms are described as debilitating in nature.;surgery
brain_glioma_0279;Brain Glioma;33;M;Patient is experiencing frequent seizures and persistent headaches for more than 6 months. The symptoms are described as high-grade in nature.;radiation therapy
brain_glioma_0280;Brain Glioma;36;M;Patient is experiencing frequent seizures and visual disturbances over the past 2 months. The symptoms are described as debilitating in nature.;surgery
brain_glioma_0281;Brain Glioma;67;F;Patient is experiencing memory lapses and visual disturbances over the past 2 months. The symptoms are described as moderate in nature.;chemotherapy
brain_glioma_0282;Brain Glioma;57;M;Patient is experiencing memory lapses and persistent headaches for more than 6 months. The symptoms are described as severe in nature.;chemotherapy
brain_glioma_0283;Brain Glioma;63;F;Patient is experiencing visual disturbances and speech difficulties for more than 6 months. The symptoms are described as severe in nature.;radiation therapy
brain_glioma_0284;Brain Glioma;56;F;Patient is experiencing frequent seizures and dizziness for more than 6 months. The symptoms are described as significant in nature.;chemotherapy
brain_glioma_0285;Brain Glioma;45;F;Patient is experiencing dizziness and persistent headaches for the last few weeks. The symptoms are described as severe in nature.;surgery
brain_glioma_0286;Brain Glioma;60;F;Patient is experiencing frequent seizures and visual disturbances for more than 6 months. The symptoms are described as high-grade in nature.;surgery
brain_glioma_0287;Brain Glioma;51;F;Patient is experiencing confusion and persistent headaches over the past 2 months. The symptoms are described as debilitating in nature.;radiation therapy
brain_glioma_0288;Brain Glioma;58;F;Patient is experiencing frequent seizures and visual disturbances for the last few weeks. The symptoms are described as significant in nature.;chemotherapy
brain_glioma_0289;Brain Glioma;34;M;Patient is experiencing visual disturbances and speech difficulties over the past 2 months. The symptoms are described as debilitating in nature.;radiation therapy
brain_glioma_0290;Brain Glioma;22;M;Patient is experiencing memory lapses and visual disturbances for more than 6 months. The symptoms are described as noticeable in nature.;surgery
brain_glioma_0291;Brain Glioma;74;F;Patient is experiencing frequent seizures and visual disturbances for more than 6 months. The symptoms are described as noticeable in nature.;surgery
brain_glioma_0292;Brain Glioma;30;F;Patient is experiencing dizziness and frequent seizures over the past 2 months. The symptoms are described as high-grade in nature.;surgery
brain_glioma_0293;Brain Glioma;42;M;Patient is experiencing memory lapses and persistent headaches for the last few weeks. The symptoms are described as significant in nature.;radiation therapy
brain_glioma_0294;Brain Glioma;75;F;Patient is experiencing confusion and visual disturbances for the last few weeks. The symptoms are described as significant in nature.;radiation therapy
brain_glioma_0295;Brain Glioma;39;F;Patient is experiencing confusion and memory lapses for the last few weeks. The symptoms are described as noticeable in nature.;chemotherapy
brain_glioma_0296;Brain Glioma;42;F;Patient is experiencing frequent seizures and dizziness over the past 2 months. The symptoms are described as debilitating in nature.;radiation therapy
brain_glioma_0297;Brain Glioma;71;M;Patient is experiencing confusion and speech difficulties for more than 6 months. The symptoms are described as noticeable in nature.;chemotherapy
brain_glioma_0298;Brain Glioma;61;F;Patient is experiencing visual disturbances and speech difficulties for more than 6 months. The symptoms are described as debilitating in nature.;surgery
brain_glioma_0299;Brain Glioma;21;F;Patient is experiencing speech difficulties and frequent seizures for more than 6 months. The symptoms are described as significant in nature.;surgery
brain_glioma_0300;Brain Glioma;27;M;Patient is experiencing speech difficulties and visual disturbances for more than 6 months. The symptoms are described as debilitating in nature.;surgery
brain_glioma_0301;Brain Glioma;34;M;Patient is experiencing persistent headaches and confusion for more than 6 months. The symptoms are described as moderate in nature.;chemotherapy
brain_glioma_0302;Brain Glioma;54;M;Patient is experiencing speech difficulties and persistent headaches for more than 6 months. The symptoms are described as debilitating in nature.;chemotherapy
brain_glioma_0303;Brain Glioma;59;M;Patient is experiencing dizziness and persistent headaches for more than 6 months. The symptoms are described as debilitating in nature.;radiation therapy
brain_glioma_0304;Brain Glioma;78;M;Patient is experiencing persistent headaches and confusion for the last few weeks. The symptoms are described as noticeable in nature.;chemotherapy
brain_glioma_0305;Brain Glioma;21;M;Patient is experiencing dizziness and visual disturbances for more than 6 months. The symptoms are described as debilitating in nature.;chemotherapy
brain_glioma_0306;Brain Glioma;68;F;Patient is experiencing confusion and dizziness over the past 2 months. The symptoms are described as debilitating in nature.;radiation therapy
brain_glioma_0307;Brain Glioma;44;F;Patient is experiencing frequent seizures and visual disturbances over the past 2 months. The symptoms are described as intense in nature.;chemotherapy
brain_glioma_0308;Brain Glioma;82;F;Patient is experiencing speech difficulties and memory lapses for the last few weeks. The symptoms are described as severe in nature.;chemotherapy
brain_glioma_0309;Brain Glioma;25;F;Patient is experiencing confusion and dizziness over the past 2 months. The symptoms are described as severe in nature.;radiation therapy
brain_glioma_0310;Brain Glioma;75;F;Patient is experiencing visual disturbances and dizziness for more than 6 months. The symptoms are described as significant in nature.;chemotherapy
brain_glioma_0311;Brain Glioma;80;F;Patient is experiencing speech difficulties and persistent headaches for more than 6 months. The symptoms are described as noticeable in nature.;radiation therapy
brain_glioma_0312;Brain Glioma;48;F;Patient is experiencing confusion and memory lapses for more than 6 months. The symptoms are described as noticeable in nature.;radiation therapy
brain_glioma_0313;Brain Glioma;36;F;Patient is experiencing speech difficulties and dizziness over the past 2 months. The symptoms are described as moderate in nature.;chemotherapy
brain_glioma_0314;Brain Glioma;60;F;Patient is experiencing speech difficulties and visual disturbances for more than 6 months. The symptoms are described as debilitating in nature.;surgery
brain_glioma_0315;Brain Glioma;27;F;Patient is experiencing confusion and persistent headaches over the past 2 months. The symptoms are described as high-grade in nature.;surgery
brain_glioma_0316;Brain Glioma;22;F;Patient is experiencing confusion and dizziness for more than 6 months. The symptoms are described as high-grade in nature.;chemotherapy
brain_glioma_0317;Brain Glioma;30;F;Patient is experiencing frequent seizures and confusion for more than 6 months. The symptoms are described as moderate in nature.;radiation therapy
brain_glioma_0318;Brain Glioma;52;F;Patient is experiencing persistent headaches and dizziness for the last few weeks. The symptoms are described as moderate in nature.;radiation therapy
brain_glioma_0319;Brain Glioma;80;F;Patient is experiencing visual disturbances and confusion over the past 2 months. The symptoms are described as severe in nature.;chemotherapy
brain_glioma_0320;Brain Glioma;65;F;Patient is experiencing dizziness and visual disturbances for the last few weeks. The symptoms are described as moderate in nature.;radiation therapy
brain_glioma_0321;Brain Glioma;33;F;Patient is experiencing persistent headaches and visual disturbances for more than 6 months. The symptoms are described as debilitating in nature.;radiation therapy
brain_glioma_0322;Brain Glioma;23;M;Patient is experiencing confusion and speech difficulties over the past 2 months. The symptoms are described as debilitating in nature.;chemotherapy
brain_glioma_0323;Brain Glioma;69;F;Patient is experiencing speech difficulties and visual disturbances for the last few weeks. The symptoms are described as high-grade in nature.;surgery
brain_glioma_0324;Brain Glioma;65;M;Patient is experiencing frequent seizures and memory lapses for more than 6 months. The symptoms are described as severe in nature.;chemotherapy
brain_glioma_0325;Brain Glioma;40;F;Patient is experiencing frequent seizures and dizziness for the last few weeks. The symptoms are described as debilitating in nature.;chemotherapy
brain_glioma_0326;Brain Glioma;51;F;Patient is experiencing visual disturbances and persistent headaches for more than 6 months. The symptoms are described as intense in nature.;radiation therapy
brain_glioma_0327;Brain Glioma;38;M;Patient is experiencing memory lapses and speech difficulties for the last few weeks. The symptoms are described as intense in nature.;radiation therapy
brain_glioma_0328;Brain Glioma;75;M;Patient is experiencing confusion and frequent seizures for more than 6 months. The symptoms are described as moderate in nature.;surgery
brain_glioma_0329;Brain Glioma;63;F;Patient is experiencing memory lapses and dizziness for more than 6 months. The symptoms are described as debilitating in nature.;radiation therapy
brain_glioma_0330;Brain Glioma;85;F;Patient is experiencing memory lapses and persistent headaches over the past 2 months. The symptoms are described as intense in nature.;surgery
brain_glioma_0331;Brain Glioma;74;F;Patient is experiencing memory lapses and persistent headaches for more than 6 months. The symptoms are described as debilitating in nature.;chemotherapy
brain_glioma_0332;Brain Glioma;42;M;Patient is experiencing visual disturbances and memory lapses over the past 2 months. The symptoms are described as intense in nature.;surgery
brain_glioma_0333;Brain Glioma;21;F;Patient is experiencing speech difficulties and memory lapses over the past 2 months. The symptoms are described as significant in nature.;radiation therapy
brain_glioma_0334;Brain Glioma;59;M;Patient is experiencing confusion and visual disturbances for more than 6 months. The symptoms are described as high-grade in nature.;surgery
brain_glioma_0335;Brain Glioma;30;F;Patient is experiencing confusion and persistent headaches for more than 6 months. The symptoms are described as significant in nature.;radiation therapy
brain_glioma_0336;Brain Glioma;67;F;Patient is experiencing visual disturbances and frequent seizures for the last few weeks. The symptoms are described as significant in nature.;surgery
brain_glioma_0337;Brain Glioma;79;F;Patient is experiencing speech difficulties and frequent seizures over the past 2 months. The symptoms are described as debilitating in nature.;radiation therapy
brain_glioma_0338;Brain Glioma;74;M;Patient is experiencing persistent headaches and speech difficulties for the last few weeks. The symptoms are described as severe in nature.;radiation therapy
brain_glioma_0339;Brain Glioma;67;M;Patient is experiencing visual disturbances and speech difficulties for more than 6 months. The symptoms are described as noticeable in nature.;radiation therapy
brain_glioma_0340;Brain Glioma;35;M;Patient is experiencing memory lapses and dizziness over the past 2 months. The symptoms are described as severe in nature.;chemotherapy
brain_glioma_0341;Brain Glioma;50;M;Patient is experiencing frequent seizures and confusion over the past 2 months. The symptoms are described as moderate in nature.;surgery
brain_glioma_0342;Brain Glioma;28;F;Patient is experiencing dizziness and memory lapses for the last few weeks. The symptoms are described as intense in nature.;chemotherapy
brain_glioma_0343;Brain Glioma;25;M;Patient is experiencing visual disturbances and speech difficulties over the past 2 months. The symptoms are described as high-grade in nature.;chemotherapy
brain_glioma_0344;Brain Glioma;58;M;Patient is experiencing dizziness and frequent seizures over the past 2 months. The symptoms are described as significant in nature.;radiation therapy
brain_glioma_0345;Brain Glioma;76;M;Patient is experiencing persistent headaches and memory lapses over the past 2 months. The symptoms are described as intense in nature.;radiation therapy
brain_glioma_0346;Brain Glioma;81;F;Patient is experiencing confusion and speech difficulties for more than 6 months. The symptoms are described as debilitating in nature.;chemotherapy
brain_glioma_0347;Brain Glioma;57;M;Patient is experiencing speech difficulties and visual disturbances over the past 2 months. The symptoms are described as intense in nature.;radiation therapy
brain_glioma_0348;Brain Glioma;53;F;Patient is experiencing persistent headaches and visual disturbances for the last few weeks. The symptoms are described as debilitating in nature.;surgery
brain_glioma_0349;Brain Glioma;78;F;Patient is experiencing speech difficulties and persistent headaches over the past 2 months. The symptoms are described as moderate in nature.;radiation therapy
brain_glioma_0350;Brain Glioma;83;F;Patient is experiencing dizziness and persistent headaches for the last few weeks. The symptoms are described as debilitating in nature.;chemotherapy
brain_glioma_0351;Brain Glioma;21;F;Patient is experiencing dizziness and visual disturbances over the past 2 months. The symptoms are described as high-grade in nature.;chemotherapy
brain_glioma_0352;Brain Glioma;53;F;Patient is experiencing memory lapses and visual disturbances for the last few weeks. The symptoms are described as severe in nature.;radiation therapy
brain_glioma_0353;Brain Glioma;78;F;Patient is experiencing visual disturbances and persistent headaches for more than 6 months. The symptoms are described as intense in nature.;chemotherapy
brain_glioma_0354;Brain Glioma;63;F;Patient is experiencing dizziness and persistent headaches for more than 6 months. The symptoms are described as high-grade in nature.;chemotherapy
brain_glioma_0355;Brain Glioma;26;M;Patient is experiencing visual disturbances and confusion over the past 2 months. The symptoms are described as noticeable in nature.;surgery
brain_glioma_0356;Brain Glioma;32;M;Patient is experiencing confusion and memory lapses for the last few weeks. The symptoms are described as severe in nature.;chemotherapy
brain_glioma_0357;Brain Glioma;81;M;Patient is experiencing dizziness and frequent seizures for the last few weeks. The symptoms are described as moderate in nature.;chemotherapy
brain_glioma_0358;Brain Glioma;79;M;Patient is experiencing speech difficulties and dizziness over the past 2 months. The symptoms are described as severe in nature.;radiation therapy
brain_glioma_0359;Brain Glioma;39;M;Patient is experiencing visual disturbances and dizziness over the past 2 months. The symptoms are described as significant in nature.;chemotherapy
brain_glioma_0360;Brain Glioma;45;F;Patient is experiencing confusion and speech difficulties over the past 2 months. The symptoms are described as severe in nature.;radiation therapy
brain_glioma_0361;Brain Glioma;61;F;Patient is experiencing frequent seizures and visual disturbances for more than 6 months. The symptoms are described as intense in nature.;radiation therapy
brain_glioma_0362;Brain Glioma;27;F;Patient is experiencing visual disturbances and memory lapses for more than 6 months. The symptoms are described as debilitating in nature.;surgery
brain_glioma_0363;Brain Glioma;60;F;Patient is experiencing speech difficulties and dizziness for more than 6 months. The symptoms are described as debilitating in nature.;chemotherapy
brain_glioma_0364;Brain Glioma;19;F;Patient is experiencing confusion and speech difficulties over the past 2 months. The symptoms are described as noticeable in nature.;surgery
brain_glioma_0365;Brain Glioma;43;M;Patient is experiencing confusion and persistent headaches over the past 2 months. The symptoms are described as significant in nature.;chemotherapy
brain_glioma_0366;Brain Glioma;27;F;Patient is experiencing confusion and speech difficulties for more than 6 months. The symptoms are described as significant in nature.;surgery
brain_glioma_0367;Brain Glioma;63;M;Patient is experiencing persistent headaches and frequent seizures over the past 2 months. The symptoms are described as significant in nature.;chemotherapy
brain_glioma_0368;Brain Glioma;56;M;Patient is experiencing speech difficulties and memory lapses for the last few weeks. The symptoms are described as noticeable in nature.;surgery
brain_glioma_0369;Brain Glioma;80;M;Patient is experiencing persistent headaches and memory lapses for more than 6 months. The symptoms are described as high-grade in nature.;chemotherapy
brain_glioma_0370;Brain Glioma;79;M;Patient is experiencing memory lapses and speech difficulties for more than 6 months. The symptoms are described as intense in nature.;chemotherapy
brain_glioma_0371;Brain Glioma;83;F;Patient is experiencing dizziness and confusion for more than 6 months. The symptoms are described as significant in nature.;chemotherapy
brain_glioma_0372;Brain Glioma;48;F;Patient is experiencing frequent seizures and memory lapses for more than 6 months. The symptoms are described as high-grade in nature.;radiation therapy
brain_glioma_0373;Brain Glioma;64;M;Patient is experiencing persistent headaches and dizziness over the past 2 months. The symptoms are described as noticeable in nature.;radiation therapy
brain_glioma_0374;Brain Glioma;45;M;Patient is experiencing memory lapses and frequent seizures over the past 2 months. The symptoms are described as noticeable in nature.;surgery
brain_glioma_0375;Brain Glioma;42;M;Patient is experiencing memory lapses and confusion over the past 2 months. The symptoms are described as debilitating in nature.;chemotherapy
brain_glioma_0376;Brain Glioma;67;F;Patient is experiencing memory lapses and persistent headaches for the last few weeks. The symptoms are described as debilitating in nature.;radiation therapy
brain_glioma_0377;Brain Glioma;55;F;Patient is experiencing frequent seizures and confusion for more than 6 months. The symptoms are described as noticeable in nature.;radiation therapy
brain_glioma_0378;Brain Glioma;77;F;Patient is experiencing dizziness and speech difficulties over the past 2 months. The symptoms are described as high-grade in nature.;surgery
brain_glioma_0379;Brain Glioma;76;M;Patient is experiencing persistent headaches and dizziness over the past 2 months. The symptoms are described as severe in nature.;chemotherapy
brain_glioma_0380;Brain Glioma;39;M;Patient is experiencing dizziness and confusion over the past 2 months. The symptoms are described as moderate in nature.;radiation therapy
brain_glioma_0381;Brain Glioma;36;M;Patient is experiencing memory lapses and speech difficulties for the last few weeks. The symptoms are described as intense in nature.;surgery
brain_glioma_0382;Brain Glioma;35;M;Patient is experiencing persistent headaches and confusion for the last few weeks. The symptoms are described as moderate in nature.;chemotherapy
brain_glioma_0383;Brain Glioma;20;F;Patient is experiencing dizziness and memory lapses for the last few weeks. The symptoms are described as debilitating in nature.;radiation therapy
brain_glioma_0384;Brain Glioma;21;M;Patient is experiencing frequent seizures and visual disturbances for more than 6 months. The symptoms are described as intense in nature.;radiation therapy
brain_glioma_0385;Brain Glioma;42;M;Patient is experiencing memory lapses and visual disturbances over the past 2 months. The symptoms are described as intense in nature.;surgery
brain_glioma_0386;Brain Glioma;35;M;Patient is experiencing dizziness and speech difficulties for more than 6 months. The symptoms are described as debilitating in nature.;surgery
brain_glioma_0387;Brain Glioma;40;F;Patient is experiencing persistent headaches and visual disturbances for the last few weeks. The symptoms are described as high-grade in nature.;surgery
brain_glioma_0388;Brain Glioma;44;F;Patient is experiencing confusion and memory lapses for the last few weeks. The symptoms are described as intense in nature.;radiation therapy
brain_glioma_0389;Brain Glioma;22;M;Patient is experiencing visual disturbances and confusion over the past 2 months. The symptoms are described as noticeable in nature.;chemotherapy
brain_glioma_0390;Brain Glioma;72;M;Patient is experiencing memory lapses and speech difficulties for more than 6 months. The symptoms are described as significant in nature.;radiation therapy
brain_glioma_0391;Brain Glioma;49;F;Patient is experiencing dizziness and memory lapses for more than 6 months. The symptoms are described as debilitating in nature.;surgery
brain_glioma_0392;Brain Glioma;40;F;Patient is experiencing frequent seizures and memory lapses over the past 2 months. The symptoms are described as significant in nature.;chemotherapy
brain_glioma_0393;Brain Glioma;23;M;Patient is experiencing memory lapses and speech difficulties for the last few weeks. The symptoms are described as debilitating in nature.;chemotherapy
brain_glioma_0394;Brain Glioma;25;M;Patient is experiencing confusion and visual disturbances for the last few weeks. The symptoms are described as high-grade in nature.;surgery
brain_glioma_0395;Brain Glioma;63;M;Patient is experiencing dizziness and frequent seizures for more than 6 months. The symptoms are described as intense in nature.;chemotherapy
brain_glioma_0396;Brain Glioma;66;M;Patient is experiencing dizziness and visual disturbances for the last few weeks. The symptoms are described as moderate in nature.;chemotherapy
brain_glioma_0397;Brain Glioma;47;F;Patient is experiencing speech difficulties and dizziness for the last few weeks. The symptoms are described as debilitating in nature.;chemotherapy
brain_glioma_0398;Brain Glioma;57;F;Patient is experiencing visual disturbances and speech difficulties for more than 6 months. The symptoms are described as noticeable in nature.;radiation therapy
brain_glioma_0399;Brain Glioma;64;M;Patient is experiencing dizziness and frequent seizures for the last few weeks. The symptoms are described as high-grade in nature.;chemotherapy
brain_glioma_0400;Brain Glioma;80;F;Patient is experiencing memory lapses and confusion for more than 6 months. The symptoms are described as moderate in nature.;surgery
brain_glioma_0401;Brain Glioma;33;M;Patient is experiencing speech difficulties and confusion for the last few weeks. The symptoms are described as intense in nature.;chemotherapy
brain_glioma_0402;Brain Glioma;23;M;Patient is experiencing speech difficulties and persistent headaches for the last few weeks. The symptoms are described as significant in nature.;radiation therapy
brain_glioma_0403;Brain Glioma;45;F;Patient is experiencing visual disturbances and confusion over the past 2 months. The symptoms are described as high-grade in nature.;chemotherapy
brain_glioma_0404;Brain Glioma;79;M;Patient is experiencing memory lapses and frequent seizures for the last few weeks. The symptoms are described as high-grade in nature.;chemotherapy
brain_glioma_0405;Brain Glioma;31;F;Patient is experiencing memory lapses and confusion for more than 6 months. The symptoms are described as debilitating in nature.;radiation therapy
brain_glioma_0406;Brain Glioma;62;F;Patient is experiencing visual disturbances and memory lapses over the past 2 months. The symptoms are described as significant in nature.;radiation therapy
brain_glioma_0407;Brain Glioma;44;M;Patient is experiencing visual disturbances and frequent seizures for more than 6 months. The symptoms are described as high-grade in nature.;radiation therapy
brain_glioma_0408;Brain Glioma;48;F;Patient is experiencing confusion and persistent headaches for more than 6 months. The symptoms are described as moderate in nature.;chemotherapy
brain_glioma_0409;Brain Glioma;51;F;Patient is experiencing confusion and persistent headaches over the past 2 months. The symptoms are described as debilitating in nature.;surgery
brain_glioma_0410;Brain Glioma;33;F;Patient is experiencing persistent headaches and visual disturbances for more than 6 months. The symptoms are described as noticeable in nature.;radiation therapy
brain_glioma_0411;Brain Glioma;42;M;Patient is experiencing memory lapses and dizziness over the past 2 months. The symptoms are described as significant in nature.;surgery
brain_glioma_0412;Brain Glioma;66;F;Patient is experiencing visual disturbances and frequent seizures over the past 2 months. The symptoms are described as significant in nature.;chemotherapy
brain_glioma_0413;Brain Glioma;74;F;Patient is experiencing speech difficulties and persistent headaches for more than 6 months. The symptoms are described as noticeable in nature.;chemotherapy
brain_glioma_0414;Brain Glioma;50;F;Patient is experiencing memory lapses and dizziness over the past 2 months. The symptoms are described as significant in nature.;radiation therapy
brain_glioma_0415;Brain Glioma;75;M;Patient is experiencing confusion and visual disturbances for the last few weeks. The symptoms are described as significant in nature.;radiation therapy
brain_glioma_0416;Brain Glioma;69;M;Patient is experiencing persistent headaches and dizziness for more than 6 months. The symptoms are described as noticeable in nature.;radiation therapy
brain_glioma_0417;Brain Glioma;36;F;Patient is experiencing memory lapses and persistent headaches for more than 6 months. The symptoms are described as severe in nature.;surgery
brain_glioma_0418;Brain Glioma;42;M;Patient is experiencing dizziness and visual disturbances for the last few weeks. The symptoms are described as moderate in nature.;chemotherapy
brain_glioma_0419;Brain Glioma;68;F;Patient is experiencing dizziness and frequent seizures for the last few weeks. The symptoms are described as debilitating in nature.;chemotherapy
brain_glioma_0420;Brain Glioma;71;F;Patient is experiencing frequent seizures and memory lapses over the past 2 months. The symptoms are described as high-grade in nature.;chemotherapy
brain_glioma_0421;Brain Glioma;66;M;Patient is experiencing memory lapses and speech difficulties for the last few weeks. The symptoms are described as intense in nature.;chemotherapy
brain_glioma_0422;Brain Glioma;22;F;Patient is experiencing dizziness and frequent seizures for the last few weeks. The symptoms are described as moderate in nature.;radiation therapy
brain_glioma_0423;Brain Glioma;57;M;Patient is experiencing speech difficulties and persistent headaches for more than 6 months. The symptoms are described as noticeable in nature.;radiation therapy
brain_glioma_0424;Brain Glioma;63;M;Patient is experiencing visual disturbances and confusion for more than 6 months. The symptoms are described as intense in nature.;chemotherapy
brain_glioma_0425;Brain Glioma;51;M;Patient is experiencing confusion and dizziness over the past 2 months. The symptoms are described as significant in nature.;chemotherapy
brain_glioma_0426;Brain Glioma;47;M;Patient is experiencing memory lapses and frequent seizures for the last few weeks. The symptoms are described as intense in nature.;chemotherapy
brain_glioma_0427;Brain Glioma;80;F;Patient is experiencing dizziness and persistent headaches for more than 6 months. The symptoms are described as intense in nature.;radiation therapy
brain_glioma_0428;Brain Glioma;84;M;Patient is experiencing confusion and visual disturbances for the last few weeks. The symptoms are described as intense in nature.;surgery
brain_glioma_0429;Brain Glioma;64;M;Patient is experiencing persistent headaches and speech difficulties over the past 2 months. The symptoms are described as moderate in nature.;surgery
brain_glioma_0430;Brain Glioma;69;M;Patient is experiencing confusion and visual disturbances over the past 2 months. The symptoms are described as noticeable in nature.;chemotherapy
brain_glioma_0431;Brain Glioma;58;M;Patient is experiencing frequent seizures and memory lapses for the last few weeks. The symptoms are described as moderate in nature.;chemotherapy
brain_glioma_0432;Brain Glioma;21;F;Patient is experiencing speech difficulties and memory lapses over the past 2 months. The symptoms are described as moderate in nature.;chemotherapy
brain_glioma_0433;Brain Glioma;42;F;Patient is experiencing visual disturbances and confusion for more than 6 months. The symptoms are described as moderate in nature.;chemotherapy
brain_glioma_0434;Brain Glioma;31;F;Patient is experiencing visual disturbances and speech difficulties for more than 6 months. The symptoms are described as significant in nature.;chemotherapy
brain_glioma_0435;Brain Glioma;54;F;Patient is experiencing persistent headaches and memory lapses for the last few weeks. The symptoms are described as significant in nature.;surgery
brain_glioma_0436;Brain Glioma;41;F;Patient is experiencing dizziness and confusion for more than 6 months. The symptoms are described as moderate in nature.;surgery
brain_glioma_0437;Brain Glioma;54;M;Patient is experiencing speech difficulties and persistent headaches for the last few weeks. The symptoms are described as significant in nature.;surgery
brain_glioma_0438;Brain Glioma;37;F;Patient is experiencing speech difficulties and persistent headaches over the past 2 months. The symptoms are described as noticeable in nature.;radiation therapy
brain_glioma_0439;Brain Glioma;25;F;Patient is experiencing dizziness and speech difficulties for more than 6 months. The symptoms are described as high-grade in nature.;surgery
brain_glioma_0440;Brain Glioma;47;M;Patient is experiencing confusion and memory lapses over the past 2 months. The symptoms are described as moderate in nature.;surgery
brain_glioma_0441;Brain Glioma;53;F;Patient is experiencing confusion and persistent headaches for more than 6 months. The symptoms are described as significant in nature.;chemotherapy
brain_glioma_0442;Brain Glioma;53;F;Patient is experiencing frequent seizures and memory lapses for more than 6 months. The symptoms are described as severe in nature.;chemotherapy
brain_glioma_0443;Brain Glioma;53;M;Patient is experiencing persistent headaches and visual disturbances for more than 6 months. The symptoms are described as significant in nature.;radiation therapy
brain_glioma_0444;Brain Glioma;25;M;Patient is experiencing speech difficulties and dizziness over the past 2 months. The symptoms are described as intense in nature.;surgery
brain_glioma_0445;Brain Glioma;42;M;Patient is experiencing memory lapses and visual disturbances for more than 6 months. The symptoms are described as intense in nature.;surgery
brain_glioma_0446;Brain Glioma;44;M;Patient is experiencing dizziness and persistent headaches for more than 6 months. The symptoms are described as high-grade in nature.;radiation therapy
brain_glioma_0447;Brain Glioma;62;M;Patient is experiencing memory lapses and speech difficulties for the last few weeks. The symptoms are described as noticeable in nature.;chemotherapy
brain_glioma_0448;Brain Glioma;64;M;Patient is experiencing dizziness and confusion for more than 6 months. The symptoms are described as severe in nature.;radiation therapy
brain_glioma_0449;Brain Glioma;60;M;Patient is experiencing speech difficulties and persistent headaches over the past 2 months. The symptoms are described as debilitating in nature.;chemotherapy
brain_glioma_0450;Brain Glioma;83;F;Patient is experiencing memory lapses and frequent seizures for the last few weeks. The symptoms are described as severe in nature.;chemotherapy
brain_glioma_0451;Brain Glioma;47;M;Patient is experiencing confusion and dizziness for more than 6 months. The symptoms are described as moderate in nature.;chemotherapy
brain_glioma_0452;Brain Glioma;42;M;Patient is experiencing dizziness and memory lapses over the past 2 months. The symptoms are described as high-grade in nature.;chemotherapy
brain_glioma_0453;Brain Glioma;36;F;Patient is experiencing memory lapses and persistent headaches for more than 6 months. The symptoms are described as noticeable in nature.;radiation therapy
brain_glioma_0454;Brain Glioma;46;F;Patient is experiencing persistent headaches and confusion for more than 6 months. The symptoms are described as significant in nature.;surgery
brain_glioma_0455;Brain Glioma;69;M;Patient is experiencing confusion and dizziness for the last few weeks. The symptoms are described as significant in nature.;radiation therapy
brain_glioma_0456;Brain Glioma;29;F;Patient is experiencing visual disturbances and speech difficulties over the past 2 months. The symptoms are described as severe in nature.;surgery
brain_glioma_0457;Brain Glioma;79;F;Patient is experiencing visual disturbances and persistent headaches over the past 2 months. The symptoms are described as severe in nature.;radiation therapy
brain_glioma_0458;Brain Glioma;42;M;Patient is experiencing frequent seizures and memory lapses for the last few weeks. The symptoms are described as severe in nature.;chemotherapy
brain_glioma_0459;Brain Glioma;48;M;Patient is experiencing frequent seizures and visual disturbances for the last few weeks. The symptoms are described as moderate in nature.;surgery
brain_glioma_0460;Brain Glioma;63;F;Patient is experiencing visual disturbances and speech difficulties for more than 6 months. The symptoms are described as significant in nature.;radiation therapy
brain_glioma_0461;Brain Glioma;18;F;Patient is experiencing memory lapses and visual disturbances over the past 2 months. The symptoms are described as significant in nature.;surgery
brain_glioma_0462;Brain Glioma;43;M;Patient is experiencing speech difficulties and dizziness for the last few weeks. The symptoms are described as intense in nature.;surgery
brain_glioma_0463;Brain Glioma;55;M;Patient is experiencing speech difficulties and memory lapses over the past 2 months. The symptoms are described as intense in nature.;chemotherapy
brain_glioma_0464;Brain Glioma;81;M;Patient is experiencing confusion and visual disturbances over the past 2 months. The symptoms are described as noticeable in nature.;surgery
brain_glioma_0465;Brain Glioma;63;F;Patient is experiencing confusion and memory lapses over the past 2 months. The symptoms are described as intense in nature.;chemotherapy
brain_glioma_0466;Brain Glioma;19;F;Patient is experiencing frequent seizures and speech difficulties for the last few weeks. The symptoms are described as severe in nature.;chemotherapy
brain_glioma_0467;Brain Glioma;80;M;Patient is experiencing persistent headaches and confusion for the last few weeks. The symptoms are described as moderate in nature.;radiation therapy
brain_glioma_0468;Brain Glioma;52;F;Patient is experiencing confusion and frequent seizures for the last few weeks. The symptoms are described as noticeable in nature.;surgery
brain_glioma_0469;Brain Glioma;73;F;Patient is experiencing frequent seizures and persistent headaches over the past 2 months. The symptoms are described as noticeable in nature.;surgery
brain_glioma_0470;Brain Glioma;30;M;Patient is experiencing visual disturbances and speech difficulties over the past 2 months. The symptoms are described as severe in nature.;chemotherapy
brain_glioma_0471;Brain Glioma;84;F;Patient is experiencing confusion and speech difficulties for more than 6 months. The symptoms are described as significant in nature.;radiation therapy
brain_glioma_0472;Brain Glioma;23;M;Patient is experiencing frequent seizures and visual disturbances over the past 2 months. The symptoms are described as noticeable in nature.;chemotherapy
brain_glioma_0473;Brain Glioma;22;F;Patient is experiencing memory lapses and frequent seizures for more than 6 months. The symptoms are described as moderate in nature.;chemotherapy
brain_glioma_0474;Brain Glioma;38;F;Patient is experiencing memory lapses and persistent headaches for the last few weeks. The symptoms are described as noticeable in nature.;radiation therapy
brain_glioma_0475;Brain Glioma;54;M;Patient is experiencing persistent headaches and visual disturbances for the last few weeks. The symptoms are described as moderate in nature.;chemotherapy
brain_glioma_0476;Brain Glioma;50;M;Patient is experiencing confusion and visual disturbances over the past 2 months. The symptoms are described as significant in nature.;chemotherapy
brain_glioma_0477;Brain Glioma;45;M;Patient is experiencing visual disturbances and dizziness for the last few weeks. The symptoms are described as severe in nature.;surgery
brain_glioma_0478;Brain Glioma;46;M;Patient is experiencing memory lapses and persistent headaches over the past 2 months. The symptoms are described as intense in nature.;radiation therapy
brain_glioma_0479;Brain Glioma;72;M;Patient is experiencing persistent headaches and frequent seizures for more than 6 months. The symptoms are described as noticeable in nature.;chemotherapy
brain_glioma_0480;Brain Glioma;61;F;Patient is experiencing visual disturbances and confusion for more than 6 months. The symptoms are described as severe in nature.;radiation therapy
brain_glioma_0481;Brain Glioma;48;F;Patient is experiencing visual disturbances and persistent headaches over the past 2 months. The symptoms are described as moderate in nature.;radiation therapy
brain_glioma_0482;Brain Glioma;74;M;Patient is experiencing speech difficulties and persistent headaches over the past 2 months. The symptoms are described as intense in nature.;radiation therapy
brain_glioma_0483;Brain Glioma;77;F;Patient is experiencing visual disturbances and confusion over the past 2 months. The symptoms are described as significant in nature.;radiation therapy
brain_glioma_0484;Brain Glioma;85;F;Patient is experiencing frequent seizures and dizziness for more than 6 months. The symptoms are described as moderate in nature.;surgery
brain_glioma_0485;Brain Glioma;45;F;Patient is experiencing confusion and memory lapses for the last few weeks. The symptoms are described as debilitating in nature.;radiation therapy
brain_glioma_0486;Brain Glioma;28;F;Patient is experiencing speech difficulties and confusion over the past 2 months. The symptoms are described as significant in nature.;radiation therapy
brain_glioma_0487;Brain Glioma;58;M;Patient is experiencing memory lapses and dizziness over the past 2 months. The symptoms are described as significant in nature.;chemotherapy
brain_glioma_0488;Brain Glioma;38;M;Patient is experiencing memory lapses and visual disturbances for the last few weeks. The symptoms are described as noticeable in nature.;surgery
brain_glioma_0489;Brain Glioma;75;M;Patient is experiencing confusion and memory lapses for more than 6 months. The symptoms are described as noticeable in nature.;radiation therapy
brain_glioma_0490;Brain Glioma;47;F;Patient is experiencing visual disturbances and frequent seizures for the last few weeks. The symptoms are described as noticeable in nature.;chemotherapy
brain_glioma_0491;Brain Glioma;37;F;Patient is experiencing memory lapses and dizziness for the last few weeks. The symptoms are described as significant in nature.;surgery
brain_glioma_0492;Brain Glioma;30;M;Patient is experiencing visual disturbances and speech difficulties over the past 2 months. The symptoms are described as significant in nature.;chemotherapy
brain_glioma_0493;Brain Glioma;65;M;Patient is experiencing memory lapses and speech difficulties over the past 2 months. The symptoms are described as moderate in nature.;surgery
brain_glioma_0494;Brain Glioma;57;M;Patient is experiencing persistent headaches and confusion for the last few weeks. The symptoms are described as noticeable in nature.;radiation therapy
brain_glioma_0495;Brain Glioma;31;M;Patient is experiencing frequent seizures and dizziness for the last few weeks. The symptoms are described as significant in nature.;radiation therapy
brain_glioma_0496;Brain Glioma;66;M;Patient is experiencing dizziness and speech difficulties over the past 2 months. The symptoms are described as noticeable in nature.;chemotherapy
brain_glioma_0497;Brain Glioma;25;F;Patient is experiencing dizziness and visual disturbances for the last few weeks. The symptoms are described as debilitating in nature.;radiation therapy
brain_glioma_0498;Brain Glioma;83;F;Patient is experiencing visual disturbances and memory lapses for the last few weeks. The symptoms are described as moderate in nature.;radiation therapy
brain_glioma_0499;Brain Glioma;33;F;Patient is experiencing speech difficulties and confusion for more than 6 months. The symptoms are described as significant in nature.;surgery
brain_glioma_0500;Brain Glioma;67;F;Patient is experiencing dizziness and confusion for more than 6 months. The symptoms are described as noticeable in nature.;chemotherapy
brain_glioma_0501;Brain Glioma;66;M;Patient is experiencing visual disturbances and frequent seizures for the last few weeks. The symptoms are described as intense in nature.;chemotherapy
brain_glioma_0502;Brain Glioma;56;M;Patient is experiencing dizziness and frequent seizures over the past 2 months. The symptoms are described as moderate in nature.;radiation therapy
brain_glioma_0503;Brain Glioma;72;F;Patient is experiencing dizziness and persistent headaches over the past 2 months. The symptoms are described as moderate in nature.;chemotherapy
brain_glioma_0504;Brain Glioma;24;F;Patient is experiencing dizziness and persistent headaches for more than 6 months. The symptoms are described as noticeable in nature.;chemotherapy
brain_glioma_0505;Brain Glioma;67;M;Patient is experiencing speech difficulties and confusion for more than 6 months. The symptoms are described as high-grade in nature.;chemotherapy
brain_glioma_0506;Brain Glioma;26;F;Patient is experiencing confusion and persistent headaches for the last few weeks. The symptoms are described as moderate in nature.;surgery
brain_glioma_0507;Brain Glioma;62;F;Patient is experiencing visual disturbances and speech difficulties over the past 2 months. The symptoms are described as moderate in nature.;radiation therapy
brain_glioma_0508;Brain Glioma;30;M;Patient is experiencing visual disturbances and persistent headaches over the past 2 months. The symptoms are described as moderate in nature.;radiation therapy
brain_glioma_0509;Brain Glioma;37;M;Patient is experiencing frequent seizures and confusion for the last few weeks. The symptoms are described as debilitating in nature.;radiation therapy
brain_glioma_0510;Brain Glioma;20;M;Patient is experiencing dizziness and persistent headaches for the last few weeks. The symptoms are described as debilitating in nature.;chemotherapy
brain_glioma_0511;Brain Glioma;74;F;Patient is experiencing speech difficulties and confusion for the last few weeks. The symptoms are described as noticeable in nature.;chemotherapy
brain_glioma_0512;Brain Glioma;52;F;Patient is experiencing visual disturbances and persistent headaches over the past 2 months. The symptoms are described as high-grade in nature.;surgery
brain_glioma_0513;Brain Glioma;44;M;Patient is experiencing memory lapses and frequent seizures for more than 6 months. The symptoms are described as moderate in nature.;surgery
brain_glioma_0514;Brain Glioma;62;F;Patient is experiencing persistent headaches and speech difficulties over the past 2 months. The symptoms are described as intense in nature.;surgery
brain_glioma_0515;Brain Glioma;71;F;Patient is experiencing confusion and persistent headaches for the last few weeks. The symptoms are described as intense in nature.;radiation therapy
brain_glioma_0516;Brain Glioma;72;M;Patient is experiencing visual disturbances and confusion over the past 2 months. The symptoms are described as noticeable in nature.;chemotherapy
brain_glioma_0517;Brain Glioma;20;M;Patient is experiencing speech difficulties and visual disturbances over the past 2 months. The symptoms are described as moderate in nature.;radiation therapy
brain_glioma_0518;Brain Glioma;50;F;Patient is experiencing memory lapses and frequent seizures for more than 6 months. The symptoms are described as moderate in nature.;chemotherapy
brain_glioma_0519;Brain Glioma;50;F;Patient is experiencing dizziness and visual disturbances over the past 2 months. The symptoms are described as noticeable in nature.;surgery
brain_glioma_0520;Brain Glioma;54;F;Patient is experiencing frequent seizures and visual disturbances for more than 6 months. The symptoms are described as noticeable in nature.;chemotherapy
brain_glioma_0521;Brain Glioma;23;M;Patient is experiencing persistent headaches and visual disturbances for the last few weeks. The symptoms are described as debilitating in nature.;surgery
brain_glioma_0522;Brain Glioma;23;F;Patient is experiencing dizziness and visual disturbances for more than 6 months. The symptoms are described as high-grade in nature.;chemotherapy
brain_glioma_0523;Brain Glioma;52;M;Patient is experiencing speech difficulties and dizziness over the past 2 months. The symptoms are described as severe in nature.;radiation therapy
brain_glioma_0524;Brain Glioma;46;F;Patient is experiencing visual disturbances and dizziness for the last few weeks. The symptoms are described as noticeable in nature.;surgery
brain_glioma_0525;Brain Glioma;30;M;Patient is experiencing dizziness and frequent seizures for more than 6 months. The symptoms are described as severe in nature.;radiation therapy
brain_glioma_0526;Brain Glioma;54;M;Patient is experiencing visual disturbances and memory lapses over the past 2 months. The symptoms are described as moderate in nature.;surgery
brain_glioma_0527;Brain Glioma;30;F;Patient is experiencing persistent headaches and frequent seizures for more than 6 months. The symptoms are described as high-grade in nature.;surgery
brain_glioma_0528;Brain Glioma;34;M;Patient is experiencing memory lapses and visual disturbances over the past 2 months. The symptoms are described as debilitating in nature.;surgery
brain_glioma_0529;Brain Glioma;78;F;Patient is experiencing confusion and memory lapses for the last few weeks. The symptoms are described as high-grade in nature.;surgery
brain_glioma_0530;Brain Glioma;32;M;Patient is experiencing speech difficulties and dizziness for more than 6 months. The symptoms are described as intense in nature.;surgery
brain_glioma_0531;Brain Glioma;60;M;Patient is experiencing frequent seizures and dizziness for the last few weeks. The symptoms are described as intense in nature.;radiation therapy
brain_glioma_0532;Brain Glioma;69;F;Patient is experiencing persistent headaches and speech difficulties over the past 2 months. The symptoms are described as significant in nature.;surgery
brain_glioma_0533;Brain Glioma;28;F;Patient is experiencing confusion and visual disturbances over the past 2 months. The symptoms are described as intense in nature.;surgery
brain_glioma_0534;Brain Glioma;45;M;Patient is experiencing persistent headaches and dizziness over the past 2 months. The symptoms are described as high-grade in nature.;chemotherapy
brain_glioma_0535;Brain Glioma;71;F;Patient is experiencing frequent seizures and dizziness for the last few weeks. The symptoms are described as significant in nature.;surgery
brain_glioma_0536;Brain Glioma;53;M;Patient is experiencing confusion and speech difficulties for the last few weeks. The symptoms are described as moderate in nature.;chemotherapy
brain_glioma_0537;Brain Glioma;34;F;Patient is experiencing visual disturbances and speech difficulties over the past 2 months. The symptoms are described as severe in nature.;radiation therapy
brain_glioma_0538;Brain Glioma;52;M;Patient is experiencing frequent seizures and confusion over the past 2 months. The symptoms are described as severe in nature.;radiation therapy
brain_glioma_0539;Brain Glioma;52;F;Patient is experiencing visual disturbances and memory lapses for more than 6 months. The symptoms are described as high-grade in nature.;surgery
brain_glioma_0540;Brain Glioma;76;F;Patient is experiencing dizziness and persistent headaches for the last few weeks. The symptoms are described as severe in nature.;surgery
brain_glioma_0541;Brain Glioma;46;M;Patient is experiencing visual disturbances and persistent headaches for the last few weeks. The symptoms are described as moderate in nature.;radiation therapy
brain_glioma_0542;Brain Glioma;44;F;Patient is experiencing speech difficulties and frequent seizures over the past 2 months. The symptoms are described as severe in nature.;radiation therapy
brain_glioma_0543;Brain Glioma;83;M;Patient is experiencing speech difficulties and frequent seizures for the last few weeks. The symptoms are described as debilitating in nature.;chemotherapy
brain_glioma_0544;Brain Glioma;56;F;Patient is experiencing dizziness and frequent seizures for more than 6 months. The symptoms are described as intense in nature.;chemotherapy
brain_glioma_0545;Brain Glioma;24;F;Patient is experiencing frequent seizures and visual disturbances for the last few weeks. The symptoms are described as high-grade in nature.;radiation therapy
brain_glioma_0546;Brain Glioma;80;F;Patient is experiencing visual disturbances and memory lapses for more than 6 months. The symptoms are described as high-grade in nature.;surgery
brain_glioma_0547;Brain Glioma;60;M;Patient is experiencing frequent seizures and visual disturbances over the past 2 months. The symptoms are described as debilitating in nature.;surgery
brain_glioma_0548;Brain Glioma;69;F;Patient is experiencing confusion and persistent headaches over the past 2 months. The symptoms are described as significant in nature.;chemotherapy
brain_glioma_0549;Brain Glioma;19;F;Patient is experiencing speech difficulties and visual disturbances for the last few weeks. The symptoms are described as high-grade in nature.;radiation therapy
brain_glioma_0550;Brain Glioma;53;M;Patient is experiencing speech difficulties and visual disturbances over the past 2 months. The symptoms are described as noticeable in nature.;chemotherapy
brain_glioma_0551;Brain Glioma;19;M;Patient is experiencing speech difficulties and frequent seizures over the past 2 months. The symptoms are described as significant in nature.;chemotherapy
brain_glioma_0552;Brain Glioma;61;F;Patient is experiencing dizziness and speech difficulties for more than 6 months. The symptoms are described as noticeable in nature.;surgery
brain_glioma_0553;Brain Glioma;23;M;Patient is experiencing confusion and visual disturbances over the past 2 months. The symptoms are described as significant in nature.;chemotherapy
brain_glioma_0554;Brain Glioma;68;M;Patient is experiencing confusion and speech difficulties over the past 2 months. The symptoms are described as moderate in nature.;surgery
brain_glioma_0555;Brain Glioma;52;M;Patient is experiencing memory lapses and frequent seizures for more than 6 months. The symptoms are described as moderate in nature.;radiation therapy
brain_glioma_0556;Brain Glioma;18;M;Patient is experiencing speech difficulties and frequent seizures for more than 6 months. The symptoms are described as severe in nature.;surgery
brain_glioma_0557;Brain Glioma;76;M;Patient is experiencing dizziness and frequent seizures for the last few weeks. The symptoms are described as moderate in nature.;surgery
brain_glioma_0558;Brain Glioma;27;F;Patient is experiencing dizziness and frequent seizures over the past 2 months. The symptoms are described as high-grade in nature.;radiation therapy
brain_glioma_0559;Brain Glioma;21;M;Patient is experiencing frequent seizures and visual disturbances for the last few weeks. The symptoms are described as significant in nature.;radiation therapy
brain_glioma_0560;Brain Glioma;77;F;Patient is experiencing dizziness and visual disturbances for the last few weeks. The symptoms are described as noticeable in nature.;chemotherapy
brain_glioma_0561;Brain Glioma;26;M;Patient is experiencing confusion and memory lapses over the past 2 months. The symptoms are described as severe in nature.;radiation therapy
brain_glioma_0562;Brain Glioma;26;M;Patient is experiencing memory lapses and persistent headaches for more than 6 months. The symptoms are described as significant in nature.;surgery
brain_glioma_0563;Brain Glioma;74;M;Patient is experiencing frequent seizures and dizziness for the last few weeks. The symptoms are described as intense in nature.;surgery
brain_glioma_0564;Brain Glioma;82;M;Patient is experiencing memory lapses and frequent seizures for the last few weeks. The symptoms are described as significant in nature.;chemotherapy
brain_glioma_0565;Brain Glioma;56;M;Patient is experiencing dizziness and memory lapses over the past 2 months. The symptoms are described as moderate in nature.;surgery
brain_glioma_0566;Brain Glioma;56;F;Patient is experiencing visual disturbances and persistent headaches for the last few weeks. The symptoms are described as high-grade in nature.;chemotherapy
brain_glioma_0567;Brain Glioma;20;M;Patient is experiencing persistent headaches and confusion for the last few weeks. The symptoms are described as moderate in nature.;surgery
brain_glioma_0568;Brain Glioma;81;M;Patient is experiencing frequent seizures and confusion over the past 2 months. The symptoms are described as severe in nature.;chemotherapy
brain_glioma_0569;Brain Glioma;72;F;Patient is experiencing memory lapses and confusion for more than 6 months. The symptoms are described as moderate in nature.;radiation therapy
brain_glioma_0570;Brain Glioma;45;F;Patient is experiencing confusion and visual disturbances for the last few weeks. The symptoms are described as severe in nature.;radiation therapy
brain_glioma_0571;Brain Glioma;54;M;Patient is experiencing memory lapses and persistent headaches for more than 6 months. The symptoms are described as significant in nature.;chemotherapy
brain_glioma_0572;Brain Glioma;68;M;Patient is experiencing visual disturbances and confusion over the past 2 months. The symptoms are described as severe in nature.;radiation therapy
brain_glioma_0573;Brain Glioma;83;F;Patient is experiencing memory lapses and visual disturbances for the last few weeks. The symptoms are described as high-grade in nature.;radiation therapy
brain_glioma_0574;Brain Glioma;68;F;Patient is experiencing memory lapses and persistent headaches for the last few weeks. The symptoms are described as noticeable in nature.;radiation therapy
brain_glioma_0575;Brain Glioma;58;F;Patient is experiencing visual disturbances and confusion for the last few weeks. The symptoms are described as intense in nature.;radiation therapy
brain_glioma_0576;Brain Glioma;45;F;Patient is experiencing confusion and memory lapses for the last few weeks. The symptoms are described as severe in nature.;chemotherapy
brain_glioma_0577;Brain Glioma;50;M;Patient is experiencing memory lapses and confusion over the past 2 months. The symptoms are described as significant in nature.;radiation therapy
brain_glioma_0578;Brain Glioma;50;F;Patient is experiencing frequent seizures and dizziness for the last few weeks. The symptoms are described as debilitating in nature.;chemotherapy
brain_glioma_0579;Brain Glioma;67;M;Patient is experiencing speech difficulties and dizziness over the past 2 months. The symptoms are described as high-grade in nature.;surgery
brain_glioma_0580;Brain Glioma;61;M;Patient is experiencing dizziness and memory lapses for the last few weeks. The symptoms are described as severe in nature.;radiation therapy
brain_glioma_0581;Brain Glioma;19;F;Patient is experiencing visual disturbances and dizziness for more than 6 months. The symptoms are described as noticeable in nature.;surgery
brain_glioma_0582;Brain Glioma;45;F;Patient is experiencing confusion and visual disturbances for more than 6 months. The symptoms are described as high-grade in nature.;chemotherapy
brain_glioma_0583;Brain Glioma;57;F;Patient is experiencing dizziness and speech difficulties for more than 6 months. The symptoms are described as noticeable in nature.;surgery
brain_glioma_0584;Brain Glioma;80;F;Patient is experiencing persistent headaches and speech difficulties over the past 2 months. The symptoms are described as significant in nature.;chemotherapy
brain_glioma_0585;Brain Glioma;72;F;Patient is experiencing dizziness and persistent headaches for the last few weeks. The symptoms are described as noticeable in nature.;radiation therapy
brain_glioma_0586;Brain Glioma;70;F;Patient is experiencing speech difficulties and frequent seizures over the past 2 months. The symptoms are described as moderate in nature.;radiation therapy
brain_glioma_0587;Brain Glioma;54;F;Patient is experiencing frequent seizures and memory lapses for the last few weeks. The symptoms are described as debilitating in nature.;chemotherapy
brain_glioma_0588;Brain Glioma;62;M;Patient is experiencing memory lapses and persistent headaches for more than 6 months. The symptoms are described as noticeable in nature.;radiation therapy
brain_glioma_0589;Brain Glioma;30;M;Patient is experiencing memory lapses and speech difficulties over the past 2 months. The symptoms are described as high-grade in nature.;radiation therapy
brain_glioma_0590;Brain Glioma;19;F;Patient is experiencing dizziness and frequent seizures for the last few weeks. The symptoms are described as significant in nature.;radiation therapy
brain_glioma_0591;Brain Glioma;60;F;Patient is experiencing confusion and visual disturbances for the last few weeks. The symptoms are described as significant in nature.;chemotherapy
brain_glioma_0592;Brain Glioma;23;F;Patient is experiencing dizziness and frequent seizures for the last few weeks. The symptoms are described as intense in nature.;radiation therapy
brain_glioma_0593;Brain Glioma;83;F;Patient is experiencing frequent seizures and memory lapses over the past 2 months. The symptoms are described as moderate in nature.;radiation therapy
brain_glioma_0594;Brain Glioma;37;M;Patient is experiencing frequent seizures and memory lapses over the past 2 months. The symptoms are described as intense in nature.;radiation therapy
brain_glioma_0595;Brain Glioma;74;M;Patient is experiencing speech difficulties and frequent seizures for more than 6 months. The symptoms are described as noticeable in nature.;chemotherapy
brain_glioma_0596;Brain Glioma;54;M;Patient is experiencing memory lapses and dizziness over the past 2 months. The symptoms are described as debilitating in nature.;chemotherapy
brain_glioma_0597;Brain Glioma;69;M;Patient is experiencing dizziness and confusion for more than 6 months. The symptoms are described as significant in nature.;surgery
brain_glioma_0598;Brain Glioma;49;M;Patient is experiencing dizziness and confusion for more than 6 months. The symptoms are described as debilitating in nature.;surgery
brain_glioma_0599;Brain Glioma;31;M;Patient is experiencing confusion and speech difficulties for more than 6 months. The symptoms are described as high-grade in nature.;chemotherapy
brain_glioma_0600;Brain Glioma;83;F;Patient is experiencing dizziness and frequent seizures over the past 2 months. The symptoms are described as severe in nature.;surgery
brain_glioma_0601;Brain Glioma;29;F;Patient is experiencing frequent seizures and visual disturbances for more than 6 months. The symptoms are described as high-grade in nature.;radiation therapy
brain_glioma_0602;Brain Glioma;59;F;Patient is experiencing dizziness and speech difficulties over the past 2 months. The symptoms are described as intense in nature.;radiation therapy
brain_glioma_0603;Brain Glioma;58;M;Patient is experiencing speech difficulties and confusion for the last few weeks. The symptoms are described as debilitating in nature.;radiation therapy
brain_glioma_0604;Brain Glioma;35;F;Patient is experiencing memory lapses and speech difficulties over the past 2 months. The symptoms are described as noticeable in nature.;radiation therapy
brain_glioma_0605;Brain Glioma;69;F;Patient is experiencing dizziness and confusion over the past 2 months. The symptoms are described as severe in nature.;chemotherapy
brain_glioma_0606;Brain Glioma;79;M;Patient is experiencing persistent headaches and visual disturbances for more than 6 months. The symptoms are described as noticeable in nature.;surgery
brain_glioma_0607;Brain Glioma;24;F;Patient is experiencing confusion and memory lapses over the past 2 months. The symptoms are described as intense in nature.;radiation therapy
brain_glioma_0608;Brain Glioma;43;F;Patient is experiencing memory lapses and visual disturbances for more than 6 months. The symptoms are described as significant in nature.;surgery
brain_glioma_0609;Brain Glioma;46;M;Patient is experiencing visual disturbances and frequent seizures for more than 6 months. The symptoms are described as high-grade in nature.;surgery
brain_glioma_0610;Brain Glioma;19;M;Patient is experiencing persistent headaches and dizziness over the past 2 months. The symptoms are described as noticeable in nature.;radiation therapy
brain_glioma_0611;Brain Glioma;23;F;Patient is experiencing confusion and speech difficulties for the last few weeks. The symptoms are described as high-grade in nature.;surgery
brain_glioma_0612;Brain Glioma;54;F;Patient is experiencing persistent headaches and confusion for more than 6 months. The symptoms are described as severe in nature.;radiation therapy
brain_glioma_0613;Brain Glioma;26;M;Patient is experiencing speech difficulties and frequent seizures over the past 2 months. The symptoms are described as moderate in nature.;radiation therapy
brain_glioma_0614;Brain Glioma;74;F;Patient is experiencing persistent headaches and confusion over the past 2 months. The symptoms are described as severe in nature.;chemotherapy
brain_glioma_0615;Brain Glioma;76;M;Patient is experiencing dizziness and frequent seizures for the last few weeks. The symptoms are described as high-grade in nature.;surgery
brain_glioma_0616;Brain Glioma;20;M;Patient is experiencing dizziness and frequent seizures over the past 2 months. The symptoms are described as intense in nature.;radiation therapy
brain_glioma_0617;Brain Glioma;60;F;Patient is experiencing confusion and persistent headaches for the last few weeks. The symptoms are described as debilitating in nature.;chemotherapy
brain_glioma_0618;Brain Glioma;74;F;Patient is experiencing memory lapses and frequent seizures for the last few weeks. The symptoms are described as severe in nature.;surgery
brain_glioma_0619;Brain Glioma;34;F;Patient is experiencing confusion and visual disturbances for more than 6 months. The symptoms are described as high-grade in nature.;chemotherapy
brain_glioma_0620;Brain Glioma;38;F;Patient is experiencing speech difficulties and confusion over the past 2 months. The symptoms are described as significant in nature.;surgery
brain_glioma_0621;Brain Glioma;65;M;Patient is experiencing memory lapses and frequent seizures for more than 6 months. The symptoms are described as moderate in nature.;chemotherapy
brain_glioma_0622;Brain Glioma;75;F;Patient is experiencing dizziness and visual disturbances for the last few weeks. The symptoms are described as significant in nature.;radiation therapy
brain_glioma_0623;Brain Glioma;33;F;Patient is experiencing persistent headaches and memory lapses for the last few weeks. The symptoms are described as moderate in nature.;radiation therapy
brain_glioma_0624;Brain Glioma;46;M;Patient is experiencing visual disturbances and frequent seizures over the past 2 months. The symptoms are described as significant in nature.;radiation therapy
brain_glioma_0625;Brain Glioma;50;F;Patient is experiencing confusion and dizziness over the past 2 months. The symptoms are described as debilitating in nature.;surgery
brain_glioma_0626;Brain Glioma;45;F;Patient is experiencing confusion and memory lapses for the last few weeks. The symptoms are described as high-grade in nature.;radiation therapy
brain_glioma_0627;Brain Glioma;56;M;Patient is experiencing visual disturbances and persistent headaches over the past 2 months. The symptoms are described as debilitating in nature.;surgery
brain_glioma_0628;Brain Glioma;72;M;Patient is experiencing confusion and frequent seizures for more than 6 months. The symptoms are described as severe in nature.;chemotherapy
brain_glioma_0629;Brain Glioma;42;M;Patient is experiencing visual disturbances and dizziness for more than 6 months. The symptoms are described as debilitating in nature.;surgery
brain_glioma_0630;Brain Glioma;22;F;Patient is experiencing persistent headaches and dizziness for more than 6 months. The symptoms are described as intense in nature.;radiation therapy
brain_glioma_0631;Brain Glioma;26;F;Patient is experiencing confusion and persistent headaches over the past 2 months. The symptoms are described as moderate in nature.;surgery
brain_glioma_0632;Brain Glioma;59;M;Patient is experiencing frequent seizures and persistent headaches over the past 2 months. The symptoms are described as moderate in nature.;radiation therapy
brain_glioma_0633;Brain Glioma;53;M;Patient is experiencing frequent seizures and dizziness for the last few weeks. The symptoms are described as intense in nature.;radiation therapy
brain_glioma_0634;Brain Glioma;33;M;Patient is experiencing confusion and frequent seizures for the last few weeks. The symptoms are described as significant in nature.;chemotherapy
brain_glioma_0635;Brain Glioma;37;F;Patient is experiencing memory lapses and persistent headaches over the past 2 months. The symptoms are described as severe in nature.;surgery
brain_glioma_0636;Brain Glioma;70;F;Patient is experiencing persistent headaches and frequent seizures for more than 6 months. The symptoms are described as intense in nature.;radiation therapy
brain_glioma_0637;Brain Glioma;57;M;Patient is experiencing speech difficulties and persistent headaches for the last few weeks. The symptoms are described as noticeable in nature.;surgery
brain_glioma_0638;Brain Glioma;37;M;Patient is experiencing memory lapses and frequent seizures for more than 6 months. The symptoms are described as debilitating in nature.;surgery
brain_glioma_0639;Brain Glioma;69;F;Patient is experiencing speech difficulties and memory lapses for the last few weeks. The symptoms are described as intense in nature.;chemotherapy
brain_glioma_0640;Brain Glioma;40;F;Patient is experiencing memory lapses and visual disturbances for the last few weeks. The symptoms are described as high-grade in nature.;chemotherapy
brain_glioma_0641;Brain Glioma;29;M;Patient is experiencing frequent seizures and confusion over the past 2 months. The symptoms are described as severe in nature.;radiation therapy
brain_glioma_0642;Brain Glioma;79;M;Patient is experiencing dizziness and frequent seizures for the last few weeks. The symptoms are described as moderate in nature.;surgery
brain_glioma_0643;Brain Glioma;50;F;Patient is experiencing visual disturbances and speech difficulties for the last few weeks. The symptoms are described as significant in nature.;radiation therapy
brain_glioma_0644;Brain Glioma;40;F;Patient is experiencing confusion and speech difficulties for the last few weeks. The symptoms are described as intense in nature.;chemotherapy
brain_glioma_0645;Brain Glioma;80;F;Patient is experiencing confusion and memory lapses over the past 2 months. The symptoms are described as noticeable in nature.;chemotherapy
brain_glioma_0646;Brain Glioma;53;M;Patient is experiencing visual disturbances and memory lapses for the last few weeks. The symptoms are described as high-grade in nature.;radiation therapy
brain_glioma_0647;Brain Glioma;84;M;Patient is experiencing speech difficulties and frequent seizures for more than 6 months. The symptoms are described as moderate in nature.;surgery
brain_glioma_0648;Brain Glioma;35;M;Patient is experiencing persistent headaches and dizziness for the last few weeks. The symptoms are described as noticeable in nature.;chemotherapy
brain_glioma_0649;Brain Glioma;75;M;Patient is experiencing visual disturbances and memory lapses over the past 2 months. The symptoms are described as noticeable in nature.;chemotherapy
brain_glioma_0650;Brain Glioma;73;M;Patient is experiencing frequent seizures and confusion for the last few weeks. The symptoms are described as moderate in nature.;radiation therapy
brain_glioma_0651;Brain Glioma;47;M;Patient is experiencing confusion and speech difficulties over the past 2 months. The symptoms are described as significant in nature.;surgery
brain_glioma_0652;Brain Glioma;42;F;Patient is experiencing persistent headaches and speech difficulties for the last few weeks. The symptoms are described as intense in nature.;radiation therapy
brain_glioma_0653;Brain Glioma;46;F;Patient is experiencing memory lapses and confusion for the last few weeks. The symptoms are described as severe in nature.;radiation therapy
brain_glioma_0654;Brain Glioma;22;F;Patient is experiencing confusion and speech difficulties for more than 6 months. The symptoms are described as moderate in nature.;chemotherapy
brain_glioma_0655;Brain Glioma;68;M;Patient is experiencing dizziness and persistent headaches over the past 2 months. The symptoms are described as severe in nature.;radiation therapy
brain_glioma_0656;Brain Glioma;82;M;Patient is experiencing dizziness and visual disturbances for the last few weeks. The symptoms are described as significant in nature.;radiation therapy
brain_glioma_0657;Brain Glioma;61;M;Patient is experiencing memory lapses and persistent headaches for more than 6 months. The symptoms are described as debilitating in nature.;chemotherapy
brain_glioma_0658;Brain Glioma;38;F;Patient is experiencing persistent headaches and frequent seizures for more than 6 months. The symptoms are described as intense in nature.;radiation therapy
brain_glioma_0659;Brain Glioma;61;F;Patient is experiencing frequent seizures and persistent headaches over the past 2 months. The symptoms are described as significant in nature.;chemotherapy
brain_glioma_0660;Brain Glioma;67;F;Patient is experiencing speech difficulties and persistent headaches for the last few weeks. The symptoms are described as noticeable in nature.;chemotherapy
brain_glioma_0661;Brain Glioma;29;F;Patient is experiencing confusion and visual disturbances for more than 6 months. The symptoms are described as moderate in nature.;chemotherapy
brain_glioma_0662;Brain Glioma;30;M;Patient is experiencing persistent headaches and speech difficulties for the last few weeks. The symptoms are described as moderate in nature.;surgery
brain_glioma_0663;Brain Glioma;22;F;Patient is experiencing frequent seizures and persistent headaches for the last few weeks. The symptoms are described as significant in nature.;radiation therapy
brain_glioma_0664;Brain Glioma;64;F;Patient is experiencing confusion and persistent headaches for the last few weeks. The symptoms are described as high-grade in nature.;radiation therapy
brain_glioma_0665;Brain Glioma;40;M;Patient is experiencing confusion and dizziness for the last few weeks. The symptoms are described as intense in nature.;surgery
brain_glioma_0666;Brain Glioma;33;F;Patient is experiencing speech difficulties and persistent headaches over the past 2 months. The symptoms are described as significant in nature.;radiation therapy
brain_glioma_0667;Brain Glioma;38;M;Patient is experiencing confusion and memory lapses for the last few weeks. The symptoms are described as intense in nature.;surgery
brain_glioma_0668;Brain Glioma;48;F;Patient is experiencing speech difficulties and frequent seizures over the past 2 months. The symptoms are described as severe in nature.;radiation therapy
brain_glioma_0669;Brain Glioma;38;F;Patient is experiencing dizziness and memory lapses over the past 2 months. The symptoms are described as high-grade in nature.;radiation therapy
brain_glioma_0670;Brain Glioma;59;M;Patient is experiencing frequent seizures and memory lapses for the last few weeks. The symptoms are described as significant in nature.;chemotherapy
brain_glioma_0671;Brain Glioma;21;M;Patient is experiencing memory lapses and speech difficulties over the past 2 months. The symptoms are described as noticeable in nature.;chemotherapy
brain_glioma_0672;Brain Glioma;45;F;Patient is experiencing persistent headaches and memory lapses over the past 2 months. The symptoms are described as severe in nature.;chemotherapy
brain_glioma_0673;Brain Glioma;41;M;Patient is experiencing speech difficulties and confusion for the last few weeks. The symptoms are described as high-grade in nature.;chemotherapy
brain_glioma_0674;Brain Glioma;56;M;Patient is experiencing persistent headaches and memory lapses over the past 2 months. The symptoms are described as noticeable in nature.;surgery
brain_glioma_0675;Brain Glioma;48;M;Patient is experiencing frequent seizures and confusion over the past 2 months. The symptoms are described as moderate in nature.;radiation therapy
brain_glioma_0676;Brain Glioma;80;F;Patient is experiencing memory lapses and dizziness for more than 6 months. The symptoms are described as moderate in nature.;surgery
brain_glioma_0677;Brain Glioma;52;M;Patient is experiencing frequent seizures and visual disturbances over the past 2 months. The symptoms are described as noticeable in nature.;chemotherapy
brain_glioma_0678;Brain Glioma;78;M;Patient is experiencing memory lapses and persistent headaches over the past 2 months. The symptoms are described as moderate in nature.;chemotherapy
brain_glioma_0679;Brain Glioma;29;F;Patient is experiencing dizziness and speech difficulties for more than 6 months. The symptoms are described as moderate in nature.;surgery
brain_glioma_0680;Brain Glioma;67;M;Patient is experiencing dizziness and persistent headaches over the past 2 months. The symptoms are described as debilitating in nature.;chemotherapy
brain_glioma_0681;Brain Glioma;26;F;Patient is experiencing dizziness and memory lapses for more than 6 months. The symptoms are described as moderate in nature.;radiation therapy
brain_glioma_0682;Brain Glioma;63;F;Patient is experiencing memory lapses and confusion for more than 6 months. The symptoms are described as moderate in nature.;chemotherapy
brain_glioma_0683;Brain Glioma;39;F;Patient is experiencing dizziness and visual disturbances over the past 2 months. The symptoms are described as high-grade in nature.;surgery
brain_glioma_0684;Brain Glioma;50;F;Patient is experiencing persistent headaches and frequent seizures for the last few weeks. The symptoms are described as significant in nature.;chemotherapy
brain_glioma_0685;Brain Glioma;23;F;Patient is experiencing speech difficulties and memory lapses over the past 2 months. The symptoms are described as severe in nature.;chemotherapy
brain_glioma_0686;Brain Glioma;32;M;Patient is experiencing confusion and memory lapses over the past 2 months. The symptoms are described as debilitating in nature.;surgery
brain_glioma_0687;Brain Glioma;78;M;Patient is experiencing memory lapses and confusion for more than 6 months. The symptoms are described as noticeable in nature.;chemotherapy
brain_glioma_0688;Brain Glioma;66;M;Patient is experiencing dizziness and memory lapses for more than 6 months. The symptoms are described as moderate in nature.;radiation therapy
brain_glioma_0689;Brain Glioma;45;F;Patient is experiencing persistent headaches and memory lapses for the last few weeks. The symptoms are described as high-grade in nature.;chemotherapy
brain_glioma_0690;Brain Glioma;64;M;Patient is experiencing memory lapses and visual disturbances over the past 2 months. The symptoms are described as moderate in nature.;surgery
brain_glioma_0691;Brain Glioma;26;M;Patient is experiencing persistent headaches and dizziness for the last few weeks. The symptoms are described as intense in nature.;chemotherapy
brain_glioma_0692;Brain Glioma;32;M;Patient is experiencing speech difficulties and dizziness for more than 6 months. The symptoms are described as significant in nature.;surgery
brain_glioma_0693;Brain Glioma;62;M;Patient is experiencing confusion and visual disturbances for the last few weeks. The symptoms are described as significant in nature.;radiation therapy
brain_glioma_0694;Brain Glioma;34;M;Patient is experiencing speech difficulties and visual disturbances for more than 6 months. The symptoms are described as debilitating in nature.;surgery
brain_glioma_0695;Brain Glioma;78;M;Patient is experiencing dizziness and frequent seizures for the last few weeks. The symptoms are described as significant in nature.;radiation therapy
brain_glioma_0696;Brain Glioma;83;F;Patient is experiencing confusion and speech difficulties over the past 2 months. The symptoms are described as moderate in nature.;radiation therapy
brain_glioma_0697;Brain Glioma;25;M;Patient is experiencing memory lapses and visual disturbances for more than 6 months. The symptoms are described as moderate in nature.;chemotherapy
brain_glioma_0698;Brain Glioma;40;M;Patient is experiencing confusion and speech difficulties for more than 6 months. The symptoms are described as noticeable in nature.;surgery
brain_glioma_0699;Brain Glioma;80;F;Patient is experiencing frequent seizures and memory lapses over the past 2 months. The symptoms are described as significant in nature.;surgery
brain_glioma_0700;Brain Glioma;34;F;Patient is experiencing frequent seizures and speech difficulties for more than 6 months. The symptoms are described as moderate in nature.;radiation therapy
brain_glioma_0701;Brain Glioma;27;F;Patient is experiencing confusion and dizziness over the past 2 months. The symptoms are described as noticeable in nature.;surgery
brain_glioma_0702;Brain Glioma;68;M;Patient is experiencing memory lapses and speech difficulties for the last few weeks. The symptoms are described as debilitating in nature.;surgery
brain_glioma_0703;Brain Glioma;82;F;Patient is experiencing visual disturbances and dizziness for the last few weeks. The symptoms are described as noticeable in nature.;chemotherapy
brain_glioma_0704;Brain Glioma;80;F;Patient is experiencing persistent headaches and dizziness for the last few weeks. The symptoms are described as intense in nature.;chemotherapy
brain_glioma_0705;Brain Glioma;55;F;Patient is experiencing memory lapses and speech difficulties over the past 2 months. The symptoms are described as intense in nature.;radiation therapy
brain_glioma_0706;Brain Glioma;54;M;Patient is experiencing speech difficulties and confusion over the past 2 months. The symptoms are described as debilitating in nature.;chemotherapy
brain_glioma_0707;Brain Glioma;72;M;Patient is experiencing memory lapses and visual disturbances for more than 6 months. The symptoms are described as noticeable in nature.;radiation therapy
brain_glioma_0708;Brain Glioma;38;M;Patient is experiencing memory lapses and dizziness for the last few weeks. The symptoms are described as noticeable in nature.;surgery
brain_glioma_0709;Brain Glioma;55;F;Patient is experiencing persistent headaches and confusion for the last few weeks. The symptoms are described as intense in nature.;chemotherapy
brain_glioma_0710;Brain Glioma;27;M;Patient is experiencing confusion and speech difficulties for the last few weeks. The symptoms are described as moderate in nature.;radiation therapy
brain_glioma_0711;Brain Glioma;46;F;Patient is experiencing visual disturbances and confusion for the last few weeks. The symptoms are described as debilitating in nature.;chemotherapy
brain_glioma_0712;Brain Glioma;43;M;Patient is experiencing persistent headaches and memory lapses over the past 2 months. The symptoms are described as noticeable in nature.;chemotherapy
brain_glioma_0713;Brain Glioma;25;M;Patient is experiencing frequent seizures and speech difficulties for the last few weeks. The symptoms are described as high-grade in nature.;surgery
brain_glioma_0714;Brain Glioma;28;M;Patient is experiencing speech difficulties and confusion for more than 6 months. The symptoms are described as noticeable in nature.;chemotherapy
brain_glioma_0715;Brain Glioma;29;M;Patient is experiencing frequent seizures and visual disturbances for more than 6 months. The symptoms are described as intense in nature.;radiation therapy
brain_glioma_0716;Brain Glioma;50;M;Patient is experiencing persistent headaches and dizziness for the last few weeks. The symptoms are described as severe in nature.;chemotherapy
brain_glioma_0717;Brain Glioma;58;F;Patient is experiencing persistent headaches and confusion over the past 2 months. The symptoms are described as debilitating in nature.;radiation therapy
brain_glioma_0718;Brain Glioma;72;M;Patient is experiencing persistent headaches and memory lapses over the past 2 months. The symptoms are described as intense in nature.;surgery
brain_glioma_0719;Brain Glioma;54;M;Patient is experiencing dizziness and speech difficulties for the last few weeks. The symptoms are described as severe in nature.;chemotherapy
brain_glioma_0720;Brain Glioma;40;F;Patient is experiencing visual disturbances and frequent seizures for the last few weeks. The symptoms are described as high-grade in nature.;radiation therapy
brain_glioma_0721;Brain Glioma;39;F;Patient is experiencing speech difficulties and confusion over the past 2 months. The symptoms are described as significant in nature.;radiation therapy
brain_glioma_0722;Brain Glioma;29;F;Patient is experiencing frequent seizures and persistent headaches for more than 6 months. The symptoms are described as moderate in nature.;radiation therapy
brain_glioma_0723;Brain Glioma;84;M;Patient is experiencing speech difficulties and dizziness for more than 6 months. The symptoms are described as significant in nature.;surgery
brain_glioma_0724;Brain Glioma;46;F;Patient is experiencing speech difficulties and visual disturbances for more than 6 months. The symptoms are described as significant in nature.;chemotherapy
brain_glioma_0725;Brain Glioma;20;F;Patient is experiencing frequent seizures and dizziness over the past 2 months. The symptoms are described as noticeable in nature.;radiation therapy
brain_glioma_0726;Brain Glioma;68;M;Patient is experiencing persistent headaches and dizziness over the past 2 months. The symptoms are described as significant in nature.;chemotherapy
brain_glioma_0727;Brain Glioma;85;F;Patient is experiencing dizziness and persistent headaches for more than 6 months. The symptoms are described as significant in nature.;radiation therapy
brain_glioma_0728;Brain Glioma;78;F;Patient is experiencing persistent headaches and dizziness for more than 6 months. The symptoms are described as high-grade in nature.;radiation therapy
brain_glioma_0729;Brain Glioma;82;F;Patient is experiencing memory lapses and visual disturbances for the last few weeks. The symptoms are described as moderate in nature.;chemotherapy
brain_glioma_0730;Brain Glioma;39;F;Patient is experiencing dizziness and confusion over the past 2 months. The symptoms are described as significant in nature.;radiation therapy
brain_glioma_0731;Brain Glioma;56;M;Patient is experiencing frequent seizures and dizziness for the last few weeks. The symptoms are described as severe in nature.;radiation therapy
brain_glioma_0732;Brain Glioma;30;F;Patient is experiencing frequent seizures and visual disturbances for more than 6 months. The symptoms are described as moderate in nature.;surgery
brain_glioma_0733;Brain Glioma;77;M;Patient is experiencing frequent seizures and speech difficulties over the past 2 months. The symptoms are described as high-grade in nature.;chemotherapy
brain_glioma_0734;Brain Glioma;46;M;Patient is experiencing dizziness and visual disturbances for more than 6 months. The symptoms are described as significant in nature.;radiation therapy
brain_glioma_0735;Brain Glioma;35;F;Patient is experiencing dizziness and memory lapses for more than 6 months. The symptoms are described as significant in nature.;surgery
brain_glioma_0736;Brain Glioma;27;F;Patient is experiencing dizziness and speech difficulties over the past 2 months. The symptoms are described as significant in nature.;radiation therapy
brain_glioma_0737;Brain Glioma;83;F;Patient is experiencing visual disturbances and dizziness for the last few weeks. The symptoms are described as severe in nature.;surgery
brain_glioma_0738;Brain Glioma;85;F;Patient is experiencing confusion and visual disturbances for the last few weeks. The symptoms are described as debilitating in nature.;chemotherapy
brain_glioma_0739;Brain Glioma;32;F;Patient is experiencing confusion and persistent headaches over the past 2 months. The symptoms are described as severe in nature.;surgery
brain_glioma_0740;Brain Glioma;36;F;Patient is experiencing persistent headaches and frequent seizures over the past 2 months. The symptoms are described as debilitating in nature.;surgery
brain_glioma_0741;Brain Glioma;46;M;Patient is experiencing frequent seizures and memory lapses for the last few weeks. The symptoms are described as high-grade in nature.;chemotherapy
brain_glioma_0742;Brain Glioma;38;F;Patient is experiencing persistent headaches and memory lapses for more than 6 months. The symptoms are described as significant in nature.;chemotherapy
brain_glioma_0743;Brain Glioma;69;M;Patient is experiencing visual disturbances and dizziness for more than 6 months. The symptoms are described as significant in nature.;radiation therapy
brain_glioma_0744;Brain Glioma;24;M;Patient is experiencing memory lapses and visual disturbances for more than 6 months. The symptoms are described as moderate in nature.;radiation therapy
brain_glioma_0745;Brain Glioma;84;F;Patient is experiencing dizziness and confusion for more than 6 months. The symptoms are described as severe in nature.;chemotherapy
brain_glioma_0746;Brain Glioma;21;M;Patient is experiencing frequent seizures and memory lapses for the last few weeks. The symptoms are described as significant in nature.;radiation therapy
brain_glioma_0747;Brain Glioma;84;F;Patient is experiencing memory lapses and visual disturbances for the last few weeks. The symptoms are described as moderate in nature.;chemotherapy
brain_glioma_0748;Brain Glioma;65;F;Patient is experiencing persistent headaches and confusion over the past 2 months. The symptoms are described as debilitating in nature.;chemotherapy
brain_glioma_0749;Brain Glioma;22;F;Patient is experiencing visual disturbances and dizziness over the past 2 months. The symptoms are described as debilitating in nature.;radiation therapy
brain_glioma_0750;Brain Glioma;66;M;Patient is experiencing memory lapses and visual disturbances for the last few weeks. The symptoms are described as severe in nature.;chemotherapy
brain_glioma_0751;Brain Glioma;59;F;Patient is experiencing persistent headaches and visual disturbances for more than 6 months. The symptoms are described as severe in nature.;chemotherapy
brain_glioma_0752;Brain Glioma;65;M;Patient is experiencing dizziness and frequent seizures over the past 2 months. The symptoms are described as noticeable in nature.;radiation therapy
brain_glioma_0753;Brain Glioma;71;M;Patient is experiencing confusion and visual disturbances for the last few weeks. The symptoms are described as significant in nature.;chemotherapy
brain_glioma_0754;Brain Glioma;54;F;Patient is experiencing frequent seizures and dizziness for the last few weeks. The symptoms are described as moderate in nature.;surgery
brain_glioma_0755;Brain Glioma;42;M;Patient is experiencing persistent headaches and dizziness for the last few weeks. The symptoms are described as severe in nature.;chemotherapy
brain_glioma_0756;Brain Glioma;84;F;Patient is experiencing speech difficulties and dizziness over the past 2 months. The symptoms are described as significant in nature.;radiation therapy
brain_glioma_0757;Brain Glioma;70;M;Patient is experiencing persistent headaches and confusion for the last few weeks. The symptoms are described as high-grade in nature.;radiation therapy
brain_glioma_0758;Brain Glioma;71;F;Patient is experiencing persistent headaches and speech difficulties for the last few weeks. The symptoms are described as moderate in nature.;chemotherapy
brain_glioma_0759;Brain Glioma;51;M;Patient is experiencing memory lapses and frequent seizures for more than 6 months. The symptoms are described as intense in nature.;chemotherapy
brain_glioma_0760;Brain Glioma;65;M;Patient is experiencing confusion and dizziness for more than 6 months. The symptoms are described as moderate in nature.;surgery
brain_glioma_0761;Brain Glioma;78;M;Patient is experiencing speech difficulties and visual disturbances for more than 6 months. The symptoms are described as high-grade in nature.;radiation therapy
brain_glioma_0762;Brain Glioma;34;M;Patient is experiencing confusion and persistent headaches for more than 6 months. The symptoms are described as debilitating in nature.;chemotherapy
brain_glioma_0763;Brain Glioma;37;F;Patient is experiencing persistent headaches and confusion for the last few weeks. The symptoms are described as debilitating in nature.;radiation therapy
brain_glioma_0764;Brain Glioma;43;M;Patient is experiencing persistent headaches and frequent seizures over the past 2 months. The symptoms are described as significant in nature.;surgery
brain_glioma_0765;Brain Glioma;85;M;Patient is experiencing persistent headaches and speech difficulties over the past 2 months. The symptoms are described as significant in nature.;surgery
brain_glioma_0766;Brain Glioma;71;F;Patient is experiencing visual disturbances and persistent headaches over the past 2 months. The symptoms are described as significant in nature.;radiation therapy
brain_glioma_0767;Brain Glioma;71;F;Patient is experiencing memory lapses and dizziness for more than 6 months. The symptoms are described as intense in nature.;surgery
brain_glioma_0768;Brain Glioma;72;F;Patient is experiencing frequent seizures and visual disturbances for the last few weeks. The symptoms are described as severe in nature.;surgery
brain_glioma_0769;Brain Glioma;59;F;Patient is experiencing persistent headaches and confusion over the past 2 months. The symptoms are described as debilitating in nature.;chemotherapy
brain_glioma_0770;Brain Glioma;39;F;Patient is experiencing dizziness and visual disturbances for more than 6 months. The symptoms are described as noticeable in nature.;chemotherapy
brain_glioma_0771;Brain Glioma;76;F;Patient is experiencing persistent headaches and memory lapses over the past 2 months. The symptoms are described as moderate in nature.;surgery
brain_glioma_0772;Brain Glioma;37;F;Patient is experiencing confusion and dizziness over the past 2 months. The symptoms are described as debilitating in nature.;surgery
brain_glioma_0773;Brain Glioma;75;M;Patient is experiencing memory lapses and frequent seizures for the last few weeks. The symptoms are described as high-grade in nature.;chemotherapy
brain_glioma_0774;Brain Glioma;84;F;Patient is experiencing persistent headaches and visual disturbances for more than 6 months. The symptoms are described as moderate in nature.;radiation therapy
brain_glioma_0775;Brain Glioma;27;F;Patient is experiencing confusion and frequent seizures over the past 2 months. The symptoms are described as intense in nature.;radiation therapy
brain_glioma_0776;Brain Glioma;48;F;Patient is experiencing persistent headaches and dizziness for more than 6 months. The symptoms are described as debilitating in nature.;surgery
brain_glioma_0777;Brain Glioma;75;M;Patient is experiencing memory lapses and visual disturbances over the past 2 months. The symptoms are described as moderate in nature.;surgery
brain_glioma_0778;Brain Glioma;35;F;Patient is experiencing visual disturbances and speech difficulties for more than 6 months. The symptoms are described as significant in nature.;chemotherapy
brain_glioma_0779;Brain Glioma;30;F;Patient is experiencing dizziness and visual disturbances for the last few weeks. The symptoms are described as intense in nature.;surgery
brain_glioma_0780;Brain Glioma;32;M;Patient is experiencing speech difficulties and visual disturbances for more than 6 months. The symptoms are described as debilitating in nature.;radiation therapy
brain_glioma_0781;Brain Glioma;76;F;Patient is experiencing confusion and frequent seizures for more than 6 months. The symptoms are described as noticeable in nature.;surgery
brain_glioma_0782;Brain Glioma;72;M;Patient is experiencing visual disturbances and frequent seizures over the past 2 months. The symptoms are described as significant in nature.;chemotherapy
brain_glioma_0783;Brain Glioma;65;M;Patient is experiencing visual disturbances and memory lapses for the last few weeks. The symptoms are described as moderate in nature.;chemotherapy
brain_glioma_0784;Brain Glioma;37;M;Patient is experiencing memory lapses and frequent seizures over the past 2 months. The symptoms are described as high-grade in nature.;chemotherapy
brain_glioma_0785;Brain Glioma;65;F;Patient is experiencing confusion and speech difficulties for the last few weeks. The symptoms are described as moderate in nature.;radiation therapy
brain_glioma_0786;Brain Glioma;38;F;Patient is experiencing frequent seizures and dizziness over the past 2 months. The symptoms are described as noticeable in nature.;radiation therapy
brain_glioma_0787;Brain Glioma;42;F;Patient is experiencing confusion and speech difficulties for the last few weeks. The symptoms are described as significant in nature.;chemotherapy
brain_glioma_0788;Brain Glioma;60;M;Patient is experiencing persistent headaches and memory lapses over the past 2 months. The symptoms are described as moderate in nature.;radiation therapy
brain_glioma_0789;Brain Glioma;33;F;Patient is experiencing confusion and speech difficulties over the past 2 months. The symptoms are described as noticeable in nature.;radiation therapy
brain_glioma_0790;Brain Glioma;84;F;Patient is experiencing frequent seizures and memory lapses for the last few weeks. The symptoms are described as severe in nature.;surgery
brain_glioma_0791;Brain Glioma;69;M;Patient is experiencing frequent seizures and visual disturbances for the last few weeks. The symptoms are described as significant in nature.;radiation therapy
brain_glioma_0792;Brain Glioma;81;M;Patient is experiencing dizziness and confusion over the past 2 months. The symptoms are described as significant in nature.;surgery
brain_glioma_0793;Brain Glioma;22;M;Patient is experiencing frequent seizures and speech difficulties for more than 6 months. The symptoms are described as intense in nature.;radiation therapy
brain_glioma_0794;Brain Glioma;61;F;Patient is experiencing persistent headaches and frequent seizures for the last few weeks. The symptoms are described as intense in nature.;surgery
brain_glioma_0795;Brain Glioma;85;F;Patient is experiencing confusion and speech difficulties over the past 2 months. The symptoms are described as severe in nature.;radiation therapy
brain_glioma_0796;Brain Glioma;54;F;Patient is experiencing confusion and speech difficulties for the last few weeks. The symptoms are described as noticeable in nature.;chemotherapy
brain_glioma_0797;Brain Glioma;50;F;Patient is experiencing visual disturbances and dizziness for the last few weeks. The symptoms are described as severe in nature.;surgery
brain_glioma_0798;Brain Glioma;55;F;Patient is experiencing visual disturbances and memory lapses for the last few weeks. The symptoms are described as significant in nature.;chemotherapy
brain_glioma_0799;Brain Glioma;77;F;Patient is experiencing speech difficulties and memory lapses over the past 2 months. The symptoms are described as significant in nature.;chemotherapy
brain_glioma_0800;Brain Glioma;73;M;Patient is experiencing speech difficulties and frequent seizures for the last few weeks. The symptoms are described as noticeable in nature.;radiation therapy
brain_glioma_0801;Brain Glioma;46;F;Patient is experiencing frequent seizures and dizziness over the past 2 months. The symptoms are described as high-grade in nature.;surgery
brain_glioma_0802;Brain Glioma;18;F;Patient is experiencing speech difficulties and dizziness for more than 6 months. The symptoms are described as significant in nature.;chemotherapy
brain_glioma_0803;Brain Glioma;33;M;Patient is experiencing memory lapses and visual disturbances over the past 2 months. The symptoms are described as moderate in nature.;surgery
brain_glioma_0804;Brain Glioma;61;M;Patient is experiencing persistent headaches and speech difficulties over the past 2 months. The symptoms are described as moderate in nature.;surgery
brain_glioma_0805;Brain Glioma;50;F;Patient is experiencing dizziness and visual disturbances for more than 6 months. The symptoms are described as high-grade in nature.;surgery
brain_glioma_0806;Brain Glioma;29;M;Patient is experiencing visual disturbances and speech difficulties for more than 6 months. The symptoms are described as noticeable in nature.;surgery
brain_glioma_0807;Brain Glioma;82;F;Patient is experiencing frequent seizures and persistent headaches over the past 2 months. The symptoms are described as high-grade in nature.;surgery
brain_glioma_0808;Brain Glioma;74;M;Patient is experiencing frequent seizures and visual disturbances for the last few weeks. The symptoms are described as significant in nature.;surgery
brain_glioma_0809;Brain Glioma;55;M;Patient is experiencing visual disturbances and dizziness for the last few weeks. The symptoms are described as noticeable in nature.;chemotherapy
brain_glioma_0810;Brain Glioma;43;M;Patient is experiencing dizziness and frequent seizures for more than 6 months. The symptoms are described as moderate in nature.;chemotherapy
brain_glioma_0811;Brain Glioma;85;M;Patient is experiencing speech difficulties and persistent headaches for the last few weeks. The symptoms are described as significant in nature.;chemotherapy
brain_glioma_0812;Brain Glioma;32;F;Patient is experiencing confusion and speech difficulties for more than 6 months. The symptoms are described as significant in nature.;surgery
brain_glioma_0813;Brain Glioma;65;F;Patient is experiencing speech difficulties and frequent seizures over the past 2 months. The symptoms are described as high-grade in nature.;radiation therapy
brain_glioma_0814;Brain Glioma;36;M;Patient is experiencing speech difficulties and confusion for the last few weeks. The symptoms are described as noticeable in nature.;surgery
brain_glioma_0815;Brain Glioma;69;F;Patient is experiencing memory lapses and speech difficulties for the last few weeks. The symptoms are described as severe in nature.;surgery
brain_glioma_0816;Brain Glioma;23;M;Patient is experiencing confusion and frequent seizures over the past 2 months. The symptoms are described as moderate in nature.;chemotherapy
brain_glioma_0817;Brain Glioma;57;F;Patient is experiencing visual disturbances and persistent headaches for more than 6 months. The symptoms are described as significant in nature.;radiation therapy
brain_glioma_0818;Brain Glioma;29;M;Patient is experiencing frequent seizures and dizziness for more than 6 months. The symptoms are described as debilitating in nature.;chemotherapy
brain_glioma_0819;Brain Glioma;49;F;Patient is experiencing speech difficulties and confusion over the past 2 months. The symptoms are described as moderate in nature.;surgery
brain_glioma_0820;Brain Glioma;28;M;Patient is experiencing memory lapses and persistent headaches over the past 2 months. The symptoms are described as significant in nature.;chemotherapy
brain_glioma_0821;Brain Glioma;18;M;Patient is experiencing dizziness and visual disturbances for more than 6 months. The symptoms are described as debilitating in nature.;surgery
brain_glioma_0822;Brain Glioma;76;M;Patient is experiencing confusion and speech difficulties over the past 2 months. The symptoms are described as severe in nature.;radiation therapy
brain_glioma_0823;Brain Glioma;28;F;Patient is experiencing memory lapses and dizziness for more than 6 months. The symptoms are described as intense in nature.;chemotherapy
brain_glioma_0824;Brain Glioma;54;M;Patient is experiencing persistent headaches and speech difficulties over the past 2 months. The symptoms are described as noticeable in nature.;radiation therapy
brain_glioma_0825;Brain Glioma;82;M;Patient is experiencing visual disturbances and confusion for the last few weeks. The symptoms are described as severe in nature.;radiation therapy
brain_glioma_0826;Brain Glioma;58;M;Patient is experiencing speech difficulties and persistent headaches for the last few weeks. The symptoms are described as severe in nature.;surgery
brain_glioma_0827;Brain Glioma;33;M;Patient is experiencing dizziness and confusion for the last few weeks. The symptoms are described as severe in nature.;radiation therapy
brain_glioma_0828;Brain Glioma;75;M;Patient is experiencing persistent headaches and memory lapses for more than 6 months. The symptoms are described as severe in nature.;surgery
brain_glioma_0829;Brain Glioma;64;F;Patient is experiencing visual disturbances and persistent headaches for the last few weeks. The symptoms are described as noticeable in nature.;surgery
brain_glioma_0830;Brain Glioma;21;F;Patient is experiencing visual disturbances and memory lapses over the past 2 months. The symptoms are described as severe in nature.;surgery
brain_glioma_0831;Brain Glioma;39;F;Patient is experiencing dizziness and memory lapses over the past 2 months. The symptoms are described as severe in nature.;chemotherapy
brain_glioma_0832;Brain Glioma;65;F;Patient is experiencing memory lapses and dizziness over the past 2 months. The symptoms are described as debilitating in nature.;chemotherapy
brain_glioma_0833;Brain Glioma;71;F;Patient is experiencing memory lapses and confusion over the past 2 months. The symptoms are described as intense in nature.;surgery
brain_glioma_0834;Brain Glioma;28;M;Patient is experiencing confusion and dizziness for more than 6 months. The symptoms are described as significant in nature.;surgery
brain_glioma_0835;Brain Glioma;73;F;Patient is experiencing confusion and visual disturbances over the past 2 months. The symptoms are described as noticeable in nature.;surgery
brain_glioma_0836;Brain Glioma;71;F;Patient is experiencing memory lapses and visual disturbances for the last few weeks. The symptoms are described as high-grade in nature.;surgery
brain_glioma_0837;Brain Glioma;57;F;Patient is experiencing memory lapses and visual disturbances over the past 2 months. The symptoms are described as high-grade in nature.;surgery
brain_glioma_0838;Brain Glioma;74;F;Patient is experiencing visual disturbances and speech difficulties for more than 6 months. The symptoms are described as severe in nature.;radiation therapy
brain_glioma_0839;Brain Glioma;32;F;Patient is experiencing persistent headaches and speech difficulties for the last few weeks. The symptoms are described as severe in nature.;surgery
brain_glioma_0840;Brain Glioma;73;F;Patient is experiencing memory lapses and dizziness over the past 2 months. The symptoms are described as noticeable in nature.;surgery
brain_glioma_0841;Brain Glioma;53;M;Patient is experiencing memory lapses and speech difficulties for the last few weeks. The symptoms are described as high-grade in nature.;surgery
brain_glioma_0842;Brain Glioma;51;F;Patient is experiencing memory lapses and confusion for more than 6 months. The symptoms are described as moderate in nature.;surgery
brain_glioma_0843;Brain Glioma;72;F;Patient is experiencing persistent headaches and speech difficulties for the last few weeks. The symptoms are described as debilitating in nature.;chemotherapy
brain_glioma_0844;Brain Glioma;47;M;Patient is experiencing memory lapses and frequent seizures over the past 2 months. The symptoms are described as debilitating in nature.;surgery
brain_glioma_0845;Brain Glioma;65;F;Patient is experiencing dizziness and frequent seizures over the past 2 months. The symptoms are described as debilitating in nature.;radiation therapy
brain_glioma_0846;Brain Glioma;26;F;Patient is experiencing memory lapses and visual disturbances for more than 6 months. The symptoms are described as significant in nature.;radiation therapy
brain_glioma_0847;Brain Glioma;58;M;Patient is experiencing frequent seizures and memory lapses for more than 6 months. The symptoms are described as noticeable in nature.;surgery
brain_glioma_0848;Brain Glioma;45;M;Patient is experiencing speech difficulties and memory lapses over the past 2 months. The symptoms are described as high-grade in nature.;surgery
brain_glioma_0849;Brain Glioma;18;F;Patient is experiencing dizziness and frequent seizures over the past 2 months. The symptoms are described as noticeable in nature.;surgery
brain_glioma_0850;Brain Glioma;43;F;Patient is experiencing persistent headaches and dizziness over the past 2 months. The symptoms are described as noticeable in nature.;chemotherapy
brain_glioma_0851;Brain Glioma;55;M;Patient is experiencing frequent seizures and memory lapses for more than 6 months. The symptoms are described as debilitating in nature.;chemotherapy
brain_glioma_0852;Brain Glioma;84;M;Patient is experiencing frequent seizures and dizziness over the past 2 months. The symptoms are described as debilitating in nature.;chemotherapy
brain_glioma_0853;Brain Glioma;41;F;Patient is experiencing persistent headaches and dizziness for more than 6 months. The symptoms are described as severe in nature.;radiation therapy
brain_glioma_0854;Brain Glioma;29;F;Patient is experiencing speech difficulties and persistent headaches for the last few weeks. The symptoms are described as noticeable in nature.;chemotherapy
brain_glioma_0855;Brain Glioma;30;F;Patient is experiencing confusion and visual disturbances for the last few weeks. The symptoms are described as debilitating in nature.;chemotherapy
brain_glioma_0856;Brain Glioma;63;F;Patient is experiencing frequent seizures and speech difficulties over the past 2 months. The symptoms are described as intense in nature.;radiation therapy
brain_glioma_0857;Brain Glioma;50;F;Patient is experiencing speech difficulties and dizziness for the last few weeks. The symptoms are described as noticeable in nature.;radiation therapy
brain_glioma_0858;Brain Glioma;35;F;Patient is experiencing memory lapses and visual disturbances over the past 2 months. The symptoms are described as severe in nature.;chemotherapy
brain_glioma_0859;Brain Glioma;82;F;Patient is experiencing dizziness and visual disturbances over the past 2 months. The symptoms are described as intense in nature.;chemotherapy
brain_glioma_0860;Brain Glioma;61;F;Patient is experiencing dizziness and visual disturbances for more than 6 months. The symptoms are described as moderate in nature.;chemotherapy
brain_glioma_0861;Brain Glioma;38;F;Patient is experiencing persistent headaches and visual disturbances over the past 2 months. The symptoms are described as moderate in nature.;surgery
brain_glioma_0862;Brain Glioma;29;M;Patient is experiencing speech difficulties and memory lapses for the last few weeks. The symptoms are described as moderate in nature.;radiation therapy
brain_glioma_0863;Brain Glioma;27;M;Patient is experiencing confusion and visual disturbances over the past 2 months. The symptoms are described as noticeable in nature.;radiation therapy
brain_glioma_0864;Brain Glioma;20;F;Patient is experiencing speech difficulties and frequent seizures for the last few weeks. The symptoms are described as significant in nature.;chemotherapy
brain_glioma_0865;Brain Glioma;18;F;Patient is experiencing frequent seizures and persistent headaches for the last few weeks. The symptoms are described as debilitating in nature.;chemotherapy
brain_glioma_0866;Brain Glioma;67;M;Patient is experiencing confusion and dizziness for the last few weeks. The symptoms are described as moderate in nature.;surgery
brain_glioma_0867;Brain Glioma;19;M;Patient is experiencing confusion and frequent seizures for the last few weeks. The symptoms are described as high-grade in nature.;radiation therapy
brain_glioma_0868;Brain Glioma;47;M;Patient is experiencing frequent seizures and persistent headaches over the past 2 months. The symptoms are described as moderate in nature.;surgery
brain_glioma_0869;Brain Glioma;81;M;Patient is experiencing memory lapses and speech difficulties for more than 6 months. The symptoms are described as significant in nature.;surgery
brain_glioma_0870;Brain Glioma;35;F;Patient is experiencing persistent headaches and frequent seizures for more than 6 months. The symptoms are described as high-grade in nature.;radiation therapy
brain_glioma_0871;Brain Glioma;23;F;Patient is experiencing memory lapses and visual disturbances for the last few weeks. The symptoms are described as significant in nature.;chemotherapy
brain_glioma_0872;Brain Glioma;30;F;Patient is experiencing frequent seizures and visual disturbances for more than 6 months. The symptoms are described as moderate in nature.;chemotherapy
brain_glioma_0873;Brain Glioma;57;M;Patient is experiencing speech difficulties and dizziness for the last few weeks. The symptoms are described as high-grade in nature.;surgery
brain_glioma_0874;Brain Glioma;58;M;Patient is experiencing visual disturbances and persistent headaches for the last few weeks. The symptoms are described as intense in nature.;surgery
brain_glioma_0875;Brain Glioma;23;F;Patient is experiencing speech difficulties and confusion over the past 2 months. The symptoms are described as significant in nature.;surgery
brain_glioma_0876;Brain Glioma;85;M;Patient is experiencing speech difficulties and memory lapses for more than 6 months. The symptoms are described as significant in nature.;chemotherapy
brain_glioma_0877;Brain Glioma;57;M;Patient is experiencing confusion and dizziness over the past 2 months. The symptoms are described as significant in nature.;radiation therapy
brain_glioma_0878;Brain Glioma;66;F;Patient is experiencing memory lapses and speech difficulties for more than 6 months. The symptoms are described as significant in nature.;chemotherapy
brain_glioma_0879;Brain Glioma;79;F;Patient is experiencing dizziness and speech difficulties for the last few weeks. The symptoms are described as moderate in nature.;radiation therapy
brain_glioma_0880;Brain Glioma;48;M;Patient is experiencing confusion and dizziness for the last few weeks. The symptoms are described as debilitating in nature.;radiation therapy
brain_glioma_0881;Brain Glioma;58;F;Patient is experiencing confusion and dizziness over the past 2 months. The symptoms are described as high-grade in nature.;radiation therapy
brain_glioma_0882;Brain Glioma;27;M;Patient is experiencing frequent seizures and persistent headaches for more than 6 months. The symptoms are described as significant in nature.;chemotherapy
brain_glioma_0883;Brain Glioma;50;F;Patient is experiencing dizziness and frequent seizures for the last few weeks. The symptoms are described as high-grade in nature.;radiation therapy
brain_glioma_0884;Brain Glioma;79;M;Patient is experiencing persistent headaches and confusion over the past 2 months. The symptoms are described as severe in nature.;surgery
brain_glioma_0885;Brain Glioma;57;M;Patient is experiencing speech difficulties and confusion over the past 2 months. The symptoms are described as noticeable in nature.;radiation therapy
brain_glioma_0886;Brain Glioma;54;F;Patient is experiencing frequent seizures and visual disturbances for the last few weeks. The symptoms are described as moderate in nature.;surgery
brain_glioma_0887;Brain Glioma;65;F;Patient is experiencing frequent seizures and speech difficulties over the past 2 months. The symptoms are described as severe in nature.;chemotherapy
brain_glioma_0888;Brain Glioma;74;F;Patient is experiencing persistent headaches and speech difficulties over the past 2 months. The symptoms are described as severe in nature.;chemotherapy
brain_glioma_0889;Brain Glioma;48;F;Patient is experiencing visual disturbances and persistent headaches for the last few weeks. The symptoms are described as moderate in nature.;radiation therapy
brain_glioma_0890;Brain Glioma;39;M;Patient is experiencing speech difficulties and frequent seizures for the last few weeks. The symptoms are described as intense in nature.;radiation therapy
brain_glioma_0891;Brain Glioma;35;F;Patient is experiencing frequent seizures and speech difficulties for the last few weeks. The symptoms are described as noticeable in nature.;surgery
brain_glioma_0892;Brain Glioma;25;F;Patient is experiencing memory lapses and confusion over the past 2 months. The symptoms are described as intense in nature.;chemotherapy
brain_glioma_0893;Brain Glioma;72;M;Patient is experiencing speech difficulties and frequent seizures over the past 2 months. The symptoms are described as debilitating in nature.;radiation therapy
brain_glioma_0894;Brain Glioma;50;F;Patient is experiencing visual disturbances and dizziness for the last few weeks. The symptoms are described as intense in nature.;chemotherapy
brain_glioma_0895;Brain Glioma;18;M;Patient is experiencing dizziness and memory lapses for more than 6 months. The symptoms are described as debilitating in nature.;chemotherapy
brain_glioma_0896;Brain Glioma;19;M;Patient is experiencing speech difficulties and persistent headaches for the last few weeks. The symptoms are described as significant in nature.;chemotherapy
brain_glioma_0897;Brain Glioma;24;F;Patient is experiencing speech difficulties and memory lapses over the past 2 months. The symptoms are described as moderate in nature.;chemotherapy
brain_glioma_0898;Brain Glioma;70;F;Patient is experiencing dizziness and speech difficulties for the last few weeks. The symptoms are described as high-grade in nature.;radiation therapy
brain_glioma_0899;Brain Glioma;59;F;Patient is experiencing memory lapses and persistent headaches for the last few weeks. The symptoms are described as intense in nature.;surgery
brain_glioma_0900;Brain Glioma;50;F;Patient is experiencing frequent seizures and visual disturbances for more than 6 months. The symptoms are described as noticeable in nature.;chemotherapy
brain_glioma_0901;Brain Glioma;39;F;Patient is experiencing dizziness and frequent seizures for the last few weeks. The symptoms are described as severe in nature.;radiation therapy
brain_glioma_0902;Brain Glioma;31;F;Patient is experiencing memory lapses and speech difficulties for more than 6 months. The symptoms are described as noticeable in nature.;radiation therapy
brain_glioma_0903;Brain Glioma;80;M;Patient is experiencing frequent seizures and dizziness for the last few weeks. The symptoms are described as intense in nature.;chemotherapy
brain_glioma_0904;Brain Glioma;47;M;Patient is experiencing dizziness and visual disturbances over the past 2 months. The symptoms are described as high-grade in nature.;radiation therapy
brain_glioma_0905;Brain Glioma;23;M;Patient is experiencing persistent headaches and memory lapses over the past 2 months. The symptoms are described as intense in nature.;radiation therapy
brain_glioma_0906;Brain Glioma;77;M;Patient is experiencing dizziness and visual disturbances over the past 2 months. The symptoms are described as intense in nature.;radiation therapy
brain_glioma_0907;Brain Glioma;40;M;Patient is experiencing confusion and persistent headaches over the past 2 months. The symptoms are described as moderate in nature.;surgery
brain_glioma_0908;Brain Glioma;58;F;Patient is experiencing persistent headaches and frequent seizures for the last few weeks. The symptoms are described as noticeable in nature.;radiation therapy
brain_glioma_0909;Brain Glioma;46;F;Patient is experiencing visual disturbances and frequent seizures for the last few weeks. The symptoms are described as debilitating in nature.;surgery
brain_glioma_0910;Brain Glioma;41;M;Patient is experiencing dizziness and memory lapses for the last few weeks. The symptoms are described as noticeable in nature.;chemotherapy
brain_glioma_0911;Brain Glioma;72;F;Patient is experiencing speech difficulties and frequent seizures for the last few weeks. The symptoms are described as intense in nature.;radiation therapy
brain_glioma_0912;Brain Glioma;22;M;Patient is experiencing memory lapses and confusion for the last few weeks. The symptoms are described as noticeable in nature.;radiation therapy
brain_glioma_0913;Brain Glioma;36;F;Patient is experiencing confusion and memory lapses for the last few weeks. The symptoms are described as high-grade in nature.;surgery
brain_glioma_0914;Brain Glioma;53;M;Patient is experiencing visual disturbances and persistent headaches over the past 2 months. The symptoms are described as debilitating in nature.;chemotherapy
brain_glioma_0915;Brain Glioma;45;F;Patient is experiencing persistent headaches and dizziness for the last few weeks. The symptoms are described as intense in nature.;surgery
brain_glioma_0916;Brain Glioma;28;M;Patient is experiencing memory lapses and dizziness for more than 6 months. The symptoms are described as debilitating in nature.;radiation therapy
brain_glioma_0917;Brain Glioma;55;M;Patient is experiencing visual disturbances and speech difficulties over the past 2 months. The symptoms are described as moderate in nature.;surgery
brain_glioma_0918;Brain Glioma;72;F;Patient is experiencing speech difficulties and confusion for the last few weeks. The symptoms are described as debilitating in nature.;surgery
brain_glioma_0919;Brain Glioma;47;F;Patient is experiencing visual disturbances and speech difficulties over the past 2 months. The symptoms are described as debilitating in nature.;radiation therapy
brain_glioma_0920;Brain Glioma;35;M;Patient is experiencing speech difficulties and memory lapses for more than 6 months. The symptoms are described as significant in nature.;chemotherapy
brain_glioma_0921;Brain Glioma;62;M;Patient is experiencing persistent headaches and confusion for the last few weeks. The symptoms are described as debilitating in nature.;surgery
brain_glioma_0922;Brain Glioma;22;F;Patient is experiencing persistent headaches and frequent seizures over the past 2 months. The symptoms are described as noticeable in nature.;surgery
brain_glioma_0923;Brain Glioma;68;F;Patient is experiencing dizziness and visual disturbances for the last few weeks. The symptoms are described as intense in nature.;surgery
brain_glioma_0924;Brain Glioma;83;M;Patient is experiencing speech difficulties and frequent seizures for more than 6 months. The symptoms are described as high-grade in nature.;radiation therapy
brain_glioma_0925;Brain Glioma;58;F;Patient is experiencing visual disturbances and speech difficulties over the past 2 months. The symptoms are described as moderate in nature.;radiation therapy
brain_glioma_0926;Brain Glioma;22;F;Patient is experiencing confusion and persistent headaches for more than 6 months. The symptoms are described as noticeable in nature.;radiation therapy
brain_glioma_0927;Brain Glioma;50;M;Patient is experiencing memory lapses and visual disturbances for more than 6 months. The symptoms are described as intense in nature.;chemotherapy
brain_glioma_0928;Brain Glioma;49;M;Patient is experiencing dizziness and persistent headaches for the last few weeks. The symptoms are described as moderate in nature.;surgery
brain_glioma_0929;Brain Glioma;18;F;Patient is experiencing visual disturbances and confusion for more than 6 months. The symptoms are described as moderate in nature.;chemotherapy
brain_glioma_0930;Brain Glioma;23;M;Patient is experiencing frequent seizures and visual disturbances over the past 2 months. The symptoms are described as debilitating in nature.;surgery
brain_glioma_0931;Brain Glioma;67;F;Patient is experiencing frequent seizures and memory lapses for more than 6 months. The symptoms are described as significant in nature.;surgery
brain_glioma_0932;Brain Glioma;52;M;Patient is experiencing persistent headaches and speech difficulties over the past 2 months. The symptoms are described as debilitating in nature.;surgery
brain_glioma_0933;Brain Glioma;40;F;Patient is experiencing speech difficulties and dizziness over the past 2 months. The symptoms are described as severe in nature.;surgery
brain_glioma_0934;Brain Glioma;47;M;Patient is experiencing persistent headaches and speech difficulties for more than 6 months. The symptoms are described as noticeable in nature.;chemotherapy
brain_glioma_0935;Brain Glioma;73;M;Patient is experiencing dizziness and persistent headaches for the last few weeks. The symptoms are described as noticeable in nature.;chemotherapy
brain_glioma_0936;Brain Glioma;78;M;Patient is experiencing dizziness and speech difficulties for the last few weeks. The symptoms are described as high-grade in nature.;chemotherapy
brain_glioma_0937;Brain Glioma;69;M;Patient is experiencing visual disturbances and speech difficulties for more than 6 months. The symptoms are described as severe in nature.;radiation therapy
brain_glioma_0938;Brain Glioma;42;M;Patient is experiencing memory lapses and confusion over the past 2 months. The symptoms are described as noticeable in nature.;chemotherapy
brain_glioma_0939;Brain Glioma;19;M;Patient is experiencing visual disturbances and frequent seizures for the last few weeks. The symptoms are described as high-grade in nature.;chemotherapy
brain_glioma_0940;Brain Glioma;79;M;Patient is experiencing frequent seizures and memory lapses over the past 2 months. The symptoms are described as noticeable in nature.;surgery
brain_glioma_0941;Brain Glioma;67;M;Patient is experiencing dizziness and memory lapses over the past 2 months. The symptoms are described as noticeable in nature.;radiation therapy
brain_glioma_0942;Brain Glioma;49;M;Patient is experiencing speech difficulties and memory lapses over the past 2 months. The symptoms are described as debilitating in nature.;chemotherapy
brain_glioma_0943;Brain Glioma;24;M;Patient is experiencing confusion and frequent seizures for more than 6 months. The symptoms are described as debilitating in nature.;radiation therapy
brain_glioma_0944;Brain Glioma;31;M;Patient is experiencing frequent seizures and dizziness for the last few weeks. The symptoms are described as moderate in nature.;surgery
brain_glioma_0945;Brain Glioma;63;F;Patient is experiencing confusion and persistent headaches for the last few weeks. The symptoms are described as severe in nature.;surgery
brain_glioma_0946;Brain Glioma;23;M;Patient is experiencing visual disturbances and persistent headaches for more than 6 months. The symptoms are described as intense in nature.;radiation therapy
brain_glioma_0947;Brain Glioma;47;F;Patient is experiencing confusion and frequent seizures for the last few weeks. The symptoms are described as high-grade in nature.;radiation therapy
brain_glioma_0948;Brain Glioma;48;F;Patient is experiencing memory lapses and persistent headaches for more than 6 months. The symptoms are described as severe in nature.;surgery
brain_glioma_0949;Brain Glioma;52;M;Patient is experiencing memory lapses and dizziness for more than 6 months. The symptoms are described as significant in nature.;surgery
brain_glioma_0950;Brain Glioma;63;F;Patient is experiencing speech difficulties and visual disturbances for the last few weeks. The symptoms are described as debilitating in nature.;surgery
brain_glioma_0951;Brain Glioma;37;M;Patient is experiencing visual disturbances and memory lapses for the last few weeks. The symptoms are described as moderate in nature.;chemotherapy
brain_glioma_0952;Brain Glioma;72;M;Patient is experiencing frequent seizures and persistent headaches over the past 2 months. The symptoms are described as intense in nature.;surgery
brain_glioma_0953;Brain Glioma;46;F;Patient is experiencing frequent seizures and persistent headaches for the last few weeks. The symptoms are described as moderate in nature.;chemotherapy
brain_glioma_0954;Brain Glioma;67;F;Patient is experiencing confusion and persistent headaches for the last few weeks. The symptoms are described as high-grade in nature.;radiation therapy
brain_glioma_0955;Brain Glioma;67;F;Patient is experiencing visual disturbances and confusion over the past 2 months. The symptoms are described as significant in nature.;surgery
brain_glioma_0956;Brain Glioma;42;M;Patient is experiencing confusion and persistent headaches for the last few weeks. The symptoms are described as intense in nature.;radiation therapy
brain_glioma_0957;Brain Glioma;77;F;Patient is experiencing persistent headaches and memory lapses over the past 2 months. The symptoms are described as noticeable in nature.;radiation therapy
brain_glioma_0958;Brain Glioma;40;M;Patient is experiencing visual disturbances and speech difficulties over the past 2 months. The symptoms are described as moderate in nature.;radiation therapy
brain_glioma_0959;Brain Glioma;82;M;Patient is experiencing speech difficulties and frequent seizures for more than 6 months. The symptoms are described as noticeable in nature.;surgery
brain_glioma_0960;Brain Glioma;34;M;Patient is experiencing dizziness and frequent seizures for the last few weeks. The symptoms are described as moderate in nature.;surgery
brain_glioma_0961;Brain Glioma;23;F;Patient is experiencing memory lapses and visual disturbances over the past 2 months. The symptoms are described as severe in nature.;chemotherapy
brain_glioma_0962;Brain Glioma;56;F;Patient is experiencing visual disturbances and persistent headaches for more than 6 months. The symptoms are described as severe in nature.;radiation therapy
brain_glioma_0963;Brain Glioma;82;M;Patient is experiencing frequent seizures and dizziness for the last few weeks. The symptoms are described as intense in nature.;surgery
brain_glioma_0964;Brain Glioma;82;M;Patient is experiencing persistent headaches and memory lapses over the past 2 months. The symptoms are described as intense in nature.;chemotherapy
brain_glioma_0965;Brain Glioma;48;M;Patient is experiencing visual disturbances and confusion for the last few weeks. The symptoms are described as intense in nature.;radiation therapy
brain_glioma_0966;Brain Glioma;36;F;Patient is experiencing speech difficulties and memory lapses for more than 6 months. The symptoms are described as debilitating in nature.;radiation therapy
brain_glioma_0967;Brain Glioma;30;F;Patient is experiencing confusion and visual disturbances for more than 6 months. The symptoms are described as significant in nature.;chemotherapy
brain_glioma_0968;Brain Glioma;39;F;Patient is experiencing persistent headaches and memory lapses for the last few weeks. The symptoms are described as significant in nature.;radiation therapy
brain_glioma_0969;Brain Glioma;72;M;Patient is experiencing speech difficulties and visual disturbances for the last few weeks. The symptoms are described as high-grade in nature.;surgery
brain_glioma_0970;Brain Glioma;53;M;Patient is experiencing speech difficulties and persistent headaches for the last few weeks. The symptoms are described as significant in nature.;surgery
brain_glioma_0971;Brain Glioma;61;M;Patient is experiencing speech difficulties and confusion over the past 2 months. The symptoms are described as moderate in nature.;radiation therapy
brain_glioma_0972;Brain Glioma;82;F;Patient is experiencing frequent seizures and dizziness over the past 2 months. The symptoms are described as significant in nature.;surgery
brain_glioma_0973;Brain Glioma;24;F;Patient is experiencing memory lapses and confusion over the past 2 months. The symptoms are described as significant in nature.;chemotherapy
brain_glioma_0974;Brain Glioma;53;M;Patient is experiencing visual disturbances and persistent headaches over the past 2 months. The symptoms are described as moderate in nature.;surgery
brain_glioma_0975;Brain Glioma;82;F;Patient is experiencing frequent seizures and confusion over the past 2 months. The symptoms are described as intense in nature.;radiation therapy
brain_glioma_0976;Brain Glioma;49;M;Patient is experiencing dizziness and visual disturbances for more than 6 months. The symptoms are described as high-grade in nature.;radiation therapy
brain_glioma_0977;Brain Glioma;35;F;Patient is experiencing dizziness and persistent headaches for more than 6 months. The symptoms are described as significant in nature.;surgery
brain_glioma_0978;Brain Glioma;35;M;Patient is experiencing dizziness and persistent headaches for more than 6 months. The symptoms are described as severe in nature.;surgery
brain_glioma_0979;Brain Glioma;72;F;Patient is experiencing confusion and memory lapses over the past 2 months. The symptoms are described as noticeable in nature.;chemotherapy
brain_glioma_0980;Brain Glioma;68;F;Patient is experiencing visual disturbances and confusion for the last few weeks. The symptoms are described as noticeable in nature.;chemotherapy
brain_glioma_0981;Brain Glioma;25;M;Patient is experiencing persistent headaches and memory lapses for more than 6 months. The symptoms are described as severe in nature.;radiation therapy
brain_glioma_0982;Brain Glioma;41;M;Patient is experiencing dizziness and speech difficulties for the last few weeks. The symptoms are described as severe in nature.;radiation therapy
brain_glioma_0983;Brain Glioma;55;M;Patient is experiencing persistent headaches and dizziness for the last few weeks. The symptoms are described as debilitating in nature.;radiation therapy
brain_glioma_0984;Brain Glioma;46;F;Patient is experiencing speech difficulties and persistent headaches for the last few weeks. The symptoms are described as noticeable in nature.;chemotherapy
brain_glioma_0985;Brain Glioma;23;M;Patient is experiencing visual disturbances and memory lapses for the last few weeks. The symptoms are described as moderate in nature.;chemotherapy
brain_glioma_0986;Brain Glioma;59;F;Patient is experiencing frequent seizures and dizziness for the last few weeks. The symptoms are described as debilitating in nature.;surgery
brain_glioma_0987;Brain Glioma;57;M;Patient is experiencing persistent headaches and frequent seizures for more than 6 months. The symptoms are described as moderate in nature.;surgery
brain_glioma_0988;Brain Glioma;47;F;Patient is experiencing persistent headaches and speech difficulties for the last few weeks. The symptoms are described as intense in nature.;chemotherapy
brain_glioma_0989;Brain Glioma;78;M;Patient is experiencing visual disturbances and dizziness for the last few weeks. The symptoms are described as moderate in nature.;chemotherapy
brain_glioma_0990;Brain Glioma;38;F;Patient is experiencing speech difficulties and dizziness for more than 6 months. The symptoms are described as intense in nature.;chemotherapy
brain_glioma_0991;Brain Glioma;63;M;Patient is experiencing persistent headaches and speech difficulties over the past 2 months. The symptoms are described as noticeable in nature.;surgery
brain_glioma_0992;Brain Glioma;68;M;Patient is experiencing dizziness and speech difficulties for the last few weeks. The symptoms are described as significant in nature.;radiation therapy
brain_glioma_0993;Brain Glioma;37;F;Patient is experiencing dizziness and visual disturbances over the past 2 months. The symptoms are described as intense in nature.;chemotherapy
brain_glioma_0994;Brain Glioma;69;M;Patient is experiencing frequent seizures and dizziness over the past 2 months. The symptoms are described as debilitating in nature.;radiation therapy
brain_glioma_0995;Brain Glioma;77;F;Patient is experiencing dizziness and memory lapses for more than 6 months. The symptoms are described as significant in nature.;chemotherapy
brain_glioma_0996;Brain Glioma;55;M;Patient is experiencing persistent headaches and confusion for more than 6 months. The symptoms are described as intense in nature.;chemotherapy
brain_glioma_0997;Brain Glioma;63;M;Patient is experiencing visual disturbances and frequent seizures for the last few weeks. The symptoms are described as severe in nature.;radiation therapy
brain_glioma_0998;Brain Glioma;24;M;Patient is experiencing persistent headaches and memory lapses for more than 6 months. The symptoms are described as moderate in nature.;chemotherapy
brain_glioma_0999;Brain Glioma;29;F;Patient is experiencing memory lapses and visual disturbances for more than 6 months. The symptoms are described as high-grade in nature.;chemotherapy
brain_glioma_1000;Brain Glioma;54;F;Patient is experiencing memory lapses and visual disturbances for the last few weeks. The symptoms are described as high-grade in nature.;radiation therapy
brain_glioma_1001;Brain Glioma;29;M;Patient is experiencing confusion and speech difficulties for the last few weeks. The symptoms are described as high-grade in nature.;radiation therapy
brain_glioma_1002;Brain Glioma;50;M;Patient is experiencing frequent seizures and persistent headaches for the last few weeks. The symptoms are described as significant in nature.;chemotherapy
brain_glioma_1003;Brain Glioma;80;F;Patient is experiencing dizziness and persistent headaches for the last few weeks. The symptoms are described as noticeable in nature.;chemotherapy
brain_glioma_1004;Brain Glioma;24;F;Patient is experiencing speech difficulties and persistent headaches over the past 2 months. The symptoms are described as severe in nature.;surgery
brain_glioma_1005;Brain Glioma;52;M;Patient is experiencing frequent seizures and dizziness over the past 2 months. The symptoms are described as noticeable in nature.;radiation therapy
brain_glioma_1006;Brain Glioma;48;M;Patient is experiencing speech difficulties and persistent headaches over the past 2 months. The symptoms are described as high-grade in nature.;radiation therapy
brain_glioma_1007;Brain Glioma;35;M;Patient is experiencing persistent headaches and speech difficulties for more than 6 months. The symptoms are described as noticeable in nature.;chemotherapy
brain_glioma_1008;Brain Glioma;77;M;Patient is experiencing speech difficulties and confusion for more than 6 months. The symptoms are described as severe in nature.;radiation therapy
brain_glioma_1009;Brain Glioma;74;F;Patient is experiencing visual disturbances and dizziness for the last few weeks. The symptoms are described as high-grade in nature.;radiation therapy
brain_glioma_1010;Brain Glioma;79;M;Patient is experiencing speech difficulties and persistent headaches for more than 6 months. The symptoms are described as noticeable in nature.;radiation therapy
brain_glioma_1011;Brain Glioma;82;F;Patient is experiencing frequent seizures and dizziness over the past 2 months. The symptoms are described as debilitating in nature.;radiation therapy
brain_glioma_1012;Brain Glioma;52;M;Patient is experiencing frequent seizures and confusion for more than 6 months. The symptoms are described as significant in nature.;radiation therapy
brain_glioma_1013;Brain Glioma;72;M;Patient is experiencing frequent seizures and memory lapses over the past 2 months. The symptoms are described as significant in nature.;radiation therapy
brain_glioma_1014;Brain Glioma;47;F;Patient is experiencing confusion and persistent headaches over the past 2 months. The symptoms are described as significant in nature.;radiation therapy
brain_glioma_1015;Brain Glioma;38;F;Patient is experiencing memory lapses and confusion over the past 2 months. The symptoms are described as significant in nature.;chemotherapy
brain_glioma_1016;Brain Glioma;55;M;Patient is experiencing persistent headaches and speech difficulties over the past 2 months. The symptoms are described as debilitating in nature.;surgery
brain_glioma_1017;Brain Glioma;20;M;Patient is experiencing speech difficulties and memory lapses over the past 2 months. The symptoms are described as severe in nature.;radiation therapy
brain_glioma_1018;Brain Glioma;84;F;Patient is experiencing speech difficulties and memory lapses for the last few weeks. The symptoms are described as noticeable in nature.;chemotherapy
brain_glioma_1019;Brain Glioma;44;M;Patient is experiencing speech difficulties and frequent seizures for the last few weeks. The symptoms are described as debilitating in nature.;chemotherapy
brain_glioma_1020;Brain Glioma;82;F;Patient is experiencing confusion and visual disturbances for the last few weeks. The symptoms are described as significant in nature.;surgery
brain_glioma_1021;Brain Glioma;51;M;Patient is experiencing confusion and persistent headaches over the past 2 months. The symptoms are described as significant in nature.;radiation therapy
brain_glioma_1022;Brain Glioma;82;F;Patient is experiencing speech difficulties and dizziness for the last few weeks. The symptoms are described as moderate in nature.;chemotherapy
brain_glioma_1023;Brain Glioma;18;F;Patient is experiencing speech difficulties and memory lapses over the past 2 months. The symptoms are described as noticeable in nature.;radiation therapy
brain_glioma_1024;Brain Glioma;53;F;Patient is experiencing visual disturbances and dizziness for more than 6 months. The symptoms are described as high-grade in nature.;radiation therapy
brain_glioma_1025;Brain Glioma;41;F;Patient is experiencing dizziness and memory lapses over the past 2 months. The symptoms are described as significant in nature.;radiation therapy
brain_glioma_1026;Brain Glioma;24;F;Patient is experiencing frequent seizures and memory lapses for the last few weeks. The symptoms are described as debilitating in nature.;radiation therapy
brain_glioma_1027;Brain Glioma;54;M;Patient is experiencing memory lapses and speech difficulties for the last few weeks. The symptoms are described as noticeable in nature.;radiation therapy
brain_glioma_1028;Brain Glioma;39;F;Patient is experiencing speech difficulties and memory lapses over the past 2 months. The symptoms are described as moderate in nature.;radiation therapy
brain_glioma_1029;Brain Glioma;23;F;Patient is experiencing visual disturbances and persistent headaches over the past 2 months. The symptoms are described as significant in nature.;radiation therapy
brain_glioma_1030;Brain Glioma;18;M;Patient is experiencing persistent headaches and confusion for more than 6 months. The symptoms are described as high-grade in nature.;surgery
brain_glioma_1031;Brain Glioma;22;M;Patient is experiencing memory lapses and persistent headaches for the last few weeks. The symptoms are described as significant in nature.;surgery
brain_glioma_1032;Brain Glioma;34;M;Patient is experiencing memory lapses and persistent headaches over the past 2 months. The symptoms are described as moderate in nature.;chemotherapy
brain_glioma_1033;Brain Glioma;30;F;Patient is experiencing dizziness and speech difficulties for more than 6 months. The symptoms are described as moderate in nature.;surgery
brain_glioma_1034;Brain Glioma;24;M;Patient is experiencing visual disturbances and confusion for more than 6 months. The symptoms are described as significant in nature.;chemotherapy
brain_glioma_1035;Brain Glioma;40;F;Patient is experiencing frequent seizures and persistent headaches for more than 6 months. The symptoms are described as intense in nature.;surgery
brain_glioma_1036;Brain Glioma;73;M;Patient is experiencing confusion and memory lapses over the past 2 months. The symptoms are described as debilitating in nature.;surgery
brain_glioma_1037;Brain Glioma;35;M;Patient is experiencing dizziness and visual disturbances for the last few weeks. The symptoms are described as noticeable in nature.;chemotherapy
brain_glioma_1038;Brain Glioma;76;F;Patient is experiencing frequent seizures and dizziness over the past 2 months. The symptoms are described as significant in nature.;surgery
brain_glioma_1039;Brain Glioma;58;M;Patient is experiencing memory lapses and dizziness for the last few weeks. The symptoms are described as noticeable in nature.;radiation therapy
brain_glioma_1040;Brain Glioma;75;M;Patient is experiencing memory lapses and persistent headaches for more than 6 months. The symptoms are described as debilitating in nature.;surgery
brain_glioma_1041;Brain Glioma;44;M;Patient is experiencing confusion and dizziness for more than 6 months. The symptoms are described as debilitating in nature.;surgery
brain_glioma_1042;Brain Glioma;85;M;Patient is experiencing frequent seizures and memory lapses over the past 2 months. The symptoms are described as moderate in nature.;chemotherapy
brain_glioma_1043;Brain Glioma;25;F;Patient is experiencing visual disturbances and speech difficulties over the past 2 months. The symptoms are described as significant in nature.;chemotherapy
brain_glioma_1044;Brain Glioma;49;M;Patient is experiencing memory lapses and dizziness for more than 6 months. The symptoms are described as debilitating in nature.;surgery
brain_glioma_1045;Brain Glioma;43;F;Patient is experiencing visual disturbances and dizziness for the last few weeks. The symptoms are described as noticeable in nature.;surgery
brain_glioma_1046;Brain Glioma;73;F;Patient is experiencing confusion and speech difficulties over the past 2 months. The symptoms are described as significant in nature.;chemotherapy
brain_glioma_1047;Brain Glioma;58;M;Patient is experiencing persistent headaches and visual disturbances for the last few weeks. The symptoms are described as severe in nature.;chemotherapy
brain_glioma_1048;Brain Glioma;78;F;Patient is experiencing persistent headaches and dizziness for more than 6 months. The symptoms are described as high-grade in nature.;radiation therapy
brain_glioma_1049;Brain Glioma;55;F;Patient is experiencing confusion and memory lapses over the past 2 months. The symptoms are described as high-grade in nature.;chemotherapy
brain_glioma_1050;Brain Glioma;62;F;Patient is experiencing speech difficulties and confusion for more than 6 months. The symptoms are described as significant in nature.;chemotherapy
brain_glioma_1051;Brain Glioma;55;F;Patient is experiencing confusion and persistent headaches for the last few weeks. The symptoms are described as debilitating in nature.;chemotherapy
brain_glioma_1052;Brain Glioma;76;M;Patient is experiencing persistent headaches and memory lapses for more than 6 months. The symptoms are described as intense in nature.;surgery
brain_glioma_1053;Brain Glioma;59;M;Patient is experiencing dizziness and speech difficulties over the past 2 months. The symptoms are described as debilitating in nature.;surgery
brain_glioma_1054;Brain Glioma;64;M;Patient is experiencing frequent seizures and dizziness for more than 6 months. The symptoms are described as significant in nature.;radiation therapy
brain_glioma_1055;Brain Glioma;42;F;Patient is experiencing memory lapses and speech difficulties for more than 6 months. The symptoms are described as debilitating in nature.;chemotherapy
brain_glioma_1056;Brain Glioma;42;M;Patient is experiencing dizziness and speech difficulties for more than 6 months. The symptoms are described as debilitating in nature.;surgery
brain_glioma_1057;Brain Glioma;20;F;Patient is experiencing speech difficulties and memory lapses for more than 6 months. The symptoms are described as debilitating in nature.;surgery
brain_glioma_1058;Brain Glioma;59;M;Patient is experiencing memory lapses and speech difficulties for the last few weeks. The symptoms are described as moderate in nature.;surgery
brain_glioma_1059;Brain Glioma;30;M;Patient is experiencing speech difficulties and memory lapses for the last few weeks. The symptoms are described as noticeable in nature.;chemotherapy
brain_glioma_1060;Brain Glioma;59;F;Patient is experiencing persistent headaches and memory lapses over the past 2 months. The symptoms are described as moderate in nature.;chemotherapy
brain_glioma_1061;Brain Glioma;81;M;Patient is experiencing memory lapses and speech difficulties for the last few weeks. The symptoms are described as noticeable in nature.;radiation therapy
brain_glioma_1062;Brain Glioma;48;F;Patient is experiencing speech difficulties and dizziness over the past 2 months. The symptoms are described as debilitating in nature.;radiation therapy
brain_glioma_1063;Brain Glioma;73;F;Patient is experiencing persistent headaches and confusion for more than 6 months. The symptoms are described as intense in nature.;surgery
brain_glioma_1064;Brain Glioma;68;F;Patient is experiencing persistent headaches and frequent seizures over the past 2 months. The symptoms are described as debilitating in nature.;radiation therapy
brain_glioma_1065;Brain Glioma;83;M;Patient is experiencing persistent headaches and memory lapses over the past 2 months. The symptoms are described as debilitating in nature.;surgery
brain_glioma_1066;Brain Glioma;27;F;Patient is experiencing speech difficulties and dizziness for more than 6 months. The symptoms are described as severe in nature.;surgery
brain_glioma_1067;Brain Glioma;63;M;Patient is experiencing persistent headaches and confusion for the last few weeks. The symptoms are described as severe in nature.;surgery
brain_glioma_1068;Brain Glioma;79;F;Patient is experiencing memory lapses and speech difficulties for the last few weeks. The symptoms are described as significant in nature.;surgery
brain_glioma_1069;Brain Glioma;50;M;Patient is experiencing visual disturbances and persistent headaches for the last few weeks. The symptoms are described as severe in nature.;surgery
brain_glioma_1070;Brain Glioma;74;F;Patient is experiencing confusion and frequent seizures for more than 6 months. The symptoms are described as noticeable in nature.;chemotherapy
brain_glioma_1071;Brain Glioma;62;M;Patient is experiencing persistent headaches and frequent seizures over the past 2 months. The symptoms are described as moderate in nature.;surgery
brain_glioma_1072;Brain Glioma;42;M;Patient is experiencing dizziness and frequent seizures for more than 6 months. The symptoms are described as moderate in nature.;surgery
brain_glioma_1073;Brain Glioma;28;M;Patient is experiencing confusion and memory lapses for the last few weeks. The symptoms are described as significant in nature.;radiation therapy
brain_glioma_1074;Brain Glioma;54;F;Patient is experiencing frequent seizures and confusion for the last few weeks. The symptoms are described as debilitating in nature.;chemotherapy
brain_glioma_1075;Brain Glioma;47;M;Patient is experiencing dizziness and frequent seizures for more than 6 months. The symptoms are described as noticeable in nature.;radiation therapy
brain_glioma_1076;Brain Glioma;22;F;Patient is experiencing dizziness and memory lapses for the last few weeks. The symptoms are described as intense in nature.;surgery
brain_glioma_1077;Brain Glioma;51;F;Patient is experiencing speech difficulties and frequent seizures for the last few weeks. The symptoms are described as moderate in nature.;chemotherapy
brain_glioma_1078;Brain Glioma;47;M;Patient is experiencing confusion and dizziness over the past 2 months. The symptoms are described as severe in nature.;radiation therapy
brain_glioma_1079;Brain Glioma;47;F;Patient is experiencing persistent headaches and frequent seizures for more than 6 months. The symptoms are described as intense in nature.;chemotherapy
brain_glioma_1080;Brain Glioma;24;M;Patient is experiencing memory lapses and persistent headaches for more than 6 months. The symptoms are described as intense in nature.;surgery
brain_glioma_1081;Brain Glioma;51;F;Patient is experiencing frequent seizures and confusion for the last few weeks. The symptoms are described as significant in nature.;chemotherapy
brain_glioma_1082;Brain Glioma;33;M;Patient is experiencing persistent headaches and confusion over the past 2 months. The symptoms are described as intense in nature.;chemotherapy
brain_glioma_1083;Brain Glioma;64;F;Patient is experiencing frequent seizures and dizziness for more than 6 months. The symptoms are described as severe in nature.;surgery
brain_glioma_1084;Brain Glioma;39;M;Patient is experiencing persistent headaches and speech difficulties for the last few weeks. The symptoms are described as high-grade in nature.;surgery
brain_glioma_1085;Brain Glioma;68;M;Patient is experiencing confusion and dizziness for more than 6 months. The symptoms are described as intense in nature.;surgery
brain_glioma_1086;Brain Glioma;30;M;Patient is experiencing memory lapses and frequent seizures for the last few weeks. The symptoms are described as moderate in nature.;chemotherapy
brain_glioma_1087;Brain Glioma;52;M;Patient is experiencing frequent seizures and visual disturbances for more than 6 months. The symptoms are described as moderate in nature.;surgery
brain_glioma_1088;Brain Glioma;21;M;Patient is experiencing persistent headaches and speech difficulties for the last few weeks. The symptoms are described as moderate in nature.;surgery
brain_glioma_1089;Brain Glioma;39;M;Patient is experiencing speech difficulties and visual disturbances for more than 6 months. The symptoms are described as intense in nature.;surgery
brain_glioma_1090;Brain Glioma;41;M;Patient is experiencing visual disturbances and speech difficulties over the past 2 months. The symptoms are described as severe in nature.;chemotherapy
brain_glioma_1091;Brain Glioma;24;F;Patient is experiencing dizziness and speech difficulties over the past 2 months. The symptoms are described as severe in nature.;radiation therapy
brain_glioma_1092;Brain Glioma;40;F;Patient is experiencing memory lapses and persistent headaches for the last few weeks. The symptoms are described as significant in nature.;surgery
brain_glioma_1093;Brain Glioma;21;F;Patient is experiencing dizziness and speech difficulties for the last few weeks. The symptoms are described as moderate in nature.;surgery
brain_glioma_1094;Brain Glioma;58;F;Patient is experiencing visual disturbances and dizziness for more than 6 months. The symptoms are described as severe in nature.;surgery
brain_glioma_1095;Brain Glioma;28;M;Patient is experiencing memory lapses and persistent headaches for the last few weeks. The symptoms are described as significant in nature.;radiation therapy
brain_glioma_1096;Brain Glioma;79;F;Patient is experiencing visual disturbances and persistent headaches for more than 6 months. The symptoms are described as debilitating in nature.;chemotherapy
brain_glioma_1097;Brain Glioma;53;M;Patient is experiencing dizziness and frequent seizures for more than 6 months. The symptoms are described as debilitating in nature.;chemotherapy
brain_glioma_1098;Brain Glioma;53;F;Patient is experiencing confusion and visual disturbances over the past 2 months. The symptoms are described as moderate in nature.;chemotherapy
brain_glioma_1099;Brain Glioma;70;F;Patient is experiencing frequent seizures and confusion for the last few weeks. The symptoms are described as noticeable in nature.;surgery
brain_glioma_1100;Brain Glioma;22;M;Patient is experiencing visual disturbances and speech difficulties for the last few weeks. The symptoms are described as noticeable in nature.;radiation therapy
brain_glioma_1101;Brain Glioma;31;F;Patient is experiencing frequent seizures and confusion for the last few weeks. The symptoms are described as debilitating in nature.;chemotherapy
brain_glioma_1102;Brain Glioma;58;F;Patient is experiencing memory lapses and visual disturbances for the last few weeks. The symptoms are described as significant in nature.;radiation therapy
brain_glioma_1103;Brain Glioma;85;F;Patient is experiencing dizziness and visual disturbances over the past 2 months. The symptoms are described as significant in nature.;radiation therapy
brain_glioma_1104;Brain Glioma;30;F;Patient is experiencing visual disturbances and confusion over the past 2 months. The symptoms are described as high-grade in nature.;chemotherapy
brain_glioma_1105;Brain Glioma;44;M;Patient is experiencing frequent seizures and persistent headaches for more than 6 months. The symptoms are described as high-grade in nature.;surgery
brain_glioma_1106;Brain Glioma;55;M;Patient is experiencing visual disturbances and dizziness for more than 6 months. The symptoms are described as significant in nature.;chemotherapy
brain_glioma_1107;Brain Glioma;80;F;Patient is experiencing visual disturbances and frequent seizures for the last few weeks. The symptoms are described as intense in nature.;radiation therapy
brain_glioma_1108;Brain Glioma;30;F;Patient is experiencing dizziness and memory lapses for more than 6 months. The symptoms are described as moderate in nature.;chemotherapy
brain_glioma_1109;Brain Glioma;25;M;Patient is experiencing dizziness and memory lapses over the past 2 months. The symptoms are described as moderate in nature.;radiation therapy
brain_glioma_1110;Brain Glioma;20;F;Patient is experiencing speech difficulties and memory lapses for the last few weeks. The symptoms are described as significant in nature.;radiation therapy
brain_glioma_1111;Brain Glioma;23;F;Patient is experiencing memory lapses and speech difficulties over the past 2 months. The symptoms are described as intense in nature.;chemotherapy
brain_glioma_1112;Brain Glioma;72;F;Patient is experiencing speech difficulties and memory lapses for the last few weeks. The symptoms are described as significant in nature.;surgery
brain_glioma_1113;Brain Glioma;50;M;Patient is experiencing frequent seizures and speech difficulties for the last few weeks. The symptoms are described as high-grade in nature.;surgery
brain_glioma_1114;Brain Glioma;51;M;Patient is experiencing frequent seizures and confusion over the past 2 months. The symptoms are described as noticeable in nature.;surgery
brain_glioma_1115;Brain Glioma;75;F;Patient is experiencing confusion and memory lapses for the last few weeks. The symptoms are described as noticeable in nature.;surgery
brain_glioma_1116;Brain Glioma;29;F;Patient is experiencing visual disturbances and confusion over the past 2 months. The symptoms are described as high-grade in nature.;radiation therapy
brain_glioma_1117;Brain Glioma;50;F;Patient is experiencing visual disturbances and frequent seizures for the last few weeks. The symptoms are described as moderate in nature.;chemotherapy
brain_glioma_1118;Brain Glioma;21;F;Patient is experiencing persistent headaches and memory lapses over the past 2 months. The symptoms are described as noticeable in nature.;chemotherapy
brain_glioma_1119;Brain Glioma;34;M;Patient is experiencing dizziness and memory lapses for more than 6 months. The symptoms are described as noticeable in nature.;chemotherapy
brain_glioma_1120;Brain Glioma;70;M;Patient is experiencing memory lapses and frequent seizures for the last few weeks. The symptoms are described as noticeable in nature.;chemotherapy
brain_glioma_1121;Brain Glioma;85;F;Patient is experiencing visual disturbances and memory lapses over the past 2 months. The symptoms are described as high-grade in nature.;radiation therapy
brain_glioma_1122;Brain Glioma;65;M;Patient is experiencing confusion and dizziness over the past 2 months. The symptoms are described as debilitating in nature.;chemotherapy
brain_glioma_1123;Brain Glioma;44;F;Patient is experiencing memory lapses and speech difficulties for more than 6 months. The symptoms are described as severe in nature.;surgery
brain_glioma_1124;Brain Glioma;55;F;Patient is experiencing dizziness and confusion for more than 6 months. The symptoms are described as intense in nature.;radiation therapy
brain_glioma_1125;Brain Glioma;25;M;Patient is experiencing memory lapses and dizziness for more than 6 months. The symptoms are described as significant in nature.;radiation therapy
brain_glioma_1126;Brain Glioma;84;M;Patient is experiencing memory lapses and speech difficulties for more than 6 months. The symptoms are described as intense in nature.;surgery
brain_glioma_1127;Brain Glioma;73;F;Patient is experiencing memory lapses and confusion over the past 2 months. The symptoms are described as significant in nature.;chemotherapy
brain_glioma_1128;Brain Glioma;73;F;Patient is experiencing memory lapses and confusion for more than 6 months. The symptoms are described as noticeable in nature.;radiation therapy
brain_glioma_1129;Brain Glioma;69;F;Patient is experiencing dizziness and visual disturbances over the past 2 months. The symptoms are described as debilitating in nature.;chemotherapy
brain_glioma_1130;Brain Glioma;72;F;Patient is experiencing memory lapses and visual disturbances for the last few weeks. The symptoms are described as noticeable in nature.;radiation therapy
brain_glioma_1131;Brain Glioma;76;M;Patient is experiencing memory lapses and speech difficulties over the past 2 months. The symptoms are described as significant in nature.;surgery
brain_glioma_1132;Brain Glioma;71;F;Patient is experiencing speech difficulties and memory lapses for the last few weeks. The symptoms are described as intense in nature.;radiation therapy
brain_glioma_1133;Brain Glioma;70;F;Patient is experiencing dizziness and visual disturbances for the last few weeks. The symptoms are described as moderate in nature.;chemotherapy
brain_glioma_1134;Brain Glioma;22;M;Patient is experiencing confusion and visual disturbances over the past 2 months. The symptoms are described as debilitating in nature.;chemotherapy
brain_glioma_1135;Brain Glioma;85;M;Patient is experiencing memory lapses and visual disturbances over the past 2 months. The symptoms are described as severe in nature.;surgery
brain_glioma_1136;Brain Glioma;64;F;Patient is experiencing visual disturbances and speech difficulties for more than 6 months. The symptoms are described as high-grade in nature.;chemotherapy
brain_glioma_1137;Brain Glioma;26;M;Patient is experiencing frequent seizures and dizziness for more than 6 months. The symptoms are described as intense in nature.;chemotherapy
brain_glioma_1138;Brain Glioma;78;F;Patient is experiencing frequent seizures and visual disturbances over the past 2 months. The symptoms are described as moderate in nature.;surgery
brain_glioma_1139;Brain Glioma;42;M;Patient is experiencing memory lapses and confusion for the last few weeks. The symptoms are described as noticeable in nature.;radiation therapy
brain_glioma_1140;Brain Glioma;59;F;Patient is experiencing frequent seizures and visual disturbances over the past 2 months. The symptoms are described as noticeable in nature.;surgery
brain_glioma_1141;Brain Glioma;80;M;Patient is experiencing persistent headaches and speech difficulties for more than 6 months. The symptoms are described as high-grade in nature.;surgery
brain_glioma_1142;Brain Glioma;27;M;Patient is experiencing confusion and speech difficulties over the past 2 months. The symptoms are described as severe in nature.;radiation therapy
brain_glioma_1143;Brain Glioma;38;M;Patient is experiencing confusion and persistent headaches over the past 2 months. The symptoms are described as intense in nature.;surgery
brain_glioma_1144;Brain Glioma;41;F;Patient is experiencing dizziness and frequent seizures for more than 6 months. The symptoms are described as debilitating in nature.;radiation therapy
brain_glioma_1145;Brain Glioma;27;F;Patient is experiencing confusion and visual disturbances for more than 6 months. The symptoms are described as moderate in nature.;surgery
brain_glioma_1146;Brain Glioma;37;M;Patient is experiencing confusion and frequent seizures for the last few weeks. The symptoms are described as noticeable in nature.;radiation therapy
brain_glioma_1147;Brain Glioma;66;F;Patient is experiencing frequent seizures and confusion for more than 6 months. The symptoms are described as moderate in nature.;chemotherapy
brain_glioma_1148;Brain Glioma;55;F;Patient is experiencing frequent seizures and visual disturbances for the last few weeks. The symptoms are described as debilitating in nature.;surgery
brain_glioma_1149;Brain Glioma;55;F;Patient is experiencing memory lapses and visual disturbances for the last few weeks. The symptoms are described as high-grade in nature.;surgery
brain_glioma_1150;Brain Glioma;55;M;Patient is experiencing memory lapses and visual disturbances for the last few weeks. The symptoms are described as moderate in nature.;chemotherapy
brain_glioma_1151;Brain Glioma;51;M;Patient is experiencing frequent seizures and dizziness over the past 2 months. The symptoms are described as moderate in nature.;chemotherapy
brain_glioma_1152;Brain Glioma;46;F;Patient is experiencing frequent seizures and confusion for more than 6 months. The symptoms are described as noticeable in nature.;radiation therapy
brain_glioma_1153;Brain Glioma;25;F;Patient is experiencing confusion and speech difficulties for more than 6 months. The symptoms are described as intense in nature.;surgery
brain_glioma_1154;Brain Glioma;27;F;Patient is experiencing dizziness and frequent seizures for more than 6 months. The symptoms are described as moderate in nature.;radiation therapy
brain_glioma_1155;Brain Glioma;26;F;Patient is experiencing confusion and speech difficulties for more than 6 months. The symptoms are described as noticeable in nature.;radiation therapy
brain_glioma_1156;Brain Glioma;19;M;Patient is experiencing speech difficulties and confusion for more than 6 months. The symptoms are described as intense in nature.;radiation therapy
brain_glioma_1157;Brain Glioma;20;F;Patient is experiencing memory lapses and frequent seizures over the past 2 months. The symptoms are described as severe in nature.;surgery
brain_glioma_1158;Brain Glioma;72;F;Patient is experiencing dizziness and memory lapses over the past 2 months. The symptoms are described as moderate in nature.;radiation therapy
brain_glioma_1159;Brain Glioma;50;F;Patient is experiencing speech difficulties and confusion over the past 2 months. The symptoms are described as noticeable in nature.;radiation therapy
brain_glioma_1160;Brain Glioma;83;F;Patient is experiencing dizziness and visual disturbances for the last few weeks. The symptoms are described as noticeable in nature.;chemotherapy
brain_glioma_1161;Brain Glioma;69;M;Patient is experiencing frequent seizures and memory lapses over the past 2 months. The symptoms are described as noticeable in nature.;surgery
brain_glioma_1162;Brain Glioma;22;M;Patient is experiencing persistent headaches and visual disturbances for more than 6 months. The symptoms are described as noticeable in nature.;chemotherapy
brain_glioma_1163;Brain Glioma;52;M;Patient is experiencing dizziness and visual disturbances for more than 6 months. The symptoms are described as significant in nature.;chemotherapy
brain_glioma_1164;Brain Glioma;42;F;Patient is experiencing persistent headaches and visual disturbances for more than 6 months. The symptoms are described as significant in nature.;chemotherapy
brain_glioma_1165;Brain Glioma;41;M;Patient is experiencing memory lapses and dizziness over the past 2 months. The symptoms are described as intense in nature.;chemotherapy
brain_glioma_1166;Brain Glioma;26;M;Patient is experiencing persistent headaches and visual disturbances over the past 2 months. The symptoms are described as noticeable in nature.;surgery
brain_glioma_1167;Brain Glioma;75;M;Patient is experiencing speech difficulties and frequent seizures over the past 2 months. The symptoms are described as severe in nature.;chemotherapy
brain_glioma_1168;Brain Glioma;24;F;Patient is experiencing dizziness and persistent headaches over the past 2 months. The symptoms are described as noticeable in nature.;surgery
brain_glioma_1169;Brain Glioma;82;M;Patient is experiencing visual disturbances and frequent seizures for the last few weeks. The symptoms are described as noticeable in nature.;chemotherapy
brain_glioma_1170;Brain Glioma;41;F;Patient is experiencing dizziness and persistent headaches for more than 6 months. The symptoms are described as high-grade in nature.;surgery
brain_glioma_1171;Brain Glioma;75;F;Patient is experiencing speech difficulties and visual disturbances over the past 2 months. The symptoms are described as debilitating in nature.;chemotherapy
brain_glioma_1172;Brain Glioma;35;F;Patient is experiencing persistent headaches and memory lapses over the past 2 months. The symptoms are described as severe in nature.;chemotherapy
brain_glioma_1173;Brain Glioma;22;M;Patient is experiencing frequent seizures and confusion for the last few weeks. The symptoms are described as high-grade in nature.;chemotherapy
brain_glioma_1174;Brain Glioma;24;F;Patient is experiencing speech difficulties and visual disturbances over the past 2 months. The symptoms are described as high-grade in nature.;radiation therapy
brain_glioma_1175;Brain Glioma;81;M;Patient is experiencing dizziness and memory lapses over the past 2 months. The symptoms are described as noticeable in nature.;surgery
brain_glioma_1176;Brain Glioma;28;M;Patient is experiencing confusion and frequent seizures for more than 6 months. The symptoms are described as significant in nature.;chemotherapy
brain_glioma_1177;Brain Glioma;23;M;Patient is experiencing visual disturbances and persistent headaches for more than 6 months. The symptoms are described as significant in nature.;surgery
brain_glioma_1178;Brain Glioma;80;M;Patient is experiencing speech difficulties and visual disturbances over the past 2 months. The symptoms are described as significant in nature.;radiation therapy
brain_glioma_1179;Brain Glioma;81;F;Patient is experiencing frequent seizures and memory lapses for the last few weeks. The symptoms are described as moderate in nature.;surgery
brain_glioma_1180;Brain Glioma;25;M;Patient is experiencing memory lapses and speech difficulties over the past 2 months. The symptoms are described as intense in nature.;surgery
brain_glioma_1181;Brain Glioma;80;M;Patient is experiencing dizziness and memory lapses for the last few weeks. The symptoms are described as noticeable in nature.;surgery
brain_glioma_1182;Brain Glioma;77;F;Patient is experiencing memory lapses and speech difficulties for more than 6 months. The symptoms are described as moderate in nature.;radiation therapy
brain_glioma_1183;Brain Glioma;66;M;Patient is experiencing confusion and memory lapses over the past 2 months. The symptoms are described as high-grade in nature.;radiation therapy
brain_glioma_1184;Brain Glioma;63;F;Patient is experiencing visual disturbances and persistent headaches for the last few weeks. The symptoms are described as high-grade in nature.;surgery
brain_glioma_1185;Brain Glioma;59;F;Patient is experiencing memory lapses and confusion for more than 6 months. The symptoms are described as debilitating in nature.;radiation therapy
brain_glioma_1186;Brain Glioma;25;M;Patient is experiencing frequent seizures and confusion over the past 2 months. The symptoms are described as significant in nature.;chemotherapy
brain_glioma_1187;Brain Glioma;30;F;Patient is experiencing confusion and memory lapses for more than 6 months. The symptoms are described as moderate in nature.;radiation therapy
brain_glioma_1188;Brain Glioma;84;F;Patient is experiencing confusion and frequent seizures over the past 2 months. The symptoms are described as severe in nature.;surgery
brain_glioma_1189;Brain Glioma;28;M;Patient is experiencing visual disturbances and memory lapses over the past 2 months. The symptoms are described as significant in nature.;radiation therapy
brain_glioma_1190;Brain Glioma;25;M;Patient is experiencing visual disturbances and confusion for more than 6 months. The symptoms are described as high-grade in nature.;surgery
brain_glioma_1191;Brain Glioma;60;F;Patient is experiencing memory lapses and visual disturbances over the past 2 months. The symptoms are described as moderate in nature.;radiation therapy
brain_glioma_1192;Brain Glioma;43;M;Patient is experiencing speech difficulties and confusion for the last few weeks. The symptoms are described as debilitating in nature.;chemotherapy
brain_glioma_1193;Brain Glioma;63;M;Patient is experiencing visual disturbances and confusion over the past 2 months. The symptoms are described as significant in nature.;surgery
brain_glioma_1194;Brain Glioma;42;M;Patient is experiencing frequent seizures and speech difficulties for more than 6 months. The symptoms are described as moderate in nature.;chemotherapy
brain_glioma_1195;Brain Glioma;55;M;Patient is experiencing memory lapses and dizziness for the last few weeks. The symptoms are described as noticeable in nature.;surgery
brain_glioma_1196;Brain Glioma;68;F;Patient is experiencing frequent seizures and memory lapses for the last few weeks. The symptoms are described as moderate in nature.;surgery
brain_glioma_1197;Brain Glioma;59;M;Patient is experiencing persistent headaches and dizziness for the last few weeks. The symptoms are described as debilitating in nature.;chemotherapy
brain_glioma_1198;Brain Glioma;44;M;Patient is experiencing speech difficulties and persistent headaches over the past 2 months. The symptoms are described as noticeable in nature.;radiation therapy
brain_glioma_1199;Brain Glioma;77;M;Patient is experiencing dizziness and memory lapses over the past 2 months. The symptoms are described as moderate in nature.;radiation therapy
brain_glioma_1200;Brain Glioma;65;F;Patient is experiencing visual disturbances and confusion over the past 2 months. The symptoms are described as severe in nature.;radiation therapy
brain_glioma_1201;Brain Glioma;84;M;Patient is experiencing persistent headaches and confusion for the last few weeks. The symptoms are described as moderate in nature.;radiation therapy
brain_glioma_1202;Brain Glioma;40;M;Patient is experiencing dizziness and memory lapses for the last few weeks. The symptoms are described as severe in nature.;surgery
brain_glioma_1203;Brain Glioma;23;F;Patient is experiencing confusion and dizziness over the past 2 months. The symptoms are described as intense in nature.;radiation therapy
brain_glioma_1204;Brain Glioma;32;M;Patient is experiencing dizziness and persistent headaches for the last few weeks. The symptoms are described as debilitating in nature.;radiation therapy
brain_glioma_1205;Brain Glioma;20;M;Patient is experiencing frequent seizures and persistent headaches over the past 2 months. The symptoms are described as severe in nature.;radiation therapy
brain_glioma_1206;Brain Glioma;19;F;Patient is experiencing persistent headaches and dizziness for the last few weeks. The symptoms are described as severe in nature.;surgery
brain_glioma_1207;Brain Glioma;31;M;Patient is experiencing speech difficulties and memory lapses over the past 2 months. The symptoms are described as severe in nature.;surgery
brain_glioma_1208;Brain Glioma;78;M;Patient is experiencing speech difficulties and persistent headaches for the last few weeks. The symptoms are described as moderate in nature.;radiation therapy
brain_glioma_1209;Brain Glioma;45;F;Patient is experiencing dizziness and memory lapses for the last few weeks. The symptoms are described as noticeable in nature.;chemotherapy
brain_glioma_1210;Brain Glioma;50;M;Patient is experiencing visual disturbances and memory lapses for the last few weeks. The symptoms are described as moderate in nature.;surgery
brain_glioma_1211;Brain Glioma;19;F;Patient is experiencing confusion and frequent seizures for more than 6 months. The symptoms are described as intense in nature.;radiation therapy
brain_glioma_1212;Brain Glioma;32;M;Patient is experiencing memory lapses and dizziness for more than 6 months. The symptoms are described as high-grade in nature.;radiation therapy
brain_glioma_1213;Brain Glioma;70;F;Patient is experiencing speech difficulties and frequent seizures over the past 2 months. The symptoms are described as severe in nature.;chemotherapy
brain_glioma_1214;Brain Glioma;71;F;Patient is experiencing dizziness and speech difficulties for the last few weeks. The symptoms are described as noticeable in nature.;chemotherapy
brain_glioma_1215;Brain Glioma;61;M;Patient is experiencing memory lapses and persistent headaches for the last few weeks. The symptoms are described as significant in nature.;chemotherapy
brain_glioma_1216;Brain Glioma;85;F;Patient is experiencing memory lapses and dizziness for the last few weeks. The symptoms are described as significant in nature.;surgery
brain_glioma_1217;Brain Glioma;72;M;Patient is experiencing memory lapses and visual disturbances for more than 6 months. The symptoms are described as significant in nature.;radiation therapy
brain_glioma_1218;Brain Glioma;19;M;Patient is experiencing confusion and dizziness for the last few weeks. The symptoms are described as high-grade in nature.;chemotherapy
brain_glioma_1219;Brain Glioma;32;M;Patient is experiencing visual disturbances and speech difficulties for more than 6 months. The symptoms are described as noticeable in nature.;chemotherapy
brain_glioma_1220;Brain Glioma;26;M;Patient is experiencing persistent headaches and dizziness over the past 2 months. The symptoms are described as severe in nature.;radiation therapy
brain_glioma_1221;Brain Glioma;43;M;Patient is experiencing frequent seizures and speech difficulties for the last few weeks. The symptoms are described as severe in nature.;surgery
brain_glioma_1222;Brain Glioma;50;F;Patient is experiencing speech difficulties and visual disturbances over the past 2 months. The symptoms are described as high-grade in nature.;surgery
brain_glioma_1223;Brain Glioma;75;M;Patient is experiencing dizziness and confusion over the past 2 months. The symptoms are described as moderate in nature.;chemotherapy
brain_glioma_1224;Brain Glioma;72;F;Patient is experiencing speech difficulties and confusion for the last few weeks. The symptoms are described as noticeable in nature.;chemotherapy
brain_glioma_1225;Brain Glioma;28;F;Patient is experiencing memory lapses and frequent seizures for the last few weeks. The symptoms are described as high-grade in nature.;radiation therapy
brain_glioma_1226;Brain Glioma;18;F;Patient is experiencing frequent seizures and confusion for the last few weeks. The symptoms are described as intense in nature.;surgery
brain_glioma_1227;Brain Glioma;40;M;Patient is experiencing memory lapses and frequent seizures for more than 6 months. The symptoms are described as severe in nature.;radiation therapy
brain_glioma_1228;Brain Glioma;69;F;Patient is experiencing speech difficulties and persistent headaches for the last few weeks. The symptoms are described as moderate in nature.;radiation therapy
brain_glioma_1229;Brain Glioma;81;F;Patient is experiencing speech difficulties and dizziness for more than 6 months. The symptoms are described as high-grade in nature.;radiation therapy
brain_glioma_1230;Brain Glioma;70;F;Patient is experiencing persistent headaches and dizziness for more than 6 months. The symptoms are described as debilitating in nature.;chemotherapy
brain_glioma_1231;Brain Glioma;85;F;Patient is experiencing visual disturbances and persistent headaches for the last few weeks. The symptoms are described as significant in nature.;radiation therapy
brain_glioma_1232;Brain Glioma;56;F;Patient is experiencing visual disturbances and dizziness for the last few weeks. The symptoms are described as debilitating in nature.;radiation therapy
brain_glioma_1233;Brain Glioma;19;F;Patient is experiencing speech difficulties and frequent seizures over the past 2 months. The symptoms are described as severe in nature.;surgery
brain_glioma_1234;Brain Glioma;35;F;Patient is experiencing memory lapses and persistent headaches over the past 2 months. The symptoms are described as noticeable in nature.;chemotherapy
brain_glioma_1235;Brain Glioma;25;M;Patient is experiencing persistent headaches and frequent seizures over the past 2 months. The symptoms are described as high-grade in nature.;radiation therapy
brain_glioma_1236;Brain Glioma;59;M;Patient is experiencing speech difficulties and memory lapses over the past 2 months. The symptoms are described as high-grade in nature.;radiation therapy
brain_glioma_1237;Brain Glioma;47;M;Patient is experiencing frequent seizures and memory lapses over the past 2 months. The symptoms are described as significant in nature.;chemotherapy
brain_glioma_1238;Brain Glioma;26;M;Patient is experiencing speech difficulties and persistent headaches over the past 2 months. The symptoms are described as noticeable in nature.;radiation therapy
brain_glioma_1239;Brain Glioma;84;F;Patient is experiencing frequent seizures and confusion for more than 6 months. The symptoms are described as significant in nature.;chemotherapy
brain_glioma_1240;Brain Glioma;61;F;Patient is experiencing visual disturbances and persistent headaches over the past 2 months. The symptoms are described as intense in nature.;surgery
brain_glioma_1241;Brain Glioma;77;F;Patient is experiencing persistent headaches and confusion for more than 6 months. The symptoms are described as significant in nature.;surgery
brain_glioma_1242;Brain Glioma;25;M;Patient is experiencing persistent headaches and speech difficulties for the last few weeks. The symptoms are described as debilitating in nature.;radiation therapy
brain_glioma_1243;Brain Glioma;76;M;Patient is experiencing persistent headaches and frequent seizures over the past 2 months. The symptoms are described as significant in nature.;chemotherapy
brain_glioma_1244;Brain Glioma;48;F;Patient is experiencing speech difficulties and frequent seizures over the past 2 months. The symptoms are described as moderate in nature.;chemotherapy
brain_glioma_1245;Brain Glioma;56;M;Patient is experiencing memory lapses and dizziness over the past 2 months. The symptoms are described as intense in nature.;chemotherapy
brain_glioma_1246;Brain Glioma;61;F;Patient is experiencing persistent headaches and visual disturbances over the past 2 months. The symptoms are described as debilitating in nature.;radiation therapy
brain_glioma_1247;Brain Glioma;84;M;Patient is experiencing persistent headaches and frequent seizures for the last few weeks. The symptoms are described as noticeable in nature.;surgery
brain_glioma_1248;Brain Glioma;80;F;Patient is experiencing memory lapses and speech difficulties for more than 6 months. The symptoms are described as debilitating in nature.;radiation therapy
brain_glioma_1249;Brain Glioma;77;M;Patient is experiencing confusion and persistent headaches over the past 2 months. The symptoms are described as intense in nature.;radiation therapy
brain_glioma_1250;Brain Glioma;19;M;Patient is experiencing dizziness and frequent seizures for the last few weeks. The symptoms are described as noticeable in nature.;radiation therapy
brain_glioma_1251;Brain Glioma;70;M;Patient is experiencing visual disturbances and frequent seizures for the last few weeks. The symptoms are described as debilitating in nature.;chemotherapy
brain_glioma_1252;Brain Glioma;66;M;Patient is experiencing confusion and memory lapses over the past 2 months. The symptoms are described as moderate in nature.;surgery
brain_glioma_1253;Brain Glioma;51;F;Patient is experiencing frequent seizures and dizziness over the past 2 months. The symptoms are described as noticeable in nature.;chemotherapy
brain_glioma_1254;Brain Glioma;27;M;Patient is experiencing speech difficulties and frequent seizures over the past 2 months. The symptoms are described as moderate in nature.;surgery
brain_glioma_1255;Brain Glioma;19;M;Patient is experiencing memory lapses and speech difficulties over the past 2 months. The symptoms are described as significant in nature.;chemotherapy
brain_glioma_1256;Brain Glioma;50;F;Patient is experiencing memory lapses and speech difficulties over the past 2 months. The symptoms are described as noticeable in nature.;surgery
brain_glioma_1257;Brain Glioma;34;F;Patient is experiencing dizziness and visual disturbances for the last few weeks. The symptoms are described as high-grade in nature.;surgery
brain_glioma_1258;Brain Glioma;67;M;Patient is experiencing memory lapses and persistent headaches for the last few weeks. The symptoms are described as debilitating in nature.;radiation therapy
brain_glioma_1259;Brain Glioma;71;F;Patient is experiencing memory lapses and dizziness for the last few weeks. The symptoms are described as intense in nature.;radiation therapy
brain_glioma_1260;Brain Glioma;61;M;Patient is experiencing dizziness and frequent seizures for the last few weeks. The symptoms are described as debilitating in nature.;surgery
brain_glioma_1261;Brain Glioma;69;M;Patient is experiencing speech difficulties and frequent seizures for more than 6 months. The symptoms are described as intense in nature.;chemotherapy
brain_glioma_1262;Brain Glioma;33;F;Patient is experiencing speech difficulties and persistent headaches for the last few weeks. The symptoms are described as moderate in nature.;chemotherapy
brain_glioma_1263;Brain Glioma;47;F;Patient is experiencing frequent seizures and speech difficulties for more than 6 months. The symptoms are described as moderate in nature.;radiation therapy
brain_glioma_1264;Brain Glioma;65;F;Patient is experiencing memory lapses and frequent seizures over the past 2 months. The symptoms are described as debilitating in nature.;surgery
brain_glioma_1265;Brain Glioma;50;M;Patient is experiencing memory lapses and frequent seizures for the last few weeks. The symptoms are described as high-grade in nature.;surgery
brain_glioma_1266;Brain Glioma;38;F;Patient is experiencing frequent seizures and visual disturbances over the past 2 months. The symptoms are described as severe in nature.;chemotherapy
brain_glioma_1267;Brain Glioma;50;F;Patient is experiencing memory lapses and speech difficulties for more than 6 months. The symptoms are described as noticeable in nature.;surgery
brain_glioma_1268;Brain Glioma;34;F;Patient is experiencing persistent headaches and speech difficulties over the past 2 months. The symptoms are described as significant in nature.;radiation therapy
brain_glioma_1269;Brain Glioma;35;M;Patient is experiencing dizziness and confusion for the last few weeks. The symptoms are described as high-grade in nature.;surgery
brain_glioma_1270;Brain Glioma;44;F;Patient is experiencing confusion and memory lapses over the past 2 months. The symptoms are described as debilitating in nature.;surgery
brain_glioma_1271;Brain Glioma;29;F;Patient is experiencing confusion and frequent seizures for the last few weeks. The symptoms are described as severe in nature.;radiation therapy
brain_glioma_1272;Brain Glioma;63;M;Patient is experiencing dizziness and speech difficulties over the past 2 months. The symptoms are described as high-grade in nature.;radiation therapy
brain_glioma_1273;Brain Glioma;81;F;Patient is experiencing confusion and memory lapses for the last few weeks. The symptoms are described as intense in nature.;surgery
brain_glioma_1274;Brain Glioma;82;M;Patient is experiencing speech difficulties and frequent seizures over the past 2 months. The symptoms are described as high-grade in nature.;surgery
brain_glioma_1275;Brain Glioma;54;M;Patient is experiencing visual disturbances and dizziness over the past 2 months. The symptoms are described as moderate in nature.;surgery
brain_glioma_1276;Brain Glioma;30;F;Patient is experiencing visual disturbances and memory lapses over the past 2 months. The symptoms are described as debilitating in nature.;radiation therapy
brain_glioma_1277;Brain Glioma;23;F;Patient is experiencing confusion and frequent seizures over the past 2 months. The symptoms are described as noticeable in nature.;radiation therapy
brain_glioma_1278;Brain Glioma;78;M;Patient is experiencing memory lapses and frequent seizures for more than 6 months. The symptoms are described as debilitating in nature.;radiation therapy
brain_glioma_1279;Brain Glioma;77;M;Patient is experiencing memory lapses and persistent headaches over the past 2 months. The symptoms are described as noticeable in nature.;surgery
brain_glioma_1280;Brain Glioma;85;F;Patient is experiencing speech difficulties and dizziness for more than 6 months. The symptoms are described as noticeable in nature.;chemotherapy
brain_glioma_1281;Brain Glioma;20;M;Patient is experiencing frequent seizures and persistent headaches for the last few weeks. The symptoms are described as noticeable in nature.;surgery
brain_glioma_1282;Brain Glioma;85;F;Patient is experiencing memory lapses and confusion for the last few weeks. The symptoms are described as high-grade in nature.;chemotherapy
brain_glioma_1283;Brain Glioma;70;M;Patient is experiencing speech difficulties and confusion for the last few weeks. The symptoms are described as debilitating in nature.;radiation therapy
brain_glioma_1284;Brain Glioma;28;F;Patient is experiencing persistent headaches and dizziness over the past 2 months. The symptoms are described as severe in nature.;radiation therapy
brain_glioma_1285;Brain Glioma;78;M;Patient is experiencing speech difficulties and visual disturbances for the last few weeks. The symptoms are described as intense in nature.;chemotherapy
brain_glioma_1286;Brain Glioma;83;M;Patient is experiencing speech difficulties and dizziness for the last few weeks. The symptoms are described as intense in nature.;chemotherapy
brain_glioma_1287;Brain Glioma;83;M;Patient is experiencing dizziness and visual disturbances over the past 2 months. The symptoms are described as significant in nature.;surgery
brain_glioma_1288;Brain Glioma;21;F;Patient is experiencing dizziness and speech difficulties over the past 2 months. The symptoms are described as debilitating in nature.;chemotherapy
brain_glioma_1289;Brain Glioma;69;F;Patient is experiencing speech difficulties and frequent seizures for more than 6 months. The symptoms are described as significant in nature.;chemotherapy
brain_glioma_1290;Brain Glioma;66;F;Patient is experiencing persistent headaches and memory lapses for the last few weeks. The symptoms are described as noticeable in nature.;radiation therapy
brain_glioma_1291;Brain Glioma;30;M;Patient is experiencing persistent headaches and visual disturbances for the last few weeks. The symptoms are described as moderate in nature.;surgery
brain_glioma_1292;Brain Glioma;39;F;Patient is experiencing memory lapses and visual disturbances for more than 6 months. The symptoms are described as high-grade in nature.;surgery
brain_glioma_1293;Brain Glioma;31;F;Patient is experiencing persistent headaches and confusion for the last few weeks. The symptoms are described as intense in nature.;surgery
brain_glioma_1294;Brain Glioma;79;M;Patient is experiencing visual disturbances and persistent headaches for more than 6 months. The symptoms are described as severe in nature.;radiation therapy
brain_glioma_1295;Brain Glioma;61;M;Patient is experiencing memory lapses and visual disturbances over the past 2 months. The symptoms are described as intense in nature.;radiation therapy
brain_glioma_1296;Brain Glioma;55;M;Patient is experiencing memory lapses and persistent headaches for more than 6 months. The symptoms are described as moderate in nature.;surgery
brain_glioma_1297;Brain Glioma;27;M;Patient is experiencing frequent seizures and speech difficulties for more than 6 months. The symptoms are described as significant in nature.;surgery
brain_glioma_1298;Brain Glioma;20;F;Patient is experiencing memory lapses and persistent headaches for more than 6 months. The symptoms are described as moderate in nature.;radiation therapy
brain_glioma_1299;Brain Glioma;50;M;Patient is experiencing dizziness and memory lapses for the last few weeks. The symptoms are described as severe in nature.;surgery
brain_glioma_1300;Brain Glioma;73;M;Patient is experiencing dizziness and memory lapses for the last few weeks. The symptoms are described as moderate in nature.;surgery
brain_glioma_1301;Brain Glioma;47;F;Patient is experiencing speech difficulties and persistent headaches for more than 6 months. The symptoms are described as debilitating in nature.;chemotherapy
brain_glioma_1302;Brain Glioma;51;M;Patient is experiencing confusion and memory lapses for the last few weeks. The symptoms are described as debilitating in nature.;radiation therapy
brain_glioma_1303;Brain Glioma;21;F;Patient is experiencing dizziness and speech difficulties for more than 6 months. The symptoms are described as severe in nature.;chemotherapy
brain_glioma_1304;Brain Glioma;18;F;Patient is experiencing speech difficulties and dizziness for the last few weeks. The symptoms are described as debilitating in nature.;chemotherapy
brain_glioma_1305;Brain Glioma;41;M;Patient is experiencing visual disturbances and persistent headaches for the last few weeks. The symptoms are described as intense in nature.;radiation therapy
brain_glioma_1306;Brain Glioma;20;F;Patient is experiencing frequent seizures and memory lapses for more than 6 months. The symptoms are described as high-grade in nature.;surgery
brain_glioma_1307;Brain Glioma;81;F;Patient is experiencing persistent headaches and dizziness for more than 6 months. The symptoms are described as high-grade in nature.;surgery
brain_glioma_1308;Brain Glioma;70;M;Patient is experiencing memory lapses and dizziness for the last few weeks. The symptoms are described as debilitating in nature.;radiation therapy
brain_glioma_1309;Brain Glioma;67;F;Patient is experiencing visual disturbances and dizziness over the past 2 months. The symptoms are described as noticeable in nature.;surgery
brain_glioma_1310;Brain Glioma;18;M;Patient is experiencing persistent headaches and frequent seizures for more than 6 months. The symptoms are described as significant in nature.;surgery
brain_glioma_1311;Brain Glioma;53;M;Patient is experiencing speech difficulties and visual disturbances for the last few weeks. The symptoms are described as high-grade in nature.;chemotherapy
brain_glioma_1312;Brain Glioma;33;F;Patient is experiencing speech difficulties and confusion for the last few weeks. The symptoms are described as moderate in nature.;chemotherapy
brain_glioma_1313;Brain Glioma;28;M;Patient is experiencing confusion and visual disturbances for the last few weeks. The symptoms are described as noticeable in nature.;radiation therapy
brain_glioma_1314;Brain Glioma;75;F;Patient is experiencing speech difficulties and dizziness over the past 2 months. The symptoms are described as severe in nature.;radiation therapy
brain_glioma_1315;Brain Glioma;45;F;Patient is experiencing confusion and frequent seizures for more than 6 months. The symptoms are described as severe in nature.;surgery
brain_glioma_1316;Brain Glioma;57;F;Patient is experiencing confusion and dizziness over the past 2 months. The symptoms are described as severe in nature.;radiation therapy
brain_glioma_1317;Brain Glioma;77;F;Patient is experiencing persistent headaches and speech difficulties over the past 2 months. The symptoms are described as significant in nature.;chemotherapy
brain_glioma_1318;Brain Glioma;48;F;Patient is experiencing persistent headaches and visual disturbances for more than 6 months. The symptoms are described as debilitating in nature.;chemotherapy
brain_glioma_1319;Brain Glioma;69;M;Patient is experiencing visual disturbances and frequent seizures for more than 6 months. The symptoms are described as intense in nature.;chemotherapy
brain_glioma_1320;Brain Glioma;62;M;Patient is experiencing dizziness and memory lapses over the past 2 months. The symptoms are described as noticeable in nature.;radiation therapy
brain_glioma_1321;Brain Glioma;83;F;Patient is experiencing confusion and dizziness for the last few weeks. The symptoms are described as noticeable in nature.;surgery
brain_glioma_1322;Brain Glioma;18;F;Patient is experiencing frequent seizures and memory lapses for more than 6 months. The symptoms are described as high-grade in nature.;radiation therapy
brain_glioma_1323;Brain Glioma;48;F;Patient is experiencing frequent seizures and persistent headaches over the past 2 months. The symptoms are described as significant in nature.;chemotherapy
brain_glioma_1324;Brain Glioma;45;M;Patient is experiencing persistent headaches and visual disturbances for the last few weeks. The symptoms are described as severe in nature.;chemotherapy
brain_glioma_1325;Brain Glioma;27;M;Patient is experiencing speech difficulties and visual disturbances for more than 6 months. The symptoms are described as significant in nature.;chemotherapy
brain_glioma_1326;Brain Glioma;73;M;Patient is experiencing visual disturbances and memory lapses for more than 6 months. The symptoms are described as debilitating in nature.;chemotherapy
brain_glioma_1327;Brain Glioma;79;F;Patient is experiencing dizziness and frequent seizures for the last few weeks. The symptoms are described as debilitating in nature.;chemotherapy
brain_glioma_1328;Brain Glioma;39;F;Patient is experiencing visual disturbances and confusion for the last few weeks. The symptoms are described as debilitating in nature.;chemotherapy
brain_glioma_1329;Brain Glioma;54;M;Patient is experiencing confusion and frequent seizures for the last few weeks. The symptoms are described as significant in nature.;radiation therapy
brain_glioma_1330;Brain Glioma;69;M;Patient is experiencing visual disturbances and frequent seizures for more than 6 months. The symptoms are described as noticeable in nature.;surgery
brain_glioma_1331;Brain Glioma;64;M;Patient is experiencing confusion and visual disturbances for more than 6 months. The symptoms are described as noticeable in nature.;chemotherapy
brain_glioma_1332;Brain Glioma;62;M;Patient is experiencing speech difficulties and dizziness for more than 6 months. The symptoms are described as significant in nature.;radiation therapy
brain_glioma_1333;Brain Glioma;29;F;Patient is experiencing visual disturbances and dizziness for the last few weeks. The symptoms are described as debilitating in nature.;surgery
brain_glioma_1334;Brain Glioma;61;M;Patient is experiencing confusion and frequent seizures for more than 6 months. The symptoms are described as debilitating in nature.;radiation therapy
brain_glioma_1335;Brain Glioma;35;M;Patient is experiencing memory lapses and dizziness for the last few weeks. The symptoms are described as severe in nature.;chemotherapy
brain_glioma_1336;Brain Glioma;58;F;Patient is experiencing speech difficulties and visual disturbances for the last few weeks. The symptoms are described as noticeable in nature.;surgery
brain_glioma_1337;Brain Glioma;69;F;Patient is experiencing frequent seizures and confusion for the last few weeks. The symptoms are described as significant in nature.;surgery
brain_glioma_1338;Brain Glioma;35;M;Patient is experiencing frequent seizures and speech difficulties over the past 2 months. The symptoms are described as noticeable in nature.;surgery
brain_glioma_1339;Brain Glioma;51;F;Patient is experiencing frequent seizures and memory lapses over the past 2 months. The symptoms are described as debilitating in nature.;radiation therapy
brain_glioma_1340;Brain Glioma;70;F;Patient is experiencing frequent seizures and persistent headaches over the past 2 months. The symptoms are described as moderate in nature.;chemotherapy
brain_glioma_1341;Brain Glioma;84;F;Patient is experiencing visual disturbances and confusion for the last few weeks. The symptoms are described as intense in nature.;chemotherapy
brain_glioma_1342;Brain Glioma;77;F;Patient is experiencing frequent seizures and speech difficulties for the last few weeks. The symptoms are described as moderate in nature.;surgery
brain_glioma_1343;Brain Glioma;64;F;Patient is experiencing confusion and frequent seizures over the past 2 months. The symptoms are described as noticeable in nature.;surgery
brain_glioma_1344;Brain Glioma;77;M;Patient is experiencing visual disturbances and frequent seizures over the past 2 months. The symptoms are described as moderate in nature.;surgery
brain_glioma_1345;Brain Glioma;77;F;Patient is experiencing speech difficulties and frequent seizures over the past 2 months. The symptoms are described as debilitating in nature.;radiation therapy
brain_glioma_1346;Brain Glioma;31;M;Patient is experiencing memory lapses and visual disturbances for the last few weeks. The symptoms are described as moderate in nature.;radiation therapy
brain_glioma_1347;Brain Glioma;83;F;Patient is experiencing confusion and frequent seizures for more than 6 months. The symptoms are described as debilitating in nature.;radiation therapy
brain_glioma_1348;Brain Glioma;23;M;Patient is experiencing visual disturbances and confusion for more than 6 months. The symptoms are described as moderate in nature.;chemotherapy
brain_glioma_1349;Brain Glioma;24;F;Patient is experiencing memory lapses and speech difficulties for more than 6 months. The symptoms are described as intense in nature.;radiation therapy
brain_glioma_1350;Brain Glioma;76;F;Patient is experiencing dizziness and confusion for more than 6 months. The symptoms are described as severe in nature.;radiation therapy
brain_glioma_1351;Brain Glioma;58;F;Patient is experiencing confusion and visual disturbances for the last few weeks. The symptoms are described as severe in nature.;radiation therapy
brain_glioma_1352;Brain Glioma;81;F;Patient is experiencing dizziness and confusion for the last few weeks. The symptoms are described as debilitating in nature.;chemotherapy
brain_glioma_1353;Brain Glioma;34;F;Patient is experiencing memory lapses and persistent headaches over the past 2 months. The symptoms are described as high-grade in nature.;chemotherapy
brain_glioma_1354;Brain Glioma;26;F;Patient is experiencing speech difficulties and frequent seizures over the past 2 months. The symptoms are described as severe in nature.;chemotherapy
brain_glioma_1355;Brain Glioma;73;F;Patient is experiencing confusion and visual disturbances over the past 2 months. The symptoms are described as noticeable in nature.;surgery
brain_glioma_1356;Brain Glioma;53;F;Patient is experiencing memory lapses and speech difficulties for the last few weeks. The symptoms are described as significant in nature.;radiation therapy
brain_glioma_1357;Brain Glioma;56;M;Patient is experiencing visual disturbances and confusion for the last few weeks. The symptoms are described as noticeable in nature.;radiation therapy
brain_glioma_1358;Brain Glioma;31;M;Patient is experiencing frequent seizures and confusion for more than 6 months. The symptoms are described as high-grade in nature.;surgery
brain_glioma_1359;Brain Glioma;45;M;Patient is experiencing dizziness and persistent headaches for the last few weeks. The symptoms are described as severe in nature.;radiation therapy
brain_glioma_1360;Brain Glioma;54;F;Patient is experiencing speech difficulties and dizziness for more than 6 months. The symptoms are described as high-grade in nature.;chemotherapy
brain_glioma_1361;Brain Glioma;70;M;Patient is experiencing speech difficulties and visual disturbances for the last few weeks. The symptoms are described as intense in nature.;chemotherapy
brain_glioma_1362;Brain Glioma;60;F;Patient is experiencing visual disturbances and persistent headaches over the past 2 months. The symptoms are described as high-grade in nature.;surgery
brain_glioma_1363;Brain Glioma;39;F;Patient is experiencing frequent seizures and speech difficulties over the past 2 months. The symptoms are described as noticeable in nature.;radiation therapy
brain_glioma_1364;Brain Glioma;48;F;Patient is experiencing visual disturbances and speech difficulties over the past 2 months. The symptoms are described as noticeable in nature.;surgery
brain_glioma_1365;Brain Glioma;32;F;Patient is experiencing visual disturbances and frequent seizures for more than 6 months. The symptoms are described as significant in nature.;chemotherapy
brain_glioma_1366;Brain Glioma;43;F;Patient is experiencing visual disturbances and confusion for the last few weeks. The symptoms are described as severe in nature.;surgery
brain_glioma_1367;Brain Glioma;44;F;Patient is experiencing speech difficulties and memory lapses for the last few weeks. The symptoms are described as severe in nature.;surgery
brain_glioma_1368;Brain Glioma;46;M;Patient is experiencing speech difficulties and frequent seizures for the last few weeks. The symptoms are described as noticeable in nature.;chemotherapy
brain_glioma_1369;Brain Glioma;40;F;Patient is experiencing persistent headaches and frequent seizures for more than 6 months. The symptoms are described as severe in nature.;chemotherapy
brain_glioma_1370;Brain Glioma;48;F;Patient is experiencing persistent headaches and visual disturbances for the last few weeks. The symptoms are described as high-grade in nature.;surgery
brain_glioma_1371;Brain Glioma;85;M;Patient is experiencing confusion and visual disturbances for the last few weeks. The symptoms are described as debilitating in nature.;chemotherapy
brain_glioma_1372;Brain Glioma;28;F;Patient is experiencing persistent headaches and speech difficulties for the last few weeks. The symptoms are described as noticeable in nature.;surgery
brain_glioma_1373;Brain Glioma;46;F;Patient is experiencing speech difficulties and persistent headaches over the past 2 months. The symptoms are described as severe in nature.;chemotherapy
brain_glioma_1374;Brain Glioma;84;M;Patient is experiencing visual disturbances and memory lapses for the last few weeks. The symptoms are described as intense in nature.;chemotherapy
brain_glioma_1375;Brain Glioma;41;F;Patient is experiencing memory lapses and visual disturbances for more than 6 months. The symptoms are described as intense in nature.;radiation therapy
brain_glioma_1376;Brain Glioma;42;M;Patient is experiencing memory lapses and frequent seizures for the last few weeks. The symptoms are described as significant in nature.;chemotherapy
brain_glioma_1377;Brain Glioma;20;F;Patient is experiencing frequent seizures and confusion for more than 6 months. The symptoms are described as severe in nature.;surgery
brain_glioma_1378;Brain Glioma;70;M;Patient is experiencing dizziness and speech difficulties for the last few weeks. The symptoms are described as noticeable in nature.;radiation therapy
brain_glioma_1379;Brain Glioma;61;F;Patient is experiencing persistent headaches and confusion over the past 2 months. The symptoms are described as high-grade in nature.;chemotherapy
brain_glioma_1380;Brain Glioma;21;M;Patient is experiencing frequent seizures and persistent headaches for more than 6 months. The symptoms are described as significant in nature.;surgery
brain_glioma_1381;Brain Glioma;80;F;Patient is experiencing speech difficulties and visual disturbances for more than 6 months. The symptoms are described as intense in nature.;surgery
brain_glioma_1382;Brain Glioma;44;F;Patient is experiencing persistent headaches and visual disturbances for more than 6 months. The symptoms are described as severe in nature.;radiation therapy
brain_glioma_1383;Brain Glioma;36;M;Patient is experiencing confusion and memory lapses over the past 2 months. The symptoms are described as significant in nature.;radiation therapy
brain_glioma_1384;Brain Glioma;68;F;Patient is experiencing dizziness and memory lapses over the past 2 months. The symptoms are described as noticeable in nature.;chemotherapy
brain_glioma_1385;Brain Glioma;50;M;Patient is experiencing speech difficulties and confusion for the last few weeks. The symptoms are described as moderate in nature.;surgery
brain_glioma_1386;Brain Glioma;20;F;Patient is experiencing visual disturbances and speech difficulties for more than 6 months. The symptoms are described as noticeable in nature.;surgery
brain_glioma_1387;Brain Glioma;72;F;Patient is experiencing frequent seizures and confusion over the past 2 months. The symptoms are described as debilitating in nature.;radiation therapy
brain_glioma_1388;Brain Glioma;30;F;Patient is experiencing memory lapses and persistent headaches for the last few weeks. The symptoms are described as noticeable in nature.;radiation therapy
brain_glioma_1389;Brain Glioma;34;M;Patient is experiencing frequent seizures and memory lapses for the last few weeks. The symptoms are described as noticeable in nature.;chemotherapy
brain_glioma_1390;Brain Glioma;46;M;Patient is experiencing dizziness and visual disturbances for the last few weeks. The symptoms are described as noticeable in nature.;surgery
brain_glioma_1391;Brain Glioma;33;F;Patient is experiencing dizziness and speech difficulties for the last few weeks. The symptoms are described as noticeable in nature.;radiation therapy
brain_glioma_1392;Brain Glioma;33;F;Patient is experiencing confusion and frequent seizures over the past 2 months. The symptoms are described as significant in nature.;chemotherapy
brain_glioma_1393;Brain Glioma;43;F;Patient is experiencing persistent headaches and visual disturbances over the past 2 months. The symptoms are described as debilitating in nature.;surgery
brain_glioma_1394;Brain Glioma;30;M;Patient is experiencing visual disturbances and confusion for more than 6 months. The symptoms are described as noticeable in nature.;surgery
brain_glioma_1395;Brain Glioma;57;M;Patient is experiencing persistent headaches and confusion for the last few weeks. The symptoms are described as severe in nature.;surgery
brain_glioma_1396;Brain Glioma;75;M;Patient is experiencing speech difficulties and confusion over the past 2 months. The symptoms are described as intense in nature.;radiation therapy
brain_glioma_1397;Brain Glioma;77;F;Patient is experiencing dizziness and frequent seizures for more than 6 months. The symptoms are described as significant in nature.;chemotherapy
brain_glioma_1398;Brain Glioma;60;M;Patient is experiencing speech difficulties and memory lapses for more than 6 months. The symptoms are described as noticeable in nature.;surgery
brain_glioma_1399;Brain Glioma;57;M;Patient is experiencing frequent seizures and confusion for the last few weeks. The symptoms are described as significant in nature.;radiation therapy
brain_glioma_1400;Brain Glioma;77;F;Patient is experiencing visual disturbances and memory lapses over the past 2 months. The symptoms are described as moderate in nature.;chemotherapy
brain_glioma_1401;Brain Glioma;28;F;Patient is experiencing persistent headaches and visual disturbances for more than 6 months. The symptoms are described as intense in nature.;surgery
brain_glioma_1402;Brain Glioma;73;F;Patient is experiencing speech difficulties and visual disturbances over the past 2 months. The symptoms are described as significant in nature.;radiation therapy
brain_glioma_1403;Brain Glioma;83;F;Patient is experiencing confusion and persistent headaches for the last few weeks. The symptoms are described as significant in nature.;radiation therapy
brain_glioma_1404;Brain Glioma;18;M;Patient is experiencing persistent headaches and dizziness for the last few weeks. The symptoms are described as severe in nature.;radiation therapy
brain_glioma_1405;Brain Glioma;36;M;Patient is experiencing persistent headaches and speech difficulties over the past 2 months. The symptoms are described as significant in nature.;surgery
brain_glioma_1406;Brain Glioma;47;F;Patient is experiencing memory lapses and dizziness for more than 6 months. The symptoms are described as high-grade in nature.;chemotherapy
brain_glioma_1407;Brain Glioma;29;F;Patient is experiencing visual disturbances and persistent headaches over the past 2 months. The symptoms are described as moderate in nature.;surgery
brain_glioma_1408;Brain Glioma;47;M;Patient is experiencing visual disturbances and persistent headaches over the past 2 months. The symptoms are described as moderate in nature.;chemotherapy
brain_glioma_1409;Brain Glioma;28;M;Patient is experiencing confusion and dizziness for more than 6 months. The symptoms are described as debilitating in nature.;radiation therapy
brain_glioma_1410;Brain Glioma;26;F;Patient is experiencing speech difficulties and dizziness for more than 6 months. The symptoms are described as debilitating in nature.;radiation therapy
brain_glioma_1411;Brain Glioma;49;M;Patient is experiencing persistent headaches and confusion for the last few weeks. The symptoms are described as noticeable in nature.;radiation therapy
brain_glioma_1412;Brain Glioma;23;M;Patient is experiencing confusion and memory lapses for more than 6 months. The symptoms are described as intense in nature.;chemotherapy
brain_glioma_1413;Brain Glioma;51;M;Patient is experiencing persistent headaches and confusion for more than 6 months. The symptoms are described as significant in nature.;surgery
brain_glioma_1414;Brain Glioma;72;M;Patient is experiencing persistent headaches and visual disturbances for more than 6 months. The symptoms are described as moderate in nature.;surgery
brain_glioma_1415;Brain Glioma;32;M;Patient is experiencing frequent seizures and memory lapses over the past 2 months. The symptoms are described as noticeable in nature.;chemotherapy
brain_glioma_1416;Brain Glioma;63;F;Patient is experiencing persistent headaches and frequent seizures for the last few weeks. The symptoms are described as noticeable in nature.;chemotherapy
brain_glioma_1417;Brain Glioma;43;F;Patient is experiencing visual disturbances and persistent headaches over the past 2 months. The symptoms are described as severe in nature.;chemotherapy
brain_glioma_1418;Brain Glioma;72;F;Patient is experiencing confusion and memory lapses for the last few weeks. The symptoms are described as noticeable in nature.;radiation therapy
brain_glioma_1419;Brain Glioma;62;M;Patient is experiencing confusion and speech difficulties for the last few weeks. The symptoms are described as noticeable in nature.;radiation therapy
brain_glioma_1420;Brain Glioma;47;M;Patient is experiencing visual disturbances and speech difficulties over the past 2 months. The symptoms are described as intense in nature.;surgery
brain_glioma_1421;Brain Glioma;73;F;Patient is experiencing visual disturbances and memory lapses for more than 6 months. The symptoms are described as moderate in nature.;chemotherapy
brain_glioma_1422;Brain Glioma;66;F;Patient is experiencing memory lapses and dizziness for the last few weeks. The symptoms are described as moderate in nature.;surgery
brain_glioma_1423;Brain Glioma;42;F;Patient is experiencing frequent seizures and visual disturbances for the last few weeks. The symptoms are described as high-grade in nature.;surgery
brain_glioma_1424;Brain Glioma;26;F;Patient is experiencing confusion and memory lapses for more than 6 months. The symptoms are described as high-grade in nature.;surgery
brain_glioma_1425;Brain Glioma;26;F;Patient is experiencing memory lapses and dizziness for more than 6 months. The symptoms are described as high-grade in nature.;surgery
brain_glioma_1426;Brain Glioma;76;F;Patient is experiencing frequent seizures and memory lapses for more than 6 months. The symptoms are described as debilitating in nature.;chemotherapy
brain_glioma_1427;Brain Glioma;41;M;Patient is experiencing frequent seizures and speech difficulties for more than 6 months. The symptoms are described as moderate in nature.;radiation therapy
brain_glioma_1428;Brain Glioma;28;M;Patient is experiencing memory lapses and visual disturbances for more than 6 months. The symptoms are described as significant in nature.;radiation therapy
brain_glioma_1429;Brain Glioma;54;F;Patient is experiencing speech difficulties and memory lapses over the past 2 months. The symptoms are described as moderate in nature.;surgery
brain_glioma_1430;Brain Glioma;71;M;Patient is experiencing memory lapses and dizziness for the last few weeks. The symptoms are described as moderate in nature.;radiation therapy
brain_glioma_1431;Brain Glioma;48;M;Patient is experiencing dizziness and frequent seizures for more than 6 months. The symptoms are described as significant in nature.;surgery
brain_glioma_1432;Brain Glioma;51;M;Patient is experiencing confusion and speech difficulties for more than 6 months. The symptoms are described as significant in nature.;surgery
brain_glioma_1433;Brain Glioma;73;F;Patient is experiencing visual disturbances and persistent headaches over the past 2 months. The symptoms are described as significant in nature.;radiation therapy
brain_glioma_1434;Brain Glioma;52;F;Patient is experiencing frequent seizures and visual disturbances over the past 2 months. The symptoms are described as moderate in nature.;surgery
brain_glioma_1435;Brain Glioma;42;F;Patient is experiencing speech difficulties and memory lapses over the past 2 months. The symptoms are described as noticeable in nature.;surgery
brain_glioma_1436;Brain Glioma;85;F;Patient is experiencing persistent headaches and visual disturbances for the last few weeks. The symptoms are described as noticeable in nature.;radiation therapy
brain_glioma_1437;Brain Glioma;29;M;Patient is experiencing memory lapses and speech difficulties for the last few weeks. The symptoms are described as severe in nature.;surgery
brain_glioma_1438;Brain Glioma;56;F;Patient is experiencing confusion and dizziness over the past 2 months. The symptoms are described as debilitating in nature.;surgery
brain_glioma_1439;Brain Glioma;77;F;Patient is experiencing frequent seizures and memory lapses for the last few weeks. The symptoms are described as intense in nature.;surgery
brain_glioma_1440;Brain Glioma;81;M;Patient is experiencing frequent seizures and memory lapses for the last few weeks. The symptoms are described as moderate in nature.;chemotherapy
brain_glioma_1441;Brain Glioma;26;F;Patient is experiencing visual disturbances and persistent headaches for the last few weeks. The symptoms are described as severe in nature.;surgery
brain_glioma_1442;Brain Glioma;63;F;Patient is experiencing frequent seizures and speech difficulties for the last few weeks. The symptoms are described as severe in nature.;radiation therapy
brain_glioma_1443;Brain Glioma;43;M;Patient is experiencing frequent seizures and persistent headaches for the last few weeks. The symptoms are described as severe in nature.;radiation therapy
brain_glioma_1444;Brain Glioma;43;F;Patient is experiencing persistent headaches and memory lapses for more than 6 months. The symptoms are described as debilitating in nature.;radiation therapy
brain_glioma_1445;Brain Glioma;40;M;Patient is experiencing confusion and persistent headaches for the last few weeks. The symptoms are described as high-grade in nature.;radiation therapy
brain_glioma_1446;Brain Glioma;34;F;Patient is experiencing frequent seizures and persistent headaches for more than 6 months. The symptoms are described as significant in nature.;radiation therapy
brain_glioma_1447;Brain Glioma;51;M;Patient is experiencing speech difficulties and visual disturbances for more than 6 months. The symptoms are described as high-grade in nature.;chemotherapy
brain_glioma_1448;Brain Glioma;29;F;Patient is experiencing visual disturbances and confusion for the last few weeks. The symptoms are described as high-grade in nature.;radiation therapy
brain_glioma_1449;Brain Glioma;41;M;Patient is experiencing speech difficulties and persistent headaches for more than 6 months. The symptoms are described as intense in nature.;surgery
brain_glioma_1450;Brain Glioma;46;F;Patient is experiencing speech difficulties and memory lapses for the last few weeks. The symptoms are described as high-grade in nature.;radiation therapy
brain_glioma_1451;Brain Glioma;62;F;Patient is experiencing memory lapses and speech difficulties over the past 2 months. The symptoms are described as high-grade in nature.;radiation therapy
brain_glioma_1452;Brain Glioma;69;F;Patient is experiencing speech difficulties and persistent headaches for the last few weeks. The symptoms are described as noticeable in nature.;radiation therapy
brain_glioma_1453;Brain Glioma;52;M;Patient is experiencing memory lapses and dizziness over the past 2 months. The symptoms are described as high-grade in nature.;radiation therapy
brain_glioma_1454;Brain Glioma;69;M;Patient is experiencing dizziness and speech difficulties for more than 6 months. The symptoms are described as severe in nature.;chemotherapy
brain_glioma_1455;Brain Glioma;47;F;Patient is experiencing confusion and dizziness for more than 6 months. The symptoms are described as severe in nature.;chemotherapy
brain_glioma_1456;Brain Glioma;47;M;Patient is experiencing visual disturbances and dizziness for the last few weeks. The symptoms are described as severe in nature.;radiation therapy
brain_glioma_1457;Brain Glioma;59;M;Patient is experiencing confusion and dizziness for more than 6 months. The symptoms are described as debilitating in nature.;chemotherapy
brain_glioma_1458;Brain Glioma;24;F;Patient is experiencing persistent headaches and frequent seizures over the past 2 months. The symptoms are described as intense in nature.;chemotherapy
brain_glioma_1459;Brain Glioma;46;M;Patient is experiencing speech difficulties and visual disturbances for more than 6 months. The symptoms are described as moderate in nature.;chemotherapy
brain_glioma_1460;Brain Glioma;23;F;Patient is experiencing frequent seizures and visual disturbances over the past 2 months. The symptoms are described as moderate in nature.;chemotherapy
brain_glioma_1461;Brain Glioma;39;M;Patient is experiencing speech difficulties and persistent headaches for more than 6 months. The symptoms are described as moderate in nature.;chemotherapy
brain_glioma_1462;Brain Glioma;54;F;Patient is experiencing persistent headaches and confusion for the last few weeks. The symptoms are described as high-grade in nature.;chemotherapy
brain_glioma_1463;Brain Glioma;62;M;Patient is experiencing memory lapses and speech difficulties over the past 2 months. The symptoms are described as high-grade in nature.;surgery
brain_glioma_1464;Brain Glioma;67;F;Patient is experiencing memory lapses and persistent headaches for more than 6 months. The symptoms are described as moderate in nature.;radiation therapy
brain_glioma_1465;Brain Glioma;43;M;Patient is experiencing memory lapses and persistent headaches for the last few weeks. The symptoms are described as high-grade in nature.;radiation therapy
brain_glioma_1466;Brain Glioma;56;F;Patient is experiencing dizziness and persistent headaches for more than 6 months. The symptoms are described as noticeable in nature.;chemotherapy
brain_glioma_1467;Brain Glioma;38;M;Patient is experiencing visual disturbances and dizziness for the last few weeks. The symptoms are described as debilitating in nature.;surgery
brain_glioma_1468;Brain Glioma;64;F;Patient is experiencing persistent headaches and speech difficulties for the last few weeks. The symptoms are described as severe in nature.;radiation therapy
brain_glioma_1469;Brain Glioma;38;M;Patient is experiencing confusion and memory lapses for the last few weeks. The symptoms are described as moderate in nature.;radiation therapy
brain_glioma_1470;Brain Glioma;45;F;Patient is experiencing speech difficulties and confusion over the past 2 months. The symptoms are described as debilitating in nature.;surgery
brain_glioma_1471;Brain Glioma;32;M;Patient is experiencing confusion and visual disturbances for more than 6 months. The symptoms are described as severe in nature.;radiation therapy
brain_glioma_1472;Brain Glioma;70;M;Patient is experiencing memory lapses and persistent headaches over the past 2 months. The symptoms are described as noticeable in nature.;chemotherapy
brain_glioma_1473;Brain Glioma;51;M;Patient is experiencing confusion and dizziness for the last few weeks. The symptoms are described as severe in nature.;chemotherapy
brain_glioma_1474;Brain Glioma;22;M;Patient is experiencing memory lapses and dizziness for the last few weeks. The symptoms are described as debilitating in nature.;surgery
brain_glioma_1475;Brain Glioma;46;F;Patient is experiencing persistent headaches and memory lapses for the last few weeks. The symptoms are described as intense in nature.;surgery
brain_glioma_1476;Brain Glioma;26;F;Patient is experiencing speech difficulties and persistent headaches for more than 6 months. The symptoms are described as moderate in nature.;surgery
brain_glioma_1477;Brain Glioma;22;M;Patient is experiencing memory lapses and dizziness for the last few weeks. The symptoms are described as noticeable in nature.;radiation therapy
brain_glioma_1478;Brain Glioma;61;F;Patient is experiencing speech difficulties and dizziness for the last few weeks. The symptoms are described as moderate in nature.;radiation therapy
brain_glioma_1479;Brain Glioma;33;F;Patient is experiencing persistent headaches and visual disturbances over the past 2 months. The symptoms are described as intense in nature.;chemotherapy
brain_glioma_1480;Brain Glioma;35;F;Patient is experiencing confusion and speech difficulties for the last few weeks. The symptoms are described as moderate in nature.;surgery
brain_glioma_1481;Brain Glioma;51;M;Patient is experiencing visual disturbances and persistent headaches for the last few weeks. The symptoms are described as severe in nature.;chemotherapy
brain_glioma_1482;Brain Glioma;63;M;Patient is experiencing memory lapses and dizziness for the last few weeks. The symptoms are described as severe in nature.;surgery
brain_glioma_1483;Brain Glioma;64;F;Patient is experiencing frequent seizures and memory lapses over the past 2 months. The symptoms are described as significant in nature.;surgery
brain_glioma_1484;Brain Glioma;81;F;Patient is experiencing persistent headaches and frequent seizures over the past 2 months. The symptoms are described as debilitating in nature.;chemotherapy
brain_glioma_1485;Brain Glioma;21;M;Patient is experiencing persistent headaches and speech difficulties over the past 2 months. The symptoms are described as significant in nature.;radiation therapy
brain_glioma_1486;Brain Glioma;19;F;Patient is experiencing speech difficulties and persistent headaches for more than 6 months. The symptoms are described as high-grade in nature.;radiation therapy
brain_glioma_1487;Brain Glioma;44;M;Patient is experiencing dizziness and memory lapses for more than 6 months. The symptoms are described as debilitating in nature.;radiation therapy
brain_glioma_1488;Brain Glioma;72;M;Patient is experiencing dizziness and confusion for the last few weeks. The symptoms are described as significant in nature.;radiation therapy
brain_glioma_1489;Brain Glioma;75;F;Patient is experiencing memory lapses and visual disturbances over the past 2 months. The symptoms are described as moderate in nature.;surgery
brain_glioma_1490;Brain Glioma;55;F;Patient is experiencing persistent headaches and speech difficulties for more than 6 months. The symptoms are described as severe in nature.;radiation therapy
brain_glioma_1491;Brain Glioma;27;M;Patient is experiencing speech difficulties and memory lapses for the last few weeks. The symptoms are described as high-grade in nature.;surgery
brain_glioma_1492;Brain Glioma;61;F;Patient is experiencing confusion and frequent seizures over the past 2 months. The symptoms are described as noticeable in nature.;surgery
brain_glioma_1493;Brain Glioma;29;F;Patient is experiencing memory lapses and frequent seizures for the last few weeks. The symptoms are described as debilitating in nature.;chemotherapy
brain_glioma_1494;Brain Glioma;56;F;Patient is experiencing memory lapses and visual disturbances over the past 2 months. The symptoms are described as significant in nature.;surgery
brain_glioma_1495;Brain Glioma;51;F;Patient is experiencing memory lapses and persistent headaches for more than 6 months. The symptoms are described as high-grade in nature.;chemotherapy
brain_glioma_1496;Brain Glioma;70;M;Patient is experiencing visual disturbances and speech difficulties over the past 2 months. The symptoms are described as noticeable in nature.;surgery
brain_glioma_1497;Brain Glioma;82;F;Patient is experiencing frequent seizures and speech difficulties for the last few weeks. The symptoms are described as intense in nature.;chemotherapy
brain_glioma_1498;Brain Glioma;39;F;Patient is experiencing persistent headaches and visual disturbances over the past 2 months. The symptoms are described as debilitating in nature.;chemotherapy
brain_glioma_1499;Brain Glioma;55;M;Patient is experiencing speech difficulties and visual disturbances for the last few weeks. The symptoms are described as noticeable in nature.;chemotherapy
brain_glioma_1500;Brain Glioma;39;F;Patient is experiencing persistent headaches and confusion for the last few weeks. The symptoms are described as noticeable in nature.;surgery
brain_glioma_1501;Brain Glioma;60;F;Patient is experiencing speech difficulties and dizziness over the past 2 months. The symptoms are described as moderate in nature.;radiation therapy
brain_glioma_1502;Brain Glioma;34;M;Patient is experiencing frequent seizures and persistent headaches for the last few weeks. The symptoms are described as noticeable in nature.;surgery
brain_glioma_1503;Brain Glioma;68;F;Patient is experiencing persistent headaches and dizziness for the last few weeks. The symptoms are described as high-grade in nature.;chemotherapy
brain_glioma_1504;Brain Glioma;31;F;Patient is experiencing frequent seizures and persistent headaches over the past 2 months. The symptoms are described as intense in nature.;chemotherapy
brain_glioma_1505;Brain Glioma;73;F;Patient is experiencing speech difficulties and confusion for more than 6 months. The symptoms are described as moderate in nature.;chemotherapy
brain_glioma_1506;Brain Glioma;20;F;Patient is experiencing persistent headaches and memory lapses over the past 2 months. The symptoms are described as significant in nature.;surgery
brain_glioma_1507;Brain Glioma;51;M;Patient is experiencing persistent headaches and speech difficulties over the past 2 months. The symptoms are described as severe in nature.;chemotherapy
brain_glioma_1508;Brain Glioma;52;F;Patient is experiencing dizziness and speech difficulties for the last few weeks. The symptoms are described as intense in nature.;surgery
brain_glioma_1509;Brain Glioma;44;F;Patient is experiencing persistent headaches and confusion over the past 2 months. The symptoms are described as high-grade in nature.;surgery
brain_glioma_1510;Brain Glioma;68;F;Patient is experiencing speech difficulties and persistent headaches over the past 2 months. The symptoms are described as high-grade in nature.;radiation therapy
brain_glioma_1511;Brain Glioma;82;M;Patient is experiencing dizziness and persistent headaches for the last few weeks. The symptoms are described as noticeable in nature.;surgery
brain_glioma_1512;Brain Glioma;34;F;Patient is experiencing dizziness and visual disturbances over the past 2 months. The symptoms are described as intense in nature.;radiation therapy
brain_glioma_1513;Brain Glioma;18;F;Patient is experiencing confusion and memory lapses for the last few weeks. The symptoms are described as significant in nature.;radiation therapy
brain_glioma_1514;Brain Glioma;66;F;Patient is experiencing speech difficulties and persistent headaches over the past 2 months. The symptoms are described as moderate in nature.;surgery
brain_glioma_1515;Brain Glioma;25;M;Patient is experiencing visual disturbances and confusion for the last few weeks. The symptoms are described as severe in nature.;surgery
brain_glioma_1516;Brain Glioma;55;M;Patient is experiencing dizziness and confusion for the last few weeks. The symptoms are described as high-grade in nature.;surgery
brain_glioma_1517;Brain Glioma;71;M;Patient is experiencing confusion and memory lapses for more than 6 months. The symptoms are described as intense in nature.;surgery
brain_glioma_1518;Brain Glioma;64;F;Patient is experiencing persistent headaches and speech difficulties for more than 6 months. The symptoms are described as intense in nature.;surgery
brain_glioma_1519;Brain Glioma;61;M;Patient is experiencing frequent seizures and dizziness for more than 6 months. The symptoms are described as significant in nature.;radiation therapy
brain_glioma_1520;Brain Glioma;24;M;Patient is experiencing persistent headaches and dizziness for more than 6 months. The symptoms are described as intense in nature.;radiation therapy
brain_glioma_1521;Brain Glioma;64;M;Patient is experiencing confusion and visual disturbances over the past 2 months. The symptoms are described as significant in nature.;chemotherapy
brain_glioma_1522;Brain Glioma;42;M;Patient is experiencing memory lapses and frequent seizures for more than 6 months. The symptoms are described as noticeable in nature.;radiation therapy
brain_glioma_1523;Brain Glioma;29;F;Patient is experiencing visual disturbances and memory lapses over the past 2 months. The symptoms are described as moderate in nature.;radiation therapy
brain_glioma_1524;Brain Glioma;33;F;Patient is experiencing visual disturbances and confusion for more than 6 months. The symptoms are described as moderate in nature.;surgery
brain_glioma_1525;Brain Glioma;84;M;Patient is experiencing persistent headaches and memory lapses for the last few weeks. The symptoms are described as high-grade in nature.;surgery
brain_glioma_1526;Brain Glioma;44;M;Patient is experiencing dizziness and confusion for the last few weeks. The symptoms are described as noticeable in nature.;surgery
brain_glioma_1527;Brain Glioma;63;M;Patient is experiencing speech difficulties and visual disturbances for the last few weeks. The symptoms are described as moderate in nature.;radiation therapy
brain_glioma_1528;Brain Glioma;75;M;Patient is experiencing dizziness and visual disturbances for more than 6 months. The symptoms are described as noticeable in nature.;chemotherapy
brain_glioma_1529;Brain Glioma;42;F;Patient is experiencing visual disturbances and confusion for the last few weeks. The symptoms are described as debilitating in nature.;radiation therapy
brain_glioma_1530;Brain Glioma;83;M;Patient is experiencing frequent seizures and speech difficulties over the past 2 months. The symptoms are described as significant in nature.;surgery
brain_glioma_1531;Brain Glioma;33;M;Patient is experiencing confusion and memory lapses for the last few weeks. The symptoms are described as significant in nature.;chemotherapy
brain_glioma_1532;Brain Glioma;56;M;Patient is experiencing memory lapses and frequent seizures for more than 6 months. The symptoms are described as significant in nature.;surgery
brain_glioma_1533;Brain Glioma;19;M;Patient is experiencing memory lapses and speech difficulties over the past 2 months. The symptoms are described as intense in nature.;chemotherapy
brain_glioma_1534;Brain Glioma;62;F;Patient is experiencing memory lapses and persistent headaches over the past 2 months. The symptoms are described as severe in nature.;surgery
brain_glioma_1535;Brain Glioma;46;M;Patient is experiencing visual disturbances and confusion for more than 6 months. The symptoms are described as noticeable in nature.;radiation therapy
brain_glioma_1536;Brain Glioma;24;M;Patient is experiencing persistent headaches and speech difficulties for more than 6 months. The symptoms are described as significant in nature.;radiation therapy
brain_glioma_1537;Brain Glioma;83;F;Patient is experiencing visual disturbances and persistent headaches for more than 6 months. The symptoms are described as high-grade in nature.;radiation therapy
brain_glioma_1538;Brain Glioma;18;F;Patient is experiencing dizziness and confusion over the past 2 months. The symptoms are described as significant in nature.;chemotherapy
brain_glioma_1539;Brain Glioma;38;M;Patient is experiencing dizziness and speech difficulties for more than 6 months. The symptoms are described as moderate in nature.;chemotherapy
brain_glioma_1540;Brain Glioma;70;M;Patient is experiencing confusion and visual disturbances over the past 2 months. The symptoms are described as high-grade in nature.;radiation therapy
brain_glioma_1541;Brain Glioma;68;M;Patient is experiencing speech difficulties and persistent headaches for the last few weeks. The symptoms are described as severe in nature.;radiation therapy
brain_glioma_1542;Brain Glioma;57;M;Patient is experiencing visual disturbances and speech difficulties for the last few weeks. The symptoms are described as severe in nature.;chemotherapy
brain_glioma_1543;Brain Glioma;81;M;Patient is experiencing memory lapses and speech difficulties for more than 6 months. The symptoms are described as debilitating in nature.;surgery
brain_glioma_1544;Brain Glioma;75;M;Patient is experiencing confusion and dizziness for the last few weeks. The symptoms are described as significant in nature.;radiation therapy
brain_glioma_1545;Brain Glioma;64;M;Patient is experiencing persistent headaches and confusion for the last few weeks. The symptoms are described as noticeable in nature.;chemotherapy
brain_glioma_1546;Brain Glioma;56;M;Patient is experiencing memory lapses and confusion for more than 6 months. The symptoms are described as high-grade in nature.;radiation therapy
brain_glioma_1547;Brain Glioma;79;F;Patient is experiencing confusion and dizziness for the last few weeks. The symptoms are described as debilitating in nature.;radiation therapy
brain_glioma_1548;Brain Glioma;33;M;Patient is experiencing memory lapses and speech difficulties over the past 2 months. The symptoms are described as intense in nature.;radiation therapy
brain_glioma_1549;Brain Glioma;64;F;Patient is experiencing speech difficulties and frequent seizures over the past 2 months. The symptoms are described as moderate in nature.;surgery
brain_glioma_1550;Brain Glioma;47;F;Patient is experiencing dizziness and frequent seizures for more than 6 months. The symptoms are described as severe in nature.;radiation therapy
brain_glioma_1551;Brain Glioma;49;M;Patient is experiencing dizziness and speech difficulties for more than 6 months. The symptoms are described as severe in nature.;chemotherapy
brain_glioma_1552;Brain Glioma;71;M;Patient is experiencing memory lapses and confusion over the past 2 months. The symptoms are described as debilitating in nature.;chemotherapy
brain_glioma_1553;Brain Glioma;30;M;Patient is experiencing dizziness and frequent seizures over the past 2 months. The symptoms are described as severe in nature.;surgery
brain_glioma_1554;Brain Glioma;85;F;Patient is experiencing frequent seizures and confusion for more than 6 months. The symptoms are described as moderate in nature.;surgery
brain_glioma_1555;Brain Glioma;78;M;Patient is experiencing speech difficulties and dizziness over the past 2 months. The symptoms are described as noticeable in nature.;radiation therapy
brain_glioma_1556;Brain Glioma;73;F;Patient is experiencing dizziness and visual disturbances for the last few weeks. The symptoms are described as moderate in nature.;radiation therapy
brain_glioma_1557;Brain Glioma;63;F;Patient is experiencing frequent seizures and speech difficulties for more than 6 months. The symptoms are described as high-grade in nature.;chemotherapy
brain_glioma_1558;Brain Glioma;28;F;Patient is experiencing memory lapses and visual disturbances over the past 2 months. The symptoms are described as debilitating in nature.;chemotherapy
brain_glioma_1559;Brain Glioma;49;M;Patient is experiencing persistent headaches and speech difficulties for the last few weeks. The symptoms are described as high-grade in nature.;chemotherapy
brain_glioma_1560;Brain Glioma;41;F;Patient is experiencing dizziness and speech difficulties for the last few weeks. The symptoms are described as intense in nature.;radiation therapy
brain_glioma_1561;Brain Glioma;63;M;Patient is experiencing visual disturbances and memory lapses over the past 2 months. The symptoms are described as significant in nature.;surgery
brain_glioma_1562;Brain Glioma;24;F;Patient is experiencing dizziness and frequent seizures over the past 2 months. The symptoms are described as noticeable in nature.;chemotherapy
brain_glioma_1563;Brain Glioma;50;F;Patient is experiencing confusion and visual disturbances for the last few weeks. The symptoms are described as significant in nature.;chemotherapy
brain_glioma_1564;Brain Glioma;51;M;Patient is experiencing frequent seizures and visual disturbances over the past 2 months. The symptoms are described as significant in nature.;radiation therapy
brain_glioma_1565;Brain Glioma;46;M;Patient is experiencing persistent headaches and confusion over the past 2 months. The symptoms are described as moderate in nature.;radiation therapy
brain_glioma_1566;Brain Glioma;73;F;Patient is experiencing visual disturbances and frequent seizures for more than 6 months. The symptoms are described as severe in nature.;chemotherapy
brain_glioma_1567;Brain Glioma;42;F;Patient is experiencing speech difficulties and dizziness for the last few weeks. The symptoms are described as significant in nature.;chemotherapy
brain_glioma_1568;Brain Glioma;55;M;Patient is experiencing memory lapses and visual disturbances for more than 6 months. The symptoms are described as debilitating in nature.;radiation therapy
brain_glioma_1569;Brain Glioma;51;F;Patient is experiencing persistent headaches and frequent seizures for the last few weeks. The symptoms are described as intense in nature.;chemotherapy
brain_glioma_1570;Brain Glioma;21;F;Patient is experiencing visual disturbances and speech difficulties over the past 2 months. The symptoms are described as noticeable in nature.;radiation therapy
brain_glioma_1571;Brain Glioma;47;F;Patient is experiencing memory lapses and visual disturbances for more than 6 months. The symptoms are described as high-grade in nature.;radiation therapy
brain_glioma_1572;Brain Glioma;22;M;Patient is experiencing frequent seizures and persistent headaches for the last few weeks. The symptoms are described as significant in nature.;chemotherapy
brain_glioma_1573;Brain Glioma;78;F;Patient is experiencing persistent headaches and frequent seizures over the past 2 months. The symptoms are described as intense in nature.;chemotherapy
brain_glioma_1574;Brain Glioma;41;F;Patient is experiencing memory lapses and frequent seizures for more than 6 months. The symptoms are described as high-grade in nature.;radiation therapy
brain_glioma_1575;Brain Glioma;52;M;Patient is experiencing dizziness and frequent seizures for the last few weeks. The symptoms are described as severe in nature.;chemotherapy
brain_glioma_1576;Brain Glioma;23;F;Patient is experiencing visual disturbances and speech difficulties over the past 2 months. The symptoms are described as moderate in nature.;surgery
brain_glioma_1577;Brain Glioma;63;M;Patient is experiencing speech difficulties and memory lapses over the past 2 months. The symptoms are described as intense in nature.;radiation therapy
brain_glioma_1578;Brain Glioma;67;M;Patient is experiencing frequent seizures and persistent headaches for the last few weeks. The symptoms are described as significant in nature.;chemotherapy
brain_glioma_1579;Brain Glioma;54;M;Patient is experiencing dizziness and confusion for the last few weeks. The symptoms are described as severe in nature.;surgery
brain_glioma_1580;Brain Glioma;19;F;Patient is experiencing confusion and visual disturbances for the last few weeks. The symptoms are described as moderate in nature.;chemotherapy
brain_glioma_1581;Brain Glioma;43;M;Patient is experiencing confusion and persistent headaches over the past 2 months. The symptoms are described as moderate in nature.;surgery
brain_glioma_1582;Brain Glioma;43;F;Patient is experiencing dizziness and confusion for more than 6 months. The symptoms are described as noticeable in nature.;chemotherapy
brain_glioma_1583;Brain Glioma;36;F;Patient is experiencing dizziness and persistent headaches for the last few weeks. The symptoms are described as debilitating in nature.;chemotherapy
brain_glioma_1584;Brain Glioma;69;F;Patient is experiencing confusion and visual disturbances for more than 6 months. The symptoms are described as significant in nature.;surgery
brain_glioma_1585;Brain Glioma;68;M;Patient is experiencing persistent headaches and speech difficulties for more than 6 months. The symptoms are described as intense in nature.;radiation therapy
brain_glioma_1586;Brain Glioma;75;F;Patient is experiencing speech difficulties and visual disturbances for the last few weeks. The symptoms are described as moderate in nature.;radiation therapy
brain_glioma_1587;Brain Glioma;50;F;Patient is experiencing dizziness and persistent headaches over the past 2 months. The symptoms are described as significant in nature.;chemotherapy
brain_glioma_1588;Brain Glioma;58;F;Patient is experiencing dizziness and speech difficulties over the past 2 months. The symptoms are described as intense in nature.;surgery
brain_glioma_1589;Brain Glioma;68;F;Patient is experiencing memory lapses and speech difficulties for more than 6 months. The symptoms are described as high-grade in nature.;surgery
brain_glioma_1590;Brain Glioma;29;M;Patient is experiencing speech difficulties and dizziness over the past 2 months. The symptoms are described as intense in nature.;chemotherapy
brain_glioma_1591;Brain Glioma;56;M;Patient is experiencing frequent seizures and speech difficulties for more than 6 months. The symptoms are described as noticeable in nature.;chemotherapy
brain_glioma_1592;Brain Glioma;63;M;Patient is experiencing frequent seizures and dizziness over the past 2 months. The symptoms are described as significant in nature.;radiation therapy
brain_glioma_1593;Brain Glioma;51;F;Patient is experiencing dizziness and memory lapses for more than 6 months. The symptoms are described as intense in nature.;chemotherapy
brain_glioma_1594;Brain Glioma;28;M;Patient is experiencing dizziness and confusion for more than 6 months. The symptoms are described as noticeable in nature.;radiation therapy
brain_glioma_1595;Brain Glioma;68;F;Patient is experiencing dizziness and persistent headaches for the last few weeks. The symptoms are described as moderate in nature.;chemotherapy
brain_glioma_1596;Brain Glioma;50;M;Patient is experiencing memory lapses and confusion for the last few weeks. The symptoms are described as high-grade in nature.;radiation therapy
brain_glioma_1597;Brain Glioma;48;F;Patient is experiencing persistent headaches and visual disturbances for more than 6 months. The symptoms are described as noticeable in nature.;surgery
brain_glioma_1598;Brain Glioma;81;F;Patient is experiencing dizziness and speech difficulties for more than 6 months. The symptoms are described as noticeable in nature.;radiation therapy
brain_glioma_1599;Brain Glioma;67;F;Patient is experiencing dizziness and confusion for more than 6 months. The symptoms are described as debilitating in nature.;chemotherapy
brain_glioma_1600;Brain Glioma;69;M;Patient is experiencing persistent headaches and dizziness for more than 6 months. The symptoms are described as significant in nature.;surgery
brain_glioma_1601;Brain Glioma;42;F;Patient is experiencing confusion and speech difficulties for more than 6 months. The symptoms are described as significant in nature.;surgery
brain_glioma_1602;Brain Glioma;70;M;Patient is experiencing confusion and speech difficulties over the past 2 months. The symptoms are described as high-grade in nature.;radiation therapy
brain_glioma_1603;Brain Glioma;63;M;Patient is experiencing persistent headaches and frequent seizures for more than 6 months. The symptoms are described as intense in nature.;chemotherapy
brain_glioma_1604;Brain Glioma;32;M;Patient is experiencing confusion and frequent seizures over the past 2 months. The symptoms are described as moderate in nature.;radiation therapy
brain_glioma_1605;Brain Glioma;28;F;Patient is experiencing speech difficulties and dizziness for the last few weeks. The symptoms are described as moderate in nature.;surgery
brain_glioma_1606;Brain Glioma;50;F;Patient is experiencing frequent seizures and dizziness over the past 2 months. The symptoms are described as noticeable in nature.;chemotherapy
brain_glioma_1607;Brain Glioma;69;M;Patient is experiencing dizziness and speech difficulties over the past 2 months. The symptoms are described as moderate in nature.;radiation therapy
brain_glioma_1608;Brain Glioma;73;F;Patient is experiencing dizziness and frequent seizures for the last few weeks. The symptoms are described as noticeable in nature.;surgery
brain_glioma_1609;Brain Glioma;82;F;Patient is experiencing visual disturbances and frequent seizures for more than 6 months. The symptoms are described as intense in nature.;radiation therapy
brain_glioma_1610;Brain Glioma;36;F;Patient is experiencing persistent headaches and memory lapses for the last few weeks. The symptoms are described as high-grade in nature.;chemotherapy
brain_glioma_1611;Brain Glioma;28;M;Patient is experiencing visual disturbances and memory lapses for the last few weeks. The symptoms are described as noticeable in nature.;surgery
brain_glioma_1612;Brain Glioma;60;F;Patient is experiencing frequent seizures and visual disturbances for more than 6 months. The symptoms are described as noticeable in nature.;radiation therapy
brain_glioma_1613;Brain Glioma;72;F;Patient is experiencing frequent seizures and visual disturbances over the past 2 months. The symptoms are described as intense in nature.;chemotherapy
brain_glioma_1614;Brain Glioma;75;M;Patient is experiencing speech difficulties and visual disturbances for more than 6 months. The symptoms are described as moderate in nature.;surgery
brain_glioma_1615;Brain Glioma;61;M;Patient is experiencing dizziness and confusion for more than 6 months. The symptoms are described as moderate in nature.;chemotherapy
brain_glioma_1616;Brain Glioma;43;M;Patient is experiencing persistent headaches and speech difficulties for more than 6 months. The symptoms are described as noticeable in nature.;radiation therapy
brain_glioma_1617;Brain Glioma;83;M;Patient is experiencing confusion and memory lapses for the last few weeks. The symptoms are described as moderate in nature.;surgery
brain_glioma_1618;Brain Glioma;52;M;Patient is experiencing speech difficulties and frequent seizures for more than 6 months. The symptoms are described as debilitating in nature.;chemotherapy
brain_glioma_1619;Brain Glioma;55;F;Patient is experiencing frequent seizures and visual disturbances for the last few weeks. The symptoms are described as moderate in nature.;radiation therapy
brain_glioma_1620;Brain Glioma;60;M;Patient is experiencing persistent headaches and dizziness for more than 6 months. The symptoms are described as significant in nature.;chemotherapy
brain_glioma_1621;Brain Glioma;56;M;Patient is experiencing dizziness and confusion over the past 2 months. The symptoms are described as intense in nature.;surgery
brain_glioma_1622;Brain Glioma;71;F;Patient is experiencing visual disturbances and speech difficulties for the last few weeks. The symptoms are described as high-grade in nature.;surgery
brain_glioma_1623;Brain Glioma;62;F;Patient is experiencing frequent seizures and persistent headaches over the past 2 months. The symptoms are described as noticeable in nature.;surgery
brain_glioma_1624;Brain Glioma;51;F;Patient is experiencing visual disturbances and speech difficulties over the past 2 months. The symptoms are described as intense in nature.;surgery
brain_glioma_1625;Brain Glioma;45;M;Patient is experiencing confusion and visual disturbances for the last few weeks. The symptoms are described as significant in nature.;chemotherapy
brain_glioma_1626;Brain Glioma;30;M;Patient is experiencing frequent seizures and confusion for more than 6 months. The symptoms are described as severe in nature.;radiation therapy
brain_glioma_1627;Brain Glioma;27;M;Patient is experiencing visual disturbances and persistent headaches over the past 2 months. The symptoms are described as severe in nature.;surgery
brain_glioma_1628;Brain Glioma;51;F;Patient is experiencing persistent headaches and memory lapses for more than 6 months. The symptoms are described as severe in nature.;radiation therapy
brain_glioma_1629;Brain Glioma;77;M;Patient is experiencing speech difficulties and frequent seizures for the last few weeks. The symptoms are described as noticeable in nature.;radiation therapy
brain_glioma_1630;Brain Glioma;59;F;Patient is experiencing memory lapses and confusion for more than 6 months. The symptoms are described as noticeable in nature.;radiation therapy
brain_glioma_1631;Brain Glioma;53;M;Patient is experiencing frequent seizures and speech difficulties for more than 6 months. The symptoms are described as moderate in nature.;surgery
brain_glioma_1632;Brain Glioma;53;M;Patient is experiencing frequent seizures and persistent headaches for the last few weeks. The symptoms are described as noticeable in nature.;chemotherapy
brain_glioma_1633;Brain Glioma;72;F;Patient is experiencing frequent seizures and visual disturbances for more than 6 months. The symptoms are described as noticeable in nature.;chemotherapy
brain_glioma_1634;Brain Glioma;26;M;Patient is experiencing dizziness and visual disturbances for the last few weeks. The symptoms are described as significant in nature.;surgery
brain_glioma_1635;Brain Glioma;49;F;Patient is experiencing confusion and dizziness for more than 6 months. The symptoms are described as noticeable in nature.;chemotherapy
brain_glioma_1636;Brain Glioma;78;F;Patient is experiencing persistent headaches and visual disturbances over the past 2 months. The symptoms are described as noticeable in nature.;radiation therapy
brain_glioma_1637;Brain Glioma;67;F;Patient is experiencing memory lapses and confusion over the past 2 months. The symptoms are described as intense in nature.;surgery
brain_glioma_1638;Brain Glioma;74;F;Patient is experiencing speech difficulties and memory lapses over the past 2 months. The symptoms are described as moderate in nature.;radiation therapy
brain_glioma_1639;Brain Glioma;69;F;Patient is experiencing frequent seizures and speech difficulties for the last few weeks. The symptoms are described as noticeable in nature.;chemotherapy
brain_glioma_1640;Brain Glioma;61;M;Patient is experiencing speech difficulties and visual disturbances for more than 6 months. The symptoms are described as severe in nature.;radiation therapy
brain_glioma_1641;Brain Glioma;49;M;Patient is experiencing confusion and persistent headaches for more than 6 months. The symptoms are described as moderate in nature.;radiation therapy
brain_glioma_1642;Brain Glioma;34;F;Patient is experiencing memory lapses and speech difficulties over the past 2 months. The symptoms are described as moderate in nature.;radiation therapy
brain_glioma_1643;Brain Glioma;36;F;Patient is experiencing persistent headaches and confusion for more than 6 months. The symptoms are described as debilitating in nature.;chemotherapy
brain_glioma_1644;Brain Glioma;50;M;Patient is experiencing frequent seizures and persistent headaches over the past 2 months. The symptoms are described as noticeable in nature.;radiation therapy
brain_glioma_1645;Brain Glioma;56;F;Patient is experiencing confusion and visual disturbances for more than 6 months. The symptoms are described as noticeable in nature.;chemotherapy
brain_glioma_1646;Brain Glioma;50;M;Patient is experiencing dizziness and speech difficulties over the past 2 months. The symptoms are described as high-grade in nature.;radiation therapy
brain_glioma_1647;Brain Glioma;65;F;Patient is experiencing visual disturbances and memory lapses for the last few weeks. The symptoms are described as moderate in nature.;radiation therapy
brain_glioma_1648;Brain Glioma;22;F;Patient is experiencing frequent seizures and persistent headaches for the last few weeks. The symptoms are described as noticeable in nature.;radiation therapy
brain_glioma_1649;Brain Glioma;42;F;Patient is experiencing dizziness and speech difficulties over the past 2 months. The symptoms are described as intense in nature.;surgery
brain_glioma_1650;Brain Glioma;36;M;Patient is experiencing dizziness and visual disturbances for the last few weeks. The symptoms are described as high-grade in nature.;surgery
brain_glioma_1651;Brain Glioma;47;F;Patient is experiencing dizziness and frequent seizures over the past 2 months. The symptoms are described as severe in nature.;radiation therapy
brain_glioma_1652;Brain Glioma;39;F;Patient is experiencing memory lapses and speech difficulties for more than 6 months. The symptoms are described as noticeable in nature.;radiation therapy
brain_glioma_1653;Brain Glioma;34;F;Patient is experiencing dizziness and confusion for the last few weeks. The symptoms are described as significant in nature.;chemotherapy
brain_glioma_1654;Brain Glioma;18;M;Patient is experiencing visual disturbances and memory lapses for more than 6 months. The symptoms are described as debilitating in nature.;surgery
brain_glioma_1655;Brain Glioma;62;F;Patient is experiencing frequent seizures and memory lapses over the past 2 months. The symptoms are described as significant in nature.;surgery
brain_glioma_1656;Brain Glioma;70;F;Patient is experiencing confusion and frequent seizures over the past 2 months. The symptoms are described as moderate in nature.;radiation therapy
brain_glioma_1657;Brain Glioma;20;F;Patient is experiencing dizziness and speech difficulties over the past 2 months. The symptoms are described as significant in nature.;surgery
brain_glioma_1658;Brain Glioma;35;F;Patient is experiencing memory lapses and dizziness for more than 6 months. The symptoms are described as significant in nature.;surgery
brain_glioma_1659;Brain Glioma;48;F;Patient is experiencing persistent headaches and dizziness for the last few weeks. The symptoms are described as severe in nature.;chemotherapy
brain_glioma_1660;Brain Glioma;27;M;Patient is experiencing memory lapses and dizziness for the last few weeks. The symptoms are described as noticeable in nature.;chemotherapy
brain_glioma_1661;Brain Glioma;23;F;Patient is experiencing dizziness and memory lapses for the last few weeks. The symptoms are described as moderate in nature.;radiation therapy
brain_glioma_1662;Brain Glioma;48;M;Patient is experiencing frequent seizures and memory lapses for more than 6 months. The symptoms are described as debilitating in nature.;radiation therapy
brain_glioma_1663;Brain Glioma;73;M;Patient is experiencing frequent seizures and visual disturbances over the past 2 months. The symptoms are described as moderate in nature.;chemotherapy
brain_glioma_1664;Brain Glioma;27;F;Patient is experiencing memory lapses and visual disturbances over the past 2 months. The symptoms are described as high-grade in nature.;chemotherapy
brain_glioma_1665;Brain Glioma;66;F;Patient is experiencing confusion and persistent headaches over the past 2 months. The symptoms are described as intense in nature.;chemotherapy
brain_glioma_1666;Brain Glioma;75;M;Patient is experiencing visual disturbances and dizziness over the past 2 months. The symptoms are described as significant in nature.;radiation therapy
brain_glioma_1667;Brain Glioma;45;M;Patient is experiencing confusion and memory lapses for the last few weeks. The symptoms are described as high-grade in nature.;chemotherapy
brain_glioma_1668;Brain Glioma;74;F;Patient is experiencing persistent headaches and confusion over the past 2 months. The symptoms are described as debilitating in nature.;surgery
brain_glioma_1669;Brain Glioma;59;F;Patient is experiencing speech difficulties and visual disturbances for the last few weeks. The symptoms are described as noticeable in nature.;surgery
brain_glioma_1670;Brain Glioma;62;F;Patient is experiencing frequent seizures and visual disturbances over the past 2 months. The symptoms are described as high-grade in nature.;chemotherapy
brain_glioma_1671;Brain Glioma;27;M;Patient is experiencing frequent seizures and persistent headaches over the past 2 months. The symptoms are described as intense in nature.;surgery
brain_glioma_1672;Brain Glioma;33;M;Patient is experiencing dizziness and visual disturbances for more than 6 months. The symptoms are described as significant in nature.;chemotherapy
brain_glioma_1673;Brain Glioma;74;M;Patient is experiencing visual disturbances and memory lapses for the last few weeks. The symptoms are described as noticeable in nature.;surgery
brain_glioma_1674;Brain Glioma;70;F;Patient is experiencing memory lapses and frequent seizures for more than 6 months. The symptoms are described as significant in nature.;surgery
brain_glioma_1675;Brain Glioma;47;M;Patient is experiencing visual disturbances and speech difficulties for more than 6 months. The symptoms are described as debilitating in nature.;chemotherapy
brain_glioma_1676;Brain Glioma;47;F;Patient is experiencing dizziness and speech difficulties over the past 2 months. The symptoms are described as significant in nature.;radiation therapy
brain_glioma_1677;Brain Glioma;79;M;Patient is experiencing dizziness and visual disturbances over the past 2 months. The symptoms are described as moderate in nature.;chemotherapy
brain_glioma_1678;Brain Glioma;34;M;Patient is experiencing frequent seizures and persistent headaches for the last few weeks. The symptoms are described as noticeable in nature.;chemotherapy
brain_glioma_1679;Brain Glioma;38;M;Patient is experiencing persistent headaches and dizziness for the last few weeks. The symptoms are described as noticeable in nature.;chemotherapy
brain_glioma_1680;Brain Glioma;27;M;Patient is experiencing frequent seizures and dizziness for the last few weeks. The symptoms are described as moderate in nature.;surgery
brain_glioma_1681;Brain Glioma;79;M;Patient is experiencing speech difficulties and confusion for more than 6 months. The symptoms are described as high-grade in nature.;chemotherapy
brain_glioma_1682;Brain Glioma;38;M;Patient is experiencing speech difficulties and frequent seizures for more than 6 months. The symptoms are described as noticeable in nature.;chemotherapy
brain_glioma_1683;Brain Glioma;21;F;Patient is experiencing confusion and dizziness over the past 2 months. The symptoms are described as severe in nature.;surgery
brain_glioma_1684;Brain Glioma;48;M;Patient is experiencing dizziness and visual disturbances over the past 2 months. The symptoms are described as noticeable in nature.;chemotherapy
brain_glioma_1685;Brain Glioma;66;F;Patient is experiencing persistent headaches and dizziness for more than 6 months. The symptoms are described as severe in nature.;surgery
brain_glioma_1686;Brain Glioma;62;F;Patient is experiencing speech difficulties and visual disturbances over the past 2 months. The symptoms are described as noticeable in nature.;surgery
brain_glioma_1687;Brain Glioma;20;F;Patient is experiencing visual disturbances and dizziness over the past 2 months. The symptoms are described as noticeable in nature.;radiation therapy
brain_glioma_1688;Brain Glioma;68;M;Patient is experiencing dizziness and speech difficulties for the last few weeks. The symptoms are described as moderate in nature.;radiation therapy
brain_glioma_1689;Brain Glioma;73;F;Patient is experiencing confusion and persistent headaches for more than 6 months. The symptoms are described as significant in nature.;chemotherapy
brain_glioma_1690;Brain Glioma;78;M;Patient is experiencing visual disturbances and confusion for more than 6 months. The symptoms are described as significant in nature.;surgery
brain_glioma_1691;Brain Glioma;82;F;Patient is experiencing dizziness and frequent seizures for more than 6 months. The symptoms are described as high-grade in nature.;surgery
brain_glioma_1692;Brain Glioma;37;F;Patient is experiencing dizziness and confusion over the past 2 months. The symptoms are described as significant in nature.;radiation therapy
brain_glioma_1693;Brain Glioma;57;M;Patient is experiencing memory lapses and confusion over the past 2 months. The symptoms are described as severe in nature.;surgery
brain_glioma_1694;Brain Glioma;28;M;Patient is experiencing visual disturbances and persistent headaches over the past 2 months. The symptoms are described as noticeable in nature.;chemotherapy
brain_glioma_1695;Brain Glioma;63;F;Patient is experiencing memory lapses and persistent headaches for the last few weeks. The symptoms are described as significant in nature.;chemotherapy
brain_glioma_1696;Brain Glioma;52;F;Patient is experiencing persistent headaches and speech difficulties over the past 2 months. The symptoms are described as moderate in nature.;surgery
brain_glioma_1697;Brain Glioma;67;F;Patient is experiencing visual disturbances and speech difficulties over the past 2 months. The symptoms are described as high-grade in nature.;surgery
brain_glioma_1698;Brain Glioma;74;M;Patient is experiencing visual disturbances and persistent headaches for the last few weeks. The symptoms are described as severe in nature.;chemotherapy
brain_glioma_1699;Brain Glioma;68;M;Patient is experiencing memory lapses and dizziness for more than 6 months. The symptoms are described as severe in nature.;chemotherapy
brain_glioma_1700;Brain Glioma;52;F;Patient is experiencing memory lapses and speech difficulties for more than 6 months. The symptoms are described as intense in nature.;surgery
brain_glioma_1701;Brain Glioma;38;M;Patient is experiencing memory lapses and frequent seizures over the past 2 months. The symptoms are described as severe in nature.;chemotherapy
brain_glioma_1702;Brain Glioma;62;M;Patient is experiencing dizziness and frequent seizures for more than 6 months. The symptoms are described as moderate in nature.;chemotherapy
brain_glioma_1703;Brain Glioma;68;M;Patient is experiencing memory lapses and speech difficulties for the last few weeks. The symptoms are described as moderate in nature.;radiation therapy
brain_glioma_1704;Brain Glioma;64;F;Patient is experiencing speech difficulties and memory lapses over the past 2 months. The symptoms are described as significant in nature.;surgery
brain_glioma_1705;Brain Glioma;28;F;Patient is experiencing persistent headaches and dizziness for more than 6 months. The symptoms are described as significant in nature.;surgery
brain_glioma_1706;Brain Glioma;25;F;Patient is experiencing dizziness and memory lapses over the past 2 months. The symptoms are described as moderate in nature.;surgery
brain_glioma_1707;Brain Glioma;19;M;Patient is experiencing speech difficulties and frequent seizures for the last few weeks. The symptoms are described as moderate in nature.;chemotherapy
brain_glioma_1708;Brain Glioma;51;M;Patient is experiencing frequent seizures and persistent headaches for more than 6 months. The symptoms are described as debilitating in nature.;radiation therapy
brain_glioma_1709;Brain Glioma;20;M;Patient is experiencing memory lapses and dizziness for the last few weeks. The symptoms are described as significant in nature.;chemotherapy
brain_glioma_1710;Brain Glioma;23;F;Patient is experiencing visual disturbances and dizziness for more than 6 months. The symptoms are described as intense in nature.;chemotherapy
brain_glioma_1711;Brain Glioma;63;F;Patient is experiencing dizziness and speech difficulties over the past 2 months. The symptoms are described as high-grade in nature.;radiation therapy
brain_glioma_1712;Brain Glioma;34;M;Patient is experiencing confusion and persistent headaches for more than 6 months. The symptoms are described as debilitating in nature.;radiation therapy
brain_glioma_1713;Brain Glioma;33;F;Patient is experiencing dizziness and memory lapses over the past 2 months. The symptoms are described as noticeable in nature.;chemotherapy
brain_glioma_1714;Brain Glioma;59;M;Patient is experiencing confusion and memory lapses for the last few weeks. The symptoms are described as debilitating in nature.;radiation therapy
brain_glioma_1715;Brain Glioma;65;F;Patient is experiencing speech difficulties and frequent seizures for more than 6 months. The symptoms are described as moderate in nature.;radiation therapy
brain_glioma_1716;Brain Glioma;30;F;Patient is experiencing dizziness and memory lapses for more than 6 months. The symptoms are described as intense in nature.;radiation therapy
brain_glioma_1717;Brain Glioma;79;F;Patient is experiencing confusion and dizziness for more than 6 months. The symptoms are described as high-grade in nature.;radiation therapy
brain_glioma_1718;Brain Glioma;77;F;Patient is experiencing speech difficulties and visual disturbances for the last few weeks. The symptoms are described as noticeable in nature.;radiation therapy
brain_glioma_1719;Brain Glioma;57;F;Patient is experiencing dizziness and speech difficulties over the past 2 months. The symptoms are described as moderate in nature.;surgery
brain_glioma_1720;Brain Glioma;72;F;Patient is experiencing persistent headaches and confusion for the last few weeks. The symptoms are described as severe in nature.;surgery
brain_glioma_1721;Brain Glioma;29;F;Patient is experiencing memory lapses and dizziness for more than 6 months. The symptoms are described as significant in nature.;chemotherapy
brain_glioma_1722;Brain Glioma;34;M;Patient is experiencing dizziness and frequent seizures for the last few weeks. The symptoms are described as significant in nature.;surgery
brain_glioma_1723;Brain Glioma;75;M;Patient is experiencing frequent seizures and speech difficulties over the past 2 months. The symptoms are described as noticeable in nature.;surgery
brain_glioma_1724;Brain Glioma;64;M;Patient is experiencing confusion and visual disturbances over the past 2 months. The symptoms are described as intense in nature.;surgery
brain_glioma_1725;Brain Glioma;39;F;Patient is experiencing speech difficulties and visual disturbances for more than 6 months. The symptoms are described as noticeable in nature.;radiation therapy
brain_glioma_1726;Brain Glioma;29;M;Patient is experiencing persistent headaches and visual disturbances for more than 6 months. The symptoms are described as significant in nature.;surgery
brain_glioma_1727;Brain Glioma;23;F;Patient is experiencing dizziness and frequent seizures for more than 6 months. The symptoms are described as noticeable in nature.;surgery
brain_glioma_1728;Brain Glioma;38;F;Patient is experiencing visual disturbances and speech difficulties for the last few weeks. The symptoms are described as significant in nature.;chemotherapy
brain_glioma_1729;Brain Glioma;54;F;Patient is experiencing frequent seizures and persistent headaches for the last few weeks. The symptoms are described as intense in nature.;radiation therapy
brain_glioma_1730;Brain Glioma;85;M;Patient is experiencing speech difficulties and confusion over the past 2 months. The symptoms are described as moderate in nature.;radiation therapy
brain_glioma_1731;Brain Glioma;56;M;Patient is experiencing dizziness and persistent headaches for the last few weeks. The symptoms are described as intense in nature.;surgery
brain_glioma_1732;Brain Glioma;21;F;Patient is experiencing frequent seizures and visual disturbances over the past 2 months. The symptoms are described as noticeable in nature.;chemotherapy
brain_glioma_1733;Brain Glioma;75;F;Patient is experiencing frequent seizures and visual disturbances over the past 2 months. The symptoms are described as significant in nature.;surgery
brain_glioma_1734;Brain Glioma;57;F;Patient is experiencing frequent seizures and dizziness for more than 6 months. The symptoms are described as debilitating in nature.;surgery
brain_glioma_1735;Brain Glioma;27;M;Patient is experiencing confusion and frequent seizures for more than 6 months. The symptoms are described as intense in nature.;chemotherapy
brain_glioma_1736;Brain Glioma;39;F;Patient is experiencing persistent headaches and visual disturbances over the past 2 months. The symptoms are described as moderate in nature.;chemotherapy
brain_glioma_1737;Brain Glioma;20;F;Patient is experiencing confusion and memory lapses for the last few weeks. The symptoms are described as noticeable in nature.;surgery
brain_glioma_1738;Brain Glioma;54;F;Patient is experiencing persistent headaches and dizziness for the last few weeks. The symptoms are described as debilitating in nature.;surgery
brain_glioma_1739;Brain Glioma;25;F;Patient is experiencing memory lapses and dizziness for the last few weeks. The symptoms are described as severe in nature.;radiation therapy
brain_glioma_1740;Brain Glioma;79;F;Patient is experiencing confusion and persistent headaches over the past 2 months. The symptoms are described as intense in nature.;radiation therapy
brain_glioma_1741;Brain Glioma;73;F;Patient is experiencing speech difficulties and frequent seizures over the past 2 months. The symptoms are described as noticeable in nature.;chemotherapy
brain_glioma_1742;Brain Glioma;26;M;Patient is experiencing dizziness and memory lapses over the past 2 months. The symptoms are described as debilitating in nature.;radiation therapy
brain_glioma_1743;Brain Glioma;44;M;Patient is experiencing confusion and dizziness over the past 2 months. The symptoms are described as significant in nature.;surgery
brain_glioma_1744;Brain Glioma;25;M;Patient is experiencing speech difficulties and memory lapses for more than 6 months. The symptoms are described as moderate in nature.;radiation therapy
brain_glioma_1745;Brain Glioma;45;F;Patient is experiencing frequent seizures and visual disturbances over the past 2 months. The symptoms are described as high-grade in nature.;surgery
brain_glioma_1746;Brain Glioma;64;F;Patient is experiencing frequent seizures and persistent headaches over the past 2 months. The symptoms are described as moderate in nature.;radiation therapy
brain_glioma_1747;Brain Glioma;63;M;Patient is experiencing speech difficulties and dizziness for more than 6 months. The symptoms are described as significant in nature.;radiation therapy
brain_glioma_1748;Brain Glioma;21;M;Patient is experiencing speech difficulties and confusion over the past 2 months. The symptoms are described as debilitating in nature.;radiation therapy
brain_glioma_1749;Brain Glioma;48;F;Patient is experiencing confusion and memory lapses over the past 2 months. The symptoms are described as debilitating in nature.;chemotherapy
brain_glioma_1750;Brain Glioma;27;M;Patient is experiencing dizziness and frequent seizures over the past 2 months. The symptoms are described as debilitating in nature.;surgery
brain_glioma_1751;Brain Glioma;62;M;Patient is experiencing visual disturbances and confusion for more than 6 months. The symptoms are described as severe in nature.;radiation therapy
brain_glioma_1752;Brain Glioma;73;M;Patient is experiencing confusion and visual disturbances over the past 2 months. The symptoms are described as severe in nature.;chemotherapy
brain_glioma_1753;Brain Glioma;57;M;Patient is experiencing visual disturbances and memory lapses for the last few weeks. The symptoms are described as noticeable in nature.;radiation therapy
brain_glioma_1754;Brain Glioma;22;F;Patient is experiencing speech difficulties and confusion for the last few weeks. The symptoms are described as high-grade in nature.;chemotherapy
brain_glioma_1755;Brain Glioma;33;F;Patient is experiencing confusion and visual disturbances for more than 6 months. The symptoms are described as moderate in nature.;surgery
brain_glioma_1756;Brain Glioma;63;F;Patient is experiencing speech difficulties and dizziness for more than 6 months. The symptoms are described as high-grade in nature.;surgery
brain_glioma_1757;Brain Glioma;30;F;Patient is experiencing frequent seizures and visual disturbances for more than 6 months. The symptoms are described as significant in nature.;chemotherapy
brain_glioma_1758;Brain Glioma;27;F;Patient is experiencing confusion and speech difficulties for the last few weeks. The symptoms are described as significant in nature.;chemotherapy
brain_glioma_1759;Brain Glioma;19;F;Patient is experiencing confusion and dizziness over the past 2 months. The symptoms are described as debilitating in nature.;chemotherapy
brain_glioma_1760;Brain Glioma;21;F;Patient is experiencing confusion and visual disturbances for more than 6 months. The symptoms are described as moderate in nature.;surgery
brain_glioma_1761;Brain Glioma;85;M;Patient is experiencing memory lapses and persistent headaches for more than 6 months. The symptoms are described as moderate in nature.;chemotherapy
brain_glioma_1762;Brain Glioma;66;M;Patient is experiencing persistent headaches and dizziness for the last few weeks. The symptoms are described as moderate in nature.;surgery
brain_glioma_1763;Brain Glioma;68;M;Patient is experiencing speech difficulties and visual disturbances for the last few weeks. The symptoms are described as intense in nature.;radiation therapy
brain_glioma_1764;Brain Glioma;85;F;Patient is experiencing dizziness and memory lapses for the last few weeks. The symptoms are described as debilitating in nature.;chemotherapy
brain_glioma_1765;Brain Glioma;39;F;Patient is experiencing persistent headaches and visual disturbances for more than 6 months. The symptoms are described as noticeable in nature.;surgery
brain_glioma_1766;Brain Glioma;49;M;Patient is experiencing speech difficulties and dizziness over the past 2 months. The symptoms are described as significant in nature.;chemotherapy
brain_glioma_1767;Brain Glioma;34;F;Patient is experiencing persistent headaches and frequent seizures for the last few weeks. The symptoms are described as debilitating in nature.;chemotherapy
brain_glioma_1768;Brain Glioma;32;F;Patient is experiencing memory lapses and frequent seizures over the past 2 months. The symptoms are described as intense in nature.;surgery
brain_glioma_1769;Brain Glioma;82;M;Patient is experiencing visual disturbances and persistent headaches for the last few weeks. The symptoms are described as moderate in nature.;chemotherapy
brain_glioma_1770;Brain Glioma;31;M;Patient is experiencing persistent headaches and memory lapses over the past 2 months. The symptoms are described as high-grade in nature.;surgery
brain_glioma_1771;Brain Glioma;84;M;Patient is experiencing visual disturbances and confusion for more than 6 months. The symptoms are described as moderate in nature.;chemotherapy
brain_glioma_1772;Brain Glioma;54;F;Patient is experiencing dizziness and confusion for the last few weeks. The symptoms are described as noticeable in nature.;radiation therapy
brain_glioma_1773;Brain Glioma;40;M;Patient is experiencing speech difficulties and confusion for the last few weeks. The symptoms are described as intense in nature.;radiation therapy
brain_glioma_1774;Brain Glioma;56;F;Patient is experiencing persistent headaches and speech difficulties for the last few weeks. The symptoms are described as moderate in nature.;surgery
brain_glioma_1775;Brain Glioma;68;F;Patient is experiencing dizziness and speech difficulties over the past 2 months. The symptoms are described as noticeable in nature.;chemotherapy
brain_glioma_1776;Brain Glioma;43;F;Patient is experiencing visual disturbances and confusion for the last few weeks. The symptoms are described as significant in nature.;radiation therapy
brain_glioma_1777;Brain Glioma;60;M;Patient is experiencing dizziness and memory lapses for more than 6 months. The symptoms are described as significant in nature.;radiation therapy
brain_glioma_1778;Brain Glioma;49;F;Patient is experiencing confusion and persistent headaches over the past 2 months. The symptoms are described as moderate in nature.;chemotherapy
brain_glioma_1779;Brain Glioma;48;M;Patient is experiencing memory lapses and persistent headaches for the last few weeks. The symptoms are described as noticeable in nature.;surgery
brain_glioma_1780;Brain Glioma;31;F;Patient is experiencing memory lapses and frequent seizures for the last few weeks. The symptoms are described as moderate in nature.;surgery
brain_glioma_1781;Brain Glioma;44;M;Patient is experiencing speech difficulties and frequent seizures for the last few weeks. The symptoms are described as debilitating in nature.;surgery
brain_glioma_1782;Brain Glioma;80;F;Patient is experiencing frequent seizures and memory lapses for more than 6 months. The symptoms are described as intense in nature.;surgery
brain_glioma_1783;Brain Glioma;36;M;Patient is experiencing dizziness and frequent seizures over the past 2 months. The symptoms are described as debilitating in nature.;surgery
brain_glioma_1784;Brain Glioma;70;F;Patient is experiencing persistent headaches and memory lapses for more than 6 months. The symptoms are described as significant in nature.;radiation therapy
brain_glioma_1785;Brain Glioma;43;F;Patient is experiencing visual disturbances and speech difficulties for more than 6 months. The symptoms are described as significant in nature.;radiation therapy
brain_glioma_1786;Brain Glioma;42;F;Patient is experiencing visual disturbances and memory lapses for more than 6 months. The symptoms are described as noticeable in nature.;surgery
brain_glioma_1787;Brain Glioma;61;M;Patient is experiencing confusion and speech difficulties for more than 6 months. The symptoms are described as significant in nature.;surgery
brain_glioma_1788;Brain Glioma;21;M;Patient is experiencing persistent headaches and visual disturbances for the last few weeks. The symptoms are described as significant in nature.;surgery
brain_glioma_1789;Brain Glioma;69;F;Patient is experiencing memory lapses and visual disturbances over the past 2 months. The symptoms are described as significant in nature.;radiation therapy
brain_glioma_1790;Brain Glioma;84;M;Patient is experiencing persistent headaches and frequent seizures for the last few weeks. The symptoms are described as significant in nature.;chemotherapy
brain_glioma_1791;Brain Glioma;27;F;Patient is experiencing frequent seizures and persistent headaches for the last few weeks. The symptoms are described as noticeable in nature.;chemotherapy
brain_glioma_1792;Brain Glioma;30;M;Patient is experiencing frequent seizures and persistent headaches for more than 6 months. The symptoms are described as noticeable in nature.;chemotherapy
brain_glioma_1793;Brain Glioma;22;M;Patient is experiencing dizziness and persistent headaches for more than 6 months. The symptoms are described as significant in nature.;surgery
brain_glioma_1794;Brain Glioma;79;F;Patient is experiencing visual disturbances and frequent seizures for more than 6 months. The symptoms are described as noticeable in nature.;chemotherapy
brain_glioma_1795;Brain Glioma;52;F;Patient is experiencing visual disturbances and dizziness for more than 6 months. The symptoms are described as high-grade in nature.;chemotherapy
brain_glioma_1796;Brain Glioma;78;M;Patient is experiencing dizziness and memory lapses for more than 6 months. The symptoms are described as severe in nature.;surgery
brain_glioma_1797;Brain Glioma;30;M;Patient is experiencing visual disturbances and persistent headaches for more than 6 months. The symptoms are described as moderate in nature.;chemotherapy
brain_glioma_1798;Brain Glioma;74;F;Patient is experiencing speech difficulties and visual disturbances for more than 6 months. The symptoms are described as noticeable in nature.;radiation therapy
brain_glioma_1799;Brain Glioma;57;F;Patient is experiencing speech difficulties and dizziness for the last few weeks. The symptoms are described as intense in nature.;surgery
brain_glioma_1800;Brain Glioma;27;F;Patient is experiencing memory lapses and frequent seizures over the past 2 months. The symptoms are described as noticeable in nature.;radiation therapy
brain_glioma_1801;Brain Glioma;51;M;Patient is experiencing memory lapses and frequent seizures over the past 2 months. The symptoms are described as moderate in nature.;radiation therapy
brain_glioma_1802;Brain Glioma;62;M;Patient is experiencing dizziness and memory lapses for more than 6 months. The symptoms are described as moderate in nature.;radiation therapy
brain_glioma_1803;Brain Glioma;50;M;Patient is experiencing dizziness and persistent headaches for the last few weeks. The symptoms are described as debilitating in nature.;surgery
brain_glioma_1804;Brain Glioma;55;F;Patient is experiencing dizziness and persistent headaches for the last few weeks. The symptoms are described as significant in nature.;radiation therapy
brain_glioma_1805;Brain Glioma;39;F;Patient is experiencing dizziness and memory lapses for more than 6 months. The symptoms are described as debilitating in nature.;surgery
brain_glioma_1806;Brain Glioma;48;M;Patient is experiencing frequent seizures and confusion for the last few weeks. The symptoms are described as moderate in nature.;chemotherapy
brain_glioma_1807;Brain Glioma;56;F;Patient is experiencing frequent seizures and memory lapses for more than 6 months. The symptoms are described as severe in nature.;chemotherapy
brain_glioma_1808;Brain Glioma;55;M;Patient is experiencing confusion and memory lapses for the last few weeks. The symptoms are described as high-grade in nature.;radiation therapy
brain_glioma_1809;Brain Glioma;84;F;Patient is experiencing frequent seizures and confusion for more than 6 months. The symptoms are described as noticeable in nature.;radiation therapy
brain_glioma_1810;Brain Glioma;59;F;Patient is experiencing frequent seizures and persistent headaches over the past 2 months. The symptoms are described as moderate in nature.;chemotherapy
brain_glioma_1811;Brain Glioma;21;F;Patient is experiencing frequent seizures and speech difficulties over the past 2 months. The symptoms are described as moderate in nature.;chemotherapy
brain_glioma_1812;Brain Glioma;55;M;Patient is experiencing memory lapses and confusion for the last few weeks. The symptoms are described as significant in nature.;radiation therapy
brain_glioma_1813;Brain Glioma;28;F;Patient is experiencing dizziness and confusion over the past 2 months. The symptoms are described as debilitating in nature.;chemotherapy
brain_glioma_1814;Brain Glioma;47;M;Patient is experiencing confusion and frequent seizures for more than 6 months. The symptoms are described as moderate in nature.;chemotherapy
brain_glioma_1815;Brain Glioma;26;F;Patient is experiencing memory lapses and dizziness for the last few weeks. The symptoms are described as noticeable in nature.;chemotherapy
brain_glioma_1816;Brain Glioma;45;F;Patient is experiencing frequent seizures and speech difficulties over the past 2 months. The symptoms are described as noticeable in nature.;surgery
brain_glioma_1817;Brain Glioma;65;M;Patient is experiencing dizziness and speech difficulties for the last few weeks. The symptoms are described as moderate in nature.;chemotherapy
brain_glioma_1818;Brain Glioma;82;F;Patient is experiencing persistent headaches and speech difficulties for the last few weeks. The symptoms are described as intense in nature.;chemotherapy
brain_glioma_1819;Brain Glioma;21;M;Patient is experiencing visual disturbances and memory lapses for the last few weeks. The symptoms are described as intense in nature.;surgery
brain_glioma_1820;Brain Glioma;65;F;Patient is experiencing speech difficulties and dizziness for the last few weeks. The symptoms are described as significant in nature.;surgery
brain_glioma_1821;Brain Glioma;75;F;Patient is experiencing confusion and frequent seizures for more than 6 months. The symptoms are described as high-grade in nature.;radiation therapy
brain_glioma_1822;Brain Glioma;24;M;Patient is experiencing dizziness and visual disturbances for more than 6 months. The symptoms are described as debilitating in nature.;chemotherapy
brain_glioma_1823;Brain Glioma;60;F;Patient is experiencing frequent seizures and visual disturbances for more than 6 months. The symptoms are described as severe in nature.;chemotherapy
brain_glioma_1824;Brain Glioma;66;M;Patient is experiencing dizziness and speech difficulties over the past 2 months. The symptoms are described as noticeable in nature.;chemotherapy
brain_glioma_1825;Brain Glioma;29;F;Patient is experiencing memory lapses and persistent headaches over the past 2 months. The symptoms are described as moderate in nature.;chemotherapy
brain_glioma_1826;Brain Glioma;67;F;Patient is experiencing memory lapses and confusion for the last few weeks. The symptoms are described as noticeable in nature.;chemotherapy
brain_glioma_1827;Brain Glioma;74;M;Patient is experiencing visual disturbances and speech difficulties for the last few weeks. The symptoms are described as debilitating in nature.;chemotherapy
brain_glioma_1828;Brain Glioma;67;M;Patient is experiencing persistent headaches and speech difficulties over the past 2 months. The symptoms are described as high-grade in nature.;chemotherapy
brain_glioma_1829;Brain Glioma;72;M;Patient is experiencing dizziness and visual disturbances for the last few weeks. The symptoms are described as moderate in nature.;radiation therapy
brain_glioma_1830;Brain Glioma;85;M;Patient is experiencing speech difficulties and memory lapses for more than 6 months. The symptoms are described as significant in nature.;chemotherapy
brain_glioma_1831;Brain Glioma;85;F;Patient is experiencing memory lapses and speech difficulties for the last few weeks. The symptoms are described as moderate in nature.;radiation therapy
brain_glioma_1832;Brain Glioma;49;M;Patient is experiencing persistent headaches and frequent seizures over the past 2 months. The symptoms are described as moderate in nature.;surgery
brain_glioma_1833;Brain Glioma;73;M;Patient is experiencing persistent headaches and frequent seizures over the past 2 months. The symptoms are described as intense in nature.;surgery
brain_glioma_1834;Brain Glioma;48;F;Patient is experiencing frequent seizures and dizziness for the last few weeks. The symptoms are described as debilitating in nature.;surgery
brain_glioma_1835;Brain Glioma;29;M;Patient is experiencing confusion and dizziness for more than 6 months. The symptoms are described as noticeable in nature.;surgery
brain_glioma_1836;Brain Glioma;40;F;Patient is experiencing visual disturbances and persistent headaches for more than 6 months. The symptoms are described as intense in nature.;radiation therapy
brain_glioma_1837;Brain Glioma;63;F;Patient is experiencing memory lapses and frequent seizures for the last few weeks. The symptoms are described as moderate in nature.;surgery
brain_glioma_1838;Brain Glioma;26;F;Patient is experiencing speech difficulties and persistent headaches over the past 2 months. The symptoms are described as moderate in nature.;chemotherapy
brain_glioma_1839;Brain Glioma;64;F;Patient is experiencing persistent headaches and dizziness for more than 6 months. The symptoms are described as significant in nature.;radiation therapy
brain_glioma_1840;Brain Glioma;49;F;Patient is experiencing persistent headaches and dizziness for the last few weeks. The symptoms are described as moderate in nature.;radiation therapy
brain_glioma_1841;Brain Glioma;55;M;Patient is experiencing confusion and persistent headaches for more than 6 months. The symptoms are described as significant in nature.;surgery
brain_glioma_1842;Brain Glioma;51;M;Patient is experiencing memory lapses and confusion for the last few weeks. The symptoms are described as noticeable in nature.;surgery
brain_glioma_1843;Brain Glioma;54;M;Patient is experiencing memory lapses and dizziness for the last few weeks. The symptoms are described as debilitating in nature.;surgery
brain_glioma_1844;Brain Glioma;49;M;Patient is experiencing memory lapses and speech difficulties over the past 2 months. The symptoms are described as significant in nature.;surgery
brain_glioma_1845;Brain Glioma;41;F;Patient is experiencing memory lapses and speech difficulties over the past 2 months. The symptoms are described as high-grade in nature.;chemotherapy
brain_glioma_1846;Brain Glioma;45;F;Patient is experiencing persistent headaches and frequent seizures for more than 6 months. The symptoms are described as noticeable in nature.;chemotherapy
brain_glioma_1847;Brain Glioma;30;F;Patient is experiencing dizziness and memory lapses for more than 6 months. The symptoms are described as noticeable in nature.;radiation therapy
brain_glioma_1848;Brain Glioma;55;F;Patient is experiencing frequent seizures and persistent headaches for the last few weeks. The symptoms are described as significant in nature.;chemotherapy
brain_glioma_1849;Brain Glioma;52;M;Patient is experiencing speech difficulties and memory lapses over the past 2 months. The symptoms are described as noticeable in nature.;radiation therapy
brain_glioma_1850;Brain Glioma;52;M;Patient is experiencing visual disturbances and dizziness over the past 2 months. The symptoms are described as debilitating in nature.;radiation therapy
brain_glioma_1851;Brain Glioma;83;F;Patient is experiencing frequent seizures and dizziness for the last few weeks. The symptoms are described as intense in nature.;radiation therapy
brain_glioma_1852;Brain Glioma;85;M;Patient is experiencing speech difficulties and confusion for more than 6 months. The symptoms are described as high-grade in nature.;surgery
brain_glioma_1853;Brain Glioma;34;M;Patient is experiencing memory lapses and persistent headaches for more than 6 months. The symptoms are described as moderate in nature.;radiation therapy
brain_glioma_1854;Brain Glioma;80;M;Patient is experiencing memory lapses and speech difficulties for the last few weeks. The symptoms are described as moderate in nature.;radiation therapy
brain_glioma_1855;Brain Glioma;49;F;Patient is experiencing visual disturbances and dizziness for more than 6 months. The symptoms are described as moderate in nature.;surgery
brain_glioma_1856;Brain Glioma;24;F;Patient is experiencing persistent headaches and frequent seizures for more than 6 months. The symptoms are described as high-grade in nature.;surgery
brain_glioma_1857;Brain Glioma;52;M;Patient is experiencing memory lapses and confusion for the last few weeks. The symptoms are described as significant in nature.;surgery
brain_glioma_1858;Brain Glioma;71;M;Patient is experiencing memory lapses and dizziness for more than 6 months. The symptoms are described as debilitating in nature.;surgery
brain_glioma_1859;Brain Glioma;85;M;Patient is experiencing persistent headaches and confusion for more than 6 months. The symptoms are described as noticeable in nature.;chemotherapy
brain_glioma_1860;Brain Glioma;41;F;Patient is experiencing memory lapses and visual disturbances over the past 2 months. The symptoms are described as debilitating in nature.;surgery
brain_glioma_1861;Brain Glioma;77;M;Patient is experiencing persistent headaches and memory lapses over the past 2 months. The symptoms are described as intense in nature.;radiation therapy
brain_glioma_1862;Brain Glioma;30;M;Patient is experiencing memory lapses and visual disturbances over the past 2 months. The symptoms are described as significant in nature.;chemotherapy
brain_glioma_1863;Brain Glioma;79;M;Patient is experiencing frequent seizures and confusion for more than 6 months. The symptoms are described as intense in nature.;radiation therapy
brain_glioma_1864;Brain Glioma;80;M;Patient is experiencing visual disturbances and confusion for the last few weeks. The symptoms are described as noticeable in nature.;surgery
brain_glioma_1865;Brain Glioma;47;M;Patient is experiencing memory lapses and speech difficulties for more than 6 months. The symptoms are described as high-grade in nature.;chemotherapy
brain_glioma_1866;Brain Glioma;48;F;Patient is experiencing visual disturbances and memory lapses for the last few weeks. The symptoms are described as intense in nature.;chemotherapy
brain_glioma_1867;Brain Glioma;68;M;Patient is experiencing persistent headaches and frequent seizures over the past 2 months. The symptoms are described as debilitating in nature.;surgery
brain_glioma_1868;Brain Glioma;78;M;Patient is experiencing confusion and frequent seizures for the last few weeks. The symptoms are described as moderate in nature.;surgery
brain_glioma_1869;Brain Glioma;38;M;Patient is experiencing confusion and dizziness over the past 2 months. The symptoms are described as high-grade in nature.;surgery
brain_glioma_1870;Brain Glioma;75;F;Patient is experiencing memory lapses and confusion for more than 6 months. The symptoms are described as severe in nature.;chemotherapy
brain_glioma_1871;Brain Glioma;66;M;Patient is experiencing dizziness and speech difficulties over the past 2 months. The symptoms are described as noticeable in nature.;radiation therapy
brain_glioma_1872;Brain Glioma;56;M;Patient is experiencing frequent seizures and dizziness for the last few weeks. The symptoms are described as moderate in nature.;radiation therapy
brain_glioma_1873;Brain Glioma;76;F;Patient is experiencing confusion and persistent headaches over the past 2 months. The symptoms are described as significant in nature.;radiation therapy
brain_glioma_1874;Brain Glioma;53;F;Patient is experiencing memory lapses and visual disturbances for the last few weeks. The symptoms are described as significant in nature.;surgery
brain_glioma_1875;Brain Glioma;21;M;Patient is experiencing frequent seizures and visual disturbances over the past 2 months. The symptoms are described as intense in nature.;surgery
brain_glioma_1876;Brain Glioma;66;M;Patient is experiencing visual disturbances and persistent headaches for more than 6 months. The symptoms are described as significant in nature.;chemotherapy
brain_glioma_1877;Brain Glioma;30;F;Patient is experiencing memory lapses and visual disturbances over the past 2 months. The symptoms are described as moderate in nature.;radiation therapy
brain_glioma_1878;Brain Glioma;72;M;Patient is experiencing memory lapses and speech difficulties for more than 6 months. The symptoms are described as high-grade in nature.;surgery
brain_glioma_1879;Brain Glioma;77;M;Patient is experiencing frequent seizures and persistent headaches over the past 2 months. The symptoms are described as debilitating in nature.;radiation therapy
brain_glioma_1880;Brain Glioma;23;M;Patient is experiencing persistent headaches and visual disturbances for the last few weeks. The symptoms are described as severe in nature.;radiation therapy
brain_glioma_1881;Brain Glioma;30;F;Patient is experiencing frequent seizures and speech difficulties for more than 6 months. The symptoms are described as noticeable in nature.;surgery
brain_glioma_1882;Brain Glioma;42;F;Patient is experiencing persistent headaches and confusion for the last few weeks. The symptoms are described as debilitating in nature.;surgery
brain_glioma_1883;Brain Glioma;74;F;Patient is experiencing speech difficulties and persistent headaches for the last few weeks. The symptoms are described as moderate in nature.;surgery
brain_glioma_1884;Brain Glioma;29;M;Patient is experiencing speech difficulties and confusion for more than 6 months. The symptoms are described as severe in nature.;radiation therapy
brain_glioma_1885;Brain Glioma;68;M;Patient is experiencing frequent seizures and dizziness over the past 2 months. The symptoms are described as significant in nature.;radiation therapy
brain_glioma_1886;Brain Glioma;74;M;Patient is experiencing frequent seizures and persistent headaches for more than 6 months. The symptoms are described as debilitating in nature.;chemotherapy
brain_glioma_1887;Brain Glioma;83;F;Patient is experiencing persistent headaches and confusion for more than 6 months. The symptoms are described as moderate in nature.;radiation therapy
brain_glioma_1888;Brain Glioma;35;M;Patient is experiencing visual disturbances and confusion for more than 6 months. The symptoms are described as moderate in nature.;chemotherapy
brain_glioma_1889;Brain Glioma;18;M;Patient is experiencing confusion and dizziness for more than 6 months. The symptoms are described as significant in nature.;surgery
brain_glioma_1890;Brain Glioma;49;F;Patient is experiencing memory lapses and dizziness over the past 2 months. The symptoms are described as significant in nature.;radiation therapy
brain_glioma_1891;Brain Glioma;57;F;Patient is experiencing visual disturbances and confusion for more than 6 months. The symptoms are described as high-grade in nature.;radiation therapy
brain_glioma_1892;Brain Glioma;63;M;Patient is experiencing confusion and frequent seizures over the past 2 months. The symptoms are described as significant in nature.;chemotherapy
brain_glioma_1893;Brain Glioma;61;M;Patient is experiencing persistent headaches and confusion for the last few weeks. The symptoms are described as severe in nature.;radiation therapy
brain_glioma_1894;Brain Glioma;74;M;Patient is experiencing speech difficulties and dizziness over the past 2 months. The symptoms are described as moderate in nature.;surgery
brain_glioma_1895;Brain Glioma;43;F;Patient is experiencing visual disturbances and speech difficulties for more than 6 months. The symptoms are described as noticeable in nature.;chemotherapy
brain_glioma_1896;Brain Glioma;84;F;Patient is experiencing confusion and visual disturbances for more than 6 months. The symptoms are described as noticeable in nature.;surgery
brain_glioma_1897;Brain Glioma;32;F;Patient is experiencing memory lapses and frequent seizures for the last few weeks. The symptoms are described as intense in nature.;chemotherapy
brain_glioma_1898;Brain Glioma;25;F;Patient is experiencing visual disturbances and confusion for more than 6 months. The symptoms are described as significant in nature.;chemotherapy
brain_glioma_1899;Brain Glioma;84;M;Patient is experiencing frequent seizures and speech difficulties over the past 2 months. The symptoms are described as significant in nature.;radiation therapy
brain_glioma_1900;Brain Glioma;78;M;Patient is experiencing frequent seizures and memory lapses over the past 2 months. The symptoms are described as significant in nature.;surgery
brain_glioma_1901;Brain Glioma;37;F;Patient is experiencing dizziness and visual disturbances for more than 6 months. The symptoms are described as moderate in nature.;chemotherapy
brain_glioma_1902;Brain Glioma;28;M;Patient is experiencing speech difficulties and confusion over the past 2 months. The symptoms are described as moderate in nature.;surgery
brain_glioma_1903;Brain Glioma;78;M;Patient is experiencing persistent headaches and frequent seizures for more than 6 months. The symptoms are described as intense in nature.;surgery
brain_glioma_1904;Brain Glioma;18;M;Patient is experiencing memory lapses and persistent headaches for more than 6 months. The symptoms are described as intense in nature.;chemotherapy
brain_glioma_1905;Brain Glioma;72;F;Patient is experiencing frequent seizures and memory lapses for the last few weeks. The symptoms are described as noticeable in nature.;radiation therapy
brain_glioma_1906;Brain Glioma;47;F;Patient is experiencing dizziness and persistent headaches for more than 6 months. The symptoms are described as noticeable in nature.;chemotherapy
brain_glioma_1907;Brain Glioma;52;M;Patient is experiencing speech difficulties and confusion for the last few weeks. The symptoms are described as debilitating in nature.;surgery
brain_glioma_1908;Brain Glioma;42;M;Patient is experiencing visual disturbances and speech difficulties over the past 2 months. The symptoms are described as moderate in nature.;radiation therapy
brain_glioma_1909;Brain Glioma;70;F;Patient is experiencing speech difficulties and dizziness for more than 6 months. The symptoms are described as high-grade in nature.;surgery
brain_glioma_1910;Brain Glioma;79;M;Patient is experiencing dizziness and memory lapses for more than 6 months. The symptoms are described as debilitating in nature.;radiation therapy
brain_glioma_1911;Brain Glioma;63;M;Patient is experiencing speech difficulties and memory lapses for more than 6 months. The symptoms are described as significant in nature.;surgery
brain_glioma_1912;Brain Glioma;51;M;Patient is experiencing visual disturbances and memory lapses over the past 2 months. The symptoms are described as severe in nature.;chemotherapy
brain_glioma_1913;Brain Glioma;23;M;Patient is experiencing frequent seizures and confusion for more than 6 months. The symptoms are described as severe in nature.;chemotherapy
brain_glioma_1914;Brain Glioma;19;F;Patient is experiencing persistent headaches and visual disturbances over the past 2 months. The symptoms are described as significant in nature.;radiation therapy
brain_glioma_1915;Brain Glioma;73;F;Patient is experiencing memory lapses and visual disturbances over the past 2 months. The symptoms are described as high-grade in nature.;radiation therapy
brain_glioma_1916;Brain Glioma;44;F;Patient is experiencing dizziness and confusion for more than 6 months. The symptoms are described as moderate in nature.;surgery
brain_glioma_1917;Brain Glioma;42;F;Patient is experiencing memory lapses and visual disturbances for more than 6 months. The symptoms are described as debilitating in nature.;chemotherapy
brain_glioma_1918;Brain Glioma;64;M;Patient is experiencing memory lapses and frequent seizures for more than 6 months. The symptoms are described as significant in nature.;surgery
brain_glioma_1919;Brain Glioma;19;M;Patient is experiencing frequent seizures and visual disturbances for more than 6 months. The symptoms are described as noticeable in nature.;chemotherapy
brain_glioma_1920;Brain Glioma;37;F;Patient is experiencing memory lapses and confusion for more than 6 months. The symptoms are described as intense in nature.;radiation therapy
brain_glioma_1921;Brain Glioma;84;F;Patient is experiencing persistent headaches and confusion over the past 2 months. The symptoms are described as debilitating in nature.;radiation therapy
brain_glioma_1922;Brain Glioma;23;F;Patient is experiencing persistent headaches and confusion over the past 2 months. The symptoms are described as intense in nature.;surgery
brain_glioma_1923;Brain Glioma;69;M;Patient is experiencing frequent seizures and persistent headaches for more than 6 months. The symptoms are described as debilitating in nature.;radiation therapy
brain_glioma_1924;Brain Glioma;57;M;Patient is experiencing speech difficulties and memory lapses for more than 6 months. The symptoms are described as debilitating in nature.;surgery
brain_glioma_1925;Brain Glioma;79;F;Patient is experiencing memory lapses and visual disturbances over the past 2 months. The symptoms are described as noticeable in nature.;chemotherapy
brain_glioma_1926;Brain Glioma;30;M;Patient is experiencing frequent seizures and memory lapses for more than 6 months. The symptoms are described as severe in nature.;chemotherapy
brain_glioma_1927;Brain Glioma;81;F;Patient is experiencing frequent seizures and memory lapses over the past 2 months. The symptoms are described as severe in nature.;chemotherapy
brain_glioma_1928;Brain Glioma;58;M;Patient is experiencing memory lapses and dizziness for the last few weeks. The symptoms are described as moderate in nature.;radiation therapy
brain_glioma_1929;Brain Glioma;58;F;Patient is experiencing persistent headaches and speech difficulties for the last few weeks. The symptoms are described as noticeable in nature.;radiation therapy
brain_glioma_1930;Brain Glioma;44;M;Patient is experiencing memory lapses and persistent headaches for more than 6 months. The symptoms are described as severe in nature.;chemotherapy
brain_glioma_1931;Brain Glioma;65;F;Patient is experiencing memory lapses and speech difficulties for the last few weeks. The symptoms are described as significant in nature.;chemotherapy
brain_glioma_1932;Brain Glioma;82;M;Patient is experiencing frequent seizures and visual disturbances over the past 2 months. The symptoms are described as noticeable in nature.;radiation therapy
brain_glioma_1933;Brain Glioma;37;M;Patient is experiencing dizziness and confusion for more than 6 months. The symptoms are described as intense in nature.;chemotherapy
brain_glioma_1934;Brain Glioma;70;M;Patient is experiencing visual disturbances and frequent seizures over the past 2 months. The symptoms are described as moderate in nature.;chemotherapy
brain_glioma_1935;Brain Glioma;44;F;Patient is experiencing persistent headaches and memory lapses for the last few weeks. The symptoms are described as severe in nature.;surgery
brain_glioma_1936;Brain Glioma;82;M;Patient is experiencing visual disturbances and frequent seizures over the past 2 months. The symptoms are described as noticeable in nature.;radiation therapy
brain_glioma_1937;Brain Glioma;72;F;Patient is experiencing frequent seizures and visual disturbances for the last few weeks. The symptoms are described as intense in nature.;chemotherapy
brain_glioma_1938;Brain Glioma;35;F;Patient is experiencing dizziness and frequent seizures over the past 2 months. The symptoms are described as noticeable in nature.;surgery
brain_glioma_1939;Brain Glioma;45;F;Patient is experiencing confusion and dizziness over the past 2 months. The symptoms are described as high-grade in nature.;chemotherapy
brain_glioma_1940;Brain Glioma;62;M;Patient is experiencing persistent headaches and memory lapses for the last few weeks. The symptoms are described as significant in nature.;surgery
brain_glioma_1941;Brain Glioma;78;M;Patient is experiencing visual disturbances and frequent seizures for the last few weeks. The symptoms are described as noticeable in nature.;surgery
brain_glioma_1942;Brain Glioma;30;M;Patient is experiencing dizziness and persistent headaches over the past 2 months. The symptoms are described as intense in nature.;chemotherapy
brain_glioma_1943;Brain Glioma;31;F;Patient is experiencing persistent headaches and frequent seizures over the past 2 months. The symptoms are described as significant in nature.;radiation therapy
brain_glioma_1944;Brain Glioma;70;F;Patient is experiencing frequent seizures and dizziness over the past 2 months. The symptoms are described as high-grade in nature.;chemotherapy
brain_glioma_1945;Brain Glioma;69;M;Patient is experiencing memory lapses and frequent seizures for more than 6 months. The symptoms are described as debilitating in nature.;surgery
brain_glioma_1946;Brain Glioma;77;F;Patient is experiencing speech difficulties and confusion for more than 6 months. The symptoms are described as noticeable in nature.;radiation therapy
brain_glioma_1947;Brain Glioma;19;M;Patient is experiencing frequent seizures and dizziness for the last few weeks. The symptoms are described as moderate in nature.;surgery
brain_glioma_1948;Brain Glioma;31;M;Patient is experiencing speech difficulties and confusion for more than 6 months. The symptoms are described as high-grade in nature.;radiation therapy
brain_glioma_1949;Brain Glioma;83;M;Patient is experiencing confusion and memory lapses over the past 2 months. The symptoms are described as significant in nature.;surgery
brain_glioma_1950;Brain Glioma;38;F;Patient is experiencing confusion and dizziness for the last few weeks. The symptoms are described as severe in nature.;radiation therapy
brain_glioma_1951;Brain Glioma;19;M;Patient is experiencing dizziness and speech difficulties over the past 2 months. The symptoms are described as intense in nature.;radiation therapy
brain_glioma_1952;Brain Glioma;45;F;Patient is experiencing visual disturbances and dizziness over the past 2 months. The symptoms are described as intense in nature.;chemotherapy
brain_glioma_1953;Brain Glioma;53;M;Patient is experiencing speech difficulties and frequent seizures for more than 6 months. The symptoms are described as intense in nature.;surgery
brain_glioma_1954;Brain Glioma;34;M;Patient is experiencing confusion and dizziness for the last few weeks. The symptoms are described as intense in nature.;chemotherapy
brain_glioma_1955;Brain Glioma;69;F;Patient is experiencing persistent headaches and speech difficulties over the past 2 months. The symptoms are described as intense in nature.;surgery
brain_glioma_1956;Brain Glioma;20;F;Patient is experiencing visual disturbances and confusion for the last few weeks. The symptoms are described as intense in nature.;radiation therapy
brain_glioma_1957;Brain Glioma;52;M;Patient is experiencing persistent headaches and dizziness for the last few weeks. The symptoms are described as high-grade in nature.;surgery
brain_glioma_1958;Brain Glioma;77;M;Patient is experiencing visual disturbances and frequent seizures over the past 2 months. The symptoms are described as high-grade in nature.;radiation therapy
brain_glioma_1959;Brain Glioma;72;F;Patient is experiencing persistent headaches and frequent seizures for more than 6 months. The symptoms are described as significant in nature.;chemotherapy
brain_glioma_1960;Brain Glioma;49;M;Patient is experiencing dizziness and memory lapses for more than 6 months. The symptoms are described as significant in nature.;chemotherapy
brain_glioma_1961;Brain Glioma;74;M;Patient is experiencing confusion and visual disturbances for the last few weeks. The symptoms are described as noticeable in nature.;radiation therapy
brain_glioma_1962;Brain Glioma;51;M;Patient is experiencing frequent seizures and visual disturbances for the last few weeks. The symptoms are described as moderate in nature.;surgery
brain_glioma_1963;Brain Glioma;61;M;Patient is experiencing confusion and visual disturbances for more than 6 months. The symptoms are described as significant in nature.;chemotherapy
brain_glioma_1964;Brain Glioma;84;M;Patient is experiencing visual disturbances and persistent headaches for the last few weeks. The symptoms are described as noticeable in nature.;chemotherapy
brain_glioma_1965;Brain Glioma;52;F;Patient is experiencing confusion and visual disturbances for more than 6 months. The symptoms are described as debilitating in nature.;chemotherapy
brain_glioma_1966;Brain Glioma;40;M;Patient is experiencing frequent seizures and dizziness for the last few weeks. The symptoms are described as intense in nature.;chemotherapy
brain_glioma_1967;Brain Glioma;55;M;Patient is experiencing speech difficulties and memory lapses for more than 6 months. The symptoms are described as debilitating in nature.;surgery
brain_glioma_1968;Brain Glioma;39;F;Patient is experiencing visual disturbances and memory lapses for the last few weeks. The symptoms are described as high-grade in nature.;radiation therapy
brain_glioma_1969;Brain Glioma;63;F;Patient is experiencing persistent headaches and speech difficulties for more than 6 months. The symptoms are described as moderate in nature.;radiation therapy
brain_glioma_1970;Brain Glioma;41;M;Patient is experiencing frequent seizures and persistent headaches for more than 6 months. The symptoms are described as debilitating in nature.;surgery
brain_glioma_1971;Brain Glioma;30;F;Patient is experiencing frequent seizures and memory lapses over the past 2 months. The symptoms are described as high-grade in nature.;surgery
brain_glioma_1972;Brain Glioma;54;F;Patient is experiencing frequent seizures and memory lapses over the past 2 months. The symptoms are described as severe in nature.;radiation therapy
brain_glioma_1973;Brain Glioma;33;F;Patient is experiencing confusion and persistent headaches over the past 2 months. The symptoms are described as noticeable in nature.;chemotherapy
brain_glioma_1974;Brain Glioma;75;F;Patient is experiencing persistent headaches and visual disturbances for more than 6 months. The symptoms are described as intense in nature.;radiation therapy
brain_glioma_1975;Brain Glioma;69;M;Patient is experiencing speech difficulties and dizziness for more than 6 months. The symptoms are described as noticeable in nature.;surgery
brain_glioma_1976;Brain Glioma;66;F;Patient is experiencing confusion and persistent headaches over the past 2 months. The symptoms are described as high-grade in nature.;chemotherapy
brain_glioma_1977;Brain Glioma;23;F;Patient is experiencing memory lapses and speech difficulties for the last few weeks. The symptoms are described as intense in nature.;radiation therapy
brain_glioma_1978;Brain Glioma;76;M;Patient is experiencing frequent seizures and memory lapses for the last few weeks. The symptoms are described as significant in nature.;chemotherapy
brain_glioma_1979;Brain Glioma;76;F;Patient is experiencing dizziness and visual disturbances for more than 6 months. The symptoms are described as noticeable in nature.;chemotherapy
brain_glioma_1980;Brain Glioma;77;F;Patient is experiencing visual disturbances and memory lapses for the last few weeks. The symptoms are described as significant in nature.;surgery
brain_glioma_1981;Brain Glioma;25;F;Patient is experiencing persistent headaches and visual disturbances for the last few weeks. The symptoms are described as severe in nature.;chemotherapy
brain_glioma_1982;Brain Glioma;72;M;Patient is experiencing speech difficulties and dizziness for the last few weeks. The symptoms are described as moderate in nature.;surgery
brain_glioma_1983;Brain Glioma;28;F;Patient is experiencing frequent seizures and confusion over the past 2 months. The symptoms are described as intense in nature.;chemotherapy
brain_glioma_1984;Brain Glioma;75;M;Patient is experiencing visual disturbances and dizziness for more than 6 months. The symptoms are described as moderate in nature.;radiation therapy
brain_glioma_1985;Brain Glioma;35;M;Patient is experiencing memory lapses and persistent headaches for the last few weeks. The symptoms are described as noticeable in nature.;chemotherapy
brain_glioma_1986;Brain Glioma;41;F;Patient is experiencing confusion and memory lapses over the past 2 months. The symptoms are described as significant in nature.;surgery
brain_glioma_1987;Brain Glioma;49;M;Patient is experiencing frequent seizures and visual disturbances over the past 2 months. The symptoms are described as noticeable in nature.;surgery
brain_glioma_1988;Brain Glioma;28;F;Patient is experiencing dizziness and speech difficulties for more than 6 months. The symptoms are described as severe in nature.;surgery
brain_glioma_1989;Brain Glioma;48;M;Patient is experiencing visual disturbances and confusion for the last few weeks. The symptoms are described as severe in nature.;chemotherapy
brain_glioma_1990;Brain Glioma;47;M;Patient is experiencing persistent headaches and memory lapses for more than 6 months. The symptoms are described as noticeable in nature.;chemotherapy
brain_glioma_1991;Brain Glioma;20;M;Patient is experiencing frequent seizures and memory lapses for more than 6 months. The symptoms are described as moderate in nature.;surgery
brain_glioma_1992;Brain Glioma;26;F;Patient is experiencing confusion and persistent headaches for more than 6 months. The symptoms are described as intense in nature.;chemotherapy
brain_glioma_1993;Brain Glioma;31;M;Patient is experiencing speech difficulties and persistent headaches over the past 2 months. The symptoms are described as high-grade in nature.;surgery
brain_glioma_1994;Brain Glioma;78;F;Patient is experiencing frequent seizures and confusion for the last few weeks. The symptoms are described as moderate in nature.;chemotherapy
brain_glioma_1995;Brain Glioma;35;F;Patient is experiencing confusion and speech difficulties over the past 2 months. The symptoms are described as high-grade in nature.;radiation therapy
brain_glioma_1996;Brain Glioma;78;M;Patient is experiencing speech difficulties and frequent seizures for more than 6 months. The symptoms are described as high-grade in nature.;chemotherapy
brain_glioma_1997;Brain Glioma;43;M;Patient is experiencing frequent seizures and memory lapses for the last few weeks. The symptoms are described as moderate in nature.;surgery
brain_glioma_1998;Brain Glioma;68;F;Patient is experiencing speech difficulties and memory lapses for the last few weeks. The symptoms are described as noticeable in nature.;radiation therapy
brain_glioma_1999;Brain Glioma;76;F;Patient is experiencing visual disturbances and confusion for more than 6 months. The symptoms are described as intense in nature.;radiation therapy
brain_glioma_2000;Brain Glioma;50;F;Patient is experiencing dizziness and memory lapses for more than 6 months. The symptoms are described as intense in nature.;chemotherapy
brain_glioma_2001;Brain Glioma;19;M;Patient is experiencing memory lapses and dizziness for the last few weeks. The symptoms are described as severe in nature.;radiation therapy
brain_glioma_2002;Brain Glioma;76;M;Patient is experiencing persistent headaches and confusion for the last few weeks. The symptoms are described as moderate in nature.;surgery
brain_glioma_2003;Brain Glioma;38;F;Patient is experiencing confusion and speech difficulties for the last few weeks. The symptoms are described as noticeable in nature.;chemotherapy
brain_glioma_2004;Brain Glioma;34;F;Patient is experiencing confusion and speech difficulties over the past 2 months. The symptoms are described as moderate in nature.;chemotherapy
brain_menin_0001;Brain Meningiomas;28;M;Patient is experiencing speech difficulty and fatigue for nearly 3 months. The symptoms are described as moderate in nature.;close monitoring
brain_menin_0002;Brain Meningiomas;74;F;Patient is experiencing fatigue and localized neurological weakness for nearly 3 months. The symptoms are described as significant in nature.;surgery
brain_menin_0003;Brain Meningiomas;58;F;Patient is experiencing speech difficulty and blurry vision for nearly 3 months. The symptoms are described as tolerable in nature.;surgery
brain_menin_0004;Brain Meningiomas;42;M;Patient is experiencing chronic headaches and speech difficulty for several weeks. The symptoms are described as low-grade in nature.;radiation therapy
brain_menin_0005;Brain Meningiomas;23;F;Patient is experiencing blurry vision and localized neurological weakness over the past month. The symptoms are described as noticeable in nature.;close monitoring
brain_menin_0006;Brain Meningiomas;41;M;Patient is experiencing localized neurological weakness and blurry vision for nearly 3 months. The symptoms are described as noticeable in nature.;surgery
brain_menin_0007;Brain Meningiomas;76;F;Patient is experiencing localized neurological weakness and speech difficulty over the past month. The symptoms are described as moderate in nature.;close monitoring
brain_menin_0008;Brain Meningiomas;58;F;Patient is experiencing localized neurological weakness and blurry vision for several weeks. The symptoms are described as slight in nature.;surgery
brain_menin_0009;Brain Meningiomas;75;F;Patient is experiencing fatigue and coordination problems for several weeks. The symptoms are described as tolerable in nature.;radiation therapy
brain_menin_0010;Brain Meningiomas;55;F;Patient is experiencing coordination problems and chronic headaches over the past month. The symptoms are described as significant in nature.;close monitoring
brain_menin_0011;Brain Meningiomas;77;F;Patient is experiencing fatigue and chronic headaches for several weeks. The symptoms are described as mild in nature.;radiation therapy
brain_menin_0012;Brain Meningiomas;79;F;Patient is experiencing localized neurological weakness and coordination problems over the past month. The symptoms are described as slight in nature.;surgery
brain_menin_0013;Brain Meningiomas;34;M;Patient is experiencing localized neurological weakness and blurry vision over the past month. The symptoms are described as slight in nature.;close monitoring
brain_menin_0014;Brain Meningiomas;67;M;Patient is experiencing blurry vision and coordination problems for several weeks. The symptoms are described as moderate in nature.;close monitoring
brain_menin_0015;Brain Meningiomas;33;M;Patient is experiencing fatigue and chronic headaches over the past month. The symptoms are described as low-grade in nature.;surgery
brain_menin_0016;Brain Meningiomas;81;F;Patient is experiencing fatigue and coordination problems for several weeks. The symptoms are described as slight in nature.;radiation therapy
brain_menin_0017;Brain Meningiomas;19;F;Patient is experiencing localized neurological weakness and blurry vision for nearly 3 months. The symptoms are described as moderate in nature.;surgery
brain_menin_0018;Brain Meningiomas;67;F;Patient is experiencing blurry vision and speech difficulty for nearly 3 months. The symptoms are described as low-grade in nature.;radiation therapy
brain_menin_0019;Brain Meningiomas;24;M;Patient is experiencing speech difficulty and fatigue over the past month. The symptoms are described as noticeable in nature.;radiation therapy
brain_menin_0020;Brain Meningiomas;40;M;Patient is experiencing coordination problems and chronic headaches over the past month. The symptoms are described as moderate in nature.;surgery
brain_menin_0021;Brain Meningiomas;38;M;Patient is experiencing fatigue and coordination problems for several weeks. The symptoms are described as slight in nature.;surgery
brain_menin_0022;Brain Meningiomas;30;F;Patient is experiencing blurry vision and coordination problems for several weeks. The symptoms are described as noticeable in nature.;radiation therapy
brain_menin_0023;Brain Meningiomas;82;M;Patient is experiencing localized neurological weakness and coordination problems for nearly 3 months. The symptoms are described as significant in nature.;radiation therapy
brain_menin_0024;Brain Meningiomas;85;F;Patient is experiencing speech difficulty and coordination problems over the past month. The symptoms are described as noticeable in nature.;surgery
brain_menin_0025;Brain Meningiomas;40;F;Patient is experiencing localized neurological weakness and coordination problems over the past month. The symptoms are described as moderate in nature.;radiation therapy
brain_menin_0026;Brain Meningiomas;34;F;Patient is experiencing fatigue and coordination problems for nearly 3 months. The symptoms are described as noticeable in nature.;radiation therapy
brain_menin_0027;Brain Meningiomas;45;M;Patient is experiencing fatigue and blurry vision for nearly 3 months. The symptoms are described as moderate in nature.;surgery
brain_menin_0028;Brain Meningiomas;72;F;Patient is experiencing speech difficulty and blurry vision for several weeks. The symptoms are described as noticeable in nature.;radiation therapy
brain_menin_0029;Brain Meningiomas;56;M;Patient is experiencing speech difficulty and localized neurological weakness over the past month. The symptoms are described as significant in nature.;radiation therapy
brain_menin_0030;Brain Meningiomas;73;M;Patient is experiencing speech difficulty and chronic headaches for nearly 3 months. The symptoms are described as moderate in nature.;radiation therapy
brain_menin_0031;Brain Meningiomas;44;M;Patient is experiencing fatigue and coordination problems for several weeks. The symptoms are described as slight in nature.;close monitoring
brain_menin_0032;Brain Meningiomas;23;F;Patient is experiencing blurry vision and fatigue over the past month. The symptoms are described as noticeable in nature.;radiation therapy
brain_menin_0033;Brain Meningiomas;30;M;Patient is experiencing speech difficulty and chronic headaches for several weeks. The symptoms are described as low-grade in nature.;close monitoring
brain_menin_0034;Brain Meningiomas;82;F;Patient is experiencing chronic headaches and speech difficulty over the past month. The symptoms are described as low-grade in nature.;close monitoring
brain_menin_0035;Brain Meningiomas;83;M;Patient is experiencing coordination problems and chronic headaches for several weeks. The symptoms are described as significant in nature.;close monitoring
brain_menin_0036;Brain Meningiomas;54;M;Patient is experiencing chronic headaches and fatigue over the past month. The symptoms are described as low-grade in nature.;surgery
brain_menin_0037;Brain Meningiomas;39;M;Patient is experiencing blurry vision and chronic headaches over the past month. The symptoms are described as slight in nature.;surgery
brain_menin_0038;Brain Meningiomas;44;M;Patient is experiencing blurry vision and chronic headaches over the past month. The symptoms are described as low-grade in nature.;close monitoring
brain_menin_0039;Brain Meningiomas;18;M;Patient is experiencing coordination problems and speech difficulty over the past month. The symptoms are described as noticeable in nature.;close monitoring
brain_menin_0040;Brain Meningiomas;47;M;Patient is experiencing chronic headaches and coordination problems for several weeks. The symptoms are described as tolerable in nature.;radiation therapy
brain_menin_0041;Brain Meningiomas;34;F;Patient is experiencing coordination problems and blurry vision for several weeks. The symptoms are described as low-grade in nature.;radiation therapy
brain_menin_0042;Brain Meningiomas;62;M;Patient is experiencing blurry vision and speech difficulty for several weeks. The symptoms are described as significant in nature.;radiation therapy
brain_menin_0043;Brain Meningiomas;24;F;Patient is experiencing fatigue and speech difficulty for several weeks. The symptoms are described as moderate in nature.;radiation therapy
brain_menin_0044;Brain Meningiomas;31;F;Patient is experiencing blurry vision and speech difficulty over the past month. The symptoms are described as tolerable in nature.;surgery
brain_menin_0045;Brain Meningiomas;26;M;Patient is experiencing chronic headaches and coordination problems for nearly 3 months. The symptoms are described as moderate in nature.;radiation therapy
brain_menin_0046;Brain Meningiomas;73;M;Patient is experiencing blurry vision and chronic headaches for several weeks. The symptoms are described as moderate in nature.;surgery
brain_menin_0047;Brain Meningiomas;24;F;Patient is experiencing chronic headaches and coordination problems over the past month. The symptoms are described as noticeable in nature.;radiation therapy
brain_menin_0048;Brain Meningiomas;64;M;Patient is experiencing speech difficulty and localized neurological weakness for several weeks. The symptoms are described as slight in nature.;radiation therapy
brain_menin_0049;Brain Meningiomas;45;M;Patient is experiencing coordination problems and chronic headaches for several weeks. The symptoms are described as noticeable in nature.;radiation therapy
brain_menin_0050;Brain Meningiomas;81;F;Patient is experiencing chronic headaches and speech difficulty over the past month. The symptoms are described as moderate in nature.;radiation therapy
brain_menin_0051;Brain Meningiomas;56;M;Patient is experiencing blurry vision and chronic headaches over the past month. The symptoms are described as low-grade in nature.;close monitoring
brain_menin_0052;Brain Meningiomas;73;F;Patient is experiencing localized neurological weakness and blurry vision for nearly 3 months. The symptoms are described as significant in nature.;surgery
brain_menin_0053;Brain Meningiomas;85;F;Patient is experiencing chronic headaches and blurry vision over the past month. The symptoms are described as moderate in nature.;close monitoring
brain_menin_0054;Brain Meningiomas;19;F;Patient is experiencing coordination problems and blurry vision for nearly 3 months. The symptoms are described as tolerable in nature.;surgery
brain_menin_0055;Brain Meningiomas;52;M;Patient is experiencing localized neurological weakness and chronic headaches over the past month. The symptoms are described as noticeable in nature.;surgery
brain_menin_0056;Brain Meningiomas;43;F;Patient is experiencing localized neurological weakness and chronic headaches for nearly 3 months. The symptoms are described as moderate in nature.;surgery
brain_menin_0057;Brain Meningiomas;20;M;Patient is experiencing chronic headaches and fatigue for several weeks. The symptoms are described as mild in nature.;close monitoring
brain_menin_0058;Brain Meningiomas;39;F;Patient is experiencing fatigue and coordination problems for several weeks. The symptoms are described as significant in nature.;radiation therapy
brain_menin_0059;Brain Meningiomas;40;F;Patient is experiencing localized neurological weakness and speech difficulty for several weeks. The symptoms are described as moderate in nature.;radiation therapy
brain_menin_0060;Brain Meningiomas;84;M;Patient is experiencing blurry vision and fatigue for several weeks. The symptoms are described as mild in nature.;surgery
brain_menin_0061;Brain Meningiomas;81;F;Patient is experiencing blurry vision and fatigue for nearly 3 months. The symptoms are described as mild in nature.;surgery
brain_menin_0062;Brain Meningiomas;35;M;Patient is experiencing coordination problems and fatigue for several weeks. The symptoms are described as mild in nature.;close monitoring
brain_menin_0063;Brain Meningiomas;44;M;Patient is experiencing speech difficulty and fatigue for nearly 3 months. The symptoms are described as slight in nature.;surgery
brain_menin_0064;Brain Meningiomas;83;F;Patient is experiencing chronic headaches and blurry vision over the past month. The symptoms are described as mild in nature.;radiation therapy
brain_menin_0065;Brain Meningiomas;21;M;Patient is experiencing fatigue and blurry vision over the past month. The symptoms are described as significant in nature.;surgery
brain_menin_0066;Brain Meningiomas;85;F;Patient is experiencing chronic headaches and fatigue over the past month. The symptoms are described as mild in nature.;surgery
brain_menin_0067;Brain Meningiomas;31;F;Patient is experiencing chronic headaches and speech difficulty for several weeks. The symptoms are described as slight in nature.;surgery
brain_menin_0068;Brain Meningiomas;18;M;Patient is experiencing localized neurological weakness and speech difficulty for several weeks. The symptoms are described as mild in nature.;surgery
brain_menin_0069;Brain Meningiomas;47;M;Patient is experiencing chronic headaches and blurry vision over the past month. The symptoms are described as moderate in nature.;close monitoring
brain_menin_0070;Brain Meningiomas;23;F;Patient is experiencing speech difficulty and chronic headaches for nearly 3 months. The symptoms are described as significant in nature.;close monitoring
brain_menin_0071;Brain Meningiomas;44;F;Patient is experiencing localized neurological weakness and chronic headaches for nearly 3 months. The symptoms are described as low-grade in nature.;close monitoring
brain_menin_0072;Brain Meningiomas;71;F;Patient is experiencing speech difficulty and chronic headaches for several weeks. The symptoms are described as moderate in nature.;surgery
brain_menin_0073;Brain Meningiomas;84;M;Patient is experiencing coordination problems and localized neurological weakness for several weeks. The symptoms are described as moderate in nature.;radiation therapy
brain_menin_0074;Brain Meningiomas;70;M;Patient is experiencing chronic headaches and blurry vision over the past month. The symptoms are described as moderate in nature.;surgery
brain_menin_0075;Brain Meningiomas;71;F;Patient is experiencing speech difficulty and blurry vision over the past month. The symptoms are described as low-grade in nature.;radiation therapy
brain_menin_0076;Brain Meningiomas;30;M;Patient is experiencing fatigue and localized neurological weakness over the past month. The symptoms are described as significant in nature.;close monitoring
brain_menin_0077;Brain Meningiomas;20;M;Patient is experiencing speech difficulty and chronic headaches for nearly 3 months. The symptoms are described as mild in nature.;surgery
brain_menin_0078;Brain Meningiomas;58;M;Patient is experiencing fatigue and coordination problems for several weeks. The symptoms are described as slight in nature.;radiation therapy
brain_menin_0079;Brain Meningiomas;63;F;Patient is experiencing blurry vision and coordination problems for several weeks. The symptoms are described as mild in nature.;radiation therapy
brain_menin_0080;Brain Meningiomas;49;M;Patient is experiencing chronic headaches and fatigue over the past month. The symptoms are described as mild in nature.;radiation therapy
brain_menin_0081;Brain Meningiomas;82;F;Patient is experiencing blurry vision and fatigue for several weeks. The symptoms are described as tolerable in nature.;close monitoring
brain_menin_0082;Brain Meningiomas;65;M;Patient is experiencing fatigue and speech difficulty for several weeks. The symptoms are described as low-grade in nature.;close monitoring
brain_menin_0083;Brain Meningiomas;63;F;Patient is experiencing fatigue and speech difficulty over the past month. The symptoms are described as tolerable in nature.;surgery
brain_menin_0084;Brain Meningiomas;28;M;Patient is experiencing speech difficulty and localized neurological weakness for nearly 3 months. The symptoms are described as noticeable in nature.;close monitoring
brain_menin_0085;Brain Meningiomas;74;F;Patient is experiencing chronic headaches and localized neurological weakness for nearly 3 months. The symptoms are described as significant in nature.;radiation therapy
brain_menin_0086;Brain Meningiomas;42;M;Patient is experiencing chronic headaches and fatigue for several weeks. The symptoms are described as moderate in nature.;surgery
brain_menin_0087;Brain Meningiomas;58;F;Patient is experiencing blurry vision and coordination problems over the past month. The symptoms are described as significant in nature.;radiation therapy
brain_menin_0088;Brain Meningiomas;83;F;Patient is experiencing speech difficulty and coordination problems for several weeks. The symptoms are described as noticeable in nature.;radiation therapy
brain_menin_0089;Brain Meningiomas;38;M;Patient is experiencing speech difficulty and chronic headaches for several weeks. The symptoms are described as moderate in nature.;close monitoring
brain_menin_0090;Brain Meningiomas;63;F;Patient is experiencing chronic headaches and localized neurological weakness for nearly 3 months. The symptoms are described as significant in nature.;surgery
brain_menin_0091;Brain Meningiomas;44;F;Patient is experiencing blurry vision and localized neurological weakness for nearly 3 months. The symptoms are described as moderate in nature.;radiation therapy
brain_menin_0092;Brain Meningiomas;49;M;Patient is experiencing coordination problems and chronic headaches for nearly 3 months. The symptoms are described as significant in nature.;radiation therapy
brain_menin_0093;Brain Meningiomas;85;F;Patient is experiencing blurry vision and localized neurological weakness over the past month. The symptoms are described as low-grade in nature.;surgery
brain_menin_0094;Brain Meningiomas;59;F;Patient is experiencing chronic headaches and coordination problems over the past month. The symptoms are described as moderate in nature.;radiation therapy
brain_menin_0095;Brain Meningiomas;43;M;Patient is experiencing blurry vision and fatigue for several weeks. The symptoms are described as mild in nature.;radiation therapy
brain_menin_0096;Brain Meningiomas;32;F;Patient is experiencing coordination problems and localized neurological weakness over the past month. The symptoms are described as significant in nature.;close monitoring
brain_menin_0097;Brain Meningiomas;42;M;Patient is experiencing speech difficulty and blurry vision over the past month. The symptoms are described as tolerable in nature.;radiation therapy
brain_menin_0098;Brain Meningiomas;19;F;Patient is experiencing localized neurological weakness and chronic headaches for several weeks. The symptoms are described as tolerable in nature.;radiation therapy
brain_menin_0099;Brain Meningiomas;67;M;Patient is experiencing localized neurological weakness and fatigue for several weeks. The symptoms are described as tolerable in nature.;surgery
brain_menin_0100;Brain Meningiomas;73;M;Patient is experiencing chronic headaches and localized neurological weakness for nearly 3 months. The symptoms are described as mild in nature.;surgery
brain_menin_0101;Brain Meningiomas;62;M;Patient is experiencing localized neurological weakness and speech difficulty over the past month. The symptoms are described as slight in nature.;surgery
brain_menin_0102;Brain Meningiomas;50;M;Patient is experiencing coordination problems and blurry vision for nearly 3 months. The symptoms are described as significant in nature.;surgery
brain_menin_0103;Brain Meningiomas;70;F;Patient is experiencing blurry vision and coordination problems for nearly 3 months. The symptoms are described as moderate in nature.;surgery
brain_menin_0104;Brain Meningiomas;49;M;Patient is experiencing fatigue and chronic headaches for several weeks. The symptoms are described as moderate in nature.;surgery
brain_menin_0105;Brain Meningiomas;70;F;Patient is experiencing speech difficulty and fatigue for several weeks. The symptoms are described as moderate in nature.;surgery
brain_menin_0106;Brain Meningiomas;29;M;Patient is experiencing localized neurological weakness and chronic headaches for nearly 3 months. The symptoms are described as moderate in nature.;close monitoring
brain_menin_0107;Brain Meningiomas;85;F;Patient is experiencing chronic headaches and fatigue for nearly 3 months. The symptoms are described as moderate in nature.;radiation therapy
brain_menin_0108;Brain Meningiomas;36;M;Patient is experiencing localized neurological weakness and fatigue for nearly 3 months. The symptoms are described as tolerable in nature.;radiation therapy
brain_menin_0109;Brain Meningiomas;40;F;Patient is experiencing chronic headaches and fatigue for nearly 3 months. The symptoms are described as noticeable in nature.;radiation therapy
brain_menin_0110;Brain Meningiomas;70;F;Patient is experiencing localized neurological weakness and speech difficulty for several weeks. The symptoms are described as noticeable in nature.;surgery
brain_menin_0111;Brain Meningiomas;36;M;Patient is experiencing blurry vision and coordination problems for several weeks. The symptoms are described as mild in nature.;radiation therapy
brain_menin_0112;Brain Meningiomas;71;F;Patient is experiencing localized neurological weakness and speech difficulty over the past month. The symptoms are described as slight in nature.;surgery
brain_menin_0113;Brain Meningiomas;43;M;Patient is experiencing speech difficulty and chronic headaches for several weeks. The symptoms are described as mild in nature.;radiation therapy
brain_menin_0114;Brain Meningiomas;59;F;Patient is experiencing coordination problems and chronic headaches for nearly 3 months. The symptoms are described as mild in nature.;surgery
brain_menin_0115;Brain Meningiomas;49;M;Patient is experiencing fatigue and localized neurological weakness over the past month. The symptoms are described as tolerable in nature.;close monitoring
brain_menin_0116;Brain Meningiomas;47;M;Patient is experiencing chronic headaches and coordination problems for nearly 3 months. The symptoms are described as low-grade in nature.;surgery
brain_menin_0117;Brain Meningiomas;53;F;Patient is experiencing fatigue and localized neurological weakness for nearly 3 months. The symptoms are described as significant in nature.;surgery
brain_menin_0118;Brain Meningiomas;58;F;Patient is experiencing chronic headaches and coordination problems for nearly 3 months. The symptoms are described as mild in nature.;radiation therapy
brain_menin_0119;Brain Meningiomas;82;F;Patient is experiencing localized neurological weakness and coordination problems for nearly 3 months. The symptoms are described as tolerable in nature.;surgery
brain_menin_0120;Brain Meningiomas;59;M;Patient is experiencing speech difficulty and coordination problems for nearly 3 months. The symptoms are described as significant in nature.;radiation therapy
brain_menin_0121;Brain Meningiomas;49;F;Patient is experiencing blurry vision and fatigue for nearly 3 months. The symptoms are described as significant in nature.;radiation therapy
brain_menin_0122;Brain Meningiomas;63;M;Patient is experiencing chronic headaches and fatigue over the past month. The symptoms are described as slight in nature.;close monitoring
brain_menin_0123;Brain Meningiomas;64;M;Patient is experiencing blurry vision and chronic headaches for nearly 3 months. The symptoms are described as moderate in nature.;surgery
brain_menin_0124;Brain Meningiomas;37;F;Patient is experiencing speech difficulty and chronic headaches over the past month. The symptoms are described as significant in nature.;radiation therapy
brain_menin_0125;Brain Meningiomas;25;M;Patient is experiencing speech difficulty and blurry vision over the past month. The symptoms are described as tolerable in nature.;radiation therapy
brain_menin_0126;Brain Meningiomas;79;F;Patient is experiencing localized neurological weakness and blurry vision for several weeks. The symptoms are described as moderate in nature.;radiation therapy
brain_menin_0127;Brain Meningiomas;19;F;Patient is experiencing chronic headaches and coordination problems over the past month. The symptoms are described as mild in nature.;radiation therapy
brain_menin_0128;Brain Meningiomas;80;F;Patient is experiencing speech difficulty and blurry vision for nearly 3 months. The symptoms are described as significant in nature.;surgery
brain_menin_0129;Brain Meningiomas;72;F;Patient is experiencing localized neurological weakness and speech difficulty over the past month. The symptoms are described as significant in nature.;surgery
brain_menin_0130;Brain Meningiomas;70;M;Patient is experiencing localized neurological weakness and chronic headaches over the past month. The symptoms are described as low-grade in nature.;radiation therapy
brain_menin_0131;Brain Meningiomas;28;F;Patient is experiencing chronic headaches and speech difficulty for nearly 3 months. The symptoms are described as significant in nature.;close monitoring
brain_menin_0132;Brain Meningiomas;18;F;Patient is experiencing speech difficulty and coordination problems over the past month. The symptoms are described as tolerable in nature.;radiation therapy
brain_menin_0133;Brain Meningiomas;80;M;Patient is experiencing fatigue and chronic headaches for several weeks. The symptoms are described as noticeable in nature.;close monitoring
brain_menin_0134;Brain Meningiomas;56;M;Patient is experiencing localized neurological weakness and blurry vision for nearly 3 months. The symptoms are described as moderate in nature.;surgery
brain_menin_0135;Brain Meningiomas;32;M;Patient is experiencing localized neurological weakness and blurry vision over the past month. The symptoms are described as slight in nature.;surgery
brain_menin_0136;Brain Meningiomas;59;F;Patient is experiencing chronic headaches and coordination problems over the past month. The symptoms are described as tolerable in nature.;close monitoring
brain_menin_0137;Brain Meningiomas;48;M;Patient is experiencing speech difficulty and fatigue for nearly 3 months. The symptoms are described as slight in nature.;close monitoring
brain_menin_0138;Brain Meningiomas;26;M;Patient is experiencing speech difficulty and fatigue over the past month. The symptoms are described as slight in nature.;close monitoring
brain_menin_0139;Brain Meningiomas;59;M;Patient is experiencing speech difficulty and localized neurological weakness over the past month. The symptoms are described as moderate in nature.;surgery
brain_menin_0140;Brain Meningiomas;58;M;Patient is experiencing fatigue and speech difficulty over the past month. The symptoms are described as moderate in nature.;close monitoring
brain_menin_0141;Brain Meningiomas;56;M;Patient is experiencing chronic headaches and speech difficulty for several weeks. The symptoms are described as tolerable in nature.;surgery
brain_menin_0142;Brain Meningiomas;37;F;Patient is experiencing coordination problems and speech difficulty for nearly 3 months. The symptoms are described as noticeable in nature.;close monitoring
brain_menin_0143;Brain Meningiomas;56;M;Patient is experiencing coordination problems and speech difficulty for nearly 3 months. The symptoms are described as significant in nature.;radiation therapy
brain_menin_0144;Brain Meningiomas;37;F;Patient is experiencing fatigue and coordination problems for several weeks. The symptoms are described as slight in nature.;radiation therapy
brain_menin_0145;Brain Meningiomas;74;F;Patient is experiencing localized neurological weakness and speech difficulty for several weeks. The symptoms are described as tolerable in nature.;close monitoring
brain_menin_0146;Brain Meningiomas;47;M;Patient is experiencing fatigue and speech difficulty for several weeks. The symptoms are described as moderate in nature.;close monitoring
brain_menin_0147;Brain Meningiomas;82;F;Patient is experiencing fatigue and coordination problems for nearly 3 months. The symptoms are described as moderate in nature.;radiation therapy
brain_menin_0148;Brain Meningiomas;19;F;Patient is experiencing localized neurological weakness and speech difficulty over the past month. The symptoms are described as significant in nature.;radiation therapy
brain_menin_0149;Brain Meningiomas;85;M;Patient is experiencing coordination problems and blurry vision for nearly 3 months. The symptoms are described as significant in nature.;close monitoring
brain_menin_0150;Brain Meningiomas;74;M;Patient is experiencing fatigue and speech difficulty over the past month. The symptoms are described as tolerable in nature.;close monitoring
brain_menin_0151;Brain Meningiomas;29;M;Patient is experiencing blurry vision and fatigue over the past month. The symptoms are described as tolerable in nature.;surgery
brain_menin_0152;Brain Meningiomas;57;M;Patient is experiencing fatigue and localized neurological weakness for nearly 3 months. The symptoms are described as moderate in nature.;close monitoring
brain_menin_0153;Brain Meningiomas;76;M;Patient is experiencing fatigue and chronic headaches for several weeks. The symptoms are described as moderate in nature.;radiation therapy
brain_menin_0154;Brain Meningiomas;28;F;Patient is experiencing blurry vision and localized neurological weakness for several weeks. The symptoms are described as slight in nature.;radiation therapy
brain_menin_0155;Brain Meningiomas;83;M;Patient is experiencing blurry vision and localized neurological weakness for several weeks. The symptoms are described as slight in nature.;radiation therapy
brain_menin_0156;Brain Meningiomas;66;F;Patient is experiencing speech difficulty and blurry vision over the past month. The symptoms are described as noticeable in nature.;surgery
brain_menin_0157;Brain Meningiomas;64;F;Patient is experiencing speech difficulty and chronic headaches for nearly 3 months. The symptoms are described as low-grade in nature.;close monitoring
brain_menin_0158;Brain Meningiomas;32;F;Patient is experiencing localized neurological weakness and speech difficulty for several weeks. The symptoms are described as mild in nature.;close monitoring
brain_menin_0159;Brain Meningiomas;61;M;Patient is experiencing speech difficulty and chronic headaches over the past month. The symptoms are described as slight in nature.;radiation therapy
brain_menin_0160;Brain Meningiomas;25;F;Patient is experiencing fatigue and speech difficulty for nearly 3 months. The symptoms are described as low-grade in nature.;radiation therapy
brain_menin_0161;Brain Meningiomas;72;F;Patient is experiencing fatigue and blurry vision over the past month. The symptoms are described as slight in nature.;radiation therapy
brain_menin_0162;Brain Meningiomas;21;F;Patient is experiencing speech difficulty and chronic headaches over the past month. The symptoms are described as significant in nature.;surgery
brain_menin_0163;Brain Meningiomas;23;F;Patient is experiencing coordination problems and blurry vision over the past month. The symptoms are described as moderate in nature.;close monitoring
brain_menin_0164;Brain Meningiomas;33;F;Patient is experiencing fatigue and coordination problems over the past month. The symptoms are described as low-grade in nature.;close monitoring
brain_menin_0165;Brain Meningiomas;38;M;Patient is experiencing chronic headaches and localized neurological weakness over the past month. The symptoms are described as slight in nature.;surgery
brain_menin_0166;Brain Meningiomas;58;F;Patient is experiencing localized neurological weakness and coordination problems for several weeks. The symptoms are described as moderate in nature.;radiation therapy
brain_menin_0167;Brain Meningiomas;51;M;Patient is experiencing chronic headaches and localized neurological weakness for several weeks. The symptoms are described as tolerable in nature.;close monitoring
brain_menin_0168;Brain Meningiomas;48;F;Patient is experiencing coordination problems and speech difficulty for nearly 3 months. The symptoms are described as moderate in nature.;radiation therapy
brain_menin_0169;Brain Meningiomas;76;M;Patient is experiencing chronic headaches and localized neurological weakness for nearly 3 months. The symptoms are described as mild in nature.;surgery
brain_menin_0170;Brain Meningiomas;45;F;Patient is experiencing localized neurological weakness and chronic headaches for nearly 3 months. The symptoms are described as tolerable in nature.;close monitoring
brain_menin_0171;Brain Meningiomas;54;F;Patient is experiencing chronic headaches and fatigue over the past month. The symptoms are described as tolerable in nature.;close monitoring
brain_menin_0172;Brain Meningiomas;80;F;Patient is experiencing blurry vision and fatigue over the past month. The symptoms are described as slight in nature.;radiation therapy
brain_menin_0173;Brain Meningiomas;73;M;Patient is experiencing localized neurological weakness and chronic headaches for nearly 3 months. The symptoms are described as tolerable in nature.;close monitoring
brain_menin_0174;Brain Meningiomas;77;F;Patient is experiencing fatigue and localized neurological weakness for nearly 3 months. The symptoms are described as tolerable in nature.;surgery
brain_menin_0175;Brain Meningiomas;70;F;Patient is experiencing speech difficulty and chronic headaches for nearly 3 months. The symptoms are described as mild in nature.;radiation therapy
brain_menin_0176;Brain Meningiomas;84;F;Patient is experiencing localized neurological weakness and blurry vision over the past month. The symptoms are described as noticeable in nature.;surgery
brain_menin_0177;Brain Meningiomas;80;M;Patient is experiencing chronic headaches and speech difficulty over the past month. The symptoms are described as significant in nature.;close monitoring
brain_menin_0178;Brain Meningiomas;76;M;Patient is experiencing blurry vision and chronic headaches over the past month. The symptoms are described as moderate in nature.;radiation therapy
brain_menin_0179;Brain Meningiomas;66;M;Patient is experiencing fatigue and speech difficulty over the past month. The symptoms are described as mild in nature.;surgery
brain_menin_0180;Brain Meningiomas;20;F;Patient is experiencing localized neurological weakness and blurry vision for nearly 3 months. The symptoms are described as low-grade in nature.;radiation therapy
brain_menin_0181;Brain Meningiomas;25;F;Patient is experiencing localized neurological weakness and fatigue for nearly 3 months. The symptoms are described as mild in nature.;surgery
brain_menin_0182;Brain Meningiomas;45;M;Patient is experiencing localized neurological weakness and coordination problems over the past month. The symptoms are described as moderate in nature.;close monitoring
brain_menin_0183;Brain Meningiomas;61;M;Patient is experiencing speech difficulty and coordination problems for several weeks. The symptoms are described as slight in nature.;close monitoring
brain_menin_0184;Brain Meningiomas;33;M;Patient is experiencing coordination problems and speech difficulty for several weeks. The symptoms are described as slight in nature.;close monitoring
brain_menin_0185;Brain Meningiomas;78;M;Patient is experiencing fatigue and speech difficulty for several weeks. The symptoms are described as tolerable in nature.;surgery
brain_menin_0186;Brain Meningiomas;79;F;Patient is experiencing coordination problems and chronic headaches for nearly 3 months. The symptoms are described as significant in nature.;radiation therapy
brain_menin_0187;Brain Meningiomas;71;F;Patient is experiencing localized neurological weakness and coordination problems over the past month. The symptoms are described as noticeable in nature.;surgery
brain_menin_0188;Brain Meningiomas;47;M;Patient is experiencing chronic headaches and coordination problems over the past month. The symptoms are described as significant in nature.;radiation therapy
brain_menin_0189;Brain Meningiomas;35;M;Patient is experiencing fatigue and blurry vision for several weeks. The symptoms are described as slight in nature.;radiation therapy
brain_menin_0190;Brain Meningiomas;20;M;Patient is experiencing speech difficulty and coordination problems for nearly 3 months. The symptoms are described as moderate in nature.;surgery
brain_menin_0191;Brain Meningiomas;62;F;Patient is experiencing fatigue and localized neurological weakness for several weeks. The symptoms are described as tolerable in nature.;radiation therapy
brain_menin_0192;Brain Meningiomas;27;M;Patient is experiencing localized neurological weakness and coordination problems over the past month. The symptoms are described as noticeable in nature.;radiation therapy
brain_menin_0193;Brain Meningiomas;54;F;Patient is experiencing blurry vision and localized neurological weakness for nearly 3 months. The symptoms are described as slight in nature.;radiation therapy
brain_menin_0194;Brain Meningiomas;82;F;Patient is experiencing localized neurological weakness and blurry vision for nearly 3 months. The symptoms are described as slight in nature.;radiation therapy
brain_menin_0195;Brain Meningiomas;27;F;Patient is experiencing speech difficulty and localized neurological weakness for several weeks. The symptoms are described as tolerable in nature.;close monitoring
brain_menin_0196;Brain Meningiomas;61;F;Patient is experiencing coordination problems and localized neurological weakness for nearly 3 months. The symptoms are described as tolerable in nature.;close monitoring
brain_menin_0197;Brain Meningiomas;51;M;Patient is experiencing blurry vision and chronic headaches for several weeks. The symptoms are described as tolerable in nature.;close monitoring
brain_menin_0198;Brain Meningiomas;21;F;Patient is experiencing fatigue and chronic headaches for several weeks. The symptoms are described as significant in nature.;close monitoring
brain_menin_0199;Brain Meningiomas;55;F;Patient is experiencing speech difficulty and fatigue for nearly 3 months. The symptoms are described as mild in nature.;radiation therapy
brain_menin_0200;Brain Meningiomas;37;F;Patient is experiencing localized neurological weakness and blurry vision for nearly 3 months. The symptoms are described as noticeable in nature.;close monitoring
brain_menin_0201;Brain Meningiomas;69;M;Patient is experiencing speech difficulty and coordination problems over the past month. The symptoms are described as low-grade in nature.;close monitoring
brain_menin_0202;Brain Meningiomas;49;F;Patient is experiencing blurry vision and fatigue for several weeks. The symptoms are described as tolerable in nature.;radiation therapy
brain_menin_0203;Brain Meningiomas;23;M;Patient is experiencing chronic headaches and speech difficulty for nearly 3 months. The symptoms are described as noticeable in nature.;radiation therapy
brain_menin_0204;Brain Meningiomas;67;F;Patient is experiencing fatigue and localized neurological weakness over the past month. The symptoms are described as tolerable in nature.;surgery
brain_menin_0205;Brain Meningiomas;35;F;Patient is experiencing localized neurological weakness and speech difficulty for several weeks. The symptoms are described as significant in nature.;surgery
brain_menin_0206;Brain Meningiomas;39;M;Patient is experiencing blurry vision and localized neurological weakness for nearly 3 months. The symptoms are described as significant in nature.;close monitoring
brain_menin_0207;Brain Meningiomas;54;M;Patient is experiencing speech difficulty and localized neurological weakness for several weeks. The symptoms are described as significant in nature.;radiation therapy
brain_menin_0208;Brain Meningiomas;45;M;Patient is experiencing blurry vision and fatigue over the past month. The symptoms are described as moderate in nature.;radiation therapy
brain_menin_0209;Brain Meningiomas;51;F;Patient is experiencing coordination problems and localized neurological weakness over the past month. The symptoms are described as moderate in nature.;close monitoring
brain_menin_0210;Brain Meningiomas;64;F;Patient is experiencing speech difficulty and chronic headaches for several weeks. The symptoms are described as mild in nature.;surgery
brain_menin_0211;Brain Meningiomas;69;F;Patient is experiencing fatigue and blurry vision for several weeks. The symptoms are described as tolerable in nature.;surgery
brain_menin_0212;Brain Meningiomas;36;F;Patient is experiencing fatigue and chronic headaches for nearly 3 months. The symptoms are described as moderate in nature.;radiation therapy
brain_menin_0213;Brain Meningiomas;39;F;Patient is experiencing blurry vision and localized neurological weakness for several weeks. The symptoms are described as moderate in nature.;surgery
brain_menin_0214;Brain Meningiomas;19;F;Patient is experiencing blurry vision and chronic headaches for several weeks. The symptoms are described as moderate in nature.;surgery
brain_menin_0215;Brain Meningiomas;75;M;Patient is experiencing speech difficulty and localized neurological weakness over the past month. The symptoms are described as significant in nature.;radiation therapy
brain_menin_0216;Brain Meningiomas;24;F;Patient is experiencing speech difficulty and chronic headaches for several weeks. The symptoms are described as tolerable in nature.;surgery
brain_menin_0217;Brain Meningiomas;34;M;Patient is experiencing fatigue and localized neurological weakness for nearly 3 months. The symptoms are described as mild in nature.;close monitoring
brain_menin_0218;Brain Meningiomas;71;M;Patient is experiencing fatigue and coordination problems over the past month. The symptoms are described as moderate in nature.;surgery
brain_menin_0219;Brain Meningiomas;53;M;Patient is experiencing coordination problems and chronic headaches for nearly 3 months. The symptoms are described as slight in nature.;close monitoring
brain_menin_0220;Brain Meningiomas;43;M;Patient is experiencing fatigue and speech difficulty for several weeks. The symptoms are described as moderate in nature.;surgery
brain_menin_0221;Brain Meningiomas;59;M;Patient is experiencing localized neurological weakness and chronic headaches for several weeks. The symptoms are described as moderate in nature.;surgery
brain_menin_0222;Brain Meningiomas;19;M;Patient is experiencing chronic headaches and coordination problems over the past month. The symptoms are described as low-grade in nature.;surgery
brain_menin_0223;Brain Meningiomas;66;F;Patient is experiencing chronic headaches and coordination problems for nearly 3 months. The symptoms are described as noticeable in nature.;close monitoring
brain_menin_0224;Brain Meningiomas;58;M;Patient is experiencing speech difficulty and coordination problems over the past month. The symptoms are described as moderate in nature.;close monitoring
brain_menin_0225;Brain Meningiomas;22;M;Patient is experiencing blurry vision and chronic headaches for several weeks. The symptoms are described as low-grade in nature.;surgery
brain_menin_0226;Brain Meningiomas;29;M;Patient is experiencing speech difficulty and blurry vision over the past month. The symptoms are described as significant in nature.;radiation therapy
brain_menin_0227;Brain Meningiomas;21;F;Patient is experiencing speech difficulty and localized neurological weakness for nearly 3 months. The symptoms are described as slight in nature.;radiation therapy
brain_menin_0228;Brain Meningiomas;44;M;Patient is experiencing speech difficulty and blurry vision for nearly 3 months. The symptoms are described as tolerable in nature.;radiation therapy
brain_menin_0229;Brain Meningiomas;58;M;Patient is experiencing localized neurological weakness and chronic headaches over the past month. The symptoms are described as moderate in nature.;surgery
brain_menin_0230;Brain Meningiomas;69;F;Patient is experiencing chronic headaches and speech difficulty for nearly 3 months. The symptoms are described as low-grade in nature.;surgery
brain_menin_0231;Brain Meningiomas;49;F;Patient is experiencing blurry vision and fatigue for several weeks. The symptoms are described as significant in nature.;close monitoring
brain_menin_0232;Brain Meningiomas;77;F;Patient is experiencing chronic headaches and coordination problems over the past month. The symptoms are described as mild in nature.;close monitoring
brain_menin_0233;Brain Meningiomas;78;M;Patient is experiencing coordination problems and fatigue for nearly 3 months. The symptoms are described as noticeable in nature.;surgery
brain_menin_0234;Brain Meningiomas;63;M;Patient is experiencing chronic headaches and blurry vision for several weeks. The symptoms are described as significant in nature.;radiation therapy
brain_menin_0235;Brain Meningiomas;25;F;Patient is experiencing chronic headaches and coordination problems for nearly 3 months. The symptoms are described as moderate in nature.;radiation therapy
brain_menin_0236;Brain Meningiomas;68;M;Patient is experiencing coordination problems and chronic headaches over the past month. The symptoms are described as significant in nature.;surgery
brain_menin_0237;Brain Meningiomas;45;M;Patient is experiencing blurry vision and coordination problems over the past month. The symptoms are described as noticeable in nature.;close monitoring
brain_menin_0238;Brain Meningiomas;84;M;Patient is experiencing blurry vision and chronic headaches for nearly 3 months. The symptoms are described as mild in nature.;surgery
brain_menin_0239;Brain Meningiomas;54;F;Patient is experiencing blurry vision and fatigue for nearly 3 months. The symptoms are described as moderate in nature.;close monitoring
brain_menin_0240;Brain Meningiomas;19;M;Patient is experiencing fatigue and chronic headaches for several weeks. The symptoms are described as significant in nature.;close monitoring
brain_menin_0241;Brain Meningiomas;25;F;Patient is experiencing blurry vision and chronic headaches for several weeks. The symptoms are described as noticeable in nature.;surgery
brain_menin_0242;Brain Meningiomas;73;F;Patient is experiencing chronic headaches and localized neurological weakness for several weeks. The symptoms are described as low-grade in nature.;radiation therapy
brain_menin_0243;Brain Meningiomas;56;F;Patient is experiencing fatigue and localized neurological weakness for nearly 3 months. The symptoms are described as low-grade in nature.;radiation therapy
brain_menin_0244;Brain Meningiomas;59;M;Patient is experiencing coordination problems and fatigue for nearly 3 months. The symptoms are described as moderate in nature.;radiation therapy
brain_menin_0245;Brain Meningiomas;42;M;Patient is experiencing speech difficulty and coordination problems over the past month. The symptoms are described as tolerable in nature.;close monitoring
brain_menin_0246;Brain Meningiomas;45;M;Patient is experiencing blurry vision and fatigue for several weeks. The symptoms are described as mild in nature.;surgery
brain_menin_0247;Brain Meningiomas;54;M;Patient is experiencing coordination problems and fatigue over the past month. The symptoms are described as tolerable in nature.;surgery
brain_menin_0248;Brain Meningiomas;38;F;Patient is experiencing coordination problems and speech difficulty for several weeks. The symptoms are described as low-grade in nature.;close monitoring
brain_menin_0249;Brain Meningiomas;18;M;Patient is experiencing speech difficulty and chronic headaches over the past month. The symptoms are described as tolerable in nature.;radiation therapy
brain_menin_0250;Brain Meningiomas;57;M;Patient is experiencing fatigue and coordination problems for several weeks. The symptoms are described as significant in nature.;close monitoring
brain_menin_0251;Brain Meningiomas;50;M;Patient is experiencing fatigue and localized neurological weakness for nearly 3 months. The symptoms are described as significant in nature.;close monitoring
brain_menin_0252;Brain Meningiomas;53;M;Patient is experiencing speech difficulty and blurry vision over the past month. The symptoms are described as noticeable in nature.;surgery
brain_menin_0253;Brain Meningiomas;62;F;Patient is experiencing blurry vision and chronic headaches over the past month. The symptoms are described as low-grade in nature.;surgery
brain_menin_0254;Brain Meningiomas;23;F;Patient is experiencing localized neurological weakness and speech difficulty for nearly 3 months. The symptoms are described as slight in nature.;surgery
brain_menin_0255;Brain Meningiomas;24;M;Patient is experiencing blurry vision and localized neurological weakness over the past month. The symptoms are described as tolerable in nature.;surgery
brain_menin_0256;Brain Meningiomas;80;F;Patient is experiencing speech difficulty and coordination problems for several weeks. The symptoms are described as tolerable in nature.;radiation therapy
brain_menin_0257;Brain Meningiomas;38;M;Patient is experiencing blurry vision and speech difficulty for several weeks. The symptoms are described as significant in nature.;surgery
brain_menin_0258;Brain Meningiomas;30;F;Patient is experiencing coordination problems and blurry vision for nearly 3 months. The symptoms are described as noticeable in nature.;close monitoring
brain_menin_0259;Brain Meningiomas;31;M;Patient is experiencing chronic headaches and coordination problems over the past month. The symptoms are described as tolerable in nature.;radiation therapy
brain_menin_0260;Brain Meningiomas;79;F;Patient is experiencing localized neurological weakness and chronic headaches over the past month. The symptoms are described as mild in nature.;close monitoring
brain_menin_0261;Brain Meningiomas;28;M;Patient is experiencing blurry vision and fatigue for nearly 3 months. The symptoms are described as mild in nature.;surgery
brain_menin_0262;Brain Meningiomas;85;M;Patient is experiencing chronic headaches and fatigue over the past month. The symptoms are described as tolerable in nature.;radiation therapy
brain_menin_0263;Brain Meningiomas;76;M;Patient is experiencing chronic headaches and fatigue for nearly 3 months. The symptoms are described as mild in nature.;surgery
brain_menin_0264;Brain Meningiomas;46;F;Patient is experiencing fatigue and speech difficulty for several weeks. The symptoms are described as moderate in nature.;close monitoring
brain_menin_0265;Brain Meningiomas;84;M;Patient is experiencing blurry vision and fatigue for nearly 3 months. The symptoms are described as significant in nature.;close monitoring
brain_menin_0266;Brain Meningiomas;32;M;Patient is experiencing blurry vision and speech difficulty for nearly 3 months. The symptoms are described as noticeable in nature.;surgery
brain_menin_0267;Brain Meningiomas;35;M;Patient is experiencing fatigue and localized neurological weakness for several weeks. The symptoms are described as slight in nature.;surgery
brain_menin_0268;Brain Meningiomas;73;M;Patient is experiencing coordination problems and blurry vision over the past month. The symptoms are described as noticeable in nature.;radiation therapy
brain_menin_0269;Brain Meningiomas;33;F;Patient is experiencing blurry vision and fatigue over the past month. The symptoms are described as noticeable in nature.;radiation therapy
brain_menin_0270;Brain Meningiomas;53;M;Patient is experiencing chronic headaches and blurry vision for nearly 3 months. The symptoms are described as low-grade in nature.;close monitoring
brain_menin_0271;Brain Meningiomas;31;M;Patient is experiencing speech difficulty and coordination problems for several weeks. The symptoms are described as slight in nature.;radiation therapy
brain_menin_0272;Brain Meningiomas;43;M;Patient is experiencing fatigue and blurry vision over the past month. The symptoms are described as significant in nature.;close monitoring
brain_menin_0273;Brain Meningiomas;36;M;Patient is experiencing localized neurological weakness and blurry vision for several weeks. The symptoms are described as significant in nature.;radiation therapy
brain_menin_0274;Brain Meningiomas;73;F;Patient is experiencing coordination problems and fatigue for several weeks. The symptoms are described as moderate in nature.;surgery
brain_menin_0275;Brain Meningiomas;53;F;Patient is experiencing localized neurological weakness and speech difficulty for nearly 3 months. The symptoms are described as slight in nature.;close monitoring
brain_menin_0276;Brain Meningiomas;19;F;Patient is experiencing chronic headaches and coordination problems for several weeks. The symptoms are described as mild in nature.;surgery
brain_menin_0277;Brain Meningiomas;44;M;Patient is experiencing speech difficulty and blurry vision for several weeks. The symptoms are described as noticeable in nature.;radiation therapy
brain_menin_0278;Brain Meningiomas;45;M;Patient is experiencing fatigue and localized neurological weakness over the past month. The symptoms are described as tolerable in nature.;radiation therapy
brain_menin_0279;Brain Meningiomas;24;M;Patient is experiencing fatigue and speech difficulty for several weeks. The symptoms are described as slight in nature.;close monitoring
brain_menin_0280;Brain Meningiomas;45;F;Patient is experiencing speech difficulty and localized neurological weakness for nearly 3 months. The symptoms are described as tolerable in nature.;radiation therapy
brain_menin_0281;Brain Meningiomas;68;F;Patient is experiencing blurry vision and fatigue for several weeks. The symptoms are described as noticeable in nature.;surgery
brain_menin_0282;Brain Meningiomas;56;M;Patient is experiencing fatigue and coordination problems for nearly 3 months. The symptoms are described as noticeable in nature.;close monitoring
brain_menin_0283;Brain Meningiomas;34;M;Patient is experiencing fatigue and coordination problems over the past month. The symptoms are described as significant in nature.;surgery
brain_menin_0284;Brain Meningiomas;70;F;Patient is experiencing coordination problems and speech difficulty for nearly 3 months. The symptoms are described as mild in nature.;surgery
brain_menin_0285;Brain Meningiomas;50;M;Patient is experiencing coordination problems and speech difficulty for nearly 3 months. The symptoms are described as significant in nature.;radiation therapy
brain_menin_0286;Brain Meningiomas;19;F;Patient is experiencing fatigue and localized neurological weakness over the past month. The symptoms are described as significant in nature.;surgery
brain_menin_0287;Brain Meningiomas;27;M;Patient is experiencing chronic headaches and coordination problems over the past month. The symptoms are described as mild in nature.;radiation therapy
brain_menin_0288;Brain Meningiomas;72;F;Patient is experiencing localized neurological weakness and fatigue over the past month. The symptoms are described as significant in nature.;radiation therapy
brain_menin_0289;Brain Meningiomas;23;F;Patient is experiencing speech difficulty and localized neurological weakness over the past month. The symptoms are described as noticeable in nature.;radiation therapy
brain_menin_0290;Brain Meningiomas;50;F;Patient is experiencing fatigue and blurry vision for nearly 3 months. The symptoms are described as noticeable in nature.;radiation therapy
brain_menin_0291;Brain Meningiomas;45;F;Patient is experiencing blurry vision and chronic headaches for several weeks. The symptoms are described as noticeable in nature.;close monitoring
brain_menin_0292;Brain Meningiomas;66;M;Patient is experiencing chronic headaches and localized neurological weakness over the past month. The symptoms are described as noticeable in nature.;radiation therapy
brain_menin_0293;Brain Meningiomas;60;F;Patient is experiencing localized neurological weakness and speech difficulty over the past month. The symptoms are described as noticeable in nature.;radiation therapy
brain_menin_0294;Brain Meningiomas;37;M;Patient is experiencing blurry vision and localized neurological weakness for nearly 3 months. The symptoms are described as slight in nature.;close monitoring
brain_menin_0295;Brain Meningiomas;53;M;Patient is experiencing blurry vision and fatigue for nearly 3 months. The symptoms are described as mild in nature.;surgery
brain_menin_0296;Brain Meningiomas;80;F;Patient is experiencing localized neurological weakness and blurry vision for several weeks. The symptoms are described as mild in nature.;radiation therapy
brain_menin_0297;Brain Meningiomas;57;F;Patient is experiencing localized neurological weakness and coordination problems over the past month. The symptoms are described as noticeable in nature.;close monitoring
brain_menin_0298;Brain Meningiomas;55;M;Patient is experiencing speech difficulty and localized neurological weakness over the past month. The symptoms are described as low-grade in nature.;radiation therapy
brain_menin_0299;Brain Meningiomas;43;F;Patient is experiencing chronic headaches and coordination problems for nearly 3 months. The symptoms are described as tolerable in nature.;radiation therapy
brain_menin_0300;Brain Meningiomas;19;F;Patient is experiencing localized neurological weakness and fatigue for several weeks. The symptoms are described as mild in nature.;close monitoring
brain_menin_0301;Brain Meningiomas;18;F;Patient is experiencing speech difficulty and blurry vision over the past month. The symptoms are described as tolerable in nature.;surgery
brain_menin_0302;Brain Meningiomas;69;M;Patient is experiencing coordination problems and localized neurological weakness for nearly 3 months. The symptoms are described as moderate in nature.;surgery
brain_menin_0303;Brain Meningiomas;35;F;Patient is experiencing speech difficulty and chronic headaches over the past month. The symptoms are described as noticeable in nature.;radiation therapy
brain_menin_0304;Brain Meningiomas;27;M;Patient is experiencing localized neurological weakness and speech difficulty over the past month. The symptoms are described as tolerable in nature.;close monitoring
brain_menin_0305;Brain Meningiomas;85;M;Patient is experiencing blurry vision and speech difficulty for several weeks. The symptoms are described as low-grade in nature.;surgery
brain_menin_0306;Brain Meningiomas;41;F;Patient is experiencing chronic headaches and blurry vision over the past month. The symptoms are described as moderate in nature.;radiation therapy
brain_menin_0307;Brain Meningiomas;57;F;Patient is experiencing chronic headaches and coordination problems for nearly 3 months. The symptoms are described as significant in nature.;radiation therapy
brain_menin_0308;Brain Meningiomas;83;F;Patient is experiencing fatigue and blurry vision for several weeks. The symptoms are described as low-grade in nature.;surgery
brain_menin_0309;Brain Meningiomas;79;F;Patient is experiencing localized neurological weakness and speech difficulty over the past month. The symptoms are described as tolerable in nature.;surgery
brain_menin_0310;Brain Meningiomas;58;F;Patient is experiencing speech difficulty and blurry vision for several weeks. The symptoms are described as noticeable in nature.;surgery
brain_menin_0311;Brain Meningiomas;46;M;Patient is experiencing localized neurological weakness and speech difficulty for several weeks. The symptoms are described as low-grade in nature.;radiation therapy
brain_menin_0312;Brain Meningiomas;74;M;Patient is experiencing localized neurological weakness and blurry vision for nearly 3 months. The symptoms are described as mild in nature.;radiation therapy
brain_menin_0313;Brain Meningiomas;54;F;Patient is experiencing localized neurological weakness and coordination problems for nearly 3 months. The symptoms are described as slight in nature.;close monitoring
brain_menin_0314;Brain Meningiomas;38;F;Patient is experiencing coordination problems and speech difficulty for nearly 3 months. The symptoms are described as moderate in nature.;close monitoring
brain_menin_0315;Brain Meningiomas;24;M;Patient is experiencing coordination problems and chronic headaches for nearly 3 months. The symptoms are described as low-grade in nature.;close monitoring
brain_menin_0316;Brain Meningiomas;84;M;Patient is experiencing speech difficulty and coordination problems over the past month. The symptoms are described as tolerable in nature.;radiation therapy
brain_menin_0317;Brain Meningiomas;64;M;Patient is experiencing fatigue and speech difficulty over the past month. The symptoms are described as significant in nature.;close monitoring
brain_menin_0318;Brain Meningiomas;62;F;Patient is experiencing chronic headaches and localized neurological weakness for several weeks. The symptoms are described as slight in nature.;radiation therapy
brain_menin_0319;Brain Meningiomas;82;F;Patient is experiencing fatigue and chronic headaches for nearly 3 months. The symptoms are described as moderate in nature.;radiation therapy
brain_menin_0320;Brain Meningiomas;57;F;Patient is experiencing blurry vision and chronic headaches for nearly 3 months. The symptoms are described as slight in nature.;surgery
brain_menin_0321;Brain Meningiomas;78;M;Patient is experiencing speech difficulty and localized neurological weakness for nearly 3 months. The symptoms are described as slight in nature.;radiation therapy
brain_menin_0322;Brain Meningiomas;25;F;Patient is experiencing blurry vision and speech difficulty for several weeks. The symptoms are described as low-grade in nature.;radiation therapy
brain_menin_0323;Brain Meningiomas;71;M;Patient is experiencing blurry vision and coordination problems for several weeks. The symptoms are described as noticeable in nature.;radiation therapy
brain_menin_0324;Brain Meningiomas;27;M;Patient is experiencing chronic headaches and fatigue over the past month. The symptoms are described as significant in nature.;surgery
brain_menin_0325;Brain Meningiomas;33;M;Patient is experiencing localized neurological weakness and speech difficulty over the past month. The symptoms are described as noticeable in nature.;surgery
brain_menin_0326;Brain Meningiomas;50;F;Patient is experiencing chronic headaches and coordination problems for several weeks. The symptoms are described as significant in nature.;surgery
brain_menin_0327;Brain Meningiomas;82;F;Patient is experiencing blurry vision and localized neurological weakness for several weeks. The symptoms are described as noticeable in nature.;surgery
brain_menin_0328;Brain Meningiomas;62;F;Patient is experiencing speech difficulty and localized neurological weakness for nearly 3 months. The symptoms are described as significant in nature.;close monitoring
brain_menin_0329;Brain Meningiomas;78;M;Patient is experiencing speech difficulty and chronic headaches over the past month. The symptoms are described as significant in nature.;close monitoring
brain_menin_0330;Brain Meningiomas;29;M;Patient is experiencing fatigue and blurry vision for several weeks. The symptoms are described as mild in nature.;radiation therapy
brain_menin_0331;Brain Meningiomas;57;M;Patient is experiencing speech difficulty and localized neurological weakness over the past month. The symptoms are described as slight in nature.;surgery
brain_menin_0332;Brain Meningiomas;23;F;Patient is experiencing localized neurological weakness and blurry vision for several weeks. The symptoms are described as tolerable in nature.;surgery
brain_menin_0333;Brain Meningiomas;25;F;Patient is experiencing chronic headaches and coordination problems for nearly 3 months. The symptoms are described as tolerable in nature.;radiation therapy
brain_menin_0334;Brain Meningiomas;73;F;Patient is experiencing coordination problems and localized neurological weakness for nearly 3 months. The symptoms are described as slight in nature.;close monitoring
brain_menin_0335;Brain Meningiomas;68;F;Patient is experiencing chronic headaches and localized neurological weakness for several weeks. The symptoms are described as significant in nature.;close monitoring
brain_menin_0336;Brain Meningiomas;70;F;Patient is experiencing blurry vision and localized neurological weakness for several weeks. The symptoms are described as slight in nature.;radiation therapy
brain_menin_0337;Brain Meningiomas;49;M;Patient is experiencing speech difficulty and blurry vision for several weeks. The symptoms are described as noticeable in nature.;radiation therapy
brain_menin_0338;Brain Meningiomas;20;M;Patient is experiencing fatigue and blurry vision for nearly 3 months. The symptoms are described as mild in nature.;radiation therapy
brain_menin_0339;Brain Meningiomas;59;M;Patient is experiencing coordination problems and localized neurological weakness over the past month. The symptoms are described as noticeable in nature.;surgery
brain_menin_0340;Brain Meningiomas;32;F;Patient is experiencing speech difficulty and localized neurological weakness over the past month. The symptoms are described as slight in nature.;surgery
brain_menin_0341;Brain Meningiomas;41;M;Patient is experiencing blurry vision and localized neurological weakness over the past month. The symptoms are described as low-grade in nature.;surgery
brain_menin_0342;Brain Meningiomas;27;M;Patient is experiencing localized neurological weakness and chronic headaches for several weeks. The symptoms are described as significant in nature.;surgery
brain_menin_0343;Brain Meningiomas;60;M;Patient is experiencing blurry vision and coordination problems over the past month. The symptoms are described as significant in nature.;close monitoring
brain_menin_0344;Brain Meningiomas;78;F;Patient is experiencing speech difficulty and localized neurological weakness over the past month. The symptoms are described as moderate in nature.;close monitoring
brain_menin_0345;Brain Meningiomas;36;F;Patient is experiencing fatigue and coordination problems for nearly 3 months. The symptoms are described as mild in nature.;close monitoring
brain_menin_0346;Brain Meningiomas;29;F;Patient is experiencing chronic headaches and localized neurological weakness for nearly 3 months. The symptoms are described as mild in nature.;radiation therapy
brain_menin_0347;Brain Meningiomas;70;M;Patient is experiencing chronic headaches and blurry vision over the past month. The symptoms are described as moderate in nature.;radiation therapy
brain_menin_0348;Brain Meningiomas;56;M;Patient is experiencing coordination problems and chronic headaches over the past month. The symptoms are described as tolerable in nature.;surgery
brain_menin_0349;Brain Meningiomas;45;F;Patient is experiencing chronic headaches and localized neurological weakness for several weeks. The symptoms are described as mild in nature.;close monitoring
brain_menin_0350;Brain Meningiomas;59;M;Patient is experiencing fatigue and blurry vision for nearly 3 months. The symptoms are described as significant in nature.;surgery
brain_menin_0351;Brain Meningiomas;52;M;Patient is experiencing localized neurological weakness and fatigue for nearly 3 months. The symptoms are described as tolerable in nature.;close monitoring
brain_menin_0352;Brain Meningiomas;48;F;Patient is experiencing blurry vision and coordination problems for nearly 3 months. The symptoms are described as mild in nature.;radiation therapy
brain_menin_0353;Brain Meningiomas;52;F;Patient is experiencing coordination problems and chronic headaches for several weeks. The symptoms are described as slight in nature.;close monitoring
brain_menin_0354;Brain Meningiomas;78;F;Patient is experiencing speech difficulty and chronic headaches for nearly 3 months. The symptoms are described as mild in nature.;surgery
brain_menin_0355;Brain Meningiomas;43;F;Patient is experiencing fatigue and localized neurological weakness for several weeks. The symptoms are described as low-grade in nature.;radiation therapy
brain_menin_0356;Brain Meningiomas;84;F;Patient is experiencing blurry vision and coordination problems for several weeks. The symptoms are described as noticeable in nature.;radiation therapy
brain_menin_0357;Brain Meningiomas;65;M;Patient is experiencing coordination problems and blurry vision for several weeks. The symptoms are described as low-grade in nature.;radiation therapy
brain_menin_0358;Brain Meningiomas;52;F;Patient is experiencing blurry vision and speech difficulty for several weeks. The symptoms are described as noticeable in nature.;surgery
brain_menin_0359;Brain Meningiomas;21;F;Patient is experiencing chronic headaches and blurry vision over the past month. The symptoms are described as significant in nature.;radiation therapy
brain_menin_0360;Brain Meningiomas;29;M;Patient is experiencing blurry vision and fatigue over the past month. The symptoms are described as significant in nature.;surgery
brain_menin_0361;Brain Meningiomas;18;M;Patient is experiencing chronic headaches and fatigue for several weeks. The symptoms are described as slight in nature.;radiation therapy
brain_menin_0362;Brain Meningiomas;42;F;Patient is experiencing coordination problems and localized neurological weakness for nearly 3 months. The symptoms are described as tolerable in nature.;radiation therapy
brain_menin_0363;Brain Meningiomas;49;M;Patient is experiencing blurry vision and speech difficulty over the past month. The symptoms are described as moderate in nature.;surgery
brain_menin_0364;Brain Meningiomas;70;M;Patient is experiencing speech difficulty and localized neurological weakness for several weeks. The symptoms are described as low-grade in nature.;radiation therapy
brain_menin_0365;Brain Meningiomas;31;F;Patient is experiencing coordination problems and localized neurological weakness for several weeks. The symptoms are described as tolerable in nature.;surgery
brain_menin_0366;Brain Meningiomas;54;F;Patient is experiencing blurry vision and speech difficulty over the past month. The symptoms are described as moderate in nature.;close monitoring
brain_menin_0367;Brain Meningiomas;61;F;Patient is experiencing chronic headaches and fatigue for nearly 3 months. The symptoms are described as mild in nature.;radiation therapy
brain_menin_0368;Brain Meningiomas;32;F;Patient is experiencing coordination problems and speech difficulty for nearly 3 months. The symptoms are described as slight in nature.;close monitoring
brain_menin_0369;Brain Meningiomas;62;M;Patient is experiencing blurry vision and chronic headaches over the past month. The symptoms are described as mild in nature.;close monitoring
brain_menin_0370;Brain Meningiomas;66;F;Patient is experiencing blurry vision and localized neurological weakness for nearly 3 months. The symptoms are described as slight in nature.;close monitoring
brain_menin_0371;Brain Meningiomas;73;F;Patient is experiencing localized neurological weakness and speech difficulty for several weeks. The symptoms are described as significant in nature.;radiation therapy
brain_menin_0372;Brain Meningiomas;40;F;Patient is experiencing localized neurological weakness and blurry vision for nearly 3 months. The symptoms are described as low-grade in nature.;close monitoring
brain_menin_0373;Brain Meningiomas;55;M;Patient is experiencing chronic headaches and localized neurological weakness for nearly 3 months. The symptoms are described as low-grade in nature.;surgery
brain_menin_0374;Brain Meningiomas;77;M;Patient is experiencing speech difficulty and chronic headaches over the past month. The symptoms are described as mild in nature.;radiation therapy
brain_menin_0375;Brain Meningiomas;75;F;Patient is experiencing coordination problems and chronic headaches for several weeks. The symptoms are described as low-grade in nature.;close monitoring
brain_menin_0376;Brain Meningiomas;63;F;Patient is experiencing coordination problems and speech difficulty over the past month. The symptoms are described as mild in nature.;surgery
brain_menin_0377;Brain Meningiomas;70;M;Patient is experiencing coordination problems and speech difficulty for nearly 3 months. The symptoms are described as tolerable in nature.;radiation therapy
brain_menin_0378;Brain Meningiomas;54;F;Patient is experiencing coordination problems and chronic headaches for nearly 3 months. The symptoms are described as tolerable in nature.;surgery
brain_menin_0379;Brain Meningiomas;62;F;Patient is experiencing fatigue and coordination problems for nearly 3 months. The symptoms are described as mild in nature.;surgery
brain_menin_0380;Brain Meningiomas;49;F;Patient is experiencing chronic headaches and localized neurological weakness for nearly 3 months. The symptoms are described as slight in nature.;close monitoring
brain_menin_0381;Brain Meningiomas;83;F;Patient is experiencing blurry vision and chronic headaches for nearly 3 months. The symptoms are described as slight in nature.;surgery
brain_menin_0382;Brain Meningiomas;65;M;Patient is experiencing localized neurological weakness and fatigue for nearly 3 months. The symptoms are described as noticeable in nature.;close monitoring
brain_menin_0383;Brain Meningiomas;47;F;Patient is experiencing chronic headaches and coordination problems for nearly 3 months. The symptoms are described as moderate in nature.;radiation therapy
brain_menin_0384;Brain Meningiomas;38;F;Patient is experiencing localized neurological weakness and chronic headaches for nearly 3 months. The symptoms are described as low-grade in nature.;close monitoring
brain_menin_0385;Brain Meningiomas;63;M;Patient is experiencing speech difficulty and chronic headaches for several weeks. The symptoms are described as significant in nature.;radiation therapy
brain_menin_0386;Brain Meningiomas;58;M;Patient is experiencing speech difficulty and coordination problems over the past month. The symptoms are described as mild in nature.;close monitoring
brain_menin_0387;Brain Meningiomas;21;F;Patient is experiencing speech difficulty and coordination problems over the past month. The symptoms are described as significant in nature.;close monitoring
brain_menin_0388;Brain Meningiomas;70;F;Patient is experiencing speech difficulty and chronic headaches for several weeks. The symptoms are described as slight in nature.;close monitoring
brain_menin_0389;Brain Meningiomas;64;F;Patient is experiencing chronic headaches and coordination problems for nearly 3 months. The symptoms are described as tolerable in nature.;radiation therapy
brain_menin_0390;Brain Meningiomas;42;F;Patient is experiencing blurry vision and speech difficulty for nearly 3 months. The symptoms are described as significant in nature.;close monitoring
brain_menin_0391;Brain Meningiomas;24;M;Patient is experiencing blurry vision and speech difficulty for several weeks. The symptoms are described as significant in nature.;close monitoring
brain_menin_0392;Brain Meningiomas;77;M;Patient is experiencing fatigue and speech difficulty for nearly 3 months. The symptoms are described as low-grade in nature.;close monitoring
brain_menin_0393;Brain Meningiomas;54;M;Patient is experiencing localized neurological weakness and coordination problems over the past month. The symptoms are described as noticeable in nature.;surgery
brain_menin_0394;Brain Meningiomas;41;M;Patient is experiencing speech difficulty and blurry vision for several weeks. The symptoms are described as moderate in nature.;radiation therapy
brain_menin_0395;Brain Meningiomas;67;F;Patient is experiencing fatigue and blurry vision for nearly 3 months. The symptoms are described as noticeable in nature.;radiation therapy
brain_menin_0396;Brain Meningiomas;30;M;Patient is experiencing blurry vision and chronic headaches for several weeks. The symptoms are described as mild in nature.;radiation therapy
brain_menin_0397;Brain Meningiomas;77;M;Patient is experiencing fatigue and speech difficulty for nearly 3 months. The symptoms are described as low-grade in nature.;surgery
brain_menin_0398;Brain Meningiomas;53;F;Patient is experiencing coordination problems and fatigue for nearly 3 months. The symptoms are described as tolerable in nature.;surgery
brain_menin_0399;Brain Meningiomas;36;F;Patient is experiencing localized neurological weakness and coordination problems for nearly 3 months. The symptoms are described as moderate in nature.;surgery
brain_menin_0400;Brain Meningiomas;65;M;Patient is experiencing chronic headaches and speech difficulty for nearly 3 months. The symptoms are described as noticeable in nature.;radiation therapy
brain_menin_0401;Brain Meningiomas;28;F;Patient is experiencing localized neurological weakness and speech difficulty over the past month. The symptoms are described as significant in nature.;surgery
brain_menin_0402;Brain Meningiomas;51;M;Patient is experiencing chronic headaches and coordination problems for several weeks. The symptoms are described as noticeable in nature.;radiation therapy
brain_menin_0403;Brain Meningiomas;71;F;Patient is experiencing fatigue and speech difficulty for several weeks. The symptoms are described as moderate in nature.;radiation therapy
brain_menin_0404;Brain Meningiomas;69;M;Patient is experiencing coordination problems and localized neurological weakness over the past month. The symptoms are described as noticeable in nature.;close monitoring
brain_menin_0405;Brain Meningiomas;19;F;Patient is experiencing localized neurological weakness and blurry vision for nearly 3 months. The symptoms are described as significant in nature.;close monitoring
brain_menin_0406;Brain Meningiomas;68;F;Patient is experiencing localized neurological weakness and fatigue over the past month. The symptoms are described as tolerable in nature.;radiation therapy
brain_menin_0407;Brain Meningiomas;45;M;Patient is experiencing localized neurological weakness and chronic headaches for nearly 3 months. The symptoms are described as mild in nature.;radiation therapy
brain_menin_0408;Brain Meningiomas;37;F;Patient is experiencing fatigue and localized neurological weakness for several weeks. The symptoms are described as tolerable in nature.;surgery
brain_menin_0409;Brain Meningiomas;38;M;Patient is experiencing blurry vision and speech difficulty for nearly 3 months. The symptoms are described as noticeable in nature.;surgery
brain_menin_0410;Brain Meningiomas;45;M;Patient is experiencing chronic headaches and coordination problems for nearly 3 months. The symptoms are described as slight in nature.;surgery
brain_menin_0411;Brain Meningiomas;57;M;Patient is experiencing coordination problems and speech difficulty for nearly 3 months. The symptoms are described as low-grade in nature.;close monitoring
brain_menin_0412;Brain Meningiomas;56;F;Patient is experiencing localized neurological weakness and fatigue for several weeks. The symptoms are described as moderate in nature.;radiation therapy
brain_menin_0413;Brain Meningiomas;55;F;Patient is experiencing fatigue and coordination problems over the past month. The symptoms are described as tolerable in nature.;surgery
brain_menin_0414;Brain Meningiomas;43;F;Patient is experiencing chronic headaches and blurry vision over the past month. The symptoms are described as significant in nature.;surgery
brain_menin_0415;Brain Meningiomas;26;F;Patient is experiencing localized neurological weakness and fatigue for nearly 3 months. The symptoms are described as tolerable in nature.;surgery
brain_menin_0416;Brain Meningiomas;18;M;Patient is experiencing localized neurological weakness and blurry vision for nearly 3 months. The symptoms are described as tolerable in nature.;radiation therapy
brain_menin_0417;Brain Meningiomas;39;M;Patient is experiencing blurry vision and localized neurological weakness for nearly 3 months. The symptoms are described as tolerable in nature.;surgery
brain_menin_0418;Brain Meningiomas;67;M;Patient is experiencing localized neurological weakness and blurry vision over the past month. The symptoms are described as low-grade in nature.;surgery
brain_menin_0419;Brain Meningiomas;22;M;Patient is experiencing localized neurological weakness and coordination problems for nearly 3 months. The symptoms are described as significant in nature.;radiation therapy
brain_menin_0420;Brain Meningiomas;62;M;Patient is experiencing blurry vision and speech difficulty over the past month. The symptoms are described as mild in nature.;close monitoring
brain_menin_0421;Brain Meningiomas;50;M;Patient is experiencing coordination problems and speech difficulty for several weeks. The symptoms are described as noticeable in nature.;close monitoring
brain_menin_0422;Brain Meningiomas;43;M;Patient is experiencing localized neurological weakness and blurry vision for several weeks. The symptoms are described as noticeable in nature.;surgery
brain_menin_0423;Brain Meningiomas;66;M;Patient is experiencing coordination problems and localized neurological weakness over the past month. The symptoms are described as significant in nature.;radiation therapy
brain_menin_0424;Brain Meningiomas;73;F;Patient is experiencing localized neurological weakness and chronic headaches for several weeks. The symptoms are described as significant in nature.;close monitoring
brain_menin_0425;Brain Meningiomas;26;F;Patient is experiencing chronic headaches and localized neurological weakness for nearly 3 months. The symptoms are described as slight in nature.;radiation therapy
brain_menin_0426;Brain Meningiomas;58;F;Patient is experiencing fatigue and blurry vision over the past month. The symptoms are described as low-grade in nature.;radiation therapy
brain_menin_0427;Brain Meningiomas;84;M;Patient is experiencing localized neurological weakness and coordination problems for several weeks. The symptoms are described as significant in nature.;surgery
brain_menin_0428;Brain Meningiomas;43;M;Patient is experiencing localized neurological weakness and blurry vision for nearly 3 months. The symptoms are described as significant in nature.;radiation therapy
brain_menin_0429;Brain Meningiomas;62;F;Patient is experiencing chronic headaches and speech difficulty for nearly 3 months. The symptoms are described as low-grade in nature.;surgery
brain_menin_0430;Brain Meningiomas;82;F;Patient is experiencing coordination problems and blurry vision for nearly 3 months. The symptoms are described as noticeable in nature.;radiation therapy
brain_menin_0431;Brain Meningiomas;44;F;Patient is experiencing blurry vision and localized neurological weakness for several weeks. The symptoms are described as slight in nature.;surgery
brain_menin_0432;Brain Meningiomas;81;F;Patient is experiencing coordination problems and localized neurological weakness for nearly 3 months. The symptoms are described as slight in nature.;radiation therapy
brain_menin_0433;Brain Meningiomas;54;F;Patient is experiencing speech difficulty and localized neurological weakness for nearly 3 months. The symptoms are described as significant in nature.;radiation therapy
brain_menin_0434;Brain Meningiomas;75;F;Patient is experiencing chronic headaches and speech difficulty for nearly 3 months. The symptoms are described as moderate in nature.;surgery
brain_menin_0435;Brain Meningiomas;79;M;Patient is experiencing fatigue and speech difficulty over the past month. The symptoms are described as significant in nature.;close monitoring
brain_menin_0436;Brain Meningiomas;76;F;Patient is experiencing coordination problems and speech difficulty for several weeks. The symptoms are described as noticeable in nature.;radiation therapy
brain_menin_0437;Brain Meningiomas;50;M;Patient is experiencing speech difficulty and chronic headaches for nearly 3 months. The symptoms are described as slight in nature.;close monitoring
brain_menin_0438;Brain Meningiomas;35;M;Patient is experiencing speech difficulty and blurry vision for nearly 3 months. The symptoms are described as slight in nature.;radiation therapy
brain_menin_0439;Brain Meningiomas;51;F;Patient is experiencing blurry vision and speech difficulty for several weeks. The symptoms are described as slight in nature.;close monitoring
brain_menin_0440;Brain Meningiomas;26;M;Patient is experiencing fatigue and chronic headaches over the past month. The symptoms are described as moderate in nature.;radiation therapy
brain_menin_0441;Brain Meningiomas;40;F;Patient is experiencing blurry vision and coordination problems for several weeks. The symptoms are described as noticeable in nature.;surgery
brain_menin_0442;Brain Meningiomas;64;F;Patient is experiencing blurry vision and coordination problems for nearly 3 months. The symptoms are described as moderate in nature.;surgery
brain_menin_0443;Brain Meningiomas;80;F;Patient is experiencing speech difficulty and localized neurological weakness for nearly 3 months. The symptoms are described as low-grade in nature.;surgery
brain_menin_0444;Brain Meningiomas;52;M;Patient is experiencing chronic headaches and fatigue for nearly 3 months. The symptoms are described as low-grade in nature.;close monitoring
brain_menin_0445;Brain Meningiomas;71;M;Patient is experiencing chronic headaches and localized neurological weakness over the past month. The symptoms are described as noticeable in nature.;surgery
brain_menin_0446;Brain Meningiomas;56;F;Patient is experiencing fatigue and chronic headaches over the past month. The symptoms are described as moderate in nature.;radiation therapy
brain_menin_0447;Brain Meningiomas;49;M;Patient is experiencing localized neurological weakness and fatigue over the past month. The symptoms are described as tolerable in nature.;close monitoring
brain_menin_0448;Brain Meningiomas;44;F;Patient is experiencing fatigue and chronic headaches for several weeks. The symptoms are described as moderate in nature.;radiation therapy
brain_menin_0449;Brain Meningiomas;29;M;Patient is experiencing chronic headaches and speech difficulty over the past month. The symptoms are described as significant in nature.;surgery
brain_menin_0450;Brain Meningiomas;65;M;Patient is experiencing coordination problems and fatigue for nearly 3 months. The symptoms are described as low-grade in nature.;radiation therapy
brain_menin_0451;Brain Meningiomas;53;F;Patient is experiencing blurry vision and speech difficulty for several weeks. The symptoms are described as significant in nature.;surgery
brain_menin_0452;Brain Meningiomas;53;M;Patient is experiencing speech difficulty and fatigue over the past month. The symptoms are described as moderate in nature.;close monitoring
brain_menin_0453;Brain Meningiomas;28;M;Patient is experiencing blurry vision and speech difficulty over the past month. The symptoms are described as significant in nature.;close monitoring
brain_menin_0454;Brain Meningiomas;61;M;Patient is experiencing blurry vision and speech difficulty for nearly 3 months. The symptoms are described as noticeable in nature.;radiation therapy
brain_menin_0455;Brain Meningiomas;57;F;Patient is experiencing chronic headaches and localized neurological weakness for nearly 3 months. The symptoms are described as noticeable in nature.;radiation therapy
brain_menin_0456;Brain Meningiomas;46;M;Patient is experiencing speech difficulty and blurry vision for several weeks. The symptoms are described as noticeable in nature.;radiation therapy
brain_menin_0457;Brain Meningiomas;46;F;Patient is experiencing blurry vision and chronic headaches for nearly 3 months. The symptoms are described as low-grade in nature.;radiation therapy
brain_menin_0458;Brain Meningiomas;34;F;Patient is experiencing coordination problems and localized neurological weakness for nearly 3 months. The symptoms are described as low-grade in nature.;radiation therapy
brain_menin_0459;Brain Meningiomas;62;M;Patient is experiencing fatigue and speech difficulty over the past month. The symptoms are described as moderate in nature.;radiation therapy
brain_menin_0460;Brain Meningiomas;62;M;Patient is experiencing fatigue and blurry vision for nearly 3 months. The symptoms are described as significant in nature.;surgery
brain_menin_0461;Brain Meningiomas;43;F;Patient is experiencing speech difficulty and coordination problems for nearly 3 months. The symptoms are described as significant in nature.;close monitoring
brain_menin_0462;Brain Meningiomas;79;F;Patient is experiencing speech difficulty and blurry vision over the past month. The symptoms are described as noticeable in nature.;radiation therapy
brain_menin_0463;Brain Meningiomas;77;F;Patient is experiencing speech difficulty and fatigue for nearly 3 months. The symptoms are described as noticeable in nature.;radiation therapy
brain_menin_0464;Brain Meningiomas;20;F;Patient is experiencing fatigue and speech difficulty over the past month. The symptoms are described as mild in nature.;close monitoring
brain_menin_0465;Brain Meningiomas;43;M;Patient is experiencing localized neurological weakness and fatigue for several weeks. The symptoms are described as mild in nature.;close monitoring
brain_menin_0466;Brain Meningiomas;54;F;Patient is experiencing localized neurological weakness and coordination problems for nearly 3 months. The symptoms are described as low-grade in nature.;radiation therapy
brain_menin_0467;Brain Meningiomas;76;M;Patient is experiencing chronic headaches and coordination problems for nearly 3 months. The symptoms are described as tolerable in nature.;radiation therapy
brain_menin_0468;Brain Meningiomas;21;M;Patient is experiencing chronic headaches and coordination problems over the past month. The symptoms are described as mild in nature.;radiation therapy
brain_menin_0469;Brain Meningiomas;61;F;Patient is experiencing fatigue and coordination problems for nearly 3 months. The symptoms are described as mild in nature.;surgery
brain_menin_0470;Brain Meningiomas;53;M;Patient is experiencing speech difficulty and coordination problems for nearly 3 months. The symptoms are described as low-grade in nature.;close monitoring
brain_menin_0471;Brain Meningiomas;54;F;Patient is experiencing localized neurological weakness and speech difficulty for nearly 3 months. The symptoms are described as low-grade in nature.;radiation therapy
brain_menin_0472;Brain Meningiomas;41;F;Patient is experiencing localized neurological weakness and speech difficulty for several weeks. The symptoms are described as slight in nature.;close monitoring
brain_menin_0473;Brain Meningiomas;51;F;Patient is experiencing coordination problems and chronic headaches over the past month. The symptoms are described as tolerable in nature.;close monitoring
brain_menin_0474;Brain Meningiomas;53;F;Patient is experiencing chronic headaches and localized neurological weakness for several weeks. The symptoms are described as noticeable in nature.;close monitoring
brain_menin_0475;Brain Meningiomas;50;F;Patient is experiencing localized neurological weakness and blurry vision for nearly 3 months. The symptoms are described as moderate in nature.;radiation therapy
brain_menin_0476;Brain Meningiomas;30;M;Patient is experiencing chronic headaches and coordination problems for nearly 3 months. The symptoms are described as significant in nature.;close monitoring
brain_menin_0477;Brain Meningiomas;18;M;Patient is experiencing localized neurological weakness and blurry vision over the past month. The symptoms are described as significant in nature.;close monitoring
brain_menin_0478;Brain Meningiomas;47;M;Patient is experiencing fatigue and localized neurological weakness for several weeks. The symptoms are described as significant in nature.;radiation therapy
brain_menin_0479;Brain Meningiomas;27;M;Patient is experiencing chronic headaches and blurry vision for several weeks. The symptoms are described as noticeable in nature.;radiation therapy
brain_menin_0480;Brain Meningiomas;20;M;Patient is experiencing blurry vision and localized neurological weakness for nearly 3 months. The symptoms are described as slight in nature.;radiation therapy
brain_menin_0481;Brain Meningiomas;82;M;Patient is experiencing blurry vision and localized neurological weakness for several weeks. The symptoms are described as tolerable in nature.;radiation therapy
brain_menin_0482;Brain Meningiomas;39;M;Patient is experiencing coordination problems and localized neurological weakness over the past month. The symptoms are described as slight in nature.;close monitoring
brain_menin_0483;Brain Meningiomas;46;F;Patient is experiencing fatigue and coordination problems over the past month. The symptoms are described as significant in nature.;close monitoring
brain_menin_0484;Brain Meningiomas;73;F;Patient is experiencing fatigue and coordination problems for nearly 3 months. The symptoms are described as tolerable in nature.;radiation therapy
brain_menin_0485;Brain Meningiomas;52;M;Patient is experiencing fatigue and coordination problems for several weeks. The symptoms are described as slight in nature.;radiation therapy
brain_menin_0486;Brain Meningiomas;71;F;Patient is experiencing chronic headaches and localized neurological weakness for several weeks. The symptoms are described as tolerable in nature.;close monitoring
brain_menin_0487;Brain Meningiomas;62;M;Patient is experiencing blurry vision and coordination problems for several weeks. The symptoms are described as significant in nature.;radiation therapy
brain_menin_0488;Brain Meningiomas;45;F;Patient is experiencing blurry vision and speech difficulty for nearly 3 months. The symptoms are described as tolerable in nature.;surgery
brain_menin_0489;Brain Meningiomas;21;F;Patient is experiencing coordination problems and fatigue for several weeks. The symptoms are described as tolerable in nature.;close monitoring
brain_menin_0490;Brain Meningiomas;78;F;Patient is experiencing fatigue and coordination problems over the past month. The symptoms are described as significant in nature.;close monitoring
brain_menin_0491;Brain Meningiomas;28;F;Patient is experiencing speech difficulty and blurry vision over the past month. The symptoms are described as moderate in nature.;surgery
brain_menin_0492;Brain Meningiomas;77;M;Patient is experiencing coordination problems and blurry vision for several weeks. The symptoms are described as significant in nature.;radiation therapy
brain_menin_0493;Brain Meningiomas;51;F;Patient is experiencing fatigue and blurry vision for several weeks. The symptoms are described as significant in nature.;surgery
brain_menin_0494;Brain Meningiomas;45;M;Patient is experiencing coordination problems and blurry vision over the past month. The symptoms are described as tolerable in nature.;surgery
brain_menin_0495;Brain Meningiomas;61;F;Patient is experiencing speech difficulty and localized neurological weakness for several weeks. The symptoms are described as noticeable in nature.;radiation therapy
brain_menin_0496;Brain Meningiomas;77;F;Patient is experiencing coordination problems and fatigue for nearly 3 months. The symptoms are described as slight in nature.;close monitoring
brain_menin_0497;Brain Meningiomas;78;F;Patient is experiencing localized neurological weakness and speech difficulty over the past month. The symptoms are described as noticeable in nature.;surgery
brain_menin_0498;Brain Meningiomas;77;M;Patient is experiencing speech difficulty and fatigue for several weeks. The symptoms are described as significant in nature.;radiation therapy
brain_menin_0499;Brain Meningiomas;28;M;Patient is experiencing speech difficulty and fatigue for nearly 3 months. The symptoms are described as significant in nature.;surgery
brain_menin_0500;Brain Meningiomas;37;M;Patient is experiencing blurry vision and speech difficulty for several weeks. The symptoms are described as moderate in nature.;surgery
brain_menin_0501;Brain Meningiomas;26;M;Patient is experiencing blurry vision and speech difficulty for nearly 3 months. The symptoms are described as noticeable in nature.;close monitoring
brain_menin_0502;Brain Meningiomas;34;F;Patient is experiencing localized neurological weakness and fatigue for several weeks. The symptoms are described as low-grade in nature.;radiation therapy
brain_menin_0503;Brain Meningiomas;39;M;Patient is experiencing blurry vision and fatigue for several weeks. The symptoms are described as moderate in nature.;close monitoring
brain_menin_0504;Brain Meningiomas;55;F;Patient is experiencing speech difficulty and fatigue over the past month. The symptoms are described as mild in nature.;surgery
brain_menin_0505;Brain Meningiomas;45;M;Patient is experiencing speech difficulty and coordination problems over the past month. The symptoms are described as noticeable in nature.;radiation therapy
brain_menin_0506;Brain Meningiomas;38;M;Patient is experiencing localized neurological weakness and speech difficulty for several weeks. The symptoms are described as moderate in nature.;radiation therapy
brain_menin_0507;Brain Meningiomas;25;M;Patient is experiencing localized neurological weakness and fatigue for nearly 3 months. The symptoms are described as tolerable in nature.;surgery
brain_menin_0508;Brain Meningiomas;30;F;Patient is experiencing speech difficulty and coordination problems for nearly 3 months. The symptoms are described as slight in nature.;close monitoring
brain_menin_0509;Brain Meningiomas;29;F;Patient is experiencing localized neurological weakness and chronic headaches over the past month. The symptoms are described as slight in nature.;surgery
brain_menin_0510;Brain Meningiomas;79;M;Patient is experiencing speech difficulty and blurry vision over the past month. The symptoms are described as tolerable in nature.;surgery
brain_menin_0511;Brain Meningiomas;35;F;Patient is experiencing blurry vision and coordination problems over the past month. The symptoms are described as noticeable in nature.;close monitoring
brain_menin_0512;Brain Meningiomas;74;F;Patient is experiencing coordination problems and blurry vision for several weeks. The symptoms are described as low-grade in nature.;radiation therapy
brain_menin_0513;Brain Meningiomas;71;F;Patient is experiencing speech difficulty and localized neurological weakness over the past month. The symptoms are described as significant in nature.;close monitoring
brain_menin_0514;Brain Meningiomas;59;M;Patient is experiencing coordination problems and speech difficulty for nearly 3 months. The symptoms are described as tolerable in nature.;surgery
brain_menin_0515;Brain Meningiomas;27;M;Patient is experiencing blurry vision and localized neurological weakness for nearly 3 months. The symptoms are described as moderate in nature.;close monitoring
brain_menin_0516;Brain Meningiomas;18;M;Patient is experiencing speech difficulty and fatigue for several weeks. The symptoms are described as significant in nature.;close monitoring
brain_menin_0517;Brain Meningiomas;58;F;Patient is experiencing blurry vision and chronic headaches for nearly 3 months. The symptoms are described as slight in nature.;surgery
brain_menin_0518;Brain Meningiomas;51;M;Patient is experiencing chronic headaches and coordination problems over the past month. The symptoms are described as low-grade in nature.;radiation therapy
brain_menin_0519;Brain Meningiomas;59;F;Patient is experiencing fatigue and speech difficulty for nearly 3 months. The symptoms are described as low-grade in nature.;radiation therapy
brain_menin_0520;Brain Meningiomas;57;F;Patient is experiencing coordination problems and blurry vision over the past month. The symptoms are described as slight in nature.;surgery
brain_menin_0521;Brain Meningiomas;72;F;Patient is experiencing localized neurological weakness and blurry vision for nearly 3 months. The symptoms are described as moderate in nature.;radiation therapy
brain_menin_0522;Brain Meningiomas;59;F;Patient is experiencing localized neurological weakness and coordination problems for nearly 3 months. The symptoms are described as noticeable in nature.;radiation therapy
brain_menin_0523;Brain Meningiomas;24;M;Patient is experiencing coordination problems and blurry vision for nearly 3 months. The symptoms are described as significant in nature.;close monitoring
brain_menin_0524;Brain Meningiomas;82;M;Patient is experiencing fatigue and coordination problems for several weeks. The symptoms are described as tolerable in nature.;radiation therapy
brain_menin_0525;Brain Meningiomas;54;M;Patient is experiencing coordination problems and fatigue for nearly 3 months. The symptoms are described as moderate in nature.;close monitoring
brain_menin_0526;Brain Meningiomas;51;F;Patient is experiencing chronic headaches and speech difficulty for several weeks. The symptoms are described as low-grade in nature.;surgery
brain_menin_0527;Brain Meningiomas;84;F;Patient is experiencing speech difficulty and coordination problems over the past month. The symptoms are described as significant in nature.;close monitoring
brain_menin_0528;Brain Meningiomas;81;M;Patient is experiencing speech difficulty and coordination problems over the past month. The symptoms are described as mild in nature.;radiation therapy
brain_menin_0529;Brain Meningiomas;84;M;Patient is experiencing coordination problems and blurry vision for several weeks. The symptoms are described as moderate in nature.;radiation therapy
brain_menin_0530;Brain Meningiomas;47;F;Patient is experiencing localized neurological weakness and speech difficulty for several weeks. The symptoms are described as tolerable in nature.;close monitoring
brain_menin_0531;Brain Meningiomas;55;F;Patient is experiencing fatigue and blurry vision for several weeks. The symptoms are described as low-grade in nature.;radiation therapy
brain_menin_0532;Brain Meningiomas;74;F;Patient is experiencing speech difficulty and localized neurological weakness over the past month. The symptoms are described as significant in nature.;close monitoring
brain_menin_0533;Brain Meningiomas;26;F;Patient is experiencing fatigue and localized neurological weakness for several weeks. The symptoms are described as significant in nature.;surgery
brain_menin_0534;Brain Meningiomas;33;M;Patient is experiencing speech difficulty and chronic headaches for several weeks. The symptoms are described as significant in nature.;close monitoring
brain_menin_0535;Brain Meningiomas;19;M;Patient is experiencing localized neurological weakness and coordination problems for several weeks. The symptoms are described as tolerable in nature.;radiation therapy
brain_menin_0536;Brain Meningiomas;33;M;Patient is experiencing chronic headaches and coordination problems for several weeks. The symptoms are described as low-grade in nature.;close monitoring
brain_menin_0537;Brain Meningiomas;45;M;Patient is experiencing chronic headaches and localized neurological weakness for nearly 3 months. The symptoms are described as tolerable in nature.;surgery
brain_menin_0538;Brain Meningiomas;77;F;Patient is experiencing blurry vision and chronic headaches for several weeks. The symptoms are described as noticeable in nature.;radiation therapy
brain_menin_0539;Brain Meningiomas;47;F;Patient is experiencing blurry vision and coordination problems for several weeks. The symptoms are described as moderate in nature.;radiation therapy
brain_menin_0540;Brain Meningiomas;21;F;Patient is experiencing blurry vision and localized neurological weakness for nearly 3 months. The symptoms are described as significant in nature.;radiation therapy
brain_menin_0541;Brain Meningiomas;55;M;Patient is experiencing localized neurological weakness and fatigue for nearly 3 months. The symptoms are described as significant in nature.;close monitoring
brain_menin_0542;Brain Meningiomas;58;M;Patient is experiencing fatigue and coordination problems over the past month. The symptoms are described as significant in nature.;radiation therapy
brain_menin_0543;Brain Meningiomas;61;M;Patient is experiencing localized neurological weakness and fatigue for several weeks. The symptoms are described as moderate in nature.;surgery
brain_menin_0544;Brain Meningiomas;44;M;Patient is experiencing fatigue and blurry vision for nearly 3 months. The symptoms are described as noticeable in nature.;close monitoring
brain_menin_0545;Brain Meningiomas;40;M;Patient is experiencing speech difficulty and localized neurological weakness for nearly 3 months. The symptoms are described as moderate in nature.;radiation therapy
brain_menin_0546;Brain Meningiomas;28;M;Patient is experiencing coordination problems and speech difficulty for nearly 3 months. The symptoms are described as moderate in nature.;surgery
brain_menin_0547;Brain Meningiomas;77;M;Patient is experiencing speech difficulty and coordination problems for nearly 3 months. The symptoms are described as slight in nature.;close monitoring
brain_menin_0548;Brain Meningiomas;54;M;Patient is experiencing localized neurological weakness and blurry vision for several weeks. The symptoms are described as significant in nature.;surgery
brain_menin_0549;Brain Meningiomas;55;M;Patient is experiencing chronic headaches and fatigue over the past month. The symptoms are described as moderate in nature.;surgery
brain_menin_0550;Brain Meningiomas;79;M;Patient is experiencing speech difficulty and localized neurological weakness over the past month. The symptoms are described as tolerable in nature.;radiation therapy
brain_menin_0551;Brain Meningiomas;85;F;Patient is experiencing localized neurological weakness and speech difficulty for several weeks. The symptoms are described as noticeable in nature.;surgery
brain_menin_0552;Brain Meningiomas;62;M;Patient is experiencing localized neurological weakness and blurry vision for several weeks. The symptoms are described as mild in nature.;radiation therapy
brain_menin_0553;Brain Meningiomas;70;F;Patient is experiencing coordination problems and localized neurological weakness over the past month. The symptoms are described as noticeable in nature.;radiation therapy
brain_menin_0554;Brain Meningiomas;36;F;Patient is experiencing chronic headaches and speech difficulty for several weeks. The symptoms are described as significant in nature.;surgery
brain_menin_0555;Brain Meningiomas;24;F;Patient is experiencing coordination problems and chronic headaches for nearly 3 months. The symptoms are described as tolerable in nature.;surgery
brain_menin_0556;Brain Meningiomas;29;F;Patient is experiencing blurry vision and chronic headaches over the past month. The symptoms are described as moderate in nature.;close monitoring
brain_menin_0557;Brain Meningiomas;65;F;Patient is experiencing fatigue and localized neurological weakness over the past month. The symptoms are described as moderate in nature.;surgery
brain_menin_0558;Brain Meningiomas;83;M;Patient is experiencing fatigue and speech difficulty over the past month. The symptoms are described as mild in nature.;surgery
brain_menin_0559;Brain Meningiomas;41;M;Patient is experiencing blurry vision and speech difficulty over the past month. The symptoms are described as significant in nature.;surgery
brain_menin_0560;Brain Meningiomas;35;M;Patient is experiencing speech difficulty and chronic headaches for several weeks. The symptoms are described as tolerable in nature.;surgery
brain_menin_0561;Brain Meningiomas;55;F;Patient is experiencing coordination problems and localized neurological weakness for nearly 3 months. The symptoms are described as moderate in nature.;close monitoring
brain_menin_0562;Brain Meningiomas;27;M;Patient is experiencing fatigue and speech difficulty for nearly 3 months. The symptoms are described as low-grade in nature.;close monitoring
brain_menin_0563;Brain Meningiomas;81;M;Patient is experiencing fatigue and blurry vision for nearly 3 months. The symptoms are described as significant in nature.;surgery
brain_menin_0564;Brain Meningiomas;80;M;Patient is experiencing coordination problems and speech difficulty for nearly 3 months. The symptoms are described as tolerable in nature.;close monitoring
brain_menin_0565;Brain Meningiomas;66;F;Patient is experiencing localized neurological weakness and coordination problems over the past month. The symptoms are described as moderate in nature.;close monitoring
brain_menin_0566;Brain Meningiomas;44;F;Patient is experiencing coordination problems and chronic headaches for nearly 3 months. The symptoms are described as noticeable in nature.;radiation therapy
brain_menin_0567;Brain Meningiomas;67;M;Patient is experiencing blurry vision and localized neurological weakness for several weeks. The symptoms are described as slight in nature.;radiation therapy
brain_menin_0568;Brain Meningiomas;81;M;Patient is experiencing speech difficulty and coordination problems over the past month. The symptoms are described as moderate in nature.;close monitoring
brain_menin_0569;Brain Meningiomas;28;M;Patient is experiencing blurry vision and chronic headaches for nearly 3 months. The symptoms are described as noticeable in nature.;close monitoring
brain_menin_0570;Brain Meningiomas;66;F;Patient is experiencing coordination problems and localized neurological weakness for nearly 3 months. The symptoms are described as mild in nature.;close monitoring
brain_menin_0571;Brain Meningiomas;28;F;Patient is experiencing chronic headaches and localized neurological weakness for nearly 3 months. The symptoms are described as significant in nature.;radiation therapy
brain_menin_0572;Brain Meningiomas;24;F;Patient is experiencing fatigue and blurry vision for nearly 3 months. The symptoms are described as slight in nature.;close monitoring
brain_menin_0573;Brain Meningiomas;32;M;Patient is experiencing blurry vision and localized neurological weakness over the past month. The symptoms are described as moderate in nature.;surgery
brain_menin_0574;Brain Meningiomas;58;F;Patient is experiencing chronic headaches and blurry vision for several weeks. The symptoms are described as moderate in nature.;radiation therapy
brain_menin_0575;Brain Meningiomas;84;F;Patient is experiencing coordination problems and blurry vision over the past month. The symptoms are described as slight in nature.;close monitoring
brain_menin_0576;Brain Meningiomas;62;F;Patient is experiencing blurry vision and chronic headaches for nearly 3 months. The symptoms are described as slight in nature.;surgery
brain_menin_0577;Brain Meningiomas;22;M;Patient is experiencing localized neurological weakness and speech difficulty for nearly 3 months. The symptoms are described as mild in nature.;close monitoring
brain_menin_0578;Brain Meningiomas;23;F;Patient is experiencing coordination problems and localized neurological weakness for nearly 3 months. The symptoms are described as low-grade in nature.;radiation therapy
brain_menin_0579;Brain Meningiomas;60;F;Patient is experiencing localized neurological weakness and blurry vision for nearly 3 months. The symptoms are described as significant in nature.;surgery
brain_menin_0580;Brain Meningiomas;71;F;Patient is experiencing localized neurological weakness and fatigue for several weeks. The symptoms are described as low-grade in nature.;surgery
brain_menin_0581;Brain Meningiomas;59;F;Patient is experiencing localized neurological weakness and speech difficulty for nearly 3 months. The symptoms are described as tolerable in nature.;close monitoring
brain_menin_0582;Brain Meningiomas;56;M;Patient is experiencing fatigue and localized neurological weakness for several weeks. The symptoms are described as mild in nature.;radiation therapy
brain_menin_0583;Brain Meningiomas;50;F;Patient is experiencing chronic headaches and blurry vision over the past month. The symptoms are described as noticeable in nature.;surgery
brain_menin_0584;Brain Meningiomas;61;F;Patient is experiencing speech difficulty and blurry vision for several weeks. The symptoms are described as mild in nature.;surgery
brain_menin_0585;Brain Meningiomas;18;M;Patient is experiencing chronic headaches and fatigue over the past month. The symptoms are described as mild in nature.;surgery
brain_menin_0586;Brain Meningiomas;65;F;Patient is experiencing coordination problems and blurry vision over the past month. The symptoms are described as noticeable in nature.;close monitoring
brain_menin_0587;Brain Meningiomas;28;F;Patient is experiencing coordination problems and speech difficulty for several weeks. The symptoms are described as noticeable in nature.;radiation therapy
brain_menin_0588;Brain Meningiomas;22;F;Patient is experiencing coordination problems and fatigue for nearly 3 months. The symptoms are described as tolerable in nature.;radiation therapy
brain_menin_0589;Brain Meningiomas;36;M;Patient is experiencing blurry vision and localized neurological weakness for nearly 3 months. The symptoms are described as noticeable in nature.;surgery
brain_menin_0590;Brain Meningiomas;41;M;Patient is experiencing localized neurological weakness and blurry vision for nearly 3 months. The symptoms are described as noticeable in nature.;radiation therapy
brain_menin_0591;Brain Meningiomas;25;F;Patient is experiencing speech difficulty and blurry vision over the past month. The symptoms are described as slight in nature.;radiation therapy
brain_menin_0592;Brain Meningiomas;80;M;Patient is experiencing localized neurological weakness and chronic headaches for several weeks. The symptoms are described as low-grade in nature.;radiation therapy
brain_menin_0593;Brain Meningiomas;70;M;Patient is experiencing speech difficulty and localized neurological weakness over the past month. The symptoms are described as tolerable in nature.;radiation therapy
brain_menin_0594;Brain Meningiomas;78;M;Patient is experiencing chronic headaches and fatigue for several weeks. The symptoms are described as moderate in nature.;surgery
brain_menin_0595;Brain Meningiomas;55;F;Patient is experiencing coordination problems and speech difficulty over the past month. The symptoms are described as moderate in nature.;close monitoring
brain_menin_0596;Brain Meningiomas;82;M;Patient is experiencing speech difficulty and coordination problems over the past month. The symptoms are described as moderate in nature.;surgery
brain_menin_0597;Brain Meningiomas;41;F;Patient is experiencing speech difficulty and chronic headaches for several weeks. The symptoms are described as low-grade in nature.;surgery
brain_menin_0598;Brain Meningiomas;37;F;Patient is experiencing fatigue and speech difficulty for several weeks. The symptoms are described as slight in nature.;close monitoring
brain_menin_0599;Brain Meningiomas;79;F;Patient is experiencing blurry vision and chronic headaches over the past month. The symptoms are described as mild in nature.;surgery
brain_menin_0600;Brain Meningiomas;39;F;Patient is experiencing blurry vision and localized neurological weakness for several weeks. The symptoms are described as low-grade in nature.;radiation therapy
brain_menin_0601;Brain Meningiomas;56;F;Patient is experiencing chronic headaches and speech difficulty for several weeks. The symptoms are described as slight in nature.;radiation therapy
brain_menin_0602;Brain Meningiomas;85;F;Patient is experiencing blurry vision and chronic headaches for nearly 3 months. The symptoms are described as significant in nature.;surgery
brain_menin_0603;Brain Meningiomas;60;M;Patient is experiencing chronic headaches and coordination problems for several weeks. The symptoms are described as significant in nature.;surgery
brain_menin_0604;Brain Meningiomas;55;F;Patient is experiencing blurry vision and speech difficulty for several weeks. The symptoms are described as noticeable in nature.;radiation therapy
brain_menin_0605;Brain Meningiomas;65;M;Patient is experiencing speech difficulty and fatigue for nearly 3 months. The symptoms are described as mild in nature.;radiation therapy
brain_menin_0606;Brain Meningiomas;69;F;Patient is experiencing blurry vision and chronic headaches for several weeks. The symptoms are described as tolerable in nature.;radiation therapy
brain_menin_0607;Brain Meningiomas;58;M;Patient is experiencing blurry vision and fatigue for several weeks. The symptoms are described as significant in nature.;radiation therapy
brain_menin_0608;Brain Meningiomas;60;M;Patient is experiencing fatigue and chronic headaches over the past month. The symptoms are described as moderate in nature.;surgery
brain_menin_0609;Brain Meningiomas;19;M;Patient is experiencing fatigue and coordination problems for several weeks. The symptoms are described as slight in nature.;surgery
brain_menin_0610;Brain Meningiomas;82;F;Patient is experiencing localized neurological weakness and coordination problems over the past month. The symptoms are described as low-grade in nature.;radiation therapy
brain_menin_0611;Brain Meningiomas;19;F;Patient is experiencing chronic headaches and fatigue over the past month. The symptoms are described as mild in nature.;close monitoring
brain_menin_0612;Brain Meningiomas;50;M;Patient is experiencing blurry vision and chronic headaches for nearly 3 months. The symptoms are described as moderate in nature.;close monitoring
brain_menin_0613;Brain Meningiomas;70;F;Patient is experiencing speech difficulty and blurry vision for several weeks. The symptoms are described as significant in nature.;radiation therapy
brain_menin_0614;Brain Meningiomas;22;M;Patient is experiencing coordination problems and chronic headaches for several weeks. The symptoms are described as noticeable in nature.;close monitoring
brain_menin_0615;Brain Meningiomas;76;M;Patient is experiencing fatigue and speech difficulty for several weeks. The symptoms are described as slight in nature.;radiation therapy
brain_menin_0616;Brain Meningiomas;67;F;Patient is experiencing speech difficulty and chronic headaches over the past month. The symptoms are described as moderate in nature.;radiation therapy
brain_menin_0617;Brain Meningiomas;30;F;Patient is experiencing localized neurological weakness and blurry vision for nearly 3 months. The symptoms are described as tolerable in nature.;close monitoring
brain_menin_0618;Brain Meningiomas;34;F;Patient is experiencing blurry vision and chronic headaches for several weeks. The symptoms are described as moderate in nature.;radiation therapy
brain_menin_0619;Brain Meningiomas;45;M;Patient is experiencing localized neurological weakness and blurry vision for nearly 3 months. The symptoms are described as noticeable in nature.;close monitoring
brain_menin_0620;Brain Meningiomas;84;F;Patient is experiencing chronic headaches and speech difficulty over the past month. The symptoms are described as tolerable in nature.;radiation therapy
brain_menin_0621;Brain Meningiomas;56;F;Patient is experiencing chronic headaches and speech difficulty over the past month. The symptoms are described as mild in nature.;surgery
brain_menin_0622;Brain Meningiomas;42;F;Patient is experiencing blurry vision and chronic headaches for several weeks. The symptoms are described as low-grade in nature.;close monitoring
brain_menin_0623;Brain Meningiomas;58;F;Patient is experiencing fatigue and chronic headaches over the past month. The symptoms are described as significant in nature.;radiation therapy
brain_menin_0624;Brain Meningiomas;56;M;Patient is experiencing coordination problems and chronic headaches for several weeks. The symptoms are described as noticeable in nature.;close monitoring
brain_menin_0625;Brain Meningiomas;82;M;Patient is experiencing speech difficulty and chronic headaches for several weeks. The symptoms are described as mild in nature.;radiation therapy
brain_menin_0626;Brain Meningiomas;76;F;Patient is experiencing coordination problems and localized neurological weakness over the past month. The symptoms are described as slight in nature.;surgery
brain_menin_0627;Brain Meningiomas;63;F;Patient is experiencing localized neurological weakness and chronic headaches for nearly 3 months. The symptoms are described as significant in nature.;surgery
brain_menin_0628;Brain Meningiomas;58;F;Patient is experiencing blurry vision and speech difficulty for nearly 3 months. The symptoms are described as significant in nature.;close monitoring
brain_menin_0629;Brain Meningiomas;28;F;Patient is experiencing coordination problems and speech difficulty over the past month. The symptoms are described as mild in nature.;radiation therapy
brain_menin_0630;Brain Meningiomas;20;F;Patient is experiencing speech difficulty and fatigue for several weeks. The symptoms are described as noticeable in nature.;radiation therapy
brain_menin_0631;Brain Meningiomas;65;M;Patient is experiencing chronic headaches and blurry vision for nearly 3 months. The symptoms are described as mild in nature.;radiation therapy
brain_menin_0632;Brain Meningiomas;77;M;Patient is experiencing fatigue and blurry vision over the past month. The symptoms are described as moderate in nature.;surgery
brain_menin_0633;Brain Meningiomas;41;F;Patient is experiencing fatigue and speech difficulty for several weeks. The symptoms are described as mild in nature.;surgery
brain_menin_0634;Brain Meningiomas;57;F;Patient is experiencing speech difficulty and localized neurological weakness for several weeks. The symptoms are described as low-grade in nature.;close monitoring
brain_menin_0635;Brain Meningiomas;25;M;Patient is experiencing localized neurological weakness and coordination problems for several weeks. The symptoms are described as significant in nature.;surgery
brain_menin_0636;Brain Meningiomas;19;F;Patient is experiencing speech difficulty and localized neurological weakness for several weeks. The symptoms are described as noticeable in nature.;close monitoring
brain_menin_0637;Brain Meningiomas;61;M;Patient is experiencing chronic headaches and localized neurological weakness over the past month. The symptoms are described as noticeable in nature.;surgery
brain_menin_0638;Brain Meningiomas;66;M;Patient is experiencing chronic headaches and localized neurological weakness for nearly 3 months. The symptoms are described as noticeable in nature.;radiation therapy
brain_menin_0639;Brain Meningiomas;49;M;Patient is experiencing fatigue and speech difficulty over the past month. The symptoms are described as tolerable in nature.;surgery
brain_menin_0640;Brain Meningiomas;50;F;Patient is experiencing blurry vision and fatigue over the past month. The symptoms are described as significant in nature.;radiation therapy
brain_menin_0641;Brain Meningiomas;68;F;Patient is experiencing coordination problems and fatigue for nearly 3 months. The symptoms are described as mild in nature.;close monitoring
brain_menin_0642;Brain Meningiomas;43;M;Patient is experiencing speech difficulty and chronic headaches over the past month. The symptoms are described as significant in nature.;radiation therapy
brain_menin_0643;Brain Meningiomas;23;F;Patient is experiencing fatigue and blurry vision for several weeks. The symptoms are described as tolerable in nature.;surgery
brain_menin_0644;Brain Meningiomas;56;M;Patient is experiencing speech difficulty and localized neurological weakness for several weeks. The symptoms are described as significant in nature.;close monitoring
brain_menin_0645;Brain Meningiomas;51;M;Patient is experiencing fatigue and blurry vision for nearly 3 months. The symptoms are described as noticeable in nature.;close monitoring
brain_menin_0646;Brain Meningiomas;31;F;Patient is experiencing coordination problems and speech difficulty over the past month. The symptoms are described as significant in nature.;radiation therapy
brain_menin_0647;Brain Meningiomas;84;M;Patient is experiencing chronic headaches and blurry vision over the past month. The symptoms are described as moderate in nature.;surgery
brain_menin_0648;Brain Meningiomas;79;M;Patient is experiencing fatigue and localized neurological weakness for several weeks. The symptoms are described as moderate in nature.;close monitoring
brain_menin_0649;Brain Meningiomas;22;F;Patient is experiencing localized neurological weakness and blurry vision for nearly 3 months. The symptoms are described as tolerable in nature.;close monitoring
brain_menin_0650;Brain Meningiomas;37;F;Patient is experiencing localized neurological weakness and chronic headaches over the past month. The symptoms are described as tolerable in nature.;close monitoring
brain_menin_0651;Brain Meningiomas;76;M;Patient is experiencing blurry vision and speech difficulty for nearly 3 months. The symptoms are described as mild in nature.;surgery
brain_menin_0652;Brain Meningiomas;20;F;Patient is experiencing fatigue and chronic headaches for nearly 3 months. The symptoms are described as significant in nature.;close monitoring
brain_menin_0653;Brain Meningiomas;29;F;Patient is experiencing chronic headaches and coordination problems for nearly 3 months. The symptoms are described as noticeable in nature.;radiation therapy
brain_menin_0654;Brain Meningiomas;43;M;Patient is experiencing chronic headaches and speech difficulty for nearly 3 months. The symptoms are described as low-grade in nature.;close monitoring
brain_menin_0655;Brain Meningiomas;40;F;Patient is experiencing chronic headaches and blurry vision for nearly 3 months. The symptoms are described as significant in nature.;radiation therapy
brain_menin_0656;Brain Meningiomas;32;M;Patient is experiencing blurry vision and coordination problems over the past month. The symptoms are described as slight in nature.;surgery
brain_menin_0657;Brain Meningiomas;80;M;Patient is experiencing localized neurological weakness and coordination problems over the past month. The symptoms are described as significant in nature.;surgery
brain_menin_0658;Brain Meningiomas;55;F;Patient is experiencing blurry vision and localized neurological weakness for several weeks. The symptoms are described as noticeable in nature.;close monitoring
brain_menin_0659;Brain Meningiomas;82;M;Patient is experiencing localized neurological weakness and blurry vision over the past month. The symptoms are described as significant in nature.;surgery
brain_menin_0660;Brain Meningiomas;20;M;Patient is experiencing coordination problems and localized neurological weakness over the past month. The symptoms are described as significant in nature.;close monitoring
brain_menin_0661;Brain Meningiomas;20;F;Patient is experiencing chronic headaches and speech difficulty for several weeks. The symptoms are described as mild in nature.;surgery
brain_menin_0662;Brain Meningiomas;54;F;Patient is experiencing coordination problems and blurry vision for several weeks. The symptoms are described as noticeable in nature.;radiation therapy
brain_menin_0663;Brain Meningiomas;21;M;Patient is experiencing fatigue and localized neurological weakness over the past month. The symptoms are described as moderate in nature.;radiation therapy
brain_menin_0664;Brain Meningiomas;82;M;Patient is experiencing localized neurological weakness and coordination problems for several weeks. The symptoms are described as significant in nature.;surgery
brain_menin_0665;Brain Meningiomas;67;M;Patient is experiencing speech difficulty and coordination problems for several weeks. The symptoms are described as mild in nature.;surgery
brain_menin_0666;Brain Meningiomas;82;M;Patient is experiencing coordination problems and chronic headaches for nearly 3 months. The symptoms are described as moderate in nature.;close monitoring
brain_menin_0667;Brain Meningiomas;68;F;Patient is experiencing speech difficulty and localized neurological weakness over the past month. The symptoms are described as significant in nature.;surgery
brain_menin_0668;Brain Meningiomas;75;M;Patient is experiencing chronic headaches and coordination problems for several weeks. The symptoms are described as noticeable in nature.;surgery
brain_menin_0669;Brain Meningiomas;83;F;Patient is experiencing chronic headaches and speech difficulty for nearly 3 months. The symptoms are described as moderate in nature.;radiation therapy
brain_menin_0670;Brain Meningiomas;25;F;Patient is experiencing blurry vision and speech difficulty for nearly 3 months. The symptoms are described as tolerable in nature.;surgery
brain_menin_0671;Brain Meningiomas;69;F;Patient is experiencing localized neurological weakness and coordination problems for nearly 3 months. The symptoms are described as mild in nature.;surgery
brain_menin_0672;Brain Meningiomas;83;F;Patient is experiencing fatigue and localized neurological weakness over the past month. The symptoms are described as significant in nature.;close monitoring
brain_menin_0673;Brain Meningiomas;82;M;Patient is experiencing speech difficulty and fatigue for several weeks. The symptoms are described as tolerable in nature.;radiation therapy
brain_menin_0674;Brain Meningiomas;41;F;Patient is experiencing blurry vision and chronic headaches over the past month. The symptoms are described as significant in nature.;radiation therapy
brain_menin_0675;Brain Meningiomas;61;M;Patient is experiencing fatigue and coordination problems for several weeks. The symptoms are described as moderate in nature.;radiation therapy
brain_menin_0676;Brain Meningiomas;70;F;Patient is experiencing coordination problems and localized neurological weakness for nearly 3 months. The symptoms are described as moderate in nature.;surgery
brain_menin_0677;Brain Meningiomas;57;F;Patient is experiencing fatigue and chronic headaches for several weeks. The symptoms are described as tolerable in nature.;surgery
brain_menin_0678;Brain Meningiomas;82;M;Patient is experiencing speech difficulty and coordination problems for several weeks. The symptoms are described as mild in nature.;close monitoring
brain_menin_0679;Brain Meningiomas;54;M;Patient is experiencing fatigue and speech difficulty over the past month. The symptoms are described as noticeable in nature.;surgery
brain_menin_0680;Brain Meningiomas;36;M;Patient is experiencing speech difficulty and chronic headaches for nearly 3 months. The symptoms are described as low-grade in nature.;radiation therapy
brain_menin_0681;Brain Meningiomas;21;M;Patient is experiencing fatigue and localized neurological weakness over the past month. The symptoms are described as mild in nature.;radiation therapy
brain_menin_0682;Brain Meningiomas;48;M;Patient is experiencing blurry vision and speech difficulty over the past month. The symptoms are described as moderate in nature.;close monitoring
brain_menin_0683;Brain Meningiomas;47;F;Patient is experiencing coordination problems and speech difficulty for several weeks. The symptoms are described as mild in nature.;radiation therapy
brain_menin_0684;Brain Meningiomas;19;F;Patient is experiencing blurry vision and chronic headaches for nearly 3 months. The symptoms are described as significant in nature.;close monitoring
brain_menin_0685;Brain Meningiomas;82;M;Patient is experiencing coordination problems and blurry vision over the past month. The symptoms are described as significant in nature.;close monitoring
brain_menin_0686;Brain Meningiomas;65;M;Patient is experiencing coordination problems and chronic headaches over the past month. The symptoms are described as noticeable in nature.;radiation therapy
brain_menin_0687;Brain Meningiomas;49;F;Patient is experiencing fatigue and chronic headaches over the past month. The symptoms are described as noticeable in nature.;close monitoring
brain_menin_0688;Brain Meningiomas;85;F;Patient is experiencing coordination problems and localized neurological weakness for several weeks. The symptoms are described as slight in nature.;surgery
brain_menin_0689;Brain Meningiomas;39;F;Patient is experiencing blurry vision and chronic headaches for nearly 3 months. The symptoms are described as mild in nature.;surgery
brain_menin_0690;Brain Meningiomas;35;M;Patient is experiencing coordination problems and speech difficulty over the past month. The symptoms are described as low-grade in nature.;surgery
brain_menin_0691;Brain Meningiomas;63;F;Patient is experiencing speech difficulty and chronic headaches for several weeks. The symptoms are described as slight in nature.;radiation therapy
brain_menin_0692;Brain Meningiomas;34;M;Patient is experiencing speech difficulty and blurry vision for several weeks. The symptoms are described as moderate in nature.;surgery
brain_menin_0693;Brain Meningiomas;45;M;Patient is experiencing blurry vision and localized neurological weakness for several weeks. The symptoms are described as low-grade in nature.;surgery
brain_menin_0694;Brain Meningiomas;18;M;Patient is experiencing blurry vision and localized neurological weakness for several weeks. The symptoms are described as slight in nature.;radiation therapy
brain_menin_0695;Brain Meningiomas;47;F;Patient is experiencing speech difficulty and blurry vision over the past month. The symptoms are described as slight in nature.;close monitoring
brain_menin_0696;Brain Meningiomas;73;M;Patient is experiencing speech difficulty and localized neurological weakness for nearly 3 months. The symptoms are described as tolerable in nature.;radiation therapy
brain_menin_0697;Brain Meningiomas;31;F;Patient is experiencing chronic headaches and blurry vision over the past month. The symptoms are described as low-grade in nature.;close monitoring
brain_menin_0698;Brain Meningiomas;70;M;Patient is experiencing fatigue and localized neurological weakness for nearly 3 months. The symptoms are described as tolerable in nature.;close monitoring
brain_menin_0699;Brain Meningiomas;43;F;Patient is experiencing speech difficulty and blurry vision over the past month. The symptoms are described as mild in nature.;surgery
brain_menin_0700;Brain Meningiomas;27;M;Patient is experiencing localized neurological weakness and speech difficulty for nearly 3 months. The symptoms are described as noticeable in nature.;radiation therapy
brain_menin_0701;Brain Meningiomas;42;F;Patient is experiencing fatigue and speech difficulty for several weeks. The symptoms are described as slight in nature.;surgery
brain_menin_0702;Brain Meningiomas;79;M;Patient is experiencing speech difficulty and blurry vision for several weeks. The symptoms are described as significant in nature.;radiation therapy
brain_menin_0703;Brain Meningiomas;31;F;Patient is experiencing chronic headaches and fatigue over the past month. The symptoms are described as noticeable in nature.;surgery
brain_menin_0704;Brain Meningiomas;83;F;Patient is experiencing blurry vision and fatigue over the past month. The symptoms are described as significant in nature.;radiation therapy
brain_menin_0705;Brain Meningiomas;50;M;Patient is experiencing coordination problems and speech difficulty for several weeks. The symptoms are described as moderate in nature.;radiation therapy
brain_menin_0706;Brain Meningiomas;54;F;Patient is experiencing chronic headaches and localized neurological weakness for nearly 3 months. The symptoms are described as moderate in nature.;surgery
brain_menin_0707;Brain Meningiomas;42;M;Patient is experiencing chronic headaches and speech difficulty for several weeks. The symptoms are described as noticeable in nature.;surgery
brain_menin_0708;Brain Meningiomas;67;M;Patient is experiencing fatigue and speech difficulty for nearly 3 months. The symptoms are described as significant in nature.;surgery
brain_menin_0709;Brain Meningiomas;67;F;Patient is experiencing speech difficulty and localized neurological weakness for nearly 3 months. The symptoms are described as tolerable in nature.;radiation therapy
brain_menin_0710;Brain Meningiomas;49;F;Patient is experiencing speech difficulty and coordination problems for nearly 3 months. The symptoms are described as mild in nature.;close monitoring
brain_menin_0711;Brain Meningiomas;82;M;Patient is experiencing speech difficulty and blurry vision over the past month. The symptoms are described as noticeable in nature.;close monitoring
brain_menin_0712;Brain Meningiomas;28;M;Patient is experiencing fatigue and blurry vision over the past month. The symptoms are described as significant in nature.;radiation therapy
brain_menin_0713;Brain Meningiomas;54;F;Patient is experiencing blurry vision and fatigue for nearly 3 months. The symptoms are described as mild in nature.;surgery
brain_menin_0714;Brain Meningiomas;79;M;Patient is experiencing localized neurological weakness and fatigue for several weeks. The symptoms are described as noticeable in nature.;surgery
brain_menin_0715;Brain Meningiomas;77;F;Patient is experiencing localized neurological weakness and blurry vision over the past month. The symptoms are described as tolerable in nature.;close monitoring
brain_menin_0716;Brain Meningiomas;36;F;Patient is experiencing chronic headaches and speech difficulty over the past month. The symptoms are described as mild in nature.;surgery
brain_menin_0717;Brain Meningiomas;42;F;Patient is experiencing fatigue and blurry vision for several weeks. The symptoms are described as significant in nature.;surgery
brain_menin_0718;Brain Meningiomas;38;F;Patient is experiencing coordination problems and fatigue over the past month. The symptoms are described as slight in nature.;surgery
brain_menin_0719;Brain Meningiomas;25;F;Patient is experiencing coordination problems and speech difficulty over the past month. The symptoms are described as significant in nature.;close monitoring
brain_menin_0720;Brain Meningiomas;64;M;Patient is experiencing speech difficulty and localized neurological weakness for several weeks. The symptoms are described as noticeable in nature.;radiation therapy
brain_menin_0721;Brain Meningiomas;79;F;Patient is experiencing chronic headaches and blurry vision over the past month. The symptoms are described as moderate in nature.;surgery
brain_menin_0722;Brain Meningiomas;74;M;Patient is experiencing speech difficulty and blurry vision for nearly 3 months. The symptoms are described as moderate in nature.;radiation therapy
brain_menin_0723;Brain Meningiomas;58;F;Patient is experiencing speech difficulty and fatigue for nearly 3 months. The symptoms are described as slight in nature.;surgery
brain_menin_0724;Brain Meningiomas;81;M;Patient is experiencing localized neurological weakness and speech difficulty for several weeks. The symptoms are described as moderate in nature.;surgery
brain_menin_0725;Brain Meningiomas;45;M;Patient is experiencing blurry vision and fatigue for nearly 3 months. The symptoms are described as slight in nature.;radiation therapy
brain_menin_0726;Brain Meningiomas;23;M;Patient is experiencing localized neurological weakness and speech difficulty over the past month. The symptoms are described as slight in nature.;surgery
brain_menin_0727;Brain Meningiomas;20;M;Patient is experiencing localized neurological weakness and coordination problems for nearly 3 months. The symptoms are described as low-grade in nature.;close monitoring
brain_menin_0728;Brain Meningiomas;42;M;Patient is experiencing localized neurological weakness and blurry vision over the past month. The symptoms are described as noticeable in nature.;close monitoring
brain_menin_0729;Brain Meningiomas;52;M;Patient is experiencing coordination problems and chronic headaches over the past month. The symptoms are described as noticeable in nature.;radiation therapy
brain_menin_0730;Brain Meningiomas;40;F;Patient is experiencing localized neurological weakness and speech difficulty over the past month. The symptoms are described as low-grade in nature.;surgery
brain_menin_0731;Brain Meningiomas;74;M;Patient is experiencing fatigue and coordination problems for several weeks. The symptoms are described as tolerable in nature.;radiation therapy
brain_menin_0732;Brain Meningiomas;47;M;Patient is experiencing speech difficulty and fatigue for several weeks. The symptoms are described as significant in nature.;radiation therapy
brain_menin_0733;Brain Meningiomas;78;F;Patient is experiencing coordination problems and speech difficulty for nearly 3 months. The symptoms are described as noticeable in nature.;close monitoring
brain_menin_0734;Brain Meningiomas;36;F;Patient is experiencing coordination problems and speech difficulty for nearly 3 months. The symptoms are described as significant in nature.;surgery
brain_menin_0735;Brain Meningiomas;24;F;Patient is experiencing fatigue and localized neurological weakness for nearly 3 months. The symptoms are described as tolerable in nature.;close monitoring
brain_menin_0736;Brain Meningiomas;32;F;Patient is experiencing chronic headaches and localized neurological weakness over the past month. The symptoms are described as tolerable in nature.;surgery
brain_menin_0737;Brain Meningiomas;82;F;Patient is experiencing chronic headaches and localized neurological weakness for several weeks. The symptoms are described as low-grade in nature.;surgery
brain_menin_0738;Brain Meningiomas;62;M;Patient is experiencing coordination problems and blurry vision for nearly 3 months. The symptoms are described as significant in nature.;close monitoring
brain_menin_0739;Brain Meningiomas;19;F;Patient is experiencing speech difficulty and chronic headaches for several weeks. The symptoms are described as low-grade in nature.;radiation therapy
brain_menin_0740;Brain Meningiomas;30;F;Patient is experiencing blurry vision and chronic headaches over the past month. The symptoms are described as moderate in nature.;radiation therapy
brain_menin_0741;Brain Meningiomas;85;M;Patient is experiencing localized neurological weakness and chronic headaches over the past month. The symptoms are described as noticeable in nature.;close monitoring
brain_menin_0742;Brain Meningiomas;69;F;Patient is experiencing chronic headaches and speech difficulty over the past month. The symptoms are described as significant in nature.;close monitoring
brain_menin_0743;Brain Meningiomas;63;F;Patient is experiencing localized neurological weakness and coordination problems for nearly 3 months. The symptoms are described as mild in nature.;radiation therapy
brain_menin_0744;Brain Meningiomas;64;F;Patient is experiencing localized neurological weakness and speech difficulty over the past month. The symptoms are described as significant in nature.;radiation therapy
brain_menin_0745;Brain Meningiomas;84;F;Patient is experiencing coordination problems and speech difficulty over the past month. The symptoms are described as moderate in nature.;radiation therapy
brain_menin_0746;Brain Meningiomas;78;F;Patient is experiencing fatigue and localized neurological weakness for several weeks. The symptoms are described as tolerable in nature.;radiation therapy
brain_menin_0747;Brain Meningiomas;35;M;Patient is experiencing fatigue and chronic headaches over the past month. The symptoms are described as noticeable in nature.;radiation therapy
brain_menin_0748;Brain Meningiomas;30;F;Patient is experiencing chronic headaches and speech difficulty for nearly 3 months. The symptoms are described as tolerable in nature.;close monitoring
brain_menin_0749;Brain Meningiomas;36;F;Patient is experiencing fatigue and blurry vision for nearly 3 months. The symptoms are described as significant in nature.;surgery
brain_menin_0750;Brain Meningiomas;81;F;Patient is experiencing fatigue and speech difficulty over the past month. The symptoms are described as mild in nature.;close monitoring
brain_menin_0751;Brain Meningiomas;69;F;Patient is experiencing chronic headaches and fatigue for several weeks. The symptoms are described as moderate in nature.;close monitoring
brain_menin_0752;Brain Meningiomas;83;M;Patient is experiencing fatigue and blurry vision for several weeks. The symptoms are described as moderate in nature.;radiation therapy
brain_menin_0753;Brain Meningiomas;59;F;Patient is experiencing chronic headaches and coordination problems for several weeks. The symptoms are described as slight in nature.;radiation therapy
brain_menin_0754;Brain Meningiomas;56;F;Patient is experiencing localized neurological weakness and coordination problems for nearly 3 months. The symptoms are described as tolerable in nature.;radiation therapy
brain_menin_0755;Brain Meningiomas;56;M;Patient is experiencing localized neurological weakness and blurry vision for several weeks. The symptoms are described as noticeable in nature.;radiation therapy
brain_menin_0756;Brain Meningiomas;83;M;Patient is experiencing localized neurological weakness and fatigue for nearly 3 months. The symptoms are described as significant in nature.;radiation therapy
brain_menin_0757;Brain Meningiomas;52;M;Patient is experiencing speech difficulty and chronic headaches for several weeks. The symptoms are described as noticeable in nature.;surgery
brain_menin_0758;Brain Meningiomas;61;F;Patient is experiencing coordination problems and blurry vision over the past month. The symptoms are described as slight in nature.;close monitoring
brain_menin_0759;Brain Meningiomas;57;M;Patient is experiencing fatigue and coordination problems for nearly 3 months. The symptoms are described as low-grade in nature.;radiation therapy
brain_menin_0760;Brain Meningiomas;85;F;Patient is experiencing localized neurological weakness and fatigue for nearly 3 months. The symptoms are described as slight in nature.;surgery
brain_menin_0761;Brain Meningiomas;68;M;Patient is experiencing blurry vision and fatigue for nearly 3 months. The symptoms are described as low-grade in nature.;radiation therapy
brain_menin_0762;Brain Meningiomas;81;F;Patient is experiencing speech difficulty and coordination problems for several weeks. The symptoms are described as mild in nature.;radiation therapy
brain_menin_0763;Brain Meningiomas;21;M;Patient is experiencing blurry vision and coordination problems for nearly 3 months. The symptoms are described as significant in nature.;surgery
brain_menin_0764;Brain Meningiomas;39;M;Patient is experiencing chronic headaches and speech difficulty over the past month. The symptoms are described as significant in nature.;close monitoring
brain_menin_0765;Brain Meningiomas;21;F;Patient is experiencing chronic headaches and fatigue for several weeks. The symptoms are described as mild in nature.;radiation therapy
brain_menin_0766;Brain Meningiomas;51;F;Patient is experiencing coordination problems and chronic headaches over the past month. The symptoms are described as tolerable in nature.;radiation therapy
brain_menin_0767;Brain Meningiomas;73;M;Patient is experiencing localized neurological weakness and fatigue over the past month. The symptoms are described as mild in nature.;radiation therapy
brain_menin_0768;Brain Meningiomas;58;M;Patient is experiencing blurry vision and chronic headaches for several weeks. The symptoms are described as moderate in nature.;close monitoring
brain_menin_0769;Brain Meningiomas;23;F;Patient is experiencing localized neurological weakness and speech difficulty for nearly 3 months. The symptoms are described as noticeable in nature.;radiation therapy
brain_menin_0770;Brain Meningiomas;42;M;Patient is experiencing coordination problems and speech difficulty for several weeks. The symptoms are described as low-grade in nature.;surgery
brain_menin_0771;Brain Meningiomas;43;F;Patient is experiencing chronic headaches and coordination problems for nearly 3 months. The symptoms are described as significant in nature.;radiation therapy
brain_menin_0772;Brain Meningiomas;19;M;Patient is experiencing blurry vision and localized neurological weakness for nearly 3 months. The symptoms are described as significant in nature.;radiation therapy
brain_menin_0773;Brain Meningiomas;30;F;Patient is experiencing chronic headaches and speech difficulty for several weeks. The symptoms are described as tolerable in nature.;surgery
brain_menin_0774;Brain Meningiomas;42;M;Patient is experiencing coordination problems and fatigue for nearly 3 months. The symptoms are described as moderate in nature.;surgery
brain_menin_0775;Brain Meningiomas;47;M;Patient is experiencing chronic headaches and blurry vision over the past month. The symptoms are described as mild in nature.;radiation therapy
brain_menin_0776;Brain Meningiomas;52;M;Patient is experiencing chronic headaches and speech difficulty for several weeks. The symptoms are described as significant in nature.;close monitoring
brain_menin_0777;Brain Meningiomas;67;F;Patient is experiencing localized neurological weakness and coordination problems over the past month. The symptoms are described as slight in nature.;radiation therapy
brain_menin_0778;Brain Meningiomas;47;F;Patient is experiencing localized neurological weakness and blurry vision for several weeks. The symptoms are described as low-grade in nature.;radiation therapy
brain_menin_0779;Brain Meningiomas;55;F;Patient is experiencing localized neurological weakness and coordination problems over the past month. The symptoms are described as noticeable in nature.;surgery
brain_menin_0780;Brain Meningiomas;65;F;Patient is experiencing speech difficulty and blurry vision for several weeks. The symptoms are described as significant in nature.;surgery
brain_menin_0781;Brain Meningiomas;36;M;Patient is experiencing chronic headaches and speech difficulty for several weeks. The symptoms are described as mild in nature.;radiation therapy
brain_menin_0782;Brain Meningiomas;19;F;Patient is experiencing localized neurological weakness and blurry vision for several weeks. The symptoms are described as tolerable in nature.;surgery
brain_menin_0783;Brain Meningiomas;53;M;Patient is experiencing coordination problems and blurry vision over the past month. The symptoms are described as mild in nature.;radiation therapy
brain_menin_0784;Brain Meningiomas;40;F;Patient is experiencing fatigue and speech difficulty over the past month. The symptoms are described as mild in nature.;surgery
brain_menin_0785;Brain Meningiomas;47;M;Patient is experiencing localized neurological weakness and coordination problems for nearly 3 months. The symptoms are described as moderate in nature.;surgery
brain_menin_0786;Brain Meningiomas;85;F;Patient is experiencing localized neurological weakness and chronic headaches over the past month. The symptoms are described as moderate in nature.;radiation therapy
brain_menin_0787;Brain Meningiomas;28;F;Patient is experiencing fatigue and speech difficulty for several weeks. The symptoms are described as mild in nature.;radiation therapy
brain_menin_0788;Brain Meningiomas;73;F;Patient is experiencing chronic headaches and fatigue for nearly 3 months. The symptoms are described as moderate in nature.;close monitoring
brain_menin_0789;Brain Meningiomas;61;F;Patient is experiencing speech difficulty and blurry vision over the past month. The symptoms are described as low-grade in nature.;surgery
brain_menin_0790;Brain Meningiomas;46;F;Patient is experiencing fatigue and coordination problems for several weeks. The symptoms are described as significant in nature.;surgery
brain_menin_0791;Brain Meningiomas;84;F;Patient is experiencing blurry vision and speech difficulty for several weeks. The symptoms are described as moderate in nature.;close monitoring
brain_menin_0792;Brain Meningiomas;64;M;Patient is experiencing coordination problems and fatigue for nearly 3 months. The symptoms are described as significant in nature.;radiation therapy
brain_menin_0793;Brain Meningiomas;78;F;Patient is experiencing speech difficulty and blurry vision for nearly 3 months. The symptoms are described as moderate in nature.;radiation therapy
brain_menin_0794;Brain Meningiomas;54;M;Patient is experiencing blurry vision and fatigue for nearly 3 months. The symptoms are described as slight in nature.;surgery
brain_menin_0795;Brain Meningiomas;62;M;Patient is experiencing localized neurological weakness and speech difficulty for nearly 3 months. The symptoms are described as tolerable in nature.;close monitoring
brain_menin_0796;Brain Meningiomas;47;F;Patient is experiencing blurry vision and speech difficulty for nearly 3 months. The symptoms are described as slight in nature.;close monitoring
brain_menin_0797;Brain Meningiomas;35;F;Patient is experiencing localized neurological weakness and fatigue over the past month. The symptoms are described as noticeable in nature.;radiation therapy
brain_menin_0798;Brain Meningiomas;67;F;Patient is experiencing coordination problems and speech difficulty for several weeks. The symptoms are described as noticeable in nature.;surgery
brain_menin_0799;Brain Meningiomas;33;M;Patient is experiencing fatigue and speech difficulty for several weeks. The symptoms are described as low-grade in nature.;close monitoring
brain_menin_0800;Brain Meningiomas;58;M;Patient is experiencing coordination problems and localized neurological weakness for nearly 3 months. The symptoms are described as moderate in nature.;radiation therapy
brain_menin_0801;Brain Meningiomas;72;F;Patient is experiencing coordination problems and fatigue over the past month. The symptoms are described as moderate in nature.;radiation therapy
brain_menin_0802;Brain Meningiomas;77;M;Patient is experiencing speech difficulty and fatigue for several weeks. The symptoms are described as noticeable in nature.;close monitoring
brain_menin_0803;Brain Meningiomas;35;F;Patient is experiencing blurry vision and chronic headaches for several weeks. The symptoms are described as tolerable in nature.;radiation therapy
brain_menin_0804;Brain Meningiomas;76;M;Patient is experiencing localized neurological weakness and fatigue for nearly 3 months. The symptoms are described as noticeable in nature.;radiation therapy
brain_menin_0805;Brain Meningiomas;83;M;Patient is experiencing fatigue and localized neurological weakness for nearly 3 months. The symptoms are described as noticeable in nature.;surgery
brain_menin_0806;Brain Meningiomas;67;M;Patient is experiencing fatigue and chronic headaches over the past month. The symptoms are described as slight in nature.;surgery
brain_menin_0807;Brain Meningiomas;70;M;Patient is experiencing fatigue and speech difficulty over the past month. The symptoms are described as significant in nature.;surgery
brain_menin_0808;Brain Meningiomas;38;F;Patient is experiencing blurry vision and localized neurological weakness for several weeks. The symptoms are described as noticeable in nature.;radiation therapy
brain_menin_0809;Brain Meningiomas;26;F;Patient is experiencing fatigue and coordination problems for several weeks. The symptoms are described as noticeable in nature.;surgery
brain_menin_0810;Brain Meningiomas;22;F;Patient is experiencing localized neurological weakness and speech difficulty for nearly 3 months. The symptoms are described as noticeable in nature.;surgery
brain_menin_0811;Brain Meningiomas;41;M;Patient is experiencing localized neurological weakness and speech difficulty for nearly 3 months. The symptoms are described as significant in nature.;radiation therapy
brain_menin_0812;Brain Meningiomas;52;M;Patient is experiencing speech difficulty and chronic headaches for nearly 3 months. The symptoms are described as noticeable in nature.;radiation therapy
brain_menin_0813;Brain Meningiomas;64;M;Patient is experiencing localized neurological weakness and fatigue for several weeks. The symptoms are described as moderate in nature.;surgery
brain_menin_0814;Brain Meningiomas;73;M;Patient is experiencing localized neurological weakness and fatigue for several weeks. The symptoms are described as noticeable in nature.;surgery
brain_menin_0815;Brain Meningiomas;47;F;Patient is experiencing blurry vision and coordination problems for several weeks. The symptoms are described as slight in nature.;radiation therapy
brain_menin_0816;Brain Meningiomas;53;M;Patient is experiencing chronic headaches and fatigue for several weeks. The symptoms are described as significant in nature.;surgery
brain_menin_0817;Brain Meningiomas;80;M;Patient is experiencing fatigue and blurry vision for several weeks. The symptoms are described as noticeable in nature.;radiation therapy
brain_menin_0818;Brain Meningiomas;41;F;Patient is experiencing localized neurological weakness and chronic headaches for several weeks. The symptoms are described as low-grade in nature.;surgery
brain_menin_0819;Brain Meningiomas;39;F;Patient is experiencing coordination problems and speech difficulty over the past month. The symptoms are described as noticeable in nature.;surgery
brain_menin_0820;Brain Meningiomas;40;M;Patient is experiencing localized neurological weakness and chronic headaches for nearly 3 months. The symptoms are described as significant in nature.;close monitoring
brain_menin_0821;Brain Meningiomas;80;F;Patient is experiencing blurry vision and fatigue for several weeks. The symptoms are described as significant in nature.;surgery
brain_menin_0822;Brain Meningiomas;18;F;Patient is experiencing fatigue and localized neurological weakness for several weeks. The symptoms are described as slight in nature.;radiation therapy
brain_menin_0823;Brain Meningiomas;79;M;Patient is experiencing chronic headaches and fatigue for nearly 3 months. The symptoms are described as moderate in nature.;radiation therapy
brain_menin_0824;Brain Meningiomas;82;M;Patient is experiencing chronic headaches and localized neurological weakness for nearly 3 months. The symptoms are described as low-grade in nature.;close monitoring
brain_menin_0825;Brain Meningiomas;76;F;Patient is experiencing blurry vision and chronic headaches over the past month. The symptoms are described as significant in nature.;radiation therapy
brain_menin_0826;Brain Meningiomas;24;M;Patient is experiencing coordination problems and blurry vision for nearly 3 months. The symptoms are described as significant in nature.;radiation therapy
brain_menin_0827;Brain Meningiomas;72;M;Patient is experiencing fatigue and coordination problems for nearly 3 months. The symptoms are described as mild in nature.;radiation therapy
brain_menin_0828;Brain Meningiomas;57;M;Patient is experiencing speech difficulty and coordination problems for nearly 3 months. The symptoms are described as slight in nature.;surgery
brain_menin_0829;Brain Meningiomas;39;M;Patient is experiencing localized neurological weakness and coordination problems for several weeks. The symptoms are described as mild in nature.;surgery
brain_menin_0830;Brain Meningiomas;75;F;Patient is experiencing fatigue and speech difficulty over the past month. The symptoms are described as low-grade in nature.;surgery
brain_menin_0831;Brain Meningiomas;29;F;Patient is experiencing coordination problems and fatigue over the past month. The symptoms are described as tolerable in nature.;radiation therapy
brain_menin_0832;Brain Meningiomas;65;F;Patient is experiencing speech difficulty and blurry vision for nearly 3 months. The symptoms are described as significant in nature.;close monitoring
brain_menin_0833;Brain Meningiomas;84;F;Patient is experiencing localized neurological weakness and blurry vision for several weeks. The symptoms are described as mild in nature.;surgery
brain_menin_0834;Brain Meningiomas;64;M;Patient is experiencing blurry vision and chronic headaches over the past month. The symptoms are described as low-grade in nature.;radiation therapy
brain_menin_0835;Brain Meningiomas;61;M;Patient is experiencing chronic headaches and localized neurological weakness for several weeks. The symptoms are described as tolerable in nature.;close monitoring
brain_menin_0836;Brain Meningiomas;52;F;Patient is experiencing blurry vision and fatigue for nearly 3 months. The symptoms are described as moderate in nature.;radiation therapy
brain_menin_0837;Brain Meningiomas;19;F;Patient is experiencing fatigue and blurry vision over the past month. The symptoms are described as low-grade in nature.;close monitoring
brain_menin_0838;Brain Meningiomas;34;F;Patient is experiencing fatigue and chronic headaches for nearly 3 months. The symptoms are described as moderate in nature.;radiation therapy
brain_menin_0839;Brain Meningiomas;65;M;Patient is experiencing blurry vision and coordination problems for several weeks. The symptoms are described as slight in nature.;surgery
brain_menin_0840;Brain Meningiomas;22;F;Patient is experiencing fatigue and speech difficulty for several weeks. The symptoms are described as tolerable in nature.;surgery
brain_menin_0841;Brain Meningiomas;55;F;Patient is experiencing fatigue and coordination problems for nearly 3 months. The symptoms are described as noticeable in nature.;radiation therapy
brain_menin_0842;Brain Meningiomas;83;M;Patient is experiencing coordination problems and fatigue for nearly 3 months. The symptoms are described as noticeable in nature.;surgery
brain_menin_0843;Brain Meningiomas;26;F;Patient is experiencing blurry vision and fatigue over the past month. The symptoms are described as noticeable in nature.;close monitoring
brain_menin_0844;Brain Meningiomas;59;F;Patient is experiencing chronic headaches and speech difficulty for several weeks. The symptoms are described as slight in nature.;surgery
brain_menin_0845;Brain Meningiomas;38;F;Patient is experiencing speech difficulty and fatigue for nearly 3 months. The symptoms are described as moderate in nature.;radiation therapy
brain_menin_0846;Brain Meningiomas;21;F;Patient is experiencing fatigue and localized neurological weakness over the past month. The symptoms are described as significant in nature.;close monitoring
brain_menin_0847;Brain Meningiomas;74;M;Patient is experiencing coordination problems and chronic headaches for several weeks. The symptoms are described as noticeable in nature.;close monitoring
brain_menin_0848;Brain Meningiomas;31;F;Patient is experiencing localized neurological weakness and blurry vision over the past month. The symptoms are described as significant in nature.;surgery
brain_menin_0849;Brain Meningiomas;56;F;Patient is experiencing coordination problems and localized neurological weakness for nearly 3 months. The symptoms are described as low-grade in nature.;close monitoring
brain_menin_0850;Brain Meningiomas;76;M;Patient is experiencing coordination problems and speech difficulty over the past month. The symptoms are described as slight in nature.;radiation therapy
brain_menin_0851;Brain Meningiomas;76;F;Patient is experiencing localized neurological weakness and speech difficulty for nearly 3 months. The symptoms are described as slight in nature.;radiation therapy
brain_menin_0852;Brain Meningiomas;55;F;Patient is experiencing blurry vision and speech difficulty for nearly 3 months. The symptoms are described as slight in nature.;surgery
brain_menin_0853;Brain Meningiomas;66;M;Patient is experiencing coordination problems and speech difficulty over the past month. The symptoms are described as tolerable in nature.;surgery
brain_menin_0854;Brain Meningiomas;61;F;Patient is experiencing chronic headaches and localized neurological weakness over the past month. The symptoms are described as moderate in nature.;close monitoring
brain_menin_0855;Brain Meningiomas;25;F;Patient is experiencing speech difficulty and coordination problems over the past month. The symptoms are described as significant in nature.;radiation therapy
brain_menin_0856;Brain Meningiomas;51;F;Patient is experiencing speech difficulty and localized neurological weakness for nearly 3 months. The symptoms are described as moderate in nature.;close monitoring
brain_menin_0857;Brain Meningiomas;67;M;Patient is experiencing blurry vision and localized neurological weakness for nearly 3 months. The symptoms are described as moderate in nature.;radiation therapy
brain_menin_0858;Brain Meningiomas;27;M;Patient is experiencing coordination problems and blurry vision for nearly 3 months. The symptoms are described as tolerable in nature.;surgery
brain_menin_0859;Brain Meningiomas;75;M;Patient is experiencing chronic headaches and fatigue for several weeks. The symptoms are described as mild in nature.;surgery
brain_menin_0860;Brain Meningiomas;28;F;Patient is experiencing localized neurological weakness and fatigue for nearly 3 months. The symptoms are described as noticeable in nature.;radiation therapy
brain_menin_0861;Brain Meningiomas;24;M;Patient is experiencing chronic headaches and blurry vision for nearly 3 months. The symptoms are described as moderate in nature.;close monitoring
brain_menin_0862;Brain Meningiomas;67;M;Patient is experiencing localized neurological weakness and speech difficulty for several weeks. The symptoms are described as tolerable in nature.;surgery
brain_menin_0863;Brain Meningiomas;48;M;Patient is experiencing coordination problems and speech difficulty for nearly 3 months. The symptoms are described as moderate in nature.;close monitoring
brain_menin_0864;Brain Meningiomas;77;F;Patient is experiencing blurry vision and fatigue for nearly 3 months. The symptoms are described as significant in nature.;close monitoring
brain_menin_0865;Brain Meningiomas;54;M;Patient is experiencing blurry vision and fatigue for several weeks. The symptoms are described as mild in nature.;surgery
brain_menin_0866;Brain Meningiomas;73;F;Patient is experiencing chronic headaches and localized neurological weakness over the past month. The symptoms are described as slight in nature.;surgery
brain_menin_0867;Brain Meningiomas;40;M;Patient is experiencing blurry vision and fatigue for nearly 3 months. The symptoms are described as moderate in nature.;surgery
brain_menin_0868;Brain Meningiomas;66;M;Patient is experiencing coordination problems and chronic headaches for nearly 3 months. The symptoms are described as mild in nature.;radiation therapy
brain_menin_0869;Brain Meningiomas;43;M;Patient is experiencing localized neurological weakness and blurry vision over the past month. The symptoms are described as moderate in nature.;radiation therapy
brain_menin_0870;Brain Meningiomas;81;F;Patient is experiencing chronic headaches and fatigue over the past month. The symptoms are described as slight in nature.;surgery
brain_menin_0871;Brain Meningiomas;27;F;Patient is experiencing localized neurological weakness and chronic headaches for several weeks. The symptoms are described as significant in nature.;close monitoring
brain_menin_0872;Brain Meningiomas;60;M;Patient is experiencing localized neurological weakness and fatigue for nearly 3 months. The symptoms are described as noticeable in nature.;close monitoring
brain_menin_0873;Brain Meningiomas;41;F;Patient is experiencing localized neurological weakness and speech difficulty over the past month. The symptoms are described as slight in nature.;surgery
brain_menin_0874;Brain Meningiomas;29;F;Patient is experiencing speech difficulty and coordination problems over the past month. The symptoms are described as tolerable in nature.;close monitoring
brain_menin_0875;Brain Meningiomas;54;M;Patient is experiencing speech difficulty and blurry vision over the past month. The symptoms are described as tolerable in nature.;surgery
brain_menin_0876;Brain Meningiomas;30;F;Patient is experiencing chronic headaches and blurry vision for nearly 3 months. The symptoms are described as significant in nature.;close monitoring
brain_menin_0877;Brain Meningiomas;74;M;Patient is experiencing fatigue and chronic headaches for several weeks. The symptoms are described as significant in nature.;surgery
brain_menin_0878;Brain Meningiomas;52;F;Patient is experiencing localized neurological weakness and blurry vision for several weeks. The symptoms are described as low-grade in nature.;surgery
brain_menin_0879;Brain Meningiomas;26;M;Patient is experiencing fatigue and coordination problems for several weeks. The symptoms are described as mild in nature.;close monitoring
brain_menin_0880;Brain Meningiomas;35;F;Patient is experiencing coordination problems and chronic headaches over the past month. The symptoms are described as noticeable in nature.;radiation therapy
brain_menin_0881;Brain Meningiomas;40;M;Patient is experiencing blurry vision and coordination problems over the past month. The symptoms are described as significant in nature.;surgery
brain_menin_0882;Brain Meningiomas;54;M;Patient is experiencing chronic headaches and localized neurological weakness for nearly 3 months. The symptoms are described as low-grade in nature.;surgery
brain_menin_0883;Brain Meningiomas;30;F;Patient is experiencing chronic headaches and blurry vision over the past month. The symptoms are described as moderate in nature.;close monitoring
brain_menin_0884;Brain Meningiomas;41;F;Patient is experiencing coordination problems and speech difficulty over the past month. The symptoms are described as tolerable in nature.;close monitoring
brain_menin_0885;Brain Meningiomas;53;M;Patient is experiencing fatigue and coordination problems over the past month. The symptoms are described as moderate in nature.;radiation therapy
brain_menin_0886;Brain Meningiomas;64;F;Patient is experiencing chronic headaches and speech difficulty for several weeks. The symptoms are described as tolerable in nature.;radiation therapy
brain_menin_0887;Brain Meningiomas;82;M;Patient is experiencing fatigue and localized neurological weakness over the past month. The symptoms are described as noticeable in nature.;radiation therapy
brain_menin_0888;Brain Meningiomas;26;F;Patient is experiencing speech difficulty and localized neurological weakness for several weeks. The symptoms are described as slight in nature.;close monitoring
brain_menin_0889;Brain Meningiomas;82;M;Patient is experiencing localized neurological weakness and speech difficulty for nearly 3 months. The symptoms are described as significant in nature.;close monitoring
brain_menin_0890;Brain Meningiomas;23;M;Patient is experiencing blurry vision and speech difficulty for nearly 3 months. The symptoms are described as moderate in nature.;surgery
brain_menin_0891;Brain Meningiomas;24;F;Patient is experiencing blurry vision and coordination problems for nearly 3 months. The symptoms are described as moderate in nature.;surgery
brain_menin_0892;Brain Meningiomas;21;M;Patient is experiencing fatigue and speech difficulty over the past month. The symptoms are described as moderate in nature.;radiation therapy
brain_menin_0893;Brain Meningiomas;84;M;Patient is experiencing coordination problems and speech difficulty for several weeks. The symptoms are described as slight in nature.;close monitoring
brain_menin_0894;Brain Meningiomas;72;M;Patient is experiencing fatigue and chronic headaches over the past month. The symptoms are described as significant in nature.;radiation therapy
brain_menin_0895;Brain Meningiomas;44;F;Patient is experiencing blurry vision and speech difficulty for nearly 3 months. The symptoms are described as noticeable in nature.;surgery
brain_menin_0896;Brain Meningiomas;22;F;Patient is experiencing fatigue and speech difficulty for nearly 3 months. The symptoms are described as mild in nature.;surgery
brain_menin_0897;Brain Meningiomas;36;M;Patient is experiencing localized neurological weakness and fatigue for several weeks. The symptoms are described as mild in nature.;radiation therapy
brain_menin_0898;Brain Meningiomas;31;F;Patient is experiencing fatigue and speech difficulty for nearly 3 months. The symptoms are described as noticeable in nature.;surgery
brain_menin_0899;Brain Meningiomas;64;M;Patient is experiencing blurry vision and localized neurological weakness for several weeks. The symptoms are described as significant in nature.;surgery
brain_menin_0900;Brain Meningiomas;66;F;Patient is experiencing localized neurological weakness and fatigue for several weeks. The symptoms are described as slight in nature.;radiation therapy
brain_menin_0901;Brain Meningiomas;66;M;Patient is experiencing fatigue and chronic headaches over the past month. The symptoms are described as moderate in nature.;close monitoring
brain_menin_0902;Brain Meningiomas;59;F;Patient is experiencing chronic headaches and speech difficulty for several weeks. The symptoms are described as slight in nature.;surgery
brain_menin_0903;Brain Meningiomas;43;M;Patient is experiencing coordination problems and blurry vision for several weeks. The symptoms are described as significant in nature.;surgery
brain_menin_0904;Brain Meningiomas;22;F;Patient is experiencing speech difficulty and chronic headaches over the past month. The symptoms are described as noticeable in nature.;close monitoring
brain_menin_0905;Brain Meningiomas;34;M;Patient is experiencing chronic headaches and localized neurological weakness for nearly 3 months. The symptoms are described as low-grade in nature.;radiation therapy
brain_menin_0906;Brain Meningiomas;31;M;Patient is experiencing blurry vision and speech difficulty for nearly 3 months. The symptoms are described as moderate in nature.;surgery
brain_menin_0907;Brain Meningiomas;82;F;Patient is experiencing localized neurological weakness and blurry vision for nearly 3 months. The symptoms are described as tolerable in nature.;surgery
brain_menin_0908;Brain Meningiomas;53;F;Patient is experiencing localized neurological weakness and speech difficulty for nearly 3 months. The symptoms are described as significant in nature.;surgery
brain_menin_0909;Brain Meningiomas;47;M;Patient is experiencing blurry vision and localized neurological weakness over the past month. The symptoms are described as mild in nature.;radiation therapy
brain_menin_0910;Brain Meningiomas;68;F;Patient is experiencing fatigue and coordination problems for several weeks. The symptoms are described as moderate in nature.;close monitoring
brain_menin_0911;Brain Meningiomas;82;M;Patient is experiencing blurry vision and coordination problems for several weeks. The symptoms are described as low-grade in nature.;surgery
brain_menin_0912;Brain Meningiomas;28;M;Patient is experiencing chronic headaches and blurry vision over the past month. The symptoms are described as mild in nature.;radiation therapy
brain_menin_0913;Brain Meningiomas;72;F;Patient is experiencing speech difficulty and fatigue for several weeks. The symptoms are described as moderate in nature.;radiation therapy
brain_menin_0914;Brain Meningiomas;81;M;Patient is experiencing speech difficulty and localized neurological weakness for several weeks. The symptoms are described as moderate in nature.;radiation therapy
brain_menin_0915;Brain Meningiomas;55;F;Patient is experiencing blurry vision and speech difficulty over the past month. The symptoms are described as noticeable in nature.;surgery
brain_menin_0916;Brain Meningiomas;34;M;Patient is experiencing fatigue and localized neurological weakness for several weeks. The symptoms are described as significant in nature.;close monitoring
brain_menin_0917;Brain Meningiomas;60;M;Patient is experiencing blurry vision and chronic headaches for several weeks. The symptoms are described as moderate in nature.;surgery
brain_menin_0918;Brain Meningiomas;37;F;Patient is experiencing chronic headaches and fatigue over the past month. The symptoms are described as noticeable in nature.;surgery
brain_menin_0919;Brain Meningiomas;76;F;Patient is experiencing localized neurological weakness and coordination problems over the past month. The symptoms are described as tolerable in nature.;radiation therapy
brain_menin_0920;Brain Meningiomas;27;M;Patient is experiencing localized neurological weakness and chronic headaches over the past month. The symptoms are described as slight in nature.;radiation therapy
brain_menin_0921;Brain Meningiomas;70;M;Patient is experiencing chronic headaches and coordination problems for several weeks. The symptoms are described as significant in nature.;surgery
brain_menin_0922;Brain Meningiomas;68;M;Patient is experiencing chronic headaches and fatigue over the past month. The symptoms are described as tolerable in nature.;close monitoring
brain_menin_0923;Brain Meningiomas;75;M;Patient is experiencing chronic headaches and blurry vision over the past month. The symptoms are described as low-grade in nature.;surgery
brain_menin_0924;Brain Meningiomas;65;F;Patient is experiencing speech difficulty and fatigue for nearly 3 months. The symptoms are described as significant in nature.;surgery
brain_menin_0925;Brain Meningiomas;33;F;Patient is experiencing blurry vision and speech difficulty for several weeks. The symptoms are described as noticeable in nature.;surgery
brain_menin_0926;Brain Meningiomas;25;M;Patient is experiencing fatigue and coordination problems for nearly 3 months. The symptoms are described as low-grade in nature.;surgery
brain_menin_0927;Brain Meningiomas;73;M;Patient is experiencing blurry vision and localized neurological weakness for nearly 3 months. The symptoms are described as low-grade in nature.;close monitoring
brain_menin_0928;Brain Meningiomas;65;M;Patient is experiencing chronic headaches and coordination problems over the past month. The symptoms are described as low-grade in nature.;radiation therapy
brain_menin_0929;Brain Meningiomas;76;M;Patient is experiencing coordination problems and fatigue for nearly 3 months. The symptoms are described as mild in nature.;close monitoring
brain_menin_0930;Brain Meningiomas;60;M;Patient is experiencing fatigue and chronic headaches for nearly 3 months. The symptoms are described as noticeable in nature.;surgery
brain_menin_0931;Brain Meningiomas;22;M;Patient is experiencing coordination problems and speech difficulty over the past month. The symptoms are described as slight in nature.;close monitoring
brain_menin_0932;Brain Meningiomas;38;M;Patient is experiencing coordination problems and speech difficulty for several weeks. The symptoms are described as moderate in nature.;close monitoring
brain_menin_0933;Brain Meningiomas;84;M;Patient is experiencing speech difficulty and chronic headaches for several weeks. The symptoms are described as moderate in nature.;radiation therapy
brain_menin_0934;Brain Meningiomas;24;F;Patient is experiencing speech difficulty and fatigue for nearly 3 months. The symptoms are described as significant in nature.;surgery
brain_menin_0935;Brain Meningiomas;21;M;Patient is experiencing localized neurological weakness and chronic headaches over the past month. The symptoms are described as slight in nature.;surgery
brain_menin_0936;Brain Meningiomas;42;M;Patient is experiencing localized neurological weakness and blurry vision for several weeks. The symptoms are described as significant in nature.;surgery
brain_menin_0937;Brain Meningiomas;24;M;Patient is experiencing blurry vision and fatigue for nearly 3 months. The symptoms are described as significant in nature.;surgery
brain_menin_0938;Brain Meningiomas;50;M;Patient is experiencing speech difficulty and localized neurological weakness over the past month. The symptoms are described as noticeable in nature.;surgery
brain_menin_0939;Brain Meningiomas;57;F;Patient is experiencing blurry vision and chronic headaches for nearly 3 months. The symptoms are described as noticeable in nature.;close monitoring
brain_menin_0940;Brain Meningiomas;49;F;Patient is experiencing blurry vision and localized neurological weakness for several weeks. The symptoms are described as low-grade in nature.;surgery
brain_menin_0941;Brain Meningiomas;75;M;Patient is experiencing speech difficulty and chronic headaches for several weeks. The symptoms are described as mild in nature.;surgery
brain_menin_0942;Brain Meningiomas;69;M;Patient is experiencing speech difficulty and fatigue over the past month. The symptoms are described as noticeable in nature.;surgery
brain_menin_0943;Brain Meningiomas;36;F;Patient is experiencing coordination problems and localized neurological weakness over the past month. The symptoms are described as tolerable in nature.;radiation therapy
brain_menin_0944;Brain Meningiomas;20;M;Patient is experiencing coordination problems and fatigue over the past month. The symptoms are described as moderate in nature.;surgery
brain_menin_0945;Brain Meningiomas;29;F;Patient is experiencing blurry vision and fatigue for several weeks. The symptoms are described as mild in nature.;radiation therapy
brain_menin_0946;Brain Meningiomas;77;F;Patient is experiencing localized neurological weakness and fatigue for nearly 3 months. The symptoms are described as significant in nature.;close monitoring
brain_menin_0947;Brain Meningiomas;73;F;Patient is experiencing blurry vision and localized neurological weakness for nearly 3 months. The symptoms are described as significant in nature.;close monitoring
brain_menin_0948;Brain Meningiomas;67;M;Patient is experiencing localized neurological weakness and chronic headaches over the past month. The symptoms are described as significant in nature.;close monitoring
brain_menin_0949;Brain Meningiomas;55;M;Patient is experiencing fatigue and localized neurological weakness over the past month. The symptoms are described as moderate in nature.;close monitoring
brain_menin_0950;Brain Meningiomas;41;M;Patient is experiencing fatigue and chronic headaches for nearly 3 months. The symptoms are described as slight in nature.;close monitoring
brain_menin_0951;Brain Meningiomas;35;M;Patient is experiencing speech difficulty and fatigue over the past month. The symptoms are described as tolerable in nature.;close monitoring
brain_menin_0952;Brain Meningiomas;27;M;Patient is experiencing localized neurological weakness and coordination problems for several weeks. The symptoms are described as significant in nature.;radiation therapy
brain_menin_0953;Brain Meningiomas;44;M;Patient is experiencing fatigue and chronic headaches over the past month. The symptoms are described as slight in nature.;surgery
brain_menin_0954;Brain Meningiomas;68;M;Patient is experiencing chronic headaches and speech difficulty for several weeks. The symptoms are described as moderate in nature.;close monitoring
brain_menin_0955;Brain Meningiomas;85;M;Patient is experiencing localized neurological weakness and speech difficulty for several weeks. The symptoms are described as noticeable in nature.;close monitoring
brain_menin_0956;Brain Meningiomas;49;M;Patient is experiencing blurry vision and chronic headaches for nearly 3 months. The symptoms are described as tolerable in nature.;close monitoring
brain_menin_0957;Brain Meningiomas;45;F;Patient is experiencing localized neurological weakness and coordination problems for several weeks. The symptoms are described as slight in nature.;radiation therapy
brain_menin_0958;Brain Meningiomas;19;F;Patient is experiencing fatigue and speech difficulty for nearly 3 months. The symptoms are described as significant in nature.;radiation therapy
brain_menin_0959;Brain Meningiomas;42;F;Patient is experiencing speech difficulty and coordination problems for several weeks. The symptoms are described as low-grade in nature.;close monitoring
brain_menin_0960;Brain Meningiomas;64;M;Patient is experiencing speech difficulty and chronic headaches for nearly 3 months. The symptoms are described as mild in nature.;surgery
brain_menin_0961;Brain Meningiomas;58;F;Patient is experiencing localized neurological weakness and chronic headaches for nearly 3 months. The symptoms are described as moderate in nature.;radiation therapy
brain_menin_0962;Brain Meningiomas;53;F;Patient is experiencing speech difficulty and blurry vision for nearly 3 months. The symptoms are described as noticeable in nature.;close monitoring
brain_menin_0963;Brain Meningiomas;84;M;Patient is experiencing speech difficulty and chronic headaches for several weeks. The symptoms are described as noticeable in nature.;surgery
brain_menin_0964;Brain Meningiomas;71;M;Patient is experiencing speech difficulty and localized neurological weakness for several weeks. The symptoms are described as tolerable in nature.;radiation therapy
brain_menin_0965;Brain Meningiomas;72;M;Patient is experiencing coordination problems and blurry vision for several weeks. The symptoms are described as low-grade in nature.;radiation therapy
brain_menin_0966;Brain Meningiomas;36;F;Patient is experiencing localized neurological weakness and coordination problems over the past month. The symptoms are described as significant in nature.;surgery
brain_menin_0967;Brain Meningiomas;19;F;Patient is experiencing speech difficulty and chronic headaches over the past month. The symptoms are described as moderate in nature.;close monitoring
brain_menin_0968;Brain Meningiomas;47;M;Patient is experiencing coordination problems and blurry vision for nearly 3 months. The symptoms are described as noticeable in nature.;radiation therapy
brain_menin_0969;Brain Meningiomas;35;M;Patient is experiencing coordination problems and blurry vision over the past month. The symptoms are described as noticeable in nature.;close monitoring
brain_menin_0970;Brain Meningiomas;19;F;Patient is experiencing chronic headaches and speech difficulty over the past month. The symptoms are described as moderate in nature.;close monitoring
brain_menin_0971;Brain Meningiomas;69;M;Patient is experiencing chronic headaches and localized neurological weakness for several weeks. The symptoms are described as tolerable in nature.;close monitoring
brain_menin_0972;Brain Meningiomas;65;M;Patient is experiencing speech difficulty and coordination problems for several weeks. The symptoms are described as moderate in nature.;close monitoring
brain_menin_0973;Brain Meningiomas;31;M;Patient is experiencing coordination problems and fatigue for several weeks. The symptoms are described as moderate in nature.;close monitoring
brain_menin_0974;Brain Meningiomas;62;M;Patient is experiencing chronic headaches and speech difficulty over the past month. The symptoms are described as low-grade in nature.;surgery
brain_menin_0975;Brain Meningiomas;53;M;Patient is experiencing localized neurological weakness and speech difficulty for several weeks. The symptoms are described as tolerable in nature.;close monitoring
brain_menin_0976;Brain Meningiomas;65;M;Patient is experiencing blurry vision and coordination problems for nearly 3 months. The symptoms are described as slight in nature.;surgery
brain_menin_0977;Brain Meningiomas;84;F;Patient is experiencing speech difficulty and coordination problems for nearly 3 months. The symptoms are described as significant in nature.;radiation therapy
brain_menin_0978;Brain Meningiomas;37;F;Patient is experiencing coordination problems and speech difficulty for nearly 3 months. The symptoms are described as moderate in nature.;radiation therapy
brain_menin_0979;Brain Meningiomas;61;F;Patient is experiencing localized neurological weakness and blurry vision for nearly 3 months. The symptoms are described as noticeable in nature.;close monitoring
brain_menin_0980;Brain Meningiomas;79;F;Patient is experiencing speech difficulty and fatigue over the past month. The symptoms are described as moderate in nature.;radiation therapy
brain_menin_0981;Brain Meningiomas;45;M;Patient is experiencing fatigue and speech difficulty for several weeks. The symptoms are described as low-grade in nature.;close monitoring
brain_menin_0982;Brain Meningiomas;25;M;Patient is experiencing speech difficulty and chronic headaches over the past month. The symptoms are described as significant in nature.;radiation therapy
brain_menin_0983;Brain Meningiomas;38;F;Patient is experiencing speech difficulty and chronic headaches for several weeks. The symptoms are described as significant in nature.;surgery
brain_menin_0984;Brain Meningiomas;69;M;Patient is experiencing chronic headaches and speech difficulty over the past month. The symptoms are described as low-grade in nature.;radiation therapy
brain_menin_0985;Brain Meningiomas;82;F;Patient is experiencing coordination problems and blurry vision over the past month. The symptoms are described as low-grade in nature.;surgery
brain_menin_0986;Brain Meningiomas;53;F;Patient is experiencing localized neurological weakness and speech difficulty for nearly 3 months. The symptoms are described as noticeable in nature.;close monitoring
brain_menin_0987;Brain Meningiomas;23;F;Patient is experiencing blurry vision and localized neurological weakness over the past month. The symptoms are described as low-grade in nature.;radiation therapy
brain_menin_0988;Brain Meningiomas;27;M;Patient is experiencing localized neurological weakness and speech difficulty for nearly 3 months. The symptoms are described as slight in nature.;radiation therapy
brain_menin_0989;Brain Meningiomas;26;M;Patient is experiencing coordination problems and chronic headaches for several weeks. The symptoms are described as mild in nature.;radiation therapy
brain_menin_0990;Brain Meningiomas;72;M;Patient is experiencing blurry vision and speech difficulty for nearly 3 months. The symptoms are described as significant in nature.;close monitoring
brain_menin_0991;Brain Meningiomas;78;M;Patient is experiencing coordination problems and chronic headaches over the past month. The symptoms are described as low-grade in nature.;surgery
brain_menin_0992;Brain Meningiomas;85;M;Patient is experiencing fatigue and coordination problems for several weeks. The symptoms are described as tolerable in nature.;close monitoring
brain_menin_0993;Brain Meningiomas;67;M;Patient is experiencing blurry vision and localized neurological weakness for several weeks. The symptoms are described as mild in nature.;close monitoring
brain_menin_0994;Brain Meningiomas;48;M;Patient is experiencing localized neurological weakness and blurry vision for several weeks. The symptoms are described as significant in nature.;surgery
brain_menin_0995;Brain Meningiomas;54;M;Patient is experiencing speech difficulty and coordination problems over the past month. The symptoms are described as moderate in nature.;radiation therapy
brain_menin_0996;Brain Meningiomas;25;F;Patient is experiencing localized neurological weakness and fatigue for several weeks. The symptoms are described as tolerable in nature.;close monitoring
brain_menin_0997;Brain Meningiomas;67;M;Patient is experiencing blurry vision and speech difficulty for several weeks. The symptoms are described as noticeable in nature.;radiation therapy
brain_menin_0998;Brain Meningiomas;40;F;Patient is experiencing chronic headaches and fatigue for several weeks. The symptoms are described as noticeable in nature.;radiation therapy
brain_menin_0999;Brain Meningiomas;78;F;Patient is experiencing coordination problems and speech difficulty over the past month. The symptoms are described as significant in nature.;surgery
brain_menin_1000;Brain Meningiomas;31;F;Patient is experiencing blurry vision and fatigue over the past month. The symptoms are described as low-grade in nature.;radiation therapy
brain_menin_1001;Brain Meningiomas;69;M;Patient is experiencing chronic headaches and localized neurological weakness for several weeks. The symptoms are described as significant in nature.;surgery
brain_menin_1002;Brain Meningiomas;76;M;Patient is experiencing blurry vision and coordination problems for several weeks. The symptoms are described as tolerable in nature.;radiation therapy
brain_menin_1003;Brain Meningiomas;44;M;Patient is experiencing chronic headaches and speech difficulty over the past month. The symptoms are described as slight in nature.;radiation therapy
brain_menin_1004;Brain Meningiomas;56;F;Patient is experiencing blurry vision and coordination problems for nearly 3 months. The symptoms are described as tolerable in nature.;radiation therapy
brain_menin_1005;Brain Meningiomas;44;F;Patient is experiencing blurry vision and chronic headaches for several weeks. The symptoms are described as tolerable in nature.;surgery
brain_menin_1006;Brain Meningiomas;35;M;Patient is experiencing fatigue and speech difficulty for several weeks. The symptoms are described as moderate in nature.;surgery
brain_menin_1007;Brain Meningiomas;73;F;Patient is experiencing fatigue and chronic headaches for several weeks. The symptoms are described as low-grade in nature.;close monitoring
brain_menin_1008;Brain Meningiomas;36;F;Patient is experiencing fatigue and chronic headaches over the past month. The symptoms are described as noticeable in nature.;radiation therapy
brain_menin_1009;Brain Meningiomas;36;F;Patient is experiencing speech difficulty and coordination problems for nearly 3 months. The symptoms are described as slight in nature.;close monitoring
brain_menin_1010;Brain Meningiomas;31;F;Patient is experiencing chronic headaches and coordination problems over the past month. The symptoms are described as moderate in nature.;radiation therapy
brain_menin_1011;Brain Meningiomas;50;M;Patient is experiencing chronic headaches and blurry vision for nearly 3 months. The symptoms are described as significant in nature.;close monitoring
brain_menin_1012;Brain Meningiomas;31;M;Patient is experiencing localized neurological weakness and speech difficulty for nearly 3 months. The symptoms are described as mild in nature.;radiation therapy
brain_menin_1013;Brain Meningiomas;54;F;Patient is experiencing fatigue and localized neurological weakness for nearly 3 months. The symptoms are described as mild in nature.;surgery
brain_menin_1014;Brain Meningiomas;44;M;Patient is experiencing fatigue and localized neurological weakness for nearly 3 months. The symptoms are described as significant in nature.;close monitoring
brain_menin_1015;Brain Meningiomas;83;F;Patient is experiencing fatigue and chronic headaches for nearly 3 months. The symptoms are described as significant in nature.;radiation therapy
brain_menin_1016;Brain Meningiomas;73;M;Patient is experiencing localized neurological weakness and chronic headaches for several weeks. The symptoms are described as noticeable in nature.;radiation therapy
brain_menin_1017;Brain Meningiomas;43;F;Patient is experiencing speech difficulty and fatigue for nearly 3 months. The symptoms are described as moderate in nature.;radiation therapy
brain_menin_1018;Brain Meningiomas;28;M;Patient is experiencing coordination problems and localized neurological weakness for several weeks. The symptoms are described as moderate in nature.;radiation therapy
brain_menin_1019;Brain Meningiomas;40;F;Patient is experiencing coordination problems and localized neurological weakness for several weeks. The symptoms are described as noticeable in nature.;radiation therapy
brain_menin_1020;Brain Meningiomas;34;F;Patient is experiencing fatigue and coordination problems for nearly 3 months. The symptoms are described as slight in nature.;close monitoring
brain_menin_1021;Brain Meningiomas;66;M;Patient is experiencing localized neurological weakness and chronic headaches for several weeks. The symptoms are described as noticeable in nature.;radiation therapy
brain_menin_1022;Brain Meningiomas;31;M;Patient is experiencing fatigue and blurry vision for nearly 3 months. The symptoms are described as low-grade in nature.;surgery
brain_menin_1023;Brain Meningiomas;52;F;Patient is experiencing blurry vision and localized neurological weakness over the past month. The symptoms are described as noticeable in nature.;close monitoring
brain_menin_1024;Brain Meningiomas;31;F;Patient is experiencing fatigue and chronic headaches for nearly 3 months. The symptoms are described as moderate in nature.;close monitoring
brain_menin_1025;Brain Meningiomas;26;F;Patient is experiencing chronic headaches and coordination problems for nearly 3 months. The symptoms are described as low-grade in nature.;surgery
brain_menin_1026;Brain Meningiomas;43;M;Patient is experiencing coordination problems and localized neurological weakness for nearly 3 months. The symptoms are described as slight in nature.;close monitoring
brain_menin_1027;Brain Meningiomas;41;M;Patient is experiencing chronic headaches and blurry vision over the past month. The symptoms are described as tolerable in nature.;surgery
brain_menin_1028;Brain Meningiomas;36;F;Patient is experiencing speech difficulty and coordination problems over the past month. The symptoms are described as significant in nature.;radiation therapy
brain_menin_1029;Brain Meningiomas;27;M;Patient is experiencing localized neurological weakness and chronic headaches for several weeks. The symptoms are described as mild in nature.;close monitoring
brain_menin_1030;Brain Meningiomas;73;M;Patient is experiencing speech difficulty and localized neurological weakness for nearly 3 months. The symptoms are described as significant in nature.;radiation therapy
brain_menin_1031;Brain Meningiomas;55;M;Patient is experiencing speech difficulty and coordination problems for nearly 3 months. The symptoms are described as tolerable in nature.;close monitoring
brain_menin_1032;Brain Meningiomas;69;M;Patient is experiencing localized neurological weakness and blurry vision over the past month. The symptoms are described as noticeable in nature.;radiation therapy
brain_menin_1033;Brain Meningiomas;46;F;Patient is experiencing coordination problems and chronic headaches over the past month. The symptoms are described as moderate in nature.;close monitoring
brain_menin_1034;Brain Meningiomas;55;F;Patient is experiencing blurry vision and chronic headaches over the past month. The symptoms are described as moderate in nature.;radiation therapy
brain_menin_1035;Brain Meningiomas;52;F;Patient is experiencing speech difficulty and fatigue for several weeks. The symptoms are described as noticeable in nature.;surgery
brain_menin_1036;Brain Meningiomas;34;M;Patient is experiencing localized neurological weakness and coordination problems over the past month. The symptoms are described as significant in nature.;radiation therapy
brain_menin_1037;Brain Meningiomas;51;F;Patient is experiencing fatigue and chronic headaches for several weeks. The symptoms are described as significant in nature.;surgery
brain_menin_1038;Brain Meningiomas;44;M;Patient is experiencing chronic headaches and speech difficulty for several weeks. The symptoms are described as noticeable in nature.;radiation therapy
brain_menin_1039;Brain Meningiomas;67;F;Patient is experiencing localized neurological weakness and fatigue over the past month. The symptoms are described as slight in nature.;close monitoring
brain_menin_1040;Brain Meningiomas;24;F;Patient is experiencing speech difficulty and localized neurological weakness for several weeks. The symptoms are described as noticeable in nature.;surgery
brain_menin_1041;Brain Meningiomas;65;M;Patient is experiencing blurry vision and localized neurological weakness for nearly 3 months. The symptoms are described as moderate in nature.;radiation therapy
brain_menin_1042;Brain Meningiomas;52;F;Patient is experiencing localized neurological weakness and fatigue for several weeks. The symptoms are described as mild in nature.;close monitoring
brain_menin_1043;Brain Meningiomas;69;M;Patient is experiencing speech difficulty and blurry vision for nearly 3 months. The symptoms are described as tolerable in nature.;radiation therapy
brain_menin_1044;Brain Meningiomas;46;M;Patient is experiencing blurry vision and speech difficulty for nearly 3 months. The symptoms are described as tolerable in nature.;surgery
brain_menin_1045;Brain Meningiomas;59;M;Patient is experiencing coordination problems and chronic headaches over the past month. The symptoms are described as noticeable in nature.;close monitoring
brain_menin_1046;Brain Meningiomas;49;M;Patient is experiencing localized neurological weakness and speech difficulty for several weeks. The symptoms are described as tolerable in nature.;surgery
brain_menin_1047;Brain Meningiomas;75;F;Patient is experiencing fatigue and chronic headaches for several weeks. The symptoms are described as moderate in nature.;radiation therapy
brain_menin_1048;Brain Meningiomas;66;M;Patient is experiencing speech difficulty and blurry vision over the past month. The symptoms are described as low-grade in nature.;close monitoring
brain_menin_1049;Brain Meningiomas;77;M;Patient is experiencing chronic headaches and fatigue for nearly 3 months. The symptoms are described as low-grade in nature.;surgery
brain_menin_1050;Brain Meningiomas;42;M;Patient is experiencing speech difficulty and localized neurological weakness for nearly 3 months. The symptoms are described as noticeable in nature.;radiation therapy
brain_menin_1051;Brain Meningiomas;76;M;Patient is experiencing coordination problems and speech difficulty for several weeks. The symptoms are described as mild in nature.;surgery
brain_menin_1052;Brain Meningiomas;48;M;Patient is experiencing blurry vision and fatigue for nearly 3 months. The symptoms are described as significant in nature.;close monitoring
brain_menin_1053;Brain Meningiomas;43;M;Patient is experiencing localized neurological weakness and coordination problems for nearly 3 months. The symptoms are described as moderate in nature.;surgery
brain_menin_1054;Brain Meningiomas;85;M;Patient is experiencing coordination problems and blurry vision over the past month. The symptoms are described as low-grade in nature.;radiation therapy
brain_menin_1055;Brain Meningiomas;49;M;Patient is experiencing speech difficulty and blurry vision for nearly 3 months. The symptoms are described as noticeable in nature.;surgery
brain_menin_1056;Brain Meningiomas;26;M;Patient is experiencing speech difficulty and chronic headaches for nearly 3 months. The symptoms are described as moderate in nature.;surgery
brain_menin_1057;Brain Meningiomas;84;M;Patient is experiencing coordination problems and blurry vision over the past month. The symptoms are described as moderate in nature.;radiation therapy
brain_menin_1058;Brain Meningiomas;84;M;Patient is experiencing chronic headaches and fatigue for several weeks. The symptoms are described as significant in nature.;close monitoring
brain_menin_1059;Brain Meningiomas;18;M;Patient is experiencing coordination problems and localized neurological weakness over the past month. The symptoms are described as mild in nature.;surgery
brain_menin_1060;Brain Meningiomas;46;F;Patient is experiencing chronic headaches and blurry vision over the past month. The symptoms are described as mild in nature.;radiation therapy
brain_menin_1061;Brain Meningiomas;60;M;Patient is experiencing blurry vision and coordination problems for several weeks. The symptoms are described as noticeable in nature.;close monitoring
brain_menin_1062;Brain Meningiomas;82;F;Patient is experiencing localized neurological weakness and coordination problems for nearly 3 months. The symptoms are described as significant in nature.;surgery
brain_menin_1063;Brain Meningiomas;39;M;Patient is experiencing coordination problems and localized neurological weakness for several weeks. The symptoms are described as significant in nature.;surgery
brain_menin_1064;Brain Meningiomas;39;M;Patient is experiencing blurry vision and chronic headaches over the past month. The symptoms are described as mild in nature.;surgery
brain_menin_1065;Brain Meningiomas;50;F;Patient is experiencing chronic headaches and blurry vision for several weeks. The symptoms are described as significant in nature.;radiation therapy
brain_menin_1066;Brain Meningiomas;32;M;Patient is experiencing speech difficulty and chronic headaches for nearly 3 months. The symptoms are described as noticeable in nature.;surgery
brain_menin_1067;Brain Meningiomas;58;M;Patient is experiencing speech difficulty and blurry vision for several weeks. The symptoms are described as noticeable in nature.;close monitoring
brain_menin_1068;Brain Meningiomas;53;F;Patient is experiencing chronic headaches and coordination problems for several weeks. The symptoms are described as significant in nature.;close monitoring
brain_menin_1069;Brain Meningiomas;26;F;Patient is experiencing chronic headaches and speech difficulty for nearly 3 months. The symptoms are described as mild in nature.;close monitoring
brain_menin_1070;Brain Meningiomas;69;F;Patient is experiencing blurry vision and localized neurological weakness over the past month. The symptoms are described as tolerable in nature.;radiation therapy
brain_menin_1071;Brain Meningiomas;28;F;Patient is experiencing fatigue and blurry vision for nearly 3 months. The symptoms are described as moderate in nature.;radiation therapy
brain_menin_1072;Brain Meningiomas;19;M;Patient is experiencing blurry vision and coordination problems over the past month. The symptoms are described as moderate in nature.;radiation therapy
brain_menin_1073;Brain Meningiomas;60;F;Patient is experiencing fatigue and localized neurological weakness over the past month. The symptoms are described as mild in nature.;close monitoring
brain_menin_1074;Brain Meningiomas;79;F;Patient is experiencing fatigue and coordination problems for nearly 3 months. The symptoms are described as noticeable in nature.;close monitoring
brain_menin_1075;Brain Meningiomas;78;M;Patient is experiencing speech difficulty and localized neurological weakness for several weeks. The symptoms are described as significant in nature.;close monitoring
brain_menin_1076;Brain Meningiomas;23;M;Patient is experiencing chronic headaches and speech difficulty for nearly 3 months. The symptoms are described as noticeable in nature.;radiation therapy
brain_menin_1077;Brain Meningiomas;51;F;Patient is experiencing fatigue and localized neurological weakness for nearly 3 months. The symptoms are described as moderate in nature.;radiation therapy
brain_menin_1078;Brain Meningiomas;58;F;Patient is experiencing fatigue and localized neurological weakness for several weeks. The symptoms are described as slight in nature.;radiation therapy
brain_menin_1079;Brain Meningiomas;59;F;Patient is experiencing coordination problems and chronic headaches for several weeks. The symptoms are described as moderate in nature.;close monitoring
brain_menin_1080;Brain Meningiomas;78;M;Patient is experiencing coordination problems and fatigue over the past month. The symptoms are described as mild in nature.;close monitoring
brain_menin_1081;Brain Meningiomas;46;F;Patient is experiencing fatigue and speech difficulty for several weeks. The symptoms are described as slight in nature.;surgery
brain_menin_1082;Brain Meningiomas;78;F;Patient is experiencing chronic headaches and localized neurological weakness for nearly 3 months. The symptoms are described as low-grade in nature.;radiation therapy
brain_menin_1083;Brain Meningiomas;50;M;Patient is experiencing speech difficulty and coordination problems for nearly 3 months. The symptoms are described as tolerable in nature.;radiation therapy
brain_menin_1084;Brain Meningiomas;60;F;Patient is experiencing chronic headaches and blurry vision for nearly 3 months. The symptoms are described as slight in nature.;close monitoring
brain_menin_1085;Brain Meningiomas;48;M;Patient is experiencing localized neurological weakness and blurry vision for nearly 3 months. The symptoms are described as moderate in nature.;surgery
brain_menin_1086;Brain Meningiomas;77;F;Patient is experiencing chronic headaches and coordination problems over the past month. The symptoms are described as noticeable in nature.;radiation therapy
brain_menin_1087;Brain Meningiomas;25;F;Patient is experiencing fatigue and blurry vision for several weeks. The symptoms are described as mild in nature.;close monitoring
brain_menin_1088;Brain Meningiomas;55;F;Patient is experiencing coordination problems and chronic headaches over the past month. The symptoms are described as moderate in nature.;surgery
brain_menin_1089;Brain Meningiomas;46;F;Patient is experiencing localized neurological weakness and chronic headaches for several weeks. The symptoms are described as significant in nature.;surgery
brain_menin_1090;Brain Meningiomas;71;F;Patient is experiencing coordination problems and blurry vision for several weeks. The symptoms are described as tolerable in nature.;radiation therapy
brain_menin_1091;Brain Meningiomas;61;M;Patient is experiencing speech difficulty and coordination problems for several weeks. The symptoms are described as noticeable in nature.;radiation therapy
brain_menin_1092;Brain Meningiomas;42;M;Patient is experiencing chronic headaches and localized neurological weakness for nearly 3 months. The symptoms are described as slight in nature.;radiation therapy
brain_menin_1093;Brain Meningiomas;28;F;Patient is experiencing blurry vision and localized neurological weakness over the past month. The symptoms are described as noticeable in nature.;radiation therapy
brain_menin_1094;Brain Meningiomas;28;M;Patient is experiencing coordination problems and blurry vision for several weeks. The symptoms are described as significant in nature.;surgery
brain_menin_1095;Brain Meningiomas;45;F;Patient is experiencing coordination problems and speech difficulty over the past month. The symptoms are described as mild in nature.;radiation therapy
brain_menin_1096;Brain Meningiomas;48;M;Patient is experiencing chronic headaches and fatigue over the past month. The symptoms are described as mild in nature.;close monitoring
brain_menin_1097;Brain Meningiomas;39;F;Patient is experiencing coordination problems and localized neurological weakness for nearly 3 months. The symptoms are described as significant in nature.;radiation therapy
brain_menin_1098;Brain Meningiomas;27;F;Patient is experiencing coordination problems and chronic headaches over the past month. The symptoms are described as moderate in nature.;close monitoring
brain_menin_1099;Brain Meningiomas;68;M;Patient is experiencing speech difficulty and localized neurological weakness over the past month. The symptoms are described as low-grade in nature.;radiation therapy
brain_menin_1100;Brain Meningiomas;65;F;Patient is experiencing speech difficulty and coordination problems for several weeks. The symptoms are described as significant in nature.;close monitoring
brain_menin_1101;Brain Meningiomas;42;M;Patient is experiencing speech difficulty and localized neurological weakness for nearly 3 months. The symptoms are described as tolerable in nature.;surgery
brain_menin_1102;Brain Meningiomas;84;F;Patient is experiencing localized neurological weakness and fatigue over the past month. The symptoms are described as noticeable in nature.;radiation therapy
brain_menin_1103;Brain Meningiomas;47;M;Patient is experiencing blurry vision and localized neurological weakness over the past month. The symptoms are described as significant in nature.;surgery
brain_menin_1104;Brain Meningiomas;48;F;Patient is experiencing chronic headaches and localized neurological weakness over the past month. The symptoms are described as significant in nature.;surgery
brain_menin_1105;Brain Meningiomas;68;F;Patient is experiencing blurry vision and localized neurological weakness for several weeks. The symptoms are described as significant in nature.;close monitoring
brain_menin_1106;Brain Meningiomas;75;F;Patient is experiencing fatigue and coordination problems for nearly 3 months. The symptoms are described as slight in nature.;close monitoring
brain_menin_1107;Brain Meningiomas;22;M;Patient is experiencing chronic headaches and blurry vision for nearly 3 months. The symptoms are described as noticeable in nature.;close monitoring
brain_menin_1108;Brain Meningiomas;72;F;Patient is experiencing blurry vision and chronic headaches for nearly 3 months. The symptoms are described as slight in nature.;radiation therapy
brain_menin_1109;Brain Meningiomas;39;F;Patient is experiencing fatigue and chronic headaches over the past month. The symptoms are described as noticeable in nature.;surgery
brain_menin_1110;Brain Meningiomas;85;M;Patient is experiencing coordination problems and chronic headaches over the past month. The symptoms are described as low-grade in nature.;surgery
brain_menin_1111;Brain Meningiomas;56;M;Patient is experiencing blurry vision and fatigue over the past month. The symptoms are described as significant in nature.;radiation therapy
brain_menin_1112;Brain Meningiomas;57;F;Patient is experiencing speech difficulty and blurry vision over the past month. The symptoms are described as slight in nature.;surgery
brain_menin_1113;Brain Meningiomas;27;M;Patient is experiencing speech difficulty and blurry vision for nearly 3 months. The symptoms are described as low-grade in nature.;close monitoring
brain_menin_1114;Brain Meningiomas;39;M;Patient is experiencing chronic headaches and localized neurological weakness for several weeks. The symptoms are described as noticeable in nature.;radiation therapy
brain_menin_1115;Brain Meningiomas;67;F;Patient is experiencing fatigue and chronic headaches for nearly 3 months. The symptoms are described as tolerable in nature.;radiation therapy
brain_menin_1116;Brain Meningiomas;47;F;Patient is experiencing localized neurological weakness and speech difficulty over the past month. The symptoms are described as tolerable in nature.;close monitoring
brain_menin_1117;Brain Meningiomas;73;F;Patient is experiencing speech difficulty and blurry vision for several weeks. The symptoms are described as low-grade in nature.;close monitoring
brain_menin_1118;Brain Meningiomas;62;F;Patient is experiencing fatigue and speech difficulty for nearly 3 months. The symptoms are described as slight in nature.;radiation therapy
brain_menin_1119;Brain Meningiomas;31;F;Patient is experiencing localized neurological weakness and blurry vision for nearly 3 months. The symptoms are described as moderate in nature.;close monitoring
brain_menin_1120;Brain Meningiomas;35;M;Patient is experiencing localized neurological weakness and chronic headaches over the past month. The symptoms are described as moderate in nature.;close monitoring
brain_menin_1121;Brain Meningiomas;51;F;Patient is experiencing localized neurological weakness and fatigue for several weeks. The symptoms are described as moderate in nature.;surgery
brain_menin_1122;Brain Meningiomas;25;M;Patient is experiencing speech difficulty and fatigue over the past month. The symptoms are described as noticeable in nature.;radiation therapy
brain_menin_1123;Brain Meningiomas;20;F;Patient is experiencing fatigue and localized neurological weakness for nearly 3 months. The symptoms are described as tolerable in nature.;radiation therapy
brain_menin_1124;Brain Meningiomas;83;M;Patient is experiencing chronic headaches and speech difficulty for nearly 3 months. The symptoms are described as mild in nature.;radiation therapy
brain_menin_1125;Brain Meningiomas;48;F;Patient is experiencing coordination problems and localized neurological weakness for nearly 3 months. The symptoms are described as significant in nature.;radiation therapy
brain_menin_1126;Brain Meningiomas;80;F;Patient is experiencing coordination problems and localized neurological weakness over the past month. The symptoms are described as low-grade in nature.;surgery
brain_menin_1127;Brain Meningiomas;63;F;Patient is experiencing blurry vision and localized neurological weakness for nearly 3 months. The symptoms are described as tolerable in nature.;radiation therapy
brain_menin_1128;Brain Meningiomas;71;F;Patient is experiencing coordination problems and localized neurological weakness over the past month. The symptoms are described as low-grade in nature.;radiation therapy
brain_menin_1129;Brain Meningiomas;56;F;Patient is experiencing chronic headaches and coordination problems for nearly 3 months. The symptoms are described as tolerable in nature.;close monitoring
brain_menin_1130;Brain Meningiomas;77;M;Patient is experiencing fatigue and blurry vision over the past month. The symptoms are described as tolerable in nature.;surgery
brain_menin_1131;Brain Meningiomas;81;M;Patient is experiencing coordination problems and chronic headaches for several weeks. The symptoms are described as noticeable in nature.;surgery
brain_menin_1132;Brain Meningiomas;34;F;Patient is experiencing blurry vision and speech difficulty for nearly 3 months. The symptoms are described as noticeable in nature.;radiation therapy
brain_menin_1133;Brain Meningiomas;62;M;Patient is experiencing speech difficulty and fatigue for several weeks. The symptoms are described as moderate in nature.;radiation therapy
brain_menin_1134;Brain Meningiomas;35;F;Patient is experiencing blurry vision and coordination problems for several weeks. The symptoms are described as noticeable in nature.;surgery
brain_menin_1135;Brain Meningiomas;50;M;Patient is experiencing blurry vision and localized neurological weakness for nearly 3 months. The symptoms are described as slight in nature.;radiation therapy
brain_menin_1136;Brain Meningiomas;19;M;Patient is experiencing localized neurological weakness and fatigue for nearly 3 months. The symptoms are described as noticeable in nature.;surgery
brain_menin_1137;Brain Meningiomas;26;M;Patient is experiencing localized neurological weakness and coordination problems for nearly 3 months. The symptoms are described as noticeable in nature.;surgery
brain_menin_1138;Brain Meningiomas;70;M;Patient is experiencing blurry vision and chronic headaches over the past month. The symptoms are described as significant in nature.;radiation therapy
brain_menin_1139;Brain Meningiomas;74;M;Patient is experiencing coordination problems and speech difficulty over the past month. The symptoms are described as slight in nature.;close monitoring
brain_menin_1140;Brain Meningiomas;41;M;Patient is experiencing blurry vision and chronic headaches over the past month. The symptoms are described as noticeable in nature.;surgery
brain_menin_1141;Brain Meningiomas;20;F;Patient is experiencing coordination problems and speech difficulty for several weeks. The symptoms are described as significant in nature.;close monitoring
brain_menin_1142;Brain Meningiomas;26;M;Patient is experiencing chronic headaches and coordination problems for nearly 3 months. The symptoms are described as moderate in nature.;close monitoring
brain_menin_1143;Brain Meningiomas;50;M;Patient is experiencing localized neurological weakness and blurry vision for nearly 3 months. The symptoms are described as significant in nature.;surgery
brain_menin_1144;Brain Meningiomas;71;F;Patient is experiencing localized neurological weakness and blurry vision over the past month. The symptoms are described as significant in nature.;surgery
brain_menin_1145;Brain Meningiomas;74;M;Patient is experiencing chronic headaches and fatigue for nearly 3 months. The symptoms are described as noticeable in nature.;radiation therapy
brain_menin_1146;Brain Meningiomas;35;M;Patient is experiencing fatigue and blurry vision for several weeks. The symptoms are described as significant in nature.;close monitoring
brain_menin_1147;Brain Meningiomas;73;M;Patient is experiencing speech difficulty and blurry vision over the past month. The symptoms are described as moderate in nature.;surgery
brain_menin_1148;Brain Meningiomas;46;M;Patient is experiencing speech difficulty and coordination problems over the past month. The symptoms are described as low-grade in nature.;radiation therapy
brain_menin_1149;Brain Meningiomas;33;F;Patient is experiencing coordination problems and blurry vision over the past month. The symptoms are described as mild in nature.;radiation therapy
brain_menin_1150;Brain Meningiomas;55;F;Patient is experiencing localized neurological weakness and speech difficulty for nearly 3 months. The symptoms are described as moderate in nature.;close monitoring
brain_menin_1151;Brain Meningiomas;81;M;Patient is experiencing localized neurological weakness and blurry vision over the past month. The symptoms are described as moderate in nature.;surgery
brain_menin_1152;Brain Meningiomas;81;M;Patient is experiencing blurry vision and speech difficulty for several weeks. The symptoms are described as moderate in nature.;radiation therapy
brain_menin_1153;Brain Meningiomas;29;M;Patient is experiencing chronic headaches and speech difficulty for several weeks. The symptoms are described as mild in nature.;radiation therapy
brain_menin_1154;Brain Meningiomas;42;F;Patient is experiencing fatigue and blurry vision over the past month. The symptoms are described as significant in nature.;radiation therapy
brain_menin_1155;Brain Meningiomas;27;F;Patient is experiencing speech difficulty and chronic headaches for several weeks. The symptoms are described as tolerable in nature.;close monitoring
brain_menin_1156;Brain Meningiomas;47;M;Patient is experiencing blurry vision and localized neurological weakness over the past month. The symptoms are described as slight in nature.;close monitoring
brain_menin_1157;Brain Meningiomas;20;F;Patient is experiencing blurry vision and chronic headaches for nearly 3 months. The symptoms are described as moderate in nature.;radiation therapy
brain_menin_1158;Brain Meningiomas;73;F;Patient is experiencing blurry vision and chronic headaches for nearly 3 months. The symptoms are described as noticeable in nature.;surgery
brain_menin_1159;Brain Meningiomas;79;F;Patient is experiencing chronic headaches and coordination problems for nearly 3 months. The symptoms are described as noticeable in nature.;close monitoring
brain_menin_1160;Brain Meningiomas;83;M;Patient is experiencing localized neurological weakness and fatigue for several weeks. The symptoms are described as slight in nature.;close monitoring
brain_menin_1161;Brain Meningiomas;68;M;Patient is experiencing localized neurological weakness and coordination problems for nearly 3 months. The symptoms are described as low-grade in nature.;radiation therapy
brain_menin_1162;Brain Meningiomas;44;M;Patient is experiencing speech difficulty and blurry vision over the past month. The symptoms are described as significant in nature.;close monitoring
brain_menin_1163;Brain Meningiomas;85;F;Patient is experiencing chronic headaches and fatigue over the past month. The symptoms are described as mild in nature.;close monitoring
brain_menin_1164;Brain Meningiomas;28;F;Patient is experiencing coordination problems and fatigue for several weeks. The symptoms are described as significant in nature.;radiation therapy
brain_menin_1165;Brain Meningiomas;80;F;Patient is experiencing fatigue and speech difficulty over the past month. The symptoms are described as mild in nature.;surgery
brain_menin_1166;Brain Meningiomas;66;F;Patient is experiencing blurry vision and coordination problems over the past month. The symptoms are described as moderate in nature.;close monitoring
brain_menin_1167;Brain Meningiomas;51;F;Patient is experiencing speech difficulty and fatigue for several weeks. The symptoms are described as significant in nature.;radiation therapy
brain_menin_1168;Brain Meningiomas;36;F;Patient is experiencing chronic headaches and blurry vision over the past month. The symptoms are described as moderate in nature.;close monitoring
brain_menin_1169;Brain Meningiomas;23;M;Patient is experiencing chronic headaches and fatigue for several weeks. The symptoms are described as tolerable in nature.;radiation therapy
brain_menin_1170;Brain Meningiomas;73;M;Patient is experiencing fatigue and speech difficulty for several weeks. The symptoms are described as moderate in nature.;close monitoring
brain_menin_1171;Brain Meningiomas;60;F;Patient is experiencing chronic headaches and fatigue over the past month. The symptoms are described as tolerable in nature.;radiation therapy
brain_menin_1172;Brain Meningiomas;41;M;Patient is experiencing localized neurological weakness and speech difficulty for several weeks. The symptoms are described as slight in nature.;radiation therapy
brain_menin_1173;Brain Meningiomas;67;M;Patient is experiencing chronic headaches and speech difficulty for nearly 3 months. The symptoms are described as noticeable in nature.;close monitoring
brain_menin_1174;Brain Meningiomas;47;M;Patient is experiencing chronic headaches and blurry vision for nearly 3 months. The symptoms are described as significant in nature.;radiation therapy
brain_menin_1175;Brain Meningiomas;66;F;Patient is experiencing chronic headaches and speech difficulty for several weeks. The symptoms are described as tolerable in nature.;close monitoring
brain_menin_1176;Brain Meningiomas;37;M;Patient is experiencing chronic headaches and coordination problems for several weeks. The symptoms are described as low-grade in nature.;radiation therapy
brain_menin_1177;Brain Meningiomas;47;M;Patient is experiencing coordination problems and blurry vision for several weeks. The symptoms are described as tolerable in nature.;surgery
brain_menin_1178;Brain Meningiomas;41;F;Patient is experiencing speech difficulty and fatigue for nearly 3 months. The symptoms are described as low-grade in nature.;close monitoring
brain_menin_1179;Brain Meningiomas;81;M;Patient is experiencing blurry vision and chronic headaches for several weeks. The symptoms are described as significant in nature.;radiation therapy
brain_menin_1180;Brain Meningiomas;54;M;Patient is experiencing blurry vision and coordination problems for several weeks. The symptoms are described as noticeable in nature.;radiation therapy
brain_menin_1181;Brain Meningiomas;20;F;Patient is experiencing chronic headaches and coordination problems for nearly 3 months. The symptoms are described as significant in nature.;surgery
brain_menin_1182;Brain Meningiomas;49;F;Patient is experiencing fatigue and blurry vision for several weeks. The symptoms are described as low-grade in nature.;close monitoring
brain_menin_1183;Brain Meningiomas;39;M;Patient is experiencing speech difficulty and coordination problems over the past month. The symptoms are described as low-grade in nature.;close monitoring
brain_menin_1184;Brain Meningiomas;52;F;Patient is experiencing blurry vision and localized neurological weakness over the past month. The symptoms are described as mild in nature.;close monitoring
brain_menin_1185;Brain Meningiomas;56;F;Patient is experiencing coordination problems and localized neurological weakness for several weeks. The symptoms are described as moderate in nature.;close monitoring
brain_menin_1186;Brain Meningiomas;27;M;Patient is experiencing blurry vision and localized neurological weakness over the past month. The symptoms are described as tolerable in nature.;surgery
brain_menin_1187;Brain Meningiomas;22;M;Patient is experiencing blurry vision and chronic headaches over the past month. The symptoms are described as low-grade in nature.;surgery
brain_menin_1188;Brain Meningiomas;22;M;Patient is experiencing chronic headaches and localized neurological weakness over the past month. The symptoms are described as tolerable in nature.;close monitoring
brain_menin_1189;Brain Meningiomas;71;F;Patient is experiencing blurry vision and fatigue for nearly 3 months. The symptoms are described as slight in nature.;radiation therapy
brain_menin_1190;Brain Meningiomas;68;F;Patient is experiencing blurry vision and chronic headaches for nearly 3 months. The symptoms are described as slight in nature.;surgery
brain_menin_1191;Brain Meningiomas;72;F;Patient is experiencing coordination problems and blurry vision over the past month. The symptoms are described as moderate in nature.;close monitoring
brain_menin_1192;Brain Meningiomas;24;M;Patient is experiencing fatigue and speech difficulty for several weeks. The symptoms are described as mild in nature.;radiation therapy
brain_menin_1193;Brain Meningiomas;38;F;Patient is experiencing chronic headaches and speech difficulty for nearly 3 months. The symptoms are described as significant in nature.;radiation therapy
brain_menin_1194;Brain Meningiomas;42;F;Patient is experiencing coordination problems and chronic headaches for nearly 3 months. The symptoms are described as noticeable in nature.;surgery
brain_menin_1195;Brain Meningiomas;59;M;Patient is experiencing coordination problems and chronic headaches for nearly 3 months. The symptoms are described as mild in nature.;radiation therapy
brain_menin_1196;Brain Meningiomas;29;F;Patient is experiencing blurry vision and coordination problems for nearly 3 months. The symptoms are described as slight in nature.;close monitoring
brain_menin_1197;Brain Meningiomas;83;F;Patient is experiencing blurry vision and coordination problems over the past month. The symptoms are described as noticeable in nature.;radiation therapy
brain_menin_1198;Brain Meningiomas;58;F;Patient is experiencing localized neurological weakness and chronic headaches over the past month. The symptoms are described as significant in nature.;close monitoring
brain_menin_1199;Brain Meningiomas;81;F;Patient is experiencing localized neurological weakness and speech difficulty for several weeks. The symptoms are described as significant in nature.;surgery
brain_menin_1200;Brain Meningiomas;63;F;Patient is experiencing coordination problems and speech difficulty for several weeks. The symptoms are described as low-grade in nature.;close monitoring
brain_menin_1201;Brain Meningiomas;31;M;Patient is experiencing coordination problems and localized neurological weakness over the past month. The symptoms are described as significant in nature.;surgery
brain_menin_1202;Brain Meningiomas;28;M;Patient is experiencing blurry vision and fatigue for several weeks. The symptoms are described as significant in nature.;surgery
brain_menin_1203;Brain Meningiomas;63;F;Patient is experiencing coordination problems and blurry vision over the past month. The symptoms are described as low-grade in nature.;radiation therapy
brain_menin_1204;Brain Meningiomas;40;M;Patient is experiencing coordination problems and speech difficulty for several weeks. The symptoms are described as mild in nature.;surgery
brain_menin_1205;Brain Meningiomas;42;F;Patient is experiencing chronic headaches and blurry vision over the past month. The symptoms are described as noticeable in nature.;close monitoring
brain_menin_1206;Brain Meningiomas;50;M;Patient is experiencing fatigue and speech difficulty over the past month. The symptoms are described as significant in nature.;close monitoring
brain_menin_1207;Brain Meningiomas;28;M;Patient is experiencing localized neurological weakness and blurry vision over the past month. The symptoms are described as significant in nature.;surgery
brain_menin_1208;Brain Meningiomas;53;F;Patient is experiencing coordination problems and speech difficulty over the past month. The symptoms are described as mild in nature.;radiation therapy
brain_menin_1209;Brain Meningiomas;43;M;Patient is experiencing speech difficulty and fatigue over the past month. The symptoms are described as noticeable in nature.;radiation therapy
brain_menin_1210;Brain Meningiomas;24;M;Patient is experiencing chronic headaches and localized neurological weakness for nearly 3 months. The symptoms are described as mild in nature.;close monitoring
brain_menin_1211;Brain Meningiomas;32;M;Patient is experiencing speech difficulty and localized neurological weakness over the past month. The symptoms are described as noticeable in nature.;radiation therapy
brain_menin_1212;Brain Meningiomas;46;F;Patient is experiencing fatigue and chronic headaches for several weeks. The symptoms are described as significant in nature.;close monitoring
brain_menin_1213;Brain Meningiomas;52;F;Patient is experiencing blurry vision and chronic headaches over the past month. The symptoms are described as significant in nature.;close monitoring
brain_menin_1214;Brain Meningiomas;48;F;Patient is experiencing coordination problems and speech difficulty for several weeks. The symptoms are described as moderate in nature.;close monitoring
brain_menin_1215;Brain Meningiomas;36;F;Patient is experiencing localized neurological weakness and chronic headaches over the past month. The symptoms are described as significant in nature.;radiation therapy
brain_menin_1216;Brain Meningiomas;38;F;Patient is experiencing localized neurological weakness and blurry vision for nearly 3 months. The symptoms are described as low-grade in nature.;radiation therapy
brain_menin_1217;Brain Meningiomas;21;F;Patient is experiencing localized neurological weakness and chronic headaches for nearly 3 months. The symptoms are described as moderate in nature.;close monitoring
brain_menin_1218;Brain Meningiomas;59;M;Patient is experiencing localized neurological weakness and speech difficulty over the past month. The symptoms are described as noticeable in nature.;surgery
brain_menin_1219;Brain Meningiomas;35;F;Patient is experiencing chronic headaches and localized neurological weakness for several weeks. The symptoms are described as moderate in nature.;radiation therapy
brain_menin_1220;Brain Meningiomas;48;F;Patient is experiencing localized neurological weakness and coordination problems over the past month. The symptoms are described as low-grade in nature.;close monitoring
brain_menin_1221;Brain Meningiomas;83;F;Patient is experiencing fatigue and chronic headaches for nearly 3 months. The symptoms are described as slight in nature.;close monitoring
brain_menin_1222;Brain Meningiomas;57;M;Patient is experiencing coordination problems and localized neurological weakness for nearly 3 months. The symptoms are described as noticeable in nature.;surgery
brain_menin_1223;Brain Meningiomas;34;F;Patient is experiencing blurry vision and localized neurological weakness for several weeks. The symptoms are described as low-grade in nature.;surgery
brain_menin_1224;Brain Meningiomas;35;F;Patient is experiencing coordination problems and localized neurological weakness over the past month. The symptoms are described as moderate in nature.;radiation therapy
brain_menin_1225;Brain Meningiomas;56;F;Patient is experiencing coordination problems and speech difficulty for nearly 3 months. The symptoms are described as tolerable in nature.;radiation therapy
brain_menin_1226;Brain Meningiomas;39;F;Patient is experiencing fatigue and chronic headaches for several weeks. The symptoms are described as noticeable in nature.;close monitoring
brain_menin_1227;Brain Meningiomas;20;M;Patient is experiencing coordination problems and chronic headaches for several weeks. The symptoms are described as tolerable in nature.;radiation therapy
brain_menin_1228;Brain Meningiomas;58;F;Patient is experiencing coordination problems and blurry vision for several weeks. The symptoms are described as low-grade in nature.;surgery
brain_menin_1229;Brain Meningiomas;58;M;Patient is experiencing blurry vision and speech difficulty for nearly 3 months. The symptoms are described as slight in nature.;radiation therapy
brain_menin_1230;Brain Meningiomas;40;F;Patient is experiencing chronic headaches and localized neurological weakness over the past month. The symptoms are described as moderate in nature.;close monitoring
brain_menin_1231;Brain Meningiomas;76;M;Patient is experiencing speech difficulty and coordination problems for nearly 3 months. The symptoms are described as noticeable in nature.;surgery
brain_menin_1232;Brain Meningiomas;42;M;Patient is experiencing blurry vision and coordination problems for several weeks. The symptoms are described as noticeable in nature.;radiation therapy
brain_menin_1233;Brain Meningiomas;40;F;Patient is experiencing fatigue and chronic headaches over the past month. The symptoms are described as significant in nature.;surgery
brain_menin_1234;Brain Meningiomas;56;F;Patient is experiencing localized neurological weakness and chronic headaches over the past month. The symptoms are described as slight in nature.;surgery
brain_menin_1235;Brain Meningiomas;74;M;Patient is experiencing localized neurological weakness and fatigue over the past month. The symptoms are described as tolerable in nature.;radiation therapy
brain_menin_1236;Brain Meningiomas;19;F;Patient is experiencing chronic headaches and speech difficulty over the past month. The symptoms are described as noticeable in nature.;radiation therapy
brain_menin_1237;Brain Meningiomas;72;M;Patient is experiencing speech difficulty and coordination problems over the past month. The symptoms are described as noticeable in nature.;close monitoring
brain_menin_1238;Brain Meningiomas;20;F;Patient is experiencing coordination problems and fatigue for several weeks. The symptoms are described as tolerable in nature.;surgery
brain_menin_1239;Brain Meningiomas;78;F;Patient is experiencing localized neurological weakness and chronic headaches over the past month. The symptoms are described as mild in nature.;radiation therapy
brain_menin_1240;Brain Meningiomas;82;M;Patient is experiencing coordination problems and speech difficulty over the past month. The symptoms are described as significant in nature.;close monitoring
brain_menin_1241;Brain Meningiomas;76;M;Patient is experiencing coordination problems and speech difficulty for several weeks. The symptoms are described as moderate in nature.;surgery
brain_menin_1242;Brain Meningiomas;84;M;Patient is experiencing blurry vision and localized neurological weakness over the past month. The symptoms are described as noticeable in nature.;radiation therapy
brain_menin_1243;Brain Meningiomas;29;M;Patient is experiencing speech difficulty and fatigue over the past month. The symptoms are described as mild in nature.;surgery
brain_menin_1244;Brain Meningiomas;19;M;Patient is experiencing chronic headaches and localized neurological weakness for several weeks. The symptoms are described as tolerable in nature.;radiation therapy
brain_menin_1245;Brain Meningiomas;78;F;Patient is experiencing coordination problems and speech difficulty for several weeks. The symptoms are described as tolerable in nature.;close monitoring
brain_menin_1246;Brain Meningiomas;49;M;Patient is experiencing speech difficulty and blurry vision for nearly 3 months. The symptoms are described as low-grade in nature.;surgery
brain_menin_1247;Brain Meningiomas;83;M;Patient is experiencing coordination problems and blurry vision for several weeks. The symptoms are described as low-grade in nature.;close monitoring
brain_menin_1248;Brain Meningiomas;85;F;Patient is experiencing localized neurological weakness and speech difficulty for nearly 3 months. The symptoms are described as noticeable in nature.;surgery
brain_menin_1249;Brain Meningiomas;52;M;Patient is experiencing localized neurological weakness and blurry vision for several weeks. The symptoms are described as mild in nature.;surgery
brain_menin_1250;Brain Meningiomas;83;F;Patient is experiencing speech difficulty and localized neurological weakness for nearly 3 months. The symptoms are described as mild in nature.;radiation therapy
brain_menin_1251;Brain Meningiomas;23;M;Patient is experiencing fatigue and localized neurological weakness for nearly 3 months. The symptoms are described as slight in nature.;radiation therapy
brain_menin_1252;Brain Meningiomas;45;F;Patient is experiencing fatigue and chronic headaches for several weeks. The symptoms are described as significant in nature.;radiation therapy
brain_menin_1253;Brain Meningiomas;48;M;Patient is experiencing fatigue and chronic headaches for nearly 3 months. The symptoms are described as mild in nature.;radiation therapy
brain_menin_1254;Brain Meningiomas;58;F;Patient is experiencing coordination problems and chronic headaches for nearly 3 months. The symptoms are described as significant in nature.;surgery
brain_menin_1255;Brain Meningiomas;77;F;Patient is experiencing blurry vision and chronic headaches for several weeks. The symptoms are described as mild in nature.;close monitoring
brain_menin_1256;Brain Meningiomas;35;M;Patient is experiencing fatigue and localized neurological weakness for several weeks. The symptoms are described as moderate in nature.;close monitoring
brain_menin_1257;Brain Meningiomas;76;M;Patient is experiencing localized neurological weakness and chronic headaches over the past month. The symptoms are described as low-grade in nature.;close monitoring
brain_menin_1258;Brain Meningiomas;45;F;Patient is experiencing blurry vision and speech difficulty for nearly 3 months. The symptoms are described as slight in nature.;radiation therapy
brain_menin_1259;Brain Meningiomas;55;M;Patient is experiencing blurry vision and fatigue for several weeks. The symptoms are described as low-grade in nature.;radiation therapy
brain_menin_1260;Brain Meningiomas;62;F;Patient is experiencing fatigue and localized neurological weakness for nearly 3 months. The symptoms are described as moderate in nature.;close monitoring
brain_menin_1261;Brain Meningiomas;45;M;Patient is experiencing localized neurological weakness and chronic headaches over the past month. The symptoms are described as significant in nature.;close monitoring
brain_menin_1262;Brain Meningiomas;45;M;Patient is experiencing coordination problems and speech difficulty over the past month. The symptoms are described as significant in nature.;radiation therapy
brain_menin_1263;Brain Meningiomas;73;M;Patient is experiencing localized neurological weakness and coordination problems over the past month. The symptoms are described as tolerable in nature.;surgery
brain_menin_1264;Brain Meningiomas;32;M;Patient is experiencing localized neurological weakness and fatigue for several weeks. The symptoms are described as noticeable in nature.;close monitoring
brain_menin_1265;Brain Meningiomas;76;F;Patient is experiencing speech difficulty and blurry vision for several weeks. The symptoms are described as noticeable in nature.;radiation therapy
brain_menin_1266;Brain Meningiomas;75;M;Patient is experiencing chronic headaches and localized neurological weakness for nearly 3 months. The symptoms are described as tolerable in nature.;radiation therapy
brain_menin_1267;Brain Meningiomas;56;F;Patient is experiencing blurry vision and speech difficulty for several weeks. The symptoms are described as moderate in nature.;surgery
brain_menin_1268;Brain Meningiomas;36;M;Patient is experiencing blurry vision and speech difficulty over the past month. The symptoms are described as moderate in nature.;surgery
brain_menin_1269;Brain Meningiomas;54;M;Patient is experiencing blurry vision and fatigue for several weeks. The symptoms are described as slight in nature.;close monitoring
brain_menin_1270;Brain Meningiomas;63;M;Patient is experiencing fatigue and speech difficulty over the past month. The symptoms are described as low-grade in nature.;surgery
brain_menin_1271;Brain Meningiomas;71;M;Patient is experiencing speech difficulty and localized neurological weakness for nearly 3 months. The symptoms are described as noticeable in nature.;surgery
brain_menin_1272;Brain Meningiomas;69;M;Patient is experiencing chronic headaches and speech difficulty for several weeks. The symptoms are described as low-grade in nature.;surgery
brain_menin_1273;Brain Meningiomas;70;F;Patient is experiencing localized neurological weakness and blurry vision for nearly 3 months. The symptoms are described as slight in nature.;surgery
brain_menin_1274;Brain Meningiomas;68;F;Patient is experiencing speech difficulty and fatigue over the past month. The symptoms are described as moderate in nature.;surgery
brain_menin_1275;Brain Meningiomas;42;F;Patient is experiencing speech difficulty and chronic headaches for several weeks. The symptoms are described as tolerable in nature.;surgery
brain_menin_1276;Brain Meningiomas;44;M;Patient is experiencing coordination problems and speech difficulty for nearly 3 months. The symptoms are described as moderate in nature.;radiation therapy
brain_menin_1277;Brain Meningiomas;52;M;Patient is experiencing blurry vision and localized neurological weakness for nearly 3 months. The symptoms are described as moderate in nature.;close monitoring
brain_menin_1278;Brain Meningiomas;66;M;Patient is experiencing fatigue and blurry vision for several weeks. The symptoms are described as mild in nature.;radiation therapy
brain_menin_1279;Brain Meningiomas;41;M;Patient is experiencing coordination problems and fatigue for nearly 3 months. The symptoms are described as noticeable in nature.;close monitoring
brain_menin_1280;Brain Meningiomas;69;M;Patient is experiencing speech difficulty and blurry vision for nearly 3 months. The symptoms are described as mild in nature.;surgery
brain_menin_1281;Brain Meningiomas;66;M;Patient is experiencing coordination problems and fatigue for nearly 3 months. The symptoms are described as significant in nature.;surgery
brain_menin_1282;Brain Meningiomas;35;M;Patient is experiencing fatigue and localized neurological weakness for nearly 3 months. The symptoms are described as low-grade in nature.;surgery
brain_menin_1283;Brain Meningiomas;45;F;Patient is experiencing speech difficulty and localized neurological weakness for several weeks. The symptoms are described as noticeable in nature.;close monitoring
brain_menin_1284;Brain Meningiomas;65;F;Patient is experiencing blurry vision and speech difficulty for nearly 3 months. The symptoms are described as tolerable in nature.;close monitoring
brain_menin_1285;Brain Meningiomas;77;M;Patient is experiencing coordination problems and localized neurological weakness for several weeks. The symptoms are described as slight in nature.;close monitoring
brain_menin_1286;Brain Meningiomas;56;F;Patient is experiencing speech difficulty and blurry vision for nearly 3 months. The symptoms are described as moderate in nature.;close monitoring
brain_menin_1287;Brain Meningiomas;48;M;Patient is experiencing localized neurological weakness and blurry vision for several weeks. The symptoms are described as tolerable in nature.;radiation therapy
brain_menin_1288;Brain Meningiomas;49;M;Patient is experiencing blurry vision and speech difficulty for several weeks. The symptoms are described as noticeable in nature.;surgery
brain_menin_1289;Brain Meningiomas;53;F;Patient is experiencing speech difficulty and coordination problems over the past month. The symptoms are described as moderate in nature.;close monitoring
brain_menin_1290;Brain Meningiomas;61;F;Patient is experiencing chronic headaches and coordination problems over the past month. The symptoms are described as significant in nature.;surgery
brain_menin_1291;Brain Meningiomas;63;M;Patient is experiencing blurry vision and coordination problems over the past month. The symptoms are described as moderate in nature.;close monitoring
brain_menin_1292;Brain Meningiomas;52;M;Patient is experiencing fatigue and localized neurological weakness over the past month. The symptoms are described as slight in nature.;surgery
brain_menin_1293;Brain Meningiomas;53;M;Patient is experiencing fatigue and speech difficulty for several weeks. The symptoms are described as tolerable in nature.;surgery
brain_menin_1294;Brain Meningiomas;28;M;Patient is experiencing chronic headaches and localized neurological weakness for nearly 3 months. The symptoms are described as mild in nature.;radiation therapy
brain_menin_1295;Brain Meningiomas;41;M;Patient is experiencing localized neurological weakness and coordination problems for nearly 3 months. The symptoms are described as moderate in nature.;close monitoring
brain_menin_1296;Brain Meningiomas;27;M;Patient is experiencing chronic headaches and speech difficulty for several weeks. The symptoms are described as moderate in nature.;close monitoring
brain_menin_1297;Brain Meningiomas;60;M;Patient is experiencing speech difficulty and localized neurological weakness for several weeks. The symptoms are described as significant in nature.;close monitoring
brain_menin_1298;Brain Meningiomas;47;M;Patient is experiencing localized neurological weakness and chronic headaches for nearly 3 months. The symptoms are described as noticeable in nature.;close monitoring
brain_menin_1299;Brain Meningiomas;78;M;Patient is experiencing coordination problems and chronic headaches over the past month. The symptoms are described as tolerable in nature.;close monitoring
brain_menin_1300;Brain Meningiomas;66;M;Patient is experiencing localized neurological weakness and fatigue for nearly 3 months. The symptoms are described as moderate in nature.;radiation therapy
brain_menin_1301;Brain Meningiomas;48;M;Patient is experiencing localized neurological weakness and chronic headaches for several weeks. The symptoms are described as mild in nature.;radiation therapy
brain_menin_1302;Brain Meningiomas;79;F;Patient is experiencing localized neurological weakness and blurry vision over the past month. The symptoms are described as significant in nature.;surgery
brain_menin_1303;Brain Meningiomas;85;F;Patient is experiencing chronic headaches and speech difficulty over the past month. The symptoms are described as low-grade in nature.;radiation therapy
brain_menin_1304;Brain Meningiomas;50;F;Patient is experiencing localized neurological weakness and coordination problems over the past month. The symptoms are described as low-grade in nature.;radiation therapy
brain_menin_1305;Brain Meningiomas;51;F;Patient is experiencing chronic headaches and blurry vision for nearly 3 months. The symptoms are described as moderate in nature.;radiation therapy
brain_menin_1306;Brain Meningiomas;58;M;Patient is experiencing fatigue and speech difficulty over the past month. The symptoms are described as moderate in nature.;close monitoring
brain_menin_1307;Brain Meningiomas;68;F;Patient is experiencing speech difficulty and localized neurological weakness over the past month. The symptoms are described as noticeable in nature.;surgery
brain_menin_1308;Brain Meningiomas;61;M;Patient is experiencing localized neurological weakness and chronic headaches for several weeks. The symptoms are described as tolerable in nature.;close monitoring
brain_menin_1309;Brain Meningiomas;45;M;Patient is experiencing chronic headaches and fatigue over the past month. The symptoms are described as tolerable in nature.;surgery
brain_menin_1310;Brain Meningiomas;81;F;Patient is experiencing speech difficulty and fatigue for several weeks. The symptoms are described as low-grade in nature.;surgery
brain_menin_1311;Brain Meningiomas;37;F;Patient is experiencing coordination problems and chronic headaches for several weeks. The symptoms are described as mild in nature.;surgery
brain_menin_1312;Brain Meningiomas;44;M;Patient is experiencing blurry vision and localized neurological weakness over the past month. The symptoms are described as noticeable in nature.;close monitoring
brain_menin_1313;Brain Meningiomas;39;M;Patient is experiencing speech difficulty and chronic headaches for several weeks. The symptoms are described as moderate in nature.;close monitoring
brain_menin_1314;Brain Meningiomas;84;F;Patient is experiencing coordination problems and fatigue over the past month. The symptoms are described as slight in nature.;close monitoring
brain_menin_1315;Brain Meningiomas;47;F;Patient is experiencing coordination problems and localized neurological weakness over the past month. The symptoms are described as tolerable in nature.;radiation therapy
brain_menin_1316;Brain Meningiomas;61;M;Patient is experiencing coordination problems and speech difficulty for nearly 3 months. The symptoms are described as tolerable in nature.;surgery
brain_menin_1317;Brain Meningiomas;72;M;Patient is experiencing fatigue and chronic headaches over the past month. The symptoms are described as significant in nature.;close monitoring
brain_menin_1318;Brain Meningiomas;33;M;Patient is experiencing speech difficulty and localized neurological weakness for nearly 3 months. The symptoms are described as tolerable in nature.;radiation therapy
brain_menin_1319;Brain Meningiomas;84;F;Patient is experiencing localized neurological weakness and blurry vision for nearly 3 months. The symptoms are described as significant in nature.;surgery
brain_menin_1320;Brain Meningiomas;50;M;Patient is experiencing fatigue and speech difficulty over the past month. The symptoms are described as significant in nature.;radiation therapy
brain_menin_1321;Brain Meningiomas;48;F;Patient is experiencing fatigue and speech difficulty over the past month. The symptoms are described as significant in nature.;radiation therapy
brain_menin_1322;Brain Meningiomas;37;M;Patient is experiencing localized neurological weakness and blurry vision for several weeks. The symptoms are described as significant in nature.;close monitoring
brain_menin_1323;Brain Meningiomas;64;M;Patient is experiencing speech difficulty and blurry vision for several weeks. The symptoms are described as tolerable in nature.;radiation therapy
brain_menin_1324;Brain Meningiomas;80;M;Patient is experiencing blurry vision and fatigue for several weeks. The symptoms are described as noticeable in nature.;close monitoring
brain_menin_1325;Brain Meningiomas;42;M;Patient is experiencing speech difficulty and coordination problems for nearly 3 months. The symptoms are described as low-grade in nature.;radiation therapy
brain_menin_1326;Brain Meningiomas;71;M;Patient is experiencing speech difficulty and fatigue for nearly 3 months. The symptoms are described as significant in nature.;surgery
brain_menin_1327;Brain Meningiomas;72;M;Patient is experiencing fatigue and chronic headaches over the past month. The symptoms are described as tolerable in nature.;radiation therapy
brain_menin_1328;Brain Meningiomas;27;F;Patient is experiencing coordination problems and localized neurological weakness for several weeks. The symptoms are described as mild in nature.;surgery
brain_menin_1329;Brain Meningiomas;61;F;Patient is experiencing localized neurological weakness and fatigue for nearly 3 months. The symptoms are described as noticeable in nature.;close monitoring
brain_menin_1330;Brain Meningiomas;64;M;Patient is experiencing localized neurological weakness and blurry vision for several weeks. The symptoms are described as noticeable in nature.;close monitoring
brain_menin_1331;Brain Meningiomas;60;M;Patient is experiencing speech difficulty and coordination problems for nearly 3 months. The symptoms are described as moderate in nature.;radiation therapy
brain_menin_1332;Brain Meningiomas;49;F;Patient is experiencing fatigue and blurry vision over the past month. The symptoms are described as low-grade in nature.;radiation therapy
brain_menin_1333;Brain Meningiomas;47;F;Patient is experiencing coordination problems and blurry vision over the past month. The symptoms are described as moderate in nature.;surgery
brain_menin_1334;Brain Meningiomas;66;F;Patient is experiencing speech difficulty and fatigue over the past month. The symptoms are described as mild in nature.;close monitoring
brain_menin_1335;Brain Meningiomas;23;M;Patient is experiencing speech difficulty and localized neurological weakness for nearly 3 months. The symptoms are described as moderate in nature.;radiation therapy
brain_menin_1336;Brain Meningiomas;23;M;Patient is experiencing blurry vision and localized neurological weakness for several weeks. The symptoms are described as significant in nature.;close monitoring
brain_menin_1337;Brain Meningiomas;82;F;Patient is experiencing coordination problems and blurry vision over the past month. The symptoms are described as tolerable in nature.;surgery
brain_menin_1338;Brain Meningiomas;69;F;Patient is experiencing chronic headaches and speech difficulty for several weeks. The symptoms are described as moderate in nature.;surgery
brain_menin_1339;Brain Meningiomas;54;M;Patient is experiencing speech difficulty and fatigue for nearly 3 months. The symptoms are described as low-grade in nature.;surgery
brain_menin_1340;Brain Meningiomas;62;M;Patient is experiencing blurry vision and coordination problems over the past month. The symptoms are described as significant in nature.;radiation therapy
brain_menin_1341;Brain Meningiomas;42;F;Patient is experiencing coordination problems and speech difficulty for several weeks. The symptoms are described as low-grade in nature.;close monitoring
brain_menin_1342;Brain Meningiomas;55;M;Patient is experiencing speech difficulty and coordination problems for nearly 3 months. The symptoms are described as slight in nature.;close monitoring
brain_menin_1343;Brain Meningiomas;46;M;Patient is experiencing fatigue and blurry vision for several weeks. The symptoms are described as tolerable in nature.;close monitoring
brain_menin_1344;Brain Meningiomas;81;M;Patient is experiencing chronic headaches and fatigue for several weeks. The symptoms are described as mild in nature.;surgery
brain_menin_1345;Brain Meningiomas;50;M;Patient is experiencing fatigue and localized neurological weakness for nearly 3 months. The symptoms are described as mild in nature.;close monitoring
brain_menin_1346;Brain Meningiomas;76;M;Patient is experiencing localized neurological weakness and fatigue for several weeks. The symptoms are described as noticeable in nature.;radiation therapy
brain_menin_1347;Brain Meningiomas;24;F;Patient is experiencing blurry vision and chronic headaches for nearly 3 months. The symptoms are described as noticeable in nature.;surgery
brain_menin_1348;Brain Meningiomas;76;M;Patient is experiencing chronic headaches and coordination problems over the past month. The symptoms are described as noticeable in nature.;radiation therapy
brain_menin_1349;Brain Meningiomas;56;M;Patient is experiencing chronic headaches and fatigue for nearly 3 months. The symptoms are described as slight in nature.;surgery
brain_menin_1350;Brain Meningiomas;59;F;Patient is experiencing speech difficulty and localized neurological weakness for several weeks. The symptoms are described as low-grade in nature.;surgery
brain_menin_1351;Brain Meningiomas;84;M;Patient is experiencing speech difficulty and coordination problems over the past month. The symptoms are described as noticeable in nature.;close monitoring
brain_menin_1352;Brain Meningiomas;82;M;Patient is experiencing localized neurological weakness and blurry vision over the past month. The symptoms are described as tolerable in nature.;close monitoring
brain_menin_1353;Brain Meningiomas;69;F;Patient is experiencing fatigue and coordination problems for several weeks. The symptoms are described as tolerable in nature.;radiation therapy
brain_menin_1354;Brain Meningiomas;34;F;Patient is experiencing localized neurological weakness and speech difficulty for several weeks. The symptoms are described as significant in nature.;radiation therapy
brain_menin_1355;Brain Meningiomas;56;M;Patient is experiencing localized neurological weakness and coordination problems for several weeks. The symptoms are described as moderate in nature.;close monitoring
brain_menin_1356;Brain Meningiomas;69;F;Patient is experiencing coordination problems and chronic headaches over the past month. The symptoms are described as slight in nature.;radiation therapy
brain_menin_1357;Brain Meningiomas;59;M;Patient is experiencing localized neurological weakness and chronic headaches for nearly 3 months. The symptoms are described as tolerable in nature.;close monitoring
brain_menin_1358;Brain Meningiomas;36;M;Patient is experiencing speech difficulty and fatigue over the past month. The symptoms are described as significant in nature.;close monitoring
brain_menin_1359;Brain Meningiomas;76;M;Patient is experiencing coordination problems and speech difficulty for several weeks. The symptoms are described as tolerable in nature.;surgery
brain_menin_1360;Brain Meningiomas;62;F;Patient is experiencing blurry vision and localized neurological weakness over the past month. The symptoms are described as tolerable in nature.;surgery
brain_menin_1361;Brain Meningiomas;52;M;Patient is experiencing chronic headaches and speech difficulty over the past month. The symptoms are described as noticeable in nature.;close monitoring
brain_menin_1362;Brain Meningiomas;43;F;Patient is experiencing fatigue and speech difficulty over the past month. The symptoms are described as low-grade in nature.;surgery
brain_menin_1363;Brain Meningiomas;53;M;Patient is experiencing blurry vision and chronic headaches for nearly 3 months. The symptoms are described as moderate in nature.;radiation therapy
brain_menin_1364;Brain Meningiomas;85;M;Patient is experiencing localized neurological weakness and blurry vision for nearly 3 months. The symptoms are described as tolerable in nature.;surgery
brain_menin_1365;Brain Meningiomas;69;M;Patient is experiencing localized neurological weakness and fatigue for several weeks. The symptoms are described as moderate in nature.;radiation therapy
brain_menin_1366;Brain Meningiomas;69;F;Patient is experiencing localized neurological weakness and coordination problems for several weeks. The symptoms are described as mild in nature.;radiation therapy
brain_menin_1367;Brain Meningiomas;64;F;Patient is experiencing speech difficulty and localized neurological weakness over the past month. The symptoms are described as slight in nature.;close monitoring
brain_menin_1368;Brain Meningiomas;46;M;Patient is experiencing fatigue and chronic headaches over the past month. The symptoms are described as significant in nature.;surgery
brain_menin_1369;Brain Meningiomas;77;F;Patient is experiencing localized neurological weakness and blurry vision for several weeks. The symptoms are described as slight in nature.;radiation therapy
brain_menin_1370;Brain Meningiomas;81;M;Patient is experiencing speech difficulty and coordination problems over the past month. The symptoms are described as low-grade in nature.;surgery
brain_menin_1371;Brain Meningiomas;85;F;Patient is experiencing chronic headaches and coordination problems over the past month. The symptoms are described as tolerable in nature.;close monitoring
brain_menin_1372;Brain Meningiomas;21;M;Patient is experiencing chronic headaches and fatigue over the past month. The symptoms are described as mild in nature.;surgery
brain_menin_1373;Brain Meningiomas;75;F;Patient is experiencing speech difficulty and chronic headaches for nearly 3 months. The symptoms are described as slight in nature.;radiation therapy
brain_menin_1374;Brain Meningiomas;38;M;Patient is experiencing chronic headaches and coordination problems over the past month. The symptoms are described as low-grade in nature.;surgery
brain_menin_1375;Brain Meningiomas;47;M;Patient is experiencing speech difficulty and fatigue for nearly 3 months. The symptoms are described as moderate in nature.;surgery
brain_menin_1376;Brain Meningiomas;63;F;Patient is experiencing localized neurological weakness and coordination problems over the past month. The symptoms are described as noticeable in nature.;surgery
brain_menin_1377;Brain Meningiomas;40;M;Patient is experiencing blurry vision and speech difficulty for nearly 3 months. The symptoms are described as mild in nature.;surgery
brain_menin_1378;Brain Meningiomas;37;M;Patient is experiencing fatigue and chronic headaches over the past month. The symptoms are described as tolerable in nature.;radiation therapy
brain_menin_1379;Brain Meningiomas;38;F;Patient is experiencing coordination problems and chronic headaches over the past month. The symptoms are described as low-grade in nature.;surgery
brain_menin_1380;Brain Meningiomas;35;F;Patient is experiencing localized neurological weakness and speech difficulty over the past month. The symptoms are described as low-grade in nature.;close monitoring
brain_menin_1381;Brain Meningiomas;73;M;Patient is experiencing fatigue and chronic headaches for nearly 3 months. The symptoms are described as significant in nature.;close monitoring
brain_menin_1382;Brain Meningiomas;61;M;Patient is experiencing speech difficulty and fatigue for several weeks. The symptoms are described as noticeable in nature.;surgery
brain_menin_1383;Brain Meningiomas;47;F;Patient is experiencing coordination problems and speech difficulty for nearly 3 months. The symptoms are described as mild in nature.;radiation therapy
brain_menin_1384;Brain Meningiomas;55;M;Patient is experiencing chronic headaches and blurry vision for several weeks. The symptoms are described as mild in nature.;radiation therapy
brain_menin_1385;Brain Meningiomas;19;F;Patient is experiencing fatigue and speech difficulty for several weeks. The symptoms are described as significant in nature.;surgery
brain_menin_1386;Brain Meningiomas;25;M;Patient is experiencing chronic headaches and speech difficulty over the past month. The symptoms are described as noticeable in nature.;radiation therapy
brain_menin_1387;Brain Meningiomas;18;M;Patient is experiencing localized neurological weakness and speech difficulty for several weeks. The symptoms are described as slight in nature.;radiation therapy
brain_menin_1388;Brain Meningiomas;78;F;Patient is experiencing coordination problems and speech difficulty for nearly 3 months. The symptoms are described as noticeable in nature.;radiation therapy
brain_menin_1389;Brain Meningiomas;48;M;Patient is experiencing speech difficulty and coordination problems for nearly 3 months. The symptoms are described as low-grade in nature.;surgery
brain_menin_1390;Brain Meningiomas;18;M;Patient is experiencing fatigue and localized neurological weakness for several weeks. The symptoms are described as moderate in nature.;surgery
brain_menin_1391;Brain Meningiomas;63;F;Patient is experiencing speech difficulty and blurry vision for several weeks. The symptoms are described as significant in nature.;radiation therapy
brain_menin_1392;Brain Meningiomas;38;M;Patient is experiencing blurry vision and localized neurological weakness for several weeks. The symptoms are described as mild in nature.;close monitoring
brain_menin_1393;Brain Meningiomas;18;M;Patient is experiencing blurry vision and chronic headaches for nearly 3 months. The symptoms are described as significant in nature.;close monitoring
brain_menin_1394;Brain Meningiomas;49;M;Patient is experiencing localized neurological weakness and chronic headaches for several weeks. The symptoms are described as slight in nature.;radiation therapy
brain_menin_1395;Brain Meningiomas;25;M;Patient is experiencing speech difficulty and chronic headaches over the past month. The symptoms are described as low-grade in nature.;close monitoring
brain_menin_1396;Brain Meningiomas;23;F;Patient is experiencing coordination problems and localized neurological weakness over the past month. The symptoms are described as moderate in nature.;close monitoring
brain_menin_1397;Brain Meningiomas;71;M;Patient is experiencing fatigue and localized neurological weakness for nearly 3 months. The symptoms are described as moderate in nature.;radiation therapy
brain_menin_1398;Brain Meningiomas;49;F;Patient is experiencing blurry vision and localized neurological weakness for several weeks. The symptoms are described as significant in nature.;radiation therapy
brain_menin_1399;Brain Meningiomas;23;M;Patient is experiencing speech difficulty and chronic headaches for nearly 3 months. The symptoms are described as low-grade in nature.;radiation therapy
brain_menin_1400;Brain Meningiomas;82;F;Patient is experiencing speech difficulty and chronic headaches over the past month. The symptoms are described as noticeable in nature.;surgery
brain_menin_1401;Brain Meningiomas;65;M;Patient is experiencing speech difficulty and chronic headaches over the past month. The symptoms are described as noticeable in nature.;radiation therapy
brain_menin_1402;Brain Meningiomas;61;M;Patient is experiencing fatigue and speech difficulty for nearly 3 months. The symptoms are described as tolerable in nature.;close monitoring
brain_menin_1403;Brain Meningiomas;82;M;Patient is experiencing chronic headaches and blurry vision for nearly 3 months. The symptoms are described as slight in nature.;radiation therapy
brain_menin_1404;Brain Meningiomas;63;F;Patient is experiencing speech difficulty and blurry vision over the past month. The symptoms are described as significant in nature.;surgery
brain_menin_1405;Brain Meningiomas;24;M;Patient is experiencing blurry vision and fatigue for nearly 3 months. The symptoms are described as moderate in nature.;surgery
brain_menin_1406;Brain Meningiomas;43;M;Patient is experiencing coordination problems and fatigue for nearly 3 months. The symptoms are described as low-grade in nature.;surgery
brain_menin_1407;Brain Meningiomas;35;F;Patient is experiencing speech difficulty and localized neurological weakness for several weeks. The symptoms are described as moderate in nature.;surgery
brain_menin_1408;Brain Meningiomas;65;F;Patient is experiencing chronic headaches and coordination problems for nearly 3 months. The symptoms are described as low-grade in nature.;surgery
brain_menin_1409;Brain Meningiomas;73;M;Patient is experiencing blurry vision and chronic headaches for several weeks. The symptoms are described as moderate in nature.;radiation therapy
brain_menin_1410;Brain Meningiomas;64;M;Patient is experiencing speech difficulty and chronic headaches for several weeks. The symptoms are described as moderate in nature.;radiation therapy
brain_menin_1411;Brain Meningiomas;23;F;Patient is experiencing localized neurological weakness and blurry vision over the past month. The symptoms are described as tolerable in nature.;close monitoring
brain_menin_1412;Brain Meningiomas;39;M;Patient is experiencing speech difficulty and blurry vision for nearly 3 months. The symptoms are described as significant in nature.;surgery
brain_menin_1413;Brain Meningiomas;56;F;Patient is experiencing localized neurological weakness and speech difficulty for nearly 3 months. The symptoms are described as significant in nature.;radiation therapy
brain_menin_1414;Brain Meningiomas;61;M;Patient is experiencing speech difficulty and chronic headaches for several weeks. The symptoms are described as low-grade in nature.;surgery
brain_menin_1415;Brain Meningiomas;61;F;Patient is experiencing speech difficulty and fatigue for nearly 3 months. The symptoms are described as mild in nature.;surgery
brain_menin_1416;Brain Meningiomas;41;F;Patient is experiencing fatigue and speech difficulty over the past month. The symptoms are described as tolerable in nature.;radiation therapy
brain_menin_1417;Brain Meningiomas;73;M;Patient is experiencing fatigue and chronic headaches for several weeks. The symptoms are described as mild in nature.;radiation therapy
brain_menin_1418;Brain Meningiomas;25;M;Patient is experiencing chronic headaches and fatigue over the past month. The symptoms are described as mild in nature.;close monitoring
brain_menin_1419;Brain Meningiomas;67;M;Patient is experiencing speech difficulty and blurry vision for nearly 3 months. The symptoms are described as slight in nature.;radiation therapy
brain_menin_1420;Brain Meningiomas;49;M;Patient is experiencing speech difficulty and coordination problems over the past month. The symptoms are described as noticeable in nature.;close monitoring
brain_menin_1421;Brain Meningiomas;59;M;Patient is experiencing chronic headaches and blurry vision over the past month. The symptoms are described as noticeable in nature.;close monitoring
brain_menin_1422;Brain Meningiomas;74;M;Patient is experiencing blurry vision and chronic headaches for several weeks. The symptoms are described as mild in nature.;close monitoring
brain_menin_1423;Brain Meningiomas;68;F;Patient is experiencing speech difficulty and coordination problems over the past month. The symptoms are described as moderate in nature.;close monitoring
brain_menin_1424;Brain Meningiomas;70;M;Patient is experiencing blurry vision and coordination problems for nearly 3 months. The symptoms are described as low-grade in nature.;close monitoring
brain_menin_1425;Brain Meningiomas;30;M;Patient is experiencing chronic headaches and blurry vision for several weeks. The symptoms are described as moderate in nature.;radiation therapy
brain_menin_1426;Brain Meningiomas;73;M;Patient is experiencing localized neurological weakness and coordination problems for nearly 3 months. The symptoms are described as low-grade in nature.;surgery
brain_menin_1427;Brain Meningiomas;33;M;Patient is experiencing chronic headaches and localized neurological weakness for nearly 3 months. The symptoms are described as slight in nature.;close monitoring
brain_menin_1428;Brain Meningiomas;50;M;Patient is experiencing chronic headaches and blurry vision for several weeks. The symptoms are described as significant in nature.;radiation therapy
brain_menin_1429;Brain Meningiomas;58;F;Patient is experiencing coordination problems and chronic headaches for several weeks. The symptoms are described as slight in nature.;radiation therapy
brain_menin_1430;Brain Meningiomas;84;M;Patient is experiencing coordination problems and chronic headaches for nearly 3 months. The symptoms are described as tolerable in nature.;close monitoring
brain_menin_1431;Brain Meningiomas;33;M;Patient is experiencing coordination problems and blurry vision for nearly 3 months. The symptoms are described as mild in nature.;surgery
brain_menin_1432;Brain Meningiomas;61;F;Patient is experiencing fatigue and localized neurological weakness for several weeks. The symptoms are described as significant in nature.;radiation therapy
brain_menin_1433;Brain Meningiomas;49;F;Patient is experiencing blurry vision and chronic headaches for nearly 3 months. The symptoms are described as low-grade in nature.;surgery
brain_menin_1434;Brain Meningiomas;45;F;Patient is experiencing localized neurological weakness and coordination problems over the past month. The symptoms are described as significant in nature.;close monitoring
brain_menin_1435;Brain Meningiomas;54;M;Patient is experiencing chronic headaches and blurry vision for several weeks. The symptoms are described as moderate in nature.;surgery
brain_menin_1436;Brain Meningiomas;75;F;Patient is experiencing localized neurological weakness and blurry vision over the past month. The symptoms are described as slight in nature.;radiation therapy
brain_menin_1437;Brain Meningiomas;31;M;Patient is experiencing coordination problems and chronic headaches for several weeks. The symptoms are described as mild in nature.;surgery
brain_menin_1438;Brain Meningiomas;56;M;Patient is experiencing fatigue and speech difficulty for several weeks. The symptoms are described as moderate in nature.;surgery
brain_menin_1439;Brain Meningiomas;41;M;Patient is experiencing blurry vision and localized neurological weakness for nearly 3 months. The symptoms are described as mild in nature.;radiation therapy
brain_menin_1440;Brain Meningiomas;32;F;Patient is experiencing blurry vision and chronic headaches for several weeks. The symptoms are described as low-grade in nature.;close monitoring
brain_menin_1441;Brain Meningiomas;83;F;Patient is experiencing chronic headaches and fatigue over the past month. The symptoms are described as moderate in nature.;radiation therapy
brain_menin_1442;Brain Meningiomas;46;F;Patient is experiencing blurry vision and chronic headaches over the past month. The symptoms are described as noticeable in nature.;radiation therapy
brain_menin_1443;Brain Meningiomas;30;M;Patient is experiencing fatigue and coordination problems over the past month. The symptoms are described as moderate in nature.;surgery
brain_menin_1444;Brain Meningiomas;19;M;Patient is experiencing localized neurological weakness and coordination problems for several weeks. The symptoms are described as noticeable in nature.;surgery
brain_menin_1445;Brain Meningiomas;43;M;Patient is experiencing localized neurological weakness and fatigue for several weeks. The symptoms are described as low-grade in nature.;surgery
brain_menin_1446;Brain Meningiomas;75;F;Patient is experiencing fatigue and blurry vision for several weeks. The symptoms are described as mild in nature.;surgery
brain_menin_1447;Brain Meningiomas;81;F;Patient is experiencing coordination problems and blurry vision over the past month. The symptoms are described as tolerable in nature.;surgery
brain_menin_1448;Brain Meningiomas;45;M;Patient is experiencing speech difficulty and coordination problems for nearly 3 months. The symptoms are described as slight in nature.;surgery
brain_menin_1449;Brain Meningiomas;66;M;Patient is experiencing blurry vision and coordination problems for several weeks. The symptoms are described as noticeable in nature.;surgery
brain_menin_1450;Brain Meningiomas;37;F;Patient is experiencing coordination problems and blurry vision over the past month. The symptoms are described as mild in nature.;radiation therapy
brain_menin_1451;Brain Meningiomas;58;M;Patient is experiencing chronic headaches and localized neurological weakness for nearly 3 months. The symptoms are described as mild in nature.;radiation therapy
brain_menin_1452;Brain Meningiomas;60;M;Patient is experiencing speech difficulty and fatigue for several weeks. The symptoms are described as tolerable in nature.;radiation therapy
brain_menin_1453;Brain Meningiomas;55;M;Patient is experiencing localized neurological weakness and coordination problems for nearly 3 months. The symptoms are described as moderate in nature.;radiation therapy
brain_menin_1454;Brain Meningiomas;19;M;Patient is experiencing localized neurological weakness and coordination problems for several weeks. The symptoms are described as slight in nature.;close monitoring
brain_menin_1455;Brain Meningiomas;51;F;Patient is experiencing blurry vision and speech difficulty for nearly 3 months. The symptoms are described as slight in nature.;close monitoring
brain_menin_1456;Brain Meningiomas;36;M;Patient is experiencing blurry vision and localized neurological weakness for several weeks. The symptoms are described as noticeable in nature.;close monitoring
brain_menin_1457;Brain Meningiomas;54;M;Patient is experiencing speech difficulty and localized neurological weakness over the past month. The symptoms are described as tolerable in nature.;surgery
brain_menin_1458;Brain Meningiomas;27;F;Patient is experiencing fatigue and localized neurological weakness for several weeks. The symptoms are described as low-grade in nature.;radiation therapy
brain_menin_1459;Brain Meningiomas;29;M;Patient is experiencing blurry vision and chronic headaches for nearly 3 months. The symptoms are described as moderate in nature.;radiation therapy
brain_menin_1460;Brain Meningiomas;48;F;Patient is experiencing chronic headaches and speech difficulty over the past month. The symptoms are described as low-grade in nature.;surgery
brain_menin_1461;Brain Meningiomas;83;M;Patient is experiencing speech difficulty and blurry vision for several weeks. The symptoms are described as moderate in nature.;surgery
brain_menin_1462;Brain Meningiomas;27;M;Patient is experiencing coordination problems and speech difficulty for nearly 3 months. The symptoms are described as mild in nature.;close monitoring
brain_menin_1463;Brain Meningiomas;46;F;Patient is experiencing blurry vision and chronic headaches for nearly 3 months. The symptoms are described as significant in nature.;surgery
brain_menin_1464;Brain Meningiomas;57;M;Patient is experiencing fatigue and coordination problems over the past month. The symptoms are described as low-grade in nature.;close monitoring
brain_menin_1465;Brain Meningiomas;83;F;Patient is experiencing blurry vision and chronic headaches for several weeks. The symptoms are described as significant in nature.;close monitoring
brain_menin_1466;Brain Meningiomas;19;F;Patient is experiencing speech difficulty and blurry vision for nearly 3 months. The symptoms are described as moderate in nature.;radiation therapy
brain_menin_1467;Brain Meningiomas;59;F;Patient is experiencing blurry vision and chronic headaches for several weeks. The symptoms are described as tolerable in nature.;surgery
brain_menin_1468;Brain Meningiomas;58;M;Patient is experiencing fatigue and coordination problems for several weeks. The symptoms are described as slight in nature.;radiation therapy
brain_menin_1469;Brain Meningiomas;70;F;Patient is experiencing chronic headaches and coordination problems for nearly 3 months. The symptoms are described as moderate in nature.;close monitoring
brain_menin_1470;Brain Meningiomas;21;M;Patient is experiencing chronic headaches and fatigue for several weeks. The symptoms are described as low-grade in nature.;surgery
brain_menin_1471;Brain Meningiomas;33;F;Patient is experiencing blurry vision and chronic headaches for several weeks. The symptoms are described as significant in nature.;surgery
brain_menin_1472;Brain Meningiomas;74;M;Patient is experiencing speech difficulty and blurry vision over the past month. The symptoms are described as mild in nature.;surgery
brain_menin_1473;Brain Meningiomas;21;F;Patient is experiencing coordination problems and chronic headaches over the past month. The symptoms are described as tolerable in nature.;surgery
brain_menin_1474;Brain Meningiomas;43;M;Patient is experiencing fatigue and coordination problems for several weeks. The symptoms are described as low-grade in nature.;surgery
brain_menin_1475;Brain Meningiomas;76;M;Patient is experiencing fatigue and localized neurological weakness for several weeks. The symptoms are described as noticeable in nature.;radiation therapy
brain_menin_1476;Brain Meningiomas;35;F;Patient is experiencing fatigue and blurry vision over the past month. The symptoms are described as slight in nature.;close monitoring
brain_menin_1477;Brain Meningiomas;70;F;Patient is experiencing coordination problems and blurry vision for several weeks. The symptoms are described as low-grade in nature.;close monitoring
brain_menin_1478;Brain Meningiomas;28;F;Patient is experiencing fatigue and coordination problems for nearly 3 months. The symptoms are described as low-grade in nature.;close monitoring
brain_menin_1479;Brain Meningiomas;18;F;Patient is experiencing blurry vision and speech difficulty over the past month. The symptoms are described as noticeable in nature.;surgery
brain_menin_1480;Brain Meningiomas;60;M;Patient is experiencing speech difficulty and chronic headaches for several weeks. The symptoms are described as tolerable in nature.;surgery
brain_menin_1481;Brain Meningiomas;58;F;Patient is experiencing speech difficulty and fatigue for nearly 3 months. The symptoms are described as moderate in nature.;surgery
brain_menin_1482;Brain Meningiomas;26;F;Patient is experiencing fatigue and chronic headaches for several weeks. The symptoms are described as noticeable in nature.;close monitoring
brain_menin_1483;Brain Meningiomas;31;M;Patient is experiencing blurry vision and speech difficulty over the past month. The symptoms are described as moderate in nature.;radiation therapy
brain_menin_1484;Brain Meningiomas;57;F;Patient is experiencing coordination problems and chronic headaches over the past month. The symptoms are described as slight in nature.;radiation therapy
brain_menin_1485;Brain Meningiomas;51;M;Patient is experiencing fatigue and coordination problems for several weeks. The symptoms are described as significant in nature.;surgery
brain_menin_1486;Brain Meningiomas;28;F;Patient is experiencing blurry vision and coordination problems for several weeks. The symptoms are described as noticeable in nature.;surgery
brain_menin_1487;Brain Meningiomas;19;M;Patient is experiencing localized neurological weakness and fatigue for several weeks. The symptoms are described as moderate in nature.;close monitoring
brain_menin_1488;Brain Meningiomas;57;M;Patient is experiencing blurry vision and chronic headaches for nearly 3 months. The symptoms are described as mild in nature.;radiation therapy
brain_menin_1489;Brain Meningiomas;58;F;Patient is experiencing coordination problems and localized neurological weakness for nearly 3 months. The symptoms are described as significant in nature.;surgery
brain_menin_1490;Brain Meningiomas;68;M;Patient is experiencing speech difficulty and blurry vision over the past month. The symptoms are described as significant in nature.;surgery
brain_menin_1491;Brain Meningiomas;82;F;Patient is experiencing chronic headaches and fatigue over the past month. The symptoms are described as moderate in nature.;radiation therapy
brain_menin_1492;Brain Meningiomas;26;M;Patient is experiencing speech difficulty and fatigue for several weeks. The symptoms are described as moderate in nature.;radiation therapy
brain_menin_1493;Brain Meningiomas;72;M;Patient is experiencing chronic headaches and blurry vision over the past month. The symptoms are described as tolerable in nature.;radiation therapy
brain_menin_1494;Brain Meningiomas;29;M;Patient is experiencing speech difficulty and blurry vision for nearly 3 months. The symptoms are described as tolerable in nature.;surgery
brain_menin_1495;Brain Meningiomas;80;F;Patient is experiencing fatigue and chronic headaches over the past month. The symptoms are described as moderate in nature.;close monitoring
brain_menin_1496;Brain Meningiomas;42;M;Patient is experiencing fatigue and blurry vision for nearly 3 months. The symptoms are described as tolerable in nature.;surgery
brain_menin_1497;Brain Meningiomas;62;M;Patient is experiencing speech difficulty and blurry vision for nearly 3 months. The symptoms are described as mild in nature.;radiation therapy
brain_menin_1498;Brain Meningiomas;62;M;Patient is experiencing localized neurological weakness and chronic headaches for several weeks. The symptoms are described as low-grade in nature.;radiation therapy
brain_menin_1499;Brain Meningiomas;68;F;Patient is experiencing fatigue and coordination problems over the past month. The symptoms are described as significant in nature.;radiation therapy
brain_menin_1500;Brain Meningiomas;20;M;Patient is experiencing chronic headaches and fatigue for nearly 3 months. The symptoms are described as slight in nature.;close monitoring
brain_menin_1501;Brain Meningiomas;18;F;Patient is experiencing chronic headaches and fatigue for several weeks. The symptoms are described as slight in nature.;surgery
brain_menin_1502;Brain Meningiomas;76;F;Patient is experiencing coordination problems and blurry vision for nearly 3 months. The symptoms are described as mild in nature.;radiation therapy
brain_menin_1503;Brain Meningiomas;70;M;Patient is experiencing coordination problems and localized neurological weakness for nearly 3 months. The symptoms are described as tolerable in nature.;radiation therapy
brain_menin_1504;Brain Meningiomas;38;M;Patient is experiencing blurry vision and localized neurological weakness over the past month. The symptoms are described as tolerable in nature.;close monitoring
brain_menin_1505;Brain Meningiomas;77;F;Patient is experiencing blurry vision and chronic headaches for nearly 3 months. The symptoms are described as low-grade in nature.;radiation therapy
brain_menin_1506;Brain Meningiomas;29;M;Patient is experiencing fatigue and chronic headaches for nearly 3 months. The symptoms are described as noticeable in nature.;close monitoring
brain_menin_1507;Brain Meningiomas;43;M;Patient is experiencing localized neurological weakness and chronic headaches for several weeks. The symptoms are described as moderate in nature.;close monitoring
brain_menin_1508;Brain Meningiomas;80;F;Patient is experiencing coordination problems and blurry vision for nearly 3 months. The symptoms are described as significant in nature.;surgery
brain_menin_1509;Brain Meningiomas;43;F;Patient is experiencing localized neurological weakness and coordination problems for nearly 3 months. The symptoms are described as noticeable in nature.;radiation therapy
brain_menin_1510;Brain Meningiomas;72;M;Patient is experiencing localized neurological weakness and coordination problems for nearly 3 months. The symptoms are described as mild in nature.;close monitoring
brain_menin_1511;Brain Meningiomas;18;M;Patient is experiencing localized neurological weakness and blurry vision for nearly 3 months. The symptoms are described as slight in nature.;close monitoring
brain_menin_1512;Brain Meningiomas;21;F;Patient is experiencing speech difficulty and coordination problems for nearly 3 months. The symptoms are described as tolerable in nature.;close monitoring
brain_menin_1513;Brain Meningiomas;26;F;Patient is experiencing coordination problems and localized neurological weakness for nearly 3 months. The symptoms are described as significant in nature.;radiation therapy
brain_menin_1514;Brain Meningiomas;53;M;Patient is experiencing fatigue and speech difficulty for several weeks. The symptoms are described as significant in nature.;close monitoring
brain_menin_1515;Brain Meningiomas;76;M;Patient is experiencing localized neurological weakness and blurry vision for nearly 3 months. The symptoms are described as noticeable in nature.;close monitoring
brain_menin_1516;Brain Meningiomas;20;M;Patient is experiencing blurry vision and localized neurological weakness over the past month. The symptoms are described as moderate in nature.;radiation therapy
brain_menin_1517;Brain Meningiomas;52;F;Patient is experiencing fatigue and chronic headaches over the past month. The symptoms are described as low-grade in nature.;radiation therapy
brain_menin_1518;Brain Meningiomas;49;F;Patient is experiencing blurry vision and speech difficulty over the past month. The symptoms are described as moderate in nature.;close monitoring
brain_menin_1519;Brain Meningiomas;75;F;Patient is experiencing chronic headaches and speech difficulty for several weeks. The symptoms are described as slight in nature.;surgery
brain_menin_1520;Brain Meningiomas;23;F;Patient is experiencing chronic headaches and coordination problems for nearly 3 months. The symptoms are described as noticeable in nature.;radiation therapy
brain_menin_1521;Brain Meningiomas;45;M;Patient is experiencing fatigue and blurry vision over the past month. The symptoms are described as tolerable in nature.;surgery
brain_menin_1522;Brain Meningiomas;31;M;Patient is experiencing coordination problems and chronic headaches for several weeks. The symptoms are described as mild in nature.;close monitoring
brain_menin_1523;Brain Meningiomas;39;F;Patient is experiencing localized neurological weakness and fatigue over the past month. The symptoms are described as low-grade in nature.;close monitoring
brain_menin_1524;Brain Meningiomas;39;M;Patient is experiencing chronic headaches and blurry vision for several weeks. The symptoms are described as moderate in nature.;surgery
brain_menin_1525;Brain Meningiomas;30;M;Patient is experiencing fatigue and chronic headaches for several weeks. The symptoms are described as noticeable in nature.;surgery
brain_menin_1526;Brain Meningiomas;28;F;Patient is experiencing fatigue and chronic headaches over the past month. The symptoms are described as moderate in nature.;radiation therapy
brain_menin_1527;Brain Meningiomas;36;F;Patient is experiencing localized neurological weakness and coordination problems for several weeks. The symptoms are described as tolerable in nature.;surgery
brain_menin_1528;Brain Meningiomas;24;M;Patient is experiencing fatigue and localized neurological weakness for several weeks. The symptoms are described as moderate in nature.;close monitoring
brain_menin_1529;Brain Meningiomas;48;M;Patient is experiencing speech difficulty and blurry vision for nearly 3 months. The symptoms are described as significant in nature.;surgery
brain_menin_1530;Brain Meningiomas;82;F;Patient is experiencing chronic headaches and localized neurological weakness over the past month. The symptoms are described as tolerable in nature.;close monitoring
brain_menin_1531;Brain Meningiomas;26;F;Patient is experiencing coordination problems and blurry vision for several weeks. The symptoms are described as mild in nature.;close monitoring
brain_menin_1532;Brain Meningiomas;62;M;Patient is experiencing blurry vision and chronic headaches for nearly 3 months. The symptoms are described as moderate in nature.;surgery
brain_menin_1533;Brain Meningiomas;34;F;Patient is experiencing coordination problems and speech difficulty for nearly 3 months. The symptoms are described as significant in nature.;radiation therapy
brain_menin_1534;Brain Meningiomas;37;F;Patient is experiencing chronic headaches and blurry vision for several weeks. The symptoms are described as low-grade in nature.;close monitoring
brain_menin_1535;Brain Meningiomas;70;M;Patient is experiencing fatigue and coordination problems for nearly 3 months. The symptoms are described as mild in nature.;radiation therapy
brain_menin_1536;Brain Meningiomas;41;M;Patient is experiencing localized neurological weakness and fatigue for several weeks. The symptoms are described as tolerable in nature.;radiation therapy
brain_menin_1537;Brain Meningiomas;30;F;Patient is experiencing coordination problems and fatigue for nearly 3 months. The symptoms are described as significant in nature.;surgery
brain_menin_1538;Brain Meningiomas;32;F;Patient is experiencing blurry vision and chronic headaches for nearly 3 months. The symptoms are described as noticeable in nature.;radiation therapy
brain_menin_1539;Brain Meningiomas;70;F;Patient is experiencing localized neurological weakness and blurry vision for nearly 3 months. The symptoms are described as slight in nature.;radiation therapy
brain_menin_1540;Brain Meningiomas;61;F;Patient is experiencing speech difficulty and localized neurological weakness for several weeks. The symptoms are described as slight in nature.;surgery
brain_menin_1541;Brain Meningiomas;46;F;Patient is experiencing localized neurological weakness and chronic headaches for several weeks. The symptoms are described as mild in nature.;radiation therapy
brain_menin_1542;Brain Meningiomas;37;F;Patient is experiencing localized neurological weakness and coordination problems for nearly 3 months. The symptoms are described as significant in nature.;close monitoring
brain_menin_1543;Brain Meningiomas;58;F;Patient is experiencing blurry vision and speech difficulty over the past month. The symptoms are described as significant in nature.;radiation therapy
brain_menin_1544;Brain Meningiomas;19;M;Patient is experiencing chronic headaches and localized neurological weakness for several weeks. The symptoms are described as mild in nature.;surgery
brain_menin_1545;Brain Meningiomas;30;F;Patient is experiencing coordination problems and chronic headaches for nearly 3 months. The symptoms are described as low-grade in nature.;close monitoring
brain_menin_1546;Brain Meningiomas;30;F;Patient is experiencing localized neurological weakness and blurry vision for several weeks. The symptoms are described as noticeable in nature.;surgery
brain_menin_1547;Brain Meningiomas;47;F;Patient is experiencing speech difficulty and chronic headaches for several weeks. The symptoms are described as noticeable in nature.;close monitoring
brain_menin_1548;Brain Meningiomas;20;M;Patient is experiencing chronic headaches and coordination problems for nearly 3 months. The symptoms are described as slight in nature.;close monitoring
brain_menin_1549;Brain Meningiomas;72;M;Patient is experiencing fatigue and coordination problems for nearly 3 months. The symptoms are described as significant in nature.;close monitoring
brain_menin_1550;Brain Meningiomas;82;M;Patient is experiencing blurry vision and localized neurological weakness for several weeks. The symptoms are described as noticeable in nature.;surgery
brain_menin_1551;Brain Meningiomas;60;M;Patient is experiencing chronic headaches and blurry vision for nearly 3 months. The symptoms are described as tolerable in nature.;surgery
brain_menin_1552;Brain Meningiomas;21;F;Patient is experiencing speech difficulty and coordination problems over the past month. The symptoms are described as noticeable in nature.;surgery
brain_menin_1553;Brain Meningiomas;67;M;Patient is experiencing chronic headaches and fatigue over the past month. The symptoms are described as significant in nature.;close monitoring
brain_menin_1554;Brain Meningiomas;70;M;Patient is experiencing speech difficulty and chronic headaches over the past month. The symptoms are described as slight in nature.;surgery
brain_menin_1555;Brain Meningiomas;30;F;Patient is experiencing chronic headaches and speech difficulty for nearly 3 months. The symptoms are described as significant in nature.;surgery
brain_menin_1556;Brain Meningiomas;25;M;Patient is experiencing chronic headaches and blurry vision over the past month. The symptoms are described as significant in nature.;close monitoring
brain_menin_1557;Brain Meningiomas;39;F;Patient is experiencing blurry vision and coordination problems over the past month. The symptoms are described as moderate in nature.;close monitoring
brain_menin_1558;Brain Meningiomas;74;F;Patient is experiencing chronic headaches and localized neurological weakness over the past month. The symptoms are described as moderate in nature.;radiation therapy
brain_menin_1559;Brain Meningiomas;29;F;Patient is experiencing chronic headaches and fatigue for nearly 3 months. The symptoms are described as moderate in nature.;surgery
brain_menin_1560;Brain Meningiomas;64;F;Patient is experiencing blurry vision and localized neurological weakness over the past month. The symptoms are described as mild in nature.;radiation therapy
brain_menin_1561;Brain Meningiomas;46;M;Patient is experiencing localized neurological weakness and fatigue over the past month. The symptoms are described as low-grade in nature.;surgery
brain_menin_1562;Brain Meningiomas;64;M;Patient is experiencing fatigue and chronic headaches for several weeks. The symptoms are described as moderate in nature.;surgery
brain_menin_1563;Brain Meningiomas;48;F;Patient is experiencing blurry vision and chronic headaches for several weeks. The symptoms are described as noticeable in nature.;radiation therapy
brain_menin_1564;Brain Meningiomas;48;F;Patient is experiencing speech difficulty and blurry vision for nearly 3 months. The symptoms are described as moderate in nature.;surgery
brain_menin_1565;Brain Meningiomas;35;F;Patient is experiencing chronic headaches and coordination problems over the past month. The symptoms are described as low-grade in nature.;radiation therapy
brain_menin_1566;Brain Meningiomas;69;F;Patient is experiencing speech difficulty and blurry vision for several weeks. The symptoms are described as noticeable in nature.;close monitoring
brain_menin_1567;Brain Meningiomas;24;M;Patient is experiencing fatigue and speech difficulty for several weeks. The symptoms are described as moderate in nature.;surgery
brain_menin_1568;Brain Meningiomas;54;F;Patient is experiencing speech difficulty and localized neurological weakness for nearly 3 months. The symptoms are described as slight in nature.;radiation therapy
brain_menin_1569;Brain Meningiomas;78;F;Patient is experiencing speech difficulty and localized neurological weakness for nearly 3 months. The symptoms are described as moderate in nature.;radiation therapy
brain_menin_1570;Brain Meningiomas;82;F;Patient is experiencing speech difficulty and chronic headaches over the past month. The symptoms are described as noticeable in nature.;surgery
brain_menin_1571;Brain Meningiomas;78;F;Patient is experiencing localized neurological weakness and chronic headaches for nearly 3 months. The symptoms are described as noticeable in nature.;radiation therapy
brain_menin_1572;Brain Meningiomas;48;F;Patient is experiencing localized neurological weakness and speech difficulty for several weeks. The symptoms are described as tolerable in nature.;surgery
brain_menin_1573;Brain Meningiomas;83;F;Patient is experiencing localized neurological weakness and fatigue for nearly 3 months. The symptoms are described as low-grade in nature.;surgery
brain_menin_1574;Brain Meningiomas;50;M;Patient is experiencing chronic headaches and blurry vision for several weeks. The symptoms are described as moderate in nature.;radiation therapy
brain_menin_1575;Brain Meningiomas;26;M;Patient is experiencing blurry vision and coordination problems over the past month. The symptoms are described as tolerable in nature.;surgery
brain_menin_1576;Brain Meningiomas;59;M;Patient is experiencing blurry vision and localized neurological weakness for several weeks. The symptoms are described as tolerable in nature.;close monitoring
brain_menin_1577;Brain Meningiomas;67;F;Patient is experiencing fatigue and chronic headaches over the past month. The symptoms are described as significant in nature.;radiation therapy
brain_menin_1578;Brain Meningiomas;48;F;Patient is experiencing fatigue and coordination problems for several weeks. The symptoms are described as mild in nature.;close monitoring
brain_menin_1579;Brain Meningiomas;72;F;Patient is experiencing speech difficulty and chronic headaches for nearly 3 months. The symptoms are described as low-grade in nature.;radiation therapy
brain_menin_1580;Brain Meningiomas;47;F;Patient is experiencing localized neurological weakness and fatigue over the past month. The symptoms are described as moderate in nature.;radiation therapy
brain_menin_1581;Brain Meningiomas;79;M;Patient is experiencing fatigue and localized neurological weakness for several weeks. The symptoms are described as moderate in nature.;radiation therapy
brain_menin_1582;Brain Meningiomas;29;F;Patient is experiencing chronic headaches and localized neurological weakness over the past month. The symptoms are described as slight in nature.;close monitoring
brain_menin_1583;Brain Meningiomas;83;M;Patient is experiencing localized neurological weakness and chronic headaches for several weeks. The symptoms are described as significant in nature.;radiation therapy
brain_menin_1584;Brain Meningiomas;81;F;Patient is experiencing speech difficulty and blurry vision for several weeks. The symptoms are described as noticeable in nature.;radiation therapy
brain_menin_1585;Brain Meningiomas;53;F;Patient is experiencing coordination problems and fatigue for nearly 3 months. The symptoms are described as mild in nature.;radiation therapy
brain_menin_1586;Brain Meningiomas;85;F;Patient is experiencing fatigue and chronic headaches for nearly 3 months. The symptoms are described as low-grade in nature.;surgery
brain_menin_1587;Brain Meningiomas;65;F;Patient is experiencing chronic headaches and coordination problems for several weeks. The symptoms are described as noticeable in nature.;close monitoring
brain_menin_1588;Brain Meningiomas;45;M;Patient is experiencing localized neurological weakness and speech difficulty for nearly 3 months. The symptoms are described as low-grade in nature.;surgery
brain_menin_1589;Brain Meningiomas;65;M;Patient is experiencing chronic headaches and coordination problems over the past month. The symptoms are described as tolerable in nature.;close monitoring
brain_menin_1590;Brain Meningiomas;53;M;Patient is experiencing speech difficulty and blurry vision over the past month. The symptoms are described as noticeable in nature.;radiation therapy
brain_menin_1591;Brain Meningiomas;72;M;Patient is experiencing blurry vision and speech difficulty for nearly 3 months. The symptoms are described as mild in nature.;close monitoring
brain_menin_1592;Brain Meningiomas;74;M;Patient is experiencing coordination problems and blurry vision for nearly 3 months. The symptoms are described as slight in nature.;surgery
brain_menin_1593;Brain Meningiomas;20;M;Patient is experiencing speech difficulty and chronic headaches for nearly 3 months. The symptoms are described as slight in nature.;surgery
brain_menin_1594;Brain Meningiomas;45;F;Patient is experiencing chronic headaches and localized neurological weakness for several weeks. The symptoms are described as moderate in nature.;radiation therapy
brain_menin_1595;Brain Meningiomas;30;F;Patient is experiencing blurry vision and coordination problems for several weeks. The symptoms are described as mild in nature.;radiation therapy
brain_menin_1596;Brain Meningiomas;60;F;Patient is experiencing fatigue and localized neurological weakness for several weeks. The symptoms are described as low-grade in nature.;close monitoring
brain_menin_1597;Brain Meningiomas;59;F;Patient is experiencing speech difficulty and fatigue for several weeks. The symptoms are described as mild in nature.;radiation therapy
brain_menin_1598;Brain Meningiomas;81;F;Patient is experiencing coordination problems and blurry vision for nearly 3 months. The symptoms are described as noticeable in nature.;surgery
brain_menin_1599;Brain Meningiomas;18;F;Patient is experiencing blurry vision and chronic headaches for several weeks. The symptoms are described as significant in nature.;surgery
brain_menin_1600;Brain Meningiomas;64;F;Patient is experiencing coordination problems and fatigue over the past month. The symptoms are described as tolerable in nature.;radiation therapy
brain_menin_1601;Brain Meningiomas;84;F;Patient is experiencing fatigue and coordination problems over the past month. The symptoms are described as noticeable in nature.;radiation therapy
brain_menin_1602;Brain Meningiomas;54;F;Patient is experiencing fatigue and chronic headaches for several weeks. The symptoms are described as noticeable in nature.;radiation therapy
brain_menin_1603;Brain Meningiomas;44;F;Patient is experiencing speech difficulty and fatigue over the past month. The symptoms are described as low-grade in nature.;radiation therapy
brain_menin_1604;Brain Meningiomas;78;F;Patient is experiencing localized neurological weakness and blurry vision for several weeks. The symptoms are described as slight in nature.;radiation therapy
brain_menin_1605;Brain Meningiomas;53;M;Patient is experiencing fatigue and chronic headaches for nearly 3 months. The symptoms are described as slight in nature.;surgery
brain_menin_1606;Brain Meningiomas;59;F;Patient is experiencing coordination problems and speech difficulty for several weeks. The symptoms are described as moderate in nature.;surgery
brain_menin_1607;Brain Meningiomas;45;M;Patient is experiencing chronic headaches and localized neurological weakness over the past month. The symptoms are described as slight in nature.;surgery
brain_menin_1608;Brain Meningiomas;22;F;Patient is experiencing localized neurological weakness and blurry vision for several weeks. The symptoms are described as noticeable in nature.;surgery
brain_menin_1609;Brain Meningiomas;79;M;Patient is experiencing fatigue and localized neurological weakness for several weeks. The symptoms are described as tolerable in nature.;radiation therapy
brain_menin_1610;Brain Meningiomas;35;M;Patient is experiencing coordination problems and localized neurological weakness for several weeks. The symptoms are described as noticeable in nature.;radiation therapy
brain_menin_1611;Brain Meningiomas;27;F;Patient is experiencing chronic headaches and localized neurological weakness for nearly 3 months. The symptoms are described as mild in nature.;close monitoring
brain_menin_1612;Brain Meningiomas;47;M;Patient is experiencing chronic headaches and blurry vision over the past month. The symptoms are described as noticeable in nature.;radiation therapy
brain_menin_1613;Brain Meningiomas;73;F;Patient is experiencing chronic headaches and blurry vision for several weeks. The symptoms are described as slight in nature.;radiation therapy
brain_menin_1614;Brain Meningiomas;79;F;Patient is experiencing coordination problems and fatigue over the past month. The symptoms are described as slight in nature.;close monitoring
brain_menin_1615;Brain Meningiomas;33;F;Patient is experiencing localized neurological weakness and coordination problems for nearly 3 months. The symptoms are described as mild in nature.;radiation therapy
brain_menin_1616;Brain Meningiomas;21;F;Patient is experiencing chronic headaches and fatigue over the past month. The symptoms are described as slight in nature.;surgery
brain_menin_1617;Brain Meningiomas;45;F;Patient is experiencing coordination problems and speech difficulty for nearly 3 months. The symptoms are described as mild in nature.;close monitoring
brain_menin_1618;Brain Meningiomas;81;F;Patient is experiencing localized neurological weakness and blurry vision for several weeks. The symptoms are described as slight in nature.;surgery
brain_menin_1619;Brain Meningiomas;72;M;Patient is experiencing blurry vision and speech difficulty for several weeks. The symptoms are described as significant in nature.;radiation therapy
brain_menin_1620;Brain Meningiomas;23;M;Patient is experiencing chronic headaches and coordination problems over the past month. The symptoms are described as moderate in nature.;close monitoring
brain_menin_1621;Brain Meningiomas;83;F;Patient is experiencing speech difficulty and chronic headaches over the past month. The symptoms are described as moderate in nature.;close monitoring
brain_menin_1622;Brain Meningiomas;79;M;Patient is experiencing chronic headaches and blurry vision for nearly 3 months. The symptoms are described as tolerable in nature.;radiation therapy
brain_menin_1623;Brain Meningiomas;54;M;Patient is experiencing speech difficulty and fatigue over the past month. The symptoms are described as noticeable in nature.;radiation therapy
brain_menin_1624;Brain Meningiomas;32;F;Patient is experiencing chronic headaches and speech difficulty over the past month. The symptoms are described as tolerable in nature.;close monitoring
brain_menin_1625;Brain Meningiomas;47;F;Patient is experiencing blurry vision and localized neurological weakness for several weeks. The symptoms are described as tolerable in nature.;surgery
brain_menin_1626;Brain Meningiomas;51;M;Patient is experiencing fatigue and speech difficulty for nearly 3 months. The symptoms are described as noticeable in nature.;close monitoring
brain_menin_1627;Brain Meningiomas;51;F;Patient is experiencing fatigue and chronic headaches for nearly 3 months. The symptoms are described as tolerable in nature.;surgery
brain_menin_1628;Brain Meningiomas;81;M;Patient is experiencing blurry vision and coordination problems over the past month. The symptoms are described as mild in nature.;surgery
brain_menin_1629;Brain Meningiomas;71;F;Patient is experiencing fatigue and localized neurological weakness over the past month. The symptoms are described as low-grade in nature.;surgery
brain_menin_1630;Brain Meningiomas;25;F;Patient is experiencing localized neurological weakness and speech difficulty for several weeks. The symptoms are described as slight in nature.;close monitoring
brain_menin_1631;Brain Meningiomas;26;M;Patient is experiencing localized neurological weakness and fatigue over the past month. The symptoms are described as slight in nature.;surgery
brain_menin_1632;Brain Meningiomas;22;F;Patient is experiencing chronic headaches and fatigue for several weeks. The symptoms are described as moderate in nature.;close monitoring
brain_menin_1633;Brain Meningiomas;23;F;Patient is experiencing coordination problems and speech difficulty over the past month. The symptoms are described as noticeable in nature.;surgery
brain_menin_1634;Brain Meningiomas;41;F;Patient is experiencing chronic headaches and blurry vision for several weeks. The symptoms are described as slight in nature.;close monitoring
brain_menin_1635;Brain Meningiomas;21;F;Patient is experiencing blurry vision and coordination problems over the past month. The symptoms are described as low-grade in nature.;surgery
brain_menin_1636;Brain Meningiomas;69;F;Patient is experiencing speech difficulty and localized neurological weakness for several weeks. The symptoms are described as noticeable in nature.;close monitoring
brain_menin_1637;Brain Meningiomas;59;M;Patient is experiencing localized neurological weakness and speech difficulty for nearly 3 months. The symptoms are described as low-grade in nature.;radiation therapy
brain_menin_1638;Brain Meningiomas;83;F;Patient is experiencing blurry vision and speech difficulty for nearly 3 months. The symptoms are described as moderate in nature.;radiation therapy
brain_menin_1639;Brain Meningiomas;30;F;Patient is experiencing fatigue and speech difficulty for nearly 3 months. The symptoms are described as mild in nature.;surgery
brain_menin_1640;Brain Meningiomas;59;M;Patient is experiencing chronic headaches and speech difficulty for nearly 3 months. The symptoms are described as moderate in nature.;close monitoring
brain_menin_1641;Brain Meningiomas;82;F;Patient is experiencing chronic headaches and fatigue for several weeks. The symptoms are described as significant in nature.;radiation therapy
brain_menin_1642;Brain Meningiomas;22;F;Patient is experiencing localized neurological weakness and chronic headaches for several weeks. The symptoms are described as mild in nature.;surgery
brain_menin_1643;Brain Meningiomas;19;F;Patient is experiencing coordination problems and blurry vision over the past month. The symptoms are described as low-grade in nature.;close monitoring
brain_menin_1644;Brain Meningiomas;55;F;Patient is experiencing speech difficulty and fatigue for several weeks. The symptoms are described as moderate in nature.;close monitoring
brain_menin_1645;Brain Meningiomas;33;F;Patient is experiencing coordination problems and localized neurological weakness over the past month. The symptoms are described as mild in nature.;surgery
brain_menin_1646;Brain Meningiomas;39;F;Patient is experiencing speech difficulty and blurry vision for several weeks. The symptoms are described as slight in nature.;radiation therapy
brain_menin_1647;Brain Meningiomas;61;F;Patient is experiencing speech difficulty and chronic headaches for several weeks. The symptoms are described as low-grade in nature.;radiation therapy
brain_menin_1648;Brain Meningiomas;39;M;Patient is experiencing speech difficulty and blurry vision for several weeks. The symptoms are described as moderate in nature.;close monitoring
brain_menin_1649;Brain Meningiomas;47;F;Patient is experiencing chronic headaches and blurry vision over the past month. The symptoms are described as mild in nature.;close monitoring
brain_menin_1650;Brain Meningiomas;58;F;Patient is experiencing blurry vision and chronic headaches for nearly 3 months. The symptoms are described as significant in nature.;surgery
brain_menin_1651;Brain Meningiomas;26;F;Patient is experiencing coordination problems and speech difficulty over the past month. The symptoms are described as significant in nature.;radiation therapy
brain_menin_1652;Brain Meningiomas;37;M;Patient is experiencing chronic headaches and speech difficulty for nearly 3 months. The symptoms are described as tolerable in nature.;close monitoring
brain_menin_1653;Brain Meningiomas;67;F;Patient is experiencing coordination problems and chronic headaches for several weeks. The symptoms are described as significant in nature.;surgery
brain_menin_1654;Brain Meningiomas;24;F;Patient is experiencing chronic headaches and coordination problems for several weeks. The symptoms are described as moderate in nature.;radiation therapy
brain_menin_1655;Brain Meningiomas;50;M;Patient is experiencing blurry vision and coordination problems for several weeks. The symptoms are described as significant in nature.;close monitoring
brain_menin_1656;Brain Meningiomas;51;F;Patient is experiencing localized neurological weakness and blurry vision for nearly 3 months. The symptoms are described as slight in nature.;close monitoring
brain_menin_1657;Brain Meningiomas;63;F;Patient is experiencing blurry vision and coordination problems for several weeks. The symptoms are described as slight in nature.;surgery
brain_menin_1658;Brain Meningiomas;61;F;Patient is experiencing coordination problems and speech difficulty for several weeks. The symptoms are described as slight in nature.;radiation therapy
brain_menin_1659;Brain Meningiomas;78;F;Patient is experiencing fatigue and localized neurological weakness over the past month. The symptoms are described as significant in nature.;close monitoring
brain_menin_1660;Brain Meningiomas;72;F;Patient is experiencing fatigue and localized neurological weakness over the past month. The symptoms are described as noticeable in nature.;radiation therapy
brain_menin_1661;Brain Meningiomas;51;F;Patient is experiencing fatigue and coordination problems for several weeks. The symptoms are described as mild in nature.;close monitoring
brain_menin_1662;Brain Meningiomas;35;M;Patient is experiencing blurry vision and coordination problems over the past month. The symptoms are described as slight in nature.;radiation therapy
brain_menin_1663;Brain Meningiomas;33;F;Patient is experiencing speech difficulty and blurry vision over the past month. The symptoms are described as mild in nature.;close monitoring
brain_menin_1664;Brain Meningiomas;18;M;Patient is experiencing coordination problems and blurry vision over the past month. The symptoms are described as slight in nature.;surgery
brain_menin_1665;Brain Meningiomas;80;M;Patient is experiencing localized neurological weakness and chronic headaches for nearly 3 months. The symptoms are described as low-grade in nature.;surgery
brain_menin_1666;Brain Meningiomas;27;M;Patient is experiencing localized neurological weakness and fatigue for several weeks. The symptoms are described as low-grade in nature.;radiation therapy
brain_menin_1667;Brain Meningiomas;81;M;Patient is experiencing fatigue and chronic headaches over the past month. The symptoms are described as low-grade in nature.;surgery
brain_menin_1668;Brain Meningiomas;23;M;Patient is experiencing fatigue and localized neurological weakness over the past month. The symptoms are described as low-grade in nature.;close monitoring
brain_menin_1669;Brain Meningiomas;61;M;Patient is experiencing fatigue and coordination problems over the past month. The symptoms are described as moderate in nature.;close monitoring
brain_menin_1670;Brain Meningiomas;22;F;Patient is experiencing speech difficulty and localized neurological weakness for nearly 3 months. The symptoms are described as noticeable in nature.;close monitoring
brain_menin_1671;Brain Meningiomas;61;F;Patient is experiencing chronic headaches and localized neurological weakness over the past month. The symptoms are described as slight in nature.;close monitoring
brain_menin_1672;Brain Meningiomas;18;M;Patient is experiencing chronic headaches and localized neurological weakness over the past month. The symptoms are described as noticeable in nature.;close monitoring
brain_menin_1673;Brain Meningiomas;67;M;Patient is experiencing localized neurological weakness and chronic headaches over the past month. The symptoms are described as moderate in nature.;close monitoring
brain_menin_1674;Brain Meningiomas;19;M;Patient is experiencing speech difficulty and coordination problems over the past month. The symptoms are described as mild in nature.;radiation therapy
brain_menin_1675;Brain Meningiomas;78;M;Patient is experiencing speech difficulty and chronic headaches for several weeks. The symptoms are described as noticeable in nature.;radiation therapy
brain_menin_1676;Brain Meningiomas;20;F;Patient is experiencing fatigue and coordination problems over the past month. The symptoms are described as slight in nature.;close monitoring
brain_menin_1677;Brain Meningiomas;39;F;Patient is experiencing coordination problems and chronic headaches for several weeks. The symptoms are described as tolerable in nature.;close monitoring
brain_menin_1678;Brain Meningiomas;45;F;Patient is experiencing chronic headaches and coordination problems for nearly 3 months. The symptoms are described as mild in nature.;radiation therapy
brain_menin_1679;Brain Meningiomas;68;M;Patient is experiencing fatigue and coordination problems for several weeks. The symptoms are described as slight in nature.;radiation therapy
brain_menin_1680;Brain Meningiomas;61;M;Patient is experiencing localized neurological weakness and fatigue over the past month. The symptoms are described as mild in nature.;radiation therapy
brain_menin_1681;Brain Meningiomas;49;F;Patient is experiencing coordination problems and blurry vision over the past month. The symptoms are described as slight in nature.;radiation therapy
brain_menin_1682;Brain Meningiomas;83;M;Patient is experiencing blurry vision and coordination problems for several weeks. The symptoms are described as significant in nature.;radiation therapy
brain_menin_1683;Brain Meningiomas;79;M;Patient is experiencing chronic headaches and blurry vision for several weeks. The symptoms are described as low-grade in nature.;radiation therapy
brain_menin_1684;Brain Meningiomas;80;M;Patient is experiencing blurry vision and localized neurological weakness for nearly 3 months. The symptoms are described as significant in nature.;close monitoring
brain_menin_1685;Brain Meningiomas;45;F;Patient is experiencing blurry vision and localized neurological weakness over the past month. The symptoms are described as slight in nature.;close monitoring
brain_menin_1686;Brain Meningiomas;78;M;Patient is experiencing chronic headaches and blurry vision for nearly 3 months. The symptoms are described as tolerable in nature.;surgery
brain_menin_1687;Brain Meningiomas;69;F;Patient is experiencing blurry vision and fatigue for several weeks. The symptoms are described as noticeable in nature.;radiation therapy
brain_menin_1688;Brain Meningiomas;56;F;Patient is experiencing fatigue and coordination problems for nearly 3 months. The symptoms are described as mild in nature.;close monitoring
brain_menin_1689;Brain Meningiomas;50;F;Patient is experiencing localized neurological weakness and speech difficulty over the past month. The symptoms are described as moderate in nature.;close monitoring
brain_menin_1690;Brain Meningiomas;18;M;Patient is experiencing fatigue and coordination problems over the past month. The symptoms are described as low-grade in nature.;close monitoring
brain_menin_1691;Brain Meningiomas;66;F;Patient is experiencing blurry vision and fatigue for several weeks. The symptoms are described as low-grade in nature.;close monitoring
brain_menin_1692;Brain Meningiomas;71;M;Patient is experiencing chronic headaches and localized neurological weakness for several weeks. The symptoms are described as significant in nature.;surgery
brain_menin_1693;Brain Meningiomas;68;M;Patient is experiencing fatigue and blurry vision over the past month. The symptoms are described as significant in nature.;close monitoring
brain_menin_1694;Brain Meningiomas;55;M;Patient is experiencing coordination problems and blurry vision over the past month. The symptoms are described as significant in nature.;radiation therapy
brain_menin_1695;Brain Meningiomas;18;M;Patient is experiencing chronic headaches and fatigue for several weeks. The symptoms are described as mild in nature.;radiation therapy
brain_menin_1696;Brain Meningiomas;72;F;Patient is experiencing blurry vision and fatigue over the past month. The symptoms are described as slight in nature.;surgery
brain_menin_1697;Brain Meningiomas;27;F;Patient is experiencing coordination problems and blurry vision for nearly 3 months. The symptoms are described as slight in nature.;surgery
brain_menin_1698;Brain Meningiomas;52;F;Patient is experiencing localized neurological weakness and coordination problems for nearly 3 months. The symptoms are described as low-grade in nature.;radiation therapy
brain_menin_1699;Brain Meningiomas;51;F;Patient is experiencing localized neurological weakness and blurry vision for several weeks. The symptoms are described as slight in nature.;radiation therapy
brain_menin_1700;Brain Meningiomas;66;F;Patient is experiencing coordination problems and localized neurological weakness over the past month. The symptoms are described as significant in nature.;surgery
brain_menin_1701;Brain Meningiomas;80;M;Patient is experiencing blurry vision and coordination problems for nearly 3 months. The symptoms are described as significant in nature.;close monitoring
brain_menin_1702;Brain Meningiomas;34;M;Patient is experiencing localized neurological weakness and chronic headaches for nearly 3 months. The symptoms are described as noticeable in nature.;close monitoring
brain_menin_1703;Brain Meningiomas;51;F;Patient is experiencing fatigue and chronic headaches for nearly 3 months. The symptoms are described as mild in nature.;surgery
brain_menin_1704;Brain Meningiomas;65;M;Patient is experiencing chronic headaches and coordination problems for nearly 3 months. The symptoms are described as significant in nature.;close monitoring
brain_menin_1705;Brain Meningiomas;82;F;Patient is experiencing chronic headaches and localized neurological weakness for nearly 3 months. The symptoms are described as moderate in nature.;radiation therapy
brain_menin_1706;Brain Meningiomas;68;F;Patient is experiencing localized neurological weakness and coordination problems for several weeks. The symptoms are described as low-grade in nature.;surgery
brain_menin_1707;Brain Meningiomas;77;M;Patient is experiencing fatigue and speech difficulty for several weeks. The symptoms are described as significant in nature.;radiation therapy
brain_menin_1708;Brain Meningiomas;53;F;Patient is experiencing speech difficulty and coordination problems over the past month. The symptoms are described as moderate in nature.;surgery
brain_menin_1709;Brain Meningiomas;58;F;Patient is experiencing blurry vision and chronic headaches over the past month. The symptoms are described as significant in nature.;close monitoring
brain_menin_1710;Brain Meningiomas;35;M;Patient is experiencing blurry vision and fatigue for several weeks. The symptoms are described as low-grade in nature.;surgery
brain_menin_1711;Brain Meningiomas;29;M;Patient is experiencing chronic headaches and coordination problems over the past month. The symptoms are described as noticeable in nature.;close monitoring
brain_menin_1712;Brain Meningiomas;65;F;Patient is experiencing localized neurological weakness and fatigue for nearly 3 months. The symptoms are described as slight in nature.;close monitoring
brain_menin_1713;Brain Meningiomas;54;M;Patient is experiencing chronic headaches and blurry vision for nearly 3 months. The symptoms are described as moderate in nature.;surgery
brain_menin_1714;Brain Meningiomas;32;F;Patient is experiencing blurry vision and speech difficulty over the past month. The symptoms are described as significant in nature.;radiation therapy
brain_menin_1715;Brain Meningiomas;41;M;Patient is experiencing localized neurological weakness and chronic headaches over the past month. The symptoms are described as significant in nature.;radiation therapy
brain_menin_1716;Brain Meningiomas;80;F;Patient is experiencing speech difficulty and chronic headaches over the past month. The symptoms are described as mild in nature.;radiation therapy
brain_menin_1717;Brain Meningiomas;74;F;Patient is experiencing localized neurological weakness and fatigue for nearly 3 months. The symptoms are described as significant in nature.;surgery
brain_menin_1718;Brain Meningiomas;51;F;Patient is experiencing coordination problems and localized neurological weakness for several weeks. The symptoms are described as tolerable in nature.;radiation therapy
brain_menin_1719;Brain Meningiomas;63;M;Patient is experiencing blurry vision and speech difficulty for several weeks. The symptoms are described as slight in nature.;radiation therapy
brain_menin_1720;Brain Meningiomas;64;M;Patient is experiencing fatigue and chronic headaches over the past month. The symptoms are described as noticeable in nature.;close monitoring
brain_menin_1721;Brain Meningiomas;30;F;Patient is experiencing speech difficulty and fatigue for several weeks. The symptoms are described as low-grade in nature.;close monitoring
brain_menin_1722;Brain Meningiomas;19;F;Patient is experiencing fatigue and blurry vision for several weeks. The symptoms are described as low-grade in nature.;surgery
brain_menin_1723;Brain Meningiomas;44;M;Patient is experiencing blurry vision and chronic headaches for nearly 3 months. The symptoms are described as low-grade in nature.;radiation therapy
brain_menin_1724;Brain Meningiomas;58;M;Patient is experiencing fatigue and speech difficulty over the past month. The symptoms are described as noticeable in nature.;radiation therapy
brain_menin_1725;Brain Meningiomas;73;M;Patient is experiencing speech difficulty and fatigue for several weeks. The symptoms are described as significant in nature.;radiation therapy
brain_menin_1726;Brain Meningiomas;37;M;Patient is experiencing speech difficulty and chronic headaches for nearly 3 months. The symptoms are described as low-grade in nature.;close monitoring
brain_menin_1727;Brain Meningiomas;21;M;Patient is experiencing fatigue and localized neurological weakness over the past month. The symptoms are described as tolerable in nature.;close monitoring
brain_menin_1728;Brain Meningiomas;52;F;Patient is experiencing fatigue and blurry vision for several weeks. The symptoms are described as noticeable in nature.;close monitoring
brain_menin_1729;Brain Meningiomas;62;M;Patient is experiencing chronic headaches and fatigue over the past month. The symptoms are described as moderate in nature.;surgery
brain_menin_1730;Brain Meningiomas;28;F;Patient is experiencing speech difficulty and fatigue over the past month. The symptoms are described as significant in nature.;close monitoring
brain_menin_1731;Brain Meningiomas;68;M;Patient is experiencing fatigue and coordination problems over the past month. The symptoms are described as low-grade in nature.;surgery
brain_menin_1732;Brain Meningiomas;69;F;Patient is experiencing blurry vision and localized neurological weakness for several weeks. The symptoms are described as significant in nature.;radiation therapy
brain_menin_1733;Brain Meningiomas;73;F;Patient is experiencing fatigue and coordination problems over the past month. The symptoms are described as low-grade in nature.;radiation therapy
brain_menin_1734;Brain Meningiomas;79;F;Patient is experiencing speech difficulty and blurry vision over the past month. The symptoms are described as significant in nature.;close monitoring
brain_menin_1735;Brain Meningiomas;20;F;Patient is experiencing coordination problems and localized neurological weakness for nearly 3 months. The symptoms are described as moderate in nature.;close monitoring
brain_menin_1736;Brain Meningiomas;40;M;Patient is experiencing localized neurological weakness and chronic headaches for several weeks. The symptoms are described as significant in nature.;surgery
brain_menin_1737;Brain Meningiomas;66;M;Patient is experiencing blurry vision and fatigue for nearly 3 months. The symptoms are described as noticeable in nature.;surgery
brain_menin_1738;Brain Meningiomas;28;F;Patient is experiencing fatigue and speech difficulty over the past month. The symptoms are described as mild in nature.;close monitoring
brain_menin_1739;Brain Meningiomas;19;F;Patient is experiencing speech difficulty and coordination problems over the past month. The symptoms are described as tolerable in nature.;radiation therapy
brain_menin_1740;Brain Meningiomas;79;M;Patient is experiencing localized neurological weakness and blurry vision for nearly 3 months. The symptoms are described as low-grade in nature.;surgery
brain_menin_1741;Brain Meningiomas;78;F;Patient is experiencing coordination problems and localized neurological weakness for nearly 3 months. The symptoms are described as slight in nature.;radiation therapy
brain_menin_1742;Brain Meningiomas;46;M;Patient is experiencing chronic headaches and blurry vision for nearly 3 months. The symptoms are described as moderate in nature.;radiation therapy
brain_menin_1743;Brain Meningiomas;62;M;Patient is experiencing coordination problems and chronic headaches over the past month. The symptoms are described as noticeable in nature.;surgery
brain_menin_1744;Brain Meningiomas;22;F;Patient is experiencing coordination problems and chronic headaches over the past month. The symptoms are described as slight in nature.;close monitoring
brain_menin_1745;Brain Meningiomas;19;M;Patient is experiencing speech difficulty and blurry vision for nearly 3 months. The symptoms are described as low-grade in nature.;radiation therapy
brain_menin_1746;Brain Meningiomas;62;F;Patient is experiencing localized neurological weakness and chronic headaches for several weeks. The symptoms are described as low-grade in nature.;radiation therapy
brain_menin_1747;Brain Meningiomas;31;F;Patient is experiencing blurry vision and chronic headaches for nearly 3 months. The symptoms are described as low-grade in nature.;close monitoring
brain_menin_1748;Brain Meningiomas;18;F;Patient is experiencing localized neurological weakness and coordination problems for nearly 3 months. The symptoms are described as moderate in nature.;close monitoring
brain_menin_1749;Brain Meningiomas;39;M;Patient is experiencing speech difficulty and localized neurological weakness for nearly 3 months. The symptoms are described as noticeable in nature.;surgery
brain_menin_1750;Brain Meningiomas;34;F;Patient is experiencing chronic headaches and speech difficulty over the past month. The symptoms are described as low-grade in nature.;surgery
brain_menin_1751;Brain Meningiomas;66;F;Patient is experiencing fatigue and blurry vision over the past month. The symptoms are described as slight in nature.;radiation therapy
brain_menin_1752;Brain Meningiomas;33;M;Patient is experiencing blurry vision and coordination problems over the past month. The symptoms are described as tolerable in nature.;surgery
brain_menin_1753;Brain Meningiomas;42;F;Patient is experiencing blurry vision and speech difficulty for nearly 3 months. The symptoms are described as slight in nature.;radiation therapy
brain_menin_1754;Brain Meningiomas;62;F;Patient is experiencing fatigue and chronic headaches for nearly 3 months. The symptoms are described as noticeable in nature.;radiation therapy
brain_menin_1755;Brain Meningiomas;64;F;Patient is experiencing fatigue and blurry vision over the past month. The symptoms are described as moderate in nature.;close monitoring
brain_menin_1756;Brain Meningiomas;24;M;Patient is experiencing fatigue and blurry vision for several weeks. The symptoms are described as significant in nature.;radiation therapy
brain_menin_1757;Brain Meningiomas;68;F;Patient is experiencing localized neurological weakness and chronic headaches over the past month. The symptoms are described as significant in nature.;surgery
brain_menin_1758;Brain Meningiomas;67;F;Patient is experiencing speech difficulty and fatigue for several weeks. The symptoms are described as slight in nature.;close monitoring
brain_menin_1759;Brain Meningiomas;56;M;Patient is experiencing localized neurological weakness and coordination problems for nearly 3 months. The symptoms are described as significant in nature.;close monitoring
brain_menin_1760;Brain Meningiomas;38;M;Patient is experiencing blurry vision and chronic headaches over the past month. The symptoms are described as moderate in nature.;close monitoring
brain_menin_1761;Brain Meningiomas;65;F;Patient is experiencing fatigue and coordination problems for nearly 3 months. The symptoms are described as significant in nature.;surgery
brain_menin_1762;Brain Meningiomas;56;M;Patient is experiencing chronic headaches and fatigue over the past month. The symptoms are described as mild in nature.;radiation therapy
brain_menin_1763;Brain Meningiomas;74;F;Patient is experiencing fatigue and chronic headaches over the past month. The symptoms are described as tolerable in nature.;close monitoring
brain_menin_1764;Brain Meningiomas;46;F;Patient is experiencing coordination problems and localized neurological weakness for several weeks. The symptoms are described as tolerable in nature.;surgery
brain_menin_1765;Brain Meningiomas;43;M;Patient is experiencing chronic headaches and localized neurological weakness for nearly 3 months. The symptoms are described as mild in nature.;surgery
brain_menin_1766;Brain Meningiomas;74;F;Patient is experiencing speech difficulty and fatigue for several weeks. The symptoms are described as significant in nature.;surgery
brain_menin_1767;Brain Meningiomas;35;F;Patient is experiencing blurry vision and speech difficulty for several weeks. The symptoms are described as moderate in nature.;close monitoring
brain_menin_1768;Brain Meningiomas;40;M;Patient is experiencing coordination problems and chronic headaches for nearly 3 months. The symptoms are described as mild in nature.;surgery
brain_menin_1769;Brain Meningiomas;41;F;Patient is experiencing fatigue and localized neurological weakness for nearly 3 months. The symptoms are described as mild in nature.;radiation therapy
brain_menin_1770;Brain Meningiomas;28;M;Patient is experiencing localized neurological weakness and coordination problems for several weeks. The symptoms are described as mild in nature.;radiation therapy
brain_menin_1771;Brain Meningiomas;65;F;Patient is experiencing speech difficulty and fatigue for nearly 3 months. The symptoms are described as significant in nature.;radiation therapy
brain_menin_1772;Brain Meningiomas;29;M;Patient is experiencing chronic headaches and localized neurological weakness for nearly 3 months. The symptoms are described as moderate in nature.;surgery
brain_menin_1773;Brain Meningiomas;64;M;Patient is experiencing blurry vision and coordination problems over the past month. The symptoms are described as noticeable in nature.;surgery
brain_menin_1774;Brain Meningiomas;19;M;Patient is experiencing speech difficulty and blurry vision for several weeks. The symptoms are described as mild in nature.;radiation therapy
brain_menin_1775;Brain Meningiomas;58;M;Patient is experiencing localized neurological weakness and chronic headaches for nearly 3 months. The symptoms are described as mild in nature.;close monitoring
brain_menin_1776;Brain Meningiomas;65;M;Patient is experiencing localized neurological weakness and blurry vision for several weeks. The symptoms are described as moderate in nature.;surgery
brain_menin_1777;Brain Meningiomas;40;M;Patient is experiencing speech difficulty and localized neurological weakness for several weeks. The symptoms are described as low-grade in nature.;close monitoring
brain_menin_1778;Brain Meningiomas;29;M;Patient is experiencing speech difficulty and coordination problems over the past month. The symptoms are described as tolerable in nature.;radiation therapy
brain_menin_1779;Brain Meningiomas;58;M;Patient is experiencing fatigue and speech difficulty for several weeks. The symptoms are described as mild in nature.;close monitoring
brain_menin_1780;Brain Meningiomas;43;F;Patient is experiencing localized neurological weakness and speech difficulty for several weeks. The symptoms are described as mild in nature.;surgery
brain_menin_1781;Brain Meningiomas;44;M;Patient is experiencing fatigue and chronic headaches for several weeks. The symptoms are described as moderate in nature.;radiation therapy
brain_menin_1782;Brain Meningiomas;46;F;Patient is experiencing speech difficulty and fatigue over the past month. The symptoms are described as significant in nature.;radiation therapy
brain_menin_1783;Brain Meningiomas;63;M;Patient is experiencing coordination problems and chronic headaches over the past month. The symptoms are described as mild in nature.;close monitoring
brain_menin_1784;Brain Meningiomas;30;F;Patient is experiencing blurry vision and speech difficulty for nearly 3 months. The symptoms are described as tolerable in nature.;radiation therapy
brain_menin_1785;Brain Meningiomas;52;F;Patient is experiencing chronic headaches and localized neurological weakness over the past month. The symptoms are described as significant in nature.;surgery
brain_menin_1786;Brain Meningiomas;65;F;Patient is experiencing localized neurological weakness and speech difficulty over the past month. The symptoms are described as tolerable in nature.;surgery
brain_menin_1787;Brain Meningiomas;34;M;Patient is experiencing fatigue and coordination problems for nearly 3 months. The symptoms are described as tolerable in nature.;surgery
brain_menin_1788;Brain Meningiomas;79;M;Patient is experiencing chronic headaches and localized neurological weakness over the past month. The symptoms are described as tolerable in nature.;surgery
brain_menin_1789;Brain Meningiomas;40;F;Patient is experiencing speech difficulty and localized neurological weakness for nearly 3 months. The symptoms are described as mild in nature.;radiation therapy
brain_menin_1790;Brain Meningiomas;54;F;Patient is experiencing chronic headaches and blurry vision for nearly 3 months. The symptoms are described as moderate in nature.;surgery
brain_menin_1791;Brain Meningiomas;27;F;Patient is experiencing coordination problems and blurry vision over the past month. The symptoms are described as moderate in nature.;surgery
brain_menin_1792;Brain Meningiomas;50;M;Patient is experiencing speech difficulty and blurry vision for nearly 3 months. The symptoms are described as slight in nature.;close monitoring
brain_menin_1793;Brain Meningiomas;20;M;Patient is experiencing coordination problems and blurry vision for several weeks. The symptoms are described as significant in nature.;radiation therapy
brain_menin_1794;Brain Meningiomas;70;F;Patient is experiencing blurry vision and fatigue for nearly 3 months. The symptoms are described as low-grade in nature.;surgery
brain_menin_1795;Brain Meningiomas;83;F;Patient is experiencing blurry vision and chronic headaches over the past month. The symptoms are described as slight in nature.;close monitoring
brain_menin_1796;Brain Meningiomas;46;F;Patient is experiencing blurry vision and chronic headaches over the past month. The symptoms are described as slight in nature.;close monitoring
brain_menin_1797;Brain Meningiomas;40;F;Patient is experiencing speech difficulty and chronic headaches over the past month. The symptoms are described as noticeable in nature.;surgery
brain_menin_1798;Brain Meningiomas;74;M;Patient is experiencing speech difficulty and fatigue over the past month. The symptoms are described as low-grade in nature.;close monitoring
brain_menin_1799;Brain Meningiomas;74;F;Patient is experiencing coordination problems and chronic headaches for several weeks. The symptoms are described as slight in nature.;close monitoring
brain_menin_1800;Brain Meningiomas;56;F;Patient is experiencing blurry vision and fatigue for nearly 3 months. The symptoms are described as moderate in nature.;close monitoring
brain_menin_1801;Brain Meningiomas;71;F;Patient is experiencing localized neurological weakness and coordination problems over the past month. The symptoms are described as tolerable in nature.;close monitoring
brain_menin_1802;Brain Meningiomas;58;F;Patient is experiencing coordination problems and fatigue for several weeks. The symptoms are described as significant in nature.;close monitoring
brain_menin_1803;Brain Meningiomas;36;M;Patient is experiencing chronic headaches and coordination problems for nearly 3 months. The symptoms are described as slight in nature.;close monitoring
brain_menin_1804;Brain Meningiomas;74;F;Patient is experiencing blurry vision and coordination problems for nearly 3 months. The symptoms are described as tolerable in nature.;radiation therapy
brain_menin_1805;Brain Meningiomas;70;M;Patient is experiencing fatigue and blurry vision for nearly 3 months. The symptoms are described as low-grade in nature.;surgery
brain_menin_1806;Brain Meningiomas;47;M;Patient is experiencing blurry vision and speech difficulty for nearly 3 months. The symptoms are described as significant in nature.;radiation therapy
brain_menin_1807;Brain Meningiomas;50;M;Patient is experiencing fatigue and localized neurological weakness for nearly 3 months. The symptoms are described as noticeable in nature.;radiation therapy
brain_menin_1808;Brain Meningiomas;19;F;Patient is experiencing fatigue and speech difficulty for nearly 3 months. The symptoms are described as noticeable in nature.;close monitoring
brain_menin_1809;Brain Meningiomas;75;F;Patient is experiencing localized neurological weakness and fatigue for several weeks. The symptoms are described as tolerable in nature.;close monitoring
brain_menin_1810;Brain Meningiomas;28;M;Patient is experiencing chronic headaches and speech difficulty over the past month. The symptoms are described as moderate in nature.;surgery
brain_menin_1811;Brain Meningiomas;41;F;Patient is experiencing coordination problems and speech difficulty over the past month. The symptoms are described as tolerable in nature.;surgery
brain_menin_1812;Brain Meningiomas;21;M;Patient is experiencing speech difficulty and localized neurological weakness for nearly 3 months. The symptoms are described as noticeable in nature.;radiation therapy
brain_menin_1813;Brain Meningiomas;59;F;Patient is experiencing localized neurological weakness and fatigue over the past month. The symptoms are described as tolerable in nature.;radiation therapy
brain_menin_1814;Brain Meningiomas;67;M;Patient is experiencing blurry vision and chronic headaches over the past month. The symptoms are described as mild in nature.;surgery
brain_menin_1815;Brain Meningiomas;25;M;Patient is experiencing localized neurological weakness and fatigue for several weeks. The symptoms are described as noticeable in nature.;close monitoring
brain_menin_1816;Brain Meningiomas;58;F;Patient is experiencing localized neurological weakness and chronic headaches for several weeks. The symptoms are described as tolerable in nature.;surgery
brain_menin_1817;Brain Meningiomas;72;F;Patient is experiencing localized neurological weakness and blurry vision for nearly 3 months. The symptoms are described as mild in nature.;surgery
brain_menin_1818;Brain Meningiomas;25;F;Patient is experiencing localized neurological weakness and blurry vision for nearly 3 months. The symptoms are described as significant in nature.;radiation therapy
brain_menin_1819;Brain Meningiomas;76;M;Patient is experiencing localized neurological weakness and speech difficulty for nearly 3 months. The symptoms are described as tolerable in nature.;close monitoring
brain_menin_1820;Brain Meningiomas;30;F;Patient is experiencing chronic headaches and coordination problems for several weeks. The symptoms are described as moderate in nature.;close monitoring
brain_menin_1821;Brain Meningiomas;59;M;Patient is experiencing localized neurological weakness and blurry vision for several weeks. The symptoms are described as low-grade in nature.;radiation therapy
brain_menin_1822;Brain Meningiomas;43;F;Patient is experiencing fatigue and localized neurological weakness over the past month. The symptoms are described as low-grade in nature.;surgery
brain_menin_1823;Brain Meningiomas;47;M;Patient is experiencing localized neurological weakness and chronic headaches over the past month. The symptoms are described as noticeable in nature.;surgery
brain_menin_1824;Brain Meningiomas;80;F;Patient is experiencing fatigue and blurry vision for nearly 3 months. The symptoms are described as tolerable in nature.;surgery
brain_menin_1825;Brain Meningiomas;81;F;Patient is experiencing blurry vision and speech difficulty for several weeks. The symptoms are described as moderate in nature.;radiation therapy
brain_menin_1826;Brain Meningiomas;38;F;Patient is experiencing speech difficulty and blurry vision over the past month. The symptoms are described as mild in nature.;close monitoring
brain_menin_1827;Brain Meningiomas;36;F;Patient is experiencing speech difficulty and localized neurological weakness over the past month. The symptoms are described as slight in nature.;radiation therapy
brain_menin_1828;Brain Meningiomas;85;F;Patient is experiencing localized neurological weakness and fatigue for several weeks. The symptoms are described as moderate in nature.;surgery
brain_menin_1829;Brain Meningiomas;35;F;Patient is experiencing fatigue and blurry vision over the past month. The symptoms are described as mild in nature.;surgery
brain_menin_1830;Brain Meningiomas;37;F;Patient is experiencing chronic headaches and coordination problems over the past month. The symptoms are described as tolerable in nature.;close monitoring
brain_menin_1831;Brain Meningiomas;46;M;Patient is experiencing localized neurological weakness and fatigue over the past month. The symptoms are described as low-grade in nature.;close monitoring
brain_menin_1832;Brain Meningiomas;24;M;Patient is experiencing speech difficulty and chronic headaches for nearly 3 months. The symptoms are described as moderate in nature.;surgery
brain_menin_1833;Brain Meningiomas;33;M;Patient is experiencing chronic headaches and localized neurological weakness for several weeks. The symptoms are described as significant in nature.;surgery
brain_menin_1834;Brain Meningiomas;54;M;Patient is experiencing chronic headaches and coordination problems for several weeks. The symptoms are described as low-grade in nature.;surgery
brain_menin_1835;Brain Meningiomas;41;F;Patient is experiencing localized neurological weakness and coordination problems for several weeks. The symptoms are described as tolerable in nature.;close monitoring
brain_menin_1836;Brain Meningiomas;72;F;Patient is experiencing blurry vision and chronic headaches for several weeks. The symptoms are described as mild in nature.;radiation therapy
brain_menin_1837;Brain Meningiomas;50;F;Patient is experiencing blurry vision and chronic headaches over the past month. The symptoms are described as noticeable in nature.;radiation therapy
brain_menin_1838;Brain Meningiomas;27;F;Patient is experiencing coordination problems and chronic headaches for several weeks. The symptoms are described as tolerable in nature.;radiation therapy
brain_menin_1839;Brain Meningiomas;50;F;Patient is experiencing coordination problems and fatigue for nearly 3 months. The symptoms are described as tolerable in nature.;radiation therapy
brain_menin_1840;Brain Meningiomas;38;M;Patient is experiencing blurry vision and chronic headaches for nearly 3 months. The symptoms are described as tolerable in nature.;surgery
brain_menin_1841;Brain Meningiomas;26;F;Patient is experiencing localized neurological weakness and blurry vision over the past month. The symptoms are described as significant in nature.;surgery
brain_menin_1842;Brain Meningiomas;19;M;Patient is experiencing blurry vision and fatigue for nearly 3 months. The symptoms are described as significant in nature.;radiation therapy
brain_menin_1843;Brain Meningiomas;53;M;Patient is experiencing speech difficulty and blurry vision for several weeks. The symptoms are described as moderate in nature.;surgery
brain_menin_1844;Brain Meningiomas;64;M;Patient is experiencing fatigue and blurry vision for nearly 3 months. The symptoms are described as mild in nature.;surgery
brain_menin_1845;Brain Meningiomas;73;F;Patient is experiencing localized neurological weakness and coordination problems for several weeks. The symptoms are described as mild in nature.;close monitoring
brain_menin_1846;Brain Meningiomas;82;F;Patient is experiencing localized neurological weakness and chronic headaches over the past month. The symptoms are described as moderate in nature.;radiation therapy
brain_menin_1847;Brain Meningiomas;38;M;Patient is experiencing localized neurological weakness and fatigue over the past month. The symptoms are described as tolerable in nature.;surgery
brain_menin_1848;Brain Meningiomas;36;F;Patient is experiencing localized neurological weakness and chronic headaches for several weeks. The symptoms are described as significant in nature.;surgery
brain_menin_1849;Brain Meningiomas;79;F;Patient is experiencing fatigue and coordination problems for several weeks. The symptoms are described as slight in nature.;radiation therapy
brain_menin_1850;Brain Meningiomas;35;F;Patient is experiencing localized neurological weakness and speech difficulty for several weeks. The symptoms are described as significant in nature.;surgery
brain_menin_1851;Brain Meningiomas;75;F;Patient is experiencing fatigue and coordination problems for several weeks. The symptoms are described as noticeable in nature.;close monitoring
brain_menin_1852;Brain Meningiomas;45;F;Patient is experiencing fatigue and localized neurological weakness over the past month. The symptoms are described as low-grade in nature.;close monitoring
brain_menin_1853;Brain Meningiomas;78;F;Patient is experiencing speech difficulty and chronic headaches for several weeks. The symptoms are described as noticeable in nature.;surgery
brain_menin_1854;Brain Meningiomas;85;F;Patient is experiencing localized neurological weakness and speech difficulty for nearly 3 months. The symptoms are described as significant in nature.;surgery
brain_menin_1855;Brain Meningiomas;45;M;Patient is experiencing blurry vision and coordination problems over the past month. The symptoms are described as moderate in nature.;surgery
brain_menin_1856;Brain Meningiomas;32;M;Patient is experiencing speech difficulty and coordination problems over the past month. The symptoms are described as low-grade in nature.;radiation therapy
brain_menin_1857;Brain Meningiomas;42;M;Patient is experiencing localized neurological weakness and coordination problems over the past month. The symptoms are described as tolerable in nature.;radiation therapy
brain_menin_1858;Brain Meningiomas;77;F;Patient is experiencing fatigue and speech difficulty for several weeks. The symptoms are described as mild in nature.;surgery
brain_menin_1859;Brain Meningiomas;57;M;Patient is experiencing coordination problems and speech difficulty for nearly 3 months. The symptoms are described as slight in nature.;surgery
brain_menin_1860;Brain Meningiomas;59;M;Patient is experiencing fatigue and localized neurological weakness over the past month. The symptoms are described as tolerable in nature.;radiation therapy
brain_menin_1861;Brain Meningiomas;26;M;Patient is experiencing fatigue and localized neurological weakness for several weeks. The symptoms are described as low-grade in nature.;close monitoring
brain_menin_1862;Brain Meningiomas;26;M;Patient is experiencing localized neurological weakness and blurry vision for several weeks. The symptoms are described as slight in nature.;radiation therapy
brain_menin_1863;Brain Meningiomas;51;F;Patient is experiencing localized neurological weakness and speech difficulty for several weeks. The symptoms are described as significant in nature.;close monitoring
brain_menin_1864;Brain Meningiomas;77;M;Patient is experiencing localized neurological weakness and coordination problems for nearly 3 months. The symptoms are described as mild in nature.;radiation therapy
brain_menin_1865;Brain Meningiomas;72;M;Patient is experiencing chronic headaches and localized neurological weakness over the past month. The symptoms are described as tolerable in nature.;close monitoring
brain_menin_1866;Brain Meningiomas;27;M;Patient is experiencing fatigue and coordination problems for several weeks. The symptoms are described as noticeable in nature.;close monitoring
brain_menin_1867;Brain Meningiomas;51;F;Patient is experiencing chronic headaches and localized neurological weakness for several weeks. The symptoms are described as tolerable in nature.;surgery
brain_menin_1868;Brain Meningiomas;80;F;Patient is experiencing localized neurological weakness and chronic headaches for several weeks. The symptoms are described as moderate in nature.;surgery
brain_menin_1869;Brain Meningiomas;25;F;Patient is experiencing coordination problems and speech difficulty over the past month. The symptoms are described as slight in nature.;surgery
brain_menin_1870;Brain Meningiomas;53;M;Patient is experiencing localized neurological weakness and speech difficulty for several weeks. The symptoms are described as significant in nature.;close monitoring
brain_menin_1871;Brain Meningiomas;32;F;Patient is experiencing blurry vision and speech difficulty over the past month. The symptoms are described as noticeable in nature.;close monitoring
brain_menin_1872;Brain Meningiomas;21;F;Patient is experiencing chronic headaches and speech difficulty over the past month. The symptoms are described as significant in nature.;close monitoring
brain_menin_1873;Brain Meningiomas;42;M;Patient is experiencing fatigue and localized neurological weakness for nearly 3 months. The symptoms are described as moderate in nature.;surgery
brain_menin_1874;Brain Meningiomas;41;F;Patient is experiencing fatigue and blurry vision for nearly 3 months. The symptoms are described as significant in nature.;close monitoring
brain_menin_1875;Brain Meningiomas;42;M;Patient is experiencing coordination problems and blurry vision over the past month. The symptoms are described as moderate in nature.;radiation therapy
brain_menin_1876;Brain Meningiomas;41;M;Patient is experiencing chronic headaches and speech difficulty over the past month. The symptoms are described as noticeable in nature.;close monitoring
brain_menin_1877;Brain Meningiomas;72;M;Patient is experiencing coordination problems and fatigue for several weeks. The symptoms are described as low-grade in nature.;close monitoring
brain_menin_1878;Brain Meningiomas;69;F;Patient is experiencing chronic headaches and coordination problems over the past month. The symptoms are described as noticeable in nature.;surgery
brain_menin_1879;Brain Meningiomas;64;M;Patient is experiencing localized neurological weakness and fatigue for several weeks. The symptoms are described as moderate in nature.;close monitoring
brain_menin_1880;Brain Meningiomas;48;F;Patient is experiencing fatigue and speech difficulty for nearly 3 months. The symptoms are described as slight in nature.;radiation therapy
brain_menin_1881;Brain Meningiomas;21;M;Patient is experiencing fatigue and localized neurological weakness for several weeks. The symptoms are described as slight in nature.;surgery
brain_menin_1882;Brain Meningiomas;44;F;Patient is experiencing fatigue and chronic headaches for nearly 3 months. The symptoms are described as tolerable in nature.;close monitoring
brain_menin_1883;Brain Meningiomas;68;F;Patient is experiencing localized neurological weakness and chronic headaches over the past month. The symptoms are described as tolerable in nature.;close monitoring
brain_menin_1884;Brain Meningiomas;79;M;Patient is experiencing blurry vision and localized neurological weakness over the past month. The symptoms are described as low-grade in nature.;radiation therapy
brain_menin_1885;Brain Meningiomas;64;F;Patient is experiencing speech difficulty and coordination problems for nearly 3 months. The symptoms are described as noticeable in nature.;surgery
brain_menin_1886;Brain Meningiomas;22;F;Patient is experiencing localized neurological weakness and blurry vision over the past month. The symptoms are described as noticeable in nature.;close monitoring
brain_menin_1887;Brain Meningiomas;47;F;Patient is experiencing speech difficulty and coordination problems for several weeks. The symptoms are described as noticeable in nature.;radiation therapy
brain_menin_1888;Brain Meningiomas;43;M;Patient is experiencing speech difficulty and blurry vision for nearly 3 months. The symptoms are described as significant in nature.;close monitoring
brain_menin_1889;Brain Meningiomas;59;M;Patient is experiencing localized neurological weakness and fatigue over the past month. The symptoms are described as moderate in nature.;close monitoring
brain_menin_1890;Brain Meningiomas;56;M;Patient is experiencing speech difficulty and coordination problems over the past month. The symptoms are described as moderate in nature.;close monitoring
brain_menin_1891;Brain Meningiomas;70;M;Patient is experiencing speech difficulty and blurry vision for nearly 3 months. The symptoms are described as noticeable in nature.;close monitoring
brain_menin_1892;Brain Meningiomas;81;M;Patient is experiencing fatigue and blurry vision for several weeks. The symptoms are described as significant in nature.;close monitoring
brain_menin_1893;Brain Meningiomas;82;M;Patient is experiencing speech difficulty and coordination problems for several weeks. The symptoms are described as moderate in nature.;close monitoring
brain_menin_1894;Brain Meningiomas;62;F;Patient is experiencing fatigue and localized neurological weakness for several weeks. The symptoms are described as moderate in nature.;close monitoring
brain_menin_1895;Brain Meningiomas;31;F;Patient is experiencing blurry vision and fatigue for several weeks. The symptoms are described as tolerable in nature.;surgery
brain_menin_1896;Brain Meningiomas;19;M;Patient is experiencing coordination problems and fatigue for nearly 3 months. The symptoms are described as noticeable in nature.;radiation therapy
brain_menin_1897;Brain Meningiomas;20;F;Patient is experiencing coordination problems and chronic headaches over the past month. The symptoms are described as slight in nature.;surgery
brain_menin_1898;Brain Meningiomas;83;M;Patient is experiencing localized neurological weakness and fatigue over the past month. The symptoms are described as noticeable in nature.;close monitoring
brain_menin_1899;Brain Meningiomas;75;F;Patient is experiencing localized neurological weakness and chronic headaches for several weeks. The symptoms are described as significant in nature.;radiation therapy
brain_menin_1900;Brain Meningiomas;78;M;Patient is experiencing speech difficulty and blurry vision for nearly 3 months. The symptoms are described as mild in nature.;radiation therapy
brain_menin_1901;Brain Meningiomas;47;F;Patient is experiencing localized neurological weakness and fatigue for several weeks. The symptoms are described as mild in nature.;close monitoring
brain_menin_1902;Brain Meningiomas;63;M;Patient is experiencing coordination problems and speech difficulty for several weeks. The symptoms are described as noticeable in nature.;close monitoring
brain_menin_1903;Brain Meningiomas;40;F;Patient is experiencing speech difficulty and fatigue over the past month. The symptoms are described as moderate in nature.;surgery
brain_menin_1904;Brain Meningiomas;81;M;Patient is experiencing fatigue and localized neurological weakness for several weeks. The symptoms are described as noticeable in nature.;radiation therapy
brain_menin_1905;Brain Meningiomas;61;M;Patient is experiencing fatigue and coordination problems for nearly 3 months. The symptoms are described as moderate in nature.;radiation therapy
brain_menin_1906;Brain Meningiomas;50;F;Patient is experiencing localized neurological weakness and blurry vision for nearly 3 months. The symptoms are described as significant in nature.;surgery
brain_menin_1907;Brain Meningiomas;24;M;Patient is experiencing localized neurological weakness and speech difficulty for several weeks. The symptoms are described as significant in nature.;surgery
brain_menin_1908;Brain Meningiomas;39;F;Patient is experiencing chronic headaches and speech difficulty for nearly 3 months. The symptoms are described as slight in nature.;surgery
brain_menin_1909;Brain Meningiomas;31;F;Patient is experiencing fatigue and blurry vision over the past month. The symptoms are described as noticeable in nature.;surgery
brain_menin_1910;Brain Meningiomas;72;F;Patient is experiencing speech difficulty and blurry vision for nearly 3 months. The symptoms are described as moderate in nature.;close monitoring
brain_menin_1911;Brain Meningiomas;52;M;Patient is experiencing chronic headaches and localized neurological weakness for nearly 3 months. The symptoms are described as noticeable in nature.;radiation therapy
brain_menin_1912;Brain Meningiomas;61;F;Patient is experiencing speech difficulty and blurry vision over the past month. The symptoms are described as slight in nature.;close monitoring
brain_menin_1913;Brain Meningiomas;23;F;Patient is experiencing blurry vision and fatigue for several weeks. The symptoms are described as significant in nature.;close monitoring
brain_menin_1914;Brain Meningiomas;48;M;Patient is experiencing coordination problems and localized neurological weakness for nearly 3 months. The symptoms are described as tolerable in nature.;close monitoring
brain_menin_1915;Brain Meningiomas;56;F;Patient is experiencing fatigue and blurry vision over the past month. The symptoms are described as noticeable in nature.;close monitoring
brain_menin_1916;Brain Meningiomas;83;M;Patient is experiencing coordination problems and speech difficulty over the past month. The symptoms are described as noticeable in nature.;surgery
brain_menin_1917;Brain Meningiomas;55;F;Patient is experiencing localized neurological weakness and speech difficulty for nearly 3 months. The symptoms are described as moderate in nature.;radiation therapy
brain_menin_1918;Brain Meningiomas;53;F;Patient is experiencing coordination problems and speech difficulty for nearly 3 months. The symptoms are described as noticeable in nature.;surgery
brain_menin_1919;Brain Meningiomas;20;M;Patient is experiencing fatigue and coordination problems over the past month. The symptoms are described as slight in nature.;radiation therapy
brain_menin_1920;Brain Meningiomas;42;M;Patient is experiencing coordination problems and speech difficulty for several weeks. The symptoms are described as moderate in nature.;surgery
brain_menin_1921;Brain Meningiomas;42;M;Patient is experiencing localized neurological weakness and speech difficulty for nearly 3 months. The symptoms are described as tolerable in nature.;close monitoring
brain_menin_1922;Brain Meningiomas;46;M;Patient is experiencing chronic headaches and blurry vision over the past month. The symptoms are described as slight in nature.;surgery
brain_menin_1923;Brain Meningiomas;57;F;Patient is experiencing blurry vision and localized neurological weakness for several weeks. The symptoms are described as slight in nature.;close monitoring
brain_menin_1924;Brain Meningiomas;50;F;Patient is experiencing speech difficulty and chronic headaches for several weeks. The symptoms are described as noticeable in nature.;close monitoring
brain_menin_1925;Brain Meningiomas;82;M;Patient is experiencing coordination problems and blurry vision over the past month. The symptoms are described as noticeable in nature.;radiation therapy
brain_menin_1926;Brain Meningiomas;66;F;Patient is experiencing fatigue and coordination problems for nearly 3 months. The symptoms are described as noticeable in nature.;surgery
brain_menin_1927;Brain Meningiomas;43;F;Patient is experiencing coordination problems and localized neurological weakness for several weeks. The symptoms are described as significant in nature.;close monitoring
brain_menin_1928;Brain Meningiomas;23;M;Patient is experiencing blurry vision and coordination problems for several weeks. The symptoms are described as moderate in nature.;surgery
brain_menin_1929;Brain Meningiomas;72;F;Patient is experiencing speech difficulty and blurry vision over the past month. The symptoms are described as noticeable in nature.;close monitoring
brain_menin_1930;Brain Meningiomas;23;M;Patient is experiencing fatigue and blurry vision for several weeks. The symptoms are described as moderate in nature.;close monitoring
brain_menin_1931;Brain Meningiomas;30;F;Patient is experiencing chronic headaches and localized neurological weakness over the past month. The symptoms are described as tolerable in nature.;surgery
brain_menin_1932;Brain Meningiomas;23;M;Patient is experiencing localized neurological weakness and speech difficulty over the past month. The symptoms are described as low-grade in nature.;close monitoring
brain_menin_1933;Brain Meningiomas;46;M;Patient is experiencing chronic headaches and blurry vision over the past month. The symptoms are described as tolerable in nature.;close monitoring
brain_menin_1934;Brain Meningiomas;80;F;Patient is experiencing chronic headaches and speech difficulty over the past month. The symptoms are described as mild in nature.;surgery
brain_menin_1935;Brain Meningiomas;64;F;Patient is experiencing coordination problems and localized neurological weakness for nearly 3 months. The symptoms are described as low-grade in nature.;surgery
brain_menin_1936;Brain Meningiomas;56;M;Patient is experiencing blurry vision and localized neurological weakness over the past month. The symptoms are described as noticeable in nature.;surgery
brain_menin_1937;Brain Meningiomas;57;M;Patient is experiencing coordination problems and blurry vision over the past month. The symptoms are described as mild in nature.;radiation therapy
brain_menin_1938;Brain Meningiomas;63;M;Patient is experiencing speech difficulty and fatigue for nearly 3 months. The symptoms are described as slight in nature.;surgery
brain_menin_1939;Brain Meningiomas;67;M;Patient is experiencing coordination problems and blurry vision for several weeks. The symptoms are described as significant in nature.;close monitoring
brain_menin_1940;Brain Meningiomas;40;M;Patient is experiencing blurry vision and speech difficulty for several weeks. The symptoms are described as noticeable in nature.;close monitoring
brain_menin_1941;Brain Meningiomas;69;M;Patient is experiencing coordination problems and chronic headaches for nearly 3 months. The symptoms are described as slight in nature.;surgery
brain_menin_1942;Brain Meningiomas;31;F;Patient is experiencing chronic headaches and coordination problems for nearly 3 months. The symptoms are described as moderate in nature.;close monitoring
brain_menin_1943;Brain Meningiomas;44;F;Patient is experiencing localized neurological weakness and speech difficulty for several weeks. The symptoms are described as significant in nature.;radiation therapy
brain_menin_1944;Brain Meningiomas;77;F;Patient is experiencing chronic headaches and localized neurological weakness over the past month. The symptoms are described as tolerable in nature.;close monitoring
brain_menin_1945;Brain Meningiomas;63;F;Patient is experiencing localized neurological weakness and coordination problems for several weeks. The symptoms are described as tolerable in nature.;close monitoring
brain_menin_1946;Brain Meningiomas;39;F;Patient is experiencing blurry vision and localized neurological weakness over the past month. The symptoms are described as moderate in nature.;surgery
brain_menin_1947;Brain Meningiomas;30;M;Patient is experiencing speech difficulty and localized neurological weakness for several weeks. The symptoms are described as noticeable in nature.;close monitoring
brain_menin_1948;Brain Meningiomas;85;F;Patient is experiencing localized neurological weakness and fatigue for nearly 3 months. The symptoms are described as significant in nature.;close monitoring
brain_menin_1949;Brain Meningiomas;45;F;Patient is experiencing blurry vision and speech difficulty for nearly 3 months. The symptoms are described as mild in nature.;close monitoring
brain_menin_1950;Brain Meningiomas;19;F;Patient is experiencing chronic headaches and blurry vision over the past month. The symptoms are described as low-grade in nature.;radiation therapy
brain_menin_1951;Brain Meningiomas;77;F;Patient is experiencing fatigue and localized neurological weakness for several weeks. The symptoms are described as moderate in nature.;close monitoring
brain_menin_1952;Brain Meningiomas;68;M;Patient is experiencing blurry vision and speech difficulty for nearly 3 months. The symptoms are described as significant in nature.;surgery
brain_menin_1953;Brain Meningiomas;21;M;Patient is experiencing blurry vision and chronic headaches for nearly 3 months. The symptoms are described as significant in nature.;radiation therapy
brain_menin_1954;Brain Meningiomas;63;M;Patient is experiencing coordination problems and chronic headaches for nearly 3 months. The symptoms are described as noticeable in nature.;close monitoring
brain_menin_1955;Brain Meningiomas;80;F;Patient is experiencing blurry vision and chronic headaches for nearly 3 months. The symptoms are described as low-grade in nature.;radiation therapy
brain_menin_1956;Brain Meningiomas;24;M;Patient is experiencing coordination problems and fatigue over the past month. The symptoms are described as low-grade in nature.;surgery
brain_menin_1957;Brain Meningiomas;67;F;Patient is experiencing speech difficulty and localized neurological weakness over the past month. The symptoms are described as slight in nature.;close monitoring
brain_menin_1958;Brain Meningiomas;67;F;Patient is experiencing localized neurological weakness and chronic headaches over the past month. The symptoms are described as tolerable in nature.;radiation therapy
brain_menin_1959;Brain Meningiomas;84;F;Patient is experiencing fatigue and speech difficulty for nearly 3 months. The symptoms are described as significant in nature.;radiation therapy
brain_menin_1960;Brain Meningiomas;83;M;Patient is experiencing fatigue and chronic headaches over the past month. The symptoms are described as tolerable in nature.;radiation therapy
brain_menin_1961;Brain Meningiomas;70;F;Patient is experiencing chronic headaches and blurry vision over the past month. The symptoms are described as mild in nature.;radiation therapy
brain_menin_1962;Brain Meningiomas;79;M;Patient is experiencing coordination problems and fatigue for nearly 3 months. The symptoms are described as tolerable in nature.;radiation therapy
brain_menin_1963;Brain Meningiomas;57;M;Patient is experiencing localized neurological weakness and chronic headaches over the past month. The symptoms are described as mild in nature.;radiation therapy
brain_menin_1964;Brain Meningiomas;18;M;Patient is experiencing coordination problems and localized neurological weakness over the past month. The symptoms are described as moderate in nature.;radiation therapy
brain_menin_1965;Brain Meningiomas;39;F;Patient is experiencing speech difficulty and localized neurological weakness for several weeks. The symptoms are described as tolerable in nature.;radiation therapy
brain_menin_1966;Brain Meningiomas;26;F;Patient is experiencing coordination problems and fatigue for nearly 3 months. The symptoms are described as tolerable in nature.;radiation therapy
brain_menin_1967;Brain Meningiomas;34;F;Patient is experiencing speech difficulty and blurry vision for nearly 3 months. The symptoms are described as noticeable in nature.;radiation therapy
brain_menin_1968;Brain Meningiomas;80;F;Patient is experiencing blurry vision and localized neurological weakness over the past month. The symptoms are described as noticeable in nature.;surgery
brain_menin_1969;Brain Meningiomas;34;F;Patient is experiencing coordination problems and speech difficulty over the past month. The symptoms are described as slight in nature.;radiation therapy
brain_menin_1970;Brain Meningiomas;71;F;Patient is experiencing speech difficulty and blurry vision for several weeks. The symptoms are described as mild in nature.;radiation therapy
brain_menin_1971;Brain Meningiomas;36;M;Patient is experiencing chronic headaches and blurry vision over the past month. The symptoms are described as low-grade in nature.;surgery
brain_menin_1972;Brain Meningiomas;75;F;Patient is experiencing coordination problems and fatigue over the past month. The symptoms are described as moderate in nature.;radiation therapy
brain_menin_1973;Brain Meningiomas;65;M;Patient is experiencing coordination problems and chronic headaches over the past month. The symptoms are described as tolerable in nature.;surgery
brain_menin_1974;Brain Meningiomas;79;M;Patient is experiencing speech difficulty and fatigue for nearly 3 months. The symptoms are described as mild in nature.;surgery
brain_menin_1975;Brain Meningiomas;80;F;Patient is experiencing fatigue and blurry vision for nearly 3 months. The symptoms are described as tolerable in nature.;surgery
brain_menin_1976;Brain Meningiomas;82;M;Patient is experiencing localized neurological weakness and coordination problems over the past month. The symptoms are described as moderate in nature.;radiation therapy
brain_menin_1977;Brain Meningiomas;28;F;Patient is experiencing blurry vision and fatigue for nearly 3 months. The symptoms are described as tolerable in nature.;surgery
brain_menin_1978;Brain Meningiomas;66;F;Patient is experiencing coordination problems and fatigue for several weeks. The symptoms are described as mild in nature.;radiation therapy
brain_menin_1979;Brain Meningiomas;72;M;Patient is experiencing speech difficulty and chronic headaches for nearly 3 months. The symptoms are described as significant in nature.;surgery
brain_menin_1980;Brain Meningiomas;31;F;Patient is experiencing chronic headaches and speech difficulty for nearly 3 months. The symptoms are described as moderate in nature.;surgery
brain_menin_1981;Brain Meningiomas;76;M;Patient is experiencing fatigue and coordination problems for nearly 3 months. The symptoms are described as slight in nature.;surgery
brain_menin_1982;Brain Meningiomas;73;F;Patient is experiencing coordination problems and localized neurological weakness over the past month. The symptoms are described as low-grade in nature.;surgery
brain_menin_1983;Brain Meningiomas;51;F;Patient is experiencing localized neurological weakness and speech difficulty over the past month. The symptoms are described as significant in nature.;surgery
brain_menin_1984;Brain Meningiomas;36;F;Patient is experiencing blurry vision and coordination problems for several weeks. The symptoms are described as significant in nature.;surgery
brain_menin_1985;Brain Meningiomas;55;M;Patient is experiencing chronic headaches and blurry vision over the past month. The symptoms are described as tolerable in nature.;surgery
brain_menin_1986;Brain Meningiomas;27;M;Patient is experiencing localized neurological weakness and coordination problems for nearly 3 months. The symptoms are described as noticeable in nature.;radiation therapy
brain_menin_1987;Brain Meningiomas;63;M;Patient is experiencing chronic headaches and localized neurological weakness for nearly 3 months. The symptoms are described as tolerable in nature.;surgery
brain_menin_1988;Brain Meningiomas;72;F;Patient is experiencing coordination problems and localized neurological weakness over the past month. The symptoms are described as moderate in nature.;surgery
brain_menin_1989;Brain Meningiomas;43;F;Patient is experiencing speech difficulty and fatigue for nearly 3 months. The symptoms are described as tolerable in nature.;surgery
brain_menin_1990;Brain Meningiomas;33;F;Patient is experiencing blurry vision and chronic headaches over the past month. The symptoms are described as mild in nature.;close monitoring
brain_menin_1991;Brain Meningiomas;83;F;Patient is experiencing chronic headaches and coordination problems for nearly 3 months. The symptoms are described as moderate in nature.;close monitoring
brain_menin_1992;Brain Meningiomas;34;F;Patient is experiencing speech difficulty and blurry vision over the past month. The symptoms are described as significant in nature.;close monitoring
brain_menin_1993;Brain Meningiomas;77;F;Patient is experiencing speech difficulty and coordination problems for several weeks. The symptoms are described as significant in nature.;close monitoring
brain_menin_1994;Brain Meningiomas;59;F;Patient is experiencing coordination problems and speech difficulty over the past month. The symptoms are described as low-grade in nature.;close monitoring
brain_menin_1995;Brain Meningiomas;59;M;Patient is experiencing chronic headaches and fatigue for nearly 3 months. The symptoms are described as tolerable in nature.;radiation therapy
brain_menin_1996;Brain Meningiomas;71;F;Patient is experiencing fatigue and coordination problems for several weeks. The symptoms are described as tolerable in nature.;radiation therapy
brain_menin_1997;Brain Meningiomas;65;M;Patient is experiencing blurry vision and chronic headaches over the past month. The symptoms are described as mild in nature.;radiation therapy
brain_menin_1998;Brain Meningiomas;30;F;Patient is experiencing coordination problems and chronic headaches for several weeks. The symptoms are described as moderate in nature.;radiation therapy
brain_menin_1999;Brain Meningiomas;77;M;Patient is experiencing speech difficulty and blurry vision over the past month. The symptoms are described as low-grade in nature.;surgery
brain_menin_2000;Brain Meningiomas;35;M;Patient is experiencing speech difficulty and fatigue for nearly 3 months. The symptoms are described as noticeable in nature.;close monitoring
brain_menin_2001;Brain Meningiomas;66;F;Patient is experiencing speech difficulty and localized neurological weakness for nearly 3 months. The symptoms are described as significant in nature.;close monitoring
brain_menin_2002;Brain Meningiomas;18;F;Patient is experiencing speech difficulty and coordination problems for nearly 3 months. The symptoms are described as significant in nature.;surgery
brain_menin_2003;Brain Meningiomas;57;M;Patient is experiencing chronic headaches and coordination problems for several weeks. The symptoms are described as significant in nature.;close monitoring
brain_menin_2004;Brain Meningiomas;18;M;Patient is experiencing speech difficulty and coordination problems over the past month. The symptoms are described as mild in nature.;close monitoring
brain_tumor_0001;Brain Tumor;28;M;Patient is experiencing blackouts and balance issues since early this year. The symptoms are described as significant in nature.;close monitoring
brain_tumor_0002;Brain Tumor;65;F;Patient is experiencing recurring seizures and speech problems since early this year. The symptoms are described as noticeable in nature.;close monitoring
brain_tumor_0003;Brain Tumor;38;F;Patient is experiencing nausea and balance issues since early this year. The symptoms are described as noticeable in nature.;close monitoring
brain_tumor_0004;Brain Tumor;82;M;Patient is experiencing motor dysfunction and difficulty concentrating over the last few weeks. The symptoms are described as noticeable in nature.;close monitoring
brain_tumor_0005;Brain Tumor;69;M;Patient is experiencing nausea and blackouts since early this year. The symptoms are described as intense in nature.;close monitoring
brain_tumor_0006;Brain Tumor;52;F;Patient is experiencing difficulty concentrating and speech problems over the last few weeks. The symptoms are described as noticeable in nature.;radiation therapy
brain_tumor_0007;Brain Tumor;31;F;Patient is experiencing balance issues and blackouts since early this year. The symptoms are described as debilitating in nature.;surgery
brain_tumor_0008;Brain Tumor;24;F;Patient is experiencing recurring seizures and blackouts over the last few weeks. The symptoms are described as intense in nature.;surgery
brain_tumor_0009;Brain Tumor;60;M;Patient is experiencing motor dysfunction and blackouts since early this year. The symptoms are described as severe in nature.;chemotherapy
brain_tumor_0010;Brain Tumor;80;F;Patient is experiencing nausea and difficulty concentrating over the last few weeks. The symptoms are described as noticeable in nature.;close monitoring
brain_tumor_0011;Brain Tumor;60;M;Patient is experiencing speech problems and balance issues since early this year. The symptoms are described as significant in nature.;surgery
brain_tumor_0012;Brain Tumor;54;M;Patient is experiencing difficulty concentrating and blackouts over the last few weeks. The symptoms are described as significant in nature.;radiation therapy
brain_tumor_0013;Brain Tumor;74;M;Patient is experiencing recurring seizures and nausea for the past 4 months. The symptoms are described as severe in nature.;radiation therapy
brain_tumor_0014;Brain Tumor;70;F;Patient is experiencing nausea and motor dysfunction over the last few weeks. The symptoms are described as significant in nature.;chemotherapy
brain_tumor_0015;Brain Tumor;31;F;Patient is experiencing blackouts and balance issues for the past 4 months. The symptoms are described as moderate in nature.;chemotherapy
brain_tumor_0016;Brain Tumor;80;F;Patient is experiencing difficulty concentrating and speech problems since early this year. The symptoms are described as debilitating in nature.;chemotherapy
brain_tumor_0017;Brain Tumor;68;F;Patient is experiencing motor dysfunction and balance issues for the past 4 months. The symptoms are described as moderate in nature.;radiation therapy
brain_tumor_0018;Brain Tumor;26;F;Patient is experiencing blackouts and motor dysfunction since early this year. The symptoms are described as severe in nature.;surgery
brain_tumor_0019;Brain Tumor;36;M;Patient is experiencing nausea and speech problems since early this year. The symptoms are described as moderate in nature.;surgery
brain_tumor_0020;Brain Tumor;37;F;Patient is experiencing difficulty concentrating and blackouts for the past 4 months. The symptoms are described as moderate in nature.;chemotherapy
brain_tumor_0021;Brain Tumor;53;F;Patient is experiencing balance issues and speech problems for the past 4 months. The symptoms are described as moderate in nature.;surgery
brain_tumor_0022;Brain Tumor;23;M;Patient is experiencing difficulty concentrating and motor dysfunction since early this year. The symptoms are described as moderate in nature.;chemotherapy
brain_tumor_0023;Brain Tumor;74;M;Patient is experiencing balance issues and blackouts since early this year. The symptoms are described as high-grade in nature.;radiation therapy
brain_tumor_0024;Brain Tumor;34;M;Patient is experiencing nausea and motor dysfunction since early this year. The symptoms are described as significant in nature.;radiation therapy
brain_tumor_0025;Brain Tumor;52;F;Patient is experiencing nausea and difficulty concentrating over the last few weeks. The symptoms are described as noticeable in nature.;surgery
brain_tumor_0026;Brain Tumor;34;F;Patient is experiencing speech problems and recurring seizures since early this year. The symptoms are described as noticeable in nature.;chemotherapy
brain_tumor_0027;Brain Tumor;21;F;Patient is experiencing balance issues and recurring seizures since early this year. The symptoms are described as significant in nature.;radiation therapy
brain_tumor_0028;Brain Tumor;79;M;Patient is experiencing recurring seizures and motor dysfunction over the last few weeks. The symptoms are described as moderate in nature.;surgery
brain_tumor_0029;Brain Tumor;70;F;Patient is experiencing balance issues and blackouts since early this year. The symptoms are described as intense in nature.;surgery
brain_tumor_0030;Brain Tumor;61;F;Patient is experiencing difficulty concentrating and recurring seizures since early this year. The symptoms are described as noticeable in nature.;chemotherapy
brain_tumor_0031;Brain Tumor;41;M;Patient is experiencing nausea and balance issues over the last few weeks. The symptoms are described as noticeable in nature.;surgery
brain_tumor_0032;Brain Tumor;47;F;Patient is experiencing difficulty concentrating and speech problems for the past 4 months. The symptoms are described as intense in nature.;chemotherapy
brain_tumor_0033;Brain Tumor;28;F;Patient is experiencing motor dysfunction and balance issues over the last few weeks. The symptoms are described as moderate in nature.;close monitoring
brain_tumor_0034;Brain Tumor;82;M;Patient is experiencing motor dysfunction and difficulty concentrating for the past 4 months. The symptoms are described as significant in nature.;radiation therapy
brain_tumor_0035;Brain Tumor;62;M;Patient is experiencing motor dysfunction and speech problems for the past 4 months. The symptoms are described as high-grade in nature.;close monitoring
brain_tumor_0036;Brain Tumor;61;F;Patient is experiencing balance issues and nausea since early this year. The symptoms are described as noticeable in nature.;chemotherapy
brain_tumor_0037;Brain Tumor;20;F;Patient is experiencing blackouts and difficulty concentrating over the last few weeks. The symptoms are described as noticeable in nature.;chemotherapy
brain_tumor_0038;Brain Tumor;20;F;Patient is experiencing motor dysfunction and speech problems over the last few weeks. The symptoms are described as significant in nature.;surgery
brain_tumor_0039;Brain Tumor;31;M;Patient is experiencing difficulty concentrating and blackouts since early this year. The symptoms are described as severe in nature.;surgery
brain_tumor_0040;Brain Tumor;46;F;Patient is experiencing nausea and speech problems over the last few weeks. The symptoms are described as noticeable in nature.;surgery
brain_tumor_0041;Brain Tumor;63;F;Patient is experiencing difficulty concentrating and nausea for the past 4 months. The symptoms are described as severe in nature.;radiation therapy
brain_tumor_0042;Brain Tumor;70;M;Patient is experiencing motor dysfunction and blackouts for the past 4 months. The symptoms are described as severe in nature.;surgery
brain_tumor_0043;Brain Tumor;68;F;Patient is experiencing difficulty concentrating and speech problems over the last few weeks. The symptoms are described as severe in nature.;chemotherapy
brain_tumor_0044;Brain Tumor;63;M;Patient is experiencing speech problems and recurring seizures over the last few weeks. The symptoms are described as severe in nature.;surgery
brain_tumor_0045;Brain Tumor;50;M;Patient is experiencing nausea and motor dysfunction since early this year. The symptoms are described as intense in nature.;radiation therapy
brain_tumor_0046;Brain Tumor;29;F;Patient is experiencing balance issues and difficulty concentrating for the past 4 months. The symptoms are described as severe in nature.;radiation therapy
brain_tumor_0047;Brain Tumor;78;F;Patient is experiencing nausea and balance issues for the past 4 months. The symptoms are described as moderate in nature.;surgery
brain_tumor_0048;Brain Tumor;69;M;Patient is experiencing blackouts and speech problems since early this year. The symptoms are described as high-grade in nature.;surgery
brain_tumor_0049;Brain Tumor;44;M;Patient is experiencing nausea and balance issues for the past 4 months. The symptoms are described as severe in nature.;surgery
brain_tumor_0050;Brain Tumor;53;M;Patient is experiencing difficulty concentrating and blackouts over the last few weeks. The symptoms are described as noticeable in nature.;radiation therapy
brain_tumor_0051;Brain Tumor;27;M;Patient is experiencing speech problems and recurring seizures for the past 4 months. The symptoms are described as intense in nature.;chemotherapy
brain_tumor_0052;Brain Tumor;21;F;Patient is experiencing motor dysfunction and nausea since early this year. The symptoms are described as debilitating in nature.;close monitoring
brain_tumor_0053;Brain Tumor;68;M;Patient is experiencing balance issues and difficulty concentrating over the last few weeks. The symptoms are described as significant in nature.;radiation therapy
brain_tumor_0054;Brain Tumor;74;F;Patient is experiencing nausea and motor dysfunction over the last few weeks. The symptoms are described as debilitating in nature.;radiation therapy
brain_tumor_0055;Brain Tumor;63;M;Patient is experiencing balance issues and speech problems for the past 4 months. The symptoms are described as moderate in nature.;close monitoring
brain_tumor_0056;Brain Tumor;60;M;Patient is experiencing nausea and recurring seizures since early this year. The symptoms are described as intense in nature.;chemotherapy
brain_tumor_0057;Brain Tumor;42;M;Patient is experiencing nausea and blackouts over the last few weeks. The symptoms are described as significant in nature.;surgery
brain_tumor_0058;Brain Tumor;22;M;Patient is experiencing blackouts and nausea for the past 4 months. The symptoms are described as debilitating in nature.;chemotherapy
brain_tumor_0059;Brain Tumor;18;M;Patient is experiencing difficulty concentrating and motor dysfunction over the last few weeks. The symptoms are described as intense in nature.;chemotherapy
brain_tumor_0060;Brain Tumor;80;M;Patient is experiencing speech problems and nausea since early this year. The symptoms are described as intense in nature.;radiation therapy
brain_tumor_0061;Brain Tumor;42;F;Patient is experiencing balance issues and difficulty concentrating for the past 4 months. The symptoms are described as debilitating in nature.;chemotherapy
brain_tumor_0062;Brain Tumor;27;F;Patient is experiencing nausea and recurring seizures for the past 4 months. The symptoms are described as significant in nature.;close monitoring
brain_tumor_0063;Brain Tumor;38;M;Patient is experiencing recurring seizures and speech problems since early this year. The symptoms are described as moderate in nature.;radiation therapy
brain_tumor_0064;Brain Tumor;20;F;Patient is experiencing nausea and motor dysfunction over the last few weeks. The symptoms are described as high-grade in nature.;surgery
brain_tumor_0065;Brain Tumor;43;F;Patient is experiencing balance issues and recurring seizures for the past 4 months. The symptoms are described as noticeable in nature.;close monitoring
brain_tumor_0066;Brain Tumor;31;F;Patient is experiencing motor dysfunction and speech problems for the past 4 months. The symptoms are described as significant in nature.;close monitoring
brain_tumor_0067;Brain Tumor;52;F;Patient is experiencing recurring seizures and motor dysfunction over the last few weeks. The symptoms are described as high-grade in nature.;radiation therapy
brain_tumor_0068;Brain Tumor;69;F;Patient is experiencing recurring seizures and speech problems since early this year. The symptoms are described as intense in nature.;surgery
brain_tumor_0069;Brain Tumor;24;F;Patient is experiencing motor dysfunction and difficulty concentrating since early this year. The symptoms are described as significant in nature.;close monitoring
brain_tumor_0070;Brain Tumor;61;F;Patient is experiencing nausea and blackouts since early this year. The symptoms are described as high-grade in nature.;close monitoring
brain_tumor_0071;Brain Tumor;31;F;Patient is experiencing balance issues and speech problems since early this year. The symptoms are described as moderate in nature.;close monitoring
brain_tumor_0072;Brain Tumor;35;M;Patient is experiencing blackouts and difficulty concentrating for the past 4 months. The symptoms are described as severe in nature.;chemotherapy
brain_tumor_0073;Brain Tumor;84;M;Patient is experiencing difficulty concentrating and speech problems since early this year. The symptoms are described as significant in nature.;radiation therapy
brain_tumor_0074;Brain Tumor;40;M;Patient is experiencing motor dysfunction and difficulty concentrating since early this year. The symptoms are described as high-grade in nature.;chemotherapy
brain_tumor_0075;Brain Tumor;70;M;Patient is experiencing difficulty concentrating and blackouts for the past 4 months. The symptoms are described as intense in nature.;chemotherapy
brain_tumor_0076;Brain Tumor;75;F;Patient is experiencing speech problems and difficulty concentrating since early this year. The symptoms are described as moderate in nature.;surgery
brain_tumor_0077;Brain Tumor;18;M;Patient is experiencing blackouts and motor dysfunction for the past 4 months. The symptoms are described as high-grade in nature.;surgery
brain_tumor_0078;Brain Tumor;39;M;Patient is experiencing difficulty concentrating and speech problems over the last few weeks. The symptoms are described as high-grade in nature.;chemotherapy
brain_tumor_0079;Brain Tumor;73;M;Patient is experiencing difficulty concentrating and speech problems over the last few weeks. The symptoms are described as high-grade in nature.;chemotherapy
brain_tumor_0080;Brain Tumor;70;M;Patient is experiencing balance issues and motor dysfunction for the past 4 months. The symptoms are described as high-grade in nature.;chemotherapy
brain_tumor_0081;Brain Tumor;40;M;Patient is experiencing motor dysfunction and blackouts for the past 4 months. The symptoms are described as severe in nature.;surgery
brain_tumor_0082;Brain Tumor;80;M;Patient is experiencing speech problems and difficulty concentrating since early this year. The symptoms are described as debilitating in nature.;radiation therapy
brain_tumor_0083;Brain Tumor;30;F;Patient is experiencing balance issues and blackouts for the past 4 months. The symptoms are described as noticeable in nature.;surgery
brain_tumor_0084;Brain Tumor;81;M;Patient is experiencing nausea and blackouts for the past 4 months. The symptoms are described as moderate in nature.;close monitoring
brain_tumor_0085;Brain Tumor;26;M;Patient is experiencing blackouts and speech problems over the last few weeks. The symptoms are described as debilitating in nature.;chemotherapy
brain_tumor_0086;Brain Tumor;25;M;Patient is experiencing nausea and difficulty concentrating since early this year. The symptoms are described as severe in nature.;radiation therapy
brain_tumor_0087;Brain Tumor;30;M;Patient is experiencing recurring seizures and difficulty concentrating since early this year. The symptoms are described as debilitating in nature.;chemotherapy
brain_tumor_0088;Brain Tumor;78;M;Patient is experiencing blackouts and difficulty concentrating since early this year. The symptoms are described as noticeable in nature.;surgery
brain_tumor_0089;Brain Tumor;30;M;Patient is experiencing nausea and motor dysfunction over the last few weeks. The symptoms are described as severe in nature.;surgery
brain_tumor_0090;Brain Tumor;29;F;Patient is experiencing motor dysfunction and balance issues since early this year. The symptoms are described as significant in nature.;close monitoring
brain_tumor_0091;Brain Tumor;38;M;Patient is experiencing difficulty concentrating and balance issues since early this year. The symptoms are described as significant in nature.;chemotherapy
brain_tumor_0092;Brain Tumor;77;M;Patient is experiencing blackouts and recurring seizures since early this year. The symptoms are described as significant in nature.;radiation therapy
brain_tumor_0093;Brain Tumor;65;M;Patient is experiencing nausea and balance issues over the last few weeks. The symptoms are described as severe in nature.;chemotherapy
brain_tumor_0094;Brain Tumor;77;M;Patient is experiencing speech problems and motor dysfunction for the past 4 months. The symptoms are described as noticeable in nature.;surgery
brain_tumor_0095;Brain Tumor;38;M;Patient is experiencing blackouts and speech problems over the last few weeks. The symptoms are described as intense in nature.;chemotherapy
brain_tumor_0096;Brain Tumor;49;F;Patient is experiencing motor dysfunction and balance issues over the last few weeks. The symptoms are described as debilitating in nature.;chemotherapy
brain_tumor_0097;Brain Tumor;67;F;Patient is experiencing balance issues and nausea since early this year. The symptoms are described as debilitating in nature.;chemotherapy
brain_tumor_0098;Brain Tumor;62;M;Patient is experiencing difficulty concentrating and recurring seizures since early this year. The symptoms are described as significant in nature.;surgery
brain_tumor_0099;Brain Tumor;56;M;Patient is experiencing difficulty concentrating and recurring seizures for the past 4 months. The symptoms are described as severe in nature.;radiation therapy
brain_tumor_0100;Brain Tumor;44;F;Patient is experiencing recurring seizures and blackouts for the past 4 months. The symptoms are described as moderate in nature.;chemotherapy
brain_tumor_0101;Brain Tumor;77;F;Patient is experiencing motor dysfunction and nausea since early this year. The symptoms are described as debilitating in nature.;radiation therapy
brain_tumor_0102;Brain Tumor;80;F;Patient is experiencing speech problems and difficulty concentrating since early this year. The symptoms are described as debilitating in nature.;surgery
brain_tumor_0103;Brain Tumor;55;M;Patient is experiencing balance issues and recurring seizures for the past 4 months. The symptoms are described as significant in nature.;close monitoring
brain_tumor_0104;Brain Tumor;43;M;Patient is experiencing blackouts and recurring seizures over the last few weeks. The symptoms are described as debilitating in nature.;surgery
brain_tumor_0105;Brain Tumor;83;M;Patient is experiencing recurring seizures and balance issues over the last few weeks. The symptoms are described as intense in nature.;radiation therapy
brain_tumor_0106;Brain Tumor;33;F;Patient is experiencing recurring seizures and nausea over the last few weeks. The symptoms are described as severe in nature.;radiation therapy
brain_tumor_0107;Brain Tumor;69;M;Patient is experiencing recurring seizures and difficulty concentrating since early this year. The symptoms are described as noticeable in nature.;surgery
brain_tumor_0108;Brain Tumor;65;M;Patient is experiencing speech problems and nausea for the past 4 months. The symptoms are described as high-grade in nature.;chemotherapy
brain_tumor_0109;Brain Tumor;72;M;Patient is experiencing nausea and difficulty concentrating over the last few weeks. The symptoms are described as noticeable in nature.;close monitoring
brain_tumor_0110;Brain Tumor;22;F;Patient is experiencing nausea and blackouts since early this year. The symptoms are described as significant in nature.;radiation therapy
brain_tumor_0111;Brain Tumor;50;M;Patient is experiencing motor dysfunction and recurring seizures over the last few weeks. The symptoms are described as significant in nature.;close monitoring
brain_tumor_0112;Brain Tumor;37;M;Patient is experiencing balance issues and difficulty concentrating since early this year. The symptoms are described as significant in nature.;surgery
brain_tumor_0113;Brain Tumor;82;M;Patient is experiencing difficulty concentrating and speech problems since early this year. The symptoms are described as debilitating in nature.;close monitoring
brain_tumor_0114;Brain Tumor;20;F;Patient is experiencing blackouts and nausea over the last few weeks. The symptoms are described as debilitating in nature.;radiation therapy
brain_tumor_0115;Brain Tumor;31;M;Patient is experiencing motor dysfunction and recurring seizures over the last few weeks. The symptoms are described as intense in nature.;radiation therapy
brain_tumor_0116;Brain Tumor;48;M;Patient is experiencing nausea and difficulty concentrating since early this year. The symptoms are described as significant in nature.;chemotherapy
brain_tumor_0117;Brain Tumor;49;M;Patient is experiencing speech problems and recurring seizures since early this year. The symptoms are described as debilitating in nature.;surgery
brain_tumor_0118;Brain Tumor;62;F;Patient is experiencing nausea and recurring seizures over the last few weeks. The symptoms are described as moderate in nature.;radiation therapy
brain_tumor_0119;Brain Tumor;82;M;Patient is experiencing balance issues and blackouts since early this year. The symptoms are described as debilitating in nature.;surgery
brain_tumor_0120;Brain Tumor;36;F;Patient is experiencing recurring seizures and nausea over the last few weeks. The symptoms are described as high-grade in nature.;close monitoring
brain_tumor_0121;Brain Tumor;60;M;Patient is experiencing recurring seizures and motor dysfunction for the past 4 months. The symptoms are described as intense in nature.;close monitoring
brain_tumor_0122;Brain Tumor;27;M;Patient is experiencing nausea and motor dysfunction since early this year. The symptoms are described as intense in nature.;chemotherapy
brain_tumor_0123;Brain Tumor;37;F;Patient is experiencing difficulty concentrating and nausea over the last few weeks. The symptoms are described as severe in nature.;surgery
brain_tumor_0124;Brain Tumor;48;M;Patient is experiencing speech problems and blackouts since early this year. The symptoms are described as noticeable in nature.;radiation therapy
brain_tumor_0125;Brain Tumor;51;F;Patient is experiencing motor dysfunction and balance issues over the last few weeks. The symptoms are described as moderate in nature.;surgery
brain_tumor_0126;Brain Tumor;80;M;Patient is experiencing difficulty concentrating and balance issues since early this year. The symptoms are described as high-grade in nature.;close monitoring
brain_tumor_0127;Brain Tumor;51;M;Patient is experiencing motor dysfunction and balance issues over the last few weeks. The symptoms are described as significant in nature.;close monitoring
brain_tumor_0128;Brain Tumor;41;F;Patient is experiencing nausea and recurring seizures over the last few weeks. The symptoms are described as severe in nature.;close monitoring
brain_tumor_0129;Brain Tumor;31;M;Patient is experiencing blackouts and nausea over the last few weeks. The symptoms are described as intense in nature.;close monitoring
brain_tumor_0130;Brain Tumor;29;F;Patient is experiencing recurring seizures and blackouts since early this year. The symptoms are described as severe in nature.;close monitoring
brain_tumor_0131;Brain Tumor;28;M;Patient is experiencing blackouts and recurring seizures for the past 4 months. The symptoms are described as severe in nature.;radiation therapy
brain_tumor_0132;Brain Tumor;48;M;Patient is experiencing nausea and blackouts for the past 4 months. The symptoms are described as severe in nature.;chemotherapy
brain_tumor_0133;Brain Tumor;41;F;Patient is experiencing blackouts and speech problems over the last few weeks. The symptoms are described as intense in nature.;close monitoring
brain_tumor_0134;Brain Tumor;73;M;Patient is experiencing speech problems and balance issues over the last few weeks. The symptoms are described as debilitating in nature.;close monitoring
brain_tumor_0135;Brain Tumor;72;F;Patient is experiencing speech problems and difficulty concentrating since early this year. The symptoms are described as noticeable in nature.;radiation therapy
brain_tumor_0136;Brain Tumor;51;M;Patient is experiencing speech problems and blackouts for the past 4 months. The symptoms are described as moderate in nature.;chemotherapy
brain_tumor_0137;Brain Tumor;58;M;Patient is experiencing nausea and motor dysfunction since early this year. The symptoms are described as significant in nature.;radiation therapy
brain_tumor_0138;Brain Tumor;52;F;Patient is experiencing blackouts and speech problems since early this year. The symptoms are described as significant in nature.;close monitoring
brain_tumor_0139;Brain Tumor;66;F;Patient is experiencing difficulty concentrating and blackouts for the past 4 months. The symptoms are described as high-grade in nature.;chemotherapy
brain_tumor_0140;Brain Tumor;55;F;Patient is experiencing nausea and balance issues since early this year. The symptoms are described as intense in nature.;radiation therapy
brain_tumor_0141;Brain Tumor;61;M;Patient is experiencing recurring seizures and balance issues over the last few weeks. The symptoms are described as severe in nature.;chemotherapy
brain_tumor_0142;Brain Tumor;78;M;Patient is experiencing motor dysfunction and recurring seizures since early this year. The symptoms are described as moderate in nature.;radiation therapy
brain_tumor_0143;Brain Tumor;81;M;Patient is experiencing speech problems and motor dysfunction for the past 4 months. The symptoms are described as noticeable in nature.;radiation therapy
brain_tumor_0144;Brain Tumor;56;M;Patient is experiencing difficulty concentrating and motor dysfunction over the last few weeks. The symptoms are described as noticeable in nature.;surgery
brain_tumor_0145;Brain Tumor;71;F;Patient is experiencing nausea and recurring seizures over the last few weeks. The symptoms are described as severe in nature.;chemotherapy
brain_tumor_0146;Brain Tumor;44;M;Patient is experiencing speech problems and difficulty concentrating since early this year. The symptoms are described as severe in nature.;radiation therapy
brain_tumor_0147;Brain Tumor;48;M;Patient is experiencing difficulty concentrating and balance issues over the last few weeks. The symptoms are described as significant in nature.;radiation therapy
brain_tumor_0148;Brain Tumor;18;F;Patient is experiencing recurring seizures and difficulty concentrating since early this year. The symptoms are described as debilitating in nature.;radiation therapy
brain_tumor_0149;Brain Tumor;35;M;Patient is experiencing difficulty concentrating and nausea over the last few weeks. The symptoms are described as significant in nature.;chemotherapy
brain_tumor_0150;Brain Tumor;19;M;Patient is experiencing balance issues and speech problems over the last few weeks. The symptoms are described as intense in nature.;chemotherapy
brain_tumor_0151;Brain Tumor;33;M;Patient is experiencing blackouts and nausea for the past 4 months. The symptoms are described as intense in nature.;chemotherapy
brain_tumor_0152;Brain Tumor;54;M;Patient is experiencing difficulty concentrating and motor dysfunction for the past 4 months. The symptoms are described as severe in nature.;close monitoring
brain_tumor_0153;Brain Tumor;57;M;Patient is experiencing speech problems and difficulty concentrating since early this year. The symptoms are described as high-grade in nature.;chemotherapy
brain_tumor_0154;Brain Tumor;55;F;Patient is experiencing blackouts and balance issues over the last few weeks. The symptoms are described as severe in nature.;close monitoring
brain_tumor_0155;Brain Tumor;72;M;Patient is experiencing difficulty concentrating and speech problems since early this year. The symptoms are described as severe in nature.;radiation therapy
brain_tumor_0156;Brain Tumor;62;F;Patient is experiencing blackouts and recurring seizures for the past 4 months. The symptoms are described as moderate in nature.;close monitoring
brain_tumor_0157;Brain Tumor;25;F;Patient is experiencing difficulty concentrating and speech problems for the past 4 months. The symptoms are described as high-grade in nature.;radiation therapy
brain_tumor_0158;Brain Tumor;61;F;Patient is experiencing recurring seizures and difficulty concentrating since early this year. The symptoms are described as severe in nature.;close monitoring
brain_tumor_0159;Brain Tumor;65;F;Patient is experiencing balance issues and blackouts since early this year. The symptoms are described as high-grade in nature.;radiation therapy
brain_tumor_0160;Brain Tumor;18;F;Patient is experiencing motor dysfunction and speech problems over the last few weeks. The symptoms are described as high-grade in nature.;radiation therapy
brain_tumor_0161;Brain Tumor;64;M;Patient is experiencing motor dysfunction and balance issues over the last few weeks. The symptoms are described as intense in nature.;surgery
brain_tumor_0162;Brain Tumor;53;M;Patient is experiencing blackouts and motor dysfunction since early this year. The symptoms are described as intense in nature.;chemotherapy
brain_tumor_0163;Brain Tumor;60;M;Patient is experiencing blackouts and speech problems over the last few weeks. The symptoms are described as debilitating in nature.;chemotherapy
brain_tumor_0164;Brain Tumor;78;F;Patient is experiencing recurring seizures and blackouts for the past 4 months. The symptoms are described as significant in nature.;radiation therapy
brain_tumor_0165;Brain Tumor;37;M;Patient is experiencing recurring seizures and blackouts since early this year. The symptoms are described as moderate in nature.;radiation therapy
brain_tumor_0166;Brain Tumor;22;F;Patient is experiencing difficulty concentrating and motor dysfunction since early this year. The symptoms are described as significant in nature.;chemotherapy
brain_tumor_0167;Brain Tumor;55;F;Patient is experiencing difficulty concentrating and motor dysfunction since early this year. The symptoms are described as high-grade in nature.;radiation therapy
brain_tumor_0168;Brain Tumor;51;M;Patient is experiencing balance issues and difficulty concentrating for the past 4 months. The symptoms are described as noticeable in nature.;surgery
brain_tumor_0169;Brain Tumor;85;M;Patient is experiencing recurring seizures and balance issues over the last few weeks. The symptoms are described as noticeable in nature.;close monitoring
brain_tumor_0170;Brain Tumor;21;F;Patient is experiencing speech problems and recurring seizures since early this year. The symptoms are described as high-grade in nature.;close monitoring
brain_tumor_0171;Brain Tumor;71;F;Patient is experiencing speech problems and nausea over the last few weeks. The symptoms are described as moderate in nature.;chemotherapy
brain_tumor_0172;Brain Tumor;49;F;Patient is experiencing motor dysfunction and nausea since early this year. The symptoms are described as noticeable in nature.;surgery
brain_tumor_0173;Brain Tumor;31;F;Patient is experiencing blackouts and motor dysfunction since early this year. The symptoms are described as noticeable in nature.;radiation therapy
brain_tumor_0174;Brain Tumor;77;M;Patient is experiencing blackouts and recurring seizures for the past 4 months. The symptoms are described as intense in nature.;close monitoring
brain_tumor_0175;Brain Tumor;48;M;Patient is experiencing recurring seizures and nausea since early this year. The symptoms are described as debilitating in nature.;chemotherapy
brain_tumor_0176;Brain Tumor;82;M;Patient is experiencing balance issues and motor dysfunction for the past 4 months. The symptoms are described as noticeable in nature.;chemotherapy
brain_tumor_0177;Brain Tumor;45;M;Patient is experiencing motor dysfunction and nausea over the last few weeks. The symptoms are described as moderate in nature.;chemotherapy
brain_tumor_0178;Brain Tumor;21;F;Patient is experiencing nausea and blackouts for the past 4 months. The symptoms are described as high-grade in nature.;chemotherapy
brain_tumor_0179;Brain Tumor;85;F;Patient is experiencing nausea and motor dysfunction for the past 4 months. The symptoms are described as significant in nature.;close monitoring
brain_tumor_0180;Brain Tumor;82;M;Patient is experiencing recurring seizures and difficulty concentrating over the last few weeks. The symptoms are described as debilitating in nature.;radiation therapy
brain_tumor_0181;Brain Tumor;70;F;Patient is experiencing speech problems and nausea over the last few weeks. The symptoms are described as debilitating in nature.;surgery
brain_tumor_0182;Brain Tumor;83;F;Patient is experiencing balance issues and difficulty concentrating since early this year. The symptoms are described as significant in nature.;close monitoring
brain_tumor_0183;Brain Tumor;18;M;Patient is experiencing nausea and difficulty concentrating for the past 4 months. The symptoms are described as moderate in nature.;radiation therapy
brain_tumor_0184;Brain Tumor;75;M;Patient is experiencing motor dysfunction and blackouts over the last few weeks. The symptoms are described as high-grade in nature.;close monitoring
brain_tumor_0185;Brain Tumor;59;F;Patient is experiencing blackouts and balance issues over the last few weeks. The symptoms are described as moderate in nature.;surgery
brain_tumor_0186;Brain Tumor;29;M;Patient is experiencing speech problems and blackouts over the last few weeks. The symptoms are described as significant in nature.;chemotherapy
brain_tumor_0187;Brain Tumor;20;M;Patient is experiencing balance issues and recurring seizures for the past 4 months. The symptoms are described as moderate in nature.;close monitoring
brain_tumor_0188;Brain Tumor;32;F;Patient is experiencing balance issues and recurring seizures since early this year. The symptoms are described as high-grade in nature.;close monitoring
brain_tumor_0189;Brain Tumor;19;M;Patient is experiencing blackouts and difficulty concentrating over the last few weeks. The symptoms are described as intense in nature.;radiation therapy
brain_tumor_0190;Brain Tumor;28;M;Patient is experiencing motor dysfunction and nausea over the last few weeks. The symptoms are described as noticeable in nature.;chemotherapy
brain_tumor_0191;Brain Tumor;67;F;Patient is experiencing balance issues and difficulty concentrating since early this year. The symptoms are described as severe in nature.;chemotherapy
brain_tumor_0192;Brain Tumor;66;F;Patient is experiencing speech problems and balance issues for the past 4 months. The symptoms are described as debilitating in nature.;chemotherapy
brain_tumor_0193;Brain Tumor;35;F;Patient is experiencing difficulty concentrating and nausea since early this year. The symptoms are described as high-grade in nature.;close monitoring
brain_tumor_0194;Brain Tumor;41;F;Patient is experiencing difficulty concentrating and speech problems over the last few weeks. The symptoms are described as severe in nature.;radiation therapy
brain_tumor_0195;Brain Tumor;64;M;Patient is experiencing recurring seizures and difficulty concentrating since early this year. The symptoms are described as high-grade in nature.;chemotherapy
brain_tumor_0196;Brain Tumor;24;F;Patient is experiencing recurring seizures and difficulty concentrating since early this year. The symptoms are described as debilitating in nature.;surgery
brain_tumor_0197;Brain Tumor;42;F;Patient is experiencing motor dysfunction and blackouts over the last few weeks. The symptoms are described as moderate in nature.;surgery
brain_tumor_0198;Brain Tumor;58;F;Patient is experiencing nausea and balance issues for the past 4 months. The symptoms are described as intense in nature.;close monitoring
brain_tumor_0199;Brain Tumor;19;M;Patient is experiencing balance issues and nausea since early this year. The symptoms are described as high-grade in nature.;radiation therapy
brain_tumor_0200;Brain Tumor;63;F;Patient is experiencing difficulty concentrating and speech problems since early this year. The symptoms are described as debilitating in nature.;close monitoring
brain_tumor_0201;Brain Tumor;72;M;Patient is experiencing speech problems and blackouts for the past 4 months. The symptoms are described as severe in nature.;close monitoring
brain_tumor_0202;Brain Tumor;48;F;Patient is experiencing balance issues and speech problems for the past 4 months. The symptoms are described as noticeable in nature.;surgery
brain_tumor_0203;Brain Tumor;57;M;Patient is experiencing difficulty concentrating and recurring seizures since early this year. The symptoms are described as severe in nature.;chemotherapy
brain_tumor_0204;Brain Tumor;39;M;Patient is experiencing blackouts and recurring seizures since early this year. The symptoms are described as significant in nature.;surgery
brain_tumor_0205;Brain Tumor;76;F;Patient is experiencing balance issues and speech problems over the last few weeks. The symptoms are described as moderate in nature.;chemotherapy
brain_tumor_0206;Brain Tumor;75;F;Patient is experiencing blackouts and balance issues over the last few weeks. The symptoms are described as significant in nature.;chemotherapy
brain_tumor_0207;Brain Tumor;72;F;Patient is experiencing blackouts and speech problems since early this year. The symptoms are described as noticeable in nature.;chemotherapy
brain_tumor_0208;Brain Tumor;38;M;Patient is experiencing nausea and motor dysfunction since early this year. The symptoms are described as significant in nature.;close monitoring
brain_tumor_0209;Brain Tumor;75;M;Patient is experiencing difficulty concentrating and motor dysfunction over the last few weeks. The symptoms are described as noticeable in nature.;surgery
brain_tumor_0210;Brain Tumor;40;M;Patient is experiencing balance issues and motor dysfunction since early this year. The symptoms are described as severe in nature.;surgery
brain_tumor_0211;Brain Tumor;29;F;Patient is experiencing balance issues and blackouts for the past 4 months. The symptoms are described as intense in nature.;surgery
brain_tumor_0212;Brain Tumor;32;M;Patient is experiencing nausea and balance issues over the last few weeks. The symptoms are described as significant in nature.;close monitoring
brain_tumor_0213;Brain Tumor;77;M;Patient is experiencing difficulty concentrating and nausea over the last few weeks. The symptoms are described as moderate in nature.;chemotherapy
brain_tumor_0214;Brain Tumor;34;F;Patient is experiencing motor dysfunction and balance issues for the past 4 months. The symptoms are described as debilitating in nature.;radiation therapy
brain_tumor_0215;Brain Tumor;28;F;Patient is experiencing difficulty concentrating and speech problems for the past 4 months. The symptoms are described as debilitating in nature.;surgery
brain_tumor_0216;Brain Tumor;36;F;Patient is experiencing difficulty concentrating and blackouts over the last few weeks. The symptoms are described as severe in nature.;radiation therapy
brain_tumor_0217;Brain Tumor;34;M;Patient is experiencing difficulty concentrating and motor dysfunction over the last few weeks. The symptoms are described as debilitating in nature.;chemotherapy
brain_tumor_0218;Brain Tumor;39;F;Patient is experiencing blackouts and recurring seizures since early this year. The symptoms are described as significant in nature.;close monitoring
brain_tumor_0219;Brain Tumor;59;M;Patient is experiencing nausea and difficulty concentrating since early this year. The symptoms are described as severe in nature.;chemotherapy
brain_tumor_0220;Brain Tumor;72;M;Patient is experiencing motor dysfunction and blackouts over the last few weeks. The symptoms are described as moderate in nature.;close monitoring
brain_tumor_0221;Brain Tumor;40;M;Patient is experiencing difficulty concentrating and blackouts over the last few weeks. The symptoms are described as intense in nature.;surgery
brain_tumor_0222;Brain Tumor;36;F;Patient is experiencing recurring seizures and difficulty concentrating over the last few weeks. The symptoms are described as intense in nature.;radiation therapy
brain_tumor_0223;Brain Tumor;62;M;Patient is experiencing nausea and recurring seizures since early this year. The symptoms are described as high-grade in nature.;close monitoring
brain_tumor_0224;Brain Tumor;78;M;Patient is experiencing nausea and speech problems since early this year. The symptoms are described as noticeable in nature.;surgery
brain_tumor_0225;Brain Tumor;25;M;Patient is experiencing difficulty concentrating and motor dysfunction over the last few weeks. The symptoms are described as debilitating in nature.;surgery
brain_tumor_0226;Brain Tumor;60;M;Patient is experiencing motor dysfunction and speech problems over the last few weeks. The symptoms are described as intense in nature.;chemotherapy
brain_tumor_0227;Brain Tumor;60;F;Patient is experiencing difficulty concentrating and speech problems since early this year. The symptoms are described as noticeable in nature.;radiation therapy
brain_tumor_0228;Brain Tumor;26;F;Patient is experiencing difficulty concentrating and balance issues over the last few weeks. The symptoms are described as noticeable in nature.;surgery
brain_tumor_0229;Brain Tumor;29;M;Patient is experiencing nausea and blackouts since early this year. The symptoms are described as intense in nature.;surgery
brain_tumor_0230;Brain Tumor;27;M;Patient is experiencing motor dysfunction and blackouts since early this year. The symptoms are described as severe in nature.;chemotherapy
brain_tumor_0231;Brain Tumor;37;F;Patient is experiencing balance issues and motor dysfunction since early this year. The symptoms are described as severe in nature.;chemotherapy
brain_tumor_0232;Brain Tumor;58;M;Patient is experiencing difficulty concentrating and speech problems for the past 4 months. The symptoms are described as significant in nature.;surgery
brain_tumor_0233;Brain Tumor;64;M;Patient is experiencing blackouts and balance issues for the past 4 months. The symptoms are described as high-grade in nature.;chemotherapy
brain_tumor_0234;Brain Tumor;61;M;Patient is experiencing blackouts and motor dysfunction for the past 4 months. The symptoms are described as significant in nature.;radiation therapy
brain_tumor_0235;Brain Tumor;26;F;Patient is experiencing nausea and balance issues for the past 4 months. The symptoms are described as moderate in nature.;chemotherapy
brain_tumor_0236;Brain Tumor;28;M;Patient is experiencing nausea and recurring seizures for the past 4 months. The symptoms are described as intense in nature.;chemotherapy
brain_tumor_0237;Brain Tumor;35;F;Patient is experiencing motor dysfunction and balance issues for the past 4 months. The symptoms are described as severe in nature.;close monitoring
brain_tumor_0238;Brain Tumor;46;M;Patient is experiencing difficulty concentrating and blackouts over the last few weeks. The symptoms are described as debilitating in nature.;chemotherapy
brain_tumor_0239;Brain Tumor;62;F;Patient is experiencing blackouts and difficulty concentrating over the last few weeks. The symptoms are described as significant in nature.;radiation therapy
brain_tumor_0240;Brain Tumor;77;F;Patient is experiencing balance issues and blackouts since early this year. The symptoms are described as high-grade in nature.;close monitoring
brain_tumor_0241;Brain Tumor;68;F;Patient is experiencing difficulty concentrating and motor dysfunction since early this year. The symptoms are described as noticeable in nature.;surgery
brain_tumor_0242;Brain Tumor;24;F;Patient is experiencing speech problems and balance issues for the past 4 months. The symptoms are described as significant in nature.;chemotherapy
brain_tumor_0243;Brain Tumor;65;F;Patient is experiencing speech problems and recurring seizures since early this year. The symptoms are described as significant in nature.;surgery
brain_tumor_0244;Brain Tumor;19;F;Patient is experiencing balance issues and speech problems over the last few weeks. The symptoms are described as moderate in nature.;radiation therapy
brain_tumor_0245;Brain Tumor;39;F;Patient is experiencing motor dysfunction and balance issues over the last few weeks. The symptoms are described as significant in nature.;close monitoring
brain_tumor_0246;Brain Tumor;78;M;Patient is experiencing nausea and recurring seizures since early this year. The symptoms are described as noticeable in nature.;radiation therapy
brain_tumor_0247;Brain Tumor;63;M;Patient is experiencing nausea and motor dysfunction over the last few weeks. The symptoms are described as debilitating in nature.;close monitoring
brain_tumor_0248;Brain Tumor;64;F;Patient is experiencing difficulty concentrating and recurring seizures since early this year. The symptoms are described as moderate in nature.;chemotherapy
brain_tumor_0249;Brain Tumor;81;F;Patient is experiencing nausea and speech problems over the last few weeks. The symptoms are described as debilitating in nature.;chemotherapy
brain_tumor_0250;Brain Tumor;51;F;Patient is experiencing nausea and blackouts over the last few weeks. The symptoms are described as severe in nature.;radiation therapy
brain_tumor_0251;Brain Tumor;68;M;Patient is experiencing recurring seizures and balance issues for the past 4 months. The symptoms are described as severe in nature.;close monitoring
brain_tumor_0252;Brain Tumor;49;F;Patient is experiencing motor dysfunction and difficulty concentrating for the past 4 months. The symptoms are described as intense in nature.;surgery
brain_tumor_0253;Brain Tumor;42;M;Patient is experiencing nausea and difficulty concentrating for the past 4 months. The symptoms are described as intense in nature.;radiation therapy
brain_tumor_0254;Brain Tumor;55;M;Patient is experiencing nausea and blackouts since early this year. The symptoms are described as noticeable in nature.;radiation therapy
brain_tumor_0255;Brain Tumor;48;F;Patient is experiencing motor dysfunction and difficulty concentrating since early this year. The symptoms are described as noticeable in nature.;radiation therapy
brain_tumor_0256;Brain Tumor;61;M;Patient is experiencing blackouts and balance issues since early this year. The symptoms are described as significant in nature.;chemotherapy
brain_tumor_0257;Brain Tumor;21;M;Patient is experiencing speech problems and nausea since early this year. The symptoms are described as high-grade in nature.;radiation therapy
brain_tumor_0258;Brain Tumor;78;M;Patient is experiencing balance issues and nausea since early this year. The symptoms are described as intense in nature.;radiation therapy
brain_tumor_0259;Brain Tumor;66;M;Patient is experiencing motor dysfunction and balance issues for the past 4 months. The symptoms are described as moderate in nature.;chemotherapy
brain_tumor_0260;Brain Tumor;23;M;Patient is experiencing blackouts and difficulty concentrating for the past 4 months. The symptoms are described as intense in nature.;chemotherapy
brain_tumor_0261;Brain Tumor;34;F;Patient is experiencing speech problems and blackouts since early this year. The symptoms are described as high-grade in nature.;close monitoring
brain_tumor_0262;Brain Tumor;19;F;Patient is experiencing speech problems and motor dysfunction over the last few weeks. The symptoms are described as high-grade in nature.;radiation therapy
brain_tumor_0263;Brain Tumor;22;F;Patient is experiencing speech problems and balance issues for the past 4 months. The symptoms are described as intense in nature.;close monitoring
brain_tumor_0264;Brain Tumor;60;F;Patient is experiencing speech problems and balance issues for the past 4 months. The symptoms are described as moderate in nature.;close monitoring
brain_tumor_0265;Brain Tumor;36;F;Patient is experiencing balance issues and recurring seizures over the last few weeks. The symptoms are described as moderate in nature.;radiation therapy
brain_tumor_0266;Brain Tumor;64;M;Patient is experiencing blackouts and speech problems since early this year. The symptoms are described as noticeable in nature.;radiation therapy
brain_tumor_0267;Brain Tumor;36;F;Patient is experiencing speech problems and balance issues over the last few weeks. The symptoms are described as moderate in nature.;chemotherapy
brain_tumor_0268;Brain Tumor;79;M;Patient is experiencing speech problems and balance issues for the past 4 months. The symptoms are described as high-grade in nature.;chemotherapy
brain_tumor_0269;Brain Tumor;49;F;Patient is experiencing recurring seizures and motor dysfunction for the past 4 months. The symptoms are described as noticeable in nature.;surgery
brain_tumor_0270;Brain Tumor;69;F;Patient is experiencing balance issues and speech problems for the past 4 months. The symptoms are described as debilitating in nature.;close monitoring
brain_tumor_0271;Brain Tumor;55;M;Patient is experiencing balance issues and recurring seizures since early this year. The symptoms are described as significant in nature.;radiation therapy
brain_tumor_0272;Brain Tumor;26;F;Patient is experiencing blackouts and speech problems since early this year. The symptoms are described as moderate in nature.;close monitoring
brain_tumor_0273;Brain Tumor;38;F;Patient is experiencing nausea and recurring seizures since early this year. The symptoms are described as severe in nature.;surgery
brain_tumor_0274;Brain Tumor;81;M;Patient is experiencing balance issues and difficulty concentrating for the past 4 months. The symptoms are described as significant in nature.;surgery
brain_tumor_0275;Brain Tumor;64;M;Patient is experiencing speech problems and balance issues over the last few weeks. The symptoms are described as intense in nature.;chemotherapy
brain_tumor_0276;Brain Tumor;58;F;Patient is experiencing difficulty concentrating and blackouts for the past 4 months. The symptoms are described as moderate in nature.;surgery
brain_tumor_0277;Brain Tumor;42;M;Patient is experiencing nausea and balance issues since early this year. The symptoms are described as significant in nature.;chemotherapy
brain_tumor_0278;Brain Tumor;49;M;Patient is experiencing speech problems and nausea for the past 4 months. The symptoms are described as significant in nature.;close monitoring
brain_tumor_0279;Brain Tumor;84;M;Patient is experiencing balance issues and nausea since early this year. The symptoms are described as noticeable in nature.;surgery
brain_tumor_0280;Brain Tumor;22;M;Patient is experiencing motor dysfunction and difficulty concentrating over the last few weeks. The symptoms are described as debilitating in nature.;radiation therapy
brain_tumor_0281;Brain Tumor;80;F;Patient is experiencing motor dysfunction and speech problems since early this year. The symptoms are described as debilitating in nature.;close monitoring
brain_tumor_0282;Brain Tumor;52;F;Patient is experiencing speech problems and balance issues for the past 4 months. The symptoms are described as moderate in nature.;close monitoring
brain_tumor_0283;Brain Tumor;36;M;Patient is experiencing nausea and recurring seizures since early this year. The symptoms are described as significant in nature.;radiation therapy
brain_tumor_0284;Brain Tumor;29;M;Patient is experiencing nausea and speech problems for the past 4 months. The symptoms are described as noticeable in nature.;close monitoring
brain_tumor_0285;Brain Tumor;72;M;Patient is experiencing difficulty concentrating and balance issues over the last few weeks. The symptoms are described as high-grade in nature.;close monitoring
brain_tumor_0286;Brain Tumor;44;M;Patient is experiencing recurring seizures and speech problems over the last few weeks. The symptoms are described as intense in nature.;close monitoring
brain_tumor_0287;Brain Tumor;25;M;Patient is experiencing recurring seizures and balance issues for the past 4 months. The symptoms are described as severe in nature.;surgery
brain_tumor_0288;Brain Tumor;19;F;Patient is experiencing nausea and speech problems over the last few weeks. The symptoms are described as debilitating in nature.;radiation therapy
brain_tumor_0289;Brain Tumor;83;M;Patient is experiencing recurring seizures and difficulty concentrating since early this year. The symptoms are described as severe in nature.;chemotherapy
brain_tumor_0290;Brain Tumor;74;F;Patient is experiencing speech problems and nausea over the last few weeks. The symptoms are described as moderate in nature.;close monitoring
brain_tumor_0291;Brain Tumor;46;M;Patient is experiencing nausea and recurring seizures for the past 4 months. The symptoms are described as intense in nature.;close monitoring
brain_tumor_0292;Brain Tumor;32;M;Patient is experiencing recurring seizures and speech problems since early this year. The symptoms are described as moderate in nature.;surgery
brain_tumor_0293;Brain Tumor;58;F;Patient is experiencing nausea and speech problems for the past 4 months. The symptoms are described as debilitating in nature.;radiation therapy
brain_tumor_0294;Brain Tumor;82;M;Patient is experiencing blackouts and nausea over the last few weeks. The symptoms are described as significant in nature.;close monitoring
brain_tumor_0295;Brain Tumor;77;F;Patient is experiencing blackouts and motor dysfunction over the last few weeks. The symptoms are described as severe in nature.;chemotherapy
brain_tumor_0296;Brain Tumor;60;F;Patient is experiencing balance issues and nausea over the last few weeks. The symptoms are described as high-grade in nature.;radiation therapy
brain_tumor_0297;Brain Tumor;64;F;Patient is experiencing difficulty concentrating and motor dysfunction since early this year. The symptoms are described as significant in nature.;surgery
brain_tumor_0298;Brain Tumor;82;M;Patient is experiencing balance issues and difficulty concentrating since early this year. The symptoms are described as moderate in nature.;radiation therapy
brain_tumor_0299;Brain Tumor;73;F;Patient is experiencing recurring seizures and speech problems for the past 4 months. The symptoms are described as intense in nature.;radiation therapy
brain_tumor_0300;Brain Tumor;62;M;Patient is experiencing blackouts and motor dysfunction over the last few weeks. The symptoms are described as noticeable in nature.;radiation therapy
brain_tumor_0301;Brain Tumor;57;F;Patient is experiencing difficulty concentrating and motor dysfunction over the last few weeks. The symptoms are described as debilitating in nature.;close monitoring
brain_tumor_0302;Brain Tumor;80;M;Patient is experiencing nausea and balance issues over the last few weeks. The symptoms are described as debilitating in nature.;chemotherapy
brain_tumor_0303;Brain Tumor;38;F;Patient is experiencing balance issues and blackouts for the past 4 months. The symptoms are described as noticeable in nature.;chemotherapy
brain_tumor_0304;Brain Tumor;55;F;Patient is experiencing speech problems and recurring seizures since early this year. The symptoms are described as significant in nature.;radiation therapy
brain_tumor_0305;Brain Tumor;26;M;Patient is experiencing motor dysfunction and balance issues over the last few weeks. The symptoms are described as moderate in nature.;close monitoring
brain_tumor_0306;Brain Tumor;65;F;Patient is experiencing recurring seizures and balance issues over the last few weeks. The symptoms are described as significant in nature.;radiation therapy
brain_tumor_0307;Brain Tumor;33;M;Patient is experiencing recurring seizures and nausea for the past 4 months. The symptoms are described as high-grade in nature.;chemotherapy
brain_tumor_0308;Brain Tumor;22;F;Patient is experiencing difficulty concentrating and balance issues over the last few weeks. The symptoms are described as noticeable in nature.;chemotherapy
brain_tumor_0309;Brain Tumor;47;M;Patient is experiencing speech problems and recurring seizures over the last few weeks. The symptoms are described as debilitating in nature.;radiation therapy
brain_tumor_0310;Brain Tumor;79;M;Patient is experiencing speech problems and nausea for the past 4 months. The symptoms are described as moderate in nature.;surgery
brain_tumor_0311;Brain Tumor;83;F;Patient is experiencing nausea and balance issues over the last few weeks. The symptoms are described as high-grade in nature.;radiation therapy
brain_tumor_0312;Brain Tumor;36;F;Patient is experiencing difficulty concentrating and nausea since early this year. The symptoms are described as debilitating in nature.;surgery
brain_tumor_0313;Brain Tumor;31;M;Patient is experiencing speech problems and balance issues for the past 4 months. The symptoms are described as severe in nature.;chemotherapy
brain_tumor_0314;Brain Tumor;84;F;Patient is experiencing motor dysfunction and difficulty concentrating over the last few weeks. The symptoms are described as intense in nature.;close monitoring
brain_tumor_0315;Brain Tumor;37;F;Patient is experiencing blackouts and balance issues since early this year. The symptoms are described as high-grade in nature.;close monitoring
brain_tumor_0316;Brain Tumor;32;M;Patient is experiencing balance issues and motor dysfunction for the past 4 months. The symptoms are described as debilitating in nature.;surgery
brain_tumor_0317;Brain Tumor;31;M;Patient is experiencing speech problems and difficulty concentrating since early this year. The symptoms are described as high-grade in nature.;surgery
brain_tumor_0318;Brain Tumor;33;F;Patient is experiencing motor dysfunction and difficulty concentrating for the past 4 months. The symptoms are described as intense in nature.;surgery
brain_tumor_0319;Brain Tumor;53;F;Patient is experiencing motor dysfunction and balance issues since early this year. The symptoms are described as significant in nature.;close monitoring
brain_tumor_0320;Brain Tumor;39;F;Patient is experiencing balance issues and nausea since early this year. The symptoms are described as significant in nature.;chemotherapy
brain_tumor_0321;Brain Tumor;28;M;Patient is experiencing recurring seizures and difficulty concentrating since early this year. The symptoms are described as moderate in nature.;surgery
brain_tumor_0322;Brain Tumor;35;M;Patient is experiencing balance issues and difficulty concentrating over the last few weeks. The symptoms are described as severe in nature.;chemotherapy
brain_tumor_0323;Brain Tumor;77;M;Patient is experiencing motor dysfunction and balance issues over the last few weeks. The symptoms are described as high-grade in nature.;surgery
brain_tumor_0324;Brain Tumor;24;M;Patient is experiencing difficulty concentrating and nausea for the past 4 months. The symptoms are described as moderate in nature.;surgery
brain_tumor_0325;Brain Tumor;62;F;Patient is experiencing difficulty concentrating and blackouts since early this year. The symptoms are described as debilitating in nature.;close monitoring
brain_tumor_0326;Brain Tumor;66;F;Patient is experiencing nausea and balance issues since early this year. The symptoms are described as significant in nature.;surgery
brain_tumor_0327;Brain Tumor;29;F;Patient is experiencing blackouts and balance issues for the past 4 months. The symptoms are described as debilitating in nature.;chemotherapy
brain_tumor_0328;Brain Tumor;62;F;Patient is experiencing motor dysfunction and blackouts for the past 4 months. The symptoms are described as moderate in nature.;close monitoring
brain_tumor_0329;Brain Tumor;20;M;Patient is experiencing nausea and balance issues over the last few weeks. The symptoms are described as significant in nature.;close monitoring
brain_tumor_0330;Brain Tumor;62;F;Patient is experiencing blackouts and motor dysfunction over the last few weeks. The symptoms are described as noticeable in nature.;chemotherapy
brain_tumor_0331;Brain Tumor;43;M;Patient is experiencing blackouts and speech problems for the past 4 months. The symptoms are described as noticeable in nature.;radiation therapy
brain_tumor_0332;Brain Tumor;49;F;Patient is experiencing balance issues and speech problems over the last few weeks. The symptoms are described as severe in nature.;chemotherapy
brain_tumor_0333;Brain Tumor;25;F;Patient is experiencing balance issues and recurring seizures for the past 4 months. The symptoms are described as noticeable in nature.;surgery
brain_tumor_0334;Brain Tumor;58;M;Patient is experiencing difficulty concentrating and recurring seizures over the last few weeks. The symptoms are described as severe in nature.;surgery
brain_tumor_0335;Brain Tumor;30;F;Patient is experiencing difficulty concentrating and speech problems for the past 4 months. The symptoms are described as intense in nature.;radiation therapy
brain_tumor_0336;Brain Tumor;54;M;Patient is experiencing recurring seizures and blackouts since early this year. The symptoms are described as debilitating in nature.;surgery
brain_tumor_0337;Brain Tumor;81;F;Patient is experiencing recurring seizures and difficulty concentrating since early this year. The symptoms are described as noticeable in nature.;chemotherapy
brain_tumor_0338;Brain Tumor;46;F;Patient is experiencing nausea and speech problems since early this year. The symptoms are described as debilitating in nature.;radiation therapy
brain_tumor_0339;Brain Tumor;33;M;Patient is experiencing nausea and balance issues since early this year. The symptoms are described as noticeable in nature.;chemotherapy
brain_tumor_0340;Brain Tumor;78;M;Patient is experiencing balance issues and difficulty concentrating since early this year. The symptoms are described as moderate in nature.;radiation therapy
brain_tumor_0341;Brain Tumor;69;M;Patient is experiencing motor dysfunction and difficulty concentrating over the last few weeks. The symptoms are described as significant in nature.;surgery
brain_tumor_0342;Brain Tumor;22;M;Patient is experiencing blackouts and balance issues for the past 4 months. The symptoms are described as significant in nature.;radiation therapy
brain_tumor_0343;Brain Tumor;30;M;Patient is experiencing nausea and recurring seizures for the past 4 months. The symptoms are described as significant in nature.;chemotherapy
brain_tumor_0344;Brain Tumor;57;M;Patient is experiencing recurring seizures and nausea over the last few weeks. The symptoms are described as debilitating in nature.;radiation therapy
brain_tumor_0345;Brain Tumor;68;M;Patient is experiencing nausea and difficulty concentrating over the last few weeks. The symptoms are described as moderate in nature.;close monitoring
brain_tumor_0346;Brain Tumor;37;F;Patient is experiencing recurring seizures and nausea for the past 4 months. The symptoms are described as significant in nature.;close monitoring
brain_tumor_0347;Brain Tumor;42;M;Patient is experiencing difficulty concentrating and blackouts over the last few weeks. The symptoms are described as moderate in nature.;chemotherapy
brain_tumor_0348;Brain Tumor;58;F;Patient is experiencing balance issues and motor dysfunction for the past 4 months. The symptoms are described as noticeable in nature.;close monitoring
brain_tumor_0349;Brain Tumor;29;M;Patient is experiencing motor dysfunction and balance issues for the past 4 months. The symptoms are described as moderate in nature.;close monitoring
brain_tumor_0350;Brain Tumor;66;M;Patient is experiencing motor dysfunction and balance issues since early this year. The symptoms are described as high-grade in nature.;close monitoring
brain_tumor_0351;Brain Tumor;41;M;Patient is experiencing motor dysfunction and recurring seizures over the last few weeks. The symptoms are described as debilitating in nature.;chemotherapy
brain_tumor_0352;Brain Tumor;78;M;Patient is experiencing nausea and recurring seizures since early this year. The symptoms are described as noticeable in nature.;close monitoring
brain_tumor_0353;Brain Tumor;65;F;Patient is experiencing speech problems and recurring seizures since early this year. The symptoms are described as noticeable in nature.;close monitoring
brain_tumor_0354;Brain Tumor;57;F;Patient is experiencing recurring seizures and difficulty concentrating over the last few weeks. The symptoms are described as moderate in nature.;chemotherapy
brain_tumor_0355;Brain Tumor;53;F;Patient is experiencing blackouts and motor dysfunction over the last few weeks. The symptoms are described as debilitating in nature.;surgery
brain_tumor_0356;Brain Tumor;33;F;Patient is experiencing difficulty concentrating and motor dysfunction since early this year. The symptoms are described as noticeable in nature.;surgery
brain_tumor_0357;Brain Tumor;70;M;Patient is experiencing speech problems and motor dysfunction since early this year. The symptoms are described as noticeable in nature.;surgery
brain_tumor_0358;Brain Tumor;57;F;Patient is experiencing nausea and speech problems since early this year. The symptoms are described as significant in nature.;radiation therapy
brain_tumor_0359;Brain Tumor;51;M;Patient is experiencing recurring seizures and motor dysfunction for the past 4 months. The symptoms are described as high-grade in nature.;radiation therapy
brain_tumor_0360;Brain Tumor;27;F;Patient is experiencing blackouts and difficulty concentrating over the last few weeks. The symptoms are described as intense in nature.;radiation therapy
brain_tumor_0361;Brain Tumor;57;M;Patient is experiencing motor dysfunction and blackouts since early this year. The symptoms are described as severe in nature.;chemotherapy
brain_tumor_0362;Brain Tumor;39;M;Patient is experiencing balance issues and blackouts over the last few weeks. The symptoms are described as significant in nature.;radiation therapy
brain_tumor_0363;Brain Tumor;32;F;Patient is experiencing recurring seizures and speech problems over the last few weeks. The symptoms are described as noticeable in nature.;radiation therapy
brain_tumor_0364;Brain Tumor;78;F;Patient is experiencing nausea and difficulty concentrating for the past 4 months. The symptoms are described as significant in nature.;radiation therapy
brain_tumor_0365;Brain Tumor;55;M;Patient is experiencing balance issues and blackouts since early this year. The symptoms are described as severe in nature.;close monitoring
brain_tumor_0366;Brain Tumor;82;F;Patient is experiencing recurring seizures and nausea since early this year. The symptoms are described as debilitating in nature.;close monitoring
brain_tumor_0367;Brain Tumor;80;F;Patient is experiencing blackouts and speech problems for the past 4 months. The symptoms are described as severe in nature.;close monitoring
brain_tumor_0368;Brain Tumor;41;M;Patient is experiencing nausea and blackouts for the past 4 months. The symptoms are described as moderate in nature.;chemotherapy
brain_tumor_0369;Brain Tumor;68;M;Patient is experiencing balance issues and blackouts for the past 4 months. The symptoms are described as moderate in nature.;surgery
brain_tumor_0370;Brain Tumor;32;M;Patient is experiencing nausea and recurring seizures for the past 4 months. The symptoms are described as debilitating in nature.;close monitoring
brain_tumor_0371;Brain Tumor;76;F;Patient is experiencing balance issues and blackouts since early this year. The symptoms are described as moderate in nature.;close monitoring
brain_tumor_0372;Brain Tumor;49;M;Patient is experiencing nausea and blackouts over the last few weeks. The symptoms are described as debilitating in nature.;radiation therapy
brain_tumor_0373;Brain Tumor;49;M;Patient is experiencing difficulty concentrating and recurring seizures for the past 4 months. The symptoms are described as severe in nature.;radiation therapy
brain_tumor_0374;Brain Tumor;66;M;Patient is experiencing balance issues and recurring seizures over the last few weeks. The symptoms are described as intense in nature.;surgery
brain_tumor_0375;Brain Tumor;50;M;Patient is experiencing difficulty concentrating and blackouts for the past 4 months. The symptoms are described as noticeable in nature.;chemotherapy
brain_tumor_0376;Brain Tumor;77;F;Patient is experiencing blackouts and recurring seizures for the past 4 months. The symptoms are described as noticeable in nature.;radiation therapy
brain_tumor_0377;Brain Tumor;42;F;Patient is experiencing speech problems and difficulty concentrating since early this year. The symptoms are described as high-grade in nature.;surgery
brain_tumor_0378;Brain Tumor;61;F;Patient is experiencing recurring seizures and nausea since early this year. The symptoms are described as significant in nature.;surgery
brain_tumor_0379;Brain Tumor;53;M;Patient is experiencing difficulty concentrating and blackouts since early this year. The symptoms are described as debilitating in nature.;chemotherapy
brain_tumor_0380;Brain Tumor;48;F;Patient is experiencing difficulty concentrating and motor dysfunction over the last few weeks. The symptoms are described as debilitating in nature.;chemotherapy
brain_tumor_0381;Brain Tumor;28;F;Patient is experiencing recurring seizures and difficulty concentrating since early this year. The symptoms are described as noticeable in nature.;close monitoring
brain_tumor_0382;Brain Tumor;69;M;Patient is experiencing balance issues and motor dysfunction over the last few weeks. The symptoms are described as significant in nature.;surgery
brain_tumor_0383;Brain Tumor;66;M;Patient is experiencing balance issues and motor dysfunction over the last few weeks. The symptoms are described as noticeable in nature.;close monitoring
brain_tumor_0384;Brain Tumor;50;F;Patient is experiencing difficulty concentrating and nausea over the last few weeks. The symptoms are described as intense in nature.;surgery
brain_tumor_0385;Brain Tumor;51;M;Patient is experiencing speech problems and motor dysfunction over the last few weeks. The symptoms are described as moderate in nature.;chemotherapy
brain_tumor_0386;Brain Tumor;81;M;Patient is experiencing balance issues and recurring seizures for the past 4 months. The symptoms are described as noticeable in nature.;radiation therapy
brain_tumor_0387;Brain Tumor;67;M;Patient is experiencing difficulty concentrating and motor dysfunction for the past 4 months. The symptoms are described as significant in nature.;chemotherapy
brain_tumor_0388;Brain Tumor;67;F;Patient is experiencing speech problems and nausea over the last few weeks. The symptoms are described as debilitating in nature.;surgery
brain_tumor_0389;Brain Tumor;21;F;Patient is experiencing blackouts and balance issues over the last few weeks. The symptoms are described as significant in nature.;radiation therapy
brain_tumor_0390;Brain Tumor;23;F;Patient is experiencing speech problems and nausea over the last few weeks. The symptoms are described as high-grade in nature.;chemotherapy
brain_tumor_0391;Brain Tumor;61;F;Patient is experiencing motor dysfunction and balance issues for the past 4 months. The symptoms are described as noticeable in nature.;chemotherapy
brain_tumor_0392;Brain Tumor;58;M;Patient is experiencing balance issues and motor dysfunction over the last few weeks. The symptoms are described as significant in nature.;chemotherapy
brain_tumor_0393;Brain Tumor;23;M;Patient is experiencing difficulty concentrating and motor dysfunction for the past 4 months. The symptoms are described as significant in nature.;radiation therapy
brain_tumor_0394;Brain Tumor;77;M;Patient is experiencing motor dysfunction and nausea for the past 4 months. The symptoms are described as moderate in nature.;close monitoring
brain_tumor_0395;Brain Tumor;34;F;Patient is experiencing blackouts and motor dysfunction over the last few weeks. The symptoms are described as significant in nature.;close monitoring
brain_tumor_0396;Brain Tumor;70;M;Patient is experiencing difficulty concentrating and blackouts since early this year. The symptoms are described as severe in nature.;surgery
brain_tumor_0397;Brain Tumor;22;F;Patient is experiencing nausea and motor dysfunction since early this year. The symptoms are described as moderate in nature.;chemotherapy
brain_tumor_0398;Brain Tumor;74;M;Patient is experiencing difficulty concentrating and speech problems for the past 4 months. The symptoms are described as moderate in nature.;close monitoring
brain_tumor_0399;Brain Tumor;34;M;Patient is experiencing speech problems and difficulty concentrating for the past 4 months. The symptoms are described as significant in nature.;surgery
brain_tumor_0400;Brain Tumor;46;M;Patient is experiencing speech problems and nausea over the last few weeks. The symptoms are described as noticeable in nature.;surgery
brain_tumor_0401;Brain Tumor;47;M;Patient is experiencing speech problems and difficulty concentrating over the last few weeks. The symptoms are described as moderate in nature.;chemotherapy
brain_tumor_0402;Brain Tumor;24;F;Patient is experiencing blackouts and motor dysfunction over the last few weeks. The symptoms are described as high-grade in nature.;radiation therapy
brain_tumor_0403;Brain Tumor;55;F;Patient is experiencing difficulty concentrating and motor dysfunction over the last few weeks. The symptoms are described as moderate in nature.;radiation therapy
brain_tumor_0404;Brain Tumor;18;M;Patient is experiencing difficulty concentrating and speech problems since early this year. The symptoms are described as significant in nature.;chemotherapy
brain_tumor_0405;Brain Tumor;24;M;Patient is experiencing motor dysfunction and nausea for the past 4 months. The symptoms are described as intense in nature.;chemotherapy
brain_tumor_0406;Brain Tumor;57;M;Patient is experiencing motor dysfunction and speech problems since early this year. The symptoms are described as noticeable in nature.;close monitoring
brain_tumor_0407;Brain Tumor;44;F;Patient is experiencing recurring seizures and blackouts since early this year. The symptoms are described as intense in nature.;surgery
brain_tumor_0408;Brain Tumor;75;M;Patient is experiencing nausea and balance issues since early this year. The symptoms are described as moderate in nature.;surgery
brain_tumor_0409;Brain Tumor;75;M;Patient is experiencing blackouts and motor dysfunction since early this year. The symptoms are described as significant in nature.;close monitoring
brain_tumor_0410;Brain Tumor;44;M;Patient is experiencing nausea and blackouts since early this year. The symptoms are described as significant in nature.;radiation therapy
brain_tumor_0411;Brain Tumor;26;F;Patient is experiencing recurring seizures and balance issues since early this year. The symptoms are described as high-grade in nature.;surgery
brain_tumor_0412;Brain Tumor;64;F;Patient is experiencing difficulty concentrating and balance issues since early this year. The symptoms are described as high-grade in nature.;close monitoring
brain_tumor_0413;Brain Tumor;38;F;Patient is experiencing balance issues and difficulty concentrating for the past 4 months. The symptoms are described as severe in nature.;surgery
brain_tumor_0414;Brain Tumor;31;F;Patient is experiencing blackouts and difficulty concentrating since early this year. The symptoms are described as noticeable in nature.;radiation therapy
brain_tumor_0415;Brain Tumor;18;M;Patient is experiencing motor dysfunction and blackouts for the past 4 months. The symptoms are described as high-grade in nature.;chemotherapy
brain_tumor_0416;Brain Tumor;38;M;Patient is experiencing motor dysfunction and balance issues over the last few weeks. The symptoms are described as significant in nature.;radiation therapy
brain_tumor_0417;Brain Tumor;27;M;Patient is experiencing balance issues and nausea for the past 4 months. The symptoms are described as moderate in nature.;chemotherapy
brain_tumor_0418;Brain Tumor;59;F;Patient is experiencing recurring seizures and blackouts since early this year. The symptoms are described as severe in nature.;close monitoring
brain_tumor_0419;Brain Tumor;51;M;Patient is experiencing balance issues and speech problems for the past 4 months. The symptoms are described as moderate in nature.;surgery
brain_tumor_0420;Brain Tumor;80;M;Patient is experiencing balance issues and blackouts since early this year. The symptoms are described as severe in nature.;radiation therapy
brain_tumor_0421;Brain Tumor;41;F;Patient is experiencing blackouts and difficulty concentrating since early this year. The symptoms are described as noticeable in nature.;radiation therapy
brain_tumor_0422;Brain Tumor;52;M;Patient is experiencing blackouts and difficulty concentrating over the last few weeks. The symptoms are described as significant in nature.;radiation therapy
brain_tumor_0423;Brain Tumor;31;F;Patient is experiencing nausea and balance issues for the past 4 months. The symptoms are described as noticeable in nature.;radiation therapy
brain_tumor_0424;Brain Tumor;75;F;Patient is experiencing nausea and difficulty concentrating for the past 4 months. The symptoms are described as debilitating in nature.;surgery
brain_tumor_0425;Brain Tumor;37;F;Patient is experiencing difficulty concentrating and speech problems since early this year. The symptoms are described as intense in nature.;surgery
brain_tumor_0426;Brain Tumor;82;F;Patient is experiencing recurring seizures and motor dysfunction over the last few weeks. The symptoms are described as high-grade in nature.;chemotherapy
brain_tumor_0427;Brain Tumor;82;F;Patient is experiencing motor dysfunction and blackouts over the last few weeks. The symptoms are described as high-grade in nature.;surgery
brain_tumor_0428;Brain Tumor;84;M;Patient is experiencing blackouts and speech problems since early this year. The symptoms are described as significant in nature.;surgery
brain_tumor_0429;Brain Tumor;30;F;Patient is experiencing motor dysfunction and balance issues for the past 4 months. The symptoms are described as high-grade in nature.;radiation therapy
brain_tumor_0430;Brain Tumor;66;F;Patient is experiencing blackouts and balance issues for the past 4 months. The symptoms are described as debilitating in nature.;surgery
brain_tumor_0431;Brain Tumor;57;M;Patient is experiencing nausea and recurring seizures over the last few weeks. The symptoms are described as debilitating in nature.;surgery
brain_tumor_0432;Brain Tumor;68;M;Patient is experiencing nausea and blackouts for the past 4 months. The symptoms are described as intense in nature.;radiation therapy
brain_tumor_0433;Brain Tumor;46;M;Patient is experiencing nausea and motor dysfunction since early this year. The symptoms are described as moderate in nature.;radiation therapy
brain_tumor_0434;Brain Tumor;74;M;Patient is experiencing motor dysfunction and nausea since early this year. The symptoms are described as noticeable in nature.;radiation therapy
brain_tumor_0435;Brain Tumor;68;F;Patient is experiencing balance issues and motor dysfunction over the last few weeks. The symptoms are described as significant in nature.;close monitoring
brain_tumor_0436;Brain Tumor;24;M;Patient is experiencing blackouts and motor dysfunction since early this year. The symptoms are described as high-grade in nature.;close monitoring
brain_tumor_0437;Brain Tumor;56;M;Patient is experiencing nausea and balance issues over the last few weeks. The symptoms are described as debilitating in nature.;chemotherapy
brain_tumor_0438;Brain Tumor;66;F;Patient is experiencing balance issues and difficulty concentrating since early this year. The symptoms are described as debilitating in nature.;close monitoring
brain_tumor_0439;Brain Tumor;48;F;Patient is experiencing recurring seizures and nausea for the past 4 months. The symptoms are described as noticeable in nature.;radiation therapy
brain_tumor_0440;Brain Tumor;83;F;Patient is experiencing speech problems and blackouts since early this year. The symptoms are described as high-grade in nature.;close monitoring
brain_tumor_0441;Brain Tumor;35;M;Patient is experiencing speech problems and motor dysfunction for the past 4 months. The symptoms are described as severe in nature.;radiation therapy
brain_tumor_0442;Brain Tumor;60;M;Patient is experiencing speech problems and motor dysfunction since early this year. The symptoms are described as significant in nature.;close monitoring
brain_tumor_0443;Brain Tumor;50;M;Patient is experiencing nausea and speech problems since early this year. The symptoms are described as intense in nature.;radiation therapy
brain_tumor_0444;Brain Tumor;65;M;Patient is experiencing difficulty concentrating and motor dysfunction for the past 4 months. The symptoms are described as intense in nature.;surgery
brain_tumor_0445;Brain Tumor;38;F;Patient is experiencing nausea and recurring seizures since early this year. The symptoms are described as debilitating in nature.;surgery
brain_tumor_0446;Brain Tumor;61;M;Patient is experiencing difficulty concentrating and nausea for the past 4 months. The symptoms are described as intense in nature.;chemotherapy
brain_tumor_0447;Brain Tumor;42;F;Patient is experiencing difficulty concentrating and balance issues since early this year. The symptoms are described as significant in nature.;surgery
brain_tumor_0448;Brain Tumor;45;M;Patient is experiencing nausea and balance issues for the past 4 months. The symptoms are described as noticeable in nature.;close monitoring
brain_tumor_0449;Brain Tumor;37;M;Patient is experiencing blackouts and motor dysfunction since early this year. The symptoms are described as significant in nature.;chemotherapy
brain_tumor_0450;Brain Tumor;45;M;Patient is experiencing motor dysfunction and nausea for the past 4 months. The symptoms are described as significant in nature.;close monitoring
brain_tumor_0451;Brain Tumor;40;F;Patient is experiencing recurring seizures and motor dysfunction since early this year. The symptoms are described as intense in nature.;radiation therapy
brain_tumor_0452;Brain Tumor;79;M;Patient is experiencing speech problems and blackouts for the past 4 months. The symptoms are described as intense in nature.;close monitoring
brain_tumor_0453;Brain Tumor;55;M;Patient is experiencing balance issues and difficulty concentrating since early this year. The symptoms are described as high-grade in nature.;radiation therapy
brain_tumor_0454;Brain Tumor;51;F;Patient is experiencing balance issues and motor dysfunction since early this year. The symptoms are described as intense in nature.;surgery
brain_tumor_0455;Brain Tumor;20;M;Patient is experiencing speech problems and difficulty concentrating since early this year. The symptoms are described as noticeable in nature.;surgery
brain_tumor_0456;Brain Tumor;26;M;Patient is experiencing motor dysfunction and difficulty concentrating for the past 4 months. The symptoms are described as high-grade in nature.;surgery
brain_tumor_0457;Brain Tumor;80;F;Patient is experiencing balance issues and motor dysfunction over the last few weeks. The symptoms are described as noticeable in nature.;close monitoring
brain_tumor_0458;Brain Tumor;18;F;Patient is experiencing speech problems and balance issues over the last few weeks. The symptoms are described as noticeable in nature.;surgery
brain_tumor_0459;Brain Tumor;47;F;Patient is experiencing recurring seizures and speech problems over the last few weeks. The symptoms are described as moderate in nature.;close monitoring
brain_tumor_0460;Brain Tumor;25;F;Patient is experiencing difficulty concentrating and recurring seizures for the past 4 months. The symptoms are described as significant in nature.;close monitoring
brain_tumor_0461;Brain Tumor;59;F;Patient is experiencing nausea and recurring seizures since early this year. The symptoms are described as noticeable in nature.;radiation therapy
brain_tumor_0462;Brain Tumor;56;M;Patient is experiencing speech problems and blackouts for the past 4 months. The symptoms are described as high-grade in nature.;surgery
brain_tumor_0463;Brain Tumor;36;M;Patient is experiencing recurring seizures and difficulty concentrating over the last few weeks. The symptoms are described as significant in nature.;chemotherapy
brain_tumor_0464;Brain Tumor;83;M;Patient is experiencing motor dysfunction and balance issues since early this year. The symptoms are described as high-grade in nature.;close monitoring
brain_tumor_0465;Brain Tumor;45;M;Patient is experiencing blackouts and nausea for the past 4 months. The symptoms are described as moderate in nature.;close monitoring
brain_tumor_0466;Brain Tumor;77;M;Patient is experiencing balance issues and nausea since early this year. The symptoms are described as significant in nature.;chemotherapy
brain_tumor_0467;Brain Tumor;22;M;Patient is experiencing recurring seizures and speech problems for the past 4 months. The symptoms are described as noticeable in nature.;surgery
brain_tumor_0468;Brain Tumor;58;M;Patient is experiencing difficulty concentrating and nausea since early this year. The symptoms are described as intense in nature.;surgery
brain_tumor_0469;Brain Tumor;22;M;Patient is experiencing recurring seizures and nausea for the past 4 months. The symptoms are described as high-grade in nature.;chemotherapy
brain_tumor_0470;Brain Tumor;53;M;Patient is experiencing recurring seizures and speech problems for the past 4 months. The symptoms are described as significant in nature.;chemotherapy
brain_tumor_0471;Brain Tumor;56;M;Patient is experiencing recurring seizures and motor dysfunction since early this year. The symptoms are described as high-grade in nature.;chemotherapy
brain_tumor_0472;Brain Tumor;84;F;Patient is experiencing recurring seizures and motor dysfunction for the past 4 months. The symptoms are described as high-grade in nature.;surgery
brain_tumor_0473;Brain Tumor;36;M;Patient is experiencing speech problems and difficulty concentrating for the past 4 months. The symptoms are described as significant in nature.;surgery
brain_tumor_0474;Brain Tumor;73;F;Patient is experiencing nausea and speech problems for the past 4 months. The symptoms are described as severe in nature.;chemotherapy
brain_tumor_0475;Brain Tumor;56;M;Patient is experiencing nausea and balance issues for the past 4 months. The symptoms are described as noticeable in nature.;close monitoring
brain_tumor_0476;Brain Tumor;62;F;Patient is experiencing motor dysfunction and blackouts for the past 4 months. The symptoms are described as significant in nature.;chemotherapy
brain_tumor_0477;Brain Tumor;77;M;Patient is experiencing recurring seizures and blackouts over the last few weeks. The symptoms are described as intense in nature.;surgery
brain_tumor_0478;Brain Tumor;77;F;Patient is experiencing recurring seizures and nausea since early this year. The symptoms are described as moderate in nature.;radiation therapy
brain_tumor_0479;Brain Tumor;73;F;Patient is experiencing speech problems and nausea for the past 4 months. The symptoms are described as noticeable in nature.;close monitoring
brain_tumor_0480;Brain Tumor;70;F;Patient is experiencing nausea and blackouts for the past 4 months. The symptoms are described as severe in nature.;close monitoring
brain_tumor_0481;Brain Tumor;18;M;Patient is experiencing motor dysfunction and speech problems since early this year. The symptoms are described as severe in nature.;chemotherapy
brain_tumor_0482;Brain Tumor;58;M;Patient is experiencing nausea and speech problems for the past 4 months. The symptoms are described as significant in nature.;surgery
brain_tumor_0483;Brain Tumor;18;F;Patient is experiencing speech problems and nausea since early this year. The symptoms are described as moderate in nature.;surgery
brain_tumor_0484;Brain Tumor;53;F;Patient is experiencing blackouts and nausea since early this year. The symptoms are described as high-grade in nature.;chemotherapy
brain_tumor_0485;Brain Tumor;35;M;Patient is experiencing speech problems and difficulty concentrating over the last few weeks. The symptoms are described as intense in nature.;chemotherapy
brain_tumor_0486;Brain Tumor;24;M;Patient is experiencing balance issues and speech problems over the last few weeks. The symptoms are described as moderate in nature.;chemotherapy
brain_tumor_0487;Brain Tumor;42;M;Patient is experiencing motor dysfunction and recurring seizures for the past 4 months. The symptoms are described as severe in nature.;radiation therapy
brain_tumor_0488;Brain Tumor;85;F;Patient is experiencing motor dysfunction and recurring seizures since early this year. The symptoms are described as intense in nature.;radiation therapy
brain_tumor_0489;Brain Tumor;84;M;Patient is experiencing blackouts and recurring seizures for the past 4 months. The symptoms are described as debilitating in nature.;surgery
brain_tumor_0490;Brain Tumor;40;M;Patient is experiencing nausea and difficulty concentrating for the past 4 months. The symptoms are described as noticeable in nature.;chemotherapy
brain_tumor_0491;Brain Tumor;23;M;Patient is experiencing nausea and difficulty concentrating since early this year. The symptoms are described as moderate in nature.;surgery
brain_tumor_0492;Brain Tumor;31;M;Patient is experiencing balance issues and motor dysfunction since early this year. The symptoms are described as high-grade in nature.;close monitoring
brain_tumor_0493;Brain Tumor;45;M;Patient is experiencing difficulty concentrating and balance issues since early this year. The symptoms are described as intense in nature.;surgery
brain_tumor_0494;Brain Tumor;19;F;Patient is experiencing motor dysfunction and balance issues since early this year. The symptoms are described as noticeable in nature.;radiation therapy
brain_tumor_0495;Brain Tumor;57;M;Patient is experiencing motor dysfunction and recurring seizures over the last few weeks. The symptoms are described as severe in nature.;close monitoring
brain_tumor_0496;Brain Tumor;72;M;Patient is experiencing difficulty concentrating and nausea for the past 4 months. The symptoms are described as intense in nature.;radiation therapy
brain_tumor_0497;Brain Tumor;65;M;Patient is experiencing blackouts and nausea since early this year. The symptoms are described as debilitating in nature.;close monitoring
brain_tumor_0498;Brain Tumor;46;M;Patient is experiencing speech problems and difficulty concentrating for the past 4 months. The symptoms are described as debilitating in nature.;chemotherapy
brain_tumor_0499;Brain Tumor;20;M;Patient is experiencing blackouts and nausea over the last few weeks. The symptoms are described as significant in nature.;close monitoring
brain_tumor_0500;Brain Tumor;24;M;Patient is experiencing blackouts and motor dysfunction since early this year. The symptoms are described as intense in nature.;radiation therapy
brain_tumor_0501;Brain Tumor;83;F;Patient is experiencing balance issues and difficulty concentrating for the past 4 months. The symptoms are described as high-grade in nature.;surgery
brain_tumor_0502;Brain Tumor;32;M;Patient is experiencing nausea and motor dysfunction over the last few weeks. The symptoms are described as high-grade in nature.;radiation therapy
brain_tumor_0503;Brain Tumor;50;M;Patient is experiencing blackouts and difficulty concentrating over the last few weeks. The symptoms are described as moderate in nature.;surgery
brain_tumor_0504;Brain Tumor;76;F;Patient is experiencing recurring seizures and motor dysfunction for the past 4 months. The symptoms are described as intense in nature.;radiation therapy
brain_tumor_0505;Brain Tumor;23;M;Patient is experiencing nausea and recurring seizures over the last few weeks. The symptoms are described as intense in nature.;radiation therapy
brain_tumor_0506;Brain Tumor;79;F;Patient is experiencing recurring seizures and speech problems over the last few weeks. The symptoms are described as noticeable in nature.;radiation therapy
brain_tumor_0507;Brain Tumor;38;M;Patient is experiencing nausea and difficulty concentrating since early this year. The symptoms are described as debilitating in nature.;close monitoring
brain_tumor_0508;Brain Tumor;25;M;Patient is experiencing nausea and recurring seizures for the past 4 months. The symptoms are described as moderate in nature.;surgery
brain_tumor_0509;Brain Tumor;30;F;Patient is experiencing recurring seizures and speech problems over the last few weeks. The symptoms are described as debilitating in nature.;chemotherapy
brain_tumor_0510;Brain Tumor;68;F;Patient is experiencing nausea and difficulty concentrating over the last few weeks. The symptoms are described as high-grade in nature.;chemotherapy
brain_tumor_0511;Brain Tumor;47;M;Patient is experiencing motor dysfunction and difficulty concentrating since early this year. The symptoms are described as high-grade in nature.;surgery
brain_tumor_0512;Brain Tumor;27;M;Patient is experiencing nausea and speech problems for the past 4 months. The symptoms are described as moderate in nature.;surgery
brain_tumor_0513;Brain Tumor;50;F;Patient is experiencing recurring seizures and speech problems for the past 4 months. The symptoms are described as moderate in nature.;radiation therapy
brain_tumor_0514;Brain Tumor;51;F;Patient is experiencing speech problems and motor dysfunction for the past 4 months. The symptoms are described as severe in nature.;radiation therapy
brain_tumor_0515;Brain Tumor;83;M;Patient is experiencing motor dysfunction and balance issues for the past 4 months. The symptoms are described as intense in nature.;chemotherapy
brain_tumor_0516;Brain Tumor;82;M;Patient is experiencing nausea and blackouts over the last few weeks. The symptoms are described as high-grade in nature.;radiation therapy
brain_tumor_0517;Brain Tumor;53;M;Patient is experiencing difficulty concentrating and speech problems since early this year. The symptoms are described as severe in nature.;close monitoring
brain_tumor_0518;Brain Tumor;36;M;Patient is experiencing speech problems and difficulty concentrating over the last few weeks. The symptoms are described as severe in nature.;surgery
brain_tumor_0519;Brain Tumor;76;M;Patient is experiencing motor dysfunction and blackouts over the last few weeks. The symptoms are described as significant in nature.;radiation therapy
brain_tumor_0520;Brain Tumor;47;F;Patient is experiencing balance issues and speech problems over the last few weeks. The symptoms are described as moderate in nature.;radiation therapy
brain_tumor_0521;Brain Tumor;65;M;Patient is experiencing blackouts and motor dysfunction for the past 4 months. The symptoms are described as intense in nature.;chemotherapy
brain_tumor_0522;Brain Tumor;47;M;Patient is experiencing motor dysfunction and nausea since early this year. The symptoms are described as debilitating in nature.;surgery
brain_tumor_0523;Brain Tumor;25;F;Patient is experiencing speech problems and nausea since early this year. The symptoms are described as debilitating in nature.;close monitoring
brain_tumor_0524;Brain Tumor;59;M;Patient is experiencing blackouts and nausea over the last few weeks. The symptoms are described as moderate in nature.;chemotherapy
brain_tumor_0525;Brain Tumor;67;M;Patient is experiencing difficulty concentrating and speech problems over the last few weeks. The symptoms are described as intense in nature.;close monitoring
brain_tumor_0526;Brain Tumor;85;M;Patient is experiencing motor dysfunction and nausea over the last few weeks. The symptoms are described as debilitating in nature.;chemotherapy
brain_tumor_0527;Brain Tumor;42;F;Patient is experiencing blackouts and difficulty concentrating for the past 4 months. The symptoms are described as moderate in nature.;radiation therapy
brain_tumor_0528;Brain Tumor;72;M;Patient is experiencing nausea and recurring seizures for the past 4 months. The symptoms are described as moderate in nature.;radiation therapy
brain_tumor_0529;Brain Tumor;23;M;Patient is experiencing difficulty concentrating and motor dysfunction for the past 4 months. The symptoms are described as severe in nature.;chemotherapy
brain_tumor_0530;Brain Tumor;69;F;Patient is experiencing nausea and speech problems over the last few weeks. The symptoms are described as high-grade in nature.;radiation therapy
brain_tumor_0531;Brain Tumor;43;F;Patient is experiencing motor dysfunction and difficulty concentrating since early this year. The symptoms are described as high-grade in nature.;close monitoring
brain_tumor_0532;Brain Tumor;72;M;Patient is experiencing blackouts and motor dysfunction since early this year. The symptoms are described as significant in nature.;close monitoring
brain_tumor_0533;Brain Tumor;26;M;Patient is experiencing speech problems and blackouts since early this year. The symptoms are described as high-grade in nature.;radiation therapy
brain_tumor_0534;Brain Tumor;21;M;Patient is experiencing recurring seizures and nausea for the past 4 months. The symptoms are described as debilitating in nature.;surgery
brain_tumor_0535;Brain Tumor;36;F;Patient is experiencing recurring seizures and nausea since early this year. The symptoms are described as noticeable in nature.;radiation therapy
brain_tumor_0536;Brain Tumor;79;M;Patient is experiencing recurring seizures and difficulty concentrating since early this year. The symptoms are described as high-grade in nature.;close monitoring
brain_tumor_0537;Brain Tumor;47;F;Patient is experiencing blackouts and recurring seizures for the past 4 months. The symptoms are described as noticeable in nature.;chemotherapy
brain_tumor_0538;Brain Tumor;80;M;Patient is experiencing motor dysfunction and nausea since early this year. The symptoms are described as moderate in nature.;chemotherapy
brain_tumor_0539;Brain Tumor;44;F;Patient is experiencing blackouts and balance issues for the past 4 months. The symptoms are described as high-grade in nature.;radiation therapy
brain_tumor_0540;Brain Tumor;36;F;Patient is experiencing speech problems and nausea over the last few weeks. The symptoms are described as high-grade in nature.;surgery
brain_tumor_0541;Brain Tumor;33;F;Patient is experiencing balance issues and motor dysfunction for the past 4 months. The symptoms are described as high-grade in nature.;close monitoring
brain_tumor_0542;Brain Tumor;61;F;Patient is experiencing difficulty concentrating and nausea since early this year. The symptoms are described as debilitating in nature.;radiation therapy
brain_tumor_0543;Brain Tumor;29;M;Patient is experiencing motor dysfunction and recurring seizures for the past 4 months. The symptoms are described as high-grade in nature.;surgery
brain_tumor_0544;Brain Tumor;42;F;Patient is experiencing motor dysfunction and speech problems over the last few weeks. The symptoms are described as severe in nature.;close monitoring
brain_tumor_0545;Brain Tumor;70;M;Patient is experiencing speech problems and nausea over the last few weeks. The symptoms are described as intense in nature.;chemotherapy
brain_tumor_0546;Brain Tumor;50;F;Patient is experiencing difficulty concentrating and balance issues since early this year. The symptoms are described as intense in nature.;radiation therapy
brain_tumor_0547;Brain Tumor;54;F;Patient is experiencing balance issues and motor dysfunction for the past 4 months. The symptoms are described as intense in nature.;surgery
brain_tumor_0548;Brain Tumor;65;M;Patient is experiencing motor dysfunction and recurring seizures since early this year. The symptoms are described as high-grade in nature.;chemotherapy
brain_tumor_0549;Brain Tumor;54;F;Patient is experiencing recurring seizures and blackouts over the last few weeks. The symptoms are described as significant in nature.;close monitoring
brain_tumor_0550;Brain Tumor;43;M;Patient is experiencing blackouts and motor dysfunction for the past 4 months. The symptoms are described as debilitating in nature.;chemotherapy
brain_tumor_0551;Brain Tumor;61;M;Patient is experiencing nausea and balance issues for the past 4 months. The symptoms are described as moderate in nature.;radiation therapy
brain_tumor_0552;Brain Tumor;83;F;Patient is experiencing blackouts and balance issues for the past 4 months. The symptoms are described as severe in nature.;surgery
brain_tumor_0553;Brain Tumor;81;M;Patient is experiencing blackouts and motor dysfunction over the last few weeks. The symptoms are described as high-grade in nature.;chemotherapy
brain_tumor_0554;Brain Tumor;64;F;Patient is experiencing motor dysfunction and blackouts for the past 4 months. The symptoms are described as intense in nature.;surgery
brain_tumor_0555;Brain Tumor;82;F;Patient is experiencing nausea and motor dysfunction for the past 4 months. The symptoms are described as significant in nature.;radiation therapy
brain_tumor_0556;Brain Tumor;82;F;Patient is experiencing balance issues and blackouts over the last few weeks. The symptoms are described as intense in nature.;surgery
brain_tumor_0557;Brain Tumor;47;F;Patient is experiencing motor dysfunction and nausea over the last few weeks. The symptoms are described as noticeable in nature.;close monitoring
brain_tumor_0558;Brain Tumor;24;F;Patient is experiencing recurring seizures and nausea since early this year. The symptoms are described as intense in nature.;close monitoring
brain_tumor_0559;Brain Tumor;54;M;Patient is experiencing difficulty concentrating and balance issues over the last few weeks. The symptoms are described as significant in nature.;radiation therapy
brain_tumor_0560;Brain Tumor;55;M;Patient is experiencing speech problems and nausea over the last few weeks. The symptoms are described as severe in nature.;radiation therapy
brain_tumor_0561;Brain Tumor;54;M;Patient is experiencing motor dysfunction and blackouts for the past 4 months. The symptoms are described as moderate in nature.;chemotherapy
brain_tumor_0562;Brain Tumor;35;M;Patient is experiencing nausea and blackouts for the past 4 months. The symptoms are described as high-grade in nature.;close monitoring
brain_tumor_0563;Brain Tumor;63;F;Patient is experiencing recurring seizures and balance issues over the last few weeks. The symptoms are described as moderate in nature.;radiation therapy
brain_tumor_0564;Brain Tumor;48;M;Patient is experiencing difficulty concentrating and nausea since early this year. The symptoms are described as noticeable in nature.;radiation therapy
brain_tumor_0565;Brain Tumor;22;M;Patient is experiencing difficulty concentrating and blackouts over the last few weeks. The symptoms are described as severe in nature.;radiation therapy
brain_tumor_0566;Brain Tumor;32;M;Patient is experiencing speech problems and recurring seizures since early this year. The symptoms are described as noticeable in nature.;radiation therapy
brain_tumor_0567;Brain Tumor;67;M;Patient is experiencing recurring seizures and motor dysfunction for the past 4 months. The symptoms are described as high-grade in nature.;surgery
brain_tumor_0568;Brain Tumor;54;M;Patient is experiencing motor dysfunction and speech problems over the last few weeks. The symptoms are described as debilitating in nature.;chemotherapy
brain_tumor_0569;Brain Tumor;59;M;Patient is experiencing motor dysfunction and difficulty concentrating for the past 4 months. The symptoms are described as debilitating in nature.;surgery
brain_tumor_0570;Brain Tumor;56;F;Patient is experiencing recurring seizures and nausea for the past 4 months. The symptoms are described as intense in nature.;close monitoring
brain_tumor_0571;Brain Tumor;45;M;Patient is experiencing balance issues and difficulty concentrating since early this year. The symptoms are described as high-grade in nature.;chemotherapy
brain_tumor_0572;Brain Tumor;78;F;Patient is experiencing motor dysfunction and difficulty concentrating over the last few weeks. The symptoms are described as debilitating in nature.;surgery
brain_tumor_0573;Brain Tumor;49;M;Patient is experiencing difficulty concentrating and recurring seizures for the past 4 months. The symptoms are described as moderate in nature.;surgery
brain_tumor_0574;Brain Tumor;57;F;Patient is experiencing speech problems and recurring seizures for the past 4 months. The symptoms are described as moderate in nature.;surgery
brain_tumor_0575;Brain Tumor;64;M;Patient is experiencing motor dysfunction and balance issues for the past 4 months. The symptoms are described as moderate in nature.;close monitoring
brain_tumor_0576;Brain Tumor;24;F;Patient is experiencing nausea and blackouts for the past 4 months. The symptoms are described as noticeable in nature.;radiation therapy
brain_tumor_0577;Brain Tumor;63;F;Patient is experiencing nausea and speech problems for the past 4 months. The symptoms are described as significant in nature.;close monitoring
brain_tumor_0578;Brain Tumor;85;M;Patient is experiencing difficulty concentrating and balance issues since early this year. The symptoms are described as debilitating in nature.;surgery
brain_tumor_0579;Brain Tumor;51;M;Patient is experiencing nausea and difficulty concentrating since early this year. The symptoms are described as moderate in nature.;surgery
brain_tumor_0580;Brain Tumor;75;M;Patient is experiencing motor dysfunction and speech problems for the past 4 months. The symptoms are described as high-grade in nature.;chemotherapy
brain_tumor_0581;Brain Tumor;41;F;Patient is experiencing motor dysfunction and difficulty concentrating for the past 4 months. The symptoms are described as noticeable in nature.;surgery
brain_tumor_0582;Brain Tumor;31;M;Patient is experiencing motor dysfunction and recurring seizures for the past 4 months. The symptoms are described as intense in nature.;surgery
brain_tumor_0583;Brain Tumor;82;M;Patient is experiencing speech problems and motor dysfunction over the last few weeks. The symptoms are described as intense in nature.;chemotherapy
brain_tumor_0584;Brain Tumor;54;F;Patient is experiencing blackouts and balance issues for the past 4 months. The symptoms are described as severe in nature.;chemotherapy
brain_tumor_0585;Brain Tumor;29;F;Patient is experiencing speech problems and motor dysfunction over the last few weeks. The symptoms are described as noticeable in nature.;radiation therapy
brain_tumor_0586;Brain Tumor;19;F;Patient is experiencing balance issues and blackouts for the past 4 months. The symptoms are described as moderate in nature.;surgery
brain_tumor_0587;Brain Tumor;36;F;Patient is experiencing nausea and motor dysfunction over the last few weeks. The symptoms are described as debilitating in nature.;chemotherapy
brain_tumor_0588;Brain Tumor;47;F;Patient is experiencing blackouts and speech problems since early this year. The symptoms are described as moderate in nature.;radiation therapy
brain_tumor_0589;Brain Tumor;51;M;Patient is experiencing difficulty concentrating and motor dysfunction since early this year. The symptoms are described as severe in nature.;close monitoring
brain_tumor_0590;Brain Tumor;83;F;Patient is experiencing recurring seizures and blackouts since early this year. The symptoms are described as moderate in nature.;radiation therapy
brain_tumor_0591;Brain Tumor;60;F;Patient is experiencing recurring seizures and balance issues since early this year. The symptoms are described as noticeable in nature.;chemotherapy
brain_tumor_0592;Brain Tumor;30;F;Patient is experiencing nausea and difficulty concentrating since early this year. The symptoms are described as noticeable in nature.;close monitoring
brain_tumor_0593;Brain Tumor;53;F;Patient is experiencing nausea and blackouts since early this year. The symptoms are described as severe in nature.;radiation therapy
brain_tumor_0594;Brain Tumor;67;M;Patient is experiencing motor dysfunction and recurring seizures for the past 4 months. The symptoms are described as moderate in nature.;radiation therapy
brain_tumor_0595;Brain Tumor;33;F;Patient is experiencing motor dysfunction and difficulty concentrating since early this year. The symptoms are described as debilitating in nature.;close monitoring
brain_tumor_0596;Brain Tumor;53;M;Patient is experiencing blackouts and speech problems since early this year. The symptoms are described as significant in nature.;surgery
brain_tumor_0597;Brain Tumor;50;F;Patient is experiencing speech problems and nausea since early this year. The symptoms are described as significant in nature.;chemotherapy
brain_tumor_0598;Brain Tumor;63;M;Patient is experiencing balance issues and blackouts for the past 4 months. The symptoms are described as high-grade in nature.;surgery
brain_tumor_0599;Brain Tumor;18;M;Patient is experiencing difficulty concentrating and blackouts since early this year. The symptoms are described as debilitating in nature.;close monitoring
brain_tumor_0600;Brain Tumor;42;F;Patient is experiencing blackouts and nausea since early this year. The symptoms are described as debilitating in nature.;close monitoring
brain_tumor_0601;Brain Tumor;80;M;Patient is experiencing balance issues and recurring seizures since early this year. The symptoms are described as intense in nature.;chemotherapy
brain_tumor_0602;Brain Tumor;38;M;Patient is experiencing balance issues and blackouts since early this year. The symptoms are described as high-grade in nature.;close monitoring
brain_tumor_0603;Brain Tumor;82;F;Patient is experiencing nausea and blackouts over the last few weeks. The symptoms are described as noticeable in nature.;close monitoring
brain_tumor_0604;Brain Tumor;35;F;Patient is experiencing balance issues and difficulty concentrating over the last few weeks. The symptoms are described as intense in nature.;chemotherapy
brain_tumor_0605;Brain Tumor;73;M;Patient is experiencing difficulty concentrating and motor dysfunction since early this year. The symptoms are described as noticeable in nature.;radiation therapy
brain_tumor_0606;Brain Tumor;65;M;Patient is experiencing nausea and recurring seizures since early this year. The symptoms are described as moderate in nature.;close monitoring
brain_tumor_0607;Brain Tumor;82;M;Patient is experiencing recurring seizures and speech problems for the past 4 months. The symptoms are described as moderate in nature.;surgery
brain_tumor_0608;Brain Tumor;37;F;Patient is experiencing recurring seizures and blackouts for the past 4 months. The symptoms are described as high-grade in nature.;surgery
brain_tumor_0609;Brain Tumor;52;M;Patient is experiencing nausea and speech problems since early this year. The symptoms are described as significant in nature.;surgery
brain_tumor_0610;Brain Tumor;48;F;Patient is experiencing balance issues and blackouts for the past 4 months. The symptoms are described as moderate in nature.;close monitoring
brain_tumor_0611;Brain Tumor;45;F;Patient is experiencing difficulty concentrating and blackouts over the last few weeks. The symptoms are described as debilitating in nature.;close monitoring
brain_tumor_0612;Brain Tumor;41;M;Patient is experiencing balance issues and recurring seizures over the last few weeks. The symptoms are described as significant in nature.;chemotherapy
brain_tumor_0613;Brain Tumor;42;F;Patient is experiencing speech problems and recurring seizures for the past 4 months. The symptoms are described as moderate in nature.;surgery
brain_tumor_0614;Brain Tumor;21;M;Patient is experiencing speech problems and recurring seizures since early this year. The symptoms are described as debilitating in nature.;chemotherapy
brain_tumor_0615;Brain Tumor;45;F;Patient is experiencing difficulty concentrating and nausea since early this year. The symptoms are described as noticeable in nature.;surgery
brain_tumor_0616;Brain Tumor;41;F;Patient is experiencing blackouts and nausea over the last few weeks. The symptoms are described as moderate in nature.;radiation therapy
brain_tumor_0617;Brain Tumor;43;M;Patient is experiencing balance issues and nausea since early this year. The symptoms are described as significant in nature.;close monitoring
brain_tumor_0618;Brain Tumor;58;F;Patient is experiencing blackouts and recurring seizures since early this year. The symptoms are described as moderate in nature.;surgery
brain_tumor_0619;Brain Tumor;63;F;Patient is experiencing difficulty concentrating and motor dysfunction for the past 4 months. The symptoms are described as debilitating in nature.;close monitoring
brain_tumor_0620;Brain Tumor;62;M;Patient is experiencing speech problems and nausea for the past 4 months. The symptoms are described as severe in nature.;radiation therapy
brain_tumor_0621;Brain Tumor;85;F;Patient is experiencing blackouts and nausea for the past 4 months. The symptoms are described as debilitating in nature.;surgery
brain_tumor_0622;Brain Tumor;49;M;Patient is experiencing speech problems and nausea over the last few weeks. The symptoms are described as noticeable in nature.;close monitoring
brain_tumor_0623;Brain Tumor;25;F;Patient is experiencing speech problems and balance issues for the past 4 months. The symptoms are described as intense in nature.;radiation therapy
brain_tumor_0624;Brain Tumor;32;F;Patient is experiencing speech problems and motor dysfunction since early this year. The symptoms are described as moderate in nature.;chemotherapy
brain_tumor_0625;Brain Tumor;62;F;Patient is experiencing blackouts and balance issues for the past 4 months. The symptoms are described as intense in nature.;close monitoring
brain_tumor_0626;Brain Tumor;83;F;Patient is experiencing difficulty concentrating and blackouts for the past 4 months. The symptoms are described as significant in nature.;radiation therapy
brain_tumor_0627;Brain Tumor;70;M;Patient is experiencing speech problems and difficulty concentrating for the past 4 months. The symptoms are described as debilitating in nature.;chemotherapy
brain_tumor_0628;Brain Tumor;50;F;Patient is experiencing difficulty concentrating and speech problems over the last few weeks. The symptoms are described as high-grade in nature.;close monitoring
brain_tumor_0629;Brain Tumor;81;F;Patient is experiencing difficulty concentrating and balance issues since early this year. The symptoms are described as noticeable in nature.;chemotherapy
brain_tumor_0630;Brain Tumor;44;M;Patient is experiencing recurring seizures and balance issues since early this year. The symptoms are described as high-grade in nature.;surgery
brain_tumor_0631;Brain Tumor;19;M;Patient is experiencing nausea and difficulty concentrating over the last few weeks. The symptoms are described as high-grade in nature.;close monitoring
brain_tumor_0632;Brain Tumor;82;M;Patient is experiencing balance issues and difficulty concentrating for the past 4 months. The symptoms are described as noticeable in nature.;radiation therapy
brain_tumor_0633;Brain Tumor;40;F;Patient is experiencing balance issues and speech problems since early this year. The symptoms are described as debilitating in nature.;close monitoring
brain_tumor_0634;Brain Tumor;49;M;Patient is experiencing blackouts and recurring seizures over the last few weeks. The symptoms are described as moderate in nature.;surgery
brain_tumor_0635;Brain Tumor;25;F;Patient is experiencing recurring seizures and nausea for the past 4 months. The symptoms are described as moderate in nature.;close monitoring
brain_tumor_0636;Brain Tumor;64;F;Patient is experiencing balance issues and difficulty concentrating since early this year. The symptoms are described as moderate in nature.;surgery
brain_tumor_0637;Brain Tumor;42;M;Patient is experiencing nausea and recurring seizures since early this year. The symptoms are described as noticeable in nature.;surgery
brain_tumor_0638;Brain Tumor;65;F;Patient is experiencing speech problems and difficulty concentrating over the last few weeks. The symptoms are described as high-grade in nature.;radiation therapy
brain_tumor_0639;Brain Tumor;36;F;Patient is experiencing blackouts and balance issues for the past 4 months. The symptoms are described as moderate in nature.;radiation therapy
brain_tumor_0640;Brain Tumor;81;M;Patient is experiencing balance issues and blackouts over the last few weeks. The symptoms are described as severe in nature.;radiation therapy
brain_tumor_0641;Brain Tumor;28;F;Patient is experiencing nausea and balance issues since early this year. The symptoms are described as intense in nature.;surgery
brain_tumor_0642;Brain Tumor;82;F;Patient is experiencing nausea and balance issues since early this year. The symptoms are described as debilitating in nature.;chemotherapy
brain_tumor_0643;Brain Tumor;62;F;Patient is experiencing nausea and balance issues over the last few weeks. The symptoms are described as high-grade in nature.;surgery
brain_tumor_0644;Brain Tumor;35;F;Patient is experiencing blackouts and speech problems for the past 4 months. The symptoms are described as noticeable in nature.;radiation therapy
brain_tumor_0645;Brain Tumor;64;M;Patient is experiencing balance issues and difficulty concentrating for the past 4 months. The symptoms are described as debilitating in nature.;radiation therapy
brain_tumor_0646;Brain Tumor;22;F;Patient is experiencing motor dysfunction and recurring seizures since early this year. The symptoms are described as debilitating in nature.;close monitoring
brain_tumor_0647;Brain Tumor;57;M;Patient is experiencing blackouts and difficulty concentrating for the past 4 months. The symptoms are described as moderate in nature.;radiation therapy
brain_tumor_0648;Brain Tumor;39;F;Patient is experiencing blackouts and nausea since early this year. The symptoms are described as debilitating in nature.;radiation therapy
brain_tumor_0649;Brain Tumor;40;M;Patient is experiencing difficulty concentrating and recurring seizures since early this year. The symptoms are described as debilitating in nature.;surgery
brain_tumor_0650;Brain Tumor;26;F;Patient is experiencing motor dysfunction and speech problems since early this year. The symptoms are described as noticeable in nature.;surgery
brain_tumor_0651;Brain Tumor;25;M;Patient is experiencing balance issues and speech problems since early this year. The symptoms are described as significant in nature.;close monitoring
brain_tumor_0652;Brain Tumor;65;F;Patient is experiencing balance issues and motor dysfunction for the past 4 months. The symptoms are described as significant in nature.;radiation therapy
brain_tumor_0653;Brain Tumor;43;M;Patient is experiencing speech problems and balance issues over the last few weeks. The symptoms are described as noticeable in nature.;close monitoring
brain_tumor_0654;Brain Tumor;55;M;Patient is experiencing balance issues and blackouts over the last few weeks. The symptoms are described as severe in nature.;radiation therapy
brain_tumor_0655;Brain Tumor;28;F;Patient is experiencing motor dysfunction and recurring seizures for the past 4 months. The symptoms are described as significant in nature.;close monitoring
brain_tumor_0656;Brain Tumor;40;F;Patient is experiencing difficulty concentrating and motor dysfunction over the last few weeks. The symptoms are described as high-grade in nature.;radiation therapy
brain_tumor_0657;Brain Tumor;22;F;Patient is experiencing nausea and recurring seizures over the last few weeks. The symptoms are described as intense in nature.;surgery
brain_tumor_0658;Brain Tumor;18;F;Patient is experiencing balance issues and nausea over the last few weeks. The symptoms are described as moderate in nature.;surgery
brain_tumor_0659;Brain Tumor;42;M;Patient is experiencing recurring seizures and difficulty concentrating since early this year. The symptoms are described as moderate in nature.;chemotherapy
brain_tumor_0660;Brain Tumor;75;F;Patient is experiencing recurring seizures and motor dysfunction for the past 4 months. The symptoms are described as noticeable in nature.;surgery
brain_tumor_0661;Brain Tumor;40;M;Patient is experiencing blackouts and nausea for the past 4 months. The symptoms are described as intense in nature.;chemotherapy
brain_tumor_0662;Brain Tumor;37;F;Patient is experiencing motor dysfunction and nausea for the past 4 months. The symptoms are described as noticeable in nature.;chemotherapy
brain_tumor_0663;Brain Tumor;85;M;Patient is experiencing difficulty concentrating and recurring seizures for the past 4 months. The symptoms are described as moderate in nature.;close monitoring
brain_tumor_0664;Brain Tumor;45;F;Patient is experiencing blackouts and motor dysfunction for the past 4 months. The symptoms are described as significant in nature.;close monitoring
brain_tumor_0665;Brain Tumor;63;F;Patient is experiencing nausea and balance issues over the last few weeks. The symptoms are described as moderate in nature.;close monitoring
brain_tumor_0666;Brain Tumor;78;F;Patient is experiencing blackouts and motor dysfunction for the past 4 months. The symptoms are described as debilitating in nature.;radiation therapy
brain_tumor_0667;Brain Tumor;18;M;Patient is experiencing difficulty concentrating and balance issues for the past 4 months. The symptoms are described as high-grade in nature.;chemotherapy
brain_tumor_0668;Brain Tumor;83;F;Patient is experiencing difficulty concentrating and recurring seizures for the past 4 months. The symptoms are described as moderate in nature.;chemotherapy
brain_tumor_0669;Brain Tumor;79;F;Patient is experiencing motor dysfunction and speech problems for the past 4 months. The symptoms are described as noticeable in nature.;close monitoring
brain_tumor_0670;Brain Tumor;63;F;Patient is experiencing blackouts and balance issues for the past 4 months. The symptoms are described as severe in nature.;chemotherapy
brain_tumor_0671;Brain Tumor;26;F;Patient is experiencing motor dysfunction and blackouts for the past 4 months. The symptoms are described as noticeable in nature.;surgery
brain_tumor_0672;Brain Tumor;52;F;Patient is experiencing balance issues and blackouts over the last few weeks. The symptoms are described as noticeable in nature.;surgery
brain_tumor_0673;Brain Tumor;48;M;Patient is experiencing blackouts and difficulty concentrating since early this year. The symptoms are described as severe in nature.;radiation therapy
brain_tumor_0674;Brain Tumor;70;F;Patient is experiencing nausea and blackouts for the past 4 months. The symptoms are described as debilitating in nature.;close monitoring
brain_tumor_0675;Brain Tumor;69;F;Patient is experiencing recurring seizures and nausea since early this year. The symptoms are described as noticeable in nature.;radiation therapy
brain_tumor_0676;Brain Tumor;28;M;Patient is experiencing blackouts and speech problems since early this year. The symptoms are described as significant in nature.;radiation therapy
brain_tumor_0677;Brain Tumor;68;F;Patient is experiencing blackouts and nausea over the last few weeks. The symptoms are described as intense in nature.;chemotherapy
brain_tumor_0678;Brain Tumor;30;M;Patient is experiencing recurring seizures and difficulty concentrating for the past 4 months. The symptoms are described as moderate in nature.;surgery
brain_tumor_0679;Brain Tumor;51;F;Patient is experiencing nausea and blackouts since early this year. The symptoms are described as severe in nature.;radiation therapy
brain_tumor_0680;Brain Tumor;19;F;Patient is experiencing speech problems and blackouts for the past 4 months. The symptoms are described as moderate in nature.;close monitoring
brain_tumor_0681;Brain Tumor;19;M;Patient is experiencing difficulty concentrating and recurring seizures over the last few weeks. The symptoms are described as intense in nature.;radiation therapy
brain_tumor_0682;Brain Tumor;40;M;Patient is experiencing blackouts and nausea for the past 4 months. The symptoms are described as noticeable in nature.;surgery
brain_tumor_0683;Brain Tumor;76;M;Patient is experiencing blackouts and difficulty concentrating since early this year. The symptoms are described as debilitating in nature.;close monitoring
brain_tumor_0684;Brain Tumor;75;F;Patient is experiencing blackouts and recurring seizures for the past 4 months. The symptoms are described as significant in nature.;chemotherapy
brain_tumor_0685;Brain Tumor;30;F;Patient is experiencing recurring seizures and difficulty concentrating over the last few weeks. The symptoms are described as noticeable in nature.;chemotherapy
brain_tumor_0686;Brain Tumor;80;F;Patient is experiencing motor dysfunction and blackouts since early this year. The symptoms are described as moderate in nature.;close monitoring
brain_tumor_0687;Brain Tumor;47;F;Patient is experiencing motor dysfunction and nausea for the past 4 months. The symptoms are described as noticeable in nature.;close monitoring
brain_tumor_0688;Brain Tumor;70;F;Patient is experiencing speech problems and difficulty concentrating over the last few weeks. The symptoms are described as high-grade in nature.;chemotherapy
brain_tumor_0689;Brain Tumor;67;M;Patient is experiencing speech problems and nausea for the past 4 months. The symptoms are described as moderate in nature.;surgery
brain_tumor_0690;Brain Tumor;82;M;Patient is experiencing motor dysfunction and difficulty concentrating over the last few weeks. The symptoms are described as severe in nature.;surgery
brain_tumor_0691;Brain Tumor;51;F;Patient is experiencing recurring seizures and balance issues over the last few weeks. The symptoms are described as noticeable in nature.;close monitoring
brain_tumor_0692;Brain Tumor;24;F;Patient is experiencing balance issues and speech problems for the past 4 months. The symptoms are described as intense in nature.;radiation therapy
brain_tumor_0693;Brain Tumor;66;F;Patient is experiencing nausea and speech problems since early this year. The symptoms are described as severe in nature.;radiation therapy
brain_tumor_0694;Brain Tumor;29;M;Patient is experiencing blackouts and difficulty concentrating since early this year. The symptoms are described as significant in nature.;radiation therapy
brain_tumor_0695;Brain Tumor;37;M;Patient is experiencing speech problems and balance issues over the last few weeks. The symptoms are described as debilitating in nature.;chemotherapy
brain_tumor_0696;Brain Tumor;65;M;Patient is experiencing balance issues and speech problems since early this year. The symptoms are described as significant in nature.;chemotherapy
brain_tumor_0697;Brain Tumor;50;M;Patient is experiencing balance issues and speech problems over the last few weeks. The symptoms are described as intense in nature.;chemotherapy
brain_tumor_0698;Brain Tumor;65;M;Patient is experiencing difficulty concentrating and recurring seizures since early this year. The symptoms are described as significant in nature.;radiation therapy
brain_tumor_0699;Brain Tumor;41;F;Patient is experiencing balance issues and speech problems since early this year. The symptoms are described as significant in nature.;close monitoring
brain_tumor_0700;Brain Tumor;26;M;Patient is experiencing nausea and speech problems since early this year. The symptoms are described as severe in nature.;surgery
brain_tumor_0701;Brain Tumor;50;F;Patient is experiencing balance issues and difficulty concentrating for the past 4 months. The symptoms are described as intense in nature.;chemotherapy
brain_tumor_0702;Brain Tumor;57;M;Patient is experiencing blackouts and difficulty concentrating over the last few weeks. The symptoms are described as significant in nature.;chemotherapy
brain_tumor_0703;Brain Tumor;31;M;Patient is experiencing balance issues and blackouts over the last few weeks. The symptoms are described as severe in nature.;chemotherapy
brain_tumor_0704;Brain Tumor;62;M;Patient is experiencing difficulty concentrating and recurring seizures since early this year. The symptoms are described as noticeable in nature.;chemotherapy
brain_tumor_0705;Brain Tumor;57;M;Patient is experiencing difficulty concentrating and balance issues since early this year. The symptoms are described as debilitating in nature.;chemotherapy
brain_tumor_0706;Brain Tumor;19;M;Patient is experiencing motor dysfunction and blackouts over the last few weeks. The symptoms are described as intense in nature.;radiation therapy
brain_tumor_0707;Brain Tumor;27;F;Patient is experiencing blackouts and motor dysfunction for the past 4 months. The symptoms are described as debilitating in nature.;chemotherapy
brain_tumor_0708;Brain Tumor;84;F;Patient is experiencing nausea and speech problems over the last few weeks. The symptoms are described as severe in nature.;close monitoring
brain_tumor_0709;Brain Tumor;64;F;Patient is experiencing motor dysfunction and recurring seizures for the past 4 months. The symptoms are described as noticeable in nature.;chemotherapy
brain_tumor_0710;Brain Tumor;25;F;Patient is experiencing speech problems and balance issues since early this year. The symptoms are described as noticeable in nature.;radiation therapy
brain_tumor_0711;Brain Tumor;59;M;Patient is experiencing blackouts and recurring seizures for the past 4 months. The symptoms are described as significant in nature.;close monitoring
brain_tumor_0712;Brain Tumor;73;F;Patient is experiencing nausea and speech problems over the last few weeks. The symptoms are described as noticeable in nature.;chemotherapy
brain_tumor_0713;Brain Tumor;49;M;Patient is experiencing balance issues and blackouts over the last few weeks. The symptoms are described as noticeable in nature.;surgery
brain_tumor_0714;Brain Tumor;69;F;Patient is experiencing blackouts and recurring seizures since early this year. The symptoms are described as moderate in nature.;radiation therapy
brain_tumor_0715;Brain Tumor;24;F;Patient is experiencing nausea and speech problems over the last few weeks. The symptoms are described as moderate in nature.;radiation therapy
brain_tumor_0716;Brain Tumor;24;M;Patient is experiencing motor dysfunction and difficulty concentrating over the last few weeks. The symptoms are described as debilitating in nature.;close monitoring
brain_tumor_0717;Brain Tumor;74;F;Patient is experiencing nausea and speech problems over the last few weeks. The symptoms are described as intense in nature.;chemotherapy
brain_tumor_0718;Brain Tumor;68;M;Patient is experiencing recurring seizures and speech problems for the past 4 months. The symptoms are described as significant in nature.;close monitoring
brain_tumor_0719;Brain Tumor;48;M;Patient is experiencing recurring seizures and speech problems over the last few weeks. The symptoms are described as noticeable in nature.;radiation therapy
brain_tumor_0720;Brain Tumor;24;F;Patient is experiencing speech problems and difficulty concentrating over the last few weeks. The symptoms are described as debilitating in nature.;close monitoring
brain_tumor_0721;Brain Tumor;77;F;Patient is experiencing blackouts and nausea for the past 4 months. The symptoms are described as noticeable in nature.;close monitoring
brain_tumor_0722;Brain Tumor;37;M;Patient is experiencing nausea and balance issues since early this year. The symptoms are described as debilitating in nature.;surgery
brain_tumor_0723;Brain Tumor;60;F;Patient is experiencing difficulty concentrating and balance issues over the last few weeks. The symptoms are described as debilitating in nature.;radiation therapy
brain_tumor_0724;Brain Tumor;56;M;Patient is experiencing blackouts and balance issues since early this year. The symptoms are described as noticeable in nature.;surgery
brain_tumor_0725;Brain Tumor;74;M;Patient is experiencing blackouts and nausea since early this year. The symptoms are described as noticeable in nature.;radiation therapy
brain_tumor_0726;Brain Tumor;71;F;Patient is experiencing nausea and balance issues since early this year. The symptoms are described as intense in nature.;close monitoring
brain_tumor_0727;Brain Tumor;47;F;Patient is experiencing recurring seizures and speech problems since early this year. The symptoms are described as high-grade in nature.;close monitoring
brain_tumor_0728;Brain Tumor;39;F;Patient is experiencing nausea and recurring seizures over the last few weeks. The symptoms are described as debilitating in nature.;radiation therapy
brain_tumor_0729;Brain Tumor;57;M;Patient is experiencing balance issues and blackouts for the past 4 months. The symptoms are described as significant in nature.;close monitoring
brain_tumor_0730;Brain Tumor;41;F;Patient is experiencing speech problems and nausea for the past 4 months. The symptoms are described as moderate in nature.;radiation therapy
brain_tumor_0731;Brain Tumor;25;F;Patient is experiencing balance issues and speech problems over the last few weeks. The symptoms are described as moderate in nature.;surgery
brain_tumor_0732;Brain Tumor;36;F;Patient is experiencing recurring seizures and speech problems since early this year. The symptoms are described as severe in nature.;chemotherapy
brain_tumor_0733;Brain Tumor;41;F;Patient is experiencing nausea and motor dysfunction since early this year. The symptoms are described as high-grade in nature.;radiation therapy
brain_tumor_0734;Brain Tumor;55;M;Patient is experiencing nausea and motor dysfunction for the past 4 months. The symptoms are described as moderate in nature.;chemotherapy
brain_tumor_0735;Brain Tumor;39;F;Patient is experiencing speech problems and difficulty concentrating since early this year. The symptoms are described as noticeable in nature.;surgery
brain_tumor_0736;Brain Tumor;79;F;Patient is experiencing blackouts and recurring seizures since early this year. The symptoms are described as intense in nature.;surgery
brain_tumor_0737;Brain Tumor;37;M;Patient is experiencing motor dysfunction and balance issues since early this year. The symptoms are described as debilitating in nature.;surgery
brain_tumor_0738;Brain Tumor;79;M;Patient is experiencing motor dysfunction and nausea for the past 4 months. The symptoms are described as significant in nature.;surgery
brain_tumor_0739;Brain Tumor;34;M;Patient is experiencing motor dysfunction and blackouts for the past 4 months. The symptoms are described as moderate in nature.;chemotherapy
brain_tumor_0740;Brain Tumor;44;M;Patient is experiencing recurring seizures and balance issues for the past 4 months. The symptoms are described as severe in nature.;surgery
brain_tumor_0741;Brain Tumor;63;M;Patient is experiencing speech problems and balance issues over the last few weeks. The symptoms are described as moderate in nature.;close monitoring
brain_tumor_0742;Brain Tumor;76;M;Patient is experiencing blackouts and nausea for the past 4 months. The symptoms are described as severe in nature.;radiation therapy
brain_tumor_0743;Brain Tumor;70;M;Patient is experiencing motor dysfunction and balance issues since early this year. The symptoms are described as intense in nature.;close monitoring
brain_tumor_0744;Brain Tumor;82;M;Patient is experiencing balance issues and nausea for the past 4 months. The symptoms are described as high-grade in nature.;radiation therapy
brain_tumor_0745;Brain Tumor;36;F;Patient is experiencing difficulty concentrating and motor dysfunction over the last few weeks. The symptoms are described as high-grade in nature.;close monitoring
brain_tumor_0746;Brain Tumor;47;M;Patient is experiencing nausea and recurring seizures since early this year. The symptoms are described as noticeable in nature.;close monitoring
brain_tumor_0747;Brain Tumor;68;M;Patient is experiencing speech problems and blackouts over the last few weeks. The symptoms are described as significant in nature.;radiation therapy
brain_tumor_0748;Brain Tumor;58;M;Patient is experiencing difficulty concentrating and blackouts since early this year. The symptoms are described as significant in nature.;surgery
brain_tumor_0749;Brain Tumor;38;M;Patient is experiencing motor dysfunction and balance issues since early this year. The symptoms are described as moderate in nature.;chemotherapy
brain_tumor_0750;Brain Tumor;19;M;Patient is experiencing difficulty concentrating and recurring seizures for the past 4 months. The symptoms are described as severe in nature.;chemotherapy
brain_tumor_0751;Brain Tumor;34;M;Patient is experiencing motor dysfunction and speech problems since early this year. The symptoms are described as noticeable in nature.;radiation therapy
brain_tumor_0752;Brain Tumor;30;F;Patient is experiencing blackouts and motor dysfunction since early this year. The symptoms are described as severe in nature.;surgery
brain_tumor_0753;Brain Tumor;19;F;Patient is experiencing blackouts and nausea since early this year. The symptoms are described as moderate in nature.;surgery
brain_tumor_0754;Brain Tumor;63;F;Patient is experiencing nausea and difficulty concentrating for the past 4 months. The symptoms are described as intense in nature.;radiation therapy
brain_tumor_0755;Brain Tumor;56;M;Patient is experiencing blackouts and difficulty concentrating since early this year. The symptoms are described as debilitating in nature.;radiation therapy
brain_tumor_0756;Brain Tumor;32;M;Patient is experiencing motor dysfunction and recurring seizures since early this year. The symptoms are described as noticeable in nature.;chemotherapy
brain_tumor_0757;Brain Tumor;77;F;Patient is experiencing speech problems and balance issues over the last few weeks. The symptoms are described as intense in nature.;close monitoring
brain_tumor_0758;Brain Tumor;24;F;Patient is experiencing nausea and balance issues since early this year. The symptoms are described as severe in nature.;chemotherapy
brain_tumor_0759;Brain Tumor;48;F;Patient is experiencing blackouts and difficulty concentrating over the last few weeks. The symptoms are described as high-grade in nature.;radiation therapy
brain_tumor_0760;Brain Tumor;43;F;Patient is experiencing speech problems and motor dysfunction since early this year. The symptoms are described as significant in nature.;chemotherapy
brain_tumor_0761;Brain Tumor;28;F;Patient is experiencing motor dysfunction and difficulty concentrating for the past 4 months. The symptoms are described as high-grade in nature.;surgery
brain_tumor_0762;Brain Tumor;65;F;Patient is experiencing nausea and motor dysfunction since early this year. The symptoms are described as moderate in nature.;chemotherapy
brain_tumor_0763;Brain Tumor;59;F;Patient is experiencing difficulty concentrating and recurring seizures for the past 4 months. The symptoms are described as high-grade in nature.;chemotherapy
brain_tumor_0764;Brain Tumor;80;M;Patient is experiencing motor dysfunction and balance issues for the past 4 months. The symptoms are described as high-grade in nature.;close monitoring
brain_tumor_0765;Brain Tumor;31;F;Patient is experiencing blackouts and nausea since early this year. The symptoms are described as moderate in nature.;surgery
brain_tumor_0766;Brain Tumor;81;M;Patient is experiencing recurring seizures and difficulty concentrating over the last few weeks. The symptoms are described as intense in nature.;surgery
brain_tumor_0767;Brain Tumor;19;F;Patient is experiencing speech problems and blackouts over the last few weeks. The symptoms are described as high-grade in nature.;chemotherapy
brain_tumor_0768;Brain Tumor;76;F;Patient is experiencing difficulty concentrating and nausea since early this year. The symptoms are described as high-grade in nature.;surgery
brain_tumor_0769;Brain Tumor;40;M;Patient is experiencing balance issues and speech problems since early this year. The symptoms are described as noticeable in nature.;radiation therapy
brain_tumor_0770;Brain Tumor;37;F;Patient is experiencing motor dysfunction and balance issues since early this year. The symptoms are described as noticeable in nature.;chemotherapy
brain_tumor_0771;Brain Tumor;46;M;Patient is experiencing speech problems and blackouts for the past 4 months. The symptoms are described as noticeable in nature.;close monitoring
brain_tumor_0772;Brain Tumor;72;M;Patient is experiencing balance issues and blackouts for the past 4 months. The symptoms are described as moderate in nature.;chemotherapy
brain_tumor_0773;Brain Tumor;52;M;Patient is experiencing blackouts and speech problems for the past 4 months. The symptoms are described as noticeable in nature.;chemotherapy
brain_tumor_0774;Brain Tumor;18;M;Patient is experiencing motor dysfunction and balance issues for the past 4 months. The symptoms are described as moderate in nature.;close monitoring
brain_tumor_0775;Brain Tumor;72;M;Patient is experiencing difficulty concentrating and balance issues since early this year. The symptoms are described as intense in nature.;close monitoring
brain_tumor_0776;Brain Tumor;59;M;Patient is experiencing difficulty concentrating and recurring seizures for the past 4 months. The symptoms are described as significant in nature.;surgery
brain_tumor_0777;Brain Tumor;52;F;Patient is experiencing speech problems and difficulty concentrating since early this year. The symptoms are described as significant in nature.;close monitoring
brain_tumor_0778;Brain Tumor;36;F;Patient is experiencing nausea and balance issues since early this year. The symptoms are described as intense in nature.;surgery
brain_tumor_0779;Brain Tumor;39;F;Patient is experiencing difficulty concentrating and recurring seizures since early this year. The symptoms are described as debilitating in nature.;chemotherapy
brain_tumor_0780;Brain Tumor;36;M;Patient is experiencing difficulty concentrating and nausea over the last few weeks. The symptoms are described as intense in nature.;surgery
brain_tumor_0781;Brain Tumor;56;M;Patient is experiencing motor dysfunction and difficulty concentrating since early this year. The symptoms are described as significant in nature.;chemotherapy
brain_tumor_0782;Brain Tumor;25;M;Patient is experiencing difficulty concentrating and speech problems since early this year. The symptoms are described as noticeable in nature.;radiation therapy
brain_tumor_0783;Brain Tumor;38;F;Patient is experiencing recurring seizures and motor dysfunction for the past 4 months. The symptoms are described as noticeable in nature.;surgery
brain_tumor_0784;Brain Tumor;51;M;Patient is experiencing blackouts and balance issues over the last few weeks. The symptoms are described as moderate in nature.;close monitoring
brain_tumor_0785;Brain Tumor;24;M;Patient is experiencing speech problems and nausea for the past 4 months. The symptoms are described as debilitating in nature.;surgery
brain_tumor_0786;Brain Tumor;22;F;Patient is experiencing blackouts and speech problems for the past 4 months. The symptoms are described as significant in nature.;radiation therapy
brain_tumor_0787;Brain Tumor;19;F;Patient is experiencing recurring seizures and difficulty concentrating since early this year. The symptoms are described as significant in nature.;close monitoring
brain_tumor_0788;Brain Tumor;52;M;Patient is experiencing blackouts and difficulty concentrating since early this year. The symptoms are described as moderate in nature.;close monitoring
brain_tumor_0789;Brain Tumor;51;M;Patient is experiencing balance issues and blackouts since early this year. The symptoms are described as debilitating in nature.;close monitoring
brain_tumor_0790;Brain Tumor;59;M;Patient is experiencing nausea and difficulty concentrating for the past 4 months. The symptoms are described as noticeable in nature.;radiation therapy
brain_tumor_0791;Brain Tumor;51;F;Patient is experiencing motor dysfunction and recurring seizures for the past 4 months. The symptoms are described as debilitating in nature.;close monitoring
brain_tumor_0792;Brain Tumor;59;M;Patient is experiencing recurring seizures and speech problems since early this year. The symptoms are described as moderate in nature.;surgery
brain_tumor_0793;Brain Tumor;57;F;Patient is experiencing nausea and speech problems over the last few weeks. The symptoms are described as severe in nature.;radiation therapy
brain_tumor_0794;Brain Tumor;82;M;Patient is experiencing difficulty concentrating and speech problems over the last few weeks. The symptoms are described as debilitating in nature.;chemotherapy
brain_tumor_0795;Brain Tumor;68;F;Patient is experiencing speech problems and blackouts since early this year. The symptoms are described as intense in nature.;radiation therapy
brain_tumor_0796;Brain Tumor;36;M;Patient is experiencing speech problems and blackouts since early this year. The symptoms are described as debilitating in nature.;close monitoring
brain_tumor_0797;Brain Tumor;70;M;Patient is experiencing recurring seizures and difficulty concentrating over the last few weeks. The symptoms are described as significant in nature.;chemotherapy
brain_tumor_0798;Brain Tumor;54;F;Patient is experiencing motor dysfunction and speech problems over the last few weeks. The symptoms are described as severe in nature.;surgery
brain_tumor_0799;Brain Tumor;70;F;Patient is experiencing speech problems and recurring seizures for the past 4 months. The symptoms are described as intense in nature.;radiation therapy
brain_tumor_0800;Brain Tumor;78;M;Patient is experiencing balance issues and difficulty concentrating for the past 4 months. The symptoms are described as significant in nature.;surgery
brain_tumor_0801;Brain Tumor;82;F;Patient is experiencing balance issues and blackouts for the past 4 months. The symptoms are described as moderate in nature.;radiation therapy
brain_tumor_0802;Brain Tumor;80;F;Patient is experiencing motor dysfunction and speech problems for the past 4 months. The symptoms are described as debilitating in nature.;surgery
brain_tumor_0803;Brain Tumor;63;M;Patient is experiencing difficulty concentrating and speech problems since early this year. The symptoms are described as high-grade in nature.;radiation therapy
brain_tumor_0804;Brain Tumor;32;M;Patient is experiencing recurring seizures and nausea since early this year. The symptoms are described as moderate in nature.;radiation therapy
brain_tumor_0805;Brain Tumor;79;F;Patient is experiencing recurring seizures and difficulty concentrating for the past 4 months. The symptoms are described as significant in nature.;surgery
brain_tumor_0806;Brain Tumor;67;F;Patient is experiencing speech problems and recurring seizures over the last few weeks. The symptoms are described as intense in nature.;chemotherapy
brain_tumor_0807;Brain Tumor;78;F;Patient is experiencing difficulty concentrating and speech problems for the past 4 months. The symptoms are described as noticeable in nature.;close monitoring
brain_tumor_0808;Brain Tumor;65;M;Patient is experiencing motor dysfunction and balance issues over the last few weeks. The symptoms are described as high-grade in nature.;chemotherapy
brain_tumor_0809;Brain Tumor;84;M;Patient is experiencing motor dysfunction and difficulty concentrating over the last few weeks. The symptoms are described as high-grade in nature.;chemotherapy
brain_tumor_0810;Brain Tumor;60;M;Patient is experiencing speech problems and motor dysfunction since early this year. The symptoms are described as high-grade in nature.;close monitoring
brain_tumor_0811;Brain Tumor;81;F;Patient is experiencing nausea and recurring seizures since early this year. The symptoms are described as moderate in nature.;chemotherapy
brain_tumor_0812;Brain Tumor;29;M;Patient is experiencing recurring seizures and motor dysfunction over the last few weeks. The symptoms are described as moderate in nature.;surgery
brain_tumor_0813;Brain Tumor;62;M;Patient is experiencing recurring seizures and nausea over the last few weeks. The symptoms are described as intense in nature.;surgery
brain_tumor_0814;Brain Tumor;60;F;Patient is experiencing nausea and speech problems over the last few weeks. The symptoms are described as intense in nature.;close monitoring
brain_tumor_0815;Brain Tumor;75;M;Patient is experiencing blackouts and recurring seizures since early this year. The symptoms are described as intense in nature.;radiation therapy
brain_tumor_0816;Brain Tumor;65;M;Patient is experiencing motor dysfunction and blackouts over the last few weeks. The symptoms are described as debilitating in nature.;close monitoring
brain_tumor_0817;Brain Tumor;70;M;Patient is experiencing recurring seizures and motor dysfunction since early this year. The symptoms are described as high-grade in nature.;close monitoring
brain_tumor_0818;Brain Tumor;74;M;Patient is experiencing motor dysfunction and balance issues since early this year. The symptoms are described as intense in nature.;close monitoring
brain_tumor_0819;Brain Tumor;85;M;Patient is experiencing nausea and motor dysfunction since early this year. The symptoms are described as intense in nature.;close monitoring
brain_tumor_0820;Brain Tumor;20;F;Patient is experiencing difficulty concentrating and balance issues since early this year. The symptoms are described as moderate in nature.;chemotherapy
brain_tumor_0821;Brain Tumor;71;F;Patient is experiencing blackouts and nausea over the last few weeks. The symptoms are described as intense in nature.;radiation therapy
brain_tumor_0822;Brain Tumor;63;M;Patient is experiencing recurring seizures and speech problems over the last few weeks. The symptoms are described as noticeable in nature.;chemotherapy
brain_tumor_0823;Brain Tumor;59;M;Patient is experiencing blackouts and speech problems over the last few weeks. The symptoms are described as noticeable in nature.;surgery
brain_tumor_0824;Brain Tumor;83;F;Patient is experiencing balance issues and nausea over the last few weeks. The symptoms are described as significant in nature.;surgery
brain_tumor_0825;Brain Tumor;81;F;Patient is experiencing difficulty concentrating and nausea since early this year. The symptoms are described as intense in nature.;chemotherapy
brain_tumor_0826;Brain Tumor;28;M;Patient is experiencing motor dysfunction and balance issues since early this year. The symptoms are described as significant in nature.;surgery
brain_tumor_0827;Brain Tumor;36;M;Patient is experiencing blackouts and difficulty concentrating over the last few weeks. The symptoms are described as noticeable in nature.;chemotherapy
brain_tumor_0828;Brain Tumor;72;F;Patient is experiencing blackouts and difficulty concentrating over the last few weeks. The symptoms are described as moderate in nature.;radiation therapy
brain_tumor_0829;Brain Tumor;64;M;Patient is experiencing difficulty concentrating and balance issues since early this year. The symptoms are described as severe in nature.;surgery
brain_tumor_0830;Brain Tumor;29;F;Patient is experiencing speech problems and motor dysfunction for the past 4 months. The symptoms are described as intense in nature.;surgery
brain_tumor_0831;Brain Tumor;80;F;Patient is experiencing nausea and balance issues since early this year. The symptoms are described as severe in nature.;chemotherapy
brain_tumor_0832;Brain Tumor;69;M;Patient is experiencing speech problems and motor dysfunction for the past 4 months. The symptoms are described as high-grade in nature.;radiation therapy
brain_tumor_0833;Brain Tumor;80;F;Patient is experiencing difficulty concentrating and speech problems since early this year. The symptoms are described as significant in nature.;close monitoring
brain_tumor_0834;Brain Tumor;47;F;Patient is experiencing speech problems and recurring seizures over the last few weeks. The symptoms are described as high-grade in nature.;chemotherapy
brain_tumor_0835;Brain Tumor;82;F;Patient is experiencing nausea and blackouts over the last few weeks. The symptoms are described as moderate in nature.;radiation therapy
brain_tumor_0836;Brain Tumor;73;F;Patient is experiencing difficulty concentrating and recurring seizures for the past 4 months. The symptoms are described as high-grade in nature.;surgery
brain_tumor_0837;Brain Tumor;46;F;Patient is experiencing speech problems and recurring seizures since early this year. The symptoms are described as moderate in nature.;chemotherapy
brain_tumor_0838;Brain Tumor;78;F;Patient is experiencing recurring seizures and speech problems since early this year. The symptoms are described as noticeable in nature.;chemotherapy
brain_tumor_0839;Brain Tumor;28;F;Patient is experiencing speech problems and balance issues for the past 4 months. The symptoms are described as severe in nature.;surgery
brain_tumor_0840;Brain Tumor;61;M;Patient is experiencing motor dysfunction and recurring seizures for the past 4 months. The symptoms are described as moderate in nature.;surgery
brain_tumor_0841;Brain Tumor;74;M;Patient is experiencing speech problems and balance issues for the past 4 months. The symptoms are described as significant in nature.;chemotherapy
brain_tumor_0842;Brain Tumor;75;F;Patient is experiencing motor dysfunction and nausea for the past 4 months. The symptoms are described as noticeable in nature.;radiation therapy
brain_tumor_0843;Brain Tumor;42;F;Patient is experiencing recurring seizures and motor dysfunction for the past 4 months. The symptoms are described as noticeable in nature.;radiation therapy
brain_tumor_0844;Brain Tumor;85;F;Patient is experiencing difficulty concentrating and recurring seizures over the last few weeks. The symptoms are described as debilitating in nature.;close monitoring
brain_tumor_0845;Brain Tumor;62;M;Patient is experiencing balance issues and speech problems over the last few weeks. The symptoms are described as high-grade in nature.;radiation therapy
brain_tumor_0846;Brain Tumor;73;M;Patient is experiencing motor dysfunction and nausea over the last few weeks. The symptoms are described as severe in nature.;surgery
brain_tumor_0847;Brain Tumor;43;M;Patient is experiencing recurring seizures and balance issues over the last few weeks. The symptoms are described as intense in nature.;surgery
brain_tumor_0848;Brain Tumor;68;F;Patient is experiencing nausea and speech problems for the past 4 months. The symptoms are described as high-grade in nature.;surgery
brain_tumor_0849;Brain Tumor;57;M;Patient is experiencing speech problems and recurring seizures over the last few weeks. The symptoms are described as noticeable in nature.;radiation therapy
brain_tumor_0850;Brain Tumor;71;F;Patient is experiencing nausea and difficulty concentrating for the past 4 months. The symptoms are described as moderate in nature.;radiation therapy
brain_tumor_0851;Brain Tumor;20;M;Patient is experiencing balance issues and speech problems for the past 4 months. The symptoms are described as high-grade in nature.;radiation therapy
brain_tumor_0852;Brain Tumor;57;F;Patient is experiencing difficulty concentrating and recurring seizures over the last few weeks. The symptoms are described as high-grade in nature.;close monitoring
brain_tumor_0853;Brain Tumor;36;M;Patient is experiencing nausea and speech problems for the past 4 months. The symptoms are described as intense in nature.;close monitoring
brain_tumor_0854;Brain Tumor;72;M;Patient is experiencing speech problems and blackouts for the past 4 months. The symptoms are described as high-grade in nature.;chemotherapy
brain_tumor_0855;Brain Tumor;41;F;Patient is experiencing blackouts and nausea since early this year. The symptoms are described as debilitating in nature.;chemotherapy
brain_tumor_0856;Brain Tumor;34;F;Patient is experiencing blackouts and motor dysfunction since early this year. The symptoms are described as intense in nature.;surgery
brain_tumor_0857;Brain Tumor;33;M;Patient is experiencing nausea and motor dysfunction over the last few weeks. The symptoms are described as debilitating in nature.;close monitoring
brain_tumor_0858;Brain Tumor;22;F;Patient is experiencing motor dysfunction and recurring seizures over the last few weeks. The symptoms are described as significant in nature.;surgery
brain_tumor_0859;Brain Tumor;21;F;Patient is experiencing recurring seizures and balance issues since early this year. The symptoms are described as high-grade in nature.;chemotherapy
brain_tumor_0860;Brain Tumor;67;M;Patient is experiencing speech problems and balance issues for the past 4 months. The symptoms are described as high-grade in nature.;surgery
brain_tumor_0861;Brain Tumor;78;M;Patient is experiencing balance issues and difficulty concentrating over the last few weeks. The symptoms are described as severe in nature.;surgery
brain_tumor_0862;Brain Tumor;80;F;Patient is experiencing blackouts and speech problems over the last few weeks. The symptoms are described as severe in nature.;radiation therapy
brain_tumor_0863;Brain Tumor;67;M;Patient is experiencing speech problems and recurring seizures for the past 4 months. The symptoms are described as intense in nature.;close monitoring
brain_tumor_0864;Brain Tumor;67;F;Patient is experiencing balance issues and speech problems over the last few weeks. The symptoms are described as significant in nature.;close monitoring
brain_tumor_0865;Brain Tumor;59;M;Patient is experiencing nausea and difficulty concentrating over the last few weeks. The symptoms are described as intense in nature.;chemotherapy
brain_tumor_0866;Brain Tumor;63;F;Patient is experiencing blackouts and nausea since early this year. The symptoms are described as severe in nature.;chemotherapy
brain_tumor_0867;Brain Tumor;68;F;Patient is experiencing balance issues and blackouts over the last few weeks. The symptoms are described as noticeable in nature.;radiation therapy
brain_tumor_0868;Brain Tumor;64;M;Patient is experiencing motor dysfunction and balance issues since early this year. The symptoms are described as severe in nature.;chemotherapy
brain_tumor_0869;Brain Tumor;61;M;Patient is experiencing blackouts and balance issues since early this year. The symptoms are described as noticeable in nature.;chemotherapy
brain_tumor_0870;Brain Tumor;31;M;Patient is experiencing balance issues and speech problems over the last few weeks. The symptoms are described as significant in nature.;close monitoring
brain_tumor_0871;Brain Tumor;23;M;Patient is experiencing nausea and blackouts for the past 4 months. The symptoms are described as moderate in nature.;close monitoring
brain_tumor_0872;Brain Tumor;20;M;Patient is experiencing recurring seizures and speech problems for the past 4 months. The symptoms are described as debilitating in nature.;close monitoring
brain_tumor_0873;Brain Tumor;29;F;Patient is experiencing difficulty concentrating and nausea for the past 4 months. The symptoms are described as severe in nature.;close monitoring
brain_tumor_0874;Brain Tumor;56;F;Patient is experiencing motor dysfunction and speech problems for the past 4 months. The symptoms are described as high-grade in nature.;radiation therapy
brain_tumor_0875;Brain Tumor;72;M;Patient is experiencing recurring seizures and balance issues since early this year. The symptoms are described as noticeable in nature.;radiation therapy
brain_tumor_0876;Brain Tumor;70;M;Patient is experiencing difficulty concentrating and balance issues over the last few weeks. The symptoms are described as high-grade in nature.;surgery
brain_tumor_0877;Brain Tumor;34;F;Patient is experiencing nausea and difficulty concentrating over the last few weeks. The symptoms are described as debilitating in nature.;surgery
brain_tumor_0878;Brain Tumor;80;F;Patient is experiencing nausea and blackouts over the last few weeks. The symptoms are described as severe in nature.;close monitoring
brain_tumor_0879;Brain Tumor;31;F;Patient is experiencing blackouts and difficulty concentrating over the last few weeks. The symptoms are described as moderate in nature.;chemotherapy
brain_tumor_0880;Brain Tumor;34;M;Patient is experiencing recurring seizures and difficulty concentrating for the past 4 months. The symptoms are described as severe in nature.;chemotherapy
brain_tumor_0881;Brain Tumor;25;M;Patient is experiencing motor dysfunction and difficulty concentrating over the last few weeks. The symptoms are described as intense in nature.;radiation therapy
brain_tumor_0882;Brain Tumor;62;F;Patient is experiencing blackouts and recurring seizures since early this year. The symptoms are described as intense in nature.;surgery
brain_tumor_0883;Brain Tumor;64;F;Patient is experiencing blackouts and motor dysfunction over the last few weeks. The symptoms are described as severe in nature.;chemotherapy
brain_tumor_0884;Brain Tumor;82;F;Patient is experiencing recurring seizures and speech problems over the last few weeks. The symptoms are described as intense in nature.;chemotherapy
brain_tumor_0885;Brain Tumor;61;M;Patient is experiencing speech problems and blackouts over the last few weeks. The symptoms are described as moderate in nature.;chemotherapy
brain_tumor_0886;Brain Tumor;38;M;Patient is experiencing difficulty concentrating and blackouts over the last few weeks. The symptoms are described as significant in nature.;close monitoring
brain_tumor_0887;Brain Tumor;47;M;Patient is experiencing motor dysfunction and difficulty concentrating for the past 4 months. The symptoms are described as high-grade in nature.;chemotherapy
brain_tumor_0888;Brain Tumor;41;F;Patient is experiencing nausea and difficulty concentrating over the last few weeks. The symptoms are described as high-grade in nature.;close monitoring
brain_tumor_0889;Brain Tumor;67;M;Patient is experiencing motor dysfunction and nausea for the past 4 months. The symptoms are described as debilitating in nature.;chemotherapy
brain_tumor_0890;Brain Tumor;77;F;Patient is experiencing motor dysfunction and blackouts for the past 4 months. The symptoms are described as debilitating in nature.;chemotherapy
brain_tumor_0891;Brain Tumor;79;M;Patient is experiencing balance issues and nausea for the past 4 months. The symptoms are described as severe in nature.;close monitoring
brain_tumor_0892;Brain Tumor;47;F;Patient is experiencing balance issues and recurring seizures over the last few weeks. The symptoms are described as significant in nature.;chemotherapy
brain_tumor_0893;Brain Tumor;33;F;Patient is experiencing recurring seizures and balance issues over the last few weeks. The symptoms are described as significant in nature.;surgery
brain_tumor_0894;Brain Tumor;83;F;Patient is experiencing balance issues and recurring seizures for the past 4 months. The symptoms are described as severe in nature.;surgery
brain_tumor_0895;Brain Tumor;51;M;Patient is experiencing balance issues and nausea for the past 4 months. The symptoms are described as noticeable in nature.;close monitoring
brain_tumor_0896;Brain Tumor;21;M;Patient is experiencing difficulty concentrating and nausea for the past 4 months. The symptoms are described as moderate in nature.;chemotherapy
brain_tumor_0897;Brain Tumor;74;M;Patient is experiencing balance issues and blackouts since early this year. The symptoms are described as significant in nature.;chemotherapy
brain_tumor_0898;Brain Tumor;63;F;Patient is experiencing nausea and balance issues over the last few weeks. The symptoms are described as noticeable in nature.;radiation therapy
brain_tumor_0899;Brain Tumor;68;M;Patient is experiencing difficulty concentrating and balance issues since early this year. The symptoms are described as noticeable in nature.;surgery
brain_tumor_0900;Brain Tumor;49;F;Patient is experiencing motor dysfunction and balance issues since early this year. The symptoms are described as high-grade in nature.;radiation therapy
brain_tumor_0901;Brain Tumor;62;M;Patient is experiencing blackouts and balance issues for the past 4 months. The symptoms are described as noticeable in nature.;close monitoring
brain_tumor_0902;Brain Tumor;46;F;Patient is experiencing difficulty concentrating and recurring seizures over the last few weeks. The symptoms are described as noticeable in nature.;surgery
brain_tumor_0903;Brain Tumor;79;M;Patient is experiencing difficulty concentrating and balance issues over the last few weeks. The symptoms are described as intense in nature.;chemotherapy
brain_tumor_0904;Brain Tumor;39;F;Patient is experiencing nausea and balance issues over the last few weeks. The symptoms are described as moderate in nature.;radiation therapy
brain_tumor_0905;Brain Tumor;59;M;Patient is experiencing balance issues and motor dysfunction for the past 4 months. The symptoms are described as high-grade in nature.;close monitoring
brain_tumor_0906;Brain Tumor;85;F;Patient is experiencing balance issues and nausea over the last few weeks. The symptoms are described as debilitating in nature.;radiation therapy
brain_tumor_0907;Brain Tumor;78;M;Patient is experiencing speech problems and balance issues for the past 4 months. The symptoms are described as high-grade in nature.;close monitoring
brain_tumor_0908;Brain Tumor;27;F;Patient is experiencing difficulty concentrating and motor dysfunction over the last few weeks. The symptoms are described as significant in nature.;radiation therapy
brain_tumor_0909;Brain Tumor;67;M;Patient is experiencing difficulty concentrating and recurring seizures since early this year. The symptoms are described as debilitating in nature.;radiation therapy
brain_tumor_0910;Brain Tumor;42;F;Patient is experiencing motor dysfunction and nausea for the past 4 months. The symptoms are described as significant in nature.;close monitoring
brain_tumor_0911;Brain Tumor;43;M;Patient is experiencing balance issues and nausea over the last few weeks. The symptoms are described as debilitating in nature.;chemotherapy
brain_tumor_0912;Brain Tumor;27;F;Patient is experiencing nausea and motor dysfunction since early this year. The symptoms are described as moderate in nature.;surgery
brain_tumor_0913;Brain Tumor;81;F;Patient is experiencing difficulty concentrating and recurring seizures since early this year. The symptoms are described as noticeable in nature.;close monitoring
brain_tumor_0914;Brain Tumor;18;M;Patient is experiencing difficulty concentrating and balance issues for the past 4 months. The symptoms are described as high-grade in nature.;radiation therapy
brain_tumor_0915;Brain Tumor;54;M;Patient is experiencing recurring seizures and motor dysfunction since early this year. The symptoms are described as high-grade in nature.;close monitoring
brain_tumor_0916;Brain Tumor;25;F;Patient is experiencing balance issues and speech problems over the last few weeks. The symptoms are described as severe in nature.;close monitoring
brain_tumor_0917;Brain Tumor;78;M;Patient is experiencing speech problems and motor dysfunction since early this year. The symptoms are described as noticeable in nature.;close monitoring
brain_tumor_0918;Brain Tumor;67;F;Patient is experiencing speech problems and motor dysfunction since early this year. The symptoms are described as moderate in nature.;surgery
brain_tumor_0919;Brain Tumor;31;M;Patient is experiencing recurring seizures and nausea over the last few weeks. The symptoms are described as high-grade in nature.;surgery
brain_tumor_0920;Brain Tumor;63;F;Patient is experiencing motor dysfunction and speech problems over the last few weeks. The symptoms are described as noticeable in nature.;surgery
brain_tumor_0921;Brain Tumor;36;F;Patient is experiencing nausea and blackouts for the past 4 months. The symptoms are described as significant in nature.;radiation therapy
brain_tumor_0922;Brain Tumor;55;F;Patient is experiencing difficulty concentrating and balance issues since early this year. The symptoms are described as debilitating in nature.;chemotherapy
brain_tumor_0923;Brain Tumor;24;M;Patient is experiencing speech problems and difficulty concentrating over the last few weeks. The symptoms are described as severe in nature.;radiation therapy
brain_tumor_0924;Brain Tumor;66;M;Patient is experiencing blackouts and difficulty concentrating for the past 4 months. The symptoms are described as severe in nature.;close monitoring
brain_tumor_0925;Brain Tumor;72;M;Patient is experiencing difficulty concentrating and motor dysfunction since early this year. The symptoms are described as high-grade in nature.;surgery
brain_tumor_0926;Brain Tumor;52;M;Patient is experiencing blackouts and recurring seizures since early this year. The symptoms are described as intense in nature.;surgery
brain_tumor_0927;Brain Tumor;35;M;Patient is experiencing speech problems and motor dysfunction for the past 4 months. The symptoms are described as moderate in nature.;radiation therapy
brain_tumor_0928;Brain Tumor;33;M;Patient is experiencing motor dysfunction and balance issues since early this year. The symptoms are described as debilitating in nature.;radiation therapy
brain_tumor_0929;Brain Tumor;63;F;Patient is experiencing nausea and recurring seizures over the last few weeks. The symptoms are described as debilitating in nature.;close monitoring
brain_tumor_0930;Brain Tumor;35;F;Patient is experiencing difficulty concentrating and balance issues for the past 4 months. The symptoms are described as significant in nature.;radiation therapy
brain_tumor_0931;Brain Tumor;55;M;Patient is experiencing blackouts and difficulty concentrating over the last few weeks. The symptoms are described as high-grade in nature.;close monitoring
brain_tumor_0932;Brain Tumor;28;F;Patient is experiencing speech problems and recurring seizures over the last few weeks. The symptoms are described as noticeable in nature.;close monitoring
brain_tumor_0933;Brain Tumor;62;F;Patient is experiencing recurring seizures and difficulty concentrating over the last few weeks. The symptoms are described as debilitating in nature.;radiation therapy
brain_tumor_0934;Brain Tumor;57;F;Patient is experiencing nausea and motor dysfunction since early this year. The symptoms are described as noticeable in nature.;surgery
brain_tumor_0935;Brain Tumor;67;F;Patient is experiencing speech problems and blackouts for the past 4 months. The symptoms are described as intense in nature.;surgery
brain_tumor_0936;Brain Tumor;63;M;Patient is experiencing nausea and speech problems for the past 4 months. The symptoms are described as significant in nature.;surgery
brain_tumor_0937;Brain Tumor;38;M;Patient is experiencing nausea and difficulty concentrating over the last few weeks. The symptoms are described as severe in nature.;chemotherapy
brain_tumor_0938;Brain Tumor;50;F;Patient is experiencing recurring seizures and motor dysfunction for the past 4 months. The symptoms are described as high-grade in nature.;surgery
brain_tumor_0939;Brain Tumor;58;M;Patient is experiencing blackouts and nausea over the last few weeks. The symptoms are described as debilitating in nature.;chemotherapy
brain_tumor_0940;Brain Tumor;64;M;Patient is experiencing difficulty concentrating and nausea since early this year. The symptoms are described as moderate in nature.;close monitoring
brain_tumor_0941;Brain Tumor;63;F;Patient is experiencing nausea and difficulty concentrating over the last few weeks. The symptoms are described as significant in nature.;chemotherapy
brain_tumor_0942;Brain Tumor;82;F;Patient is experiencing speech problems and nausea for the past 4 months. The symptoms are described as noticeable in nature.;chemotherapy
brain_tumor_0943;Brain Tumor;46;F;Patient is experiencing speech problems and motor dysfunction over the last few weeks. The symptoms are described as significant in nature.;surgery
brain_tumor_0944;Brain Tumor;39;M;Patient is experiencing nausea and balance issues over the last few weeks. The symptoms are described as significant in nature.;surgery
brain_tumor_0945;Brain Tumor;64;M;Patient is experiencing blackouts and nausea for the past 4 months. The symptoms are described as noticeable in nature.;close monitoring
brain_tumor_0946;Brain Tumor;25;M;Patient is experiencing nausea and recurring seizures since early this year. The symptoms are described as moderate in nature.;close monitoring
brain_tumor_0947;Brain Tumor;43;M;Patient is experiencing motor dysfunction and nausea since early this year. The symptoms are described as moderate in nature.;radiation therapy
brain_tumor_0948;Brain Tumor;55;F;Patient is experiencing blackouts and recurring seizures since early this year. The symptoms are described as noticeable in nature.;radiation therapy
brain_tumor_0949;Brain Tumor;82;F;Patient is experiencing nausea and speech problems for the past 4 months. The symptoms are described as moderate in nature.;surgery
brain_tumor_0950;Brain Tumor;71;M;Patient is experiencing motor dysfunction and balance issues over the last few weeks. The symptoms are described as noticeable in nature.;surgery
brain_tumor_0951;Brain Tumor;84;M;Patient is experiencing recurring seizures and motor dysfunction since early this year. The symptoms are described as severe in nature.;surgery
brain_tumor_0952;Brain Tumor;18;F;Patient is experiencing speech problems and balance issues for the past 4 months. The symptoms are described as moderate in nature.;surgery
brain_tumor_0953;Brain Tumor;45;F;Patient is experiencing motor dysfunction and blackouts over the last few weeks. The symptoms are described as intense in nature.;close monitoring
brain_tumor_0954;Brain Tumor;61;M;Patient is experiencing blackouts and nausea over the last few weeks. The symptoms are described as moderate in nature.;radiation therapy
brain_tumor_0955;Brain Tumor;30;F;Patient is experiencing balance issues and recurring seizures over the last few weeks. The symptoms are described as significant in nature.;chemotherapy
brain_tumor_0956;Brain Tumor;36;M;Patient is experiencing speech problems and difficulty concentrating over the last few weeks. The symptoms are described as intense in nature.;chemotherapy
brain_tumor_0957;Brain Tumor;62;F;Patient is experiencing nausea and recurring seizures over the last few weeks. The symptoms are described as significant in nature.;surgery
brain_tumor_0958;Brain Tumor;67;F;Patient is experiencing recurring seizures and blackouts over the last few weeks. The symptoms are described as high-grade in nature.;surgery
brain_tumor_0959;Brain Tumor;48;F;Patient is experiencing blackouts and balance issues for the past 4 months. The symptoms are described as significant in nature.;close monitoring
brain_tumor_0960;Brain Tumor;76;M;Patient is experiencing recurring seizures and difficulty concentrating since early this year. The symptoms are described as intense in nature.;radiation therapy
brain_tumor_0961;Brain Tumor;21;F;Patient is experiencing blackouts and motor dysfunction since early this year. The symptoms are described as moderate in nature.;chemotherapy
brain_tumor_0962;Brain Tumor;54;F;Patient is experiencing difficulty concentrating and speech problems for the past 4 months. The symptoms are described as noticeable in nature.;radiation therapy
brain_tumor_0963;Brain Tumor;67;M;Patient is experiencing nausea and recurring seizures over the last few weeks. The symptoms are described as intense in nature.;radiation therapy
brain_tumor_0964;Brain Tumor;60;F;Patient is experiencing balance issues and speech problems since early this year. The symptoms are described as high-grade in nature.;close monitoring
brain_tumor_0965;Brain Tumor;46;F;Patient is experiencing blackouts and motor dysfunction for the past 4 months. The symptoms are described as significant in nature.;close monitoring
brain_tumor_0966;Brain Tumor;78;M;Patient is experiencing blackouts and difficulty concentrating since early this year. The symptoms are described as noticeable in nature.;close monitoring
brain_tumor_0967;Brain Tumor;18;M;Patient is experiencing blackouts and balance issues for the past 4 months. The symptoms are described as significant in nature.;chemotherapy
brain_tumor_0968;Brain Tumor;73;F;Patient is experiencing difficulty concentrating and motor dysfunction since early this year. The symptoms are described as intense in nature.;radiation therapy
brain_tumor_0969;Brain Tumor;82;F;Patient is experiencing balance issues and recurring seizures over the last few weeks. The symptoms are described as significant in nature.;close monitoring
brain_tumor_0970;Brain Tumor;80;M;Patient is experiencing speech problems and nausea since early this year. The symptoms are described as moderate in nature.;surgery
brain_tumor_0971;Brain Tumor;38;M;Patient is experiencing motor dysfunction and speech problems over the last few weeks. The symptoms are described as moderate in nature.;close monitoring
brain_tumor_0972;Brain Tumor;77;M;Patient is experiencing motor dysfunction and speech problems over the last few weeks. The symptoms are described as severe in nature.;chemotherapy
brain_tumor_0973;Brain Tumor;73;M;Patient is experiencing motor dysfunction and speech problems for the past 4 months. The symptoms are described as debilitating in nature.;radiation therapy
brain_tumor_0974;Brain Tumor;48;F;Patient is experiencing difficulty concentrating and balance issues for the past 4 months. The symptoms are described as severe in nature.;close monitoring
brain_tumor_0975;Brain Tumor;59;F;Patient is experiencing difficulty concentrating and speech problems over the last few weeks. The symptoms are described as significant in nature.;surgery
brain_tumor_0976;Brain Tumor;81;M;Patient is experiencing nausea and difficulty concentrating over the last few weeks. The symptoms are described as significant in nature.;radiation therapy
brain_tumor_0977;Brain Tumor;37;M;Patient is experiencing blackouts and recurring seizures over the last few weeks. The symptoms are described as intense in nature.;surgery
brain_tumor_0978;Brain Tumor;72;F;Patient is experiencing blackouts and recurring seizures since early this year. The symptoms are described as severe in nature.;chemotherapy
brain_tumor_0979;Brain Tumor;50;M;Patient is experiencing balance issues and difficulty concentrating since early this year. The symptoms are described as moderate in nature.;surgery
brain_tumor_0980;Brain Tumor;18;F;Patient is experiencing difficulty concentrating and balance issues for the past 4 months. The symptoms are described as significant in nature.;close monitoring
brain_tumor_0981;Brain Tumor;24;F;Patient is experiencing blackouts and nausea over the last few weeks. The symptoms are described as severe in nature.;chemotherapy
brain_tumor_0982;Brain Tumor;70;M;Patient is experiencing balance issues and blackouts since early this year. The symptoms are described as debilitating in nature.;close monitoring
brain_tumor_0983;Brain Tumor;70;M;Patient is experiencing recurring seizures and difficulty concentrating over the last few weeks. The symptoms are described as noticeable in nature.;chemotherapy
brain_tumor_0984;Brain Tumor;63;M;Patient is experiencing speech problems and nausea over the last few weeks. The symptoms are described as high-grade in nature.;close monitoring
brain_tumor_0985;Brain Tumor;56;F;Patient is experiencing balance issues and nausea for the past 4 months. The symptoms are described as moderate in nature.;radiation therapy
brain_tumor_0986;Brain Tumor;66;M;Patient is experiencing speech problems and blackouts for the past 4 months. The symptoms are described as debilitating in nature.;close monitoring
brain_tumor_0987;Brain Tumor;53;M;Patient is experiencing speech problems and difficulty concentrating for the past 4 months. The symptoms are described as severe in nature.;radiation therapy
brain_tumor_0988;Brain Tumor;44;F;Patient is experiencing motor dysfunction and difficulty concentrating over the last few weeks. The symptoms are described as intense in nature.;chemotherapy
brain_tumor_0989;Brain Tumor;26;M;Patient is experiencing recurring seizures and motor dysfunction over the last few weeks. The symptoms are described as debilitating in nature.;surgery
brain_tumor_0990;Brain Tumor;72;F;Patient is experiencing blackouts and recurring seizures for the past 4 months. The symptoms are described as noticeable in nature.;surgery
brain_tumor_0991;Brain Tumor;26;F;Patient is experiencing balance issues and motor dysfunction over the last few weeks. The symptoms are described as intense in nature.;close monitoring
brain_tumor_0992;Brain Tumor;29;F;Patient is experiencing blackouts and balance issues since early this year. The symptoms are described as high-grade in nature.;radiation therapy
brain_tumor_0993;Brain Tumor;50;F;Patient is experiencing difficulty concentrating and speech problems for the past 4 months. The symptoms are described as severe in nature.;chemotherapy
brain_tumor_0994;Brain Tumor;67;M;Patient is experiencing blackouts and nausea for the past 4 months. The symptoms are described as noticeable in nature.;close monitoring
brain_tumor_0995;Brain Tumor;42;F;Patient is experiencing motor dysfunction and nausea over the last few weeks. The symptoms are described as high-grade in nature.;close monitoring
brain_tumor_0996;Brain Tumor;28;M;Patient is experiencing speech problems and difficulty concentrating since early this year. The symptoms are described as moderate in nature.;chemotherapy
brain_tumor_0997;Brain Tumor;39;M;Patient is experiencing blackouts and balance issues since early this year. The symptoms are described as noticeable in nature.;surgery
brain_tumor_0998;Brain Tumor;75;F;Patient is experiencing blackouts and recurring seizures over the last few weeks. The symptoms are described as noticeable in nature.;surgery
brain_tumor_0999;Brain Tumor;18;F;Patient is experiencing balance issues and difficulty concentrating since early this year. The symptoms are described as noticeable in nature.;radiation therapy
brain_tumor_1000;Brain Tumor;64;F;Patient is experiencing speech problems and motor dysfunction since early this year. The symptoms are described as significant in nature.;close monitoring
brain_tumor_1001;Brain Tumor;56;M;Patient is experiencing blackouts and motor dysfunction over the last few weeks. The symptoms are described as noticeable in nature.;close monitoring
brain_tumor_1002;Brain Tumor;46;M;Patient is experiencing blackouts and speech problems since early this year. The symptoms are described as noticeable in nature.;surgery
brain_tumor_1003;Brain Tumor;36;F;Patient is experiencing speech problems and difficulty concentrating since early this year. The symptoms are described as significant in nature.;close monitoring
brain_tumor_1004;Brain Tumor;77;F;Patient is experiencing speech problems and blackouts since early this year. The symptoms are described as severe in nature.;radiation therapy
brain_tumor_1005;Brain Tumor;84;M;Patient is experiencing motor dysfunction and nausea since early this year. The symptoms are described as high-grade in nature.;radiation therapy
brain_tumor_1006;Brain Tumor;83;F;Patient is experiencing nausea and motor dysfunction since early this year. The symptoms are described as significant in nature.;surgery
brain_tumor_1007;Brain Tumor;46;M;Patient is experiencing recurring seizures and nausea for the past 4 months. The symptoms are described as severe in nature.;chemotherapy
brain_tumor_1008;Brain Tumor;59;F;Patient is experiencing speech problems and balance issues over the last few weeks. The symptoms are described as significant in nature.;close monitoring
brain_tumor_1009;Brain Tumor;75;F;Patient is experiencing speech problems and difficulty concentrating for the past 4 months. The symptoms are described as intense in nature.;surgery
brain_tumor_1010;Brain Tumor;44;F;Patient is experiencing difficulty concentrating and blackouts over the last few weeks. The symptoms are described as noticeable in nature.;surgery
brain_tumor_1011;Brain Tumor;72;M;Patient is experiencing motor dysfunction and difficulty concentrating over the last few weeks. The symptoms are described as significant in nature.;surgery
brain_tumor_1012;Brain Tumor;32;F;Patient is experiencing motor dysfunction and balance issues for the past 4 months. The symptoms are described as severe in nature.;chemotherapy
brain_tumor_1013;Brain Tumor;54;F;Patient is experiencing nausea and balance issues for the past 4 months. The symptoms are described as noticeable in nature.;radiation therapy
brain_tumor_1014;Brain Tumor;24;M;Patient is experiencing recurring seizures and difficulty concentrating for the past 4 months. The symptoms are described as noticeable in nature.;radiation therapy
brain_tumor_1015;Brain Tumor;74;M;Patient is experiencing nausea and blackouts over the last few weeks. The symptoms are described as high-grade in nature.;surgery
brain_tumor_1016;Brain Tumor;50;F;Patient is experiencing blackouts and nausea for the past 4 months. The symptoms are described as noticeable in nature.;radiation therapy
brain_tumor_1017;Brain Tumor;38;M;Patient is experiencing recurring seizures and nausea for the past 4 months. The symptoms are described as debilitating in nature.;surgery
brain_tumor_1018;Brain Tumor;71;M;Patient is experiencing recurring seizures and speech problems for the past 4 months. The symptoms are described as noticeable in nature.;chemotherapy
brain_tumor_1019;Brain Tumor;62;M;Patient is experiencing blackouts and motor dysfunction for the past 4 months. The symptoms are described as noticeable in nature.;radiation therapy
brain_tumor_1020;Brain Tumor;35;F;Patient is experiencing nausea and blackouts since early this year. The symptoms are described as severe in nature.;chemotherapy
brain_tumor_1021;Brain Tumor;44;F;Patient is experiencing blackouts and balance issues since early this year. The symptoms are described as severe in nature.;radiation therapy
brain_tumor_1022;Brain Tumor;22;F;Patient is experiencing nausea and balance issues for the past 4 months. The symptoms are described as intense in nature.;chemotherapy
brain_tumor_1023;Brain Tumor;77;M;Patient is experiencing balance issues and speech problems over the last few weeks. The symptoms are described as moderate in nature.;radiation therapy
brain_tumor_1024;Brain Tumor;58;M;Patient is experiencing difficulty concentrating and blackouts for the past 4 months. The symptoms are described as significant in nature.;chemotherapy
brain_tumor_1025;Brain Tumor;72;F;Patient is experiencing difficulty concentrating and nausea for the past 4 months. The symptoms are described as significant in nature.;close monitoring
brain_tumor_1026;Brain Tumor;59;F;Patient is experiencing balance issues and motor dysfunction since early this year. The symptoms are described as moderate in nature.;radiation therapy
brain_tumor_1027;Brain Tumor;34;F;Patient is experiencing blackouts and balance issues for the past 4 months. The symptoms are described as intense in nature.;close monitoring
brain_tumor_1028;Brain Tumor;81;F;Patient is experiencing difficulty concentrating and motor dysfunction since early this year. The symptoms are described as intense in nature.;close monitoring
brain_tumor_1029;Brain Tumor;56;M;Patient is experiencing blackouts and recurring seizures since early this year. The symptoms are described as intense in nature.;chemotherapy
brain_tumor_1030;Brain Tumor;18;M;Patient is experiencing nausea and balance issues for the past 4 months. The symptoms are described as significant in nature.;radiation therapy
brain_tumor_1031;Brain Tumor;44;M;Patient is experiencing speech problems and motor dysfunction since early this year. The symptoms are described as significant in nature.;close monitoring
brain_tumor_1032;Brain Tumor;50;M;Patient is experiencing nausea and motor dysfunction for the past 4 months. The symptoms are described as high-grade in nature.;surgery
brain_tumor_1033;Brain Tumor;68;F;Patient is experiencing balance issues and nausea since early this year. The symptoms are described as moderate in nature.;close monitoring
brain_tumor_1034;Brain Tumor;28;F;Patient is experiencing speech problems and balance issues over the last few weeks. The symptoms are described as debilitating in nature.;close monitoring
brain_tumor_1035;Brain Tumor;73;F;Patient is experiencing recurring seizures and difficulty concentrating for the past 4 months. The symptoms are described as significant in nature.;chemotherapy
brain_tumor_1036;Brain Tumor;76;F;Patient is experiencing motor dysfunction and difficulty concentrating over the last few weeks. The symptoms are described as noticeable in nature.;chemotherapy
brain_tumor_1037;Brain Tumor;67;F;Patient is experiencing balance issues and blackouts since early this year. The symptoms are described as severe in nature.;surgery
brain_tumor_1038;Brain Tumor;20;F;Patient is experiencing recurring seizures and nausea for the past 4 months. The symptoms are described as moderate in nature.;radiation therapy
brain_tumor_1039;Brain Tumor;52;M;Patient is experiencing blackouts and motor dysfunction for the past 4 months. The symptoms are described as debilitating in nature.;close monitoring
brain_tumor_1040;Brain Tumor;48;F;Patient is experiencing nausea and motor dysfunction since early this year. The symptoms are described as moderate in nature.;close monitoring
brain_tumor_1041;Brain Tumor;34;F;Patient is experiencing recurring seizures and motor dysfunction for the past 4 months. The symptoms are described as noticeable in nature.;close monitoring
brain_tumor_1042;Brain Tumor;37;M;Patient is experiencing difficulty concentrating and motor dysfunction for the past 4 months. The symptoms are described as moderate in nature.;close monitoring
brain_tumor_1043;Brain Tumor;40;M;Patient is experiencing difficulty concentrating and recurring seizures over the last few weeks. The symptoms are described as intense in nature.;surgery
brain_tumor_1044;Brain Tumor;24;M;Patient is experiencing speech problems and recurring seizures for the past 4 months. The symptoms are described as significant in nature.;radiation therapy
brain_tumor_1045;Brain Tumor;54;M;Patient is experiencing speech problems and nausea for the past 4 months. The symptoms are described as debilitating in nature.;radiation therapy
brain_tumor_1046;Brain Tumor;34;F;Patient is experiencing nausea and recurring seizures since early this year. The symptoms are described as noticeable in nature.;close monitoring
brain_tumor_1047;Brain Tumor;76;F;Patient is experiencing balance issues and blackouts since early this year. The symptoms are described as moderate in nature.;close monitoring
brain_tumor_1048;Brain Tumor;19;F;Patient is experiencing nausea and speech problems over the last few weeks. The symptoms are described as severe in nature.;close monitoring
brain_tumor_1049;Brain Tumor;29;M;Patient is experiencing speech problems and recurring seizures since early this year. The symptoms are described as noticeable in nature.;close monitoring
brain_tumor_1050;Brain Tumor;59;M;Patient is experiencing blackouts and balance issues over the last few weeks. The symptoms are described as high-grade in nature.;radiation therapy
brain_tumor_1051;Brain Tumor;77;F;Patient is experiencing nausea and balance issues over the last few weeks. The symptoms are described as severe in nature.;surgery
brain_tumor_1052;Brain Tumor;28;M;Patient is experiencing recurring seizures and balance issues for the past 4 months. The symptoms are described as high-grade in nature.;radiation therapy
brain_tumor_1053;Brain Tumor;23;M;Patient is experiencing speech problems and blackouts since early this year. The symptoms are described as significant in nature.;close monitoring
brain_tumor_1054;Brain Tumor;61;M;Patient is experiencing blackouts and motor dysfunction for the past 4 months. The symptoms are described as moderate in nature.;surgery
brain_tumor_1055;Brain Tumor;31;F;Patient is experiencing nausea and motor dysfunction since early this year. The symptoms are described as moderate in nature.;close monitoring
brain_tumor_1056;Brain Tumor;32;M;Patient is experiencing difficulty concentrating and blackouts over the last few weeks. The symptoms are described as high-grade in nature.;chemotherapy
brain_tumor_1057;Brain Tumor;51;F;Patient is experiencing recurring seizures and difficulty concentrating for the past 4 months. The symptoms are described as debilitating in nature.;close monitoring
brain_tumor_1058;Brain Tumor;21;F;Patient is experiencing balance issues and difficulty concentrating for the past 4 months. The symptoms are described as significant in nature.;surgery
brain_tumor_1059;Brain Tumor;29;M;Patient is experiencing motor dysfunction and difficulty concentrating over the last few weeks. The symptoms are described as moderate in nature.;surgery
brain_tumor_1060;Brain Tumor;67;F;Patient is experiencing recurring seizures and speech problems for the past 4 months. The symptoms are described as severe in nature.;chemotherapy
brain_tumor_1061;Brain Tumor;56;M;Patient is experiencing nausea and balance issues since early this year. The symptoms are described as moderate in nature.;close monitoring
brain_tumor_1062;Brain Tumor;67;F;Patient is experiencing blackouts and difficulty concentrating for the past 4 months. The symptoms are described as significant in nature.;surgery
brain_tumor_1063;Brain Tumor;53;F;Patient is experiencing motor dysfunction and difficulty concentrating over the last few weeks. The symptoms are described as significant in nature.;surgery
brain_tumor_1064;Brain Tumor;55;F;Patient is experiencing speech problems and motor dysfunction over the last few weeks. The symptoms are described as intense in nature.;close monitoring
brain_tumor_1065;Brain Tumor;84;F;Patient is experiencing blackouts and balance issues for the past 4 months. The symptoms are described as moderate in nature.;close monitoring
brain_tumor_1066;Brain Tumor;60;M;Patient is experiencing motor dysfunction and recurring seizures over the last few weeks. The symptoms are described as moderate in nature.;radiation therapy
brain_tumor_1067;Brain Tumor;66;F;Patient is experiencing difficulty concentrating and blackouts for the past 4 months. The symptoms are described as high-grade in nature.;surgery
brain_tumor_1068;Brain Tumor;44;F;Patient is experiencing speech problems and motor dysfunction since early this year. The symptoms are described as debilitating in nature.;close monitoring
brain_tumor_1069;Brain Tumor;64;F;Patient is experiencing speech problems and motor dysfunction over the last few weeks. The symptoms are described as high-grade in nature.;radiation therapy
brain_tumor_1070;Brain Tumor;41;M;Patient is experiencing blackouts and motor dysfunction for the past 4 months. The symptoms are described as high-grade in nature.;chemotherapy
brain_tumor_1071;Brain Tumor;50;F;Patient is experiencing motor dysfunction and recurring seizures since early this year. The symptoms are described as debilitating in nature.;chemotherapy
brain_tumor_1072;Brain Tumor;77;M;Patient is experiencing balance issues and motor dysfunction over the last few weeks. The symptoms are described as noticeable in nature.;chemotherapy
brain_tumor_1073;Brain Tumor;51;F;Patient is experiencing blackouts and speech problems since early this year. The symptoms are described as significant in nature.;chemotherapy
brain_tumor_1074;Brain Tumor;70;M;Patient is experiencing motor dysfunction and difficulty concentrating for the past 4 months. The symptoms are described as moderate in nature.;surgery
brain_tumor_1075;Brain Tumor;40;F;Patient is experiencing recurring seizures and nausea since early this year. The symptoms are described as noticeable in nature.;close monitoring
brain_tumor_1076;Brain Tumor;71;M;Patient is experiencing motor dysfunction and blackouts for the past 4 months. The symptoms are described as significant in nature.;surgery
brain_tumor_1077;Brain Tumor;54;M;Patient is experiencing recurring seizures and difficulty concentrating over the last few weeks. The symptoms are described as high-grade in nature.;radiation therapy
brain_tumor_1078;Brain Tumor;81;F;Patient is experiencing difficulty concentrating and motor dysfunction since early this year. The symptoms are described as moderate in nature.;radiation therapy
brain_tumor_1079;Brain Tumor;80;M;Patient is experiencing difficulty concentrating and balance issues since early this year. The symptoms are described as intense in nature.;chemotherapy
brain_tumor_1080;Brain Tumor;18;F;Patient is experiencing speech problems and motor dysfunction since early this year. The symptoms are described as debilitating in nature.;close monitoring
brain_tumor_1081;Brain Tumor;47;F;Patient is experiencing speech problems and difficulty concentrating over the last few weeks. The symptoms are described as debilitating in nature.;chemotherapy
brain_tumor_1082;Brain Tumor;18;M;Patient is experiencing balance issues and motor dysfunction for the past 4 months. The symptoms are described as significant in nature.;radiation therapy
brain_tumor_1083;Brain Tumor;55;F;Patient is experiencing speech problems and blackouts over the last few weeks. The symptoms are described as intense in nature.;chemotherapy
brain_tumor_1084;Brain Tumor;77;M;Patient is experiencing motor dysfunction and nausea over the last few weeks. The symptoms are described as debilitating in nature.;close monitoring
brain_tumor_1085;Brain Tumor;35;F;Patient is experiencing recurring seizures and motor dysfunction for the past 4 months. The symptoms are described as debilitating in nature.;surgery
brain_tumor_1086;Brain Tumor;48;F;Patient is experiencing recurring seizures and nausea for the past 4 months. The symptoms are described as significant in nature.;surgery
brain_tumor_1087;Brain Tumor;37;F;Patient is experiencing nausea and balance issues since early this year. The symptoms are described as severe in nature.;surgery
brain_tumor_1088;Brain Tumor;45;M;Patient is experiencing motor dysfunction and difficulty concentrating since early this year. The symptoms are described as moderate in nature.;surgery
brain_tumor_1089;Brain Tumor;74;F;Patient is experiencing blackouts and speech problems over the last few weeks. The symptoms are described as debilitating in nature.;close monitoring
brain_tumor_1090;Brain Tumor;75;F;Patient is experiencing difficulty concentrating and recurring seizures for the past 4 months. The symptoms are described as high-grade in nature.;radiation therapy
brain_tumor_1091;Brain Tumor;37;F;Patient is experiencing recurring seizures and motor dysfunction over the last few weeks. The symptoms are described as debilitating in nature.;chemotherapy
brain_tumor_1092;Brain Tumor;26;F;Patient is experiencing blackouts and speech problems since early this year. The symptoms are described as severe in nature.;radiation therapy
brain_tumor_1093;Brain Tumor;62;M;Patient is experiencing nausea and motor dysfunction over the last few weeks. The symptoms are described as noticeable in nature.;surgery
brain_tumor_1094;Brain Tumor;74;M;Patient is experiencing blackouts and recurring seizures over the last few weeks. The symptoms are described as noticeable in nature.;chemotherapy
brain_tumor_1095;Brain Tumor;84;F;Patient is experiencing nausea and recurring seizures for the past 4 months. The symptoms are described as noticeable in nature.;radiation therapy
brain_tumor_1096;Brain Tumor;37;F;Patient is experiencing difficulty concentrating and speech problems over the last few weeks. The symptoms are described as moderate in nature.;surgery
brain_tumor_1097;Brain Tumor;83;F;Patient is experiencing blackouts and speech problems since early this year. The symptoms are described as severe in nature.;surgery
brain_tumor_1098;Brain Tumor;27;F;Patient is experiencing blackouts and balance issues for the past 4 months. The symptoms are described as high-grade in nature.;close monitoring
brain_tumor_1099;Brain Tumor;74;M;Patient is experiencing speech problems and blackouts over the last few weeks. The symptoms are described as debilitating in nature.;surgery
brain_tumor_1100;Brain Tumor;36;F;Patient is experiencing difficulty concentrating and nausea since early this year. The symptoms are described as moderate in nature.;radiation therapy
brain_tumor_1101;Brain Tumor;54;M;Patient is experiencing motor dysfunction and nausea for the past 4 months. The symptoms are described as intense in nature.;surgery
brain_tumor_1102;Brain Tumor;63;F;Patient is experiencing blackouts and balance issues since early this year. The symptoms are described as severe in nature.;chemotherapy
brain_tumor_1103;Brain Tumor;82;F;Patient is experiencing difficulty concentrating and recurring seizures for the past 4 months. The symptoms are described as significant in nature.;surgery
brain_tumor_1104;Brain Tumor;57;F;Patient is experiencing motor dysfunction and nausea since early this year. The symptoms are described as debilitating in nature.;radiation therapy
brain_tumor_1105;Brain Tumor;67;M;Patient is experiencing difficulty concentrating and nausea since early this year. The symptoms are described as noticeable in nature.;radiation therapy
brain_tumor_1106;Brain Tumor;64;M;Patient is experiencing balance issues and motor dysfunction since early this year. The symptoms are described as significant in nature.;chemotherapy
brain_tumor_1107;Brain Tumor;63;F;Patient is experiencing nausea and difficulty concentrating over the last few weeks. The symptoms are described as severe in nature.;close monitoring
brain_tumor_1108;Brain Tumor;58;M;Patient is experiencing difficulty concentrating and speech problems for the past 4 months. The symptoms are described as high-grade in nature.;chemotherapy
brain_tumor_1109;Brain Tumor;78;M;Patient is experiencing balance issues and recurring seizures over the last few weeks. The symptoms are described as debilitating in nature.;close monitoring
brain_tumor_1110;Brain Tumor;48;F;Patient is experiencing motor dysfunction and difficulty concentrating for the past 4 months. The symptoms are described as intense in nature.;radiation therapy
brain_tumor_1111;Brain Tumor;64;M;Patient is experiencing balance issues and speech problems for the past 4 months. The symptoms are described as high-grade in nature.;close monitoring
brain_tumor_1112;Brain Tumor;77;F;Patient is experiencing blackouts and speech problems for the past 4 months. The symptoms are described as noticeable in nature.;surgery
brain_tumor_1113;Brain Tumor;80;F;Patient is experiencing speech problems and nausea over the last few weeks. The symptoms are described as moderate in nature.;surgery
brain_tumor_1114;Brain Tumor;42;F;Patient is experiencing difficulty concentrating and speech problems since early this year. The symptoms are described as noticeable in nature.;close monitoring
brain_tumor_1115;Brain Tumor;45;F;Patient is experiencing recurring seizures and difficulty concentrating since early this year. The symptoms are described as intense in nature.;surgery
brain_tumor_1116;Brain Tumor;78;F;Patient is experiencing difficulty concentrating and recurring seizures over the last few weeks. The symptoms are described as debilitating in nature.;close monitoring
brain_tumor_1117;Brain Tumor;40;M;Patient is experiencing nausea and speech problems for the past 4 months. The symptoms are described as moderate in nature.;chemotherapy
brain_tumor_1118;Brain Tumor;56;F;Patient is experiencing difficulty concentrating and nausea since early this year. The symptoms are described as significant in nature.;chemotherapy
brain_tumor_1119;Brain Tumor;56;F;Patient is experiencing nausea and difficulty concentrating since early this year. The symptoms are described as significant in nature.;radiation therapy
brain_tumor_1120;Brain Tumor;62;F;Patient is experiencing difficulty concentrating and recurring seizures since early this year. The symptoms are described as noticeable in nature.;chemotherapy
brain_tumor_1121;Brain Tumor;79;M;Patient is experiencing nausea and blackouts since early this year. The symptoms are described as significant in nature.;radiation therapy
brain_tumor_1122;Brain Tumor;55;M;Patient is experiencing blackouts and motor dysfunction for the past 4 months. The symptoms are described as significant in nature.;surgery
brain_tumor_1123;Brain Tumor;24;F;Patient is experiencing recurring seizures and balance issues over the last few weeks. The symptoms are described as noticeable in nature.;close monitoring
brain_tumor_1124;Brain Tumor;60;M;Patient is experiencing difficulty concentrating and blackouts over the last few weeks. The symptoms are described as intense in nature.;surgery
brain_tumor_1125;Brain Tumor;40;F;Patient is experiencing difficulty concentrating and blackouts for the past 4 months. The symptoms are described as significant in nature.;radiation therapy
brain_tumor_1126;Brain Tumor;29;F;Patient is experiencing nausea and difficulty concentrating over the last few weeks. The symptoms are described as noticeable in nature.;chemotherapy
brain_tumor_1127;Brain Tumor;63;M;Patient is experiencing difficulty concentrating and balance issues since early this year. The symptoms are described as debilitating in nature.;chemotherapy
brain_tumor_1128;Brain Tumor;74;F;Patient is experiencing recurring seizures and blackouts for the past 4 months. The symptoms are described as debilitating in nature.;radiation therapy
brain_tumor_1129;Brain Tumor;80;F;Patient is experiencing blackouts and motor dysfunction since early this year. The symptoms are described as significant in nature.;surgery
brain_tumor_1130;Brain Tumor;38;F;Patient is experiencing difficulty concentrating and motor dysfunction since early this year. The symptoms are described as noticeable in nature.;close monitoring
brain_tumor_1131;Brain Tumor;73;M;Patient is experiencing blackouts and difficulty concentrating since early this year. The symptoms are described as severe in nature.;surgery
brain_tumor_1132;Brain Tumor;34;M;Patient is experiencing difficulty concentrating and recurring seizures for the past 4 months. The symptoms are described as noticeable in nature.;radiation therapy
brain_tumor_1133;Brain Tumor;81;M;Patient is experiencing balance issues and motor dysfunction over the last few weeks. The symptoms are described as intense in nature.;close monitoring
brain_tumor_1134;Brain Tumor;32;M;Patient is experiencing recurring seizures and nausea for the past 4 months. The symptoms are described as noticeable in nature.;chemotherapy
brain_tumor_1135;Brain Tumor;28;M;Patient is experiencing blackouts and nausea for the past 4 months. The symptoms are described as debilitating in nature.;chemotherapy
brain_tumor_1136;Brain Tumor;69;M;Patient is experiencing nausea and difficulty concentrating over the last few weeks. The symptoms are described as debilitating in nature.;chemotherapy
brain_tumor_1137;Brain Tumor;64;F;Patient is experiencing blackouts and balance issues for the past 4 months. The symptoms are described as noticeable in nature.;radiation therapy
brain_tumor_1138;Brain Tumor;50;F;Patient is experiencing blackouts and nausea for the past 4 months. The symptoms are described as severe in nature.;chemotherapy
brain_tumor_1139;Brain Tumor;82;F;Patient is experiencing motor dysfunction and speech problems over the last few weeks. The symptoms are described as severe in nature.;radiation therapy
brain_tumor_1140;Brain Tumor;53;F;Patient is experiencing difficulty concentrating and blackouts over the last few weeks. The symptoms are described as severe in nature.;radiation therapy
brain_tumor_1141;Brain Tumor;35;F;Patient is experiencing difficulty concentrating and recurring seizures for the past 4 months. The symptoms are described as significant in nature.;chemotherapy
brain_tumor_1142;Brain Tumor;38;M;Patient is experiencing blackouts and balance issues for the past 4 months. The symptoms are described as moderate in nature.;chemotherapy
brain_tumor_1143;Brain Tumor;72;F;Patient is experiencing balance issues and difficulty concentrating since early this year. The symptoms are described as noticeable in nature.;chemotherapy
brain_tumor_1144;Brain Tumor;23;F;Patient is experiencing difficulty concentrating and balance issues over the last few weeks. The symptoms are described as moderate in nature.;chemotherapy
brain_tumor_1145;Brain Tumor;63;F;Patient is experiencing blackouts and speech problems for the past 4 months. The symptoms are described as intense in nature.;chemotherapy
brain_tumor_1146;Brain Tumor;28;M;Patient is experiencing speech problems and balance issues for the past 4 months. The symptoms are described as debilitating in nature.;close monitoring
brain_tumor_1147;Brain Tumor;26;F;Patient is experiencing blackouts and recurring seizures since early this year. The symptoms are described as noticeable in nature.;radiation therapy
brain_tumor_1148;Brain Tumor;73;M;Patient is experiencing speech problems and balance issues over the last few weeks. The symptoms are described as debilitating in nature.;radiation therapy
brain_tumor_1149;Brain Tumor;81;F;Patient is experiencing blackouts and balance issues over the last few weeks. The symptoms are described as debilitating in nature.;close monitoring
brain_tumor_1150;Brain Tumor;34;M;Patient is experiencing blackouts and speech problems since early this year. The symptoms are described as noticeable in nature.;chemotherapy
brain_tumor_1151;Brain Tumor;54;F;Patient is experiencing motor dysfunction and blackouts for the past 4 months. The symptoms are described as intense in nature.;chemotherapy
brain_tumor_1152;Brain Tumor;31;M;Patient is experiencing recurring seizures and motor dysfunction for the past 4 months. The symptoms are described as intense in nature.;close monitoring
brain_tumor_1153;Brain Tumor;81;F;Patient is experiencing nausea and recurring seizures since early this year. The symptoms are described as debilitating in nature.;radiation therapy
brain_tumor_1154;Brain Tumor;50;F;Patient is experiencing motor dysfunction and balance issues for the past 4 months. The symptoms are described as high-grade in nature.;chemotherapy
brain_tumor_1155;Brain Tumor;23;F;Patient is experiencing recurring seizures and speech problems over the last few weeks. The symptoms are described as high-grade in nature.;surgery
brain_tumor_1156;Brain Tumor;43;F;Patient is experiencing motor dysfunction and recurring seizures since early this year. The symptoms are described as intense in nature.;chemotherapy
brain_tumor_1157;Brain Tumor;80;M;Patient is experiencing speech problems and nausea since early this year. The symptoms are described as noticeable in nature.;surgery
brain_tumor_1158;Brain Tumor;44;M;Patient is experiencing recurring seizures and motor dysfunction since early this year. The symptoms are described as significant in nature.;surgery
brain_tumor_1159;Brain Tumor;79;F;Patient is experiencing recurring seizures and motor dysfunction over the last few weeks. The symptoms are described as severe in nature.;close monitoring
brain_tumor_1160;Brain Tumor;75;M;Patient is experiencing speech problems and balance issues over the last few weeks. The symptoms are described as intense in nature.;chemotherapy
brain_tumor_1161;Brain Tumor;19;M;Patient is experiencing motor dysfunction and recurring seizures for the past 4 months. The symptoms are described as severe in nature.;close monitoring
brain_tumor_1162;Brain Tumor;68;F;Patient is experiencing speech problems and recurring seizures over the last few weeks. The symptoms are described as debilitating in nature.;close monitoring
brain_tumor_1163;Brain Tumor;18;F;Patient is experiencing recurring seizures and difficulty concentrating for the past 4 months. The symptoms are described as high-grade in nature.;surgery
brain_tumor_1164;Brain Tumor;62;F;Patient is experiencing difficulty concentrating and recurring seizures since early this year. The symptoms are described as noticeable in nature.;chemotherapy
brain_tumor_1165;Brain Tumor;37;F;Patient is experiencing recurring seizures and difficulty concentrating over the last few weeks. The symptoms are described as noticeable in nature.;chemotherapy
brain_tumor_1166;Brain Tumor;43;M;Patient is experiencing blackouts and nausea since early this year. The symptoms are described as intense in nature.;radiation therapy
brain_tumor_1167;Brain Tumor;36;F;Patient is experiencing speech problems and blackouts for the past 4 months. The symptoms are described as intense in nature.;chemotherapy
brain_tumor_1168;Brain Tumor;29;M;Patient is experiencing difficulty concentrating and recurring seizures since early this year. The symptoms are described as intense in nature.;surgery
brain_tumor_1169;Brain Tumor;80;F;Patient is experiencing nausea and speech problems since early this year. The symptoms are described as debilitating in nature.;radiation therapy
brain_tumor_1170;Brain Tumor;50;F;Patient is experiencing blackouts and speech problems for the past 4 months. The symptoms are described as noticeable in nature.;radiation therapy
brain_tumor_1171;Brain Tumor;40;F;Patient is experiencing recurring seizures and blackouts over the last few weeks. The symptoms are described as high-grade in nature.;chemotherapy
brain_tumor_1172;Brain Tumor;19;F;Patient is experiencing motor dysfunction and blackouts since early this year. The symptoms are described as intense in nature.;chemotherapy
brain_tumor_1173;Brain Tumor;37;F;Patient is experiencing motor dysfunction and speech problems over the last few weeks. The symptoms are described as moderate in nature.;radiation therapy
brain_tumor_1174;Brain Tumor;81;F;Patient is experiencing difficulty concentrating and speech problems since early this year. The symptoms are described as significant in nature.;surgery
brain_tumor_1175;Brain Tumor;38;F;Patient is experiencing blackouts and nausea since early this year. The symptoms are described as moderate in nature.;chemotherapy
brain_tumor_1176;Brain Tumor;68;F;Patient is experiencing difficulty concentrating and motor dysfunction over the last few weeks. The symptoms are described as severe in nature.;chemotherapy
brain_tumor_1177;Brain Tumor;80;M;Patient is experiencing recurring seizures and blackouts for the past 4 months. The symptoms are described as moderate in nature.;chemotherapy
brain_tumor_1178;Brain Tumor;43;F;Patient is experiencing blackouts and recurring seizures for the past 4 months. The symptoms are described as moderate in nature.;radiation therapy
brain_tumor_1179;Brain Tumor;66;F;Patient is experiencing speech problems and blackouts over the last few weeks. The symptoms are described as high-grade in nature.;radiation therapy
brain_tumor_1180;Brain Tumor;23;M;Patient is experiencing difficulty concentrating and recurring seizures for the past 4 months. The symptoms are described as significant in nature.;close monitoring
brain_tumor_1181;Brain Tumor;74;F;Patient is experiencing speech problems and balance issues since early this year. The symptoms are described as high-grade in nature.;surgery
brain_tumor_1182;Brain Tumor;40;F;Patient is experiencing difficulty concentrating and motor dysfunction since early this year. The symptoms are described as noticeable in nature.;chemotherapy
brain_tumor_1183;Brain Tumor;21;M;Patient is experiencing blackouts and balance issues over the last few weeks. The symptoms are described as significant in nature.;radiation therapy
brain_tumor_1184;Brain Tumor;41;F;Patient is experiencing blackouts and balance issues over the last few weeks. The symptoms are described as moderate in nature.;chemotherapy
brain_tumor_1185;Brain Tumor;78;F;Patient is experiencing balance issues and nausea for the past 4 months. The symptoms are described as noticeable in nature.;chemotherapy
brain_tumor_1186;Brain Tumor;80;F;Patient is experiencing motor dysfunction and nausea since early this year. The symptoms are described as high-grade in nature.;chemotherapy
brain_tumor_1187;Brain Tumor;70;F;Patient is experiencing motor dysfunction and balance issues over the last few weeks. The symptoms are described as moderate in nature.;surgery
brain_tumor_1188;Brain Tumor;39;F;Patient is experiencing nausea and blackouts since early this year. The symptoms are described as high-grade in nature.;close monitoring
brain_tumor_1189;Brain Tumor;42;M;Patient is experiencing nausea and motor dysfunction over the last few weeks. The symptoms are described as significant in nature.;chemotherapy
brain_tumor_1190;Brain Tumor;44;F;Patient is experiencing balance issues and nausea since early this year. The symptoms are described as noticeable in nature.;close monitoring
brain_tumor_1191;Brain Tumor;84;M;Patient is experiencing nausea and speech problems over the last few weeks. The symptoms are described as significant in nature.;surgery
brain_tumor_1192;Brain Tumor;46;F;Patient is experiencing nausea and blackouts since early this year. The symptoms are described as moderate in nature.;surgery
brain_tumor_1193;Brain Tumor;49;F;Patient is experiencing speech problems and blackouts since early this year. The symptoms are described as significant in nature.;chemotherapy
brain_tumor_1194;Brain Tumor;30;M;Patient is experiencing motor dysfunction and recurring seizures since early this year. The symptoms are described as significant in nature.;close monitoring
brain_tumor_1195;Brain Tumor;24;M;Patient is experiencing nausea and recurring seizures for the past 4 months. The symptoms are described as severe in nature.;chemotherapy
brain_tumor_1196;Brain Tumor;76;F;Patient is experiencing recurring seizures and difficulty concentrating over the last few weeks. The symptoms are described as intense in nature.;radiation therapy
brain_tumor_1197;Brain Tumor;21;F;Patient is experiencing recurring seizures and difficulty concentrating over the last few weeks. The symptoms are described as intense in nature.;close monitoring
brain_tumor_1198;Brain Tumor;79;F;Patient is experiencing speech problems and nausea for the past 4 months. The symptoms are described as noticeable in nature.;close monitoring
brain_tumor_1199;Brain Tumor;72;M;Patient is experiencing nausea and motor dysfunction over the last few weeks. The symptoms are described as noticeable in nature.;chemotherapy
brain_tumor_1200;Brain Tumor;70;M;Patient is experiencing nausea and blackouts for the past 4 months. The symptoms are described as moderate in nature.;radiation therapy
brain_tumor_1201;Brain Tumor;42;M;Patient is experiencing blackouts and recurring seizures for the past 4 months. The symptoms are described as high-grade in nature.;surgery
brain_tumor_1202;Brain Tumor;83;F;Patient is experiencing balance issues and difficulty concentrating for the past 4 months. The symptoms are described as debilitating in nature.;chemotherapy
brain_tumor_1203;Brain Tumor;72;M;Patient is experiencing difficulty concentrating and recurring seizures over the last few weeks. The symptoms are described as noticeable in nature.;close monitoring
brain_tumor_1204;Brain Tumor;19;F;Patient is experiencing blackouts and speech problems since early this year. The symptoms are described as debilitating in nature.;chemotherapy
brain_tumor_1205;Brain Tumor;46;M;Patient is experiencing nausea and blackouts over the last few weeks. The symptoms are described as moderate in nature.;surgery
brain_tumor_1206;Brain Tumor;19;M;Patient is experiencing nausea and motor dysfunction over the last few weeks. The symptoms are described as moderate in nature.;chemotherapy
brain_tumor_1207;Brain Tumor;18;M;Patient is experiencing balance issues and difficulty concentrating for the past 4 months. The symptoms are described as noticeable in nature.;chemotherapy
brain_tumor_1208;Brain Tumor;75;F;Patient is experiencing balance issues and speech problems since early this year. The symptoms are described as severe in nature.;close monitoring
brain_tumor_1209;Brain Tumor;62;M;Patient is experiencing recurring seizures and balance issues over the last few weeks. The symptoms are described as debilitating in nature.;close monitoring
brain_tumor_1210;Brain Tumor;51;F;Patient is experiencing blackouts and nausea over the last few weeks. The symptoms are described as moderate in nature.;chemotherapy
brain_tumor_1211;Brain Tumor;26;M;Patient is experiencing balance issues and blackouts since early this year. The symptoms are described as significant in nature.;radiation therapy
brain_tumor_1212;Brain Tumor;24;M;Patient is experiencing motor dysfunction and blackouts for the past 4 months. The symptoms are described as moderate in nature.;close monitoring
brain_tumor_1213;Brain Tumor;73;M;Patient is experiencing nausea and blackouts since early this year. The symptoms are described as noticeable in nature.;radiation therapy
brain_tumor_1214;Brain Tumor;84;M;Patient is experiencing motor dysfunction and difficulty concentrating since early this year. The symptoms are described as debilitating in nature.;chemotherapy
brain_tumor_1215;Brain Tumor;31;M;Patient is experiencing balance issues and speech problems for the past 4 months. The symptoms are described as moderate in nature.;close monitoring
brain_tumor_1216;Brain Tumor;24;F;Patient is experiencing nausea and recurring seizures since early this year. The symptoms are described as intense in nature.;surgery
brain_tumor_1217;Brain Tumor;74;F;Patient is experiencing nausea and speech problems for the past 4 months. The symptoms are described as debilitating in nature.;radiation therapy
brain_tumor_1218;Brain Tumor;21;F;Patient is experiencing balance issues and blackouts over the last few weeks. The symptoms are described as high-grade in nature.;chemotherapy
brain_tumor_1219;Brain Tumor;53;M;Patient is experiencing blackouts and motor dysfunction since early this year. The symptoms are described as moderate in nature.;surgery
brain_tumor_1220;Brain Tumor;60;F;Patient is experiencing speech problems and recurring seizures over the last few weeks. The symptoms are described as intense in nature.;surgery
brain_tumor_1221;Brain Tumor;78;M;Patient is experiencing speech problems and blackouts for the past 4 months. The symptoms are described as severe in nature.;radiation therapy
brain_tumor_1222;Brain Tumor;78;F;Patient is experiencing difficulty concentrating and balance issues over the last few weeks. The symptoms are described as severe in nature.;radiation therapy
brain_tumor_1223;Brain Tumor;33;F;Patient is experiencing motor dysfunction and difficulty concentrating for the past 4 months. The symptoms are described as high-grade in nature.;chemotherapy
brain_tumor_1224;Brain Tumor;80;M;Patient is experiencing balance issues and nausea over the last few weeks. The symptoms are described as debilitating in nature.;chemotherapy
brain_tumor_1225;Brain Tumor;73;F;Patient is experiencing recurring seizures and motor dysfunction for the past 4 months. The symptoms are described as noticeable in nature.;surgery
brain_tumor_1226;Brain Tumor;48;M;Patient is experiencing motor dysfunction and nausea since early this year. The symptoms are described as severe in nature.;radiation therapy
brain_tumor_1227;Brain Tumor;47;F;Patient is experiencing difficulty concentrating and nausea for the past 4 months. The symptoms are described as noticeable in nature.;surgery
brain_tumor_1228;Brain Tumor;65;F;Patient is experiencing nausea and difficulty concentrating since early this year. The symptoms are described as significant in nature.;surgery
brain_tumor_1229;Brain Tumor;72;M;Patient is experiencing balance issues and motor dysfunction over the last few weeks. The symptoms are described as severe in nature.;radiation therapy
brain_tumor_1230;Brain Tumor;29;F;Patient is experiencing blackouts and motor dysfunction since early this year. The symptoms are described as high-grade in nature.;radiation therapy
brain_tumor_1231;Brain Tumor;43;M;Patient is experiencing speech problems and recurring seizures since early this year. The symptoms are described as moderate in nature.;surgery
brain_tumor_1232;Brain Tumor;20;M;Patient is experiencing difficulty concentrating and balance issues for the past 4 months. The symptoms are described as severe in nature.;close monitoring
brain_tumor_1233;Brain Tumor;60;M;Patient is experiencing balance issues and blackouts for the past 4 months. The symptoms are described as high-grade in nature.;radiation therapy
brain_tumor_1234;Brain Tumor;25;M;Patient is experiencing motor dysfunction and nausea over the last few weeks. The symptoms are described as significant in nature.;radiation therapy
brain_tumor_1235;Brain Tumor;41;F;Patient is experiencing speech problems and motor dysfunction over the last few weeks. The symptoms are described as intense in nature.;chemotherapy
brain_tumor_1236;Brain Tumor;65;M;Patient is experiencing balance issues and speech problems for the past 4 months. The symptoms are described as noticeable in nature.;close monitoring
brain_tumor_1237;Brain Tumor;38;M;Patient is experiencing motor dysfunction and difficulty concentrating over the last few weeks. The symptoms are described as significant in nature.;radiation therapy
brain_tumor_1238;Brain Tumor;77;M;Patient is experiencing difficulty concentrating and balance issues over the last few weeks. The symptoms are described as high-grade in nature.;surgery
brain_tumor_1239;Brain Tumor;40;M;Patient is experiencing speech problems and motor dysfunction over the last few weeks. The symptoms are described as significant in nature.;close monitoring
brain_tumor_1240;Brain Tumor;25;F;Patient is experiencing motor dysfunction and recurring seizures over the last few weeks. The symptoms are described as noticeable in nature.;surgery
brain_tumor_1241;Brain Tumor;46;F;Patient is experiencing recurring seizures and balance issues over the last few weeks. The symptoms are described as high-grade in nature.;radiation therapy
brain_tumor_1242;Brain Tumor;28;F;Patient is experiencing recurring seizures and speech problems since early this year. The symptoms are described as noticeable in nature.;chemotherapy
brain_tumor_1243;Brain Tumor;21;F;Patient is experiencing speech problems and difficulty concentrating since early this year. The symptoms are described as noticeable in nature.;radiation therapy
brain_tumor_1244;Brain Tumor;69;F;Patient is experiencing nausea and motor dysfunction since early this year. The symptoms are described as intense in nature.;radiation therapy
brain_tumor_1245;Brain Tumor;85;M;Patient is experiencing nausea and difficulty concentrating over the last few weeks. The symptoms are described as debilitating in nature.;chemotherapy
brain_tumor_1246;Brain Tumor;68;M;Patient is experiencing recurring seizures and speech problems since early this year. The symptoms are described as moderate in nature.;close monitoring
brain_tumor_1247;Brain Tumor;29;F;Patient is experiencing balance issues and nausea since early this year. The symptoms are described as intense in nature.;radiation therapy
brain_tumor_1248;Brain Tumor;66;M;Patient is experiencing motor dysfunction and nausea over the last few weeks. The symptoms are described as noticeable in nature.;close monitoring
brain_tumor_1249;Brain Tumor;31;F;Patient is experiencing recurring seizures and nausea over the last few weeks. The symptoms are described as high-grade in nature.;chemotherapy
brain_tumor_1250;Brain Tumor;19;M;Patient is experiencing balance issues and motor dysfunction for the past 4 months. The symptoms are described as significant in nature.;surgery
brain_tumor_1251;Brain Tumor;30;F;Patient is experiencing nausea and blackouts for the past 4 months. The symptoms are described as moderate in nature.;chemotherapy
brain_tumor_1252;Brain Tumor;67;F;Patient is experiencing speech problems and motor dysfunction for the past 4 months. The symptoms are described as intense in nature.;chemotherapy
brain_tumor_1253;Brain Tumor;76;M;Patient is experiencing motor dysfunction and nausea for the past 4 months. The symptoms are described as intense in nature.;chemotherapy
brain_tumor_1254;Brain Tumor;77;M;Patient is experiencing motor dysfunction and nausea for the past 4 months. The symptoms are described as debilitating in nature.;close monitoring
brain_tumor_1255;Brain Tumor;25;M;Patient is experiencing balance issues and motor dysfunction for the past 4 months. The symptoms are described as severe in nature.;close monitoring
brain_tumor_1256;Brain Tumor;34;M;Patient is experiencing difficulty concentrating and speech problems for the past 4 months. The symptoms are described as significant in nature.;radiation therapy
brain_tumor_1257;Brain Tumor;31;F;Patient is experiencing recurring seizures and nausea since early this year. The symptoms are described as intense in nature.;radiation therapy
brain_tumor_1258;Brain Tumor;41;M;Patient is experiencing balance issues and difficulty concentrating since early this year. The symptoms are described as high-grade in nature.;radiation therapy
brain_tumor_1259;Brain Tumor;65;F;Patient is experiencing speech problems and nausea for the past 4 months. The symptoms are described as significant in nature.;chemotherapy
brain_tumor_1260;Brain Tumor;43;F;Patient is experiencing difficulty concentrating and blackouts for the past 4 months. The symptoms are described as debilitating in nature.;surgery
brain_tumor_1261;Brain Tumor;50;M;Patient is experiencing balance issues and nausea since early this year. The symptoms are described as moderate in nature.;close monitoring
brain_tumor_1262;Brain Tumor;33;M;Patient is experiencing blackouts and nausea since early this year. The symptoms are described as noticeable in nature.;surgery
brain_tumor_1263;Brain Tumor;42;F;Patient is experiencing speech problems and difficulty concentrating for the past 4 months. The symptoms are described as moderate in nature.;chemotherapy
brain_tumor_1264;Brain Tumor;23;M;Patient is experiencing balance issues and speech problems for the past 4 months. The symptoms are described as high-grade in nature.;close monitoring
brain_tumor_1265;Brain Tumor;78;M;Patient is experiencing nausea and motor dysfunction since early this year. The symptoms are described as noticeable in nature.;close monitoring
brain_tumor_1266;Brain Tumor;21;F;Patient is experiencing blackouts and speech problems for the past 4 months. The symptoms are described as high-grade in nature.;radiation therapy
brain_tumor_1267;Brain Tumor;42;M;Patient is experiencing balance issues and nausea since early this year. The symptoms are described as significant in nature.;surgery
brain_tumor_1268;Brain Tumor;70;F;Patient is experiencing difficulty concentrating and speech problems for the past 4 months. The symptoms are described as debilitating in nature.;surgery
brain_tumor_1269;Brain Tumor;63;F;Patient is experiencing speech problems and motor dysfunction since early this year. The symptoms are described as high-grade in nature.;surgery
brain_tumor_1270;Brain Tumor;36;M;Patient is experiencing blackouts and speech problems since early this year. The symptoms are described as moderate in nature.;radiation therapy
brain_tumor_1271;Brain Tumor;62;F;Patient is experiencing difficulty concentrating and recurring seizures over the last few weeks. The symptoms are described as noticeable in nature.;close monitoring
brain_tumor_1272;Brain Tumor;23;M;Patient is experiencing speech problems and difficulty concentrating for the past 4 months. The symptoms are described as moderate in nature.;close monitoring
brain_tumor_1273;Brain Tumor;44;M;Patient is experiencing nausea and motor dysfunction since early this year. The symptoms are described as moderate in nature.;radiation therapy
brain_tumor_1274;Brain Tumor;52;M;Patient is experiencing recurring seizures and motor dysfunction since early this year. The symptoms are described as severe in nature.;radiation therapy
brain_tumor_1275;Brain Tumor;50;M;Patient is experiencing recurring seizures and motor dysfunction since early this year. The symptoms are described as significant in nature.;close monitoring
brain_tumor_1276;Brain Tumor;85;F;Patient is experiencing balance issues and speech problems for the past 4 months. The symptoms are described as severe in nature.;surgery
brain_tumor_1277;Brain Tumor;65;M;Patient is experiencing blackouts and speech problems for the past 4 months. The symptoms are described as high-grade in nature.;radiation therapy
brain_tumor_1278;Brain Tumor;21;F;Patient is experiencing blackouts and nausea since early this year. The symptoms are described as significant in nature.;surgery
brain_tumor_1279;Brain Tumor;85;F;Patient is experiencing balance issues and recurring seizures for the past 4 months. The symptoms are described as debilitating in nature.;chemotherapy
brain_tumor_1280;Brain Tumor;57;M;Patient is experiencing difficulty concentrating and recurring seizures over the last few weeks. The symptoms are described as intense in nature.;radiation therapy
brain_tumor_1281;Brain Tumor;21;F;Patient is experiencing difficulty concentrating and speech problems for the past 4 months. The symptoms are described as severe in nature.;close monitoring
brain_tumor_1282;Brain Tumor;59;F;Patient is experiencing difficulty concentrating and motor dysfunction over the last few weeks. The symptoms are described as severe in nature.;close monitoring
brain_tumor_1283;Brain Tumor;43;F;Patient is experiencing recurring seizures and balance issues for the past 4 months. The symptoms are described as noticeable in nature.;chemotherapy
brain_tumor_1284;Brain Tumor;39;F;Patient is experiencing balance issues and recurring seizures since early this year. The symptoms are described as debilitating in nature.;chemotherapy
brain_tumor_1285;Brain Tumor;47;F;Patient is experiencing nausea and balance issues since early this year. The symptoms are described as severe in nature.;radiation therapy
brain_tumor_1286;Brain Tumor;70;F;Patient is experiencing speech problems and motor dysfunction over the last few weeks. The symptoms are described as moderate in nature.;chemotherapy
brain_tumor_1287;Brain Tumor;20;M;Patient is experiencing blackouts and nausea since early this year. The symptoms are described as intense in nature.;close monitoring
brain_tumor_1288;Brain Tumor;55;F;Patient is experiencing difficulty concentrating and nausea over the last few weeks. The symptoms are described as moderate in nature.;close monitoring
brain_tumor_1289;Brain Tumor;82;F;Patient is experiencing speech problems and balance issues for the past 4 months. The symptoms are described as noticeable in nature.;chemotherapy
brain_tumor_1290;Brain Tumor;59;F;Patient is experiencing balance issues and blackouts over the last few weeks. The symptoms are described as moderate in nature.;surgery
brain_tumor_1291;Brain Tumor;60;F;Patient is experiencing recurring seizures and motor dysfunction over the last few weeks. The symptoms are described as severe in nature.;chemotherapy
brain_tumor_1292;Brain Tumor;58;F;Patient is experiencing balance issues and recurring seizures over the last few weeks. The symptoms are described as severe in nature.;radiation therapy
brain_tumor_1293;Brain Tumor;81;F;Patient is experiencing blackouts and difficulty concentrating since early this year. The symptoms are described as severe in nature.;surgery
brain_tumor_1294;Brain Tumor;32;M;Patient is experiencing balance issues and motor dysfunction for the past 4 months. The symptoms are described as high-grade in nature.;radiation therapy
brain_tumor_1295;Brain Tumor;45;F;Patient is experiencing balance issues and nausea over the last few weeks. The symptoms are described as significant in nature.;chemotherapy
brain_tumor_1296;Brain Tumor;44;M;Patient is experiencing speech problems and difficulty concentrating since early this year. The symptoms are described as intense in nature.;close monitoring
brain_tumor_1297;Brain Tumor;61;M;Patient is experiencing nausea and balance issues over the last few weeks. The symptoms are described as noticeable in nature.;chemotherapy
brain_tumor_1298;Brain Tumor;50;M;Patient is experiencing recurring seizures and blackouts since early this year. The symptoms are described as noticeable in nature.;radiation therapy
brain_tumor_1299;Brain Tumor;73;F;Patient is experiencing difficulty concentrating and balance issues over the last few weeks. The symptoms are described as significant in nature.;chemotherapy
brain_tumor_1300;Brain Tumor;80;M;Patient is experiencing nausea and motor dysfunction since early this year. The symptoms are described as severe in nature.;radiation therapy
brain_tumor_1301;Brain Tumor;62;F;Patient is experiencing motor dysfunction and balance issues over the last few weeks. The symptoms are described as noticeable in nature.;close monitoring
brain_tumor_1302;Brain Tumor;41;M;Patient is experiencing nausea and speech problems for the past 4 months. The symptoms are described as moderate in nature.;surgery
brain_tumor_1303;Brain Tumor;41;M;Patient is experiencing difficulty concentrating and recurring seizures over the last few weeks. The symptoms are described as significant in nature.;surgery
brain_tumor_1304;Brain Tumor;72;F;Patient is experiencing recurring seizures and motor dysfunction since early this year. The symptoms are described as noticeable in nature.;close monitoring
brain_tumor_1305;Brain Tumor;74;F;Patient is experiencing blackouts and motor dysfunction for the past 4 months. The symptoms are described as debilitating in nature.;surgery
brain_tumor_1306;Brain Tumor;53;F;Patient is experiencing difficulty concentrating and blackouts for the past 4 months. The symptoms are described as intense in nature.;surgery
brain_tumor_1307;Brain Tumor;72;F;Patient is experiencing blackouts and speech problems over the last few weeks. The symptoms are described as high-grade in nature.;close monitoring
brain_tumor_1308;Brain Tumor;74;F;Patient is experiencing speech problems and difficulty concentrating for the past 4 months. The symptoms are described as moderate in nature.;radiation therapy
brain_tumor_1309;Brain Tumor;46;M;Patient is experiencing blackouts and balance issues for the past 4 months. The symptoms are described as significant in nature.;surgery
brain_tumor_1310;Brain Tumor;36;F;Patient is experiencing balance issues and blackouts since early this year. The symptoms are described as moderate in nature.;radiation therapy
brain_tumor_1311;Brain Tumor;59;M;Patient is experiencing blackouts and difficulty concentrating since early this year. The symptoms are described as significant in nature.;close monitoring
brain_tumor_1312;Brain Tumor;80;F;Patient is experiencing blackouts and nausea since early this year. The symptoms are described as intense in nature.;close monitoring
brain_tumor_1313;Brain Tumor;25;F;Patient is experiencing blackouts and difficulty concentrating for the past 4 months. The symptoms are described as severe in nature.;chemotherapy
brain_tumor_1314;Brain Tumor;67;M;Patient is experiencing speech problems and motor dysfunction over the last few weeks. The symptoms are described as significant in nature.;chemotherapy
brain_tumor_1315;Brain Tumor;53;M;Patient is experiencing recurring seizures and balance issues over the last few weeks. The symptoms are described as significant in nature.;chemotherapy
brain_tumor_1316;Brain Tumor;28;F;Patient is experiencing nausea and speech problems since early this year. The symptoms are described as noticeable in nature.;close monitoring
brain_tumor_1317;Brain Tumor;57;F;Patient is experiencing blackouts and speech problems for the past 4 months. The symptoms are described as severe in nature.;close monitoring
brain_tumor_1318;Brain Tumor;55;F;Patient is experiencing blackouts and difficulty concentrating over the last few weeks. The symptoms are described as significant in nature.;radiation therapy
brain_tumor_1319;Brain Tumor;81;M;Patient is experiencing recurring seizures and difficulty concentrating since early this year. The symptoms are described as noticeable in nature.;surgery
brain_tumor_1320;Brain Tumor;69;F;Patient is experiencing blackouts and difficulty concentrating over the last few weeks. The symptoms are described as moderate in nature.;chemotherapy
brain_tumor_1321;Brain Tumor;81;F;Patient is experiencing recurring seizures and blackouts since early this year. The symptoms are described as noticeable in nature.;radiation therapy
brain_tumor_1322;Brain Tumor;42;M;Patient is experiencing recurring seizures and motor dysfunction for the past 4 months. The symptoms are described as moderate in nature.;radiation therapy
brain_tumor_1323;Brain Tumor;71;F;Patient is experiencing balance issues and difficulty concentrating since early this year. The symptoms are described as significant in nature.;radiation therapy
brain_tumor_1324;Brain Tumor;74;M;Patient is experiencing blackouts and recurring seizures since early this year. The symptoms are described as significant in nature.;surgery
brain_tumor_1325;Brain Tumor;21;M;Patient is experiencing blackouts and motor dysfunction since early this year. The symptoms are described as noticeable in nature.;surgery
brain_tumor_1326;Brain Tumor;85;F;Patient is experiencing speech problems and nausea since early this year. The symptoms are described as debilitating in nature.;close monitoring
brain_tumor_1327;Brain Tumor;58;F;Patient is experiencing speech problems and recurring seizures over the last few weeks. The symptoms are described as moderate in nature.;close monitoring
brain_tumor_1328;Brain Tumor;75;F;Patient is experiencing difficulty concentrating and blackouts since early this year. The symptoms are described as noticeable in nature.;close monitoring
brain_tumor_1329;Brain Tumor;51;M;Patient is experiencing speech problems and recurring seizures for the past 4 months. The symptoms are described as severe in nature.;radiation therapy
brain_tumor_1330;Brain Tumor;63;M;Patient is experiencing speech problems and balance issues for the past 4 months. The symptoms are described as severe in nature.;close monitoring
brain_tumor_1331;Brain Tumor;79;F;Patient is experiencing balance issues and speech problems for the past 4 months. The symptoms are described as noticeable in nature.;chemotherapy
brain_tumor_1332;Brain Tumor;47;F;Patient is experiencing balance issues and recurring seizures for the past 4 months. The symptoms are described as significant in nature.;radiation therapy
brain_tumor_1333;Brain Tumor;78;M;Patient is experiencing balance issues and recurring seizures since early this year. The symptoms are described as intense in nature.;radiation therapy
brain_tumor_1334;Brain Tumor;78;M;Patient is experiencing motor dysfunction and balance issues for the past 4 months. The symptoms are described as moderate in nature.;radiation therapy
brain_tumor_1335;Brain Tumor;40;F;Patient is experiencing nausea and blackouts over the last few weeks. The symptoms are described as noticeable in nature.;radiation therapy
brain_tumor_1336;Brain Tumor;32;M;Patient is experiencing speech problems and nausea since early this year. The symptoms are described as intense in nature.;radiation therapy
brain_tumor_1337;Brain Tumor;80;F;Patient is experiencing balance issues and speech problems over the last few weeks. The symptoms are described as high-grade in nature.;close monitoring
brain_tumor_1338;Brain Tumor;31;M;Patient is experiencing speech problems and difficulty concentrating over the last few weeks. The symptoms are described as debilitating in nature.;radiation therapy
brain_tumor_1339;Brain Tumor;37;F;Patient is experiencing recurring seizures and blackouts for the past 4 months. The symptoms are described as significant in nature.;surgery
brain_tumor_1340;Brain Tumor;38;M;Patient is experiencing blackouts and speech problems for the past 4 months. The symptoms are described as high-grade in nature.;chemotherapy
brain_tumor_1341;Brain Tumor;66;F;Patient is experiencing recurring seizures and nausea since early this year. The symptoms are described as noticeable in nature.;close monitoring
brain_tumor_1342;Brain Tumor;70;M;Patient is experiencing nausea and recurring seizures since early this year. The symptoms are described as moderate in nature.;surgery
brain_tumor_1343;Brain Tumor;85;F;Patient is experiencing nausea and difficulty concentrating over the last few weeks. The symptoms are described as significant in nature.;surgery
brain_tumor_1344;Brain Tumor;73;F;Patient is experiencing balance issues and speech problems since early this year. The symptoms are described as significant in nature.;close monitoring
brain_tumor_1345;Brain Tumor;34;F;Patient is experiencing difficulty concentrating and balance issues over the last few weeks. The symptoms are described as moderate in nature.;surgery
brain_tumor_1346;Brain Tumor;59;M;Patient is experiencing nausea and speech problems for the past 4 months. The symptoms are described as debilitating in nature.;radiation therapy
brain_tumor_1347;Brain Tumor;64;M;Patient is experiencing balance issues and speech problems for the past 4 months. The symptoms are described as moderate in nature.;close monitoring
brain_tumor_1348;Brain Tumor;64;F;Patient is experiencing blackouts and balance issues since early this year. The symptoms are described as severe in nature.;chemotherapy
brain_tumor_1349;Brain Tumor;79;M;Patient is experiencing nausea and motor dysfunction for the past 4 months. The symptoms are described as noticeable in nature.;surgery
brain_tumor_1350;Brain Tumor;28;M;Patient is experiencing difficulty concentrating and balance issues over the last few weeks. The symptoms are described as debilitating in nature.;radiation therapy
brain_tumor_1351;Brain Tumor;67;M;Patient is experiencing recurring seizures and speech problems for the past 4 months. The symptoms are described as noticeable in nature.;close monitoring
brain_tumor_1352;Brain Tumor;28;F;Patient is experiencing blackouts and nausea over the last few weeks. The symptoms are described as significant in nature.;close monitoring
brain_tumor_1353;Brain Tumor;54;F;Patient is experiencing balance issues and motor dysfunction since early this year. The symptoms are described as intense in nature.;radiation therapy
brain_tumor_1354;Brain Tumor;47;F;Patient is experiencing nausea and difficulty concentrating since early this year. The symptoms are described as intense in nature.;surgery
brain_tumor_1355;Brain Tumor;84;F;Patient is experiencing speech problems and recurring seizures since early this year. The symptoms are described as significant in nature.;radiation therapy
brain_tumor_1356;Brain Tumor;40;F;Patient is experiencing blackouts and recurring seizures over the last few weeks. The symptoms are described as severe in nature.;close monitoring
brain_tumor_1357;Brain Tumor;66;M;Patient is experiencing blackouts and recurring seizures for the past 4 months. The symptoms are described as noticeable in nature.;chemotherapy
brain_tumor_1358;Brain Tumor;66;M;Patient is experiencing speech problems and recurring seizures since early this year. The symptoms are described as noticeable in nature.;radiation therapy
brain_tumor_1359;Brain Tumor;71;M;Patient is experiencing blackouts and nausea for the past 4 months. The symptoms are described as severe in nature.;chemotherapy
brain_tumor_1360;Brain Tumor;37;M;Patient is experiencing recurring seizures and motor dysfunction over the last few weeks. The symptoms are described as severe in nature.;chemotherapy
brain_tumor_1361;Brain Tumor;20;M;Patient is experiencing recurring seizures and blackouts since early this year. The symptoms are described as debilitating in nature.;surgery
brain_tumor_1362;Brain Tumor;73;F;Patient is experiencing blackouts and recurring seizures since early this year. The symptoms are described as significant in nature.;surgery
brain_tumor_1363;Brain Tumor;72;M;Patient is experiencing motor dysfunction and balance issues over the last few weeks. The symptoms are described as debilitating in nature.;close monitoring
brain_tumor_1364;Brain Tumor;63;F;Patient is experiencing speech problems and difficulty concentrating over the last few weeks. The symptoms are described as intense in nature.;surgery
brain_tumor_1365;Brain Tumor;54;M;Patient is experiencing motor dysfunction and blackouts since early this year. The symptoms are described as moderate in nature.;chemotherapy
brain_tumor_1366;Brain Tumor;66;M;Patient is experiencing difficulty concentrating and blackouts over the last few weeks. The symptoms are described as moderate in nature.;close monitoring
brain_tumor_1367;Brain Tumor;56;M;Patient is experiencing motor dysfunction and nausea since early this year. The symptoms are described as significant in nature.;close monitoring
brain_tumor_1368;Brain Tumor;75;F;Patient is experiencing speech problems and blackouts since early this year. The symptoms are described as severe in nature.;radiation therapy
brain_tumor_1369;Brain Tumor;26;F;Patient is experiencing balance issues and motor dysfunction since early this year. The symptoms are described as intense in nature.;chemotherapy
brain_tumor_1370;Brain Tumor;71;F;Patient is experiencing motor dysfunction and balance issues for the past 4 months. The symptoms are described as high-grade in nature.;surgery
brain_tumor_1371;Brain Tumor;79;M;Patient is experiencing motor dysfunction and difficulty concentrating since early this year. The symptoms are described as intense in nature.;surgery
brain_tumor_1372;Brain Tumor;77;M;Patient is experiencing recurring seizures and balance issues over the last few weeks. The symptoms are described as moderate in nature.;close monitoring
brain_tumor_1373;Brain Tumor;25;M;Patient is experiencing nausea and balance issues since early this year. The symptoms are described as moderate in nature.;surgery
brain_tumor_1374;Brain Tumor;51;M;Patient is experiencing nausea and difficulty concentrating for the past 4 months. The symptoms are described as significant in nature.;chemotherapy
brain_tumor_1375;Brain Tumor;41;F;Patient is experiencing motor dysfunction and blackouts over the last few weeks. The symptoms are described as high-grade in nature.;radiation therapy
brain_tumor_1376;Brain Tumor;29;F;Patient is experiencing motor dysfunction and balance issues over the last few weeks. The symptoms are described as intense in nature.;chemotherapy
brain_tumor_1377;Brain Tumor;75;M;Patient is experiencing motor dysfunction and speech problems for the past 4 months. The symptoms are described as noticeable in nature.;surgery
brain_tumor_1378;Brain Tumor;52;F;Patient is experiencing balance issues and difficulty concentrating for the past 4 months. The symptoms are described as severe in nature.;close monitoring
brain_tumor_1379;Brain Tumor;47;F;Patient is experiencing nausea and motor dysfunction over the last few weeks. The symptoms are described as severe in nature.;surgery
brain_tumor_1380;Brain Tumor;34;F;Patient is experiencing speech problems and nausea since early this year. The symptoms are described as intense in nature.;radiation therapy
brain_tumor_1381;Brain Tumor;69;M;Patient is experiencing speech problems and blackouts over the last few weeks. The symptoms are described as severe in nature.;surgery
brain_tumor_1382;Brain Tumor;41;M;Patient is experiencing blackouts and balance issues for the past 4 months. The symptoms are described as severe in nature.;radiation therapy
brain_tumor_1383;Brain Tumor;36;F;Patient is experiencing difficulty concentrating and speech problems over the last few weeks. The symptoms are described as high-grade in nature.;radiation therapy
brain_tumor_1384;Brain Tumor;39;F;Patient is experiencing blackouts and speech problems since early this year. The symptoms are described as noticeable in nature.;close monitoring
brain_tumor_1385;Brain Tumor;82;M;Patient is experiencing blackouts and motor dysfunction over the last few weeks. The symptoms are described as significant in nature.;chemotherapy
brain_tumor_1386;Brain Tumor;59;M;Patient is experiencing speech problems and difficulty concentrating over the last few weeks. The symptoms are described as moderate in nature.;chemotherapy
brain_tumor_1387;Brain Tumor;48;F;Patient is experiencing nausea and recurring seizures since early this year. The symptoms are described as moderate in nature.;chemotherapy
brain_tumor_1388;Brain Tumor;26;M;Patient is experiencing nausea and motor dysfunction since early this year. The symptoms are described as significant in nature.;surgery
brain_tumor_1389;Brain Tumor;49;M;Patient is experiencing recurring seizures and difficulty concentrating since early this year. The symptoms are described as intense in nature.;radiation therapy
brain_tumor_1390;Brain Tumor;67;F;Patient is experiencing speech problems and recurring seizures since early this year. The symptoms are described as noticeable in nature.;chemotherapy
brain_tumor_1391;Brain Tumor;42;M;Patient is experiencing balance issues and blackouts since early this year. The symptoms are described as severe in nature.;chemotherapy
brain_tumor_1392;Brain Tumor;74;F;Patient is experiencing motor dysfunction and blackouts since early this year. The symptoms are described as severe in nature.;close monitoring
brain_tumor_1393;Brain Tumor;42;M;Patient is experiencing motor dysfunction and recurring seizures over the last few weeks. The symptoms are described as noticeable in nature.;chemotherapy
brain_tumor_1394;Brain Tumor;48;M;Patient is experiencing balance issues and blackouts since early this year. The symptoms are described as debilitating in nature.;surgery
brain_tumor_1395;Brain Tumor;45;F;Patient is experiencing difficulty concentrating and balance issues for the past 4 months. The symptoms are described as intense in nature.;chemotherapy
brain_tumor_1396;Brain Tumor;69;F;Patient is experiencing motor dysfunction and blackouts over the last few weeks. The symptoms are described as significant in nature.;chemotherapy
brain_tumor_1397;Brain Tumor;78;M;Patient is experiencing motor dysfunction and difficulty concentrating for the past 4 months. The symptoms are described as noticeable in nature.;radiation therapy
brain_tumor_1398;Brain Tumor;36;F;Patient is experiencing recurring seizures and nausea since early this year. The symptoms are described as noticeable in nature.;chemotherapy
brain_tumor_1399;Brain Tumor;33;F;Patient is experiencing motor dysfunction and speech problems for the past 4 months. The symptoms are described as moderate in nature.;radiation therapy
brain_tumor_1400;Brain Tumor;40;F;Patient is experiencing nausea and balance issues for the past 4 months. The symptoms are described as severe in nature.;radiation therapy
brain_tumor_1401;Brain Tumor;58;M;Patient is experiencing nausea and blackouts since early this year. The symptoms are described as moderate in nature.;close monitoring
brain_tumor_1402;Brain Tumor;85;F;Patient is experiencing balance issues and blackouts for the past 4 months. The symptoms are described as moderate in nature.;close monitoring
brain_tumor_1403;Brain Tumor;47;F;Patient is experiencing difficulty concentrating and recurring seizures since early this year. The symptoms are described as severe in nature.;chemotherapy
brain_tumor_1404;Brain Tumor;39;F;Patient is experiencing recurring seizures and speech problems over the last few weeks. The symptoms are described as severe in nature.;surgery
brain_tumor_1405;Brain Tumor;59;F;Patient is experiencing recurring seizures and blackouts since early this year. The symptoms are described as moderate in nature.;surgery
brain_tumor_1406;Brain Tumor;76;F;Patient is experiencing recurring seizures and nausea for the past 4 months. The symptoms are described as moderate in nature.;radiation therapy
brain_tumor_1407;Brain Tumor;65;M;Patient is experiencing blackouts and motor dysfunction over the last few weeks. The symptoms are described as moderate in nature.;chemotherapy
brain_tumor_1408;Brain Tumor;39;F;Patient is experiencing nausea and speech problems for the past 4 months. The symptoms are described as high-grade in nature.;close monitoring
brain_tumor_1409;Brain Tumor;33;M;Patient is experiencing recurring seizures and difficulty concentrating for the past 4 months. The symptoms are described as high-grade in nature.;surgery
brain_tumor_1410;Brain Tumor;18;F;Patient is experiencing balance issues and difficulty concentrating over the last few weeks. The symptoms are described as intense in nature.;chemotherapy
brain_tumor_1411;Brain Tumor;54;M;Patient is experiencing motor dysfunction and balance issues over the last few weeks. The symptoms are described as noticeable in nature.;surgery
brain_tumor_1412;Brain Tumor;46;F;Patient is experiencing nausea and balance issues over the last few weeks. The symptoms are described as severe in nature.;radiation therapy
brain_tumor_1413;Brain Tumor;71;M;Patient is experiencing difficulty concentrating and recurring seizures since early this year. The symptoms are described as severe in nature.;surgery
brain_tumor_1414;Brain Tumor;81;M;Patient is experiencing motor dysfunction and difficulty concentrating over the last few weeks. The symptoms are described as intense in nature.;surgery
brain_tumor_1415;Brain Tumor;74;M;Patient is experiencing balance issues and motor dysfunction since early this year. The symptoms are described as severe in nature.;radiation therapy
brain_tumor_1416;Brain Tumor;80;F;Patient is experiencing speech problems and motor dysfunction over the last few weeks. The symptoms are described as significant in nature.;close monitoring
brain_tumor_1417;Brain Tumor;29;F;Patient is experiencing difficulty concentrating and blackouts over the last few weeks. The symptoms are described as debilitating in nature.;surgery
brain_tumor_1418;Brain Tumor;41;M;Patient is experiencing blackouts and balance issues for the past 4 months. The symptoms are described as high-grade in nature.;close monitoring
brain_tumor_1419;Brain Tumor;44;F;Patient is experiencing difficulty concentrating and speech problems over the last few weeks. The symptoms are described as significant in nature.;surgery
brain_tumor_1420;Brain Tumor;74;F;Patient is experiencing difficulty concentrating and balance issues over the last few weeks. The symptoms are described as intense in nature.;close monitoring
brain_tumor_1421;Brain Tumor;54;F;Patient is experiencing motor dysfunction and speech problems over the last few weeks. The symptoms are described as severe in nature.;close monitoring
brain_tumor_1422;Brain Tumor;71;M;Patient is experiencing blackouts and speech problems since early this year. The symptoms are described as significant in nature.;chemotherapy
brain_tumor_1423;Brain Tumor;32;F;Patient is experiencing speech problems and balance issues for the past 4 months. The symptoms are described as debilitating in nature.;surgery
brain_tumor_1424;Brain Tumor;74;M;Patient is experiencing difficulty concentrating and recurring seizures for the past 4 months. The symptoms are described as significant in nature.;radiation therapy
brain_tumor_1425;Brain Tumor;27;M;Patient is experiencing speech problems and difficulty concentrating for the past 4 months. The symptoms are described as moderate in nature.;surgery
brain_tumor_1426;Brain Tumor;35;F;Patient is experiencing recurring seizures and balance issues over the last few weeks. The symptoms are described as debilitating in nature.;close monitoring
brain_tumor_1427;Brain Tumor;32;M;Patient is experiencing speech problems and recurring seizures over the last few weeks. The symptoms are described as debilitating in nature.;radiation therapy
brain_tumor_1428;Brain Tumor;22;M;Patient is experiencing blackouts and balance issues for the past 4 months. The symptoms are described as noticeable in nature.;chemotherapy
brain_tumor_1429;Brain Tumor;61;F;Patient is experiencing nausea and balance issues for the past 4 months. The symptoms are described as intense in nature.;close monitoring
brain_tumor_1430;Brain Tumor;37;F;Patient is experiencing difficulty concentrating and blackouts since early this year. The symptoms are described as debilitating in nature.;chemotherapy
brain_tumor_1431;Brain Tumor;50;M;Patient is experiencing balance issues and speech problems since early this year. The symptoms are described as severe in nature.;radiation therapy
brain_tumor_1432;Brain Tumor;28;M;Patient is experiencing blackouts and speech problems since early this year. The symptoms are described as intense in nature.;close monitoring
brain_tumor_1433;Brain Tumor;25;F;Patient is experiencing balance issues and recurring seizures for the past 4 months. The symptoms are described as noticeable in nature.;close monitoring
brain_tumor_1434;Brain Tumor;39;F;Patient is experiencing recurring seizures and speech problems over the last few weeks. The symptoms are described as significant in nature.;close monitoring
brain_tumor_1435;Brain Tumor;41;F;Patient is experiencing motor dysfunction and nausea over the last few weeks. The symptoms are described as intense in nature.;close monitoring
brain_tumor_1436;Brain Tumor;76;M;Patient is experiencing speech problems and recurring seizures over the last few weeks. The symptoms are described as significant in nature.;radiation therapy
brain_tumor_1437;Brain Tumor;41;M;Patient is experiencing speech problems and recurring seizures over the last few weeks. The symptoms are described as debilitating in nature.;chemotherapy
brain_tumor_1438;Brain Tumor;85;F;Patient is experiencing nausea and balance issues over the last few weeks. The symptoms are described as intense in nature.;surgery
brain_tumor_1439;Brain Tumor;18;F;Patient is experiencing speech problems and blackouts over the last few weeks. The symptoms are described as significant in nature.;surgery
brain_tumor_1440;Brain Tumor;68;F;Patient is experiencing recurring seizures and nausea over the last few weeks. The symptoms are described as significant in nature.;radiation therapy
brain_tumor_1441;Brain Tumor;65;F;Patient is experiencing speech problems and recurring seizures over the last few weeks. The symptoms are described as moderate in nature.;close monitoring
brain_tumor_1442;Brain Tumor;36;M;Patient is experiencing difficulty concentrating and balance issues since early this year. The symptoms are described as moderate in nature.;surgery
brain_tumor_1443;Brain Tumor;33;M;Patient is experiencing balance issues and recurring seizures since early this year. The symptoms are described as intense in nature.;radiation therapy
brain_tumor_1444;Brain Tumor;69;F;Patient is experiencing motor dysfunction and nausea for the past 4 months. The symptoms are described as high-grade in nature.;close monitoring
brain_tumor_1445;Brain Tumor;31;M;Patient is experiencing blackouts and recurring seizures since early this year. The symptoms are described as debilitating in nature.;chemotherapy
brain_tumor_1446;Brain Tumor;49;M;Patient is experiencing balance issues and blackouts over the last few weeks. The symptoms are described as debilitating in nature.;radiation therapy
brain_tumor_1447;Brain Tumor;79;F;Patient is experiencing balance issues and speech problems for the past 4 months. The symptoms are described as severe in nature.;surgery
brain_tumor_1448;Brain Tumor;51;M;Patient is experiencing blackouts and nausea since early this year. The symptoms are described as high-grade in nature.;surgery
brain_tumor_1449;Brain Tumor;39;M;Patient is experiencing nausea and recurring seizures over the last few weeks. The symptoms are described as noticeable in nature.;close monitoring
brain_tumor_1450;Brain Tumor;30;M;Patient is experiencing nausea and difficulty concentrating since early this year. The symptoms are described as noticeable in nature.;radiation therapy
brain_tumor_1451;Brain Tumor;49;F;Patient is experiencing difficulty concentrating and balance issues since early this year. The symptoms are described as intense in nature.;chemotherapy
brain_tumor_1452;Brain Tumor;63;F;Patient is experiencing balance issues and nausea since early this year. The symptoms are described as severe in nature.;radiation therapy
brain_tumor_1453;Brain Tumor;85;M;Patient is experiencing motor dysfunction and speech problems over the last few weeks. The symptoms are described as noticeable in nature.;radiation therapy
brain_tumor_1454;Brain Tumor;35;F;Patient is experiencing recurring seizures and blackouts over the last few weeks. The symptoms are described as high-grade in nature.;close monitoring
brain_tumor_1455;Brain Tumor;42;M;Patient is experiencing nausea and speech problems since early this year. The symptoms are described as moderate in nature.;radiation therapy
brain_tumor_1456;Brain Tumor;79;F;Patient is experiencing blackouts and balance issues for the past 4 months. The symptoms are described as significant in nature.;radiation therapy
brain_tumor_1457;Brain Tumor;46;F;Patient is experiencing speech problems and blackouts over the last few weeks. The symptoms are described as moderate in nature.;surgery
brain_tumor_1458;Brain Tumor;18;M;Patient is experiencing speech problems and nausea since early this year. The symptoms are described as significant in nature.;radiation therapy
brain_tumor_1459;Brain Tumor;72;F;Patient is experiencing speech problems and nausea over the last few weeks. The symptoms are described as significant in nature.;chemotherapy
brain_tumor_1460;Brain Tumor;84;F;Patient is experiencing blackouts and nausea for the past 4 months. The symptoms are described as intense in nature.;chemotherapy
brain_tumor_1461;Brain Tumor;78;M;Patient is experiencing difficulty concentrating and balance issues over the last few weeks. The symptoms are described as moderate in nature.;close monitoring
brain_tumor_1462;Brain Tumor;74;F;Patient is experiencing balance issues and difficulty concentrating over the last few weeks. The symptoms are described as noticeable in nature.;surgery
brain_tumor_1463;Brain Tumor;52;F;Patient is experiencing difficulty concentrating and nausea over the last few weeks. The symptoms are described as significant in nature.;surgery
brain_tumor_1464;Brain Tumor;49;M;Patient is experiencing motor dysfunction and balance issues over the last few weeks. The symptoms are described as moderate in nature.;radiation therapy
brain_tumor_1465;Brain Tumor;77;F;Patient is experiencing blackouts and nausea since early this year. The symptoms are described as intense in nature.;chemotherapy
brain_tumor_1466;Brain Tumor;77;F;Patient is experiencing nausea and difficulty concentrating since early this year. The symptoms are described as intense in nature.;radiation therapy
brain_tumor_1467;Brain Tumor;52;M;Patient is experiencing balance issues and nausea since early this year. The symptoms are described as noticeable in nature.;close monitoring
brain_tumor_1468;Brain Tumor;39;M;Patient is experiencing balance issues and speech problems for the past 4 months. The symptoms are described as debilitating in nature.;close monitoring
brain_tumor_1469;Brain Tumor;59;M;Patient is experiencing speech problems and motor dysfunction since early this year. The symptoms are described as high-grade in nature.;close monitoring
brain_tumor_1470;Brain Tumor;56;F;Patient is experiencing balance issues and nausea since early this year. The symptoms are described as noticeable in nature.;close monitoring
brain_tumor_1471;Brain Tumor;80;M;Patient is experiencing nausea and recurring seizures since early this year. The symptoms are described as moderate in nature.;radiation therapy
brain_tumor_1472;Brain Tumor;42;M;Patient is experiencing recurring seizures and speech problems over the last few weeks. The symptoms are described as moderate in nature.;chemotherapy
brain_tumor_1473;Brain Tumor;62;F;Patient is experiencing speech problems and nausea over the last few weeks. The symptoms are described as significant in nature.;chemotherapy
brain_tumor_1474;Brain Tumor;82;M;Patient is experiencing speech problems and blackouts for the past 4 months. The symptoms are described as severe in nature.;close monitoring
brain_tumor_1475;Brain Tumor;46;M;Patient is experiencing difficulty concentrating and recurring seizures for the past 4 months. The symptoms are described as intense in nature.;surgery
brain_tumor_1476;Brain Tumor;70;M;Patient is experiencing recurring seizures and difficulty concentrating over the last few weeks. The symptoms are described as moderate in nature.;surgery
brain_tumor_1477;Brain Tumor;40;M;Patient is experiencing recurring seizures and nausea for the past 4 months. The symptoms are described as moderate in nature.;chemotherapy
brain_tumor_1478;Brain Tumor;33;M;Patient is experiencing balance issues and difficulty concentrating for the past 4 months. The symptoms are described as intense in nature.;surgery
brain_tumor_1479;Brain Tumor;49;F;Patient is experiencing recurring seizures and difficulty concentrating over the last few weeks. The symptoms are described as high-grade in nature.;close monitoring
brain_tumor_1480;Brain Tumor;83;F;Patient is experiencing difficulty concentrating and balance issues over the last few weeks. The symptoms are described as significant in nature.;radiation therapy
brain_tumor_1481;Brain Tumor;29;F;Patient is experiencing balance issues and blackouts since early this year. The symptoms are described as severe in nature.;radiation therapy
brain_tumor_1482;Brain Tumor;40;F;Patient is experiencing difficulty concentrating and speech problems over the last few weeks. The symptoms are described as noticeable in nature.;radiation therapy
brain_tumor_1483;Brain Tumor;66;M;Patient is experiencing motor dysfunction and difficulty concentrating for the past 4 months. The symptoms are described as severe in nature.;surgery
brain_tumor_1484;Brain Tumor;21;F;Patient is experiencing nausea and motor dysfunction for the past 4 months. The symptoms are described as high-grade in nature.;radiation therapy
brain_tumor_1485;Brain Tumor;73;F;Patient is experiencing difficulty concentrating and speech problems since early this year. The symptoms are described as noticeable in nature.;surgery
brain_tumor_1486;Brain Tumor;45;M;Patient is experiencing speech problems and blackouts over the last few weeks. The symptoms are described as moderate in nature.;close monitoring
brain_tumor_1487;Brain Tumor;55;F;Patient is experiencing speech problems and difficulty concentrating for the past 4 months. The symptoms are described as severe in nature.;radiation therapy
brain_tumor_1488;Brain Tumor;69;F;Patient is experiencing recurring seizures and motor dysfunction for the past 4 months. The symptoms are described as severe in nature.;close monitoring
brain_tumor_1489;Brain Tumor;51;F;Patient is experiencing nausea and motor dysfunction over the last few weeks. The symptoms are described as high-grade in nature.;radiation therapy
brain_tumor_1490;Brain Tumor;27;M;Patient is experiencing recurring seizures and speech problems for the past 4 months. The symptoms are described as debilitating in nature.;chemotherapy
brain_tumor_1491;Brain Tumor;60;M;Patient is experiencing speech problems and difficulty concentrating for the past 4 months. The symptoms are described as debilitating in nature.;close monitoring
brain_tumor_1492;Brain Tumor;84;F;Patient is experiencing nausea and difficulty concentrating since early this year. The symptoms are described as moderate in nature.;close monitoring
brain_tumor_1493;Brain Tumor;77;F;Patient is experiencing nausea and recurring seizures over the last few weeks. The symptoms are described as severe in nature.;chemotherapy
brain_tumor_1494;Brain Tumor;73;F;Patient is experiencing blackouts and balance issues since early this year. The symptoms are described as significant in nature.;chemotherapy
brain_tumor_1495;Brain Tumor;82;M;Patient is experiencing balance issues and recurring seizures over the last few weeks. The symptoms are described as debilitating in nature.;radiation therapy
brain_tumor_1496;Brain Tumor;69;M;Patient is experiencing motor dysfunction and nausea for the past 4 months. The symptoms are described as high-grade in nature.;close monitoring
brain_tumor_1497;Brain Tumor;27;F;Patient is experiencing balance issues and blackouts over the last few weeks. The symptoms are described as high-grade in nature.;surgery
brain_tumor_1498;Brain Tumor;71;M;Patient is experiencing balance issues and difficulty concentrating for the past 4 months. The symptoms are described as intense in nature.;close monitoring
brain_tumor_1499;Brain Tumor;44;F;Patient is experiencing motor dysfunction and speech problems since early this year. The symptoms are described as severe in nature.;radiation therapy
brain_tumor_1500;Brain Tumor;80;F;Patient is experiencing recurring seizures and difficulty concentrating over the last few weeks. The symptoms are described as significant in nature.;radiation therapy
brain_tumor_1501;Brain Tumor;70;F;Patient is experiencing motor dysfunction and recurring seizures since early this year. The symptoms are described as moderate in nature.;chemotherapy
brain_tumor_1502;Brain Tumor;55;F;Patient is experiencing difficulty concentrating and nausea since early this year. The symptoms are described as severe in nature.;close monitoring
brain_tumor_1503;Brain Tumor;70;F;Patient is experiencing motor dysfunction and difficulty concentrating over the last few weeks. The symptoms are described as noticeable in nature.;close monitoring
brain_tumor_1504;Brain Tumor;18;F;Patient is experiencing speech problems and recurring seizures over the last few weeks. The symptoms are described as high-grade in nature.;radiation therapy
brain_tumor_1505;Brain Tumor;32;M;Patient is experiencing motor dysfunction and balance issues for the past 4 months. The symptoms are described as significant in nature.;close monitoring
brain_tumor_1506;Brain Tumor;32;M;Patient is experiencing recurring seizures and blackouts for the past 4 months. The symptoms are described as moderate in nature.;chemotherapy
brain_tumor_1507;Brain Tumor;77;M;Patient is experiencing recurring seizures and balance issues for the past 4 months. The symptoms are described as significant in nature.;surgery
brain_tumor_1508;Brain Tumor;51;F;Patient is experiencing motor dysfunction and speech problems over the last few weeks. The symptoms are described as noticeable in nature.;close monitoring
brain_tumor_1509;Brain Tumor;51;M;Patient is experiencing recurring seizures and nausea for the past 4 months. The symptoms are described as severe in nature.;chemotherapy
brain_tumor_1510;Brain Tumor;83;F;Patient is experiencing difficulty concentrating and speech problems over the last few weeks. The symptoms are described as significant in nature.;surgery
brain_tumor_1511;Brain Tumor;85;M;Patient is experiencing blackouts and recurring seizures since early this year. The symptoms are described as high-grade in nature.;radiation therapy
brain_tumor_1512;Brain Tumor;77;F;Patient is experiencing nausea and motor dysfunction since early this year. The symptoms are described as significant in nature.;close monitoring
brain_tumor_1513;Brain Tumor;60;F;Patient is experiencing motor dysfunction and recurring seizures since early this year. The symptoms are described as moderate in nature.;close monitoring
brain_tumor_1514;Brain Tumor;67;M;Patient is experiencing difficulty concentrating and motor dysfunction since early this year. The symptoms are described as significant in nature.;surgery
brain_tumor_1515;Brain Tumor;20;F;Patient is experiencing recurring seizures and balance issues since early this year. The symptoms are described as moderate in nature.;surgery
brain_tumor_1516;Brain Tumor;27;F;Patient is experiencing speech problems and balance issues for the past 4 months. The symptoms are described as moderate in nature.;radiation therapy
brain_tumor_1517;Brain Tumor;83;M;Patient is experiencing nausea and balance issues since early this year. The symptoms are described as severe in nature.;close monitoring
brain_tumor_1518;Brain Tumor;30;F;Patient is experiencing difficulty concentrating and speech problems over the last few weeks. The symptoms are described as significant in nature.;surgery
brain_tumor_1519;Brain Tumor;74;M;Patient is experiencing balance issues and recurring seizures since early this year. The symptoms are described as intense in nature.;close monitoring
brain_tumor_1520;Brain Tumor;44;F;Patient is experiencing balance issues and speech problems for the past 4 months. The symptoms are described as debilitating in nature.;radiation therapy
brain_tumor_1521;Brain Tumor;27;M;Patient is experiencing difficulty concentrating and nausea since early this year. The symptoms are described as noticeable in nature.;chemotherapy
brain_tumor_1522;Brain Tumor;57;F;Patient is experiencing difficulty concentrating and recurring seizures over the last few weeks. The symptoms are described as moderate in nature.;surgery
brain_tumor_1523;Brain Tumor;20;F;Patient is experiencing difficulty concentrating and balance issues over the last few weeks. The symptoms are described as high-grade in nature.;radiation therapy
brain_tumor_1524;Brain Tumor;76;M;Patient is experiencing motor dysfunction and difficulty concentrating over the last few weeks. The symptoms are described as high-grade in nature.;chemotherapy
brain_tumor_1525;Brain Tumor;34;F;Patient is experiencing blackouts and recurring seizures for the past 4 months. The symptoms are described as high-grade in nature.;surgery
brain_tumor_1526;Brain Tumor;53;F;Patient is experiencing nausea and recurring seizures for the past 4 months. The symptoms are described as moderate in nature.;chemotherapy
brain_tumor_1527;Brain Tumor;38;M;Patient is experiencing motor dysfunction and balance issues over the last few weeks. The symptoms are described as noticeable in nature.;chemotherapy
brain_tumor_1528;Brain Tumor;80;F;Patient is experiencing motor dysfunction and difficulty concentrating for the past 4 months. The symptoms are described as severe in nature.;chemotherapy
brain_tumor_1529;Brain Tumor;35;F;Patient is experiencing nausea and balance issues over the last few weeks. The symptoms are described as moderate in nature.;radiation therapy
brain_tumor_1530;Brain Tumor;25;F;Patient is experiencing blackouts and balance issues since early this year. The symptoms are described as noticeable in nature.;surgery
brain_tumor_1531;Brain Tumor;23;M;Patient is experiencing blackouts and motor dysfunction for the past 4 months. The symptoms are described as noticeable in nature.;surgery
brain_tumor_1532;Brain Tumor;72;F;Patient is experiencing motor dysfunction and balance issues since early this year. The symptoms are described as severe in nature.;radiation therapy
brain_tumor_1533;Brain Tumor;84;F;Patient is experiencing balance issues and difficulty concentrating since early this year. The symptoms are described as severe in nature.;close monitoring
brain_tumor_1534;Brain Tumor;20;M;Patient is experiencing blackouts and motor dysfunction for the past 4 months. The symptoms are described as intense in nature.;close monitoring
brain_tumor_1535;Brain Tumor;65;F;Patient is experiencing difficulty concentrating and blackouts since early this year. The symptoms are described as severe in nature.;close monitoring
brain_tumor_1536;Brain Tumor;73;M;Patient is experiencing speech problems and balance issues over the last few weeks. The symptoms are described as severe in nature.;close monitoring
brain_tumor_1537;Brain Tumor;57;F;Patient is experiencing difficulty concentrating and speech problems for the past 4 months. The symptoms are described as moderate in nature.;surgery
brain_tumor_1538;Brain Tumor;75;F;Patient is experiencing speech problems and balance issues over the last few weeks. The symptoms are described as debilitating in nature.;surgery
brain_tumor_1539;Brain Tumor;51;F;Patient is experiencing recurring seizures and speech problems over the last few weeks. The symptoms are described as noticeable in nature.;radiation therapy
brain_tumor_1540;Brain Tumor;32;M;Patient is experiencing nausea and difficulty concentrating for the past 4 months. The symptoms are described as severe in nature.;close monitoring
brain_tumor_1541;Brain Tumor;48;F;Patient is experiencing speech problems and motor dysfunction since early this year. The symptoms are described as debilitating in nature.;close monitoring
brain_tumor_1542;Brain Tumor;46;F;Patient is experiencing difficulty concentrating and speech problems over the last few weeks. The symptoms are described as severe in nature.;chemotherapy
brain_tumor_1543;Brain Tumor;37;M;Patient is experiencing blackouts and difficulty concentrating since early this year. The symptoms are described as intense in nature.;radiation therapy
brain_tumor_1544;Brain Tumor;63;F;Patient is experiencing balance issues and recurring seizures for the past 4 months. The symptoms are described as noticeable in nature.;close monitoring
brain_tumor_1545;Brain Tumor;81;M;Patient is experiencing motor dysfunction and blackouts over the last few weeks. The symptoms are described as debilitating in nature.;surgery
brain_tumor_1546;Brain Tumor;62;M;Patient is experiencing motor dysfunction and difficulty concentrating over the last few weeks. The symptoms are described as high-grade in nature.;close monitoring
brain_tumor_1547;Brain Tumor;57;M;Patient is experiencing speech problems and blackouts over the last few weeks. The symptoms are described as significant in nature.;surgery
brain_tumor_1548;Brain Tumor;52;F;Patient is experiencing difficulty concentrating and speech problems over the last few weeks. The symptoms are described as moderate in nature.;close monitoring
brain_tumor_1549;Brain Tumor;61;M;Patient is experiencing balance issues and nausea since early this year. The symptoms are described as noticeable in nature.;radiation therapy
brain_tumor_1550;Brain Tumor;57;M;Patient is experiencing blackouts and nausea over the last few weeks. The symptoms are described as noticeable in nature.;close monitoring
brain_tumor_1551;Brain Tumor;80;M;Patient is experiencing nausea and motor dysfunction for the past 4 months. The symptoms are described as noticeable in nature.;radiation therapy
brain_tumor_1552;Brain Tumor;66;F;Patient is experiencing recurring seizures and speech problems for the past 4 months. The symptoms are described as high-grade in nature.;surgery
brain_tumor_1553;Brain Tumor;81;F;Patient is experiencing difficulty concentrating and blackouts for the past 4 months. The symptoms are described as intense in nature.;radiation therapy
brain_tumor_1554;Brain Tumor;46;F;Patient is experiencing recurring seizures and balance issues for the past 4 months. The symptoms are described as significant in nature.;chemotherapy
brain_tumor_1555;Brain Tumor;28;M;Patient is experiencing recurring seizures and balance issues for the past 4 months. The symptoms are described as noticeable in nature.;surgery
brain_tumor_1556;Brain Tumor;75;F;Patient is experiencing blackouts and motor dysfunction for the past 4 months. The symptoms are described as intense in nature.;radiation therapy
brain_tumor_1557;Brain Tumor;67;M;Patient is experiencing nausea and balance issues for the past 4 months. The symptoms are described as moderate in nature.;chemotherapy
brain_tumor_1558;Brain Tumor;81;M;Patient is experiencing blackouts and recurring seizures since early this year. The symptoms are described as significant in nature.;surgery
brain_tumor_1559;Brain Tumor;67;M;Patient is experiencing blackouts and recurring seizures over the last few weeks. The symptoms are described as noticeable in nature.;chemotherapy
brain_tumor_1560;Brain Tumor;54;F;Patient is experiencing blackouts and speech problems for the past 4 months. The symptoms are described as moderate in nature.;surgery
brain_tumor_1561;Brain Tumor;29;F;Patient is experiencing difficulty concentrating and recurring seizures since early this year. The symptoms are described as moderate in nature.;chemotherapy
brain_tumor_1562;Brain Tumor;76;M;Patient is experiencing blackouts and difficulty concentrating since early this year. The symptoms are described as moderate in nature.;chemotherapy
brain_tumor_1563;Brain Tumor;29;F;Patient is experiencing blackouts and nausea for the past 4 months. The symptoms are described as significant in nature.;radiation therapy
brain_tumor_1564;Brain Tumor;59;F;Patient is experiencing motor dysfunction and blackouts for the past 4 months. The symptoms are described as moderate in nature.;close monitoring
brain_tumor_1565;Brain Tumor;18;F;Patient is experiencing balance issues and blackouts since early this year. The symptoms are described as significant in nature.;chemotherapy
brain_tumor_1566;Brain Tumor;45;F;Patient is experiencing balance issues and speech problems since early this year. The symptoms are described as debilitating in nature.;radiation therapy
brain_tumor_1567;Brain Tumor;69;F;Patient is experiencing balance issues and recurring seizures since early this year. The symptoms are described as severe in nature.;chemotherapy
brain_tumor_1568;Brain Tumor;61;M;Patient is experiencing speech problems and blackouts since early this year. The symptoms are described as significant in nature.;chemotherapy
brain_tumor_1569;Brain Tumor;41;F;Patient is experiencing nausea and blackouts over the last few weeks. The symptoms are described as debilitating in nature.;close monitoring
brain_tumor_1570;Brain Tumor;20;M;Patient is experiencing speech problems and motor dysfunction for the past 4 months. The symptoms are described as moderate in nature.;surgery
brain_tumor_1571;Brain Tumor;53;F;Patient is experiencing speech problems and balance issues for the past 4 months. The symptoms are described as noticeable in nature.;surgery
brain_tumor_1572;Brain Tumor;81;M;Patient is experiencing motor dysfunction and speech problems for the past 4 months. The symptoms are described as intense in nature.;chemotherapy
brain_tumor_1573;Brain Tumor;58;M;Patient is experiencing balance issues and difficulty concentrating for the past 4 months. The symptoms are described as significant in nature.;chemotherapy
brain_tumor_1574;Brain Tumor;48;M;Patient is experiencing nausea and speech problems since early this year. The symptoms are described as moderate in nature.;chemotherapy
brain_tumor_1575;Brain Tumor;37;F;Patient is experiencing blackouts and difficulty concentrating over the last few weeks. The symptoms are described as intense in nature.;radiation therapy
brain_tumor_1576;Brain Tumor;58;M;Patient is experiencing blackouts and speech problems for the past 4 months. The symptoms are described as significant in nature.;close monitoring
brain_tumor_1577;Brain Tumor;18;M;Patient is experiencing blackouts and nausea over the last few weeks. The symptoms are described as debilitating in nature.;surgery
brain_tumor_1578;Brain Tumor;62;F;Patient is experiencing speech problems and recurring seizures over the last few weeks. The symptoms are described as high-grade in nature.;close monitoring
brain_tumor_1579;Brain Tumor;24;F;Patient is experiencing recurring seizures and speech problems over the last few weeks. The symptoms are described as intense in nature.;radiation therapy
brain_tumor_1580;Brain Tumor;57;M;Patient is experiencing speech problems and blackouts since early this year. The symptoms are described as noticeable in nature.;surgery
brain_tumor_1581;Brain Tumor;77;F;Patient is experiencing motor dysfunction and balance issues for the past 4 months. The symptoms are described as moderate in nature.;close monitoring
brain_tumor_1582;Brain Tumor;38;F;Patient is experiencing difficulty concentrating and blackouts for the past 4 months. The symptoms are described as debilitating in nature.;surgery
brain_tumor_1583;Brain Tumor;47;F;Patient is experiencing balance issues and blackouts over the last few weeks. The symptoms are described as noticeable in nature.;chemotherapy
brain_tumor_1584;Brain Tumor;45;F;Patient is experiencing difficulty concentrating and recurring seizures since early this year. The symptoms are described as intense in nature.;surgery
brain_tumor_1585;Brain Tumor;18;F;Patient is experiencing nausea and balance issues over the last few weeks. The symptoms are described as noticeable in nature.;radiation therapy
brain_tumor_1586;Brain Tumor;48;F;Patient is experiencing balance issues and nausea over the last few weeks. The symptoms are described as severe in nature.;chemotherapy
brain_tumor_1587;Brain Tumor;60;M;Patient is experiencing blackouts and difficulty concentrating for the past 4 months. The symptoms are described as noticeable in nature.;radiation therapy
brain_tumor_1588;Brain Tumor;81;F;Patient is experiencing recurring seizures and motor dysfunction since early this year. The symptoms are described as high-grade in nature.;chemotherapy
brain_tumor_1589;Brain Tumor;85;M;Patient is experiencing balance issues and blackouts for the past 4 months. The symptoms are described as intense in nature.;surgery
brain_tumor_1590;Brain Tumor;29;F;Patient is experiencing difficulty concentrating and nausea for the past 4 months. The symptoms are described as significant in nature.;surgery
brain_tumor_1591;Brain Tumor;21;F;Patient is experiencing nausea and difficulty concentrating over the last few weeks. The symptoms are described as debilitating in nature.;close monitoring
brain_tumor_1592;Brain Tumor;27;M;Patient is experiencing speech problems and motor dysfunction for the past 4 months. The symptoms are described as high-grade in nature.;surgery
brain_tumor_1593;Brain Tumor;48;F;Patient is experiencing motor dysfunction and balance issues over the last few weeks. The symptoms are described as moderate in nature.;radiation therapy
brain_tumor_1594;Brain Tumor;76;M;Patient is experiencing nausea and blackouts for the past 4 months. The symptoms are described as severe in nature.;chemotherapy
brain_tumor_1595;Brain Tumor;61;F;Patient is experiencing speech problems and difficulty concentrating over the last few weeks. The symptoms are described as noticeable in nature.;surgery
brain_tumor_1596;Brain Tumor;56;M;Patient is experiencing blackouts and balance issues over the last few weeks. The symptoms are described as high-grade in nature.;radiation therapy
brain_tumor_1597;Brain Tumor;46;F;Patient is experiencing balance issues and recurring seizures since early this year. The symptoms are described as debilitating in nature.;radiation therapy
brain_tumor_1598;Brain Tumor;23;M;Patient is experiencing recurring seizures and nausea over the last few weeks. The symptoms are described as moderate in nature.;chemotherapy
brain_tumor_1599;Brain Tumor;31;M;Patient is experiencing motor dysfunction and difficulty concentrating since early this year. The symptoms are described as high-grade in nature.;chemotherapy
brain_tumor_1600;Brain Tumor;74;M;Patient is experiencing blackouts and motor dysfunction for the past 4 months. The symptoms are described as significant in nature.;chemotherapy
brain_tumor_1601;Brain Tumor;28;M;Patient is experiencing blackouts and recurring seizures over the last few weeks. The symptoms are described as noticeable in nature.;radiation therapy
brain_tumor_1602;Brain Tumor;42;M;Patient is experiencing recurring seizures and balance issues for the past 4 months. The symptoms are described as significant in nature.;surgery
brain_tumor_1603;Brain Tumor;62;M;Patient is experiencing difficulty concentrating and balance issues over the last few weeks. The symptoms are described as intense in nature.;radiation therapy
brain_tumor_1604;Brain Tumor;72;F;Patient is experiencing difficulty concentrating and recurring seizures over the last few weeks. The symptoms are described as high-grade in nature.;chemotherapy
brain_tumor_1605;Brain Tumor;44;F;Patient is experiencing recurring seizures and speech problems over the last few weeks. The symptoms are described as moderate in nature.;close monitoring
brain_tumor_1606;Brain Tumor;28;M;Patient is experiencing recurring seizures and blackouts since early this year. The symptoms are described as noticeable in nature.;chemotherapy
brain_tumor_1607;Brain Tumor;69;M;Patient is experiencing motor dysfunction and speech problems since early this year. The symptoms are described as noticeable in nature.;close monitoring
brain_tumor_1608;Brain Tumor;60;M;Patient is experiencing balance issues and motor dysfunction over the last few weeks. The symptoms are described as moderate in nature.;chemotherapy
brain_tumor_1609;Brain Tumor;83;F;Patient is experiencing nausea and balance issues over the last few weeks. The symptoms are described as debilitating in nature.;radiation therapy
brain_tumor_1610;Brain Tumor;78;M;Patient is experiencing motor dysfunction and balance issues since early this year. The symptoms are described as severe in nature.;radiation therapy
brain_tumor_1611;Brain Tumor;28;M;Patient is experiencing balance issues and difficulty concentrating for the past 4 months. The symptoms are described as moderate in nature.;radiation therapy
brain_tumor_1612;Brain Tumor;85;M;Patient is experiencing balance issues and motor dysfunction over the last few weeks. The symptoms are described as severe in nature.;radiation therapy
brain_tumor_1613;Brain Tumor;38;M;Patient is experiencing difficulty concentrating and nausea over the last few weeks. The symptoms are described as debilitating in nature.;close monitoring
brain_tumor_1614;Brain Tumor;51;M;Patient is experiencing recurring seizures and balance issues since early this year. The symptoms are described as intense in nature.;close monitoring
brain_tumor_1615;Brain Tumor;45;F;Patient is experiencing balance issues and nausea over the last few weeks. The symptoms are described as intense in nature.;surgery
brain_tumor_1616;Brain Tumor;36;F;Patient is experiencing speech problems and difficulty concentrating since early this year. The symptoms are described as moderate in nature.;chemotherapy
brain_tumor_1617;Brain Tumor;79;F;Patient is experiencing motor dysfunction and balance issues for the past 4 months. The symptoms are described as significant in nature.;close monitoring
brain_tumor_1618;Brain Tumor;80;F;Patient is experiencing difficulty concentrating and nausea since early this year. The symptoms are described as intense in nature.;radiation therapy
brain_tumor_1619;Brain Tumor;41;F;Patient is experiencing difficulty concentrating and nausea over the last few weeks. The symptoms are described as debilitating in nature.;radiation therapy
brain_tumor_1620;Brain Tumor;72;M;Patient is experiencing motor dysfunction and speech problems for the past 4 months. The symptoms are described as severe in nature.;surgery
brain_tumor_1621;Brain Tumor;19;M;Patient is experiencing balance issues and motor dysfunction since early this year. The symptoms are described as severe in nature.;chemotherapy
brain_tumor_1622;Brain Tumor;25;F;Patient is experiencing blackouts and difficulty concentrating over the last few weeks. The symptoms are described as debilitating in nature.;surgery
brain_tumor_1623;Brain Tumor;79;F;Patient is experiencing difficulty concentrating and motor dysfunction over the last few weeks. The symptoms are described as noticeable in nature.;surgery
brain_tumor_1624;Brain Tumor;32;F;Patient is experiencing motor dysfunction and difficulty concentrating for the past 4 months. The symptoms are described as severe in nature.;close monitoring
brain_tumor_1625;Brain Tumor;63;M;Patient is experiencing nausea and balance issues since early this year. The symptoms are described as debilitating in nature.;radiation therapy
brain_tumor_1626;Brain Tumor;35;M;Patient is experiencing nausea and balance issues for the past 4 months. The symptoms are described as severe in nature.;radiation therapy
brain_tumor_1627;Brain Tumor;33;M;Patient is experiencing blackouts and balance issues for the past 4 months. The symptoms are described as significant in nature.;radiation therapy
brain_tumor_1628;Brain Tumor;69;M;Patient is experiencing speech problems and blackouts for the past 4 months. The symptoms are described as significant in nature.;chemotherapy
brain_tumor_1629;Brain Tumor;61;F;Patient is experiencing balance issues and speech problems for the past 4 months. The symptoms are described as noticeable in nature.;chemotherapy
brain_tumor_1630;Brain Tumor;56;M;Patient is experiencing recurring seizures and motor dysfunction over the last few weeks. The symptoms are described as intense in nature.;surgery
brain_tumor_1631;Brain Tumor;76;M;Patient is experiencing nausea and blackouts since early this year. The symptoms are described as noticeable in nature.;radiation therapy
brain_tumor_1632;Brain Tumor;73;M;Patient is experiencing balance issues and difficulty concentrating for the past 4 months. The symptoms are described as noticeable in nature.;close monitoring
brain_tumor_1633;Brain Tumor;23;F;Patient is experiencing speech problems and difficulty concentrating over the last few weeks. The symptoms are described as high-grade in nature.;chemotherapy
brain_tumor_1634;Brain Tumor;27;M;Patient is experiencing recurring seizures and speech problems over the last few weeks. The symptoms are described as moderate in nature.;chemotherapy
brain_tumor_1635;Brain Tumor;71;F;Patient is experiencing balance issues and difficulty concentrating over the last few weeks. The symptoms are described as significant in nature.;surgery
brain_tumor_1636;Brain Tumor;46;F;Patient is experiencing blackouts and balance issues over the last few weeks. The symptoms are described as significant in nature.;close monitoring
brain_tumor_1637;Brain Tumor;18;M;Patient is experiencing speech problems and blackouts for the past 4 months. The symptoms are described as moderate in nature.;close monitoring
brain_tumor_1638;Brain Tumor;18;F;Patient is experiencing difficulty concentrating and motor dysfunction since early this year. The symptoms are described as moderate in nature.;surgery
brain_tumor_1639;Brain Tumor;59;M;Patient is experiencing blackouts and nausea for the past 4 months. The symptoms are described as noticeable in nature.;close monitoring
brain_tumor_1640;Brain Tumor;21;M;Patient is experiencing speech problems and nausea over the last few weeks. The symptoms are described as severe in nature.;chemotherapy
brain_tumor_1641;Brain Tumor;41;F;Patient is experiencing blackouts and recurring seizures over the last few weeks. The symptoms are described as noticeable in nature.;close monitoring
brain_tumor_1642;Brain Tumor;62;F;Patient is experiencing nausea and balance issues since early this year. The symptoms are described as intense in nature.;radiation therapy
brain_tumor_1643;Brain Tumor;66;M;Patient is experiencing recurring seizures and nausea over the last few weeks. The symptoms are described as moderate in nature.;close monitoring
brain_tumor_1644;Brain Tumor;72;M;Patient is experiencing blackouts and difficulty concentrating since early this year. The symptoms are described as high-grade in nature.;chemotherapy
brain_tumor_1645;Brain Tumor;79;F;Patient is experiencing nausea and difficulty concentrating for the past 4 months. The symptoms are described as noticeable in nature.;surgery
brain_tumor_1646;Brain Tumor;84;F;Patient is experiencing motor dysfunction and recurring seizures since early this year. The symptoms are described as high-grade in nature.;radiation therapy
brain_tumor_1647;Brain Tumor;21;F;Patient is experiencing speech problems and blackouts for the past 4 months. The symptoms are described as noticeable in nature.;close monitoring
brain_tumor_1648;Brain Tumor;33;F;Patient is experiencing blackouts and motor dysfunction over the last few weeks. The symptoms are described as noticeable in nature.;radiation therapy
brain_tumor_1649;Brain Tumor;56;F;Patient is experiencing nausea and balance issues for the past 4 months. The symptoms are described as debilitating in nature.;close monitoring
brain_tumor_1650;Brain Tumor;65;M;Patient is experiencing balance issues and recurring seizures for the past 4 months. The symptoms are described as debilitating in nature.;radiation therapy
brain_tumor_1651;Brain Tumor;81;F;Patient is experiencing nausea and speech problems for the past 4 months. The symptoms are described as moderate in nature.;close monitoring
brain_tumor_1652;Brain Tumor;37;M;Patient is experiencing recurring seizures and balance issues for the past 4 months. The symptoms are described as debilitating in nature.;close monitoring
brain_tumor_1653;Brain Tumor;67;M;Patient is experiencing blackouts and motor dysfunction for the past 4 months. The symptoms are described as significant in nature.;surgery
brain_tumor_1654;Brain Tumor;62;F;Patient is experiencing recurring seizures and balance issues over the last few weeks. The symptoms are described as significant in nature.;surgery
brain_tumor_1655;Brain Tumor;24;F;Patient is experiencing motor dysfunction and blackouts over the last few weeks. The symptoms are described as significant in nature.;surgery
brain_tumor_1656;Brain Tumor;19;M;Patient is experiencing motor dysfunction and blackouts for the past 4 months. The symptoms are described as significant in nature.;chemotherapy
brain_tumor_1657;Brain Tumor;51;F;Patient is experiencing recurring seizures and speech problems over the last few weeks. The symptoms are described as severe in nature.;surgery
brain_tumor_1658;Brain Tumor;29;F;Patient is experiencing blackouts and difficulty concentrating for the past 4 months. The symptoms are described as significant in nature.;surgery
brain_tumor_1659;Brain Tumor;69;M;Patient is experiencing recurring seizures and difficulty concentrating for the past 4 months. The symptoms are described as high-grade in nature.;radiation therapy
brain_tumor_1660;Brain Tumor;41;F;Patient is experiencing speech problems and balance issues over the last few weeks. The symptoms are described as severe in nature.;chemotherapy
brain_tumor_1661;Brain Tumor;79;F;Patient is experiencing speech problems and balance issues for the past 4 months. The symptoms are described as severe in nature.;surgery
brain_tumor_1662;Brain Tumor;69;F;Patient is experiencing balance issues and recurring seizures since early this year. The symptoms are described as intense in nature.;surgery
brain_tumor_1663;Brain Tumor;59;F;Patient is experiencing difficulty concentrating and nausea since early this year. The symptoms are described as moderate in nature.;chemotherapy
brain_tumor_1664;Brain Tumor;39;M;Patient is experiencing recurring seizures and difficulty concentrating for the past 4 months. The symptoms are described as moderate in nature.;close monitoring
brain_tumor_1665;Brain Tumor;68;M;Patient is experiencing difficulty concentrating and recurring seizures over the last few weeks. The symptoms are described as significant in nature.;chemotherapy
brain_tumor_1666;Brain Tumor;38;M;Patient is experiencing motor dysfunction and difficulty concentrating since early this year. The symptoms are described as moderate in nature.;close monitoring
brain_tumor_1667;Brain Tumor;74;F;Patient is experiencing blackouts and speech problems over the last few weeks. The symptoms are described as moderate in nature.;close monitoring
brain_tumor_1668;Brain Tumor;28;M;Patient is experiencing difficulty concentrating and recurring seizures over the last few weeks. The symptoms are described as high-grade in nature.;surgery
brain_tumor_1669;Brain Tumor;30;F;Patient is experiencing balance issues and difficulty concentrating since early this year. The symptoms are described as debilitating in nature.;radiation therapy
brain_tumor_1670;Brain Tumor;18;M;Patient is experiencing nausea and recurring seizures since early this year. The symptoms are described as debilitating in nature.;close monitoring
brain_tumor_1671;Brain Tumor;45;M;Patient is experiencing balance issues and recurring seizures for the past 4 months. The symptoms are described as moderate in nature.;surgery
brain_tumor_1672;Brain Tumor;75;M;Patient is experiencing recurring seizures and motor dysfunction for the past 4 months. The symptoms are described as intense in nature.;radiation therapy
brain_tumor_1673;Brain Tumor;66;F;Patient is experiencing recurring seizures and motor dysfunction since early this year. The symptoms are described as debilitating in nature.;radiation therapy
brain_tumor_1674;Brain Tumor;45;M;Patient is experiencing speech problems and difficulty concentrating over the last few weeks. The symptoms are described as high-grade in nature.;radiation therapy
brain_tumor_1675;Brain Tumor;25;F;Patient is experiencing difficulty concentrating and balance issues since early this year. The symptoms are described as noticeable in nature.;chemotherapy
brain_tumor_1676;Brain Tumor;60;M;Patient is experiencing speech problems and recurring seizures over the last few weeks. The symptoms are described as intense in nature.;surgery
brain_tumor_1677;Brain Tumor;22;F;Patient is experiencing blackouts and speech problems over the last few weeks. The symptoms are described as moderate in nature.;close monitoring
brain_tumor_1678;Brain Tumor;59;F;Patient is experiencing recurring seizures and motor dysfunction since early this year. The symptoms are described as debilitating in nature.;radiation therapy
brain_tumor_1679;Brain Tumor;68;M;Patient is experiencing recurring seizures and speech problems for the past 4 months. The symptoms are described as moderate in nature.;radiation therapy
brain_tumor_1680;Brain Tumor;49;M;Patient is experiencing blackouts and recurring seizures since early this year. The symptoms are described as noticeable in nature.;close monitoring
brain_tumor_1681;Brain Tumor;22;F;Patient is experiencing recurring seizures and blackouts over the last few weeks. The symptoms are described as significant in nature.;close monitoring
brain_tumor_1682;Brain Tumor;79;M;Patient is experiencing nausea and recurring seizures for the past 4 months. The symptoms are described as high-grade in nature.;radiation therapy
brain_tumor_1683;Brain Tumor;77;F;Patient is experiencing blackouts and difficulty concentrating for the past 4 months. The symptoms are described as intense in nature.;radiation therapy
brain_tumor_1684;Brain Tumor;60;M;Patient is experiencing recurring seizures and nausea for the past 4 months. The symptoms are described as significant in nature.;surgery
brain_tumor_1685;Brain Tumor;40;F;Patient is experiencing blackouts and motor dysfunction since early this year. The symptoms are described as significant in nature.;chemotherapy
brain_tumor_1686;Brain Tumor;37;M;Patient is experiencing balance issues and recurring seizures over the last few weeks. The symptoms are described as significant in nature.;close monitoring
brain_tumor_1687;Brain Tumor;24;M;Patient is experiencing motor dysfunction and balance issues since early this year. The symptoms are described as noticeable in nature.;close monitoring
brain_tumor_1688;Brain Tumor;30;F;Patient is experiencing nausea and difficulty concentrating over the last few weeks. The symptoms are described as significant in nature.;close monitoring
brain_tumor_1689;Brain Tumor;55;F;Patient is experiencing recurring seizures and difficulty concentrating over the last few weeks. The symptoms are described as high-grade in nature.;chemotherapy
brain_tumor_1690;Brain Tumor;44;F;Patient is experiencing speech problems and blackouts over the last few weeks. The symptoms are described as noticeable in nature.;chemotherapy
brain_tumor_1691;Brain Tumor;37;M;Patient is experiencing difficulty concentrating and nausea over the last few weeks. The symptoms are described as noticeable in nature.;surgery
brain_tumor_1692;Brain Tumor;26;M;Patient is experiencing motor dysfunction and recurring seizures for the past 4 months. The symptoms are described as high-grade in nature.;radiation therapy
brain_tumor_1693;Brain Tumor;67;F;Patient is experiencing speech problems and difficulty concentrating for the past 4 months. The symptoms are described as severe in nature.;close monitoring
brain_tumor_1694;Brain Tumor;29;F;Patient is experiencing difficulty concentrating and recurring seizures over the last few weeks. The symptoms are described as significant in nature.;radiation therapy
brain_tumor_1695;Brain Tumor;34;M;Patient is experiencing blackouts and speech problems since early this year. The symptoms are described as significant in nature.;close monitoring
brain_tumor_1696;Brain Tumor;59;F;Patient is experiencing recurring seizures and difficulty concentrating since early this year. The symptoms are described as severe in nature.;close monitoring
brain_tumor_1697;Brain Tumor;81;M;Patient is experiencing speech problems and recurring seizures since early this year. The symptoms are described as debilitating in nature.;radiation therapy
brain_tumor_1698;Brain Tumor;35;F;Patient is experiencing blackouts and speech problems since early this year. The symptoms are described as debilitating in nature.;chemotherapy
brain_tumor_1699;Brain Tumor;74;F;Patient is experiencing motor dysfunction and recurring seizures since early this year. The symptoms are described as moderate in nature.;radiation therapy
brain_tumor_1700;Brain Tumor;60;F;Patient is experiencing nausea and motor dysfunction over the last few weeks. The symptoms are described as significant in nature.;chemotherapy
brain_tumor_1701;Brain Tumor;28;F;Patient is experiencing blackouts and difficulty concentrating since early this year. The symptoms are described as high-grade in nature.;chemotherapy
brain_tumor_1702;Brain Tumor;61;F;Patient is experiencing balance issues and motor dysfunction since early this year. The symptoms are described as moderate in nature.;radiation therapy
brain_tumor_1703;Brain Tumor;54;M;Patient is experiencing nausea and recurring seizures for the past 4 months. The symptoms are described as debilitating in nature.;close monitoring
brain_tumor_1704;Brain Tumor;25;M;Patient is experiencing motor dysfunction and nausea over the last few weeks. The symptoms are described as intense in nature.;close monitoring
brain_tumor_1705;Brain Tumor;38;F;Patient is experiencing recurring seizures and motor dysfunction since early this year. The symptoms are described as intense in nature.;radiation therapy
brain_tumor_1706;Brain Tumor;43;F;Patient is experiencing difficulty concentrating and speech problems for the past 4 months. The symptoms are described as severe in nature.;chemotherapy
brain_tumor_1707;Brain Tumor;25;M;Patient is experiencing speech problems and blackouts since early this year. The symptoms are described as debilitating in nature.;surgery
brain_tumor_1708;Brain Tumor;54;F;Patient is experiencing nausea and speech problems for the past 4 months. The symptoms are described as moderate in nature.;radiation therapy
brain_tumor_1709;Brain Tumor;33;F;Patient is experiencing recurring seizures and blackouts for the past 4 months. The symptoms are described as intense in nature.;surgery
brain_tumor_1710;Brain Tumor;57;M;Patient is experiencing difficulty concentrating and recurring seizures since early this year. The symptoms are described as intense in nature.;close monitoring
brain_tumor_1711;Brain Tumor;37;M;Patient is experiencing balance issues and motor dysfunction over the last few weeks. The symptoms are described as intense in nature.;close monitoring
brain_tumor_1712;Brain Tumor;37;M;Patient is experiencing speech problems and nausea over the last few weeks. The symptoms are described as moderate in nature.;surgery
brain_tumor_1713;Brain Tumor;71;F;Patient is experiencing blackouts and difficulty concentrating over the last few weeks. The symptoms are described as severe in nature.;chemotherapy
brain_tumor_1714;Brain Tumor;41;F;Patient is experiencing speech problems and nausea since early this year. The symptoms are described as moderate in nature.;surgery
brain_tumor_1715;Brain Tumor;47;F;Patient is experiencing recurring seizures and blackouts since early this year. The symptoms are described as debilitating in nature.;radiation therapy
brain_tumor_1716;Brain Tumor;46;M;Patient is experiencing recurring seizures and motor dysfunction over the last few weeks. The symptoms are described as debilitating in nature.;surgery
brain_tumor_1717;Brain Tumor;33;F;Patient is experiencing speech problems and blackouts over the last few weeks. The symptoms are described as debilitating in nature.;chemotherapy
brain_tumor_1718;Brain Tumor;22;F;Patient is experiencing recurring seizures and blackouts over the last few weeks. The symptoms are described as moderate in nature.;radiation therapy
brain_tumor_1719;Brain Tumor;52;M;Patient is experiencing speech problems and motor dysfunction over the last few weeks. The symptoms are described as moderate in nature.;surgery
brain_tumor_1720;Brain Tumor;84;M;Patient is experiencing motor dysfunction and balance issues over the last few weeks. The symptoms are described as high-grade in nature.;surgery
brain_tumor_1721;Brain Tumor;22;F;Patient is experiencing speech problems and difficulty concentrating over the last few weeks. The symptoms are described as noticeable in nature.;radiation therapy
brain_tumor_1722;Brain Tumor;51;M;Patient is experiencing motor dysfunction and recurring seizures over the last few weeks. The symptoms are described as severe in nature.;surgery
brain_tumor_1723;Brain Tumor;35;M;Patient is experiencing difficulty concentrating and recurring seizures over the last few weeks. The symptoms are described as high-grade in nature.;chemotherapy
brain_tumor_1724;Brain Tumor;65;F;Patient is experiencing recurring seizures and motor dysfunction over the last few weeks. The symptoms are described as high-grade in nature.;surgery
brain_tumor_1725;Brain Tumor;21;F;Patient is experiencing nausea and blackouts for the past 4 months. The symptoms are described as moderate in nature.;surgery
brain_tumor_1726;Brain Tumor;23;F;Patient is experiencing recurring seizures and speech problems over the last few weeks. The symptoms are described as severe in nature.;radiation therapy
brain_tumor_1727;Brain Tumor;27;F;Patient is experiencing difficulty concentrating and speech problems since early this year. The symptoms are described as moderate in nature.;chemotherapy
brain_tumor_1728;Brain Tumor;26;F;Patient is experiencing balance issues and motor dysfunction since early this year. The symptoms are described as intense in nature.;surgery
brain_tumor_1729;Brain Tumor;18;M;Patient is experiencing recurring seizures and blackouts for the past 4 months. The symptoms are described as significant in nature.;surgery
brain_tumor_1730;Brain Tumor;58;M;Patient is experiencing recurring seizures and balance issues since early this year. The symptoms are described as high-grade in nature.;close monitoring
brain_tumor_1731;Brain Tumor;26;M;Patient is experiencing blackouts and recurring seizures over the last few weeks. The symptoms are described as intense in nature.;radiation therapy
brain_tumor_1732;Brain Tumor;68;F;Patient is experiencing difficulty concentrating and blackouts over the last few weeks. The symptoms are described as noticeable in nature.;chemotherapy
brain_tumor_1733;Brain Tumor;71;M;Patient is experiencing motor dysfunction and speech problems since early this year. The symptoms are described as high-grade in nature.;radiation therapy
brain_tumor_1734;Brain Tumor;63;F;Patient is experiencing speech problems and balance issues over the last few weeks. The symptoms are described as moderate in nature.;radiation therapy
brain_tumor_1735;Brain Tumor;62;M;Patient is experiencing speech problems and nausea for the past 4 months. The symptoms are described as severe in nature.;radiation therapy
brain_tumor_1736;Brain Tumor;40;M;Patient is experiencing blackouts and speech problems for the past 4 months. The symptoms are described as noticeable in nature.;radiation therapy
brain_tumor_1737;Brain Tumor;37;M;Patient is experiencing nausea and recurring seizures since early this year. The symptoms are described as intense in nature.;close monitoring
brain_tumor_1738;Brain Tumor;59;F;Patient is experiencing balance issues and blackouts over the last few weeks. The symptoms are described as high-grade in nature.;chemotherapy
brain_tumor_1739;Brain Tumor;35;F;Patient is experiencing recurring seizures and nausea over the last few weeks. The symptoms are described as significant in nature.;close monitoring
brain_tumor_1740;Brain Tumor;82;M;Patient is experiencing motor dysfunction and balance issues since early this year. The symptoms are described as debilitating in nature.;surgery
brain_tumor_1741;Brain Tumor;38;M;Patient is experiencing balance issues and recurring seizures since early this year. The symptoms are described as debilitating in nature.;chemotherapy
brain_tumor_1742;Brain Tumor;83;M;Patient is experiencing speech problems and recurring seizures since early this year. The symptoms are described as high-grade in nature.;chemotherapy
brain_tumor_1743;Brain Tumor;19;M;Patient is experiencing difficulty concentrating and balance issues since early this year. The symptoms are described as significant in nature.;surgery
brain_tumor_1744;Brain Tumor;79;F;Patient is experiencing blackouts and motor dysfunction since early this year. The symptoms are described as high-grade in nature.;surgery
brain_tumor_1745;Brain Tumor;51;M;Patient is experiencing speech problems and blackouts over the last few weeks. The symptoms are described as moderate in nature.;close monitoring
brain_tumor_1746;Brain Tumor;55;F;Patient is experiencing speech problems and motor dysfunction for the past 4 months. The symptoms are described as noticeable in nature.;chemotherapy
brain_tumor_1747;Brain Tumor;82;M;Patient is experiencing recurring seizures and nausea for the past 4 months. The symptoms are described as significant in nature.;chemotherapy
brain_tumor_1748;Brain Tumor;24;M;Patient is experiencing nausea and motor dysfunction for the past 4 months. The symptoms are described as high-grade in nature.;surgery
brain_tumor_1749;Brain Tumor;36;M;Patient is experiencing blackouts and recurring seizures over the last few weeks. The symptoms are described as noticeable in nature.;close monitoring
brain_tumor_1750;Brain Tumor;38;M;Patient is experiencing nausea and blackouts for the past 4 months. The symptoms are described as severe in nature.;surgery
brain_tumor_1751;Brain Tumor;83;F;Patient is experiencing blackouts and nausea since early this year. The symptoms are described as moderate in nature.;surgery
brain_tumor_1752;Brain Tumor;29;F;Patient is experiencing blackouts and difficulty concentrating for the past 4 months. The symptoms are described as high-grade in nature.;close monitoring
brain_tumor_1753;Brain Tumor;60;F;Patient is experiencing recurring seizures and nausea for the past 4 months. The symptoms are described as high-grade in nature.;close monitoring
brain_tumor_1754;Brain Tumor;85;M;Patient is experiencing speech problems and nausea for the past 4 months. The symptoms are described as noticeable in nature.;close monitoring
brain_tumor_1755;Brain Tumor;33;M;Patient is experiencing motor dysfunction and balance issues since early this year. The symptoms are described as severe in nature.;radiation therapy
brain_tumor_1756;Brain Tumor;50;F;Patient is experiencing nausea and balance issues since early this year. The symptoms are described as intense in nature.;surgery
brain_tumor_1757;Brain Tumor;63;F;Patient is experiencing nausea and blackouts for the past 4 months. The symptoms are described as debilitating in nature.;radiation therapy
brain_tumor_1758;Brain Tumor;82;M;Patient is experiencing nausea and motor dysfunction for the past 4 months. The symptoms are described as debilitating in nature.;surgery
brain_tumor_1759;Brain Tumor;70;M;Patient is experiencing motor dysfunction and balance issues since early this year. The symptoms are described as high-grade in nature.;close monitoring
brain_tumor_1760;Brain Tumor;50;M;Patient is experiencing speech problems and recurring seizures for the past 4 months. The symptoms are described as significant in nature.;close monitoring
brain_tumor_1761;Brain Tumor;32;F;Patient is experiencing difficulty concentrating and blackouts for the past 4 months. The symptoms are described as noticeable in nature.;chemotherapy
brain_tumor_1762;Brain Tumor;51;M;Patient is experiencing nausea and difficulty concentrating for the past 4 months. The symptoms are described as debilitating in nature.;chemotherapy
brain_tumor_1763;Brain Tumor;33;M;Patient is experiencing recurring seizures and nausea over the last few weeks. The symptoms are described as debilitating in nature.;radiation therapy
brain_tumor_1764;Brain Tumor;64;M;Patient is experiencing blackouts and balance issues for the past 4 months. The symptoms are described as moderate in nature.;radiation therapy
brain_tumor_1765;Brain Tumor;34;M;Patient is experiencing blackouts and recurring seizures over the last few weeks. The symptoms are described as intense in nature.;close monitoring
brain_tumor_1766;Brain Tumor;72;M;Patient is experiencing difficulty concentrating and blackouts over the last few weeks. The symptoms are described as significant in nature.;surgery
brain_tumor_1767;Brain Tumor;53;F;Patient is experiencing difficulty concentrating and nausea for the past 4 months. The symptoms are described as significant in nature.;radiation therapy
brain_tumor_1768;Brain Tumor;33;F;Patient is experiencing recurring seizures and blackouts for the past 4 months. The symptoms are described as moderate in nature.;chemotherapy
brain_tumor_1769;Brain Tumor;47;F;Patient is experiencing nausea and motor dysfunction since early this year. The symptoms are described as moderate in nature.;chemotherapy
brain_tumor_1770;Brain Tumor;63;F;Patient is experiencing nausea and recurring seizures over the last few weeks. The symptoms are described as significant in nature.;radiation therapy
brain_tumor_1771;Brain Tumor;85;M;Patient is experiencing nausea and balance issues over the last few weeks. The symptoms are described as noticeable in nature.;close monitoring
brain_tumor_1772;Brain Tumor;51;M;Patient is experiencing blackouts and nausea for the past 4 months. The symptoms are described as severe in nature.;surgery
brain_tumor_1773;Brain Tumor;82;M;Patient is experiencing difficulty concentrating and motor dysfunction over the last few weeks. The symptoms are described as severe in nature.;close monitoring
brain_tumor_1774;Brain Tumor;57;M;Patient is experiencing motor dysfunction and speech problems over the last few weeks. The symptoms are described as moderate in nature.;chemotherapy
brain_tumor_1775;Brain Tumor;81;F;Patient is experiencing nausea and balance issues over the last few weeks. The symptoms are described as noticeable in nature.;close monitoring
brain_tumor_1776;Brain Tumor;83;F;Patient is experiencing difficulty concentrating and nausea over the last few weeks. The symptoms are described as noticeable in nature.;surgery
brain_tumor_1777;Brain Tumor;84;F;Patient is experiencing speech problems and blackouts for the past 4 months. The symptoms are described as debilitating in nature.;chemotherapy
brain_tumor_1778;Brain Tumor;55;M;Patient is experiencing motor dysfunction and recurring seizures since early this year. The symptoms are described as high-grade in nature.;surgery
brain_tumor_1779;Brain Tumor;22;F;Patient is experiencing nausea and balance issues since early this year. The symptoms are described as significant in nature.;close monitoring
brain_tumor_1780;Brain Tumor;44;F;Patient is experiencing motor dysfunction and difficulty concentrating since early this year. The symptoms are described as moderate in nature.;close monitoring
brain_tumor_1781;Brain Tumor;82;F;Patient is experiencing recurring seizures and nausea for the past 4 months. The symptoms are described as high-grade in nature.;close monitoring
brain_tumor_1782;Brain Tumor;60;F;Patient is experiencing speech problems and motor dysfunction since early this year. The symptoms are described as high-grade in nature.;close monitoring
brain_tumor_1783;Brain Tumor;29;M;Patient is experiencing speech problems and motor dysfunction since early this year. The symptoms are described as moderate in nature.;chemotherapy
brain_tumor_1784;Brain Tumor;25;F;Patient is experiencing difficulty concentrating and speech problems since early this year. The symptoms are described as moderate in nature.;radiation therapy
brain_tumor_1785;Brain Tumor;38;M;Patient is experiencing difficulty concentrating and nausea over the last few weeks. The symptoms are described as noticeable in nature.;radiation therapy
brain_tumor_1786;Brain Tumor;21;F;Patient is experiencing recurring seizures and speech problems for the past 4 months. The symptoms are described as debilitating in nature.;surgery
brain_tumor_1787;Brain Tumor;18;F;Patient is experiencing speech problems and blackouts since early this year. The symptoms are described as moderate in nature.;close monitoring
brain_tumor_1788;Brain Tumor;22;M;Patient is experiencing speech problems and motor dysfunction since early this year. The symptoms are described as debilitating in nature.;radiation therapy
brain_tumor_1789;Brain Tumor;44;M;Patient is experiencing balance issues and motor dysfunction since early this year. The symptoms are described as intense in nature.;close monitoring
brain_tumor_1790;Brain Tumor;65;F;Patient is experiencing motor dysfunction and speech problems since early this year. The symptoms are described as moderate in nature.;chemotherapy
brain_tumor_1791;Brain Tumor;81;M;Patient is experiencing nausea and speech problems for the past 4 months. The symptoms are described as severe in nature.;radiation therapy
brain_tumor_1792;Brain Tumor;57;M;Patient is experiencing speech problems and difficulty concentrating since early this year. The symptoms are described as significant in nature.;surgery
brain_tumor_1793;Brain Tumor;27;M;Patient is experiencing balance issues and motor dysfunction since early this year. The symptoms are described as high-grade in nature.;radiation therapy
brain_tumor_1794;Brain Tumor;49;M;Patient is experiencing nausea and blackouts since early this year. The symptoms are described as high-grade in nature.;radiation therapy
brain_tumor_1795;Brain Tumor;69;F;Patient is experiencing blackouts and balance issues since early this year. The symptoms are described as moderate in nature.;close monitoring
brain_tumor_1796;Brain Tumor;38;M;Patient is experiencing difficulty concentrating and nausea since early this year. The symptoms are described as significant in nature.;surgery
brain_tumor_1797;Brain Tumor;40;F;Patient is experiencing difficulty concentrating and motor dysfunction for the past 4 months. The symptoms are described as high-grade in nature.;radiation therapy
brain_tumor_1798;Brain Tumor;56;F;Patient is experiencing speech problems and nausea for the past 4 months. The symptoms are described as debilitating in nature.;radiation therapy
brain_tumor_1799;Brain Tumor;38;M;Patient is experiencing balance issues and nausea since early this year. The symptoms are described as moderate in nature.;chemotherapy
brain_tumor_1800;Brain Tumor;31;F;Patient is experiencing balance issues and recurring seizures since early this year. The symptoms are described as severe in nature.;radiation therapy
brain_tumor_1801;Brain Tumor;44;F;Patient is experiencing recurring seizures and balance issues since early this year. The symptoms are described as moderate in nature.;close monitoring
brain_tumor_1802;Brain Tumor;19;M;Patient is experiencing motor dysfunction and balance issues over the last few weeks. The symptoms are described as significant in nature.;chemotherapy
brain_tumor_1803;Brain Tumor;60;M;Patient is experiencing recurring seizures and difficulty concentrating for the past 4 months. The symptoms are described as moderate in nature.;surgery
brain_tumor_1804;Brain Tumor;61;M;Patient is experiencing balance issues and recurring seizures since early this year. The symptoms are described as moderate in nature.;close monitoring
brain_tumor_1805;Brain Tumor;28;M;Patient is experiencing motor dysfunction and blackouts for the past 4 months. The symptoms are described as noticeable in nature.;chemotherapy
brain_tumor_1806;Brain Tumor;24;M;Patient is experiencing motor dysfunction and balance issues over the last few weeks. The symptoms are described as significant in nature.;surgery
brain_tumor_1807;Brain Tumor;62;F;Patient is experiencing balance issues and recurring seizures over the last few weeks. The symptoms are described as high-grade in nature.;chemotherapy
brain_tumor_1808;Brain Tumor;45;M;Patient is experiencing difficulty concentrating and speech problems over the last few weeks. The symptoms are described as intense in nature.;radiation therapy
brain_tumor_1809;Brain Tumor;81;F;Patient is experiencing motor dysfunction and speech problems over the last few weeks. The symptoms are described as noticeable in nature.;close monitoring
brain_tumor_1810;Brain Tumor;80;F;Patient is experiencing nausea and balance issues for the past 4 months. The symptoms are described as debilitating in nature.;radiation therapy
brain_tumor_1811;Brain Tumor;63;M;Patient is experiencing blackouts and speech problems over the last few weeks. The symptoms are described as noticeable in nature.;surgery
brain_tumor_1812;Brain Tumor;28;F;Patient is experiencing nausea and speech problems over the last few weeks. The symptoms are described as significant in nature.;radiation therapy
brain_tumor_1813;Brain Tumor;31;F;Patient is experiencing motor dysfunction and speech problems since early this year. The symptoms are described as debilitating in nature.;close monitoring
brain_tumor_1814;Brain Tumor;82;M;Patient is experiencing motor dysfunction and balance issues over the last few weeks. The symptoms are described as moderate in nature.;chemotherapy
brain_tumor_1815;Brain Tumor;61;F;Patient is experiencing nausea and balance issues since early this year. The symptoms are described as high-grade in nature.;surgery
brain_tumor_1816;Brain Tumor;64;M;Patient is experiencing blackouts and motor dysfunction over the last few weeks. The symptoms are described as significant in nature.;close monitoring
brain_tumor_1817;Brain Tumor;42;M;Patient is experiencing nausea and recurring seizures for the past 4 months. The symptoms are described as noticeable in nature.;close monitoring
brain_tumor_1818;Brain Tumor;25;M;Patient is experiencing speech problems and difficulty concentrating over the last few weeks. The symptoms are described as high-grade in nature.;surgery
brain_tumor_1819;Brain Tumor;52;F;Patient is experiencing nausea and speech problems for the past 4 months. The symptoms are described as debilitating in nature.;surgery
brain_tumor_1820;Brain Tumor;67;F;Patient is experiencing speech problems and motor dysfunction over the last few weeks. The symptoms are described as moderate in nature.;radiation therapy
brain_tumor_1821;Brain Tumor;35;F;Patient is experiencing nausea and recurring seizures since early this year. The symptoms are described as intense in nature.;close monitoring
brain_tumor_1822;Brain Tumor;27;F;Patient is experiencing motor dysfunction and difficulty concentrating since early this year. The symptoms are described as severe in nature.;close monitoring
brain_tumor_1823;Brain Tumor;77;M;Patient is experiencing speech problems and balance issues over the last few weeks. The symptoms are described as significant in nature.;close monitoring
brain_tumor_1824;Brain Tumor;81;M;Patient is experiencing balance issues and nausea for the past 4 months. The symptoms are described as debilitating in nature.;close monitoring
brain_tumor_1825;Brain Tumor;28;F;Patient is experiencing blackouts and nausea for the past 4 months. The symptoms are described as significant in nature.;close monitoring
brain_tumor_1826;Brain Tumor;36;F;Patient is experiencing blackouts and speech problems for the past 4 months. The symptoms are described as significant in nature.;close monitoring
brain_tumor_1827;Brain Tumor;75;M;Patient is experiencing nausea and difficulty concentrating since early this year. The symptoms are described as significant in nature.;radiation therapy
brain_tumor_1828;Brain Tumor;57;F;Patient is experiencing motor dysfunction and speech problems since early this year. The symptoms are described as significant in nature.;close monitoring
brain_tumor_1829;Brain Tumor;73;F;Patient is experiencing recurring seizures and blackouts for the past 4 months. The symptoms are described as noticeable in nature.;chemotherapy
brain_tumor_1830;Brain Tumor;18;M;Patient is experiencing nausea and difficulty concentrating for the past 4 months. The symptoms are described as severe in nature.;close monitoring
brain_tumor_1831;Brain Tumor;76;F;Patient is experiencing speech problems and motor dysfunction since early this year. The symptoms are described as debilitating in nature.;close monitoring
brain_tumor_1832;Brain Tumor;80;M;Patient is experiencing blackouts and motor dysfunction over the last few weeks. The symptoms are described as debilitating in nature.;surgery
brain_tumor_1833;Brain Tumor;82;M;Patient is experiencing recurring seizures and speech problems since early this year. The symptoms are described as moderate in nature.;close monitoring
brain_tumor_1834;Brain Tumor;80;F;Patient is experiencing nausea and balance issues since early this year. The symptoms are described as moderate in nature.;close monitoring
brain_tumor_1835;Brain Tumor;83;M;Patient is experiencing blackouts and speech problems for the past 4 months. The symptoms are described as significant in nature.;close monitoring
brain_tumor_1836;Brain Tumor;51;M;Patient is experiencing balance issues and speech problems since early this year. The symptoms are described as noticeable in nature.;radiation therapy
brain_tumor_1837;Brain Tumor;24;M;Patient is experiencing balance issues and blackouts since early this year. The symptoms are described as significant in nature.;surgery
brain_tumor_1838;Brain Tumor;29;F;Patient is experiencing nausea and difficulty concentrating over the last few weeks. The symptoms are described as noticeable in nature.;chemotherapy
brain_tumor_1839;Brain Tumor;77;F;Patient is experiencing difficulty concentrating and recurring seizures for the past 4 months. The symptoms are described as significant in nature.;chemotherapy
brain_tumor_1840;Brain Tumor;80;M;Patient is experiencing nausea and difficulty concentrating over the last few weeks. The symptoms are described as moderate in nature.;radiation therapy
brain_tumor_1841;Brain Tumor;24;M;Patient is experiencing speech problems and recurring seizures since early this year. The symptoms are described as intense in nature.;close monitoring
brain_tumor_1842;Brain Tumor;60;M;Patient is experiencing nausea and balance issues for the past 4 months. The symptoms are described as severe in nature.;radiation therapy
brain_tumor_1843;Brain Tumor;36;F;Patient is experiencing motor dysfunction and speech problems since early this year. The symptoms are described as significant in nature.;close monitoring
brain_tumor_1844;Brain Tumor;35;M;Patient is experiencing blackouts and nausea over the last few weeks. The symptoms are described as moderate in nature.;chemotherapy
brain_tumor_1845;Brain Tumor;22;F;Patient is experiencing difficulty concentrating and balance issues for the past 4 months. The symptoms are described as moderate in nature.;surgery
brain_tumor_1846;Brain Tumor;24;M;Patient is experiencing speech problems and blackouts for the past 4 months. The symptoms are described as noticeable in nature.;close monitoring
brain_tumor_1847;Brain Tumor;58;M;Patient is experiencing recurring seizures and nausea for the past 4 months. The symptoms are described as severe in nature.;radiation therapy
brain_tumor_1848;Brain Tumor;77;F;Patient is experiencing balance issues and motor dysfunction for the past 4 months. The symptoms are described as intense in nature.;surgery
brain_tumor_1849;Brain Tumor;72;F;Patient is experiencing motor dysfunction and nausea since early this year. The symptoms are described as intense in nature.;close monitoring
brain_tumor_1850;Brain Tumor;55;F;Patient is experiencing blackouts and motor dysfunction for the past 4 months. The symptoms are described as noticeable in nature.;close monitoring
brain_tumor_1851;Brain Tumor;78;F;Patient is experiencing recurring seizures and blackouts over the last few weeks. The symptoms are described as noticeable in nature.;surgery
brain_tumor_1852;Brain Tumor;32;F;Patient is experiencing recurring seizures and blackouts since early this year. The symptoms are described as moderate in nature.;surgery
brain_tumor_1853;Brain Tumor;32;M;Patient is experiencing recurring seizures and balance issues for the past 4 months. The symptoms are described as significant in nature.;chemotherapy
brain_tumor_1854;Brain Tumor;57;F;Patient is experiencing balance issues and blackouts for the past 4 months. The symptoms are described as noticeable in nature.;radiation therapy
brain_tumor_1855;Brain Tumor;35;M;Patient is experiencing motor dysfunction and speech problems since early this year. The symptoms are described as intense in nature.;surgery
brain_tumor_1856;Brain Tumor;61;M;Patient is experiencing blackouts and speech problems over the last few weeks. The symptoms are described as high-grade in nature.;radiation therapy
brain_tumor_1857;Brain Tumor;77;M;Patient is experiencing recurring seizures and balance issues for the past 4 months. The symptoms are described as debilitating in nature.;close monitoring
brain_tumor_1858;Brain Tumor;21;M;Patient is experiencing balance issues and speech problems over the last few weeks. The symptoms are described as significant in nature.;chemotherapy
brain_tumor_1859;Brain Tumor;82;F;Patient is experiencing motor dysfunction and balance issues over the last few weeks. The symptoms are described as moderate in nature.;radiation therapy
brain_tumor_1860;Brain Tumor;38;M;Patient is experiencing recurring seizures and difficulty concentrating over the last few weeks. The symptoms are described as debilitating in nature.;radiation therapy
brain_tumor_1861;Brain Tumor;38;M;Patient is experiencing blackouts and difficulty concentrating over the last few weeks. The symptoms are described as moderate in nature.;surgery
brain_tumor_1862;Brain Tumor;36;F;Patient is experiencing motor dysfunction and nausea since early this year. The symptoms are described as high-grade in nature.;close monitoring
brain_tumor_1863;Brain Tumor;30;M;Patient is experiencing balance issues and recurring seizures for the past 4 months. The symptoms are described as noticeable in nature.;radiation therapy
brain_tumor_1864;Brain Tumor;36;F;Patient is experiencing balance issues and recurring seizures since early this year. The symptoms are described as significant in nature.;radiation therapy
brain_tumor_1865;Brain Tumor;36;F;Patient is experiencing recurring seizures and speech problems for the past 4 months. The symptoms are described as significant in nature.;close monitoring
brain_tumor_1866;Brain Tumor;63;F;Patient is experiencing blackouts and nausea since early this year. The symptoms are described as severe in nature.;chemotherapy
brain_tumor_1867;Brain Tumor;72;F;Patient is experiencing motor dysfunction and blackouts since early this year. The symptoms are described as severe in nature.;close monitoring
brain_tumor_1868;Brain Tumor;40;M;Patient is experiencing balance issues and recurring seizures for the past 4 months. The symptoms are described as severe in nature.;surgery
brain_tumor_1869;Brain Tumor;28;M;Patient is experiencing blackouts and nausea over the last few weeks. The symptoms are described as high-grade in nature.;surgery
brain_tumor_1870;Brain Tumor;27;F;Patient is experiencing balance issues and speech problems since early this year. The symptoms are described as significant in nature.;radiation therapy
brain_tumor_1871;Brain Tumor;68;M;Patient is experiencing difficulty concentrating and speech problems for the past 4 months. The symptoms are described as intense in nature.;close monitoring
brain_tumor_1872;Brain Tumor;27;M;Patient is experiencing nausea and speech problems over the last few weeks. The symptoms are described as debilitating in nature.;close monitoring
brain_tumor_1873;Brain Tumor;85;F;Patient is experiencing difficulty concentrating and motor dysfunction since early this year. The symptoms are described as high-grade in nature.;surgery
brain_tumor_1874;Brain Tumor;70;F;Patient is experiencing motor dysfunction and speech problems since early this year. The symptoms are described as high-grade in nature.;close monitoring
brain_tumor_1875;Brain Tumor;60;M;Patient is experiencing balance issues and blackouts for the past 4 months. The symptoms are described as intense in nature.;chemotherapy
brain_tumor_1876;Brain Tumor;59;M;Patient is experiencing motor dysfunction and speech problems since early this year. The symptoms are described as intense in nature.;surgery
brain_tumor_1877;Brain Tumor;29;F;Patient is experiencing speech problems and difficulty concentrating since early this year. The symptoms are described as severe in nature.;radiation therapy
brain_tumor_1878;Brain Tumor;67;M;Patient is experiencing recurring seizures and nausea over the last few weeks. The symptoms are described as noticeable in nature.;chemotherapy
brain_tumor_1879;Brain Tumor;59;M;Patient is experiencing blackouts and recurring seizures for the past 4 months. The symptoms are described as significant in nature.;radiation therapy
brain_tumor_1880;Brain Tumor;19;M;Patient is experiencing recurring seizures and speech problems for the past 4 months. The symptoms are described as noticeable in nature.;surgery
brain_tumor_1881;Brain Tumor;82;F;Patient is experiencing speech problems and difficulty concentrating for the past 4 months. The symptoms are described as moderate in nature.;radiation therapy
brain_tumor_1882;Brain Tumor;32;F;Patient is experiencing nausea and blackouts for the past 4 months. The symptoms are described as significant in nature.;surgery
brain_tumor_1883;Brain Tumor;77;M;Patient is experiencing difficulty concentrating and recurring seizures for the past 4 months. The symptoms are described as severe in nature.;close monitoring
brain_tumor_1884;Brain Tumor;43;M;Patient is experiencing speech problems and recurring seizures since early this year. The symptoms are described as noticeable in nature.;radiation therapy
brain_tumor_1885;Brain Tumor;43;F;Patient is experiencing difficulty concentrating and speech problems for the past 4 months. The symptoms are described as noticeable in nature.;surgery
brain_tumor_1886;Brain Tumor;20;F;Patient is experiencing speech problems and motor dysfunction for the past 4 months. The symptoms are described as intense in nature.;close monitoring
brain_tumor_1887;Brain Tumor;71;M;Patient is experiencing speech problems and difficulty concentrating over the last few weeks. The symptoms are described as high-grade in nature.;close monitoring
brain_tumor_1888;Brain Tumor;50;F;Patient is experiencing balance issues and nausea for the past 4 months. The symptoms are described as intense in nature.;surgery
brain_tumor_1889;Brain Tumor;39;F;Patient is experiencing balance issues and difficulty concentrating over the last few weeks. The symptoms are described as debilitating in nature.;chemotherapy
brain_tumor_1890;Brain Tumor;50;F;Patient is experiencing blackouts and balance issues since early this year. The symptoms are described as moderate in nature.;chemotherapy
brain_tumor_1891;Brain Tumor;61;F;Patient is experiencing speech problems and nausea for the past 4 months. The symptoms are described as severe in nature.;radiation therapy
brain_tumor_1892;Brain Tumor;49;F;Patient is experiencing recurring seizures and motor dysfunction over the last few weeks. The symptoms are described as significant in nature.;surgery
brain_tumor_1893;Brain Tumor;64;F;Patient is experiencing speech problems and motor dysfunction since early this year. The symptoms are described as debilitating in nature.;radiation therapy
brain_tumor_1894;Brain Tumor;41;F;Patient is experiencing speech problems and nausea over the last few weeks. The symptoms are described as moderate in nature.;surgery
brain_tumor_1895;Brain Tumor;22;F;Patient is experiencing speech problems and nausea for the past 4 months. The symptoms are described as intense in nature.;surgery
brain_tumor_1896;Brain Tumor;23;F;Patient is experiencing nausea and recurring seizures since early this year. The symptoms are described as moderate in nature.;chemotherapy
brain_tumor_1897;Brain Tumor;29;M;Patient is experiencing speech problems and blackouts since early this year. The symptoms are described as severe in nature.;surgery
brain_tumor_1898;Brain Tumor;73;M;Patient is experiencing motor dysfunction and difficulty concentrating since early this year. The symptoms are described as noticeable in nature.;radiation therapy
brain_tumor_1899;Brain Tumor;59;F;Patient is experiencing blackouts and recurring seizures for the past 4 months. The symptoms are described as significant in nature.;chemotherapy
brain_tumor_1900;Brain Tumor;22;M;Patient is experiencing nausea and motor dysfunction over the last few weeks. The symptoms are described as high-grade in nature.;radiation therapy
brain_tumor_1901;Brain Tumor;38;F;Patient is experiencing nausea and recurring seizures over the last few weeks. The symptoms are described as severe in nature.;close monitoring
brain_tumor_1902;Brain Tumor;35;M;Patient is experiencing nausea and motor dysfunction since early this year. The symptoms are described as debilitating in nature.;chemotherapy
brain_tumor_1903;Brain Tumor;49;F;Patient is experiencing blackouts and motor dysfunction since early this year. The symptoms are described as intense in nature.;radiation therapy
brain_tumor_1904;Brain Tumor;74;F;Patient is experiencing motor dysfunction and blackouts since early this year. The symptoms are described as severe in nature.;surgery
brain_tumor_1905;Brain Tumor;78;M;Patient is experiencing motor dysfunction and nausea over the last few weeks. The symptoms are described as severe in nature.;chemotherapy
brain_tumor_1906;Brain Tumor;51;M;Patient is experiencing blackouts and motor dysfunction for the past 4 months. The symptoms are described as noticeable in nature.;chemotherapy
brain_tumor_1907;Brain Tumor;74;F;Patient is experiencing motor dysfunction and recurring seizures since early this year. The symptoms are described as significant in nature.;close monitoring
brain_tumor_1908;Brain Tumor;65;F;Patient is experiencing nausea and difficulty concentrating for the past 4 months. The symptoms are described as moderate in nature.;surgery
brain_tumor_1909;Brain Tumor;33;F;Patient is experiencing blackouts and motor dysfunction since early this year. The symptoms are described as debilitating in nature.;radiation therapy
brain_tumor_1910;Brain Tumor;61;F;Patient is experiencing motor dysfunction and recurring seizures over the last few weeks. The symptoms are described as high-grade in nature.;radiation therapy
brain_tumor_1911;Brain Tumor;41;M;Patient is experiencing balance issues and speech problems since early this year. The symptoms are described as significant in nature.;close monitoring
brain_tumor_1912;Brain Tumor;71;F;Patient is experiencing recurring seizures and speech problems since early this year. The symptoms are described as noticeable in nature.;surgery
brain_tumor_1913;Brain Tumor;54;M;Patient is experiencing recurring seizures and blackouts since early this year. The symptoms are described as debilitating in nature.;close monitoring
brain_tumor_1914;Brain Tumor;44;F;Patient is experiencing speech problems and motor dysfunction since early this year. The symptoms are described as severe in nature.;surgery
brain_tumor_1915;Brain Tumor;37;M;Patient is experiencing balance issues and recurring seizures for the past 4 months. The symptoms are described as debilitating in nature.;chemotherapy
brain_tumor_1916;Brain Tumor;53;F;Patient is experiencing blackouts and motor dysfunction since early this year. The symptoms are described as significant in nature.;radiation therapy
brain_tumor_1917;Brain Tumor;77;M;Patient is experiencing difficulty concentrating and balance issues over the last few weeks. The symptoms are described as moderate in nature.;surgery
brain_tumor_1918;Brain Tumor;24;M;Patient is experiencing recurring seizures and nausea over the last few weeks. The symptoms are described as moderate in nature.;surgery
brain_tumor_1919;Brain Tumor;56;F;Patient is experiencing difficulty concentrating and speech problems for the past 4 months. The symptoms are described as significant in nature.;chemotherapy
brain_tumor_1920;Brain Tumor;53;F;Patient is experiencing nausea and speech problems over the last few weeks. The symptoms are described as intense in nature.;radiation therapy
brain_tumor_1921;Brain Tumor;49;F;Patient is experiencing balance issues and recurring seizures over the last few weeks. The symptoms are described as intense in nature.;radiation therapy
brain_tumor_1922;Brain Tumor;83;M;Patient is experiencing recurring seizures and blackouts over the last few weeks. The symptoms are described as significant in nature.;radiation therapy
brain_tumor_1923;Brain Tumor;41;M;Patient is experiencing motor dysfunction and difficulty concentrating over the last few weeks. The symptoms are described as noticeable in nature.;chemotherapy
brain_tumor_1924;Brain Tumor;40;M;Patient is experiencing speech problems and nausea over the last few weeks. The symptoms are described as severe in nature.;chemotherapy
brain_tumor_1925;Brain Tumor;68;F;Patient is experiencing speech problems and recurring seizures over the last few weeks. The symptoms are described as severe in nature.;surgery
brain_tumor_1926;Brain Tumor;26;F;Patient is experiencing nausea and speech problems since early this year. The symptoms are described as moderate in nature.;chemotherapy
brain_tumor_1927;Brain Tumor;62;M;Patient is experiencing recurring seizures and nausea since early this year. The symptoms are described as noticeable in nature.;surgery
brain_tumor_1928;Brain Tumor;33;F;Patient is experiencing difficulty concentrating and balance issues since early this year. The symptoms are described as noticeable in nature.;close monitoring
brain_tumor_1929;Brain Tumor;22;M;Patient is experiencing recurring seizures and nausea for the past 4 months. The symptoms are described as debilitating in nature.;surgery
brain_tumor_1930;Brain Tumor;46;M;Patient is experiencing difficulty concentrating and nausea over the last few weeks. The symptoms are described as debilitating in nature.;surgery
brain_tumor_1931;Brain Tumor;22;F;Patient is experiencing balance issues and motor dysfunction over the last few weeks. The symptoms are described as intense in nature.;chemotherapy
brain_tumor_1932;Brain Tumor;59;F;Patient is experiencing difficulty concentrating and motor dysfunction for the past 4 months. The symptoms are described as significant in nature.;radiation therapy
brain_tumor_1933;Brain Tumor;76;F;Patient is experiencing nausea and balance issues since early this year. The symptoms are described as significant in nature.;surgery
brain_tumor_1934;Brain Tumor;19;M;Patient is experiencing speech problems and recurring seizures for the past 4 months. The symptoms are described as high-grade in nature.;close monitoring
brain_tumor_1935;Brain Tumor;67;M;Patient is experiencing blackouts and nausea over the last few weeks. The symptoms are described as noticeable in nature.;chemotherapy
brain_tumor_1936;Brain Tumor;84;F;Patient is experiencing balance issues and motor dysfunction for the past 4 months. The symptoms are described as severe in nature.;radiation therapy
brain_tumor_1937;Brain Tumor;77;F;Patient is experiencing difficulty concentrating and balance issues over the last few weeks. The symptoms are described as high-grade in nature.;surgery
brain_tumor_1938;Brain Tumor;85;M;Patient is experiencing nausea and recurring seizures for the past 4 months. The symptoms are described as moderate in nature.;surgery
brain_tumor_1939;Brain Tumor;30;M;Patient is experiencing difficulty concentrating and motor dysfunction for the past 4 months. The symptoms are described as intense in nature.;close monitoring
brain_tumor_1940;Brain Tumor;18;F;Patient is experiencing nausea and blackouts over the last few weeks. The symptoms are described as debilitating in nature.;chemotherapy
brain_tumor_1941;Brain Tumor;36;M;Patient is experiencing difficulty concentrating and nausea for the past 4 months. The symptoms are described as debilitating in nature.;close monitoring
brain_tumor_1942;Brain Tumor;55;M;Patient is experiencing recurring seizures and nausea over the last few weeks. The symptoms are described as moderate in nature.;surgery
brain_tumor_1943;Brain Tumor;43;F;Patient is experiencing difficulty concentrating and blackouts over the last few weeks. The symptoms are described as high-grade in nature.;chemotherapy
brain_tumor_1944;Brain Tumor;32;M;Patient is experiencing balance issues and motor dysfunction for the past 4 months. The symptoms are described as high-grade in nature.;chemotherapy
brain_tumor_1945;Brain Tumor;19;F;Patient is experiencing speech problems and recurring seizures over the last few weeks. The symptoms are described as noticeable in nature.;surgery
brain_tumor_1946;Brain Tumor;67;M;Patient is experiencing blackouts and nausea since early this year. The symptoms are described as debilitating in nature.;chemotherapy
brain_tumor_1947;Brain Tumor;33;F;Patient is experiencing difficulty concentrating and balance issues over the last few weeks. The symptoms are described as noticeable in nature.;surgery
brain_tumor_1948;Brain Tumor;31;F;Patient is experiencing recurring seizures and blackouts over the last few weeks. The symptoms are described as severe in nature.;close monitoring
brain_tumor_1949;Brain Tumor;57;F;Patient is experiencing recurring seizures and nausea since early this year. The symptoms are described as high-grade in nature.;surgery
brain_tumor_1950;Brain Tumor;85;F;Patient is experiencing blackouts and nausea for the past 4 months. The symptoms are described as debilitating in nature.;chemotherapy
brain_tumor_1951;Brain Tumor;36;F;Patient is experiencing recurring seizures and nausea for the past 4 months. The symptoms are described as severe in nature.;radiation therapy
brain_tumor_1952;Brain Tumor;27;F;Patient is experiencing balance issues and blackouts over the last few weeks. The symptoms are described as high-grade in nature.;surgery
brain_tumor_1953;Brain Tumor;77;F;Patient is experiencing blackouts and recurring seizures for the past 4 months. The symptoms are described as debilitating in nature.;surgery
brain_tumor_1954;Brain Tumor;44;F;Patient is experiencing blackouts and recurring seizures over the last few weeks. The symptoms are described as moderate in nature.;close monitoring
brain_tumor_1955;Brain Tumor;74;F;Patient is experiencing nausea and balance issues for the past 4 months. The symptoms are described as noticeable in nature.;chemotherapy
brain_tumor_1956;Brain Tumor;82;F;Patient is experiencing blackouts and speech problems for the past 4 months. The symptoms are described as noticeable in nature.;radiation therapy
brain_tumor_1957;Brain Tumor;64;F;Patient is experiencing motor dysfunction and balance issues for the past 4 months. The symptoms are described as noticeable in nature.;surgery
brain_tumor_1958;Brain Tumor;76;M;Patient is experiencing nausea and difficulty concentrating for the past 4 months. The symptoms are described as high-grade in nature.;chemotherapy
brain_tumor_1959;Brain Tumor;25;M;Patient is experiencing recurring seizures and balance issues over the last few weeks. The symptoms are described as noticeable in nature.;surgery
brain_tumor_1960;Brain Tumor;26;M;Patient is experiencing nausea and blackouts for the past 4 months. The symptoms are described as severe in nature.;surgery
brain_tumor_1961;Brain Tumor;23;M;Patient is experiencing recurring seizures and difficulty concentrating over the last few weeks. The symptoms are described as debilitating in nature.;radiation therapy
brain_tumor_1962;Brain Tumor;75;M;Patient is experiencing balance issues and blackouts for the past 4 months. The symptoms are described as significant in nature.;close monitoring
brain_tumor_1963;Brain Tumor;78;M;Patient is experiencing speech problems and motor dysfunction for the past 4 months. The symptoms are described as debilitating in nature.;surgery
brain_tumor_1964;Brain Tumor;63;M;Patient is experiencing speech problems and motor dysfunction for the past 4 months. The symptoms are described as significant in nature.;chemotherapy
brain_tumor_1965;Brain Tumor;71;F;Patient is experiencing speech problems and blackouts since early this year. The symptoms are described as moderate in nature.;chemotherapy
brain_tumor_1966;Brain Tumor;79;M;Patient is experiencing difficulty concentrating and nausea since early this year. The symptoms are described as severe in nature.;surgery
brain_tumor_1967;Brain Tumor;69;M;Patient is experiencing speech problems and nausea for the past 4 months. The symptoms are described as significant in nature.;radiation therapy
brain_tumor_1968;Brain Tumor;54;M;Patient is experiencing speech problems and difficulty concentrating over the last few weeks. The symptoms are described as significant in nature.;chemotherapy
brain_tumor_1969;Brain Tumor;56;F;Patient is experiencing nausea and difficulty concentrating since early this year. The symptoms are described as noticeable in nature.;close monitoring
brain_tumor_1970;Brain Tumor;75;M;Patient is experiencing balance issues and nausea for the past 4 months. The symptoms are described as severe in nature.;chemotherapy
brain_tumor_1971;Brain Tumor;85;M;Patient is experiencing balance issues and difficulty concentrating for the past 4 months. The symptoms are described as high-grade in nature.;radiation therapy
brain_tumor_1972;Brain Tumor;41;F;Patient is experiencing difficulty concentrating and speech problems over the last few weeks. The symptoms are described as debilitating in nature.;close monitoring
brain_tumor_1973;Brain Tumor;75;M;Patient is experiencing nausea and recurring seizures since early this year. The symptoms are described as high-grade in nature.;close monitoring
brain_tumor_1974;Brain Tumor;32;M;Patient is experiencing recurring seizures and speech problems over the last few weeks. The symptoms are described as noticeable in nature.;chemotherapy
brain_tumor_1975;Brain Tumor;45;M;Patient is experiencing difficulty concentrating and nausea over the last few weeks. The symptoms are described as noticeable in nature.;surgery
brain_tumor_1976;Brain Tumor;30;M;Patient is experiencing motor dysfunction and speech problems since early this year. The symptoms are described as noticeable in nature.;radiation therapy
brain_tumor_1977;Brain Tumor;45;F;Patient is experiencing recurring seizures and motor dysfunction for the past 4 months. The symptoms are described as moderate in nature.;surgery
brain_tumor_1978;Brain Tumor;34;F;Patient is experiencing balance issues and nausea since early this year. The symptoms are described as moderate in nature.;chemotherapy
brain_tumor_1979;Brain Tumor;80;F;Patient is experiencing balance issues and recurring seizures over the last few weeks. The symptoms are described as moderate in nature.;close monitoring
brain_tumor_1980;Brain Tumor;46;F;Patient is experiencing motor dysfunction and recurring seizures since early this year. The symptoms are described as moderate in nature.;chemotherapy
brain_tumor_1981;Brain Tumor;57;M;Patient is experiencing speech problems and nausea since early this year. The symptoms are described as noticeable in nature.;surgery
brain_tumor_1982;Brain Tumor;60;F;Patient is experiencing speech problems and difficulty concentrating since early this year. The symptoms are described as significant in nature.;chemotherapy
brain_tumor_1983;Brain Tumor;45;M;Patient is experiencing nausea and recurring seizures for the past 4 months. The symptoms are described as intense in nature.;chemotherapy
brain_tumor_1984;Brain Tumor;28;F;Patient is experiencing blackouts and difficulty concentrating for the past 4 months. The symptoms are described as intense in nature.;radiation therapy
brain_tumor_1985;Brain Tumor;19;F;Patient is experiencing recurring seizures and motor dysfunction since early this year. The symptoms are described as debilitating in nature.;chemotherapy
brain_tumor_1986;Brain Tumor;76;M;Patient is experiencing nausea and difficulty concentrating since early this year. The symptoms are described as significant in nature.;surgery
brain_tumor_1987;Brain Tumor;67;M;Patient is experiencing blackouts and motor dysfunction for the past 4 months. The symptoms are described as significant in nature.;surgery
brain_tumor_1988;Brain Tumor;42;M;Patient is experiencing blackouts and nausea over the last few weeks. The symptoms are described as noticeable in nature.;chemotherapy
brain_tumor_1989;Brain Tumor;72;F;Patient is experiencing speech problems and balance issues over the last few weeks. The symptoms are described as intense in nature.;close monitoring
brain_tumor_1990;Brain Tumor;72;F;Patient is experiencing blackouts and motor dysfunction for the past 4 months. The symptoms are described as high-grade in nature.;close monitoring
brain_tumor_1991;Brain Tumor;31;M;Patient is experiencing speech problems and difficulty concentrating over the last few weeks. The symptoms are described as debilitating in nature.;radiation therapy
brain_tumor_1992;Brain Tumor;38;F;Patient is experiencing balance issues and motor dysfunction since early this year. The symptoms are described as moderate in nature.;surgery
brain_tumor_1993;Brain Tumor;57;M;Patient is experiencing blackouts and difficulty concentrating for the past 4 months. The symptoms are described as severe in nature.;surgery
brain_tumor_1994;Brain Tumor;34;F;Patient is experiencing balance issues and nausea over the last few weeks. The symptoms are described as moderate in nature.;close monitoring
brain_tumor_1995;Brain Tumor;66;F;Patient is experiencing speech problems and blackouts since early this year. The symptoms are described as intense in nature.;surgery
brain_tumor_1996;Brain Tumor;36;F;Patient is experiencing blackouts and nausea since early this year. The symptoms are described as significant in nature.;close monitoring
brain_tumor_1997;Brain Tumor;38;M;Patient is experiencing motor dysfunction and nausea over the last few weeks. The symptoms are described as severe in nature.;surgery
brain_tumor_1998;Brain Tumor;60;F;Patient is experiencing nausea and blackouts since early this year. The symptoms are described as debilitating in nature.;chemotherapy
brain_tumor_1999;Brain Tumor;51;M;Patient is experiencing nausea and blackouts over the last few weeks. The symptoms are described as moderate in nature.;chemotherapy
brain_tumor_2000;Brain Tumor;18;F;Patient is experiencing speech problems and recurring seizures over the last few weeks. The symptoms are described as high-grade in nature.;close monitoring
brain_tumor_2001;Brain Tumor;78;M;Patient is experiencing motor dysfunction and nausea over the last few weeks. The symptoms are described as moderate in nature.;radiation therapy
brain_tumor_2002;Brain Tumor;55;M;Patient is experiencing recurring seizures and motor dysfunction for the past 4 months. The symptoms are described as debilitating in nature.;chemotherapy
brain_tumor_2003;Brain Tumor;49;F;Patient is experiencing balance issues and speech problems over the last few weeks. The symptoms are described as noticeable in nature.;close monitoring
brain_tumor_2004;Brain Tumor;49;M;Patient is experiencing nausea and balance issues since early this year. The symptoms are described as severe in nature.;close monitoring
;Brain Tumor;24;F;Patient is experiencing balance issues and recurring seizures since early this year. The symptoms are described as moderate in nature.;close monitoring
;Brain Tumor;68;M;Patient is experiencing blackouts and motor dysfunction for the past 4 months. The symptoms are described as noticeable in nature.;chemotherapy
;Brain Tumor;72;M;Patient is experiencing recurring seizures and balance issues since early this year. The symptoms are described as moderate in nature.;radiation therapy
;Brain Tumor;18;F;Patient is experiencing nausea and recurring seizures over the last few weeks. The symptoms are described as moderate in nature.;surgery
;Brain Tumor;37;F;Patient is experiencing balance issues and nausea for the past 4 months. The symptoms are described as debilitating in nature.;surgery
;Brain Tumor;51;M;Patient is experiencing recurring seizures and nausea since early this year. The symptoms are described as significant in nature.;surgery
;Brain Tumor;19;F;Patient is experiencing balance issues and nausea since early this year. The symptoms are described as intense in nature.;close monitoring
;Brain Tumor;48;M;Patient is experiencing motor dysfunction and blackouts over the last few weeks. The symptoms are described as debilitating in nature.;radiation therapy
;Brain Tumor;32;M;Patient is experiencing speech problems and motor dysfunction since early this year. The symptoms are described as significant in nature.;radiation therapy
;Brain Tumor;85;M;Patient is experiencing difficulty concentrating and recurring seizures over the last few weeks. The symptoms are described as moderate in nature.;chemotherapy
;Brain Tumor;32;F;Patient is experiencing recurring seizures and speech problems over the last few weeks. The symptoms are described as intense in nature.;radiation therapy
;Brain Tumor;68;M;Patient is experiencing motor dysfunction and recurring seizures over the last few weeks. The symptoms are described as noticeable in nature.;surgery
;Brain Tumor;37;F;Patient is experiencing nausea and speech problems for the past 4 months. The symptoms are described as severe in nature.;chemotherapy
;Brain Tumor;54;M;Patient is experiencing balance issues and nausea for the past 4 months. The symptoms are described as debilitating in nature.;surgery
;Brain Tumor;45;M;Patient is experiencing recurring seizures and motor dysfunction for the past 4 months. The symptoms are described as high-grade in nature.;close monitoring
;Brain Tumor;52;F;Patient is experiencing nausea and balance issues since early this year. The symptoms are described as noticeable in nature.;chemotherapy
;Brain Tumor;40;M;Patient is experiencing nausea and recurring seizures over the last few weeks. The symptoms are described as high-grade in nature.;chemotherapy
;Brain Tumor;47;F;Patient is experiencing motor dysfunction and speech problems since early this year. The symptoms are described as significant in nature.;chemotherapy
;Brain Tumor;41;M;Patient is experiencing nausea and recurring seizures over the last few weeks. The symptoms are described as significant in nature.;radiation therapy
;Brain Tumor;85;F;Patient is experiencing blackouts and recurring seizures for the past 4 months. The symptoms are described as severe in nature.;radiation therapy
;Brain Tumor;68;F;Patient is experiencing balance issues and blackouts for the past 4 months. The symptoms are described as moderate in nature.;surgery
;Brain Tumor;38;M;Patient is experiencing difficulty concentrating and speech problems over the last few weeks. The symptoms are described as significant in nature.;chemotherapy
;Brain Tumor;48;M;Patient is experiencing balance issues and motor dysfunction over the last few weeks. The symptoms are described as significant in nature.;close monitoring
;Brain Tumor;77;M;Patient is experiencing difficulty concentrating and motor dysfunction for the past 4 months. The symptoms are described as severe in nature.;chemotherapy
;Brain Tumor;29;M;Patient is experiencing nausea and speech problems since early this year. The symptoms are described as debilitating in nature.;close monitoring
;Brain Tumor;69;M;Patient is experiencing speech problems and difficulty concentrating since early this year. The symptoms are described as intense in nature.;surgery
;Brain Tumor;45;F;Patient is experiencing difficulty concentrating and nausea for the past 4 months. The symptoms are described as noticeable in nature.;close monitoring
;Brain Tumor;52;M;Patient is experiencing speech problems and blackouts since early this year. The symptoms are described as intense in nature.;radiation therapy
;Brain Tumor;22;F;Patient is experiencing blackouts and difficulty concentrating since early this year. The symptoms are described as noticeable in nature.;radiation therapy
;Brain Tumor;56;F;Patient is experiencing blackouts and motor dysfunction over the last few weeks. The symptoms are described as noticeable in nature.;close monitoring
;Brain Tumor;81;M;Patient is experiencing nausea and blackouts since early this year. The symptoms are described as significant in nature.;surgery
;Brain Tumor;26;F;Patient is experiencing balance issues and blackouts since early this year. The symptoms are described as intense in nature.;radiation therapy
;Brain Tumor;54;F;Patient is experiencing difficulty concentrating and balance issues since early this year. The symptoms are described as significant in nature.;radiation therapy
;Brain Tumor;70;M;Patient is experiencing balance issues and blackouts since early this year. The symptoms are described as high-grade in nature.;close monitoring
;Brain Tumor;41;M;Patient is experiencing nausea and difficulty concentrating over the last few weeks. The symptoms are described as intense in nature.;surgery
;Brain Tumor;42;M;Patient is experiencing difficulty concentrating and nausea since early this year. The symptoms are described as moderate in nature.;surgery
;Brain Tumor;83;M;Patient is experiencing blackouts and nausea over the last few weeks. The symptoms are described as debilitating in nature.;surgery
;Brain Tumor;40;M;Patient is experiencing nausea and recurring seizures for the past 4 months. The symptoms are described as intense in nature.;radiation therapy
;Brain Tumor;58;F;Patient is experiencing balance issues and speech problems since early this year. The symptoms are described as intense in nature.;close monitoring
;Brain Tumor;52;F;Patient is experiencing speech problems and balance issues over the last few weeks. The symptoms are described as intense in nature.;radiation therapy
;Brain Tumor;49;F;Patient is experiencing nausea and difficulty concentrating over the last few weeks. The symptoms are described as noticeable in nature.;surgery
;Brain Tumor;38;F;Patient is experiencing nausea and balance issues for the past 4 months. The symptoms are described as noticeable in nature.;close monitoring
;Brain Tumor;65;M;Patient is experiencing balance issues and difficulty concentrating for the past 4 months. The symptoms are described as moderate in nature.;radiation therapy
;Brain Tumor;84;F;Patient is experiencing nausea and recurring seizures since early this year. The symptoms are described as significant in nature.;radiation therapy